data_5lxk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5lxk _Structure_validation_residue.Date_analyzed 2017-07-28 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.429 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.428 -1.56 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.3 m -172.57 173.38 4.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.48 -51.56 2.06 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 120.412 1.46 . . . . 0.0 112.263 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.3 t -170.6 142.66 2.07 Favored 'General case' 0 C--N 1.363 1.18 0 O-C-N 119.415 -2.053 . . . . 0.0 114.339 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.6 118.78 19.62 Favored 'General case' 0 C--N 1.377 1.772 0 O-C-N 121.417 -0.802 . . . . 0.0 109.887 167.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -105.87 114.91 29.35 Favored 'General case' 0 C--N 1.376 1.746 0 O-C-N 120.459 -1.401 . . . . 0.0 109.18 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 86' ' ' GLU . 9.8 p -150.93 173.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.688 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.249 -175.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.441 ' O ' HG21 ' A' ' 85' ' ' VAL . 99.0 mt-10 -79.96 143.51 34.1 Favored 'General case' 0 C--N 1.369 1.456 0 C-N-CA 127.259 2.224 . . . . 0.0 105.432 157.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.433 5.1 pt-20 -44.21 122.88 3.15 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 117.338 -3.352 . . . . 0.0 118.626 -166.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.0 51.75 0.12 Allowed Glycine 0 C--N 1.352 1.467 0 C-N-CA 128.908 3.147 . . . . 0.0 110.741 -163.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.76 162.34 22.96 Favored 'General case' 0 C--N 1.375 1.689 0 C-N-CA 124.957 1.303 . . . . 0.0 112.339 171.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.91 105.87 14.43 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 124.628 1.171 . . . . 0.0 111.635 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.252 2.3 mp -119.73 129.88 54.72 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -173.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.87 137.93 51.39 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 166.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.432 HD13 ' CD1' ' A' ' 136' ' ' TYR . 3.9 mm? -113.69 115.62 28.15 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 102.104 -3.295 . . . . 0.0 102.104 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.429 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 2.5 t -154.62 132.47 11.52 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 120.933 1.697 . . . . 0.0 114.098 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 m -150.22 174.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.011 1 C-N-CA 133.643 4.777 . . . . 0.0 106.822 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.0 t -104.36 141.73 35.8 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 127.637 2.375 . . . . 0.0 106.734 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.2 145.95 39.93 Favored 'General case' 0 C--N 1.379 1.856 1 N-CA-C 123.228 4.529 . . . . 0.0 123.228 -174.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.4 p -156.58 175.49 13.97 Favored 'General case' 0 C--N 1.365 1.248 1 C-N-CA 133.34 4.656 . . . . 0.0 104.391 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.51 42.11 1.02 Allowed Glycine 0 C--N 1.365 2.162 0 O-C-N 119.802 -1.811 . . . . 0.0 117.318 168.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.18 28.35 28.28 Favored Glycine 0 C--N 1.361 1.966 0 C-N-CA 127.616 2.531 . . . . 0.0 115.412 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.453 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 59.3 m -117.67 110.88 18.42 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 114.217 -2.801 . . . . 0.0 108.453 174.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.617 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.91 -86.21 0.56 Allowed Glycine 0 C--N 1.38 3.007 0 C-N-CA 129.249 3.309 . . . . 0.0 110.389 -176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 101' ' ' THR . 20.0 Cg_exo -59.88 168.38 5.83 Favored 'Trans proline' 0 CA--C 1.57 2.312 1 C-N-CA 126.164 4.576 . . . . 0.0 115.676 158.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.512 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 77.7 m-85 -106.31 146.09 30.83 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 119.892 3.293 . . . . 0.0 119.892 -163.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.9 t -103.34 142.65 33.85 Favored 'General case' 0 C--N 1.38 1.928 0 C-N-CA 127.879 2.472 . . . . 0.0 104.358 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.43 165.4 27.5 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 122.783 4.364 . . . . 0.0 122.783 -161.555 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.42 119.06 18.09 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 128.265 2.626 . . . . 0.0 105.083 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -109.62 136.41 49.02 Favored 'General case' 0 C--N 1.368 1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 110.55 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.91 169.87 18.25 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 122.717 1.246 . . . . 0.0 107.69 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.485 ' HZ3' ' HH ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -144.73 105.64 4.17 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 175.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.16 1.8 t70 35.05 52.95 0.66 Allowed 'General case' 0 C--N 1.377 1.785 1 N-CA-C 122.307 4.188 . . . . 0.0 122.307 139.829 . . . . . . . . 4 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.45 -4.77 85.86 Favored Glycine 0 C--N 1.369 2.384 2 O-C-N 133.53 6.769 . . . . 0.0 119.206 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.269 3.5 m -124.45 147.46 55.42 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 129.532 3.133 . . . . 0.0 118.329 -171.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.01 145.05 84.46 Favored 'Trans proline' 0 N--CA 1.493 1.498 1 C-N-CA 125.882 4.388 . . . . 0.0 114.722 171.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.09 159.04 30.57 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 118.739 -2.476 . . . . 0.0 112.244 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -67.42 87.73 0.33 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 125.247 3.965 . . . . 0.0 116.177 -175.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 74.62 -57.22 0.62 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 127.372 2.269 . . . . 0.0 115.425 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 74.13 174.83 0.26 Allowed 'General case' 0 CA--C 1.482 -1.657 0 C-N-CA 130.189 3.396 . . . . 0.0 116.494 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.6 71.87 0.09 Allowed 'General case' 0 C--N 1.356 0.867 0 CA-C-N 114.114 -1.403 . . . . 0.0 114.735 171.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.42 -67.92 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 117.382 1.713 . . . . 0.0 117.382 -172.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 150.32 -69.86 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 126.503 1.921 . . . . 0.0 106.74 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.284 13.6 t -135.38 109.87 8.51 Favored 'General case' 0 C--N 1.363 1.153 0 CA-C-O 123.35 1.548 . . . . 0.0 113.878 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.368 9.1 p90 -127.23 142.12 51.56 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 129.473 3.109 . . . . 0.0 112.716 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.5 m -128.28 139.57 52.35 Favored 'General case' 0 C--N 1.366 1.288 0 O-C-N 119.323 -2.11 . . . . 0.0 110.305 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.415 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -110.54 100.23 44.33 Favored Pre-proline 0 C--N 1.366 1.324 0 C-N-CA 128.708 2.803 . . . . 0.0 106.411 175.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.26 -17.1 15.11 Favored 'Trans proline' 0 C--N 1.353 0.814 1 C-N-CA 126.096 4.531 . . . . 0.0 114.061 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 52.4 m -156.11 102.48 2.14 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 102.596 -3.113 . . . . 0.0 102.596 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.79 133.33 34.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.623 1.969 . . . . 0.0 111.499 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.5 -179.52 4.92 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.193 2.597 . . . . 0.0 111.027 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.02 -49.0 32.57 Favored 'General case' 0 C--N 1.366 1.305 0 N-CA-C 119.194 3.035 . . . . 0.0 119.194 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.35 -10.26 57.11 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 126.335 1.854 . . . . 0.0 114.53 173.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.366 48.7 m-20 -80.41 -18.31 49.26 Favored 'General case' 0 CA--C 1.572 1.793 0 C-N-CA 129.581 3.152 . . . . 0.0 111.84 168.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.64 126.49 29.1 Favored 'General case' 0 C--N 1.387 2.212 0 N-CA-C 119.536 3.161 . . . . 0.0 119.536 168.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 160.44 -157.5 28.89 Favored Glycine 0 CA--C 1.459 -3.446 0 C-N-CA 127.117 2.294 . . . . 0.0 109.694 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 m -120.63 129.7 53.84 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 115.004 -2.679 . . . . 0.0 108.235 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.485 ' HH ' ' HZ3' ' A' ' 110' ' ' LYS 0.274 30.1 m-85 -95.21 134.85 37.5 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 130.163 3.385 . . . . 0.0 111.651 -170.083 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -147.02 153.87 40.54 Favored 'General case' 0 C--N 1.369 1.429 0 C-N-CA 125.509 1.524 . . . . 0.0 108.202 -173.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.43 2.4 p -143.58 134.3 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 117.677 -1.609 . . . . 0.0 114.339 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.42 109.22 21.01 Favored 'General case' 0 C--N 1.385 2.132 0 C-N-CA 129.669 3.188 . . . . 0.0 106.345 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.7 118.62 49.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 C-N-CA 125.482 1.513 . . . . 0.0 111.037 -168.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 11.1 m -104.32 130.86 52.14 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 120.451 -1.406 . . . . 0.0 113.552 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.512 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.344 18.9 p-10 -124.99 -176.58 3.59 Favored 'General case' 0 C--N 1.379 1.853 0 C-N-CA 124.312 1.045 . . . . 0.0 111.909 175.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.617 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 6.2 p -48.84 2.73 0.01 OUTLIER 'General case' 0 C--N 1.372 1.574 1 C-N-CA 137.428 6.291 . . . . 0.0 119.867 -168.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.76 4.29 35.04 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 118.16 -1.416 . . . . 0.0 107.678 163.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.435 93.6 mm-40 65.54 40.3 4.63 Favored 'General case' 0 C--N 1.374 1.662 1 C-N-CA 132.736 4.414 . . . . 0.0 110.783 -172.164 . . . . . . . . 3 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 141' ' ' THR . 3.1 m -112.9 129.36 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 CA-C-N 111.944 -2.389 . . . . 0.0 112.201 -171.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.19 124.12 35.16 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 127.68 2.392 . . . . 0.0 108.205 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 157.43 25.23 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 128.308 2.643 . . . . 0.0 105.375 -173.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -121.46 132.09 54.53 Favored 'General case' 0 C--N 1.358 0.943 0 CA-C-O 124.611 2.148 . . . . 0.0 108.892 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 51.1 m -108.26 147.84 30.85 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 111.509 -2.587 . . . . 0.0 106.942 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.5 m -52.95 146.92 10.05 Favored 'General case' 0 CA--C 1.49 -1.36 1 C-N-CA 135.012 5.325 . . . . 0.0 119.477 -159.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.1 p -70.69 111.04 5.86 Favored 'General case' 0 C--N 1.368 1.403 0 C-N-CA 127.317 2.247 . . . . 0.0 109.321 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.74 110.46 22.77 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 102.214 -3.254 . . . . 0.0 102.214 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.24 113.37 25.6 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 123.247 1.499 . . . . 0.0 112.092 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.67 128.39 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 O-C-N 119.99 -1.694 . . . . 0.0 109.281 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 102.508 -3.145 . . . . 0.0 102.508 178.267 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.571 1.785 0 CA-C-O 120.828 0.347 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.0 m -161.93 172.0 16.75 Favored 'General case' 0 C--N 1.347 0.465 0 O-C-N 116.835 -3.666 . . . . 0.0 103.856 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.72 -43.24 1.0 Allowed 'General case' 0 C--N 1.363 1.187 0 C-N-CA 126.792 2.037 . . . . 0.0 113.359 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.2 p -172.24 127.98 0.57 Allowed 'General case' 0 C--N 1.366 1.319 0 N-CA-C 118.426 2.751 . . . . 0.0 118.426 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.7 tpt -142.4 116.12 9.21 Favored 'General case' 0 C--N 1.377 1.785 0 CA-C-N 120.985 1.721 . . . . 0.0 109.909 162.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.4 p -112.81 116.39 29.99 Favored 'General case' 0 C--N 1.364 1.201 0 O-C-N 118.719 -2.488 . . . . 0.0 110.178 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.59 172.04 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 125.951 1.7 . . . . 0.0 110.331 -170.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -83.27 130.21 35.06 Favored 'General case' 0 C--N 1.373 1.615 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 164.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -41.73 122.4 1.99 Allowed 'General case' 0 C--N 1.372 1.555 0 N-CA-C 120.469 3.507 . . . . 0.0 120.469 -151.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 145.57 45.75 0.04 OUTLIER Glycine 0 C--N 1.363 2.052 0 CA-C-N 110.292 -3.14 . . . . 0.0 110.993 -166.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.64 165.7 17.71 Favored 'General case' 0 C--N 1.375 1.712 0 C-N-CA 125.336 1.454 . . . . 0.0 113.527 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.99 105.68 14.16 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 124.525 1.13 . . . . 0.0 110.85 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 mp -119.58 119.92 35.19 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.87 1.668 . . . . 0.0 114.388 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.87 127.04 53.69 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 173.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -123.78 114.73 20.29 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 173.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.9 m -151.18 132.94 14.96 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 119.63 -1.919 . . . . 0.0 110.909 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 m -148.97 175.18 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.406 0 C-N-CA 130.423 3.489 . . . . 0.0 104.605 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -104.24 139.39 39.33 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 127.511 2.324 . . . . 0.0 105.555 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.59 137.03 31.62 Favored 'General case' 0 C--N 1.379 1.891 1 N-CA-C 122.502 4.26 . . . . 0.0 122.502 -173.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.1 p -156.52 174.72 15.02 Favored 'General case' 0 C--N 1.359 0.991 1 C-N-CA 133.904 4.882 . . . . 0.0 101.25 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.66 40.7 1.37 Allowed Glycine 0 C--N 1.363 2.076 0 N-CA-C 118.102 2.001 . . . . 0.0 118.102 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.53 25.1 28.93 Favored Glycine 0 C--N 1.36 1.91 0 C-N-CA 127.8 2.619 . . . . 0.0 114.458 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.448 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 29.8 p -116.55 110.32 18.4 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 113.089 -3.339 . . . . 0.0 107.876 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.645 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 69.13 -86.93 0.23 Allowed Glycine 0 C--N 1.382 3.089 0 C-N-CA 130.014 3.674 . . . . 0.0 111.117 -170.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 101' ' ' THR . 37.3 Cg_exo -59.91 168.88 5.2 Favored 'Trans proline' 0 CA--C 1.571 2.37 1 C-N-CA 127.514 5.476 . . . . 0.0 116.957 160.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 66.8 m-85 -98.6 144.27 28.08 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 119.758 3.244 . . . . 0.0 119.758 -167.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 t -102.51 159.16 15.68 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -157.17 166.32 33.55 Favored 'General case' 0 C--N 1.365 1.255 0 N-CA-C 120.508 3.521 . . . . 0.0 120.508 -164.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.84 112.5 10.08 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 128.398 2.679 . . . . 0.0 105.846 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -112.64 142.73 44.89 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 125.346 1.458 . . . . 0.0 108.041 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.29 0.0 OUTLIER -158.25 161.36 37.74 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 166.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.549 ' HZ3' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -133.01 103.89 6.27 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 116.717 -1.993 . . . . 0.0 115.873 177.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.406 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.226 1.7 t70 36.99 54.68 1.21 Allowed 'General case' 0 CA--C 1.455 -2.68 1 CA-C-O 111.111 -4.28 . . . . 0.0 119.918 154.075 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.11 -15.28 58.03 Favored Glycine 0 C--N 1.369 2.365 2 O-C-N 134.153 7.158 . . . . 0.0 116.681 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.271 26.6 m -124.23 148.92 59.27 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 129.863 3.265 . . . . 0.0 116.909 -167.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.32 155.86 43.99 Favored 'Trans proline' 0 N--CA 1.502 2.01 1 C-N-CA 126.644 4.896 . . . . 0.0 116.323 171.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.58 147.53 34.56 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 119.539 -1.976 . . . . 0.0 110.162 174.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.418 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 1.6 Cg_endo -58.8 -76.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.919 1 C-N-CA 126.504 4.802 . . . . 0.0 120.377 -165.274 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -141.54 64.75 1.4 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.83 -172.72 4.13 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 126.788 2.035 . . . . 0.0 115.498 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.309 8.4 t 101.79 13.13 0.01 OUTLIER 'General case' 0 C--N 1.354 0.783 0 C-N-CA 129.076 2.95 . . . . 0.0 111.825 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.81 96.75 0.1 Allowed Glycine 0 CA--C 1.475 -2.431 0 C-N-CA 116.733 -2.651 . . . . 0.0 117.687 166.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.481 . . 84.26 -84.52 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 170.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.9 t -138.92 121.1 15.8 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 122.316 2.325 . . . . 0.0 115.609 -170.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.418 ' CD2' ' HG2' ' A' ' 116' ' ' PRO . 29.2 p90 -127.66 139.69 52.56 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 127.638 2.375 . . . . 0.0 110.745 173.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 35.1 m -129.76 139.91 51.18 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 119.33 -2.106 . . . . 0.0 109.774 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.35 98.04 41.92 Favored Pre-proline 0 C--N 1.363 1.159 0 C-N-CA 127.638 2.375 . . . . 0.0 107.316 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.12 -16.5 15.69 Favored 'Trans proline' 0 C--N 1.363 1.31 1 C-N-CA 126.635 4.89 . . . . 0.0 113.83 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -161.69 104.32 1.21 Allowed 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 102.426 -3.176 . . . . 0.0 102.426 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.74 134.37 34.47 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 128.382 2.673 . . . . 0.0 113.082 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.2 176.92 6.76 Favored 'General case' 0 C--N 1.37 1.473 0 C-N-CA 128.193 2.597 . . . . 0.0 111.031 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.9 -48.59 31.45 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 -172.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.8 -12.3 60.31 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 126.493 1.917 . . . . 0.0 114.65 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.549 ' HA ' ' HZ3' ' A' ' 110' ' ' LYS 0.354 32.0 m-20 -80.84 -18.64 46.77 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 129.873 3.269 . . . . 0.0 111.977 169.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.79 133.31 46.43 Favored 'General case' 0 C--N 1.379 1.882 0 N-CA-C 119.448 3.129 . . . . 0.0 119.448 166.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.47 -157.08 29.16 Favored Glycine 0 CA--C 1.461 -3.341 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 170.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.412 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.31 19.2 m -114.0 134.76 54.64 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 114.632 -2.827 . . . . 0.0 107.33 170.229 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.455 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 9.2 m-85 -96.66 133.5 41.11 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 122.014 2.188 . . . . 0.0 113.351 -172.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -140.95 145.6 36.25 Favored 'General case' 0 C--N 1.37 1.477 0 O-C-N 124.035 0.834 . . . . 0.0 109.458 -173.435 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.326 7.6 p -144.94 136.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.37 1.495 0 C-N-CA 118.289 -1.364 . . . . 0.0 113.834 176.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -104.31 118.05 35.68 Favored 'General case' 0 C--N 1.375 1.692 0 C-N-CA 130.081 3.352 . . . . 0.0 106.755 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.41 126.08 65.03 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 C-N-CA 127.572 2.349 . . . . 0.0 113.108 -173.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.3 m -117.24 133.68 55.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 119.401 -2.062 . . . . 0.0 113.883 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.425 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.344 29.3 p-10 -126.46 -177.76 4.1 Favored 'General case' 0 C--N 1.376 1.725 0 CA-C-N 120.301 1.41 . . . . 0.0 112.798 174.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.645 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 66.2 p -49.64 3.75 0.01 OUTLIER 'General case' 0 C--N 1.366 1.324 1 C-N-CA 137.082 6.153 . . . . 0.0 121.01 -170.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -100.73 4.63 43.22 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 163.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.378 1.9 mp0 65.23 39.77 5.25 Favored 'General case' 0 C--N 1.379 1.86 1 C-N-CA 133.46 4.704 . . . . 0.0 110.783 -174.239 . . . . . . . . 3 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.0 m -113.11 127.81 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 CA-C-N 111.541 -2.572 . . . . 0.0 110.974 -169.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.71 128.13 37.42 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 126.982 2.113 . . . . 0.0 107.735 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.75 156.15 27.68 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 128.083 2.553 . . . . 0.0 104.577 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -130.62 146.48 52.13 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.69 -1.256 . . . . 0.0 109.688 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.5 p -129.71 142.95 50.62 Favored 'General case' 0 C--O 1.253 1.24 0 C-N-CA 123.173 0.589 . . . . 0.0 111.627 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 m -54.57 147.24 14.66 Favored 'General case' 0 C--N 1.376 1.758 2 C-N-CA 136.582 5.953 . . . . 0.0 117.108 -163.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.3 p -68.14 110.76 4.13 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 129.754 3.222 . . . . 0.0 109.844 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.08 108.75 21.55 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -93.96 106.9 18.86 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-O 124.324 2.012 . . . . 0.0 110.838 -172.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.52 126.81 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 O-C-N 120.675 -1.266 . . . . 0.0 108.11 -173.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.5 m . . . . . 0 CA--C 1.483 -1.618 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.817 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.422 ' H ' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.578 2.02 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.0 m -172.04 179.53 2.64 Favored 'General case' 0 N--CA 1.468 0.434 1 N-CA-C 99.647 -4.205 . . . . 0.0 99.647 173.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.51 -48.69 1.17 Allowed 'General case' 0 C--N 1.355 0.838 0 CA-C-N 121.508 1.958 . . . . 0.0 108.773 169.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.4 t -172.07 134.52 0.75 Allowed 'General case' 0 C--N 1.356 0.876 0 O-C-N 120.396 -1.44 . . . . 0.0 113.106 174.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 54.5 ttm -134.36 116.91 15.77 Favored 'General case' 0 C--N 1.369 1.446 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 162.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 p -108.57 115.36 29.95 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 119.727 -1.858 . . . . 0.0 107.327 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 86' ' ' GLU . 13.7 p -149.62 174.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 125.88 1.672 . . . . 0.0 111.857 -165.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 85' ' ' VAL . 7.5 mp0 -79.22 134.2 36.67 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 126.959 2.104 . . . . 0.0 105.689 161.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.39 0.0 OUTLIER -43.63 122.88 2.87 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 -164.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 135.0 52.53 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 128.372 2.892 . . . . 0.0 107.654 -165.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.75 153.23 19.76 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 126.577 1.951 . . . . 0.0 108.932 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.15 110.72 21.68 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -166.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.8 mt -120.62 144.44 48.14 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -126.86 138.51 53.34 Favored 'General case' 0 CA--C 1.506 -0.734 1 N-CA-C 100.165 -4.013 . . . . 0.0 100.165 166.347 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mp -121.86 113.95 20.36 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 100.608 -3.849 . . . . 0.0 100.608 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.402 ' H ' HD22 ' A' ' 79' ' ' LEU . 4.0 t -150.33 133.4 16.16 Favored 'General case' 0 C--N 1.369 1.423 0 CA-C-N 119.568 1.077 . . . . 0.0 112.717 -173.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.76 173.94 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.879 1 C-N-CA 132.191 4.196 . . . . 0.0 104.396 175.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.2 t -103.0 141.81 35.17 Favored 'General case' 0 C--N 1.367 1.334 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.5 140.87 46.5 Favored 'General case' 0 C--N 1.368 1.408 1 N-CA-C 122.285 4.18 . . . . 0.0 122.285 -171.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.0 m -158.24 174.26 15.44 Favored 'General case' 0 C--N 1.357 0.891 0 C-N-CA 130.797 3.639 . . . . 0.0 102.222 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.82 43.7 2.2 Favored Glycine 0 C--N 1.365 2.16 0 CA-C-N 122.763 2.529 . . . . 0.0 116.714 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.52 21.33 62.28 Favored Glycine 0 C--N 1.359 1.832 0 C-N-CA 128.413 2.911 . . . . 0.0 114.082 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.7 p -117.1 110.94 18.82 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.271 1.829 . . . . 0.0 108.457 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.708 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.34 -96.64 1.02 Allowed Glycine 0 C--N 1.371 2.488 0 C-N-CA 127.943 2.687 . . . . 0.0 110.985 -168.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.98 169.22 10.78 Favored 'Trans proline' 0 CA--C 1.556 1.579 1 C-N-CA 127.258 5.305 . . . . 0.0 116.855 159.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 58.5 m-85 -92.1 148.07 22.46 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 120.782 3.623 . . . . 0.0 120.782 -168.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -102.84 141.45 35.63 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 129.097 2.959 . . . . 0.0 104.439 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.72 159.47 30.81 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 120.076 3.361 . . . . 0.0 120.076 -166.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.0 117.53 20.19 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 101.865 -3.383 . . . . 0.0 101.865 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -107.23 134.76 49.85 Favored 'General case' 0 C--N 1.363 1.176 0 C-N-CA 124.664 1.185 . . . . 0.0 109.073 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.7 170.31 19.52 Favored 'General case' 0 CA--C 1.487 -1.451 0 O-C-N 120.34 -1.475 . . . . 0.0 108.311 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.435 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.5 ptmm? -148.32 106.46 3.73 Favored 'General case' 0 N--CA 1.423 -1.795 0 O-C-N 119.643 -1.91 . . . . 0.0 108.45 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.456 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.213 0.9 OUTLIER 35.27 54.31 0.77 Allowed 'General case' 0 CA--C 1.47 -2.114 2 CA-C-O 109.472 -5.061 . . . . 0.0 122.73 146.212 . . . . . . . . 5 4 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.55 -0.42 85.45 Favored Glycine 0 C--N 1.384 3.242 2 O-C-N 135.113 7.758 . . . . 0.0 118.887 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.3 0.9 OUTLIER -124.49 147.57 55.85 Favored Pre-proline 0 CA--C 1.563 1.474 0 C-N-CA 129.429 3.091 . . . . 0.0 118.812 -167.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.75 139.17 56.53 Favored 'Trans proline' 0 N--CA 1.5 1.887 1 C-N-CA 125.992 4.461 . . . . 0.0 117.15 170.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.425 ' CD1' ' H ' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -89.18 162.46 37.37 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 118.374 -2.704 . . . . 0.0 114.303 177.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.89 94.02 0.39 Allowed 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.564 4.176 . . . . 0.0 115.556 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.3 t70 82.05 -72.14 0.05 OUTLIER 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.61 2.364 . . . . 0.0 110.921 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 97.06 142.45 0.02 OUTLIER 'General case' 0 CA--C 1.479 -1.767 0 C-N-CA 129.057 2.943 . . . . 0.0 111.757 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.281 0.2 OUTLIER 82.48 53.54 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.028 -1.896 . . . . 0.0 112.709 179.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.58 -55.84 0.32 Allowed Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 116.305 1.282 . . . . 0.0 116.305 -168.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.304 . . 103.43 -47.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.395 0 C-N-CA 126.59 1.956 . . . . 0.0 113.953 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.4 6.4 t -145.92 92.6 2.22 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 124.135 1.921 . . . . 0.0 109.582 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.291 4.3 p90 -126.88 142.18 51.61 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 129.003 2.921 . . . . 0.0 111.332 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.5 m -124.97 139.66 53.62 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 120.096 -1.628 . . . . 0.0 109.349 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 89.5 45.97 Favored Pre-proline 0 C--N 1.354 0.799 0 C-N-CA 127.937 2.495 . . . . 0.0 107.857 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -68.16 -32.57 27.01 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 124.712 3.608 . . . . 0.0 115.335 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.3 m -130.18 100.67 5.49 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.3 118.63 29.95 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.918 1.287 . . . . 0.0 113.555 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.07 -179.84 6.54 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.348 2.659 . . . . 0.0 109.646 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.87 -51.26 23.68 Favored 'General case' 0 C--N 1.368 1.387 0 O-C-N 118.16 -2.837 . . . . 0.0 117.761 -174.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -68.08 0.17 3.89 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 128.45 2.7 . . . . 0.0 114.966 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -116.66 -12.08 10.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 130.435 3.494 . . . . 0.0 111.316 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.34 157.26 16.3 Favored 'General case' 0 C--N 1.394 2.509 0 N-CA-C 119.409 3.115 . . . . 0.0 119.409 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 152.43 -158.36 27.8 Favored Glycine 0 C--N 1.39 3.535 0 C-N-CA 128.832 3.111 . . . . 0.0 111.042 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.429 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.328 3.8 m -106.07 131.94 52.74 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 112.947 -3.501 . . . . 0.0 105.989 167.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.493 ' HB2' ' HB2' ' A' ' 153' ' ' CYS . 18.3 m-85 -97.23 134.96 39.84 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 122.757 2.526 . . . . 0.0 113.599 -172.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -147.97 152.3 37.25 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-O 122.422 1.106 . . . . 0.0 110.175 -174.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.254 8.3 p -135.91 137.69 48.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 118.471 -1.292 . . . . 0.0 113.901 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.3 m -105.69 116.61 32.23 Favored 'General case' 0 C--N 1.377 1.787 0 C-N-CA 129.098 2.959 . . . . 0.0 104.925 176.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.88 119.09 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 124.086 0.954 . . . . 0.0 109.67 -167.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 10.2 m -103.73 128.8 51.06 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 120.951 -1.093 . . . . 0.0 113.497 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.47 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.488 11.1 p-10 -127.55 -174.78 3.27 Favored 'General case' 0 C--N 1.371 1.52 0 CA-C-N 119.191 0.905 . . . . 0.0 111.84 174.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.708 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 80.5 p -49.97 2.44 0.01 OUTLIER 'General case' 0 C--N 1.361 1.069 2 C-N-CA 135.549 5.54 . . . . 0.0 121.816 -163.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.52 4.37 38.5 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 164.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.394 68.8 mm-40 66.39 40.01 3.78 Favored 'General case' 0 C--N 1.375 1.678 1 C-N-CA 132.803 4.441 . . . . 0.0 110.84 -172.623 . . . . . . . . 3 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 141' ' ' THR . 3.9 m -113.26 129.8 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.253 -171.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.29 123.58 34.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 126.661 1.984 . . . . 0.0 107.691 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.514 ' HZ2' ' HB3' ' A' ' 150' ' ' SER . 0.0 OUTLIER -116.55 157.53 25.11 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 -175.256 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -128.68 132.22 48.03 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.646 -1.284 . . . . 0.0 109.706 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.514 ' HB3' ' HZ2' ' A' ' 148' ' ' LYS 0.474 55.9 p -114.35 151.88 32.32 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 123.75 0.82 . . . . 0.0 111.13 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -53.69 146.81 12.62 Favored 'General case' 0 C--N 1.371 1.508 1 C-N-CA 133.843 4.857 . . . . 0.0 120.146 -153.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 64.5 p -70.33 110.96 5.57 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 129.745 3.218 . . . . 0.0 109.323 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 18.0 m -106.01 109.62 21.63 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.58 107.23 19.62 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 124.773 2.225 . . . . 0.0 111.308 -170.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . 0.263 1.1 t -118.0 114.95 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 -172.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.368 1.373 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -174.45 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.577 2.005 0 CA-C-O 121.756 0.788 . . . . 0.0 112.336 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.2 m -164.81 171.32 14.37 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 116.667 -3.77 . . . . 0.0 103.785 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.41 -45.41 1.51 Allowed 'General case' 0 C--N 1.366 1.315 0 C-N-CA 127.031 2.132 . . . . 0.0 112.932 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 86.1 p -176.17 134.12 0.25 Allowed 'General case' 0 C--N 1.365 1.262 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.6 ttt -134.75 117.93 16.52 Favored 'General case' 0 C--N 1.373 1.629 0 CA-C-N 119.696 1.134 . . . . 0.0 109.203 159.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.5 p -111.13 116.15 30.62 Favored 'General case' 0 C--N 1.363 1.188 0 O-C-N 119.482 -2.011 . . . . 0.0 109.789 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.74 171.98 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 126.825 2.05 . . . . 0.0 112.937 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.4 127.56 33.79 Favored 'General case' 0 C--N 1.372 1.55 0 O-C-N 118.961 -2.337 . . . . 0.0 105.258 163.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.278 8.6 pt-20 -41.83 122.57 2.07 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 120.389 3.477 . . . . 0.0 120.389 -150.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 144.34 54.71 0.03 OUTLIER Glycine 0 C--N 1.356 1.639 0 CA-C-N 109.656 -3.429 . . . . 0.0 110.55 -172.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.11 158.79 23.56 Favored 'General case' 0 C--N 1.372 1.58 0 C-N-CA 125.482 1.513 . . . . 0.0 113.101 174.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.91 101.62 9.92 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 125.415 1.486 . . . . 0.0 112.312 -174.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.413 HD23 ' CE1' ' A' ' 136' ' ' TYR . 1.1 mp -119.79 130.83 55.13 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 125.943 1.697 . . . . 0.0 115.318 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.98 132.8 53.9 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 172.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.475 HD23 ' CD2' ' A' ' 136' ' ' TYR . 3.1 mp -131.83 115.16 15.58 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 170.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.416 ' HG ' ' CB ' ' A' ' 122' ' ' THR . 3.5 t -148.1 133.84 18.93 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.529 -1.357 . . . . 0.0 110.981 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.7 174.57 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 129.549 3.14 . . . . 0.0 104.0 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 t -104.26 141.38 36.39 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 126.948 2.099 . . . . 0.0 105.696 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.31 134.2 32.23 Favored 'General case' 0 C--N 1.37 1.472 0 N-CA-C 120.127 3.38 . . . . 0.0 120.127 -172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.3 m -157.86 174.04 15.88 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 131.363 3.865 . . . . 0.0 100.843 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.52 44.24 2.21 Favored Glycine 0 C--N 1.363 2.045 0 CA-C-N 122.584 2.447 . . . . 0.0 117.582 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.4 12.73 81.63 Favored Glycine 0 C--N 1.362 1.991 0 C-N-CA 128.705 3.05 . . . . 0.0 113.068 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.7 p -115.87 111.17 20.05 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 126.481 1.913 . . . . 0.0 107.396 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.538 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 71.83 -101.4 1.01 Allowed Glycine 0 C--N 1.36 1.886 0 C-N-CA 127.181 2.324 . . . . 0.0 109.315 -161.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.79 168.32 7.22 Favored 'Trans proline' 0 CA--C 1.555 1.573 1 C-N-CA 129.227 6.618 . . . . 0.0 118.349 165.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -82.07 138.86 34.73 Favored 'General case' 0 CA--C 1.562 1.419 1 N-CA-C 122.274 4.175 . . . . 0.0 122.274 -170.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 t -102.82 154.96 18.68 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 129.756 3.223 . . . . 0.0 104.309 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.71 166.27 33.35 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -165.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.2 112.81 10.76 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 128.417 2.687 . . . . 0.0 105.64 170.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -111.94 137.5 49.85 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.349 1.859 . . . . 0.0 108.595 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.308 0.2 OUTLIER -158.61 162.77 37.35 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.32 -1.487 . . . . 0.0 107.427 168.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.44 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -137.31 103.59 5.14 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 116.954 -1.898 . . . . 0.0 115.412 177.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.153 2.3 t70 36.6 53.82 1.07 Allowed 'General case' 0 CA--C 1.467 -2.22 1 CA-C-O 111.433 -4.127 . . . . 0.0 119.609 153.898 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.71 -0.56 70.46 Favored Glycine 0 C--N 1.373 2.6 2 O-C-N 134.227 7.204 . . . . 0.0 117.38 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.384 1.3 p -124.82 147.8 57.51 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 130.074 3.349 . . . . 0.0 119.445 -167.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.02 143.7 79.7 Favored 'Trans proline' 0 N--CA 1.498 1.747 1 C-N-CA 125.964 4.442 . . . . 0.0 115.817 167.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.99 144.91 28.6 Favored Pre-proline 0 CA--C 1.551 1.004 0 O-C-N 119.437 -2.039 . . . . 0.0 112.916 176.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.55 93.43 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.447 1 C-N-CA 125.938 4.425 . . . . 0.0 118.83 -172.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.3 t70 65.1 48.26 2.28 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 169.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.32 -165.64 0.9 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 127.598 2.359 . . . . 0.0 115.694 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.304 8.4 t 99.92 8.04 0.01 OUTLIER 'General case' 0 C--N 1.354 0.765 0 C-N-CA 128.959 2.904 . . . . 0.0 112.121 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.2 91.77 0.08 OUTLIER Glycine 0 CA--C 1.48 -2.129 0 C-N-CA 115.979 -3.01 . . . . 0.0 118.568 167.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.461 . . 89.6 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 167.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.416 ' CB ' ' HG ' ' A' ' 94' ' ' SER . 12.0 t -139.32 118.27 12.5 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 122.106 2.23 . . . . 0.0 115.915 -169.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -127.63 140.13 52.29 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 127.381 2.272 . . . . 0.0 111.197 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 89.1 m -129.25 140.55 51.41 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 119.306 -2.121 . . . . 0.0 109.68 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -111.85 95.97 31.21 Favored Pre-proline 0 C--N 1.366 1.293 0 C-N-CA 128.203 2.601 . . . . 0.0 108.455 178.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.19 -14.11 16.77 Favored 'Trans proline' 0 C--N 1.356 0.948 1 C-N-CA 126.278 4.652 . . . . 0.0 113.563 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.5 m -161.6 101.0 1.18 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 102.43 -3.174 . . . . 0.0 102.43 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.12 134.05 35.02 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.83 2.452 . . . . 0.0 112.183 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.62 173.19 7.74 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 127.935 2.494 . . . . 0.0 110.086 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -41.12 23.61 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 120.166 3.395 . . . . 0.0 120.166 -173.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -66.95 -14.57 62.96 Favored 'General case' 0 C--N 1.366 1.317 0 C-N-CA 126.801 2.04 . . . . 0.0 115.393 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -80.42 -17.05 52.94 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 129.475 3.11 . . . . 0.0 111.559 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.86 107.88 2.79 Favored 'General case' 0 C--N 1.384 2.077 0 N-CA-C 120.45 3.5 . . . . 0.0 120.45 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.65 -154.12 19.13 Favored Glycine 0 CA--C 1.459 -3.413 0 C-N-CA 126.77 2.129 . . . . 0.0 108.935 172.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.418 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.288 19.6 m -117.64 135.49 53.95 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 114.892 -2.723 . . . . 0.0 108.296 175.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.475 ' CD2' HD23 ' A' ' 93' ' ' LEU . 10.1 m-85 -96.77 133.32 41.5 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 120.299 -1.501 . . . . 0.0 113.487 -171.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -146.05 149.32 33.87 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 121.573 0.702 . . . . 0.0 110.782 -173.032 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.474 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 14.6 p -142.49 142.94 26.51 Favored 'Isoleucine or valine' 0 C--N 1.372 1.56 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 175.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -105.15 118.45 36.58 Favored 'General case' 0 C--N 1.375 1.681 0 C-N-CA 129.732 3.213 . . . . 0.0 105.333 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.1 122.66 56.86 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 126.765 2.026 . . . . 0.0 112.347 -175.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.4 m -111.78 133.96 53.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 118.995 -2.315 . . . . 0.0 114.043 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . 0.591 4.4 p30 -134.86 -167.18 1.94 Allowed 'General case' 0 C--N 1.373 1.62 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 173.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.538 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 90.6 p -48.88 3.51 0.01 OUTLIER 'General case' 0 C--N 1.366 1.297 2 C-N-CA 134.838 5.255 . . . . 0.0 122.208 -158.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -106.75 4.87 28.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.468 164.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.397 89.3 mm-40 66.19 40.19 3.93 Favored 'General case' 0 C--N 1.375 1.696 1 C-N-CA 132.077 4.151 . . . . 0.0 110.455 -171.72 . . . . . . . . 3 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.92 129.85 67.82 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.376 0 CA-C-N 111.759 -2.473 . . . . 0.0 111.362 -171.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.89 130.54 37.63 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.885 1.274 . . . . 0.0 110.027 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.93 156.99 26.45 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 128.172 2.589 . . . . 0.0 104.913 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -130.5 146.72 52.09 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 120.877 -1.139 . . . . 0.0 108.128 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.474 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.337 88.4 p -130.82 143.83 51.02 Favored 'General case' 0 C--O 1.251 1.133 0 O-C-N 121.726 -0.609 . . . . 0.0 110.734 175.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.0 m -54.35 148.02 12.49 Favored 'General case' 0 CA--C 1.481 -1.675 2 C-N-CA 137.127 6.171 . . . . 0.0 118.089 -162.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 65.5 p -68.38 110.35 4.08 Favored 'General case' 0 C--N 1.375 1.675 0 CA-C-N 111.865 -2.425 . . . . 0.0 109.136 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 109.78 22.47 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 102.172 -3.27 . . . . 0.0 102.172 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.42 114.58 27.17 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 125.125 2.393 . . . . 0.0 110.628 -174.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.4 t -117.83 117.4 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 CA--C 1.492 -1.257 0 N-CA-C 103.182 -2.895 . . . . 0.0 103.182 173.123 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.561 1.365 0 N-CA-C 121.003 3.705 . . . . 0.0 121.003 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 m -173.78 172.37 3.54 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 102.982 -2.969 . . . . 0.0 102.982 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.01 -52.79 2.59 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.294 -1.504 . . . . 0.0 110.205 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 t -172.16 136.04 0.82 Allowed 'General case' 0 C--N 1.357 0.928 0 O-C-N 119.842 -1.786 . . . . 0.0 113.709 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 25.0 ttt -130.56 117.9 20.25 Favored 'General case' 0 C--N 1.373 1.605 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 163.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -105.5 115.61 30.55 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 119.612 -1.93 . . . . 0.0 107.496 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 86' ' ' GLU . 11.1 p -149.24 173.72 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.752 0 CA-C-O 123.255 1.502 . . . . 0.0 112.208 -168.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.402 ' O ' HG21 ' A' ' 85' ' ' VAL . 8.6 pt-20 -80.02 132.65 36.04 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 126.864 2.066 . . . . 0.0 105.455 159.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.29 0.3 OUTLIER -43.77 121.71 2.48 Favored 'General case' 0 N--CA 1.513 2.719 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 -161.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.44 51.66 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.226 0 CA-C-N 111.446 -2.615 . . . . 0.0 108.938 -164.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.13 163.34 17.91 Favored 'General case' 0 C--N 1.367 1.352 0 C-N-CA 125.804 1.642 . . . . 0.0 111.455 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.15 105.69 14.48 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.925 0.89 . . . . 0.0 112.755 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mp -119.87 120.22 35.82 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 126.505 1.922 . . . . 0.0 115.313 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.75 126.37 52.2 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 170.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.34 114.87 18.14 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 103.452 -2.795 . . . . 0.0 103.452 176.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -156.75 140.32 15.9 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.951 -1.093 . . . . 0.0 109.63 -172.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.64 172.73 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 129.395 3.078 . . . . 0.0 104.884 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.3 t -104.01 141.76 35.63 Favored 'General case' 0 C--N 1.373 1.605 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' A' ' 121' ' ' ALA . . . -125.26 149.88 47.59 Favored 'General case' 0 C--N 1.363 1.194 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.4 m -159.4 174.92 13.99 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.17 42.48 2.74 Favored Glycine 0 C--N 1.362 2.009 0 CA-C-N 122.905 2.593 . . . . 0.0 116.239 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.84 0.8 60.22 Favored Glycine 0 C--N 1.362 1.979 0 C-N-CA 125.649 1.595 . . . . 0.0 114.393 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.9 m -117.24 123.91 47.76 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.346 1.458 . . . . 0.0 110.034 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.636 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.45 -113.26 4.36 Favored Glycine 0 C--N 1.361 1.917 0 CA-C-O 116.153 -2.47 . . . . 0.0 108.798 -163.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -66.96 168.45 17.18 Favored 'Trans proline' 0 CA--C 1.564 1.985 1 C-N-CA 127.759 5.64 . . . . 0.0 117.353 163.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.401 ' CE2' ' CG ' ' A' ' 142' ' ' ASP . 27.4 m-85 -82.1 144.33 30.87 Favored 'General case' 0 C--N 1.358 0.947 1 N-CA-C 125.453 5.353 . . . . 0.0 125.453 -164.494 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.3 t -103.24 141.47 35.84 Favored 'General case' 0 C--N 1.371 1.529 0 C-N-CA 127.914 2.486 . . . . 0.0 104.525 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.39 160.32 39.43 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 120.354 3.464 . . . . 0.0 120.354 -166.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.08 113.69 9.09 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 110.593 -3.003 . . . . 0.0 105.112 173.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -111.98 154.77 24.8 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 120.676 -1.265 . . . . 0.0 108.595 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.383 0.2 OUTLIER -158.3 168.73 26.2 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 166.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HZ2' ' HB3' ' A' ' 113' ' ' SER . 1.0 OUTLIER -144.5 105.01 4.12 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 120.138 -1.601 . . . . 0.0 114.911 -178.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.481 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.224 0.6 OUTLIER 36.39 53.75 1.01 Allowed 'General case' 0 CA--C 1.464 -2.336 1 CA-C-O 111.394 -4.145 . . . . 0.0 119.198 153.699 . . . . . . . . 5 4 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.38 -0.65 78.24 Favored Glycine 0 C--N 1.373 2.607 2 O-C-N 134.747 7.529 . . . . 0.0 118.375 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.48 ' HB3' ' HZ2' ' A' ' 110' ' ' LYS 0.268 58.2 m -124.89 148.87 61.15 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 120.304 3.446 . . . . 0.0 120.304 -167.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -60.22 148.75 88.69 Favored 'Trans proline' 0 N--CA 1.507 2.301 1 C-N-CA 126.231 4.62 . . . . 0.0 116.194 166.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.401 ' HB ' ' HD2' ' A' ' 116' ' ' PRO 0.325 0.8 OUTLIER -98.64 165.1 15.71 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 117.846 -3.034 . . . . 0.0 112.285 175.279 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 6.0 Cg_endo -69.2 87.92 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.739 1 C-N-CA 125.826 4.351 . . . . 0.0 113.984 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.6 t70 84.99 -57.51 0.09 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.877 3.271 . . . . 0.0 110.612 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.302 . . 102.97 -62.87 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 130.715 3.606 . . . . 0.0 115.285 171.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.301 8.0 t -73.7 80.12 1.54 Allowed 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 130.732 3.613 . . . . 0.0 113.886 -174.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.94 -71.48 0.02 OUTLIER Glycine 0 C--N 1.36 1.867 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 -172.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' A' ' 97' ' ' ALA 0.318 . . 129.4 -24.73 0.01 OUTLIER 'General case' 0 C--N 1.365 1.247 0 C-N-CA 127.265 2.226 . . . . 0.0 116.044 178.008 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.34 15.0 t -154.85 102.23 2.34 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-N 121.013 1.733 . . . . 0.0 112.657 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.313 0.1 OUTLIER -127.43 141.48 51.67 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 127.897 2.479 . . . . 0.0 111.472 176.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 60.1 m -128.32 138.65 52.48 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 118.991 -2.318 . . . . 0.0 107.28 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.89 102.72 52.88 Favored Pre-proline 0 C--N 1.362 1.137 0 C-N-CA 128.042 2.537 . . . . 0.0 105.209 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -77.04 -11.86 17.77 Favored 'Trans proline' 0 C--N 1.348 0.548 1 C-N-CA 126.227 4.618 . . . . 0.0 112.731 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 62.1 m -157.22 100.9 1.87 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.46 128.47 39.56 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 124.312 1.045 . . . . 0.0 112.317 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.27 179.06 5.17 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 129.462 3.105 . . . . 0.0 108.574 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.62 -53.96 13.26 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -172.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.38 0.93 3.37 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 127.234 2.213 . . . . 0.0 115.788 172.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -113.8 -13.79 12.59 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 130.362 3.465 . . . . 0.0 110.695 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.28 160.18 14.46 Favored 'General case' 0 C--N 1.4 2.775 0 N-CA-C 120.157 3.391 . . . . 0.0 120.157 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.6 -158.59 27.75 Favored Glycine 0 CA--C 1.469 -2.831 0 C-N-CA 128.585 2.993 . . . . 0.0 106.905 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.331 1.2 m -105.8 129.39 54.0 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 114.677 -2.809 . . . . 0.0 107.559 168.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.42 ' CZ ' ' HD2' ' A' ' 110' ' ' LYS . 12.7 m-85 -96.59 134.92 39.21 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 123.404 2.82 . . . . 0.0 113.159 -171.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -146.16 152.15 38.78 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 123.9 0.88 . . . . 0.0 110.385 -175.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.666 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 8.5 p -142.95 141.12 27.11 Favored 'Isoleucine or valine' 0 C--N 1.371 1.525 0 C-N-CA 117.474 -1.69 . . . . 0.0 114.928 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 61.5 m -103.64 110.98 23.26 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 129.96 3.304 . . . . 0.0 106.206 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.78 114.9 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.334 2.254 . . . . 0.0 109.87 -172.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 4.7 m -102.16 130.15 48.72 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.322 -1.486 . . . . 0.0 113.807 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.401 ' CG ' ' CE2' ' A' ' 104' ' ' TYR 0.481 7.1 p30 -138.39 -165.38 1.8 Allowed 'General case' 0 C--N 1.371 1.531 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 174.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.636 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 91.3 p -48.91 3.69 0.01 OUTLIER 'General case' 0 C--N 1.369 1.45 2 C-N-CA 134.986 5.315 . . . . 0.0 123.135 -163.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -105.65 5.92 31.58 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 163.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.395 6.9 mm100 64.27 39.98 6.97 Favored 'General case' 0 C--N 1.374 1.655 1 C-N-CA 133.403 4.681 . . . . 0.0 111.261 -171.164 . . . . . . . . 3 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 141' ' ' THR . 3.1 m -113.88 134.77 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.826 0 CA-C-N 111.774 -2.466 . . . . 0.0 112.318 -170.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.14 123.45 34.61 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 129.13 2.972 . . . . 0.0 106.287 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.82 157.84 24.93 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 128.781 2.833 . . . . 0.0 105.038 -175.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 30.3 t70 -125.82 134.23 51.74 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 122.284 1.04 . . . . 0.0 109.108 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.666 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.508 54.2 p -111.79 146.8 36.99 Favored 'General case' 0 C--O 1.252 1.227 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.0 m -53.95 147.87 11.57 Favored 'General case' 0 C--N 1.375 1.702 1 C-N-CA 135.261 5.424 . . . . 0.0 120.004 -157.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.3 p -69.38 110.89 4.92 Favored 'General case' 0 C--N 1.37 1.468 0 C-N-CA 126.115 1.766 . . . . 0.0 110.192 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.36 109.46 21.1 Favored 'General case' 0 C--N 1.358 0.957 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -94.54 107.22 19.21 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-O 123.622 1.677 . . . . 0.0 110.99 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.82 115.09 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.369 1.415 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.53 -174.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.428 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.9 m -171.97 172.63 4.67 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 100.483 -3.895 . . . . 0.0 100.483 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.47 -51.32 1.96 Allowed 'General case' 0 C--N 1.351 0.673 0 CA-C-N 120.561 1.528 . . . . 0.0 111.117 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.4 t -172.62 145.41 1.55 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 120.35 -1.469 . . . . 0.0 114.728 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.5 ttt -135.7 128.57 31.23 Favored 'General case' 0 C--N 1.371 1.517 0 O-C-N 121.36 -0.837 . . . . 0.0 109.608 160.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 p -104.9 114.49 28.72 Favored 'General case' 0 C--N 1.373 1.611 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 86' ' ' GLU 0.252 7.4 p -149.87 174.03 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.899 -167.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 85' ' ' VAL . 1.3 pp20? -89.31 144.23 26.24 Favored 'General case' 0 C--N 1.364 1.209 0 O-C-N 119.392 -2.067 . . . . 0.0 106.813 163.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.473 3.8 pt-20 -44.39 124.91 4.35 Favored 'General case' 0 N--CA 1.516 2.847 0 O-C-N 118.121 -2.862 . . . . 0.0 117.863 -172.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.05 50.4 0.24 Allowed Glycine 0 C--N 1.345 1.049 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 -150.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.04 152.28 18.9 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 127.023 2.129 . . . . 0.0 111.663 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.05 113.79 26.79 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-O 122.466 1.127 . . . . 0.0 113.632 -169.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -121.03 138.1 54.33 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 126.343 1.857 . . . . 0.0 115.9 174.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.87 137.38 54.66 Favored 'General case' 0 CA--C 1.494 -1.173 1 N-CA-C 99.817 -4.142 . . . . 0.0 99.817 160.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.29 115.13 21.79 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 101.003 -3.702 . . . . 0.0 101.003 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.428 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 5.7 t -152.49 132.27 13.22 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -174.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.84 174.43 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.052 1 C-N-CA 132.476 4.31 . . . . 0.0 105.629 176.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.3 t -104.15 141.24 36.59 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 119.773 -1.83 . . . . 0.0 107.72 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.76 146.01 35.47 Favored 'General case' 0 C--N 1.382 2.008 1 N-CA-C 124.947 5.166 . . . . 0.0 124.947 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.9 p -156.95 175.33 14.24 Favored 'General case' 0 C--N 1.369 1.414 1 C-N-CA 133.786 4.834 . . . . 0.0 104.031 177.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.06 42.91 0.79 Allowed Glycine 0 C--N 1.367 2.273 0 O-C-N 119.597 -1.939 . . . . 0.0 117.779 171.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.85 25.69 52.05 Favored Glycine 0 C--N 1.361 1.961 0 C-N-CA 128.396 2.903 . . . . 0.0 114.851 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.419 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 6.4 p -116.91 110.01 17.78 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 116.519 -1.705 . . . . 0.0 108.368 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.728 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 71.8 -90.63 0.49 Allowed Glycine 0 C--N 1.371 2.516 0 C-N-CA 129.408 3.385 . . . . 0.0 110.731 -167.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 101' ' ' THR . 38.9 Cg_exo -59.89 169.32 4.72 Favored 'Trans proline' 0 CA--C 1.564 1.975 1 C-N-CA 128.054 5.836 . . . . 0.0 117.326 160.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.461 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 64.7 m-85 -94.74 143.18 26.66 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 120.373 3.472 . . . . 0.0 120.373 -167.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.8 t -103.24 142.34 34.35 Favored 'General case' 0 C--N 1.382 1.999 0 C-N-CA 128.772 2.829 . . . . 0.0 104.789 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -141.48 165.99 25.98 Favored 'General case' 0 C--N 1.351 0.654 1 N-CA-C 122.282 4.178 . . . . 0.0 122.282 -160.745 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.86 121.95 12.89 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 128.187 2.595 . . . . 0.0 106.642 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -112.01 142.46 44.41 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 125.335 1.454 . . . . 0.0 111.878 -175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.7 170.77 19.43 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 123.186 1.47 . . . . 0.0 107.187 174.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.512 ' HD3' ' CE2' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -147.68 106.12 3.78 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 177.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.235 1.3 t70 34.5 53.07 0.58 Allowed 'General case' 0 C--N 1.377 1.794 2 N-CA-C 123.336 4.569 . . . . 0.0 123.336 140.062 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.69 -0.74 87.77 Favored Glycine 0 C--N 1.376 2.78 2 O-C-N 134.128 7.143 . . . . 0.0 119.292 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.43 ' HB2' ' HD2' ' A' ' 110' ' ' LYS . 3.6 m -124.8 147.18 55.46 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 129.3 3.04 . . . . 0.0 118.352 -172.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.33 138.07 49.61 Favored 'Trans proline' 0 N--CA 1.495 1.577 1 C-N-CA 125.984 4.456 . . . . 0.0 115.036 171.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.36 163.64 27.94 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 117.816 -3.052 . . . . 0.0 115.57 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.22 84.4 0.91 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.703 3.602 . . . . 0.0 115.841 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.3 t70 78.01 -62.5 0.36 Allowed 'General case' 0 C--N 1.362 1.137 0 C-N-CA 127.719 2.407 . . . . 0.0 114.762 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 79.64 171.63 0.16 Allowed 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 130.284 3.434 . . . . 0.0 114.791 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 75.64 72.38 0.09 Allowed 'General case' 0 C--N 1.358 0.972 0 CA-C-N 114.345 -1.298 . . . . 0.0 114.288 173.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.76 -51.93 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.967 0 N-CA-C 118.976 2.35 . . . . 0.0 118.976 -173.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.263 . . 133.4 -73.11 0.0 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.055 2.142 . . . . 0.0 107.356 -176.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.272 6.9 t -133.82 111.61 10.65 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-O 123.092 1.425 . . . . 0.0 113.459 -175.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.331 0.6 OUTLIER -127.07 141.65 51.72 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 129.042 2.937 . . . . 0.0 112.394 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.7 m -128.51 139.71 52.18 Favored 'General case' 0 C--N 1.366 1.318 0 O-C-N 120.702 -1.249 . . . . 0.0 109.302 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.7 100.08 51.16 Favored Pre-proline 0 C--N 1.355 0.81 0 C-N-CA 129.822 3.249 . . . . 0.0 105.145 176.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -77.49 -32.4 2.92 Favored 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 125.93 4.42 . . . . 0.0 113.407 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 m -138.45 101.29 4.33 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.75 129.6 42.93 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 127.522 2.329 . . . . 0.0 109.615 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.59 175.58 7.85 Favored 'General case' 0 C--N 1.369 1.426 0 C-N-CA 128.169 2.588 . . . . 0.0 108.457 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.18 -51.35 18.63 Favored 'General case' 0 C--N 1.368 1.397 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 -171.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -63.92 -22.89 67.12 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 126.1 1.76 . . . . 0.0 114.748 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -82.87 -10.28 58.91 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 130.103 3.361 . . . . 0.0 111.909 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -94.35 166.37 12.11 Favored 'General case' 0 C--N 1.383 2.061 0 N-CA-C 116.59 2.071 . . . . 0.0 116.59 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 144.86 -156.34 26.86 Favored Glycine 0 CA--C 1.461 -3.289 0 C-N-CA 127.603 2.525 . . . . 0.0 108.867 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.325 1.4 m -113.54 130.45 56.35 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 114.276 -2.969 . . . . 0.0 107.118 171.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.512 ' CE2' ' HD3' ' A' ' 110' ' ' LYS . 31.0 m-85 -97.16 135.02 39.72 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 126.882 2.073 . . . . 0.0 112.063 -168.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -148.83 148.79 30.32 Favored 'General case' 0 C--N 1.373 1.595 0 CA-C-O 123.449 1.595 . . . . 0.0 109.12 -174.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.291 0.8 OUTLIER -141.46 141.03 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.265 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.7 m -102.64 122.98 45.5 Favored 'General case' 0 C--N 1.377 1.8 0 C-N-CA 129.138 2.975 . . . . 0.0 107.201 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.54 126.72 48.83 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 125.816 1.646 . . . . 0.0 113.391 -174.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.3 m -113.83 132.59 55.83 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 119.365 -2.084 . . . . 0.0 114.296 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.461 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.428 25.6 p30 -126.93 -174.36 3.12 Favored 'General case' 0 C--N 1.377 1.78 0 O-C-N 120.729 -1.232 . . . . 0.0 112.695 176.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.728 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 63.2 p -49.62 3.3 0.01 OUTLIER 'General case' 0 C--N 1.362 1.126 1 C-N-CA 136.302 5.841 . . . . 0.0 121.775 -164.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -104.21 4.47 33.95 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 118.215 -1.394 . . . . 0.0 107.798 163.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.405 91.8 mm-40 66.55 40.2 3.53 Favored 'General case' 0 C--N 1.375 1.683 1 C-N-CA 132.504 4.321 . . . . 0.0 110.156 -172.204 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.48 126.67 69.9 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.39 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.591 -170.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.67 134.0 35.09 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 124.613 1.165 . . . . 0.0 109.724 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 158.51 24.52 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 130.429 3.492 . . . . 0.0 105.686 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -127.21 136.51 52.13 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.252 0.1 OUTLIER -116.38 151.6 35.62 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.242 1.817 . . . . 0.0 110.772 -175.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 m -53.42 146.5 12.38 Favored 'General case' 0 CA--C 1.489 -1.399 1 C-N-CA 134.209 5.004 . . . . 0.0 119.441 -157.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.8 p -70.76 111.59 6.32 Favored 'General case' 0 C--N 1.37 1.467 0 C-N-CA 128.749 2.819 . . . . 0.0 108.867 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.19 109.93 21.87 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 102.149 -3.278 . . . . 0.0 102.149 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -100.06 111.83 24.12 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-O 123.893 1.806 . . . . 0.0 111.556 -173.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.03 123.94 70.15 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 O-C-N 119.375 -2.078 . . . . 0.0 108.882 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.369 1.44 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.299 -175.768 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.577 1.996 0 CA-C-O 121.895 0.855 . . . . 0.0 113.087 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.428 ' CG2' ' HG ' ' A' ' 153' ' ' CYS . 8.3 m -168.09 172.24 8.92 Favored 'General case' 0 CA--C 1.519 -0.248 1 O-C-N 115.33 -4.606 . . . . 0.0 101.173 171.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.61 -48.5 1.27 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 125.842 1.657 . . . . 0.0 111.132 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.4 t -170.71 140.78 1.73 Allowed 'General case' 0 C--N 1.362 1.129 0 O-C-N 119.622 -1.924 . . . . 0.0 115.78 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.17 117.07 13.2 Favored 'General case' 0 C--N 1.377 1.769 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 161.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.0 m -114.36 116.8 29.5 Favored 'General case' 0 C--N 1.363 1.186 0 O-C-N 118.209 -2.807 . . . . 0.0 108.334 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.0 p -149.46 172.09 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 125.828 1.651 . . . . 0.0 110.37 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -82.45 129.7 34.96 Favored 'General case' 0 C--N 1.373 1.589 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 163.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.258 9.1 pt-20 -41.53 123.01 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 120.397 3.48 . . . . 0.0 120.397 -152.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 142.08 52.97 0.04 OUTLIER Glycine 0 C--N 1.359 1.833 0 CA-C-N 109.73 -3.395 . . . . 0.0 110.654 -171.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.94 163.96 21.84 Favored 'General case' 0 C--N 1.374 1.631 0 C-N-CA 125.73 1.612 . . . . 0.0 112.928 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.67 108.83 18.43 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 124.272 1.029 . . . . 0.0 110.33 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 mp -119.46 123.09 43.2 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 125.797 1.639 . . . . 0.0 115.247 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.57 127.21 55.11 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 102.364 -3.198 . . . . 0.0 102.364 170.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.44 115.65 21.94 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 172.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.403 ' HG ' ' CB ' ' A' ' 122' ' ' THR . 6.6 t -154.56 134.11 12.73 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 119.947 -1.72 . . . . 0.0 112.461 -169.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.5 m -148.89 175.0 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.645 0 C-N-CA 131.637 3.975 . . . . 0.0 105.886 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.2 t -104.01 138.88 39.91 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.185 2.594 . . . . 0.0 104.625 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.35 142.19 33.8 Favored 'General case' 0 C--N 1.373 1.597 0 N-CA-C 121.642 3.942 . . . . 0.0 121.642 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.3 m -158.52 174.19 15.46 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 131.092 3.757 . . . . 0.0 102.05 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.27 44.54 1.38 Allowed Glycine 0 C--N 1.367 2.292 0 CA-C-N 121.879 2.127 . . . . 0.0 117.232 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.77 28.06 52.07 Favored Glycine 0 C--N 1.358 1.754 0 C-N-CA 128.544 2.973 . . . . 0.0 115.289 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.44 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 90.7 m -117.93 110.96 18.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 114.372 -2.728 . . . . 0.0 107.114 173.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.611 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.85 -87.4 0.86 Allowed Glycine 0 C--N 1.379 2.944 0 C-N-CA 129.729 3.538 . . . . 0.0 110.144 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 101' ' ' THR . 23.5 Cg_exo -60.18 168.12 6.62 Favored 'Trans proline' 0 CA--C 1.568 2.196 1 C-N-CA 126.51 4.806 . . . . 0.0 116.167 159.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.505 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 71.5 m-85 -103.2 143.59 32.43 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 119.593 3.182 . . . . 0.0 119.593 -165.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -103.52 146.49 28.46 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 127.255 2.222 . . . . 0.0 105.526 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.22 166.46 24.97 Favored 'General case' 0 C--N 1.354 0.778 1 N-CA-C 123.25 4.537 . . . . 0.0 123.25 -160.857 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.07 120.52 15.0 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 128.283 2.633 . . . . 0.0 106.25 172.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -112.54 146.65 38.14 Favored 'General case' 0 C--N 1.367 1.355 0 O-C-N 120.853 -1.155 . . . . 0.0 112.145 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.2 169.72 23.87 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 171.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.518 ' HZ3' ' HH ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -143.56 105.56 4.37 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 174.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.17 1.5 t70 34.79 52.79 0.6 Allowed 'General case' 0 C--N 1.376 1.744 1 N-CA-C 122.48 4.252 . . . . 0.0 122.48 140.265 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.07 -6.21 83.81 Favored Glycine 0 C--N 1.364 2.116 2 O-C-N 133.085 6.49 . . . . 0.0 119.003 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.269 3.0 m -124.28 147.13 53.95 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 129.268 3.027 . . . . 0.0 117.671 -171.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.78 142.46 76.39 Favored 'Trans proline' 0 N--CA 1.495 1.604 1 C-N-CA 126.245 4.63 . . . . 0.0 114.973 172.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.26 158.9 31.42 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 118.462 -2.649 . . . . 0.0 112.636 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.04 86.9 0.18 Allowed 'Trans proline' 0 C--N 1.363 1.291 1 C-N-CA 126.336 4.691 . . . . 0.0 115.355 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 73.21 -58.8 0.59 Allowed 'General case' 0 C--N 1.362 1.145 0 C-N-CA 128.268 2.627 . . . . 0.0 115.185 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 73.25 176.24 0.26 Allowed 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 130.824 3.65 . . . . 0.0 115.048 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.15 60.98 0.13 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-N 114.308 -1.314 . . . . 0.0 114.324 174.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.98 -82.98 0.07 OUTLIER Glycine 0 C--N 1.355 1.59 0 N-CA-C 116.316 1.287 . . . . 0.0 116.316 -170.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 165.8 -62.61 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 126.509 1.924 . . . . 0.0 106.539 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.403 ' CB ' ' HG ' ' A' ' 94' ' ' SER . 11.4 t -137.79 111.31 8.07 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.451 -1.406 . . . . 0.0 112.316 -177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.314 31.8 p90 -127.33 140.75 51.98 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 126.111 1.764 . . . . 0.0 111.925 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.6 m -128.65 139.91 52.02 Favored 'General case' 0 C--N 1.361 1.076 0 O-C-N 120.014 -1.679 . . . . 0.0 109.017 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.404 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -114.29 98.43 48.6 Favored Pre-proline 0 C--N 1.363 1.181 0 C-N-CA 129.075 2.95 . . . . 0.0 105.289 178.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -77.39 -15.32 15.87 Favored 'Trans proline' 0 C--N 1.353 0.765 1 C-N-CA 126.413 4.742 . . . . 0.0 113.736 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 53.6 m -159.01 104.9 1.73 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 101.813 -3.403 . . . . 0.0 101.813 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.86 134.45 33.94 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 127.326 2.25 . . . . 0.0 111.287 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.72 175.61 6.83 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 127.997 2.519 . . . . 0.0 110.789 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.1 -48.05 33.91 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 119.611 3.189 . . . . 0.0 119.611 -173.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.16 -9.15 51.5 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 126.722 2.009 . . . . 0.0 114.603 173.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.333 2.9 m-20 -78.32 -19.86 52.65 Favored 'General case' 0 CA--C 1.572 1.816 0 C-N-CA 129.344 3.058 . . . . 0.0 111.532 168.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.88 122.71 18.74 Favored 'General case' 0 C--N 1.384 2.084 0 N-CA-C 120.546 3.536 . . . . 0.0 120.546 171.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 164.98 -155.96 27.67 Favored Glycine 0 CA--C 1.472 -2.65 0 C-N-CA 127.044 2.259 . . . . 0.0 109.254 173.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.4 m -119.33 131.82 55.78 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 115.64 -2.424 . . . . 0.0 108.441 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.518 ' HH ' ' HZ3' ' A' ' 110' ' ' LYS 0.296 26.5 m-85 -95.39 134.23 38.44 Favored 'General case' 0 C--N 1.369 1.44 0 C-N-CA 129.799 3.239 . . . . 0.0 111.467 -172.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.3 145.09 32.42 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 124.67 1.188 . . . . 0.0 107.924 -173.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.614 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 11.3 p -135.75 143.6 35.98 Favored 'Isoleucine or valine' 0 C--N 1.359 1.02 0 C-N-CA 118.817 -1.153 . . . . 0.0 113.006 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 m -109.71 124.1 50.64 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 128.914 2.885 . . . . 0.0 105.392 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.69 131.74 53.92 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 127.701 2.4 . . . . 0.0 111.632 -176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.5 m -119.63 134.17 55.34 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 126.479 1.912 . . . . 0.0 113.813 -177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.505 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.389 9.1 p-10 -125.51 -174.17 3.0 Favored 'General case' 0 C--N 1.383 2.044 0 CA-C-N 120.831 1.65 . . . . 0.0 113.176 175.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.611 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 3.6 p -49.24 -2.09 0.01 OUTLIER 'General case' 0 C--N 1.376 1.758 1 C-N-CA 136.801 6.04 . . . . 0.0 120.015 -165.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -101.44 4.82 41.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 117.755 -1.578 . . . . 0.0 108.751 165.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.409 72.5 mm-40 66.42 40.05 3.72 Favored 'General case' 0 C--N 1.376 1.744 1 C-N-CA 133.346 4.658 . . . . 0.0 110.146 -172.911 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.8 m -112.87 129.01 69.27 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-N 111.365 -2.652 . . . . 0.0 111.362 -170.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.04 140.38 29.71 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 124.48 1.112 . . . . 0.0 111.113 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -117.78 156.56 28.11 Favored 'General case' 0 C--N 1.346 0.452 1 C-N-CA 132.193 4.197 . . . . 0.0 104.063 174.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -129.54 141.33 51.0 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 173.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.614 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.425 50.4 p -120.03 146.91 45.44 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 120.081 1.31 . . . . 0.0 109.05 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -54.07 148.43 10.94 Favored 'General case' 0 CA--C 1.484 -1.574 1 C-N-CA 137.304 6.242 . . . . 0.0 118.442 -160.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -68.45 109.85 3.88 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 125.553 1.541 . . . . 0.0 111.106 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.428 ' HG ' ' CG2' ' A' ' 80' ' ' THR . 0.0 OUTLIER -95.16 109.93 21.96 Favored 'General case' 0 C--N 1.366 1.298 0 N-CA-C 102.267 -3.234 . . . . 0.0 102.267 179.042 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.68 112.92 25.1 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 123.679 1.704 . . . . 0.0 111.82 -172.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.92 128.65 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 O-C-N 120.279 -1.513 . . . . 0.0 109.798 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 C--N 1.361 1.097 0 N-CA-C 101.847 -3.39 . . . . 0.0 101.847 174.07 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.425 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.2 OUTLIER . . . . . 0 CA--C 1.583 2.243 0 CA-C-O 121.43 0.633 . . . . 0.0 112.043 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.7 m -169.54 171.63 7.49 Favored 'General case' 0 N--CA 1.464 0.264 1 O-C-N 115.876 -4.265 . . . . 0.0 102.062 172.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.8 -45.79 1.74 Allowed 'General case' 0 C--N 1.365 1.255 0 C-N-CA 126.51 1.924 . . . . 0.0 114.157 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.0 t -174.27 141.19 0.71 Allowed 'General case' 0 C--N 1.364 1.223 0 O-C-N 119.885 -1.759 . . . . 0.0 115.068 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.3 ttt -126.38 136.89 53.26 Favored 'General case' 0 C--N 1.38 1.9 0 CA-C-N 118.352 0.524 . . . . 0.0 109.927 157.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m -114.59 113.37 24.29 Favored 'General case' 0 C--N 1.377 1.764 0 O-C-N 119.84 -1.788 . . . . 0.0 108.015 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 86' ' ' GLU 0.295 11.5 p -151.56 174.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 123.569 1.652 . . . . 0.0 114.076 -170.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.445 ' O ' HG21 ' A' ' 85' ' ' VAL . 8.0 mp0 -83.19 144.5 29.76 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 127.202 2.201 . . . . 0.0 105.573 158.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.421 4.5 pt-20 -44.01 124.37 3.8 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 117.202 -3.436 . . . . 0.0 118.071 -171.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.62 52.63 0.21 Allowed Glycine 0 C--N 1.358 1.787 0 C-N-CA 127.662 2.554 . . . . 0.0 109.887 -154.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.91 161.68 15.1 Favored 'General case' 0 C--N 1.376 1.731 0 C-N-CA 124.95 1.3 . . . . 0.0 110.908 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.74 97.43 6.7 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.298 53.7 tp -120.8 114.93 22.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -169.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.01 131.77 55.21 Favored 'General case' 0 C--N 1.373 1.591 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.416 ' HB3' ' CZ3' ' A' ' 108' ' ' TRP . 1.1 mm? -129.37 115.86 18.18 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 175.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.425 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 6.9 t -151.11 134.04 15.84 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 119.419 -2.051 . . . . 0.0 112.273 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.75 173.79 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.851 0 C-N-CA 129.594 3.158 . . . . 0.0 104.786 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -104.01 141.06 36.85 Favored 'General case' 0 C--N 1.369 1.445 0 O-C-N 119.293 -2.129 . . . . 0.0 105.349 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.24 145.25 38.99 Favored 'General case' 0 C--N 1.365 1.262 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 -173.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -158.41 174.26 15.39 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 130.741 3.616 . . . . 0.0 101.561 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.15 43.2 1.46 Allowed Glycine 0 C--N 1.364 2.128 0 CA-C-N 121.879 2.127 . . . . 0.0 117.696 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.44 22.13 52.04 Favored Glycine 0 C--N 1.359 1.82 0 C-N-CA 127.785 2.612 . . . . 0.0 116.342 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.488 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 76.1 m -116.95 111.44 19.61 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 114.018 -2.896 . . . . 0.0 107.944 176.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.616 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.93 -92.5 0.93 Allowed Glycine 0 C--N 1.38 3.004 0 CA-C-N 124.628 3.376 . . . . 0.0 110.118 -175.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 101' ' ' THR . 14.9 Cg_exo -60.5 167.54 7.95 Favored 'Trans proline' 0 CA--C 1.564 1.998 1 C-N-CA 126.82 5.013 . . . . 0.0 116.19 159.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.448 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 74.1 m-85 -98.47 143.28 29.08 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 120.613 3.56 . . . . 0.0 120.613 -165.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 t -102.96 141.12 36.31 Favored 'General case' 0 C--N 1.381 1.945 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.72 156.03 49.51 Favored 'General case' 0 C--N 1.347 0.494 1 N-CA-C 122.517 4.265 . . . . 0.0 122.517 -162.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.06 112.79 10.84 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 111.124 -2.762 . . . . 0.0 104.768 171.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.48 ' CE3' ' HB ' ' A' ' 138' ' ' VAL . 35.2 m95 -111.96 148.0 34.69 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.327 0.2 OUTLIER -159.36 169.93 22.92 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 166.019 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.436 ' HE3' ' CE2' ' A' ' 136' ' ' TYR 0.337 33.6 mtpt -123.19 127.31 48.46 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 115.431 -2.223 . . . . 0.0 107.089 173.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.402 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.308 0.7 OUTLIER 32.35 51.04 0.21 Allowed 'General case' 0 C--N 1.373 1.61 2 N-CA-C 123.763 4.727 . . . . 0.0 123.763 123.185 . . . . . . . . 5 4 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.88 1.92 49.47 Favored Glycine 0 C--N 1.377 2.821 2 O-C-N 133.907 7.004 . . . . 0.0 120.592 -169.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.574 0.6 OUTLIER -125.73 147.83 59.94 Favored Pre-proline 0 CA--C 1.563 1.466 1 N-CA-C 123.023 4.453 . . . . 0.0 123.023 -168.346 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.26 149.32 88.68 Favored 'Trans proline' 0 N--CA 1.499 1.842 1 C-N-CA 126.088 4.526 . . . . 0.0 116.245 173.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.28 153.69 43.24 Favored Pre-proline 0 CA--C 1.549 0.911 0 O-C-N 119.567 -1.958 . . . . 0.0 111.545 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.428 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 13.3 Cg_endo -68.09 90.13 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.098 1 C-N-CA 125.969 4.446 . . . . 0.0 114.992 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 t70 76.41 -52.63 0.6 Allowed 'General case' 0 C--N 1.364 1.221 0 C-N-CA 127.883 2.473 . . . . 0.0 114.474 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 85.19 -62.89 0.06 Allowed 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 130.139 3.376 . . . . 0.0 116.282 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -58.04 55.81 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.078 1 C-N-CA 134.045 4.938 . . . . 0.0 118.13 -173.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -144.52 -78.1 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.89 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -173.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 160.93 -58.93 0.0 OUTLIER 'General case' 0 C--N 1.352 0.713 0 C-N-CA 125.172 1.389 . . . . 0.0 109.329 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.9 t -135.55 112.36 10.17 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 122.537 1.161 . . . . 0.0 111.169 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . 0.428 ' CD2' ' HG2' ' A' ' 116' ' ' PRO . 35.0 p90 -127.04 139.76 52.78 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 124.627 1.171 . . . . 0.0 110.338 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.6 m -129.99 140.39 50.9 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 120.647 -1.283 . . . . 0.0 110.57 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.27 99.6 47.03 Favored Pre-proline 0 C--N 1.356 0.878 0 C-N-CA 130.213 3.405 . . . . 0.0 105.684 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -77.43 -13.28 16.75 Favored 'Trans proline' 0 CA--C 1.536 0.606 1 C-N-CA 126.04 4.493 . . . . 0.0 112.891 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -162.1 100.94 1.11 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.21 133.5 35.33 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 127.826 2.451 . . . . 0.0 111.772 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.47 173.29 8.42 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 130.141 3.376 . . . . 0.0 111.265 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.42 -45.6 25.65 Favored 'General case' 0 C--N 1.367 1.349 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.85 -17.86 65.1 Favored 'General case' 0 C--N 1.367 1.326 0 C-N-CA 126.229 1.812 . . . . 0.0 115.316 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.271 37.8 m-20 -84.09 -16.41 43.82 Favored 'General case' 0 C--N 1.362 1.144 1 C-N-CA 132.209 4.204 . . . . 0.0 110.72 171.996 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.28 156.05 35.43 Favored 'General case' 0 C--N 1.392 2.44 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 163.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 138.64 -157.36 24.61 Favored Glycine 0 CA--C 1.452 -3.865 0 C-N-CA 127.735 2.588 . . . . 0.0 106.862 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.403 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.251 3.3 m -119.73 135.73 54.72 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 114.657 -2.817 . . . . 0.0 107.27 167.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.436 ' CE2' ' HE3' ' A' ' 110' ' ' LYS . 28.8 m-85 -96.99 134.74 39.96 Favored 'General case' 0 C--N 1.373 1.589 0 C-N-CA 128.434 2.694 . . . . 0.0 111.689 -172.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -146.39 154.57 41.78 Favored 'General case' 0 C--N 1.371 1.541 0 C-N-CA 124.729 1.211 . . . . 0.0 110.419 -176.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.48 ' HB ' ' CE3' ' A' ' 108' ' ' TRP . 14.8 p -142.91 139.95 27.54 Favored 'Isoleucine or valine' 0 C--N 1.368 1.38 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.3 m -107.67 110.81 22.77 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 131.334 3.854 . . . . 0.0 106.388 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.38 116.8 45.11 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 C-N-CA 125.892 1.677 . . . . 0.0 111.918 -172.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.5 m -102.34 131.12 49.15 Favored 'General case' 0 C--N 1.358 0.959 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.35 36.4 p-10 -125.65 179.31 5.22 Favored 'General case' 0 C--N 1.376 1.718 0 CA-C-N 120.408 1.458 . . . . 0.0 111.519 174.137 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.616 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 22.0 p -49.34 3.49 0.01 OUTLIER 'General case' 0 C--N 1.371 1.503 1 C-N-CA 136.57 5.948 . . . . 0.0 120.413 -169.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -103.51 4.83 36.33 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 166.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.524 2.0 mp0 64.51 40.03 6.43 Favored 'General case' 0 C--N 1.376 1.726 1 C-N-CA 133.518 4.727 . . . . 0.0 112.528 -173.842 . . . . . . . . 3 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 m -112.68 123.48 68.41 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 CA-C-N 111.127 -2.761 . . . . 0.0 111.951 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.04 123.28 34.39 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 128.555 2.742 . . . . 0.0 105.303 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.55 158.36 23.79 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 129.14 2.976 . . . . 0.0 103.218 -174.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 9.0 t70 -129.56 141.27 51.01 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.214 1.007 . . . . 0.0 109.872 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.548 22.4 p -114.79 139.66 49.54 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 m -55.0 147.84 14.81 Favored 'General case' 0 C--N 1.366 1.321 1 C-N-CA 138.044 6.538 . . . . 0.0 117.898 -163.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.8 p -68.67 110.53 4.32 Favored 'General case' 0 C--N 1.375 1.701 0 C-N-CA 125.732 1.613 . . . . 0.0 110.33 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.2 110.35 22.36 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.55 115.22 27.12 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 123.954 1.835 . . . . 0.0 113.171 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.85 128.25 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 O-C-N 119.65 -1.906 . . . . 0.0 107.602 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.493 -1.24 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 178.71 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.586 2.329 0 CA-C-O 121.61 0.719 . . . . 0.0 112.558 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 m -169.79 171.97 7.0 Favored 'General case' 0 N--CA 1.467 0.412 1 O-C-N 114.69 -5.006 . . . . 0.0 101.598 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.13 -45.9 1.24 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.092 1.357 . . . . 0.0 111.159 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.9 p -171.03 125.2 0.65 Allowed 'General case' 0 C--N 1.361 1.103 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.0 ttt -130.6 118.0 20.37 Favored 'General case' 0 C--N 1.376 1.726 0 CA-C-N 120.605 1.548 . . . . 0.0 109.346 160.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -110.61 115.14 29.08 Favored 'General case' 0 C--N 1.368 1.407 0 O-C-N 119.823 -1.798 . . . . 0.0 108.181 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 86' ' ' GLU . 14.8 p -150.03 173.71 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 126.848 2.059 . . . . 0.0 112.977 -169.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.412 ' O ' HG23 ' A' ' 85' ' ' VAL . 94.8 mt-10 -73.46 144.59 46.21 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 128.042 2.537 . . . . 0.0 107.1 159.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.536 0.7 OUTLIER -44.13 123.28 3.3 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 124.628 3.376 . . . . 0.0 118.248 -171.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.96 43.17 0.26 Allowed Glycine 0 C--N 1.358 1.755 0 CA-C-N 111.45 -2.614 . . . . 0.0 112.09 -157.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.44 164.93 20.64 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 119.707 1.753 . . . . 0.0 112.156 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.07 114.93 28.85 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 125.994 1.718 . . . . 0.0 108.556 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.0 mp -120.5 114.49 21.85 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 127.668 2.387 . . . . 0.0 114.693 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.61 124.49 51.24 Favored 'General case' 0 C--N 1.364 1.235 0 N-CA-C 102.467 -3.16 . . . . 0.0 102.467 170.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -124.69 114.77 19.76 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.4 t -153.62 134.09 13.56 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 120.021 -1.675 . . . . 0.0 112.182 -172.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -149.12 174.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.736 0 C-N-CA 130.513 3.525 . . . . 0.0 104.591 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -103.67 140.74 37.17 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.16 142.39 34.04 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 120.588 3.551 . . . . 0.0 120.588 -173.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.3 m -158.47 174.54 14.94 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 130.337 3.455 . . . . 0.0 102.023 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.26 44.35 1.89 Allowed Glycine 0 C--N 1.366 2.2 0 CA-C-N 122.122 2.237 . . . . 0.0 117.639 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.67 20.16 62.27 Favored Glycine 0 C--N 1.358 1.806 0 C-N-CA 127.78 2.609 . . . . 0.0 114.776 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.404 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 45.2 p -116.75 110.81 18.91 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 113.948 -2.929 . . . . 0.0 108.285 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.668 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 73.03 -92.47 0.64 Allowed Glycine 0 C--N 1.376 2.762 0 C-N-CA 129.876 3.607 . . . . 0.0 111.065 -170.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 101' ' ' THR . 12.1 Cg_exo -61.86 168.75 8.26 Favored 'Trans proline' 0 CA--C 1.566 2.113 1 C-N-CA 127.128 5.219 . . . . 0.0 117.207 160.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 75.8 m-85 -93.72 141.36 28.58 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 121.186 3.772 . . . . 0.0 121.186 -167.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -103.24 147.0 27.58 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 128.19 2.596 . . . . 0.0 105.093 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.05 166.21 25.63 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 121.579 3.918 . . . . 0.0 121.579 -160.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.07 113.7 7.86 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 111.715 -2.493 . . . . 0.0 106.263 172.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -112.07 153.84 26.29 Favored 'General case' 0 C--N 1.376 1.722 0 O-C-N 120.149 -1.594 . . . . 0.0 107.87 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.345 0.0 OUTLIER -156.04 152.97 28.73 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 163.236 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.492 ' HZ2' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -128.27 103.86 7.41 Favored 'General case' 0 C--N 1.369 1.451 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 177.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.186 4.0 t70 37.54 54.98 1.46 Allowed 'General case' 0 CA--C 1.453 -2.76 1 CA-C-O 110.881 -4.39 . . . . 0.0 119.601 153.505 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.51 -17.0 51.62 Favored Glycine 0 C--N 1.372 2.559 2 O-C-N 134.729 7.518 . . . . 0.0 116.408 -175.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.282 48.5 m -124.12 149.48 60.56 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 130.754 3.622 . . . . 0.0 119.304 -165.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.12 154.46 51.44 Favored 'Trans proline' 0 N--CA 1.507 2.315 1 C-N-CA 126.937 5.091 . . . . 0.0 116.378 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.416 ' HB ' ' HD2' ' A' ' 116' ' ' PRO 0.274 0.8 OUTLIER -95.12 164.59 18.9 Favored Pre-proline 0 N--CA 1.484 1.23 0 O-C-N 117.967 -2.958 . . . . 0.0 111.917 174.309 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 1.9 Cg_endo -67.98 92.24 0.38 Allowed 'Trans proline' 0 C--N 1.368 1.584 1 C-N-CA 126.491 4.794 . . . . 0.0 112.585 177.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 78.7 -65.89 0.21 Allowed 'General case' 0 C--N 1.351 0.671 0 C-N-CA 128.448 2.699 . . . . 0.0 111.721 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 88.21 148.72 0.05 OUTLIER 'General case' 0 CA--C 1.466 -2.276 0 C-N-CA 128.029 2.532 . . . . 0.0 112.196 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.438 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 18.5 m 74.13 62.62 0.08 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.177 -1.828 . . . . 0.0 115.17 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.01 -77.96 0.08 OUTLIER Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 115.214 0.846 . . . . 0.0 115.214 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 160.53 -58.27 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 124.639 1.176 . . . . 0.0 109.187 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.4 t -141.68 112.85 7.46 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 123.367 1.556 . . . . 0.0 113.311 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.257 0.0 OUTLIER -127.47 139.72 52.62 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 124.856 1.262 . . . . 0.0 108.931 172.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 65.4 m -129.73 138.62 51.22 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.35 114.11 48.17 Favored Pre-proline 0 C--N 1.363 1.182 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 173.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.32 -14.07 16.57 Favored 'Trans proline' 0 C--N 1.354 0.852 1 C-N-CA 126.273 4.649 . . . . 0.0 112.83 174.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -161.83 106.41 1.25 Allowed 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.47 134.97 33.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.074 2.55 . . . . 0.0 113.823 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.16 176.64 6.89 Favored 'General case' 0 C--N 1.371 1.536 0 C-N-CA 127.878 2.471 . . . . 0.0 110.568 174.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.04 -48.97 32.8 Favored 'General case' 0 C--N 1.368 1.413 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 -173.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -64.31 -17.35 63.57 Favored 'General case' 0 C--N 1.366 1.283 0 C-N-CA 127.104 2.162 . . . . 0.0 114.685 173.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.492 ' HA ' ' HZ2' ' A' ' 110' ' ' LYS 0.35 32.7 m-20 -83.67 -19.13 35.9 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 130.894 3.678 . . . . 0.0 112.287 172.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.61 131.98 48.5 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 163.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 159.3 -158.82 29.89 Favored Glycine 0 CA--C 1.456 -3.616 0 C-N-CA 126.914 2.197 . . . . 0.0 107.737 167.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.333 22.8 m -116.88 136.02 53.27 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 114.964 -2.694 . . . . 0.0 108.316 170.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.429 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 22.9 m-85 -96.77 133.67 41.05 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 119.24 -2.163 . . . . 0.0 114.143 -171.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.4 141.94 37.52 Favored 'General case' 0 C--N 1.37 1.487 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -173.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.472 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 8.3 p -141.3 141.7 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 117.614 -1.635 . . . . 0.0 114.704 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 18.1 m -107.64 118.9 37.93 Favored 'General case' 0 C--N 1.378 1.844 0 C-N-CA 128.488 2.715 . . . . 0.0 107.187 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.33 118.98 42.25 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 126.058 1.743 . . . . 0.0 111.697 -172.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.6 m -108.24 129.36 55.21 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.402 28.9 p-10 -124.02 -177.15 3.67 Favored 'General case' 0 C--N 1.372 1.559 0 O-C-N 120.944 -1.098 . . . . 0.0 112.885 174.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.668 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 86.2 p -50.15 3.93 0.01 OUTLIER 'General case' 0 C--N 1.36 1.026 2 C-N-CA 135.742 5.617 . . . . 0.0 121.954 -168.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -101.8 4.65 40.61 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 164.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.348 3.1 mp0 66.78 39.69 3.41 Favored 'General case' 0 C--N 1.379 1.887 1 C-N-CA 133.678 4.791 . . . . 0.0 109.974 -174.367 . . . . . . . . 3 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.3 m -113.13 123.97 69.3 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.62 0 CA-C-N 112.418 -2.174 . . . . 0.0 113.021 -170.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.31 123.67 34.92 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.251 2.221 . . . . 0.0 107.034 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.13 156.54 26.26 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -130.35 147.07 52.02 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 121.382 -0.824 . . . . 0.0 110.104 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.472 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.294 58.7 p -123.64 143.7 50.08 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 m -54.93 148.24 13.78 Favored 'General case' 0 C--N 1.377 1.791 2 C-N-CA 138.807 6.843 . . . . 0.0 114.699 -168.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.8 p -67.61 109.81 3.43 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.223 1.809 . . . . 0.0 111.238 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.72 108.78 20.48 Favored 'General case' 0 C--N 1.37 1.488 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -94.63 109.22 21.17 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 120.519 1.509 . . . . 0.0 111.465 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.87 113.93 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 59.3 m . . . . . 0 CA--C 1.492 -1.28 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 -175.911 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.474 ' HG ' ' H ' ' A' ' 94' ' ' SER . 1.2 mp . . . . . 0 CA--C 1.578 2.046 0 CA-C-O 122.278 1.037 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.49 ' HB ' ' SG ' ' A' ' 153' ' ' CYS . 19.1 m -172.25 179.75 2.5 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 100.399 -3.926 . . . . 0.0 100.399 174.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.12 -42.66 0.46 Allowed 'General case' 0 C--N 1.367 1.353 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.0 m -164.63 99.63 0.79 Allowed 'General case' 0 N--CA 1.477 0.9 0 O-C-N 118.449 -2.657 . . . . 0.0 115.601 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 19.9 mmm -120.27 117.55 28.13 Favored 'General case' 0 C--N 1.369 1.449 0 CA-C-O 122.591 1.186 . . . . 0.0 109.664 168.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.5 p -115.15 114.86 25.85 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 86' ' ' GLU . 7.4 p -150.94 174.63 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 112.973 -1.921 . . . . 0.0 111.17 -171.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.417 ' O ' HG21 ' A' ' 85' ' ' VAL . 48.4 mt-10 -70.02 144.68 52.17 Favored 'General case' 0 CA--C 1.564 1.501 0 O-C-N 118.968 -2.332 . . . . 0.0 107.724 158.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.437 0.7 OUTLIER -44.14 123.17 3.26 Favored 'General case' 0 N--CA 1.523 3.176 0 O-C-N 117.675 -3.141 . . . . 0.0 117.733 -170.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.52 50.17 0.22 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-N 111.347 -2.661 . . . . 0.0 108.884 -154.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.9 139.43 32.12 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 125.298 1.439 . . . . 0.0 108.32 173.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.94 119.33 32.71 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -167.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 mt -121.46 129.14 52.79 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.194 2.598 . . . . 0.0 117.584 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.95 118.48 33.05 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 100.352 -3.944 . . . . 0.0 100.352 167.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.49 115.09 22.2 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.474 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 8.8 t -155.03 131.58 10.54 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -169.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 m -150.17 173.71 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.649 1 C-N-CA 131.748 4.019 . . . . 0.0 103.465 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.2 t -104.29 141.44 36.3 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 122.857 2.571 . . . . 0.0 106.67 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.75 145.53 48.53 Favored 'General case' 0 C--N 1.37 1.495 0 N-CA-C 119.618 3.192 . . . . 0.0 119.618 -174.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.6 m -158.29 174.29 15.38 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 131.644 3.978 . . . . 0.0 101.41 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.39 44.49 2.21 Favored Glycine 0 C--N 1.364 2.089 0 CA-C-N 122.111 2.232 . . . . 0.0 116.508 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.86 21.42 57.62 Favored Glycine 0 C--N 1.356 1.676 0 C-N-CA 127.297 2.379 . . . . 0.0 115.578 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.408 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 90.7 m -117.6 111.25 18.94 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 114.799 -2.524 . . . . 0.0 107.728 174.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.684 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 78.57 -91.22 1.16 Allowed Glycine 0 C--N 1.375 2.721 0 C-N-CA 129.546 3.451 . . . . 0.0 109.679 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 101' ' ' THR . 23.4 Cg_exo -60.61 167.22 8.61 Favored 'Trans proline' 0 CA--C 1.57 2.312 1 C-N-CA 126.566 4.844 . . . . 0.0 116.288 160.138 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.481 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 69.0 m-85 -98.94 145.33 27.14 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 120.473 3.508 . . . . 0.0 120.473 -166.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.7 t -102.7 140.06 37.47 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -114.32 148.98 36.69 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 -164.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.65 111.25 10.46 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 102.358 -3.201 . . . . 0.0 102.358 162.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.422 ' CE2' HG21 ' A' ' 138' ' ' VAL . 40.7 m95 -112.93 150.28 32.04 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 125.301 1.44 . . . . 0.0 108.661 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.65 169.64 19.92 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 165.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.406 ' NZ ' ' CZ ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -139.84 104.15 4.82 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 175.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.235 1.5 t70 34.77 52.85 0.6 Allowed 'General case' 0 CA--C 1.473 -1.994 2 N-CA-C 122.336 4.199 . . . . 0.0 122.336 142.339 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.77 -11.25 71.41 Favored Glycine 0 C--N 1.366 2.195 2 O-C-N 133.346 6.654 . . . . 0.0 118.629 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.1 m -124.14 148.17 56.74 Favored Pre-proline 0 CA--C 1.564 1.497 0 C-N-CA 131.287 3.835 . . . . 0.0 121.034 -168.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.62 148.52 92.26 Favored 'Trans proline' 0 C--N 1.378 2.122 1 C-N-CA 126.834 5.023 . . . . 0.0 115.247 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.12 162.11 20.76 Favored Pre-proline 0 C--N 1.354 0.788 0 O-C-N 119.741 -1.85 . . . . 0.0 115.482 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -73.82 88.96 1.02 Allowed 'Trans proline' 0 C--N 1.363 1.335 1 C-N-CA 125.923 4.415 . . . . 0.0 114.699 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.1 t70 82.19 -53.71 0.23 Allowed 'General case' 0 C--N 1.361 1.098 0 C-N-CA 128.528 2.731 . . . . 0.0 113.48 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 91.55 -48.34 0.02 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 129.789 3.236 . . . . 0.0 113.639 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.416 ' HA ' ' CE1' ' A' ' 106' ' ' TYR 0.252 33.1 t -77.61 49.33 0.73 Allowed 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 129.479 3.112 . . . . 0.0 114.017 -174.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -131.0 -46.16 0.15 Allowed Glycine 0 C--N 1.367 2.267 1 N-CA-C 124.665 4.626 . . . . 0.0 124.665 -162.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.291 . . 99.72 -75.99 0.0 OUTLIER 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.734 2.267 . . . . 0.0 111.564 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.298 6.5 t -130.95 102.32 6.0 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-O 123.528 1.633 . . . . 0.0 110.805 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.262 19.2 p90 -126.97 141.74 51.72 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 128.324 2.65 . . . . 0.0 111.485 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 38.0 m -128.42 139.29 52.44 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 119.645 -1.909 . . . . 0.0 107.861 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.16 92.39 35.51 Favored Pre-proline 0 C--N 1.358 0.96 0 C-N-CA 129.494 3.118 . . . . 0.0 104.362 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -68.47 -33.16 23.56 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.47 3.447 . . . . 0.0 112.719 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 97.5 m -127.4 104.12 7.74 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 126.008 1.723 . . . . 0.0 106.442 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.09 124.06 35.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.305 1.442 . . . . 0.0 110.51 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.38 170.86 13.16 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.91 2.084 . . . . 0.0 108.002 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.12 -47.51 23.37 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -170.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.65 -23.38 67.06 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 126.753 2.021 . . . . 0.0 115.061 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -83.43 -12.85 55.92 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.846 2.858 . . . . 0.0 112.574 172.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.51 155.83 19.43 Favored 'General case' 0 C--N 1.381 1.951 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 170.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 141.54 -149.39 21.07 Favored Glycine 0 CA--C 1.457 -3.554 0 N-CA-C 104.713 -3.355 . . . . 0.0 104.713 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.264 66.8 m -125.97 138.26 53.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 114.543 -2.863 . . . . 0.0 107.606 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.406 ' CZ ' ' NZ ' ' A' ' 110' ' ' LYS . 8.7 m-85 -96.96 134.64 40.06 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 126.445 1.898 . . . . 0.0 112.054 -168.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.58 143.43 30.8 Favored 'General case' 0 C--N 1.365 1.26 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.622 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 14.9 p -143.25 143.51 24.68 Favored 'Isoleucine or valine' 0 C--N 1.364 1.236 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -111.56 122.63 48.33 Favored 'General case' 0 C--N 1.375 1.705 0 C-N-CA 130.921 3.688 . . . . 0.0 105.994 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.414 ' CG2' ' HZ2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -134.55 120.37 32.35 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 124.518 1.127 . . . . 0.0 109.844 -172.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.9 m -105.22 132.87 50.89 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.481 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.384 23.9 p-10 -126.12 -174.45 3.11 Favored 'General case' 0 C--N 1.38 1.904 0 C-N-CA 124.589 1.155 . . . . 0.0 112.691 176.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.684 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 6.5 p -49.24 0.31 0.01 OUTLIER 'General case' 0 C--N 1.372 1.551 1 C-N-CA 136.577 5.951 . . . . 0.0 120.821 -166.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -104.04 4.54 34.52 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 118.474 -1.29 . . . . 0.0 107.836 165.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.464 94.7 mm-40 67.24 40.3 2.82 Favored 'General case' 0 C--N 1.374 1.631 1 C-N-CA 132.707 4.403 . . . . 0.0 110.56 -172.692 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.78 126.07 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.346 0 CA-C-N 111.605 -2.543 . . . . 0.0 112.845 -171.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.83 125.9 35.87 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 127.777 2.431 . . . . 0.0 108.109 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.468 ' HZ1' ' HB3' ' A' ' 150' ' ' SER . 0.1 OUTLIER -116.24 156.74 26.05 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 -176.421 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -130.65 146.88 52.24 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 120.543 -1.348 . . . . 0.0 111.492 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.622 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.433 91.8 p -127.19 146.29 50.46 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.557 0.743 . . . . 0.0 111.807 176.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.0 m -54.61 148.59 12.19 Favored 'General case' 0 CA--C 1.488 -1.407 1 C-N-CA 138.496 6.718 . . . . 0.0 117.42 -164.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.8 p -68.56 110.2 4.1 Favored 'General case' 0 C--N 1.377 1.768 0 C-N-CA 127.764 2.426 . . . . 0.0 110.046 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.49 ' SG ' ' HB ' ' A' ' 80' ' ' THR . 1.0 OUTLIER -106.35 109.35 21.25 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 -172.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.54 122.46 42.64 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -168.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.17 115.03 44.43 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 C-N-CA 125.045 1.338 . . . . 0.0 108.128 176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 62.7 m . . . . . 0 C--N 1.372 1.561 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 177.627 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 m -171.48 172.94 4.92 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 116.726 -3.734 . . . . 0.0 101.032 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.48 -42.71 0.55 Allowed 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.467 1.485 . . . . 0.0 111.479 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.1 m -162.86 113.39 1.45 Allowed 'General case' 0 C--N 1.356 0.875 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -174.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.77 117.26 19.97 Favored 'General case' 0 C--N 1.371 1.532 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 162.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.6 m -116.41 116.81 28.38 Favored 'General case' 0 C--N 1.364 1.198 0 O-C-N 117.946 -2.971 . . . . 0.0 110.066 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 p -149.57 172.29 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.533 1.133 . . . . 0.0 113.059 -173.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -83.72 130.67 34.96 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 162.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.326 0.3 OUTLIER -41.53 123.09 2.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 120.076 3.361 . . . . 0.0 120.076 -150.492 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.64 48.84 0.05 OUTLIER Glycine 0 C--N 1.357 1.701 0 CA-C-N 109.941 -3.299 . . . . 0.0 111.896 -170.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.98 171.67 11.94 Favored 'General case' 0 C--N 1.37 1.471 0 C-N-CA 124.731 1.213 . . . . 0.0 112.95 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.54 115.77 30.2 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.251 1.42 . . . . 0.0 108.508 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.47 113.06 19.76 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.467 2.307 . . . . 0.0 113.346 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.97 126.92 54.44 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 170.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.423 HD11 ' CG ' ' A' ' 136' ' ' TYR . 1.9 mm? -112.57 114.43 27.08 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 102.625 -3.102 . . . . 0.0 102.625 174.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.1 m -150.24 134.58 17.22 Favored 'General case' 0 C--N 1.368 1.389 0 CA-C-O 121.729 0.776 . . . . 0.0 112.043 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.17 173.03 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 C-N-CA 131.521 3.928 . . . . 0.0 103.766 174.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.9 p -103.59 137.43 41.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.48 2.712 . . . . 0.0 108.121 -173.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.6 145.82 35.5 Favored 'General case' 0 C--N 1.384 2.098 1 N-CA-C 127.602 6.149 . . . . 0.0 127.602 -170.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.7 p -156.67 175.07 14.54 Favored 'General case' 0 C--N 1.37 1.491 1 C-N-CA 134.241 5.016 . . . . 0.0 103.985 173.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.64 40.19 0.78 Allowed Glycine 0 C--N 1.367 2.27 0 O-C-N 119.279 -2.138 . . . . 0.0 117.798 170.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.5 30.73 15.06 Favored Glycine 0 C--N 1.359 1.812 0 C-N-CA 128.54 2.972 . . . . 0.0 114.648 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 33.5 p -117.35 109.67 17.1 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 114.39 -2.719 . . . . 0.0 108.79 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.548 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.68 -90.64 0.86 Allowed Glycine 0 C--N 1.378 2.886 0 CA-C-N 124.147 3.158 . . . . 0.0 111.591 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -62.29 169.17 8.31 Favored 'Trans proline' 0 CA--C 1.569 2.256 1 C-N-CA 126.528 4.819 . . . . 0.0 113.62 158.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 61.0 m-85 -100.68 159.79 14.88 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 119.655 3.206 . . . . 0.0 119.655 -165.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.7 t -110.14 141.49 42.95 Favored 'General case' 0 C--N 1.368 1.392 0 N-CA-C 102.393 -3.188 . . . . 0.0 102.393 171.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.39 151.03 47.12 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 120.501 3.519 . . . . 0.0 120.501 -165.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.11 124.51 34.93 Favored 'General case' 0 C--N 1.368 1.391 0 C-N-CA 128.776 2.83 . . . . 0.0 106.908 172.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.444 ' HB2' HG13 ' A' ' 115' ' ' ILE . 8.8 m95 -113.2 147.62 37.09 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 125.344 1.457 . . . . 0.0 113.76 -177.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.14 169.63 17.5 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 166.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.842 ' HZ2' ' HB2' ' A' ' 113' ' ' SER . 1.8 ptmm? -140.74 107.43 5.35 Favored 'General case' 0 N--CA 1.42 -1.97 0 O-C-N 119.92 -1.738 . . . . 0.0 108.087 173.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.205 1.7 t70 34.23 52.25 0.49 Allowed 'General case' 0 C--N 1.373 1.605 1 N-CA-C 123.649 4.685 . . . . 0.0 123.649 141.859 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.14 -5.98 84.11 Favored Glycine 0 C--N 1.367 2.271 2 O-C-N 132.724 6.265 . . . . 0.0 119.712 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.842 ' HB2' ' HZ2' ' A' ' 110' ' ' LYS 0.359 2.2 m -124.05 149.37 60.03 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 130.468 3.507 . . . . 0.0 118.115 -171.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.09 158.6 38.39 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 124.221 3.281 . . . . 0.0 115.161 164.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.444 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.1 OUTLIER -108.94 155.95 39.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 120.04 -1.662 . . . . 0.0 110.255 177.345 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -69.06 84.37 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.216 3.944 . . . . 0.0 115.837 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.6 t70 80.13 -54.18 0.37 Allowed 'General case' 0 C--N 1.366 1.312 0 C-N-CA 129.302 3.041 . . . . 0.0 113.131 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 88.51 -163.52 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 130.405 3.482 . . . . 0.0 110.878 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.06 4.91 5.04 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.95 -31.95 6.07 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 120.651 3.02 . . . . 0.0 120.651 -163.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.279 . . 91.52 -52.91 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 127.684 2.393 . . . . 0.0 111.317 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.319 12.1 t -140.33 97.44 3.22 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 123.022 1.392 . . . . 0.0 109.561 177.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.27 2.5 p90 -126.69 140.25 52.54 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 128.03 2.532 . . . . 0.0 111.374 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.8 m -129.58 140.26 51.26 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 119.804 -1.81 . . . . 0.0 112.802 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.313 0.7 OUTLIER -108.73 111.99 60.69 Favored Pre-proline 0 C--N 1.373 1.609 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 168.183 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -77.65 -17.3 14.32 Favored 'Trans proline' 0 CA--C 1.538 0.681 1 C-N-CA 126.373 4.715 . . . . 0.0 113.503 171.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 61.5 m -157.79 107.05 2.1 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 103.277 -2.861 . . . . 0.0 103.277 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.33 134.79 36.44 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.234 2.213 . . . . 0.0 113.822 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.07 172.2 11.45 Favored 'General case' 0 C--N 1.371 1.505 0 C-N-CA 128.444 2.697 . . . . 0.0 110.47 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.62 -45.81 28.0 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 119.817 3.265 . . . . 0.0 119.817 -171.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -62.75 -17.66 61.31 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 127.833 2.453 . . . . 0.0 114.977 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -79.55 -14.89 58.54 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 128.146 2.578 . . . . 0.0 112.713 170.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.48 38.99 Favored 'General case' 0 C--N 1.389 2.325 1 N-CA-C 122.339 4.2 . . . . 0.0 122.339 172.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.573 ' CA ' ' HZ3' ' A' ' 110' ' ' LYS . . . 150.73 -135.91 5.37 Favored Glycine 0 C--N 1.374 2.652 0 C-N-CA 130.314 3.816 . . . . 0.0 109.253 169.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.414 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 19.7 m -129.78 140.25 51.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 115.853 -2.339 . . . . 0.0 110.679 173.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.57 ' CZ ' ' HD2' ' A' ' 110' ' ' LYS . 43.2 m-85 -97.03 134.75 39.98 Favored 'General case' 0 C--N 1.366 1.323 0 C-N-CA 127.09 2.156 . . . . 0.0 113.016 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -142.45 141.54 32.21 Favored 'General case' 0 C--N 1.368 1.398 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -174.234 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.36 2.2 p -133.75 134.63 56.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.94 107.81 19.01 Favored 'General case' 0 C--N 1.377 1.773 0 C-N-CA 130.345 3.458 . . . . 0.0 106.541 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.62 118.67 56.58 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 C-N-CA 128.243 2.617 . . . . 0.0 112.49 -168.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 4.2 m -103.57 132.81 49.51 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 119.318 -2.114 . . . . 0.0 114.391 -177.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.458 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.327 24.4 p-10 -128.39 -178.96 4.77 Favored 'General case' 0 C--N 1.378 1.816 0 CA-C-N 120.321 1.419 . . . . 0.0 111.52 175.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.548 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 13.3 p -49.23 3.22 0.01 OUTLIER 'General case' 0 C--N 1.372 1.562 1 C-N-CA 136.515 5.926 . . . . 0.0 120.332 -169.26 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -101.01 4.78 42.7 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.618 162.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.439 0.7 OUTLIER 64.96 39.63 5.68 Favored 'General case' 0 C--N 1.372 1.569 1 C-N-CA 134.024 4.93 . . . . 0.0 111.635 -174.625 . . . . . . . . 4 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 141' ' ' THR . 3.0 m -113.19 133.7 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 CA-C-N 111.213 -2.721 . . . . 0.0 111.885 -170.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.84 125.78 35.83 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 127.65 2.38 . . . . 0.0 106.87 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.8 158.78 22.37 Favored 'General case' 0 CA--C 1.486 -1.481 0 C-N-CA 129.267 3.027 . . . . 0.0 103.123 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -126.47 135.33 51.22 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 123.836 1.779 . . . . 0.0 109.605 -174.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.283 2.8 p -121.96 146.51 47.07 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.001 -1.908 . . . . 0.0 109.952 -176.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 m -54.14 147.1 13.53 Favored 'General case' 0 CA--C 1.481 -1.682 1 C-N-CA 136.91 6.084 . . . . 0.0 118.273 -158.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.7 p -69.47 110.67 4.86 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.677 2.391 . . . . 0.0 110.549 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 109.77 21.94 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -98.22 113.44 25.37 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-O 123.844 1.783 . . . . 0.0 112.837 -173.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.18 128.35 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 O-C-N 119.187 -2.196 . . . . 0.0 109.511 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.493 -1.216 0 N-CA-C 103.795 -2.669 . . . . 0.0 103.795 175.463 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.211 -0.946 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -172.61 172.41 4.26 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 117.279 -3.388 . . . . 0.0 104.499 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.46 -48.33 1.69 Allowed 'General case' 0 C--N 1.355 0.844 0 C-N-CA 126.844 2.057 . . . . 0.0 112.061 175.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.2 t -173.68 138.07 0.64 Allowed 'General case' 0 C--N 1.362 1.117 0 O-C-N 119.36 -2.087 . . . . 0.0 115.088 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.3 ttt -141.03 116.56 10.18 Favored 'General case' 0 C--N 1.377 1.78 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 158.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.5 p -109.45 116.18 31.32 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 119.409 -2.057 . . . . 0.0 109.432 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 86' ' ' GLU . 7.1 p -149.52 172.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.794 0 C-N-CA 126.327 1.851 . . . . 0.0 110.174 -171.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.403 ' O ' HG22 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -80.86 133.8 35.65 Favored 'General case' 0 C--N 1.371 1.505 0 O-C-N 119.424 -2.048 . . . . 0.0 106.561 163.213 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.288 9.5 pt-20 -42.55 122.41 2.27 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 120.232 3.419 . . . . 0.0 120.232 -156.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.37 46.09 0.06 OUTLIER Glycine 0 C--N 1.361 1.954 0 CA-C-N 110.312 -3.131 . . . . 0.0 110.979 -164.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.38 167.12 16.79 Favored 'General case' 0 C--N 1.375 1.69 0 C-N-CA 125.222 1.409 . . . . 0.0 112.984 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.31 105.8 14.19 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.419 1.087 . . . . 0.0 110.578 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.31 121.51 42.21 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.464 1.506 . . . . 0.0 113.418 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.08 131.04 53.09 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 102.221 -3.251 . . . . 0.0 102.221 172.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.2 113.57 20.63 Favored 'General case' 0 C--N 1.352 0.682 1 N-CA-C 98.967 -4.457 . . . . 0.0 98.967 170.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.6 m -153.67 132.79 12.59 Favored 'General case' 0 C--N 1.365 1.269 0 CA-C-N 121.093 1.769 . . . . 0.0 109.8 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.7 m -149.22 174.64 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 130.893 3.677 . . . . 0.0 104.104 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -103.89 139.65 38.78 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 128.25 2.62 . . . . 0.0 105.254 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.58 144.26 34.14 Favored 'General case' 0 C--N 1.381 1.964 1 N-CA-C 123.91 4.781 . . . . 0.0 123.91 -174.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.7 p -156.71 175.62 13.82 Favored 'General case' 0 C--N 1.364 1.212 1 C-N-CA 133.812 4.845 . . . . 0.0 104.288 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.54 40.0 0.76 Allowed Glycine 0 C--N 1.366 2.233 0 O-C-N 119.992 -1.693 . . . . 0.0 117.243 168.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.28 29.46 27.72 Favored Glycine 0 C--N 1.362 2.0 0 C-N-CA 128.199 2.809 . . . . 0.0 115.419 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.437 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 66.7 m -117.94 110.6 17.92 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 115.178 -2.344 . . . . 0.0 109.008 173.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.6 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 77.59 -87.08 1.03 Allowed Glycine 0 C--N 1.377 2.822 0 C-N-CA 129.402 3.382 . . . . 0.0 109.655 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 101' ' ' THR . 36.4 Cg_exo -59.93 168.65 5.53 Favored 'Trans proline' 0 CA--C 1.566 2.09 1 C-N-CA 126.628 4.885 . . . . 0.0 115.143 157.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 67.8 m-85 -103.98 146.59 28.47 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 -166.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -102.64 140.01 37.48 Favored 'General case' 0 C--N 1.373 1.619 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.37 157.51 31.67 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 119.862 3.282 . . . . 0.0 119.862 -164.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -131.02 119.59 22.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 110.391 -3.095 . . . . 0.0 104.273 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.412 ' CE3' HG23 ' A' ' 138' ' ' VAL . 38.1 m95 -111.01 128.54 55.88 Favored 'General case' 0 C--N 1.379 1.87 0 CA-C-N 119.606 1.094 . . . . 0.0 111.235 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.328 0.2 OUTLIER -143.58 170.83 15.08 Favored 'General case' 0 C--N 1.377 1.779 0 CA-C-N 121.462 1.937 . . . . 0.0 108.145 170.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.472 ' HZ2' ' C ' ' A' ' 132' ' ' ASP . 31.4 tttt -151.0 107.3 3.47 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 120.138 -1.601 . . . . 0.0 108.843 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.268 1.3 t70 34.25 52.42 0.5 Allowed 'General case' 0 CA--C 1.467 -2.249 2 N-CA-C 122.477 4.251 . . . . 0.0 122.477 142.186 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.44 2.2 83.81 Favored Glycine 0 C--N 1.373 2.637 2 O-C-N 133.935 7.022 . . . . 0.0 118.266 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.265 3.2 m -125.06 147.1 55.85 Favored Pre-proline 0 C--N 1.349 0.553 0 C-N-CA 127.672 2.389 . . . . 0.0 116.853 -172.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.63 152.37 78.3 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 124.697 3.598 . . . . 0.0 113.842 170.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.76 148.83 36.42 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 120.06 -1.65 . . . . 0.0 108.296 175.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -62.61 -78.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.996 3.797 . . . . 0.0 119.384 -166.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -125.42 63.65 1.18 Allowed 'General case' 0 C--N 1.349 0.548 0 C-N-CA 124.673 1.189 . . . . 0.0 108.387 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.66 150.5 44.13 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 119.386 3.106 . . . . 0.0 119.386 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 81.16 75.94 0.03 OUTLIER 'General case' 0 C--N 1.363 1.193 0 C-N-CA 125.266 1.426 . . . . 0.0 111.987 175.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -165.24 -46.85 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 117.908 1.923 . . . . 0.0 117.908 -172.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.334 . . 135.65 -68.96 0.0 OUTLIER 'General case' 0 C--N 1.351 0.67 0 C-N-CA 128.174 2.59 . . . . 0.0 108.01 -178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.256 9.0 t -138.33 115.93 11.34 Favored 'General case' 0 C--N 1.359 0.978 0 CA-C-N 120.61 1.55 . . . . 0.0 114.467 -174.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.302 4.3 p90 -127.77 140.69 51.89 Favored 'General case' 0 C--N 1.368 1.402 0 C-N-CA 129.458 3.103 . . . . 0.0 110.957 175.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.4 m -129.81 140.22 51.07 Favored 'General case' 0 C--N 1.358 0.951 0 O-C-N 118.344 -2.722 . . . . 0.0 110.368 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.37 96.42 35.61 Favored Pre-proline 0 C--N 1.367 1.355 0 C-N-CA 128.399 2.68 . . . . 0.0 106.982 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -77.38 -14.64 16.22 Favored 'Trans proline' 0 C--N 1.359 1.127 1 C-N-CA 126.946 5.097 . . . . 0.0 114.502 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -161.97 105.79 1.2 Allowed 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 176.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.28 133.95 37.27 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.173 2.189 . . . . 0.0 112.772 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.5 177.97 7.24 Favored 'General case' 0 C--N 1.371 1.518 0 C-N-CA 128.191 2.596 . . . . 0.0 111.066 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.05 -48.6 33.11 Favored 'General case' 0 C--N 1.364 1.22 0 N-CA-C 118.955 2.946 . . . . 0.0 118.955 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.44 -14.18 62.7 Favored 'General case' 0 C--N 1.366 1.296 0 C-N-CA 126.696 1.999 . . . . 0.0 114.573 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.472 ' C ' ' HZ2' ' A' ' 110' ' ' LYS 0.332 31.5 m-20 -82.58 -14.28 55.11 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 130.354 3.462 . . . . 0.0 111.48 170.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.79 133.86 41.88 Favored 'General case' 0 C--N 1.383 2.059 0 N-CA-C 118.09 2.626 . . . . 0.0 118.09 165.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.9 -158.92 31.6 Favored Glycine 0 C--N 1.37 2.421 0 C-N-CA 126.793 2.139 . . . . 0.0 109.492 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.268 11.0 t -117.74 135.94 53.7 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 114.612 -2.835 . . . . 0.0 106.879 169.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.433 ' HB2' ' HB2' ' A' ' 153' ' ' CYS 0.26 13.7 m-85 -97.4 134.49 40.59 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 127.072 2.149 . . . . 0.0 112.342 -173.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.63 153.96 43.05 Favored 'General case' 0 C--N 1.365 1.282 0 CA-C-O 123.231 1.491 . . . . 0.0 108.851 -174.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.497 HG13 HG22 ' A' ' 140' ' ' VAL . 1.1 t -143.62 148.15 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 117.388 -1.725 . . . . 0.0 114.672 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -120.29 120.8 37.12 Favored 'General case' 0 C--N 1.381 1.96 0 C-N-CA 126.127 1.771 . . . . 0.0 106.308 171.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 138' ' ' VAL . 0.1 OUTLIER -131.91 123.56 51.61 Favored 'Isoleucine or valine' 0 C--N 1.367 1.341 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -176.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.6 m -106.63 133.62 51.03 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 119.366 -2.084 . . . . 0.0 114.625 -176.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.485 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.37 18.9 p-10 -127.85 -179.05 4.75 Favored 'General case' 0 C--N 1.38 1.929 0 CA-C-N 119.962 1.256 . . . . 0.0 112.064 175.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.6 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 8.0 p -49.17 1.33 0.01 OUTLIER 'General case' 0 C--N 1.375 1.713 1 C-N-CA 136.593 5.957 . . . . 0.0 119.964 -167.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -101.29 4.81 42.03 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 118.502 -1.279 . . . . 0.0 108.271 164.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.462 1.3 tp60 64.83 39.69 5.94 Favored 'General case' 0 C--N 1.371 1.502 1 C-N-CA 134.582 5.153 . . . . 0.0 111.569 -173.6 . . . . . . . . 3 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.4 m -112.88 131.45 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 CA-C-N 111.54 -2.573 . . . . 0.0 111.632 -169.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.64 128.72 38.59 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.249 1.82 . . . . 0.0 108.425 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 147.13 41.68 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 101.246 -3.613 . . . . 0.0 101.246 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -130.36 147.09 52.03 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 119.43 -2.043 . . . . 0.0 107.051 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 54.2 p -116.94 151.96 35.56 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 120.822 -1.174 . . . . 0.0 113.273 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.3 148.04 15.61 Favored 'General case' 0 C--N 1.375 1.677 1 C-N-CA 136.782 6.033 . . . . 0.0 116.153 -172.019 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.1 p -68.1 111.63 4.59 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 127.034 2.134 . . . . 0.0 111.417 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 1.8 m -97.06 108.45 21.19 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 102.461 -3.163 . . . . 0.0 102.461 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.73 106.81 18.75 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-O 124.704 2.192 . . . . 0.0 109.195 -172.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.46 127.79 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 O-C-N 120.309 -1.494 . . . . 0.0 107.421 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 92.6 m . . . . . 0 CA--C 1.484 -1.564 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.006 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.575 1.906 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.5 m -161.88 173.0 15.14 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 117.221 -3.424 . . . . 0.0 103.652 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.98 -47.15 0.59 Allowed 'General case' 0 C--N 1.365 1.275 0 C-N-CA 127.834 2.454 . . . . 0.0 115.468 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.7 p -172.36 116.25 0.34 Allowed 'General case' 0 C--N 1.368 1.385 0 N-CA-C 120.479 3.511 . . . . 0.0 120.479 -172.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.1 ttt -127.06 126.44 43.06 Favored 'General case' 0 C--N 1.38 1.905 0 CA-C-N 121.843 2.11 . . . . 0.0 114.267 165.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -105.5 116.44 31.94 Favored 'General case' 0 C--N 1.373 1.601 0 O-C-N 119.568 -1.957 . . . . 0.0 108.506 174.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 86' ' ' GLU . 9.1 p -149.01 172.94 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.639 0 CA-C-O 122.714 1.245 . . . . 0.0 114.251 -169.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' HG21 ' A' ' 85' ' ' VAL . 40.9 mt-10 -86.1 123.99 32.02 Favored 'General case' 0 C--N 1.368 1.404 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 161.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -42.07 122.31 2.08 Favored 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 124.239 3.199 . . . . 0.0 118.234 -155.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 143.53 54.23 0.03 OUTLIER Glycine 0 C--N 1.356 1.672 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.636 -162.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.38 166.34 14.33 Favored 'General case' 0 C--N 1.363 1.152 0 C-N-CA 125.099 1.36 . . . . 0.0 112.143 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.9 111.16 22.1 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.166 0.986 . . . . 0.0 108.744 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.0 mp -119.75 116.01 25.06 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 125.854 1.662 . . . . 0.0 113.774 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.93 125.09 52.47 Favored 'General case' 0 C--N 1.364 1.219 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 173.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -121.24 113.61 20.2 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 101.412 -3.551 . . . . 0.0 101.412 171.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.8 m -147.92 133.38 18.66 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 119.753 -1.842 . . . . 0.0 111.387 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.13 175.48 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 130.258 3.423 . . . . 0.0 104.364 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 t -104.13 139.26 39.44 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 128.066 2.547 . . . . 0.0 105.69 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.76 147.48 37.41 Favored 'General case' 0 C--N 1.381 1.943 1 N-CA-C 123.885 4.772 . . . . 0.0 123.885 -175.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.4 p -157.04 176.06 13.26 Favored 'General case' 0 C--N 1.361 1.096 1 C-N-CA 133.999 4.92 . . . . 0.0 103.701 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.72 41.63 0.69 Allowed Glycine 0 C--N 1.367 2.288 0 N-CA-C 117.2 1.64 . . . . 0.0 117.2 167.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.1 29.0 35.25 Favored Glycine 0 C--N 1.361 1.936 0 C-N-CA 128.526 2.965 . . . . 0.0 115.476 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.435 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 26.5 p -117.02 110.15 17.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 114.334 -2.746 . . . . 0.0 108.598 176.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.659 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.09 -88.66 0.78 Allowed Glycine 0 C--N 1.38 3.003 0 C-N-CA 129.677 3.513 . . . . 0.0 110.022 -174.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 101' ' ' THR . 25.1 Cg_exo -59.97 169.1 5.03 Favored 'Trans proline' 0 CA--C 1.571 2.335 1 C-N-CA 127.223 5.282 . . . . 0.0 116.139 158.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.45 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 57.3 m-85 -101.09 143.18 31.52 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 120.616 3.561 . . . . 0.0 120.616 -166.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -102.86 141.21 36.06 Favored 'General case' 0 C--N 1.379 1.876 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.95 156.32 49.21 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 121.015 3.709 . . . . 0.0 121.015 -163.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -136.33 111.85 9.28 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 112.295 -2.23 . . . . 0.0 105.121 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.444 ' CE3' ' HB ' ' A' ' 138' ' ' VAL . 24.7 m95 -112.8 150.0 32.27 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.473 1.509 . . . . 0.0 108.68 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.295 0.1 OUTLIER -156.28 160.5 39.81 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 164.174 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.439 ' HZ1' ' HB3' ' A' ' 113' ' ' SER . 1.8 pptp? -133.93 104.98 6.51 Favored 'General case' 0 C--N 1.368 1.39 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.422 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.243 2.7 t70 37.45 55.17 1.42 Allowed 'General case' 0 CA--C 1.458 -2.585 1 CA-C-O 110.337 -4.649 . . . . 0.0 120.289 155.349 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.97 -10.15 65.89 Favored Glycine 0 C--N 1.376 2.786 2 O-C-N 134.632 7.457 . . . . 0.0 115.716 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.439 ' HB3' ' HZ1' ' A' ' 110' ' ' LYS . 73.9 m -124.68 148.86 60.45 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 129.995 3.318 . . . . 0.0 119.495 -165.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.25 43.8 Cg_endo -60.04 156.98 36.29 Favored 'Trans proline' 0 N--CA 1.5 1.909 1 C-N-CA 125.777 4.318 . . . . 0.0 116.865 167.782 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -112.13 150.02 41.81 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 119.408 -2.057 . . . . 0.0 111.301 175.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.77 -81.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.09 1 C-N-CA 127.966 5.777 . . . . 0.0 119.516 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -100.58 -42.1 6.68 Favored 'General case' 0 C--N 1.359 1.02 0 C-N-CA 125.461 1.504 . . . . 0.0 111.369 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 71.51 -68.93 0.2 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 129.045 2.938 . . . . 0.0 118.155 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.302 8.3 t -75.8 52.77 0.7 Allowed 'General case' 0 N--CA 1.418 -2.051 1 C-N-CA 134.517 5.127 . . . . 0.0 115.544 -169.81 . . . . . . . . 3 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.07 -60.81 0.01 OUTLIER Glycine 0 CA--C 1.476 -2.359 0 N-CA-C 119.152 2.421 . . . . 0.0 119.152 -173.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 150.49 -62.68 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -174.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.6 t -136.68 117.24 13.84 Favored 'General case' 0 C--N 1.359 0.991 0 O-C-N 120.39 -1.444 . . . . 0.0 113.003 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -127.48 138.12 52.86 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.786 2.034 . . . . 0.0 110.751 172.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 27.1 m -129.98 139.46 51.06 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 119.851 -1.781 . . . . 0.0 109.583 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.25 106.8 54.38 Favored Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 127.799 2.439 . . . . 0.0 106.095 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.95 -11.9 17.92 Favored 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.459 4.106 . . . . 0.0 112.738 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -161.24 111.88 1.72 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.25 126.91 45.17 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.98 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.06 -179.31 5.65 Favored 'General case' 0 C--N 1.365 1.281 0 C-N-CA 128.746 2.818 . . . . 0.0 108.584 171.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.6 -53.77 13.72 Favored 'General case' 0 C--N 1.367 1.332 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -69.2 0.14 5.23 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 127.913 2.485 . . . . 0.0 115.304 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -116.23 -7.46 11.8 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 131.423 3.889 . . . . 0.0 110.344 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.54 160.18 14.45 Favored 'General case' 0 C--N 1.397 2.643 0 N-CA-C 120.575 3.546 . . . . 0.0 120.575 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.64 -152.72 24.07 Favored Glycine 0 CA--C 1.465 -3.033 0 C-N-CA 127.643 2.544 . . . . 0.0 107.11 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.315 19.4 m -118.12 136.52 53.54 Favored 'General case' 0 N--CA 1.507 2.384 0 C-N-CA 114.001 -3.08 . . . . 0.0 109.881 171.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.438 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 14.9 m-85 -96.73 133.65 41.02 Favored 'General case' 0 C--N 1.368 1.391 0 CA-C-N 123.136 2.698 . . . . 0.0 115.283 -171.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -141.16 146.38 36.93 Favored 'General case' 0 C--N 1.373 1.596 0 CA-C-O 121.132 0.492 . . . . 0.0 110.393 -175.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.452 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 15.0 p -141.53 143.49 27.39 Favored 'Isoleucine or valine' 0 C--N 1.372 1.564 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.8 m -107.67 120.39 42.11 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 130.341 3.457 . . . . 0.0 107.14 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.54 120.23 44.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 C-N-CA 125.975 1.71 . . . . 0.0 110.752 -173.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -106.88 132.02 53.3 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.475 -1.391 . . . . 0.0 114.522 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.45 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.36 37.3 p-10 -125.93 179.35 5.25 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 119.578 1.081 . . . . 0.0 112.28 175.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.659 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 25.4 p -49.62 3.22 0.01 OUTLIER 'General case' 0 C--N 1.372 1.569 1 C-N-CA 135.384 5.474 . . . . 0.0 120.775 -168.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -101.96 4.75 40.32 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 165.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.494 0.7 OUTLIER 65.72 40.04 4.54 Favored 'General case' 0 C--N 1.37 1.482 1 C-N-CA 133.653 4.781 . . . . 0.0 111.899 -174.342 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.68 124.49 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.649 0 CA-C-N 111.36 -2.655 . . . . 0.0 112.185 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.63 123.72 35.25 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 127.623 2.369 . . . . 0.0 106.404 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.71 153.38 31.47 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 101.809 -3.404 . . . . 0.0 101.809 -175.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -130.4 146.54 51.98 Favored 'General case' 0 CA--C 1.494 -1.204 0 O-C-N 120.958 -1.089 . . . . 0.0 109.688 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.452 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.323 84.2 p -130.6 145.29 51.86 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.0 m -55.0 147.91 14.66 Favored 'General case' 0 C--N 1.376 1.734 1 C-N-CA 137.06 6.144 . . . . 0.0 117.725 -165.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.5 p -67.34 110.22 3.46 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 128.528 2.731 . . . . 0.0 111.075 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.74 108.19 20.2 Favored 'General case' 0 C--N 1.372 1.557 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.85 110.33 22.53 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 123.242 1.496 . . . . 0.0 112.654 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.61 114.88 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.251 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . 0.294 0.6 OUTLIER . . . . . 0 C--N 1.368 1.371 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.437 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 123.927 1.822 . . . . 0.0 112.67 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.6 m -171.92 171.84 4.96 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.24 -48.08 1.99 Allowed 'General case' 0 C--N 1.368 1.372 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 175.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.5 t -171.68 148.55 2.44 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 119.299 -2.125 . . . . 0.0 113.535 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.49 117.35 6.27 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 124.21 1.004 . . . . 0.0 108.48 166.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.8 t -110.57 115.63 29.95 Favored 'General case' 0 C--N 1.366 1.321 0 O-C-N 118.792 -2.442 . . . . 0.0 107.348 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 86' ' ' GLU 0.25 9.5 p -150.97 174.16 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 125.411 1.484 . . . . 0.0 113.757 -169.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.435 ' O ' HG21 ' A' ' 85' ' ' VAL . 49.4 mt-10 -77.68 132.89 38.4 Favored 'General case' 0 C--N 1.374 1.667 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 159.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.359 0.0 OUTLIER -42.97 122.61 2.48 Favored 'General case' 0 N--CA 1.514 2.763 0 N-CA-C 119.606 3.187 . . . . 0.0 119.606 -161.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.84 50.76 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 110.225 -3.171 . . . . 0.0 106.226 -163.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.47 145.91 24.45 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 126.72 2.008 . . . . 0.0 107.469 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.62 121.57 36.32 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 -170.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -120.84 133.82 55.3 Favored 'General case' 0 C--N 1.372 1.583 0 C-N-CA 127.172 2.189 . . . . 0.0 115.956 172.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.81 120.36 32.4 Favored 'General case' 0 C--N 1.359 0.986 1 N-CA-C 98.155 -4.757 . . . . 0.0 98.155 165.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -115.19 115.49 26.8 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 102.018 -3.327 . . . . 0.0 102.018 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 4.9 t -154.62 133.29 12.11 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 117.801 -1.559 . . . . 0.0 111.789 -174.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.87 174.35 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.743 0 C-N-CA 130.405 3.482 . . . . 0.0 105.573 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.8 t -104.03 141.53 36.04 Favored 'General case' 0 C--N 1.361 1.077 0 O-C-N 119.487 -2.008 . . . . 0.0 106.578 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.19 145.21 35.36 Favored 'General case' 0 C--N 1.376 1.759 1 N-CA-C 122.989 4.44 . . . . 0.0 122.989 -173.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.9 p -156.48 175.28 14.23 Favored 'General case' 0 C--N 1.364 1.223 1 C-N-CA 133.234 4.614 . . . . 0.0 103.36 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.61 41.49 1.0 Allowed Glycine 0 C--N 1.362 2.019 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.36 18.92 54.38 Favored Glycine 0 C--N 1.362 1.982 0 C-N-CA 127.14 2.305 . . . . 0.0 116.121 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.6 m -118.19 111.02 18.28 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 115.039 -2.41 . . . . 0.0 110.185 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.658 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 79.35 -93.05 1.31 Allowed Glycine 0 C--N 1.379 2.961 0 C-N-CA 129.665 3.507 . . . . 0.0 109.221 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.36 168.54 6.29 Favored 'Trans proline' 0 CA--C 1.564 1.998 1 C-N-CA 127.485 5.457 . . . . 0.0 116.316 159.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.457 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 74.0 m-85 -99.12 148.14 24.36 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 119.804 3.261 . . . . 0.0 119.804 -165.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -110.7 144.69 39.25 Favored 'General case' 0 C--N 1.381 1.938 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.439 ' CD2' ' N ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -141.09 165.95 26.14 Favored 'General case' 0 C--N 1.346 0.444 1 N-CA-C 122.345 4.202 . . . . 0.0 122.345 -159.75 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.15 118.49 12.81 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 110.723 -2.944 . . . . 0.0 105.044 172.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -111.79 134.48 53.32 Favored 'General case' 0 C--N 1.366 1.288 0 C-N-CA 125.797 1.639 . . . . 0.0 109.321 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.367 0.2 OUTLIER -155.79 170.01 23.06 Favored 'General case' 0 CA--C 1.488 -1.422 0 O-C-N 120.468 -1.395 . . . . 0.0 107.458 170.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.412 ' HD2' ' CE2' ' A' ' 136' ' ' TYR . 1.6 ptmm? -143.01 106.49 4.6 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 119.52 -1.988 . . . . 0.0 111.555 -177.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.44 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.141 2.0 t70 36.41 54.8 1.07 Allowed 'General case' 0 C--N 1.384 2.084 1 CA-C-O 109.687 -4.959 . . . . 0.0 121.53 149.042 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.33 2.83 80.81 Favored Glycine 0 C--N 1.386 3.319 2 O-C-N 135.353 7.908 . . . . 0.0 119.561 -172.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.274 1.0 OUTLIER -125.23 147.48 57.53 Favored Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 129.39 3.076 . . . . 0.0 117.936 -167.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.85 139.39 62.15 Favored 'Trans proline' 0 N--CA 1.504 2.103 1 C-N-CA 126.037 4.492 . . . . 0.0 117.501 169.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -91.63 160.02 37.36 Favored Pre-proline 0 CA--C 1.553 1.059 0 O-C-N 118.441 -2.662 . . . . 0.0 112.773 175.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -72.42 -82.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 124.959 3.773 . . . . 0.0 118.284 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -117.29 60.85 0.75 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.277 1.431 . . . . 0.0 109.643 -171.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . 0.413 ' HB3' HG12 ' A' ' 115' ' ' ILE . . . -67.65 151.79 46.69 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 129.085 2.954 . . . . 0.0 117.565 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.412 ' HA ' ' CD2' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 80.54 63.71 0.02 OUTLIER 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.73 1.612 . . . . 0.0 111.015 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.36 -85.56 0.06 OUTLIER Glycine 0 C--N 1.355 1.598 0 N-CA-C 115.474 0.949 . . . . 0.0 115.474 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 165.74 -65.75 0.0 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 126.068 1.747 . . . . 0.0 106.712 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.263 14.8 t -133.03 110.11 10.0 Favored 'General case' 0 C--N 1.36 1.056 0 CA-C-O 122.994 1.378 . . . . 0.0 113.308 -177.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.293 9.4 p90 -127.09 141.12 51.85 Favored 'General case' 0 C--N 1.369 1.448 0 C-N-CA 128.339 2.656 . . . . 0.0 112.474 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.5 m -128.82 139.7 52.05 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 119.924 -1.735 . . . . 0.0 108.854 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.71 92.19 45.45 Favored Pre-proline 0 C--N 1.354 0.801 0 C-N-CA 128.748 2.819 . . . . 0.0 104.903 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -74.43 -32.89 5.92 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 124.879 3.719 . . . . 0.0 112.854 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 69.0 m -128.38 100.6 5.86 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.67 118.5 31.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.877 1.671 . . . . 0.0 113.111 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.43 -179.06 6.86 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.451 2.301 . . . . 0.0 109.438 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -51.32 23.62 Favored 'General case' 0 C--N 1.366 1.316 0 O-C-N 117.803 -3.06 . . . . 0.0 118.088 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.31 0.86 2.53 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 128.851 2.86 . . . . 0.0 115.111 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -116.36 -13.91 11.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 129.544 3.138 . . . . 0.0 111.102 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.75 154.64 17.46 Favored 'General case' 0 C--N 1.399 2.739 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 174.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.46 -157.78 27.36 Favored Glycine 0 C--N 1.382 3.095 0 C-N-CA 128.923 3.154 . . . . 0.0 109.81 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.393 5.7 m -110.66 130.83 55.47 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 112.343 -3.743 . . . . 0.0 107.545 167.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.451 ' HB2' ' HB3' ' A' ' 153' ' ' CYS . 24.5 m-85 -96.81 134.77 39.68 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-N 122.605 2.457 . . . . 0.0 113.011 -172.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.44 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -148.5 150.64 33.77 Favored 'General case' 0 C--N 1.376 1.743 0 C-N-CA 124.878 1.271 . . . . 0.0 110.456 -175.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.677 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 8.9 p -143.67 137.49 24.95 Favored 'Isoleucine or valine' 0 C--N 1.371 1.501 0 C-N-CA 117.956 -1.497 . . . . 0.0 114.314 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.23 111.77 24.65 Favored 'General case' 0 C--N 1.378 1.811 0 C-N-CA 130.34 3.456 . . . . 0.0 105.341 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.21 112.21 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 128.124 2.569 . . . . 0.0 110.73 -169.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 8.0 m -99.3 130.93 45.62 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.457 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.364 25.3 p-10 -127.7 -177.03 3.94 Favored 'General case' 0 C--N 1.372 1.584 0 CA-C-N 119.234 0.925 . . . . 0.0 112.213 174.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.658 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 20.4 p -49.83 3.36 0.01 OUTLIER 'General case' 0 C--N 1.369 1.414 1 C-N-CA 136.749 6.02 . . . . 0.0 120.501 -169.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -101.27 4.89 42.18 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 163.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.358 2.1 mp0 65.44 39.53 5.12 Favored 'General case' 0 C--N 1.378 1.825 1 C-N-CA 134.249 5.02 . . . . 0.0 110.678 -175.149 . . . . . . . . 3 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 141' ' ' THR . 3.0 m -113.58 133.4 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 CA-C-N 112.137 -2.302 . . . . 0.0 111.99 -170.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.8 t -91.69 132.16 36.57 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 120.744 1.611 . . . . 0.0 106.883 174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.13 157.99 23.92 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 -176.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 22.6 t70 -126.11 134.18 51.42 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.814 0.816 . . . . 0.0 109.294 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.677 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.528 59.8 p -111.13 143.9 41.12 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.8 m -54.05 146.74 13.97 Favored 'General case' 0 C--N 1.368 1.404 1 C-N-CA 136.709 6.004 . . . . 0.0 119.405 -155.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.0 p -69.06 110.1 4.33 Favored 'General case' 0 C--N 1.376 1.719 0 C-N-CA 124.264 1.026 . . . . 0.0 110.711 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 4.7 t -100.02 110.12 22.43 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.14 103.89 15.86 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 122.758 1.266 . . . . 0.0 112.267 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.2 m -112.43 115.18 49.11 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -174.739 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.575 1.907 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -175.93 176.21 1.84 Allowed 'General case' 0 CA--C 1.5 -0.96 1 N-CA-C 97.987 -4.82 . . . . 0.0 97.987 167.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.25 -51.24 2.92 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 121.713 2.052 . . . . 0.0 107.862 162.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.0 t -166.67 135.61 2.9 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 119.562 -1.961 . . . . 0.0 114.396 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 ttt -137.79 116.73 12.4 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-O 122.592 1.187 . . . . 0.0 109.388 161.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -108.57 115.22 29.68 Favored 'General case' 0 C--N 1.362 1.133 0 O-C-N 119.023 -2.298 . . . . 0.0 107.972 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 86' ' ' GLU . 14.4 p -149.55 173.17 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 127.535 2.334 . . . . 0.0 112.077 -169.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 85' ' ' VAL . 10.5 pt-20 -74.59 136.27 42.05 Favored 'General case' 0 C--N 1.37 1.484 0 O-C-N 118.739 -2.476 . . . . 0.0 107.175 158.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.28 5.8 pt-20 -43.34 122.08 2.45 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 -162.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.19 45.0 0.09 OUTLIER Glycine 0 C--N 1.352 1.43 0 CA-C-N 110.094 -3.23 . . . . 0.0 111.526 -162.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.23 164.57 21.11 Favored 'General case' 0 C--N 1.373 1.604 0 C-N-CA 125.07 1.348 . . . . 0.0 111.383 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.37 101.98 10.65 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 123.072 1.415 . . . . 0.0 113.897 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mp -119.71 128.82 54.15 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.6 t -114.53 135.69 53.85 Favored 'General case' 0 C--N 1.358 0.953 1 N-CA-C 99.422 -4.288 . . . . 0.0 99.422 165.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.01 114.79 23.68 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 100.867 -3.753 . . . . 0.0 100.867 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -150.3 132.65 15.55 Favored 'General case' 0 C--N 1.366 1.321 0 C-N-CA 118.2 -1.4 . . . . 0.0 114.147 -168.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 m -149.59 174.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.943 1 C-N-CA 132.971 4.508 . . . . 0.0 106.198 177.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -104.37 141.52 36.18 Favored 'General case' 0 C--N 1.367 1.368 0 O-C-N 118.948 -2.345 . . . . 0.0 106.669 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.98 135.9 38.04 Favored 'General case' 0 C--N 1.374 1.654 0 N-CA-C 120.986 3.699 . . . . 0.0 120.986 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.0 m -157.69 172.11 19.11 Favored 'General case' 0 C--N 1.359 1.012 1 C-N-CA 131.789 4.035 . . . . 0.0 101.518 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.98 44.12 1.27 Allowed Glycine 0 C--N 1.367 2.301 0 CA-C-N 122.535 2.425 . . . . 0.0 117.381 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.29 25.49 57.1 Favored Glycine 0 C--N 1.355 1.596 0 C-N-CA 128.552 2.977 . . . . 0.0 115.422 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.421 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 88.2 m -117.9 110.96 18.38 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 114.444 -2.693 . . . . 0.0 107.587 173.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.615 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 78.03 -89.27 1.08 Allowed Glycine 0 C--N 1.376 2.783 0 C-N-CA 130.148 3.737 . . . . 0.0 109.953 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 101' ' ' THR . 25.1 Cg_exo -60.68 167.99 7.55 Favored 'Trans proline' 0 CA--C 1.564 2.01 1 C-N-CA 127.009 5.14 . . . . 0.0 116.258 159.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.467 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 82.1 m-85 -102.57 146.58 27.94 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 120.036 3.347 . . . . 0.0 120.036 -166.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 t -105.63 153.83 21.26 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 129.354 3.062 . . . . 0.0 104.083 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.02 164.9 38.25 Favored 'General case' 0 C--N 1.366 1.295 1 N-CA-C 122.231 4.16 . . . . 0.0 122.231 -161.135 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.29 114.63 14.64 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 128.614 2.766 . . . . 0.0 106.258 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -111.02 131.27 55.2 Favored 'General case' 0 C--N 1.368 1.404 0 C-N-CA 127.145 2.178 . . . . 0.0 109.807 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.313 0.0 OUTLIER -151.03 169.54 21.57 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 168.602 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.501 ' HZ1' ' HA ' ' A' ' 132' ' ' ASP . 4.0 ttpt -135.61 107.68 7.17 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.24 0.8 OUTLIER 33.25 50.83 0.27 Allowed 'General case' 0 C--N 1.374 1.658 1 N-CA-C 123.546 4.647 . . . . 0.0 123.546 135.421 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.96 -3.54 83.66 Favored Glycine 0 C--N 1.363 2.063 2 O-C-N 132.412 6.07 . . . . 0.0 120.199 -172.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.293 3.4 m -124.02 147.38 53.99 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 129.963 3.305 . . . . 0.0 118.598 -172.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -62.07 140.49 84.47 Favored 'Trans proline' 0 C--N 1.37 1.665 1 C-N-CA 126.215 4.61 . . . . 0.0 115.645 172.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.63 164.87 30.42 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 119.694 -1.879 . . . . 0.0 111.23 175.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -52.21 -44.62 44.86 Favored 'Trans proline' 0 C--N 1.353 0.793 1 C-N-CA 127.785 5.657 . . . . 0.0 118.72 -171.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -169.15 -50.43 0.02 OUTLIER 'General case' 0 C--N 1.348 0.507 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 81.03 -164.17 0.02 OUTLIER 'General case' 0 C--N 1.364 1.204 0 C-N-CA 129.328 3.051 . . . . 0.0 111.401 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t 82.6 3.17 1.14 Allowed 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 119.609 3.189 . . . . 0.0 119.609 170.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.97 85.11 0.06 OUTLIER Glycine 0 CA--C 1.475 -2.467 0 C-N-CA 115.597 -3.192 . . . . 0.0 119.125 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.335 . . 87.47 -78.63 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 163.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.306 6.0 t -141.37 119.95 12.45 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 123.833 1.778 . . . . 0.0 115.153 -170.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -127.3 142.67 51.4 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 129.514 3.126 . . . . 0.0 109.883 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.7 m -126.38 139.0 53.62 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 122.345 2.339 . . . . 0.0 109.678 176.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.15 89.31 39.19 Favored Pre-proline 0 C--N 1.37 1.493 0 C-N-CA 129.056 2.942 . . . . 0.0 103.847 176.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -73.28 -31.39 9.36 Favored 'Trans proline' 0 N--CA 1.471 0.204 1 C-N-CA 125.512 4.142 . . . . 0.0 112.668 -172.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.2 m -143.98 100.53 3.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 177.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.93 134.58 33.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.312 1.845 . . . . 0.0 114.443 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.15 171.69 14.59 Favored 'General case' 0 C--N 1.366 1.302 0 C-N-CA 127.436 2.294 . . . . 0.0 112.343 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.1 -43.72 20.65 Favored 'General case' 0 C--N 1.37 1.477 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -172.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.2 -13.32 61.85 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 128.545 2.738 . . . . 0.0 115.07 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.501 ' HA ' ' HZ1' ' A' ' 110' ' ' LYS . 4.9 m-20 -74.31 -21.08 59.88 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 128.113 2.565 . . . . 0.0 112.239 167.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.17 119.75 9.0 Favored 'General case' 0 C--N 1.386 2.183 0 N-CA-C 120.449 3.5 . . . . 0.0 120.449 172.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.97 -155.13 26.35 Favored Glycine 0 CA--C 1.468 -2.879 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.426 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.316 6.9 m -118.3 132.01 56.31 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 115.397 -2.521 . . . . 0.0 107.214 171.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.468 ' CD1' ' HD3' ' A' ' 110' ' ' LYS . 2.5 m-85 -97.06 133.81 41.24 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 125.85 1.66 . . . . 0.0 110.487 -170.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -145.62 144.5 30.49 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-O 122.091 0.948 . . . . 0.0 109.647 -174.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.291 7.5 p -141.8 135.94 30.23 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 117.685 -1.606 . . . . 0.0 114.166 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.8 m -103.08 121.26 42.22 Favored 'General case' 0 C--N 1.38 1.915 0 C-N-CA 129.455 3.102 . . . . 0.0 106.238 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.22 120.44 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 127.127 2.171 . . . . 0.0 110.497 -169.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 14.1 m -107.78 133.35 52.3 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 119.877 -1.764 . . . . 0.0 112.816 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.467 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.373 18.3 p-10 -129.76 -176.55 3.95 Favored 'General case' 0 C--N 1.377 1.77 0 C-N-CA 124.804 1.242 . . . . 0.0 111.929 176.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.615 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 8.1 p -49.37 1.5 0.01 OUTLIER 'General case' 0 C--N 1.369 1.437 1 C-N-CA 136.332 5.853 . . . . 0.0 120.519 -167.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -99.75 4.63 45.5 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 118.262 -1.375 . . . . 0.0 107.784 163.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.437 0.8 OUTLIER 65.67 39.77 4.72 Favored 'General case' 0 C--N 1.371 1.508 1 C-N-CA 133.961 4.904 . . . . 0.0 111.623 -174.524 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 141' ' ' THR . 3.0 m -113.43 131.94 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 CA-C-N 111.023 -2.808 . . . . 0.0 112.394 -169.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.2 124.0 35.07 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 127.856 2.462 . . . . 0.0 107.477 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.36 157.69 24.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 128.798 2.839 . . . . 0.0 103.835 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -128.5 137.34 51.74 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.861 1.21 . . . . 0.0 109.672 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.385 75.1 p -113.55 143.21 44.93 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 125.405 1.482 . . . . 0.0 109.245 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.2 m -54.11 148.47 10.99 Favored 'General case' 0 C--N 1.37 1.492 1 C-N-CA 135.839 5.656 . . . . 0.0 118.887 -159.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 66.6 p -69.09 111.31 4.99 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 127.718 2.407 . . . . 0.0 110.1 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.28 109.85 22.07 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.05 105.99 18.1 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 124.433 2.063 . . . . 0.0 110.372 -174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.1 m -118.46 128.21 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.484 -1.565 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 177.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 0.5 OUTLIER . . . . . 0 CA--C 1.584 2.254 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -170.8 172.33 5.72 Favored 'General case' 0 N--CA 1.471 0.588 1 O-C-N 114.385 -5.197 . . . . 0.0 101.903 173.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.18 -41.94 0.57 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.588 1.555 . . . . 0.0 111.349 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.1 m -163.73 117.49 1.52 Allowed 'General case' 0 C--N 1.363 1.191 0 N-CA-C 117.754 2.501 . . . . 0.0 117.754 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.4 ttt -137.18 116.57 12.74 Favored 'General case' 0 C--N 1.377 1.791 0 CA-C-N 120.378 1.445 . . . . 0.0 109.079 155.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.1 m -113.25 117.02 30.7 Favored 'General case' 0 C--N 1.365 1.261 0 O-C-N 118.607 -2.558 . . . . 0.0 109.063 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -149.4 172.58 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.937 0 C-N-CA 126.058 1.743 . . . . 0.0 110.156 -170.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.99 130.9 35.19 Favored 'General case' 0 C--N 1.373 1.625 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -41.85 122.34 2.02 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -153.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 143.61 43.36 0.05 OUTLIER Glycine 0 C--N 1.356 1.662 0 CA-C-N 109.721 -3.399 . . . . 0.0 110.7 -163.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.53 168.02 14.89 Favored 'General case' 0 C--N 1.374 1.67 0 C-N-CA 124.802 1.241 . . . . 0.0 112.543 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.48 99.37 8.15 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.188 0.995 . . . . 0.0 109.595 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.03 111.78 23.38 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 125.494 1.518 . . . . 0.0 113.94 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.19 125.5 51.05 Favored 'General case' 0 C--N 1.371 1.534 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.67 114.87 21.17 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 103.539 -2.763 . . . . 0.0 103.539 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 t -151.14 134.3 16.01 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 120.938 -1.101 . . . . 0.0 112.197 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.03 173.85 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 130.769 3.627 . . . . 0.0 103.703 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -104.16 138.47 40.6 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 121' ' ' ALA . . . -141.3 142.15 33.88 Favored 'General case' 0 C--N 1.366 1.301 0 N-CA-C 120.012 3.338 . . . . 0.0 120.012 -174.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.5 m -158.26 174.33 15.33 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 130.826 3.65 . . . . 0.0 102.178 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.36 44.29 1.64 Allowed Glycine 0 C--N 1.366 2.244 0 O-C-N 118.681 -2.512 . . . . 0.0 117.452 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.24 21.36 65.14 Favored Glycine 0 C--N 1.359 1.838 0 C-N-CA 128.823 3.106 . . . . 0.0 114.749 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.407 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 10.1 p -116.55 111.34 19.78 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 126.165 1.786 . . . . 0.0 106.823 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.804 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 70.51 -90.72 0.38 Allowed Glycine 0 C--N 1.364 2.115 0 C-N-CA 130.649 3.976 . . . . 0.0 111.586 -169.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 101' ' ' THR . 14.7 Cg_exo -60.74 168.39 7.05 Favored 'Trans proline' 0 CA--C 1.568 2.184 1 C-N-CA 127.457 5.438 . . . . 0.0 117.289 160.402 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 74.6 m-85 -93.64 142.32 27.49 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 121.317 3.821 . . . . 0.0 121.317 -167.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -102.96 155.13 18.57 Favored 'General case' 0 C--N 1.383 2.025 0 C-N-CA 128.23 2.612 . . . . 0.0 104.905 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -155.59 166.94 32.0 Favored 'General case' 0 C--N 1.362 1.133 1 N-CA-C 122.402 4.223 . . . . 0.0 122.402 -159.375 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.36 114.18 7.65 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-N 112.166 -2.288 . . . . 0.0 107.596 173.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -113.29 155.07 25.78 Favored 'General case' 0 C--N 1.373 1.606 0 O-C-N 119.622 -1.924 . . . . 0.0 110.965 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.0 p -149.06 159.13 44.51 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 167.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.416 ' CE ' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -123.5 102.23 7.76 Favored 'General case' 0 C--N 1.377 1.797 0 C-N-CA 114.411 -2.916 . . . . 0.0 112.673 161.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.173 1.6 t70 36.47 54.17 1.06 Allowed 'General case' 0 CA--C 1.458 -2.58 0 CA-C-O 111.972 -3.87 . . . . 0.0 120.526 149.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.93 -17.17 42.14 Favored Glycine 0 C--N 1.363 2.055 1 O-C-N 133.193 6.558 . . . . 0.0 116.573 -172.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m -122.73 146.41 47.95 Favored Pre-proline 0 CA--C 1.573 1.854 0 C-N-CA 131.344 3.858 . . . . 0.0 119.876 -170.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.266 65.1 Cg_endo -65.08 136.12 46.73 Favored 'Trans proline' 0 N--CA 1.509 2.43 1 C-N-CA 128.684 6.256 . . . . 0.0 116.334 176.739 . . . . . . . . 3 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.404 ' HB ' ' CD ' ' A' ' 116' ' ' PRO 0.421 0.6 OUTLIER -84.64 164.95 40.32 Favored Pre-proline 0 N--CA 1.485 1.316 2 O-C-N 116.123 -4.111 . . . . 0.0 116.846 179.889 . . . . . . . . 5 4 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.418 ' HD3' ' HH ' ' A' ' 136' ' ' TYR . 2.8 Cg_exo -67.1 80.88 0.37 Allowed 'Trans proline' 0 C--N 1.384 2.446 1 C-N-CA 127.3 5.333 . . . . 0.0 112.571 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 80.29 -62.21 0.25 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 127.874 2.47 . . . . 0.0 110.815 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 84.94 162.28 0.1 Allowed 'General case' 0 C--N 1.372 1.554 0 C-N-CA 129.207 3.003 . . . . 0.0 111.448 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.431 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.2 OUTLIER 74.03 59.54 0.08 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-O 122.767 1.27 . . . . 0.0 114.127 174.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.44 -85.51 0.09 OUTLIER Glycine 0 C--N 1.356 1.648 0 N-CA-C 117.487 1.755 . . . . 0.0 117.487 -170.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.404 ' HB3' ' CB ' ' A' ' 97' ' ' ALA 0.26 . . 160.01 -71.13 0.0 OUTLIER 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.98 1.312 . . . . 0.0 110.437 -177.589 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.1 t -136.09 104.96 5.86 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 122.859 1.314 . . . . 0.0 113.838 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.299 7.8 p90 -128.05 140.97 51.65 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 127.713 2.405 . . . . 0.0 110.563 174.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 70.9 m -129.07 139.27 52.09 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 119.931 -1.73 . . . . 0.0 109.094 177.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.259 1.3 mmmm -105.76 111.67 64.6 Favored Pre-proline 0 C--N 1.372 1.548 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 171.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.21 -16.89 15.33 Favored 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 126.37 4.713 . . . . 0.0 113.339 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -162.18 101.27 1.1 Allowed 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.425 ' HB2' ' CB ' ' A' ' 132' ' ' ASP . . . -88.53 134.59 33.82 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.395 2.278 . . . . 0.0 113.167 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.17 176.83 8.51 Favored 'General case' 0 C--N 1.372 1.579 0 C-N-CA 128.351 2.66 . . . . 0.0 112.718 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.73 -46.63 29.97 Favored 'General case' 0 C--N 1.37 1.467 0 N-CA-C 119.414 3.116 . . . . 0.0 119.414 -172.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.98 -16.88 48.01 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 129.142 2.977 . . . . 0.0 115.0 174.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.425 ' CB ' ' HB2' ' A' ' 128' ' ' ALA . 7.4 m-20 -80.43 -22.04 41.58 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 128.79 2.836 . . . . 0.0 113.855 170.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.27 124.63 22.71 Favored 'General case' 0 C--N 1.382 2.014 0 N-CA-C 120.234 3.42 . . . . 0.0 120.234 173.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.14 -159.27 31.76 Favored Glycine 0 CA--C 1.463 -3.217 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.311 50.5 m -112.6 133.78 54.47 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 115.002 -2.679 . . . . 0.0 107.775 171.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.418 ' HH ' ' HD3' ' A' ' 116' ' ' PRO . 5.9 m-85 -96.2 133.43 40.53 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 118.988 -2.32 . . . . 0.0 110.311 -171.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.61 142.98 32.22 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 125.111 1.507 . . . . 0.0 107.329 -173.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.603 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 13.1 p -133.45 143.4 39.1 Favored 'Isoleucine or valine' 0 C--N 1.36 1.031 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.781 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -110.86 120.75 43.42 Favored 'General case' 0 C--N 1.38 1.898 0 C-N-CA 127.71 2.404 . . . . 0.0 106.135 171.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.58 120.49 42.37 Favored 'Isoleucine or valine' 0 C--N 1.361 1.101 0 C-N-CA 126.439 1.896 . . . . 0.0 112.143 -172.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.9 m -108.75 129.63 55.37 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 119.652 -1.905 . . . . 0.0 114.338 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.457 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.468 17.5 p30 -126.67 -167.84 1.78 Allowed 'General case' 0 C--N 1.376 1.735 0 CA-C-N 119.972 1.26 . . . . 0.0 113.057 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.804 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 20.2 p -49.77 -0.52 0.01 OUTLIER 'General case' 0 C--N 1.365 1.259 2 C-N-CA 135.08 5.352 . . . . 0.0 122.04 -162.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -105.91 4.68 29.84 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.119 167.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.41 87.3 mm-40 68.29 40.32 2.11 Favored 'General case' 0 C--N 1.375 1.717 0 C-N-CA 131.635 3.974 . . . . 0.0 109.819 -170.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.52 122.9 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 CA-C-N 111.991 -2.368 . . . . 0.0 112.528 -170.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.49 124.11 34.73 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 128.646 2.778 . . . . 0.0 107.254 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.17 157.33 24.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 129.303 3.041 . . . . 0.0 103.066 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -130.2 143.36 50.74 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.603 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.39 5.0 p -124.62 148.18 48.05 Favored 'General case' 0 C--O 1.26 1.626 0 CA-C-N 119.378 0.99 . . . . 0.0 109.509 176.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.2 m -54.4 147.01 14.53 Favored 'General case' 0 C--N 1.385 2.127 2 C-N-CA 137.817 6.447 . . . . 0.0 115.776 -162.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 73.5 p -68.82 109.8 4.04 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.159 -1.837 . . . . 0.0 111.721 -172.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 108.95 20.29 Favored 'General case' 0 C--N 1.368 1.412 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.31 109.02 21.6 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 123.889 1.804 . . . . 0.0 110.029 -173.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.83 128.24 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 O-C-N 120.367 -1.458 . . . . 0.0 108.676 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 98.3 m . . . . . 0 CA--C 1.499 -1.012 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 175.519 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.657 ' HG ' ' H ' ' A' ' 94' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.576 1.965 0 CA-C-O 121.909 0.862 . . . . 0.0 111.588 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.6 m -163.94 172.57 13.77 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 116.556 -3.84 . . . . 0.0 104.049 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.68 -40.83 0.78 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 128.111 2.564 . . . . 0.0 112.944 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.6 p -176.0 136.13 0.29 Allowed 'General case' 0 C--N 1.369 1.423 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 34.8 tpp -134.22 118.27 17.42 Favored 'General case' 0 C--N 1.375 1.684 0 CA-C-N 119.69 1.132 . . . . 0.0 109.855 163.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.7 t -111.18 115.65 29.74 Favored 'General case' 0 C--N 1.377 1.788 0 CA-C-O 123.553 1.644 . . . . 0.0 107.796 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 86' ' ' GLU . 9.3 p -150.75 174.4 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 127.495 2.318 . . . . 0.0 110.938 -174.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 85' ' ' VAL . 43.8 mt-10 -73.57 143.83 46.28 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 126.556 1.943 . . . . 0.0 106.643 156.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.381 0.0 OUTLIER -44.14 123.38 3.36 Favored 'General case' 0 N--CA 1.514 2.773 0 O-C-N 116.947 -3.596 . . . . 0.0 116.626 -172.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 124.73 48.72 0.21 Allowed Glycine 0 C--N 1.353 1.516 0 CA-C-N 111.705 -2.498 . . . . 0.0 109.338 -151.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.19 156.75 18.11 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 125.487 1.515 . . . . 0.0 111.515 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.76 105.25 13.68 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 124.609 1.164 . . . . 0.0 111.282 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 mp -120.31 125.52 48.27 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 127.002 2.121 . . . . 0.0 115.361 -174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.62 122.27 46.74 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 170.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -123.46 115.48 21.65 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.657 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 86.2 p -157.29 131.57 8.41 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 120.775 -1.203 . . . . 0.0 113.967 -172.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.41 HG13 HG21 ' A' ' 140' ' ' VAL . 10.1 m -148.97 173.12 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 129.955 3.302 . . . . 0.0 105.974 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 p -103.77 124.71 49.4 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 115.082 -2.389 . . . . 0.0 109.808 -172.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.72 138.18 40.72 Favored 'General case' 0 C--N 1.386 2.154 1 N-CA-C 125.318 5.303 . . . . 0.0 125.318 -170.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.5 m -157.49 174.57 15.19 Favored 'General case' 0 C--N 1.367 1.354 1 C-N-CA 132.023 4.129 . . . . 0.0 101.678 169.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -69.27 46.99 0.5 Allowed Glycine 0 C--N 1.366 2.228 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.58 21.0 60.76 Favored Glycine 0 C--N 1.356 1.657 0 C-N-CA 127.146 2.308 . . . . 0.0 116.156 175.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.4 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 7.9 p -116.45 111.11 19.53 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 115.686 -2.102 . . . . 0.0 107.234 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.739 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 70.98 -90.43 0.41 Allowed Glycine 0 C--N 1.377 2.844 0 C-N-CA 128.105 2.764 . . . . 0.0 111.814 -170.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 101' ' ' THR . 62.4 Cg_endo -66.57 167.52 18.82 Favored 'Trans proline' 0 CA--C 1.571 2.343 1 C-N-CA 126.35 4.7 . . . . 0.0 115.211 162.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 67.4 m-85 -90.82 145.54 24.68 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 121.009 3.707 . . . . 0.0 121.009 -166.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 t -102.16 140.4 36.49 Favored 'General case' 0 C--N 1.38 1.895 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.421 ' HB3' ' CG1' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -132.14 158.26 42.12 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 121.589 3.922 . . . . 0.0 121.589 -160.257 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.27 119.66 10.94 Favored 'General case' 0 C--N 1.36 1.029 0 CA-C-N 112.423 -2.171 . . . . 0.0 106.977 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -112.38 151.59 29.61 Favored 'General case' 0 C--N 1.367 1.335 0 O-C-N 119.943 -1.723 . . . . 0.0 107.848 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.4 0.0 OUTLIER -157.78 146.08 19.04 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 119.559 -1.963 . . . . 0.0 105.771 164.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HB3' ' CD2' ' A' ' 136' ' ' TYR 0.307 65.8 mmtt -126.43 99.67 5.93 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 115.987 -2.285 . . . . 0.0 111.613 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.4 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.356 0.8 OUTLIER 36.65 53.22 1.05 Allowed 'General case' 0 CA--C 1.46 -2.489 1 CA-C-O 111.615 -4.04 . . . . 0.0 121.267 157.612 . . . . . . . . 5 4 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.45 -5.26 70.52 Favored Glycine 0 C--N 1.372 2.547 2 O-C-N 133.509 6.756 . . . . 0.0 114.965 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -124.09 148.56 57.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 131.179 3.792 . . . . 0.0 115.956 -168.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.36 161.69 19.5 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 124.244 3.296 . . . . 0.0 116.187 168.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.436 ' CG2' ' HG2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -93.27 165.57 18.07 Favored Pre-proline 0 N--CA 1.443 -0.791 0 C-N-CA 131.373 3.869 . . . . 0.0 109.305 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -51.24 -44.29 43.82 Favored 'Trans proline' 0 CA--C 1.538 0.675 1 C-N-CA 127.433 5.422 . . . . 0.0 118.757 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -158.62 -50.82 0.06 Allowed 'General case' 0 C--N 1.348 0.504 0 C-N-CA 126.245 1.818 . . . . 0.0 106.972 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.256 . . 97.49 140.52 0.02 OUTLIER 'General case' 0 CA--C 1.464 -2.352 0 C-N-CA 128.819 2.847 . . . . 0.0 110.472 -177.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 73.9 m 69.75 34.71 2.57 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.163 -1.835 . . . . 0.0 114.243 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -108.2 -18.46 9.78 Favored Glycine 0 CA--C 1.47 -2.762 0 N-CA-C 117.877 1.911 . . . . 0.0 117.877 -164.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.313 . . 81.99 -73.03 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 126.309 1.844 . . . . 0.0 111.786 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.28 13.4 t -128.62 104.22 7.54 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 123.199 1.476 . . . . 0.0 112.459 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.346 0.0 OUTLIER -127.49 140.99 51.78 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 128.192 2.597 . . . . 0.0 112.16 174.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.8 m -123.48 138.59 54.55 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 120.334 -1.479 . . . . 0.0 107.869 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.67 106.75 57.52 Favored Pre-proline 0 C--N 1.369 1.415 0 N-CA-C 103.449 -2.796 . . . . 0.0 103.449 170.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.72 -32.46 3.53 Favored 'Trans proline' 0 C--N 1.356 0.958 1 C-N-CA 126.925 5.083 . . . . 0.0 111.733 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -144.47 103.98 4.01 Favored 'General case' 0 N--CA 1.42 -1.928 1 N-CA-C 99.855 -4.128 . . . . 0.0 99.855 176.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.37 133.38 39.38 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 128.335 2.654 . . . . 0.0 107.611 176.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.42 -176.1 4.68 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 127.956 2.502 . . . . 0.0 113.084 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.29 -45.12 34.44 Favored 'General case' 0 C--N 1.369 1.419 0 N-CA-C 119.024 2.972 . . . . 0.0 119.024 -173.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -69.04 -7.58 37.03 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 126.753 2.021 . . . . 0.0 114.974 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -81.54 -17.9 46.85 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.293 2.237 . . . . 0.0 110.236 168.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.92 114.02 3.82 Favored 'General case' 0 C--N 1.386 2.158 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 171.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 165.63 -156.87 29.08 Favored Glycine 0 CA--C 1.454 -3.75 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.334 23.7 m -112.85 133.08 55.01 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 114.667 -2.813 . . . . 0.0 107.257 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.477 ' CD2' ' HB3' ' A' ' 110' ' ' LYS . 4.2 m-85 -96.99 132.39 42.85 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 118.506 -2.621 . . . . 0.0 113.547 -168.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -144.05 151.35 39.54 Favored 'General case' 0 C--N 1.394 2.543 0 CA-C-N 120.066 1.303 . . . . 0.0 112.138 -173.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.469 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 14.3 p -141.59 143.07 27.91 Favored 'Isoleucine or valine' 0 C--N 1.378 1.82 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.1 m -113.15 121.04 43.33 Favored 'General case' 0 C--N 1.373 1.623 0 C-N-CA 129.684 3.194 . . . . 0.0 107.366 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -132.8 125.37 52.38 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 C-N-CA 126.311 1.844 . . . . 0.0 113.112 -177.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 4.0 m -112.0 133.85 53.92 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.156 -2.215 . . . . 0.0 116.027 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.421 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.39 23.2 p30 -127.98 -173.91 3.06 Favored 'General case' 0 C--N 1.379 1.868 0 CA-C-N 120.226 1.375 . . . . 0.0 113.46 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.739 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 19.8 p -49.25 2.76 0.01 OUTLIER 'General case' 0 C--N 1.363 1.191 2 C-N-CA 136.349 5.86 . . . . 0.0 122.097 -165.466 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.89 4.62 25.57 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 164.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.447 98.3 mm-40 67.53 40.1 2.68 Favored 'General case' 0 C--N 1.371 1.526 1 C-N-CA 132.22 4.208 . . . . 0.0 110.576 -172.6 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.76 127.18 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-N 111.462 -2.608 . . . . 0.0 112.447 -171.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.9 OUTLIER -91.64 134.45 34.68 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.754 1.622 . . . . 0.0 110.318 -176.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -116.78 141.05 48.72 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 102.38 -3.193 . . . . 0.0 102.38 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -128.87 146.95 50.8 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.469 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.304 1.7 p -119.41 141.7 48.87 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 121.521 0.677 . . . . 0.0 110.738 175.536 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 m -54.23 148.22 11.78 Favored 'General case' 0 CA--C 1.479 -1.768 2 C-N-CA 138.253 6.621 . . . . 0.0 115.672 -168.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 78.3 p -68.19 110.17 3.89 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.594 2.758 . . . . 0.0 110.881 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.41 ' HG ' HG22 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -96.54 109.46 22.05 Favored 'General case' 0 C--N 1.363 1.193 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 -176.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.98 113.17 24.21 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 124.566 2.126 . . . . 0.0 111.086 -173.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.41 HG22 ' HG ' ' A' ' 153' ' ' CYS . 96.3 t -112.58 114.99 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -172.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 62.2 m . . . . . 0 CA--C 1.489 -1.37 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 175.057 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.567 1.628 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m -173.86 172.5 3.46 Favored 'General case' 0 CA--C 1.504 -0.814 1 N-CA-C 99.221 -4.363 . . . . 0.0 99.221 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.43 -47.55 2.54 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 121.051 1.75 . . . . 0.0 109.599 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -170.42 132.57 1.0 Allowed 'General case' 0 C--N 1.36 1.055 0 O-C-N 119.765 -1.835 . . . . 0.0 115.878 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 12.7 tpt -130.75 116.26 17.76 Favored 'General case' 0 C--N 1.373 1.612 0 CA-C-N 120.603 1.547 . . . . 0.0 107.793 164.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 p -109.86 115.52 29.97 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 119.397 -2.065 . . . . 0.0 107.813 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -149.55 174.27 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 126.157 1.783 . . . . 0.0 111.499 -168.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -74.08 135.74 43.0 Favored 'General case' 0 C--N 1.368 1.405 0 O-C-N 118.87 -2.394 . . . . 0.0 107.087 158.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.336 0.4 OUTLIER -44.04 122.62 2.96 Favored 'General case' 0 N--CA 1.515 2.813 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -165.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.74 50.81 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 111.337 -2.665 . . . . 0.0 108.722 -162.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.61 160.67 19.55 Favored 'General case' 0 C--N 1.369 1.415 0 C-N-CA 126.382 1.873 . . . . 0.0 109.443 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.02 99.95 8.73 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 122.494 1.14 . . . . 0.0 110.723 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.276 9.0 mp -113.27 114.24 26.41 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 126.679 1.992 . . . . 0.0 115.74 -169.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.92 137.17 45.48 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 170.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 79' ' ' LEU . 1.7 mm? -124.84 116.09 21.7 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 t -150.37 131.94 14.84 Favored 'General case' 0 C--N 1.38 1.908 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 -171.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.5 m -149.57 172.81 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.039 0 C-N-CA 129.926 3.29 . . . . 0.0 106.849 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.6 t -105.45 138.12 42.16 Favored 'General case' 0 C--N 1.371 1.515 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.42 143.91 37.85 Favored 'General case' 0 C--N 1.371 1.535 0 N-CA-C 119.914 3.302 . . . . 0.0 119.914 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.96 174.69 15.13 Favored 'General case' 0 C--N 1.361 1.091 1 C-N-CA 134.169 4.988 . . . . 0.0 102.881 177.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.19 45.57 1.75 Allowed Glycine 0 C--N 1.37 2.422 0 O-C-N 118.706 -2.496 . . . . 0.0 117.73 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.41 62.01 Favored Glycine 0 C--N 1.363 2.073 0 C-N-CA 128.073 2.749 . . . . 0.0 112.787 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.5 m -115.96 110.93 19.64 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 126.442 1.897 . . . . 0.0 107.565 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.564 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 66.95 -102.6 0.79 Allowed Glycine 0 CA--C 1.548 2.106 0 CA-C-O 116.667 -2.185 . . . . 0.0 109.783 -160.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.58 169.51 5.38 Favored 'Trans proline' 0 C--N 1.377 2.041 1 C-N-CA 129.128 6.552 . . . . 0.0 118.168 160.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.475 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 76.9 m-85 -81.74 142.3 32.77 Favored 'General case' 0 C--N 1.358 0.965 1 N-CA-C 124.301 4.926 . . . . 0.0 124.301 -164.407 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 t -102.32 141.06 35.76 Favored 'General case' 0 C--N 1.379 1.887 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.51 162.91 30.94 Favored 'General case' 0 C--N 1.351 0.662 1 N-CA-C 122.85 4.389 . . . . 0.0 122.85 -161.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.49 121.18 11.86 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.992 2.517 . . . . 0.0 106.951 176.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -112.16 138.2 49.16 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.577 1.951 . . . . 0.0 111.422 -175.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.1 169.97 19.46 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-O 123.119 1.438 . . . . 0.0 107.335 172.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -145.64 104.99 3.94 Favored 'General case' 0 N--CA 1.422 -1.851 0 O-C-N 119.37 -2.081 . . . . 0.0 105.875 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.415 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.239 1.2 t70 34.76 53.47 0.63 Allowed 'General case' 0 CA--C 1.472 -2.024 2 CA-C-O 110.414 -4.613 . . . . 0.0 123.073 141.976 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.74 -1.11 84.67 Favored Glycine 0 C--N 1.377 2.859 2 O-C-N 134.349 7.28 . . . . 0.0 118.964 -173.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.5 t -124.96 145.43 50.14 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -171.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -64.79 136.24 48.36 Favored 'Trans proline' 0 N--CA 1.495 1.588 1 C-N-CA 126.158 4.572 . . . . 0.0 115.315 173.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.23 165.6 35.54 Favored Pre-proline 0 CA--C 1.552 1.039 0 O-C-N 119.337 -2.102 . . . . 0.0 116.319 178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -68.1 81.45 0.5 Allowed 'Trans proline' 0 C--N 1.363 1.319 1 C-N-CA 125.406 4.071 . . . . 0.0 114.647 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 74.82 -62.15 0.46 Allowed 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.43 2.292 . . . . 0.0 115.033 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 85.3 162.68 0.1 Allowed 'General case' 0 CA--C 1.481 -1.703 0 C-N-CA 129.431 3.092 . . . . 0.0 112.584 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 79.16 52.98 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 CA-C-N 113.531 -1.668 . . . . 0.0 111.049 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.99 -86.44 0.84 Allowed Glycine 0 C--N 1.362 2.018 0 CA-C-N 114.172 -1.376 . . . . 0.0 116.494 -170.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.339 . . 144.45 -74.97 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.406 2.282 . . . . 0.0 111.079 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.3 9.0 t -126.0 93.47 3.83 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.909 1.814 . . . . 0.0 110.301 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.277 3.3 p90 -125.98 141.05 52.13 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.228 1.811 . . . . 0.0 110.319 -177.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 88.8 m -129.71 139.8 51.26 Favored 'General case' 0 CA--C 1.493 -1.238 0 O-C-N 120.389 -1.444 . . . . 0.0 110.041 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.09 103.93 55.51 Favored Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 129.485 3.114 . . . . 0.0 105.293 176.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -72.65 -32.76 9.14 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.718 3.612 . . . . 0.0 113.772 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 99.4 m -136.54 100.99 4.51 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.07 124.04 36.76 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 124.212 1.005 . . . . 0.0 113.196 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.93 -178.49 4.67 Favored 'General case' 0 C--N 1.364 1.234 0 C-N-CA 129.2 3.0 . . . . 0.0 109.719 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -54.19 13.39 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -173.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.13 1.03 1.65 Allowed 'General case' 0 C--N 1.365 1.241 0 C-N-CA 128.6 2.76 . . . . 0.0 115.357 172.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -116.06 -18.56 10.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 129.409 3.084 . . . . 0.0 111.266 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.18 164.55 12.81 Favored 'General case' 0 C--N 1.391 2.412 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.87 -155.86 26.74 Favored Glycine 0 C--N 1.383 3.149 0 C-N-CA 128.318 2.866 . . . . 0.0 109.734 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.356 6.9 m -109.41 130.73 55.49 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 112.974 -3.491 . . . . 0.0 107.135 164.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . 0.255 3.5 m-85 -97.01 134.49 40.31 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 125.704 1.602 . . . . 0.0 111.492 -169.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -145.49 152.61 40.05 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-N 119.459 1.027 . . . . 0.0 109.021 -175.746 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.612 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 7.7 p -141.39 142.69 28.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 C-N-CA 116.568 -2.053 . . . . 0.0 111.592 178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.5 m -105.99 119.37 39.03 Favored 'General case' 0 C--N 1.368 1.401 0 C-N-CA 129.778 3.231 . . . . 0.0 106.286 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.16 124.27 45.66 Favored 'Isoleucine or valine' 0 C--N 1.35 0.591 0 C-N-CA 124.268 1.027 . . . . 0.0 113.613 -173.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 6.0 m -109.23 131.71 54.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 119.412 -2.055 . . . . 0.0 114.599 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.475 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.444 10.2 p-10 -128.45 -170.48 2.26 Favored 'General case' 0 C--N 1.367 1.366 0 O-C-N 120.682 -1.261 . . . . 0.0 113.894 175.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.564 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 22.1 p -48.71 3.84 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.317 1 C-N-CA 136.218 5.807 . . . . 0.0 121.634 -164.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -106.74 4.57 27.82 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 118.286 -1.366 . . . . 0.0 107.898 163.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.433 89.9 mm-40 66.45 40.09 3.67 Favored 'General case' 0 C--N 1.373 1.62 1 C-N-CA 132.924 4.49 . . . . 0.0 110.273 -171.992 . . . . . . . . 3 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.2 m -112.54 126.32 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 C-N-CA 128.08 2.552 . . . . 0.0 112.061 -171.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.3 OUTLIER -91.83 130.24 37.64 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 124.61 1.164 . . . . 0.0 109.849 -178.203 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.62 158.89 23.84 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.755 3.222 . . . . 0.0 104.455 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -129.77 146.51 51.52 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.612 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.404 87.8 p -116.4 150.19 38.18 Favored 'General case' 0 C--O 1.254 1.303 0 C-N-CA 124.469 1.108 . . . . 0.0 110.004 177.401 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.92 148.83 12.59 Favored 'General case' 0 C--N 1.382 2.012 1 C-N-CA 134.245 5.018 . . . . 0.0 118.719 -158.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.0 p -68.74 111.13 4.66 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 127.866 2.466 . . . . 0.0 110.434 -177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.16 109.25 22.04 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.52 107.43 19.59 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 124.84 2.257 . . . . 0.0 110.882 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.0 m -119.75 120.25 62.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 O-C-N 119.821 -1.799 . . . . 0.0 106.386 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.364 1.235 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -174.845 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.204 -1.298 0 CA-C-O 122.165 0.983 . . . . 0.0 112.354 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.9 m -172.13 175.46 3.74 Favored 'General case' 0 C--N 1.317 -0.822 1 C-N-CA 132.142 4.177 . . . . 0.0 101.478 168.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.75 -62.86 1.44 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.827 2.051 . . . . 0.0 113.065 169.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 p -179.99 125.14 0.07 Allowed 'General case' 0 C--N 1.36 1.048 0 O-C-N 118.434 -2.666 . . . . 0.0 117.636 -175.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.1 mmm -120.29 134.63 55.22 Favored 'General case' 0 C--N 1.379 1.888 0 CA-C-N 120.464 1.483 . . . . 0.0 113.198 168.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.2 p -114.54 115.66 27.56 Favored 'General case' 0 C--N 1.365 1.241 0 O-C-N 119.127 -2.233 . . . . 0.0 108.629 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 86' ' ' GLU . 14.9 p -150.1 173.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-N 114.011 -1.449 . . . . 0.0 113.134 -167.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.425 ' O ' HG23 ' A' ' 85' ' ' VAL . 35.6 mt-10 -81.11 131.48 35.3 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 128.01 2.524 . . . . 0.0 104.931 161.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.317 0.2 OUTLIER -43.23 122.38 2.51 Favored 'General case' 0 N--CA 1.518 2.968 0 CA-C-N 123.418 2.827 . . . . 0.0 118.55 -161.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 134.57 54.24 0.07 OUTLIER Glycine 0 C--N 1.35 1.354 0 CA-C-N 111.854 -2.43 . . . . 0.0 111.503 -164.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.69 172.27 10.99 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.775 1.23 . . . . 0.0 112.095 173.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.55 100.95 9.41 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.9 -1.125 . . . . 0.0 109.298 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.405 ' CD2' ' HB1' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -121.47 114.31 21.08 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.531 1.532 . . . . 0.0 111.218 -172.511 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.29 2.4 t -113.84 137.54 51.52 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 7.1 mt -126.68 115.74 19.91 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 t -152.86 132.41 13.01 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.808 1.289 . . . . 0.0 112.185 -169.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.9 175.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.665 1 C-N-CA 132.171 4.188 . . . . 0.0 106.583 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -103.98 140.97 36.98 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.853 2.461 . . . . 0.0 106.375 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' A' ' 121' ' ' ALA . . . -141.33 144.38 34.54 Favored 'General case' 0 C--N 1.381 1.978 1 N-CA-C 122.934 4.42 . . . . 0.0 122.934 -174.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.5 p -156.41 175.84 13.49 Favored 'General case' 0 C--N 1.364 1.199 1 C-N-CA 133.883 4.873 . . . . 0.0 104.094 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.38 40.33 0.75 Allowed Glycine 0 C--N 1.365 2.183 0 C-N-CA 125.858 1.694 . . . . 0.0 117.232 167.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.06 30.67 25.12 Favored Glycine 0 C--N 1.361 1.944 0 C-N-CA 127.616 2.531 . . . . 0.0 116.164 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.449 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 63.5 m -117.44 110.9 18.58 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 113.653 -3.07 . . . . 0.0 108.351 175.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.79 -86.73 0.54 Allowed Glycine 0 C--N 1.383 3.15 0 CA-C-N 124.837 3.471 . . . . 0.0 110.172 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 101' ' ' THR . 23.9 Cg_exo -59.86 168.13 6.12 Favored 'Trans proline' 0 CA--C 1.57 2.291 1 C-N-CA 126.102 4.535 . . . . 0.0 115.364 157.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 78.4 m-85 -105.97 145.13 31.72 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 119.798 3.259 . . . . 0.0 119.798 -164.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.6 t -103.02 141.51 35.68 Favored 'General case' 0 C--N 1.378 1.837 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -140.13 160.98 38.74 Favored 'General case' 0 C--N 1.347 0.466 1 N-CA-C 121.923 4.045 . . . . 0.0 121.923 -160.133 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -136.2 120.89 18.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.674 2.79 . . . . 0.0 105.796 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -112.05 132.8 54.6 Favored 'General case' 0 C--N 1.366 1.29 0 C-N-CA 125.178 1.391 . . . . 0.0 111.574 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.89 169.69 17.58 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 123.252 1.501 . . . . 0.0 107.334 172.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.429 ' HD3' ' CE1' ' A' ' 136' ' ' TYR . 13.0 ttpp -142.79 105.7 4.53 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.22 1.7 t70 34.91 53.63 0.66 Allowed 'General case' 0 CA--C 1.472 -2.035 2 CA-C-O 109.685 -4.96 . . . . 0.0 123.473 140.739 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.09 -10.43 60.74 Favored Glycine 0 C--N 1.383 3.179 2 O-C-N 135.222 7.826 . . . . 0.0 119.365 -172.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.407 9.8 p -124.89 147.15 55.6 Favored Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 130.607 3.563 . . . . 0.0 120.586 -167.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -63.8 139.72 70.17 Favored 'Trans proline' 0 N--CA 1.499 1.817 1 C-N-CA 126.484 4.789 . . . . 0.0 116.933 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.51 164.27 30.23 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 119.237 -2.164 . . . . 0.0 115.568 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -72.05 82.9 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 125.119 3.879 . . . . 0.0 115.009 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 74.52 -61.06 0.5 Allowed 'General case' 0 C--N 1.36 1.05 0 C-N-CA 126.626 1.97 . . . . 0.0 115.846 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 79.16 176.21 0.14 Allowed 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 130.3 3.44 . . . . 0.0 114.805 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 74.55 70.08 0.1 Allowed 'General case' 0 C--N 1.356 0.864 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.752 173.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -154.77 -53.11 0.01 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 120.078 2.791 . . . . 0.0 120.078 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.405 ' HB3' ' CB ' ' A' ' 97' ' ' ALA 0.292 . . 131.94 -65.87 0.0 OUTLIER 'General case' 0 C--N 1.351 0.634 0 C-N-CA 127.129 2.172 . . . . 0.0 107.777 -176.017 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.27 14.7 t -137.53 108.84 6.86 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-N 120.475 1.489 . . . . 0.0 113.688 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.289 0.2 OUTLIER -128.02 140.25 52.08 Favored 'General case' 0 C--N 1.372 1.567 0 C-N-CA 127.881 2.472 . . . . 0.0 111.846 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.8 m -129.39 139.75 51.57 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 119.909 -1.745 . . . . 0.0 111.596 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 105.27 56.68 Favored Pre-proline 0 C--N 1.358 0.949 0 C-N-CA 129.377 3.071 . . . . 0.0 105.966 173.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -75.56 -11.51 20.47 Favored 'Trans proline' 0 C--N 1.353 0.782 1 C-N-CA 125.745 4.297 . . . . 0.0 112.819 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 62.1 m -157.93 105.65 1.99 Allowed 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.405 ' HB1' ' CD2' ' A' ' 91' ' ' LEU . . . -94.17 118.9 32.22 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.313 1.045 . . . . 0.0 112.825 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.97 -176.98 6.2 Favored 'General case' 0 C--N 1.367 1.351 0 C-N-CA 127.131 2.173 . . . . 0.0 109.236 172.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.12 -54.19 14.08 Favored 'General case' 0 C--N 1.368 1.384 0 O-C-N 118.273 -2.767 . . . . 0.0 117.209 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.8 0.79 1.58 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 128.692 2.797 . . . . 0.0 115.58 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -116.43 -18.33 10.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 129.299 3.04 . . . . 0.0 111.347 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.65 164.74 13.29 Favored 'General case' 0 C--N 1.397 2.655 0 CA-C-N 122.534 2.424 . . . . 0.0 116.673 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.24 -155.08 25.42 Favored Glycine 0 CA--C 1.459 -3.446 0 C-N-CA 127.107 2.289 . . . . 0.0 109.012 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.351 9.3 m -113.49 133.41 55.23 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 111.912 -3.915 . . . . 0.0 108.595 166.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.429 ' CE1' ' HD3' ' A' ' 110' ' ' LYS 0.252 21.1 m-85 -96.26 135.2 38.41 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 122.228 2.285 . . . . 0.0 110.984 -170.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 147.52 31.97 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 123.982 0.913 . . . . 0.0 108.908 -176.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.656 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 10.4 p -138.76 137.38 42.95 Favored 'Isoleucine or valine' 0 C--N 1.365 1.267 0 C-N-CA 118.189 -1.404 . . . . 0.0 113.402 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 113.89 27.74 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 129.29 3.036 . . . . 0.0 105.848 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.98 119.68 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.936 1.694 . . . . 0.0 110.513 -171.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 5.2 m -106.24 133.1 51.47 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.228 -1.545 . . . . 0.0 113.719 -176.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.488 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.328 15.6 p-10 -126.21 179.43 5.26 Favored 'General case' 0 C--N 1.376 1.757 0 C-N-CA 124.164 0.986 . . . . 0.0 111.971 174.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 13.1 p -49.18 2.29 0.01 OUTLIER 'General case' 0 C--N 1.375 1.677 1 C-N-CA 136.971 6.108 . . . . 0.0 119.306 -170.768 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -101.28 4.24 41.53 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 165.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.523 0.9 OUTLIER 62.89 39.87 10.12 Favored 'General case' 0 C--N 1.372 1.554 1 C-N-CA 134.266 5.026 . . . . 0.0 112.715 -172.692 . . . . . . . . 4 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 141' ' ' THR . 4.6 m -112.85 128.37 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.858 0 CA-C-N 111.596 -2.547 . . . . 0.0 111.882 -170.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.02 123.0 35.06 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.456 1.902 . . . . 0.0 106.777 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 157.74 24.56 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 128.031 2.532 . . . . 0.0 104.804 -174.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 27.3 t70 -125.06 140.32 53.0 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.708 1.242 . . . . 0.0 108.205 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.656 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.486 44.6 p -116.98 144.05 45.01 Favored 'General case' 0 C--O 1.254 1.334 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.257 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 m -54.11 147.98 11.84 Favored 'General case' 0 CA--C 1.478 -1.789 2 C-N-CA 138.798 6.839 . . . . 0.0 118.049 -159.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 73.6 p -68.29 109.77 3.76 Favored 'General case' 0 C--N 1.367 1.348 0 C-N-CA 124.486 1.114 . . . . 0.0 111.907 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -95.22 108.49 20.63 Favored 'General case' 0 C--N 1.373 1.608 0 N-CA-C 102.653 -3.092 . . . . 0.0 102.653 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.53 113.72 25.48 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 123.732 1.729 . . . . 0.0 111.152 -172.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.33 116.21 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 C--N 1.372 1.549 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -179.556 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.566 1.568 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER -175.09 -177.02 1.01 Allowed 'General case' 0 N--CA 1.476 0.83 1 N-CA-C 98.716 -4.549 . . . . 0.0 98.716 162.75 . . . . . . . . 4 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.86 -53.09 2.67 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 119.567 -1.958 . . . . 0.0 106.767 162.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.0 p -168.91 128.92 1.12 Allowed 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.037 -1.664 . . . . 0.0 115.079 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.0 tpt -124.95 123.45 39.92 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-N 120.81 1.641 . . . . 0.0 111.247 167.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.2 t -112.05 116.73 31.01 Favored 'General case' 0 C--N 1.374 1.652 0 O-C-N 119.724 -1.86 . . . . 0.0 107.273 171.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 86' ' ' GLU . 7.8 p -149.67 173.7 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 112.065 -2.334 . . . . 0.0 109.981 -173.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.438 ' O ' HG22 ' A' ' 85' ' ' VAL . 12.0 pt-20 -76.55 144.7 39.51 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 126.302 1.841 . . . . 0.0 106.609 158.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.436 0.0 OUTLIER -44.42 121.97 2.84 Favored 'General case' 0 N--CA 1.515 2.807 0 O-C-N 117.376 -3.327 . . . . 0.0 118.339 -168.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.74 55.49 0.1 OUTLIER Glycine 0 C--N 1.36 1.866 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.651 -155.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.5 165.23 12.85 Favored 'General case' 0 C--N 1.369 1.413 0 O-C-N 120.643 -1.504 . . . . 0.0 110.487 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.93 100.96 9.84 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-O 123.17 1.462 . . . . 0.0 113.393 -173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mp -119.36 127.23 52.96 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 125.113 1.365 . . . . 0.0 111.835 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 t -116.04 115.3 25.88 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 168.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.12 112.0 24.71 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 103.04 -2.948 . . . . 0.0 103.04 173.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.9 t -146.35 131.2 18.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.621 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.1 m -150.54 174.23 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.649 1 C-N-CA 131.789 4.035 . . . . 0.0 103.565 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.3 t -106.38 140.39 39.37 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 122.096 2.225 . . . . 0.0 106.976 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.71 142.61 36.85 Favored 'General case' 0 C--N 1.379 1.863 0 N-CA-C 121.021 3.712 . . . . 0.0 121.021 -174.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.2 p -156.29 175.54 13.86 Favored 'General case' 0 C--N 1.367 1.346 1 C-N-CA 134.365 5.066 . . . . 0.0 103.352 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.73 39.77 0.78 Allowed Glycine 0 C--N 1.368 2.31 0 O-C-N 119.514 -1.991 . . . . 0.0 117.649 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.19 26.08 49.49 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 128.459 2.933 . . . . 0.0 114.427 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.41 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 7.2 p -116.88 109.84 17.58 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 116.249 -1.834 . . . . 0.0 107.856 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.726 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.01 -91.07 0.51 Allowed Glycine 0 C--N 1.374 2.643 0 C-N-CA 129.073 3.225 . . . . 0.0 111.053 -167.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 101' ' ' THR . 22.9 Cg_exo -60.22 169.16 5.29 Favored 'Trans proline' 0 CA--C 1.566 2.111 1 C-N-CA 127.993 5.795 . . . . 0.0 116.968 160.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 75.1 m-85 -94.58 146.27 24.24 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -168.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -102.69 140.78 36.53 Favored 'General case' 0 C--N 1.382 2.013 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.46 139.84 44.38 Favored 'General case' 0 C--N 1.352 0.691 1 N-CA-C 123.668 4.692 . . . . 0.0 123.668 -158.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.07 111.56 14.83 Favored 'General case' 0 C--N 1.371 1.533 0 C-N-CA 126.403 1.881 . . . . 0.0 107.238 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TRP . . . . . 0.4 ' CE2' HG22 ' A' ' 138' ' ' VAL . 76.4 m95 -113.06 145.14 41.42 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.053 1.741 . . . . 0.0 111.405 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.32 0.0 OUTLIER -157.95 156.38 31.16 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 164.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.439 ' HB2' ' HZ3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -128.05 102.84 6.91 Favored 'General case' 0 C--N 1.37 1.493 0 C-N-CA 117.271 -1.771 . . . . 0.0 113.517 175.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.231 2.5 t70 36.94 54.53 1.19 Allowed 'General case' 0 CA--C 1.456 -2.656 1 CA-C-O 110.772 -4.442 . . . . 0.0 120.837 152.829 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.19 -11.49 63.74 Favored Glycine 0 C--N 1.37 2.462 2 O-C-N 133.928 7.018 . . . . 0.0 116.041 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.262 3.6 m -123.96 149.16 59.14 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 131.216 3.806 . . . . 0.0 117.161 -168.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.15 152.32 80.27 Favored 'Trans proline' 0 N--CA 1.494 1.544 1 C-N-CA 125.473 4.115 . . . . 0.0 116.211 169.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.04 157.76 33.51 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.469 1.508 . . . . 0.0 109.243 174.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -62.64 -75.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.839 1 C-N-CA 126.039 4.493 . . . . 0.0 116.773 -170.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -102.86 -34.46 8.97 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.267 1.427 . . . . 0.0 111.281 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 75.93 -72.36 0.11 Allowed 'General case' 0 CA--C 1.486 -1.512 0 C-N-CA 130.075 3.35 . . . . 0.0 114.393 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.348 5.2 t -81.82 72.64 8.87 Favored 'General case' 0 N--CA 1.416 -2.155 1 C-N-CA 133.627 4.771 . . . . 0.0 111.348 -175.108 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.23 -41.5 0.02 OUTLIER Glycine 0 CA--C 1.469 -2.794 0 N-CA-C 122.072 3.589 . . . . 0.0 122.072 -168.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.301 . . 105.16 -62.57 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.505 1.522 . . . . 0.0 110.151 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.296 15.3 t -136.49 96.33 3.33 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-O 122.622 1.201 . . . . 0.0 113.841 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -126.5 138.0 53.44 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 127.121 2.169 . . . . 0.0 107.823 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 91.5 m -128.92 133.2 47.78 Favored 'General case' 0 CA--C 1.478 -1.789 0 O-C-N 119.536 -1.977 . . . . 0.0 106.256 -176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.83 93.22 8.49 Favored Pre-proline 0 C--N 1.359 1.018 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.69 -11.83 26.27 Favored 'Trans proline' 0 C--N 1.348 0.544 1 C-N-CA 125.525 4.15 . . . . 0.0 111.048 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -161.62 104.29 1.22 Allowed 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.16 133.48 33.63 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.253 2.621 . . . . 0.0 113.119 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.11 178.92 5.72 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 128.995 2.918 . . . . 0.0 110.683 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.13 -45.3 32.99 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 118.937 2.94 . . . . 0.0 118.937 -174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -66.88 -17.59 64.97 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 126.855 2.062 . . . . 0.0 114.205 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -82.05 -14.26 56.13 Favored 'General case' 0 CA--C 1.573 1.854 0 C-N-CA 128.52 2.728 . . . . 0.0 111.361 170.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.28 127.15 32.03 Favored 'General case' 0 C--N 1.393 2.48 0 N-CA-C 119.474 3.139 . . . . 0.0 119.474 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.18 -147.9 18.01 Favored Glycine 0 CA--C 1.473 -2.542 0 C-N-CA 128.404 2.907 . . . . 0.0 108.651 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.408 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.265 21.1 m -125.46 140.08 53.09 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 114.47 -2.892 . . . . 0.0 109.533 173.317 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -95.91 134.52 38.8 Favored 'General case' 0 C--N 1.367 1.361 0 O-C-N 118.722 -2.486 . . . . 0.0 112.456 -172.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -142.45 146.68 35.07 Favored 'General case' 0 C--N 1.368 1.393 0 C-N-CA 123.993 0.917 . . . . 0.0 108.602 -174.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . 0.4 HG22 ' CE2' ' A' ' 108' ' ' TRP 0.251 13.4 p -146.99 139.95 19.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.185 0 C-N-CA 118.64 -1.224 . . . . 0.0 114.144 176.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.48 115.67 27.63 Favored 'General case' 0 C--N 1.375 1.702 0 C-N-CA 127.22 2.208 . . . . 0.0 106.321 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.09 116.46 44.51 Favored 'Isoleucine or valine' 0 C--N 1.369 1.444 0 C-N-CA 127.996 2.518 . . . . 0.0 112.155 -171.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.0 m -99.12 132.89 44.11 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.449 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.424 16.2 p-10 -126.58 -176.93 3.82 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-N 120.769 1.622 . . . . 0.0 112.171 173.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.726 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 77.5 p -49.58 3.3 0.01 OUTLIER 'General case' 0 C--N 1.36 1.025 1 C-N-CA 136.634 5.973 . . . . 0.0 121.279 -165.15 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.29 4.47 36.57 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 164.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.422 81.0 mm-40 65.52 40.01 4.79 Favored 'General case' 0 C--N 1.374 1.659 1 C-N-CA 132.874 4.47 . . . . 0.0 111.183 -172.55 . . . . . . . . 3 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.4 m -112.64 130.09 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.754 -172.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.59 124.57 35.14 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 128.742 2.817 . . . . 0.0 107.733 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.69 152.89 32.34 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 45.8 p30 -130.56 147.14 52.21 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 123.061 1.41 . . . . 0.0 112.455 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.283 9.9 p -119.15 144.75 46.49 Favored 'General case' 0 C--O 1.259 1.58 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.277 168.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.8 m -55.12 148.83 13.29 Favored 'General case' 0 CA--C 1.478 -1.804 3 C-N-CA 140.098 7.359 . . . . 0.0 115.101 -172.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 72.5 p -68.58 109.86 3.95 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 127.835 2.454 . . . . 0.0 109.49 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 108.92 21.07 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 102.274 -3.232 . . . . 0.0 102.274 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.88 112.74 24.81 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 122.426 1.108 . . . . 0.0 111.502 -172.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.0 m -121.61 118.37 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 58.5 m . . . . . 0 CA--C 1.489 -1.38 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 178.347 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.092 0 CA-C-O 121.747 0.784 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.9 tp -87.84 119.63 28.37 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.109 1.763 . . . . 0.0 111.354 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.9 t -98.82 172.92 7.14 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 129.841 3.257 . . . . 0.0 109.728 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 75' ' ' LEU 0.329 0.4 OUTLIER -75.13 98.4 3.69 Favored 'General case' 0 C--N 1.36 1.063 0 O-C-N 120.804 -1.185 . . . . 0.0 109.893 169.501 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 58.24 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 117.91 -2.994 . . . . 0.0 115.551 -171.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -133.0 141.03 48.06 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 131.648 3.979 . . . . 0.0 105.501 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.297 0.0 OUTLIER -82.71 171.08 14.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 125.348 2.499 . . . . 0.0 110.162 177.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.429 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -72.42 -33.31 67.03 Favored 'General case' 0 N--CA 1.428 -1.56 0 O-C-N 119.858 -1.776 . . . . 0.0 112.963 169.222 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.3 m -172.57 173.38 4.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.48 -51.56 2.06 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 120.412 1.46 . . . . 0.0 112.263 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.3 t -170.6 142.66 2.07 Favored 'General case' 0 C--N 1.363 1.18 0 O-C-N 119.415 -2.053 . . . . 0.0 114.339 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.6 118.78 19.62 Favored 'General case' 0 C--N 1.377 1.772 0 O-C-N 121.417 -0.802 . . . . 0.0 109.887 167.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -105.87 114.91 29.35 Favored 'General case' 0 C--N 1.376 1.746 0 O-C-N 120.459 -1.401 . . . . 0.0 109.18 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 86' ' ' GLU . 9.8 p -150.93 173.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.688 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.249 -175.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.441 ' O ' HG21 ' A' ' 85' ' ' VAL . 99.0 mt-10 -79.96 143.51 34.1 Favored 'General case' 0 C--N 1.369 1.456 0 C-N-CA 127.259 2.224 . . . . 0.0 105.432 157.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.46 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.433 5.1 pt-20 -44.21 122.88 3.15 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 117.338 -3.352 . . . . 0.0 118.626 -166.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.0 51.75 0.12 Allowed Glycine 0 C--N 1.352 1.467 0 C-N-CA 128.908 3.147 . . . . 0.0 110.741 -163.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.76 162.34 22.96 Favored 'General case' 0 C--N 1.375 1.689 0 C-N-CA 124.957 1.303 . . . . 0.0 112.339 171.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.91 105.87 14.43 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 124.628 1.171 . . . . 0.0 111.635 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.252 2.3 mp -119.73 129.88 54.72 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -173.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -114.87 137.93 51.39 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 166.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.432 HD13 ' CD1' ' A' ' 136' ' ' TYR . 3.9 mm? -113.69 115.62 28.15 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 102.104 -3.295 . . . . 0.0 102.104 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.429 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 2.5 t -154.62 132.47 11.52 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 120.933 1.697 . . . . 0.0 114.098 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 m -150.22 174.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.011 1 C-N-CA 133.643 4.777 . . . . 0.0 106.822 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.0 t -104.36 141.73 35.8 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 127.637 2.375 . . . . 0.0 106.734 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.2 145.95 39.93 Favored 'General case' 0 C--N 1.379 1.856 1 N-CA-C 123.228 4.529 . . . . 0.0 123.228 -174.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.4 p -156.58 175.49 13.97 Favored 'General case' 0 C--N 1.365 1.248 1 C-N-CA 133.34 4.656 . . . . 0.0 104.391 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.51 42.11 1.02 Allowed Glycine 0 C--N 1.365 2.162 0 O-C-N 119.802 -1.811 . . . . 0.0 117.318 168.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.18 28.35 28.28 Favored Glycine 0 C--N 1.361 1.966 0 C-N-CA 127.616 2.531 . . . . 0.0 115.412 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.453 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 59.3 m -117.67 110.88 18.42 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 114.217 -2.801 . . . . 0.0 108.453 174.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.617 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.91 -86.21 0.56 Allowed Glycine 0 C--N 1.38 3.007 0 C-N-CA 129.249 3.309 . . . . 0.0 110.389 -176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 101' ' ' THR . 20.0 Cg_exo -59.88 168.38 5.83 Favored 'Trans proline' 0 CA--C 1.57 2.312 1 C-N-CA 126.164 4.576 . . . . 0.0 115.676 158.107 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.512 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 77.7 m-85 -106.31 146.09 30.83 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 119.892 3.293 . . . . 0.0 119.892 -163.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.9 t -103.34 142.65 33.85 Favored 'General case' 0 C--N 1.38 1.928 0 C-N-CA 127.879 2.472 . . . . 0.0 104.358 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.406 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -142.43 165.4 27.5 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 122.783 4.364 . . . . 0.0 122.783 -161.555 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.42 119.06 18.09 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 128.265 2.626 . . . . 0.0 105.083 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -109.62 136.41 49.02 Favored 'General case' 0 C--N 1.368 1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 110.55 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.91 169.87 18.25 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 122.717 1.246 . . . . 0.0 107.69 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.485 ' HZ3' ' HH ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -144.73 105.64 4.17 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 175.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.16 1.8 t70 35.05 52.95 0.66 Allowed 'General case' 0 C--N 1.377 1.785 1 N-CA-C 122.307 4.188 . . . . 0.0 122.307 139.829 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.45 -4.77 85.86 Favored Glycine 0 C--N 1.369 2.384 2 O-C-N 133.53 6.769 . . . . 0.0 119.206 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.269 3.5 m -124.45 147.46 55.42 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 129.532 3.133 . . . . 0.0 118.329 -171.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.01 145.05 84.46 Favored 'Trans proline' 0 N--CA 1.493 1.498 1 C-N-CA 125.882 4.388 . . . . 0.0 114.722 171.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.09 159.04 30.57 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 118.739 -2.476 . . . . 0.0 112.244 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -67.42 87.73 0.33 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 125.247 3.965 . . . . 0.0 116.177 -175.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 74.62 -57.22 0.62 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 127.372 2.269 . . . . 0.0 115.425 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 74.13 174.83 0.26 Allowed 'General case' 0 CA--C 1.482 -1.657 0 C-N-CA 130.189 3.396 . . . . 0.0 116.494 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.6 71.87 0.09 Allowed 'General case' 0 C--N 1.356 0.867 0 CA-C-N 114.114 -1.403 . . . . 0.0 114.735 171.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.42 -67.92 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 117.382 1.713 . . . . 0.0 117.382 -172.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 150.32 -69.86 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 126.503 1.921 . . . . 0.0 106.74 -176.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.284 13.6 t -135.38 109.87 8.51 Favored 'General case' 0 C--N 1.363 1.153 0 CA-C-O 123.35 1.548 . . . . 0.0 113.878 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.368 9.1 p90 -127.23 142.12 51.56 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 129.473 3.109 . . . . 0.0 112.716 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.5 m -128.28 139.57 52.35 Favored 'General case' 0 C--N 1.366 1.288 0 O-C-N 119.323 -2.11 . . . . 0.0 110.305 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.415 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -110.54 100.23 44.33 Favored Pre-proline 0 C--N 1.366 1.324 0 C-N-CA 128.708 2.803 . . . . 0.0 106.411 175.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.26 -17.1 15.11 Favored 'Trans proline' 0 C--N 1.353 0.814 1 C-N-CA 126.096 4.531 . . . . 0.0 114.061 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 52.4 m -156.11 102.48 2.14 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 102.596 -3.113 . . . . 0.0 102.596 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.79 133.33 34.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.623 1.969 . . . . 0.0 111.499 175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.5 -179.52 4.92 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.193 2.597 . . . . 0.0 111.027 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.02 -49.0 32.57 Favored 'General case' 0 C--N 1.366 1.305 0 N-CA-C 119.194 3.035 . . . . 0.0 119.194 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.35 -10.26 57.11 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 126.335 1.854 . . . . 0.0 114.53 173.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.366 48.7 m-20 -80.41 -18.31 49.26 Favored 'General case' 0 CA--C 1.572 1.793 0 C-N-CA 129.581 3.152 . . . . 0.0 111.84 168.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.64 126.49 29.1 Favored 'General case' 0 C--N 1.387 2.212 0 N-CA-C 119.536 3.161 . . . . 0.0 119.536 168.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 160.44 -157.5 28.89 Favored Glycine 0 CA--C 1.459 -3.446 0 C-N-CA 127.117 2.294 . . . . 0.0 109.694 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 m -120.63 129.7 53.84 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 115.004 -2.679 . . . . 0.0 108.235 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.485 ' HH ' ' HZ3' ' A' ' 110' ' ' LYS 0.274 30.1 m-85 -95.21 134.85 37.5 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 130.163 3.385 . . . . 0.0 111.651 -170.083 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -147.02 153.87 40.54 Favored 'General case' 0 C--N 1.369 1.429 0 C-N-CA 125.509 1.524 . . . . 0.0 108.202 -173.515 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.43 2.4 p -143.58 134.3 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 117.677 -1.609 . . . . 0.0 114.339 -178.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.42 109.22 21.01 Favored 'General case' 0 C--N 1.385 2.132 0 C-N-CA 129.669 3.188 . . . . 0.0 106.345 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.7 118.62 49.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 C-N-CA 125.482 1.513 . . . . 0.0 111.037 -168.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 11.1 m -104.32 130.86 52.14 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 120.451 -1.406 . . . . 0.0 113.552 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.512 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.344 18.9 p-10 -124.99 -176.58 3.59 Favored 'General case' 0 C--N 1.379 1.853 0 C-N-CA 124.312 1.045 . . . . 0.0 111.909 175.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.617 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 6.2 p -48.84 2.73 0.01 OUTLIER 'General case' 0 C--N 1.372 1.574 1 C-N-CA 137.428 6.291 . . . . 0.0 119.867 -168.01 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.76 4.29 35.04 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 118.16 -1.416 . . . . 0.0 107.678 163.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.435 93.6 mm-40 65.54 40.3 4.63 Favored 'General case' 0 C--N 1.374 1.662 1 C-N-CA 132.736 4.414 . . . . 0.0 110.783 -172.164 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 141' ' ' THR . 3.1 m -112.9 129.36 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 CA-C-N 111.944 -2.389 . . . . 0.0 112.201 -171.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.19 124.12 35.16 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 127.68 2.392 . . . . 0.0 108.205 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 157.43 25.23 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 128.308 2.643 . . . . 0.0 105.375 -173.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -121.46 132.09 54.53 Favored 'General case' 0 C--N 1.358 0.943 0 CA-C-O 124.611 2.148 . . . . 0.0 108.892 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 51.1 m -108.26 147.84 30.85 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 111.509 -2.587 . . . . 0.0 106.942 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.5 m -52.95 146.92 10.05 Favored 'General case' 0 CA--C 1.49 -1.36 1 C-N-CA 135.012 5.325 . . . . 0.0 119.477 -159.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.1 p -70.69 111.04 5.86 Favored 'General case' 0 C--N 1.368 1.403 0 C-N-CA 127.317 2.247 . . . . 0.0 109.321 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.74 110.46 22.77 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 102.214 -3.254 . . . . 0.0 102.214 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.24 113.37 25.6 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 123.247 1.499 . . . . 0.0 112.092 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.67 128.39 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 O-C-N 119.99 -1.694 . . . . 0.0 109.281 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 34.6 m -122.23 122.77 39.91 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 102.508 -3.145 . . . . 0.0 102.508 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.46 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 2.7 m -124.43 104.41 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -85.75 157.96 57.16 Favored Pre-proline 0 C--N 1.356 0.875 0 C-N-CA 124.662 1.185 . . . . 0.0 111.454 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -68.87 165.8 28.61 Favored 'Trans proline' 0 CA--C 1.55 1.278 1 C-N-CA 125.986 4.458 . . . . 0.0 108.782 154.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 20.9 p -67.32 127.01 31.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 119.089 -2.257 . . . . 0.0 108.95 -173.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.06 125.2 89.67 Favored Pre-proline 0 C--N 1.366 1.318 0 N-CA-C 121.648 3.944 . . . . 0.0 121.648 -123.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.63 141.09 84.49 Favored 'Trans proline' 0 C--N 1.386 2.519 1 C-N-CA 125.811 4.341 . . . . 0.0 111.873 168.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -52.71 60.93 0.0 OUTLIER Glycine 0 C--N 1.366 2.221 0 N-CA-C 121.728 3.451 . . . . 0.0 121.728 -168.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -125.42 -40.27 0.4 Allowed Glycine 0 C--N 1.353 1.513 0 C-N-CA 125.701 1.62 . . . . 0.0 113.673 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 9.6 mp -86.37 -64.45 1.15 Allowed 'General case' 0 C--N 1.357 0.93 0 C-N-CA 125.5 1.52 . . . . 0.0 113.907 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.11 13.4 4.71 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 125.205 1.402 . . . . 0.0 112.704 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 75.4 t60 . . . . . 0 C--N 1.351 0.652 0 O-C-N 120.906 -1.121 . . . . 0.0 110.801 -175.308 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.3 tp -106.82 132.2 53.06 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-O 123.585 1.659 . . . . 0.0 108.507 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . 0.269 1.2 t -105.11 170.16 8.03 Favored 'General case' 0 N--CA 1.414 -2.253 0 C-N-CA 125.474 1.51 . . . . 0.0 107.146 177.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.256 0.3 OUTLIER -88.96 98.44 11.76 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 119.808 -1.808 . . . . 0.0 107.963 175.73 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.14 -79.45 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.025 -1.672 . . . . 0.0 111.815 -168.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -133.81 140.61 47.01 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.086 3.355 . . . . 0.0 107.012 161.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.378 0.3 OUTLIER -82.39 174.21 11.32 Favored 'General case' 0 C--N 1.356 0.866 1 C-N-CA 132.109 4.164 . . . . 0.0 109.129 175.242 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -34.83 74.34 Favored 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.912 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.0 m -161.93 172.0 16.75 Favored 'General case' 0 C--N 1.347 0.465 0 O-C-N 116.835 -3.666 . . . . 0.0 103.856 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.72 -43.24 1.0 Allowed 'General case' 0 C--N 1.363 1.187 0 C-N-CA 126.792 2.037 . . . . 0.0 113.359 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.2 p -172.24 127.98 0.57 Allowed 'General case' 0 C--N 1.366 1.319 0 N-CA-C 118.426 2.751 . . . . 0.0 118.426 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.7 tpt -142.4 116.12 9.21 Favored 'General case' 0 C--N 1.377 1.785 0 CA-C-N 120.985 1.721 . . . . 0.0 109.909 162.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.4 p -112.81 116.39 29.99 Favored 'General case' 0 C--N 1.364 1.201 0 O-C-N 118.719 -2.488 . . . . 0.0 110.178 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.59 172.04 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 125.951 1.7 . . . . 0.0 110.331 -170.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -83.27 130.21 35.06 Favored 'General case' 0 C--N 1.373 1.615 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 164.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 8.8 pt-20 -41.73 122.4 1.99 Allowed 'General case' 0 C--N 1.372 1.555 0 N-CA-C 120.469 3.507 . . . . 0.0 120.469 -151.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 145.57 45.75 0.04 OUTLIER Glycine 0 C--N 1.363 2.052 0 CA-C-N 110.292 -3.14 . . . . 0.0 110.993 -166.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.64 165.7 17.71 Favored 'General case' 0 C--N 1.375 1.712 0 C-N-CA 125.336 1.454 . . . . 0.0 113.527 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.99 105.68 14.16 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 124.525 1.13 . . . . 0.0 110.85 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.5 mp -119.58 119.92 35.19 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.87 1.668 . . . . 0.0 114.388 -176.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.87 127.04 53.69 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 173.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -123.78 114.73 20.29 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 173.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.9 m -151.18 132.94 14.96 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 119.63 -1.919 . . . . 0.0 110.909 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 m -148.97 175.18 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.406 0 C-N-CA 130.423 3.489 . . . . 0.0 104.605 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -104.24 139.39 39.33 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 127.511 2.324 . . . . 0.0 105.555 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.59 137.03 31.62 Favored 'General case' 0 C--N 1.379 1.891 1 N-CA-C 122.502 4.26 . . . . 0.0 122.502 -173.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.1 p -156.52 174.72 15.02 Favored 'General case' 0 C--N 1.359 0.991 1 C-N-CA 133.904 4.882 . . . . 0.0 101.25 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.66 40.7 1.37 Allowed Glycine 0 C--N 1.363 2.076 0 N-CA-C 118.102 2.001 . . . . 0.0 118.102 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.53 25.1 28.93 Favored Glycine 0 C--N 1.36 1.91 0 C-N-CA 127.8 2.619 . . . . 0.0 114.458 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.448 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 29.8 p -116.55 110.32 18.4 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 113.089 -3.339 . . . . 0.0 107.876 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.645 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 69.13 -86.93 0.23 Allowed Glycine 0 C--N 1.382 3.089 0 C-N-CA 130.014 3.674 . . . . 0.0 111.117 -170.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 101' ' ' THR . 37.3 Cg_exo -59.91 168.88 5.2 Favored 'Trans proline' 0 CA--C 1.571 2.37 1 C-N-CA 127.514 5.476 . . . . 0.0 116.957 160.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.425 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 66.8 m-85 -98.6 144.27 28.08 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 119.758 3.244 . . . . 0.0 119.758 -167.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 t -102.51 159.16 15.68 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -157.17 166.32 33.55 Favored 'General case' 0 C--N 1.365 1.255 0 N-CA-C 120.508 3.521 . . . . 0.0 120.508 -164.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.84 112.5 10.08 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 128.398 2.679 . . . . 0.0 105.846 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.4 m95 -112.64 142.73 44.89 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 125.346 1.458 . . . . 0.0 108.041 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.29 0.0 OUTLIER -158.25 161.36 37.74 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 166.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.549 ' HZ3' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -133.01 103.89 6.27 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 116.717 -1.993 . . . . 0.0 115.873 177.179 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.406 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.226 1.7 t70 36.99 54.68 1.21 Allowed 'General case' 0 CA--C 1.455 -2.68 1 CA-C-O 111.111 -4.28 . . . . 0.0 119.918 154.075 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.11 -15.28 58.03 Favored Glycine 0 C--N 1.369 2.365 2 O-C-N 134.153 7.158 . . . . 0.0 116.681 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.271 26.6 m -124.23 148.92 59.27 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 129.863 3.265 . . . . 0.0 116.909 -167.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.32 155.86 43.99 Favored 'Trans proline' 0 N--CA 1.502 2.01 1 C-N-CA 126.644 4.896 . . . . 0.0 116.323 171.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.58 147.53 34.56 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 119.539 -1.976 . . . . 0.0 110.162 174.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.418 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 1.6 Cg_endo -58.8 -76.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.919 1 C-N-CA 126.504 4.802 . . . . 0.0 120.377 -165.274 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -141.54 64.75 1.4 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.83 -172.72 4.13 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 126.788 2.035 . . . . 0.0 115.498 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.309 8.4 t 101.79 13.13 0.01 OUTLIER 'General case' 0 C--N 1.354 0.783 0 C-N-CA 129.076 2.95 . . . . 0.0 111.825 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.81 96.75 0.1 Allowed Glycine 0 CA--C 1.475 -2.431 0 C-N-CA 116.733 -2.651 . . . . 0.0 117.687 166.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.481 . . 84.26 -84.52 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 170.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.9 t -138.92 121.1 15.8 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 122.316 2.325 . . . . 0.0 115.609 -170.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.418 ' CD2' ' HG2' ' A' ' 116' ' ' PRO . 29.2 p90 -127.66 139.69 52.56 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 127.638 2.375 . . . . 0.0 110.745 173.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 35.1 m -129.76 139.91 51.18 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 119.33 -2.106 . . . . 0.0 109.774 176.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.35 98.04 41.92 Favored Pre-proline 0 C--N 1.363 1.159 0 C-N-CA 127.638 2.375 . . . . 0.0 107.316 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.12 -16.5 15.69 Favored 'Trans proline' 0 C--N 1.363 1.31 1 C-N-CA 126.635 4.89 . . . . 0.0 113.83 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -161.69 104.32 1.21 Allowed 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 102.426 -3.176 . . . . 0.0 102.426 177.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.74 134.37 34.47 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 128.382 2.673 . . . . 0.0 113.082 -178.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.2 176.92 6.76 Favored 'General case' 0 C--N 1.37 1.473 0 C-N-CA 128.193 2.597 . . . . 0.0 111.031 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.9 -48.59 31.45 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 -172.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.8 -12.3 60.31 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 126.493 1.917 . . . . 0.0 114.65 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.549 ' HA ' ' HZ3' ' A' ' 110' ' ' LYS 0.354 32.0 m-20 -80.84 -18.64 46.77 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 129.873 3.269 . . . . 0.0 111.977 169.575 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.79 133.31 46.43 Favored 'General case' 0 C--N 1.379 1.882 0 N-CA-C 119.448 3.129 . . . . 0.0 119.448 166.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.47 -157.08 29.16 Favored Glycine 0 CA--C 1.461 -3.341 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 170.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.412 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.31 19.2 m -114.0 134.76 54.64 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 114.632 -2.827 . . . . 0.0 107.33 170.229 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.455 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 9.2 m-85 -96.66 133.5 41.11 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 122.014 2.188 . . . . 0.0 113.351 -172.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -140.95 145.6 36.25 Favored 'General case' 0 C--N 1.37 1.477 0 O-C-N 124.035 0.834 . . . . 0.0 109.458 -173.435 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.326 7.6 p -144.94 136.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.37 1.495 0 C-N-CA 118.289 -1.364 . . . . 0.0 113.834 176.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -104.31 118.05 35.68 Favored 'General case' 0 C--N 1.375 1.692 0 C-N-CA 130.081 3.352 . . . . 0.0 106.755 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.41 126.08 65.03 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 C-N-CA 127.572 2.349 . . . . 0.0 113.108 -173.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.3 m -117.24 133.68 55.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 119.401 -2.062 . . . . 0.0 113.883 -176.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.425 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.344 29.3 p-10 -126.46 -177.76 4.1 Favored 'General case' 0 C--N 1.376 1.725 0 CA-C-N 120.301 1.41 . . . . 0.0 112.798 174.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.645 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 66.2 p -49.64 3.75 0.01 OUTLIER 'General case' 0 C--N 1.366 1.324 1 C-N-CA 137.082 6.153 . . . . 0.0 121.01 -170.904 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -100.73 4.63 43.22 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 163.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.378 1.9 mp0 65.23 39.77 5.25 Favored 'General case' 0 C--N 1.379 1.86 1 C-N-CA 133.46 4.704 . . . . 0.0 110.783 -174.239 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.0 m -113.11 127.81 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 CA-C-N 111.541 -2.572 . . . . 0.0 110.974 -169.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.71 128.13 37.42 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 126.982 2.113 . . . . 0.0 107.735 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.75 156.15 27.68 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 128.083 2.553 . . . . 0.0 104.577 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -130.62 146.48 52.13 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.69 -1.256 . . . . 0.0 109.688 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.5 p -129.71 142.95 50.62 Favored 'General case' 0 C--O 1.253 1.24 0 C-N-CA 123.173 0.589 . . . . 0.0 111.627 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 m -54.57 147.24 14.66 Favored 'General case' 0 C--N 1.376 1.758 2 C-N-CA 136.582 5.953 . . . . 0.0 117.108 -163.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.3 p -68.14 110.76 4.13 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 129.754 3.222 . . . . 0.0 109.844 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.08 108.75 21.55 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -93.96 106.9 18.86 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-O 124.324 2.012 . . . . 0.0 110.838 -172.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.52 126.81 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 O-C-N 120.675 -1.266 . . . . 0.0 108.11 -173.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.5 m -116.64 122.08 43.54 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 4.0 m -135.07 103.36 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 103.773 -2.676 . . . . 0.0 103.773 172.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.98 155.67 38.77 Favored Pre-proline 0 C--N 1.349 0.585 0 C-N-CA 125.096 1.358 . . . . 0.0 108.264 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -66.5 165.67 24.32 Favored 'Trans proline' 0 C--N 1.363 1.324 1 C-N-CA 127.472 5.448 . . . . 0.0 110.672 160.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 10.5 p -67.86 126.63 30.05 Favored 'General case' 0 C--N 1.374 1.667 0 O-C-N 119.594 -1.941 . . . . 0.0 107.894 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.0 p -67.34 114.38 18.62 Favored Pre-proline 0 C--N 1.365 1.261 1 N-CA-C 124.392 4.96 . . . . 0.0 124.392 -121.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -63.03 123.13 11.69 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 124.894 3.729 . . . . 0.0 111.395 166.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.94 -85.27 1.57 Allowed Glycine 0 C--N 1.358 1.781 0 C-N-CA 125.2 1.381 . . . . 0.0 112.592 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.49 177.08 39.28 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 75.8 mt -93.36 60.54 3.15 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 125.38 1.472 . . . . 0.0 110.176 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -70.25 63.06 0.23 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 127.916 2.486 . . . . 0.0 116.202 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 85.7 t60 . . . . . 0 C--N 1.355 0.81 0 C-N-CA 127.086 2.155 . . . . 0.0 109.138 179.394 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.992 0 CA-C-O 121.574 0.702 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.77 144.89 27.5 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.19 2.196 . . . . 0.0 111.228 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 t -94.09 173.44 7.65 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 129.79 3.236 . . . . 0.0 112.266 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -81.44 98.77 8.39 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 120.993 -1.067 . . . . 0.0 109.656 171.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.62 -76.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 117.583 -3.198 . . . . 0.0 114.856 -171.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.7 tptm -133.33 140.44 47.41 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 130.864 3.665 . . . . 0.0 106.312 167.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.266 0.0 OUTLIER -82.86 172.05 13.25 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 130.074 3.35 . . . . 0.0 110.559 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.422 ' H ' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -70.07 -28.14 65.19 Favored 'General case' 0 CA--C 1.578 2.02 0 C-N-CA 126.476 1.91 . . . . 0.0 114.602 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.0 m -172.04 179.53 2.64 Favored 'General case' 0 N--CA 1.468 0.434 1 N-CA-C 99.647 -4.205 . . . . 0.0 99.647 173.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.51 -48.69 1.17 Allowed 'General case' 0 C--N 1.355 0.838 0 CA-C-N 121.508 1.958 . . . . 0.0 108.773 169.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.4 t -172.07 134.52 0.75 Allowed 'General case' 0 C--N 1.356 0.876 0 O-C-N 120.396 -1.44 . . . . 0.0 113.106 174.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 54.5 ttm -134.36 116.91 15.77 Favored 'General case' 0 C--N 1.369 1.446 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 162.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 p -108.57 115.36 29.95 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 119.727 -1.858 . . . . 0.0 107.327 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 86' ' ' GLU . 13.7 p -149.62 174.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 125.88 1.672 . . . . 0.0 111.857 -165.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.407 ' O ' HG22 ' A' ' 85' ' ' VAL . 7.5 mp0 -79.22 134.2 36.67 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 126.959 2.104 . . . . 0.0 105.689 161.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.39 0.0 OUTLIER -43.63 122.88 2.87 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 -164.533 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 135.0 52.53 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 128.372 2.892 . . . . 0.0 107.654 -165.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -91.75 153.23 19.76 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 126.577 1.951 . . . . 0.0 108.932 177.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.15 110.72 21.68 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -166.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.8 mt -120.62 144.44 48.14 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -178.25 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.416 HG22 ' HA ' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -126.86 138.51 53.34 Favored 'General case' 0 CA--C 1.506 -0.734 1 N-CA-C 100.165 -4.013 . . . . 0.0 100.165 166.347 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mp -121.86 113.95 20.36 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 100.608 -3.849 . . . . 0.0 100.608 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.402 ' H ' HD22 ' A' ' 79' ' ' LEU . 4.0 t -150.33 133.4 16.16 Favored 'General case' 0 C--N 1.369 1.423 0 CA-C-N 119.568 1.077 . . . . 0.0 112.717 -173.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.76 173.94 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.879 1 C-N-CA 132.191 4.196 . . . . 0.0 104.396 175.614 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.2 t -103.0 141.81 35.17 Favored 'General case' 0 C--N 1.367 1.334 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.5 140.87 46.5 Favored 'General case' 0 C--N 1.368 1.408 1 N-CA-C 122.285 4.18 . . . . 0.0 122.285 -171.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.0 m -158.24 174.26 15.44 Favored 'General case' 0 C--N 1.357 0.891 0 C-N-CA 130.797 3.639 . . . . 0.0 102.222 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.82 43.7 2.2 Favored Glycine 0 C--N 1.365 2.16 0 CA-C-N 122.763 2.529 . . . . 0.0 116.714 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.52 21.33 62.28 Favored Glycine 0 C--N 1.359 1.832 0 C-N-CA 128.413 2.911 . . . . 0.0 114.082 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.7 p -117.1 110.94 18.82 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.271 1.829 . . . . 0.0 108.457 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.708 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.34 -96.64 1.02 Allowed Glycine 0 C--N 1.371 2.488 0 C-N-CA 127.943 2.687 . . . . 0.0 110.985 -168.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.98 169.22 10.78 Favored 'Trans proline' 0 CA--C 1.556 1.579 1 C-N-CA 127.258 5.305 . . . . 0.0 116.855 159.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 58.5 m-85 -92.1 148.07 22.46 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 120.782 3.623 . . . . 0.0 120.782 -168.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -102.84 141.45 35.63 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 129.097 2.959 . . . . 0.0 104.439 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -124.72 159.47 30.81 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 120.076 3.361 . . . . 0.0 120.076 -166.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.0 117.53 20.19 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 101.865 -3.383 . . . . 0.0 101.865 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -107.23 134.76 49.85 Favored 'General case' 0 C--N 1.363 1.176 0 C-N-CA 124.664 1.185 . . . . 0.0 109.073 -178.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.7 170.31 19.52 Favored 'General case' 0 CA--C 1.487 -1.451 0 O-C-N 120.34 -1.475 . . . . 0.0 108.311 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.435 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.5 ptmm? -148.32 106.46 3.73 Favored 'General case' 0 N--CA 1.423 -1.795 0 O-C-N 119.643 -1.91 . . . . 0.0 108.45 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.456 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.213 0.9 OUTLIER 35.27 54.31 0.77 Allowed 'General case' 0 CA--C 1.47 -2.114 2 CA-C-O 109.472 -5.061 . . . . 0.0 122.73 146.212 . . . . . . . . 5 4 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.55 -0.42 85.45 Favored Glycine 0 C--N 1.384 3.242 2 O-C-N 135.113 7.758 . . . . 0.0 118.887 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.3 0.9 OUTLIER -124.49 147.57 55.85 Favored Pre-proline 0 CA--C 1.563 1.474 0 C-N-CA 129.429 3.091 . . . . 0.0 118.812 -167.398 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.75 139.17 56.53 Favored 'Trans proline' 0 N--CA 1.5 1.887 1 C-N-CA 125.992 4.461 . . . . 0.0 117.15 170.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.425 ' CD1' ' H ' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -89.18 162.46 37.37 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 118.374 -2.704 . . . . 0.0 114.303 177.109 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -67.89 94.02 0.39 Allowed 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.564 4.176 . . . . 0.0 115.556 -178.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.3 t70 82.05 -72.14 0.05 OUTLIER 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.61 2.364 . . . . 0.0 110.921 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 97.06 142.45 0.02 OUTLIER 'General case' 0 CA--C 1.479 -1.767 0 C-N-CA 129.057 2.943 . . . . 0.0 111.757 176.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.281 0.2 OUTLIER 82.48 53.54 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.028 -1.896 . . . . 0.0 112.709 179.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.58 -55.84 0.32 Allowed Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 116.305 1.282 . . . . 0.0 116.305 -168.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.304 . . 103.43 -47.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.395 0 C-N-CA 126.59 1.956 . . . . 0.0 113.953 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.4 6.4 t -145.92 92.6 2.22 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 124.135 1.921 . . . . 0.0 109.582 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.291 4.3 p90 -126.88 142.18 51.61 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 129.003 2.921 . . . . 0.0 111.332 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.5 m -124.97 139.66 53.62 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 120.096 -1.628 . . . . 0.0 109.349 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 89.5 45.97 Favored Pre-proline 0 C--N 1.354 0.799 0 C-N-CA 127.937 2.495 . . . . 0.0 107.857 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -68.16 -32.57 27.01 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 124.712 3.608 . . . . 0.0 115.335 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 96.3 m -130.18 100.67 5.49 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.3 118.63 29.95 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.918 1.287 . . . . 0.0 113.555 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.07 -179.84 6.54 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.348 2.659 . . . . 0.0 109.646 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.87 -51.26 23.68 Favored 'General case' 0 C--N 1.368 1.387 0 O-C-N 118.16 -2.837 . . . . 0.0 117.761 -174.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -68.08 0.17 3.89 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 128.45 2.7 . . . . 0.0 114.966 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -116.66 -12.08 10.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 130.435 3.494 . . . . 0.0 111.316 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.34 157.26 16.3 Favored 'General case' 0 C--N 1.394 2.509 0 N-CA-C 119.409 3.115 . . . . 0.0 119.409 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 152.43 -158.36 27.8 Favored Glycine 0 C--N 1.39 3.535 0 C-N-CA 128.832 3.111 . . . . 0.0 111.042 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.429 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.328 3.8 m -106.07 131.94 52.74 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 112.947 -3.501 . . . . 0.0 105.989 167.578 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.493 ' HB2' ' HB2' ' A' ' 153' ' ' CYS . 18.3 m-85 -97.23 134.96 39.84 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 122.757 2.526 . . . . 0.0 113.599 -172.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -147.97 152.3 37.25 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-O 122.422 1.106 . . . . 0.0 110.175 -174.493 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.254 8.3 p -135.91 137.69 48.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 118.471 -1.292 . . . . 0.0 113.901 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.3 m -105.69 116.61 32.23 Favored 'General case' 0 C--N 1.377 1.787 0 C-N-CA 129.098 2.959 . . . . 0.0 104.925 176.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.88 119.09 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 124.086 0.954 . . . . 0.0 109.67 -167.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.41 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 10.2 m -103.73 128.8 51.06 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 120.951 -1.093 . . . . 0.0 113.497 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.47 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.488 11.1 p-10 -127.55 -174.78 3.27 Favored 'General case' 0 C--N 1.371 1.52 0 CA-C-N 119.191 0.905 . . . . 0.0 111.84 174.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.708 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 80.5 p -49.97 2.44 0.01 OUTLIER 'General case' 0 C--N 1.361 1.069 2 C-N-CA 135.549 5.54 . . . . 0.0 121.816 -163.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.52 4.37 38.5 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 164.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.394 68.8 mm-40 66.39 40.01 3.78 Favored 'General case' 0 C--N 1.375 1.678 1 C-N-CA 132.803 4.441 . . . . 0.0 110.84 -172.623 . . . . . . . . 3 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 141' ' ' THR . 3.9 m -113.26 129.8 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.253 -171.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.29 123.58 34.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 126.661 1.984 . . . . 0.0 107.691 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.514 ' HZ2' ' HB3' ' A' ' 150' ' ' SER . 0.0 OUTLIER -116.55 157.53 25.11 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 -175.256 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -128.68 132.22 48.03 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.646 -1.284 . . . . 0.0 109.706 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.514 ' HB3' ' HZ2' ' A' ' 148' ' ' LYS 0.474 55.9 p -114.35 151.88 32.32 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 123.75 0.82 . . . . 0.0 111.13 178.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -53.69 146.81 12.62 Favored 'General case' 0 C--N 1.371 1.508 1 C-N-CA 133.843 4.857 . . . . 0.0 120.146 -153.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 64.5 p -70.33 110.96 5.57 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 129.745 3.218 . . . . 0.0 109.323 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 18.0 m -106.01 109.62 21.63 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.58 107.23 19.62 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 124.773 2.225 . . . . 0.0 111.308 -170.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . 0.263 1.1 t -118.0 114.95 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 -172.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m -110.37 133.63 53.08 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.4 m -128.8 105.77 13.41 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 CA-C-O 124.023 1.868 . . . . 0.0 112.802 -179.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -87.31 157.69 53.03 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 124.594 1.158 . . . . 0.0 109.086 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.82 165.91 30.43 Favored 'Trans proline' 0 C--N 1.358 1.059 1 C-N-CA 126.835 5.023 . . . . 0.0 107.02 153.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.9 p -67.29 133.57 49.93 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 118.506 -2.621 . . . . 0.0 110.784 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 14.9 t -65.72 104.47 0.58 Allowed Pre-proline 0 C--N 1.36 1.045 0 N-CA-C 121.218 3.784 . . . . 0.0 121.218 -124.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -62.77 122.86 11.34 Favored 'Trans proline' 0 C--N 1.386 2.529 1 C-N-CA 125.972 4.448 . . . . 0.0 111.544 170.007 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.58 -21.01 48.06 Favored Glycine 0 C--N 1.357 1.707 0 C-N-CA 125.559 1.552 . . . . 0.0 112.734 -170.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -101.83 -49.0 1.31 Allowed Glycine 0 C--N 1.361 1.938 0 C-N-CA 125.272 1.415 . . . . 0.0 114.986 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 19.3 mt -88.55 -5.88 57.92 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 58.94 -35.52 0.06 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 130.389 3.475 . . . . 0.0 120.126 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 1.3 p80 . . . . . 0 C--N 1.358 0.938 0 C-N-CA 129.431 3.092 . . . . 0.0 117.398 -176.489 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.132 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.1 tp -107.24 132.67 52.82 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 122.784 1.278 . . . . 0.0 108.903 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 t -104.8 171.18 7.46 Favored 'General case' 0 N--CA 1.416 -2.159 0 C-N-CA 125.463 1.505 . . . . 0.0 112.632 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.29 0.5 OUTLIER -92.46 97.85 11.1 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.299 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 t 61.16 -78.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 119.06 -2.275 . . . . 0.0 112.877 -169.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -133.68 138.72 46.02 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 128.82 2.848 . . . . 0.0 107.764 164.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.34 0.0 OUTLIER -83.53 172.66 12.16 Favored 'General case' 0 C--N 1.356 0.877 1 C-N-CA 132.911 4.485 . . . . 0.0 109.123 175.866 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -32.26 70.22 Favored 'General case' 0 CA--C 1.577 2.005 0 O-C-N 119.651 -1.906 . . . . 0.0 112.336 173.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.2 m -164.81 171.32 14.37 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 116.667 -3.77 . . . . 0.0 103.785 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.41 -45.41 1.51 Allowed 'General case' 0 C--N 1.366 1.315 0 C-N-CA 127.031 2.132 . . . . 0.0 112.932 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 86.1 p -176.17 134.12 0.25 Allowed 'General case' 0 C--N 1.365 1.262 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.6 ttt -134.75 117.93 16.52 Favored 'General case' 0 C--N 1.373 1.629 0 CA-C-N 119.696 1.134 . . . . 0.0 109.203 159.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.5 p -111.13 116.15 30.62 Favored 'General case' 0 C--N 1.363 1.188 0 O-C-N 119.482 -2.011 . . . . 0.0 109.789 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.74 171.98 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 126.825 2.05 . . . . 0.0 112.937 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.4 127.56 33.79 Favored 'General case' 0 C--N 1.372 1.55 0 O-C-N 118.961 -2.337 . . . . 0.0 105.258 163.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.453 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.278 8.6 pt-20 -41.83 122.57 2.07 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 120.389 3.477 . . . . 0.0 120.389 -150.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 144.34 54.71 0.03 OUTLIER Glycine 0 C--N 1.356 1.639 0 CA-C-N 109.656 -3.429 . . . . 0.0 110.55 -172.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.11 158.79 23.56 Favored 'General case' 0 C--N 1.372 1.58 0 C-N-CA 125.482 1.513 . . . . 0.0 113.101 174.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.91 101.62 9.92 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 125.415 1.486 . . . . 0.0 112.312 -174.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.413 HD23 ' CE1' ' A' ' 136' ' ' TYR . 1.1 mp -119.79 130.83 55.13 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 125.943 1.697 . . . . 0.0 115.318 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.98 132.8 53.9 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 172.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.475 HD23 ' CD2' ' A' ' 136' ' ' TYR . 3.1 mp -131.83 115.16 15.58 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 170.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.416 ' HG ' ' CB ' ' A' ' 122' ' ' THR . 3.5 t -148.1 133.84 18.93 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.529 -1.357 . . . . 0.0 110.981 -174.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.7 174.57 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 129.549 3.14 . . . . 0.0 104.0 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 t -104.26 141.38 36.39 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 126.948 2.099 . . . . 0.0 105.696 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.31 134.2 32.23 Favored 'General case' 0 C--N 1.37 1.472 0 N-CA-C 120.127 3.38 . . . . 0.0 120.127 -172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.3 m -157.86 174.04 15.88 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 131.363 3.865 . . . . 0.0 100.843 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.52 44.24 2.21 Favored Glycine 0 C--N 1.363 2.045 0 CA-C-N 122.584 2.447 . . . . 0.0 117.582 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.4 12.73 81.63 Favored Glycine 0 C--N 1.362 1.991 0 C-N-CA 128.705 3.05 . . . . 0.0 113.068 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.7 p -115.87 111.17 20.05 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 126.481 1.913 . . . . 0.0 107.396 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.538 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 71.83 -101.4 1.01 Allowed Glycine 0 C--N 1.36 1.886 0 C-N-CA 127.181 2.324 . . . . 0.0 109.315 -161.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.79 168.32 7.22 Favored 'Trans proline' 0 CA--C 1.555 1.573 1 C-N-CA 129.227 6.618 . . . . 0.0 118.349 165.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -82.07 138.86 34.73 Favored 'General case' 0 CA--C 1.562 1.419 1 N-CA-C 122.274 4.175 . . . . 0.0 122.274 -170.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 t -102.82 154.96 18.68 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 129.756 3.223 . . . . 0.0 104.309 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -153.71 166.27 33.35 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -165.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.2 112.81 10.76 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 128.417 2.687 . . . . 0.0 105.64 170.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 94.1 m95 -111.94 137.5 49.85 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.349 1.859 . . . . 0.0 108.595 -178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.308 0.2 OUTLIER -158.61 162.77 37.35 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.32 -1.487 . . . . 0.0 107.427 168.898 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.44 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -137.31 103.59 5.14 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 116.954 -1.898 . . . . 0.0 115.412 177.9 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.153 2.3 t70 36.6 53.82 1.07 Allowed 'General case' 0 CA--C 1.467 -2.22 1 CA-C-O 111.433 -4.127 . . . . 0.0 119.609 153.898 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.71 -0.56 70.46 Favored Glycine 0 C--N 1.373 2.6 2 O-C-N 134.227 7.204 . . . . 0.0 117.38 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.384 1.3 p -124.82 147.8 57.51 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 130.074 3.349 . . . . 0.0 119.445 -167.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.02 143.7 79.7 Favored 'Trans proline' 0 N--CA 1.498 1.747 1 C-N-CA 125.964 4.442 . . . . 0.0 115.817 167.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -94.99 144.91 28.6 Favored Pre-proline 0 CA--C 1.551 1.004 0 O-C-N 119.437 -2.039 . . . . 0.0 112.916 176.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.55 93.43 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.447 1 C-N-CA 125.938 4.425 . . . . 0.0 118.83 -172.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.3 t70 65.1 48.26 2.28 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 169.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.32 -165.64 0.9 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 127.598 2.359 . . . . 0.0 115.694 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.304 8.4 t 99.92 8.04 0.01 OUTLIER 'General case' 0 C--N 1.354 0.765 0 C-N-CA 128.959 2.904 . . . . 0.0 112.121 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.2 91.77 0.08 OUTLIER Glycine 0 CA--C 1.48 -2.129 0 C-N-CA 115.979 -3.01 . . . . 0.0 118.568 167.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.461 . . 89.6 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 167.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.416 ' CB ' ' HG ' ' A' ' 94' ' ' SER . 12.0 t -139.32 118.27 12.5 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 122.106 2.23 . . . . 0.0 115.915 -169.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -127.63 140.13 52.29 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 127.381 2.272 . . . . 0.0 111.197 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 89.1 m -129.25 140.55 51.41 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 119.306 -2.121 . . . . 0.0 109.68 177.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.4 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -111.85 95.97 31.21 Favored Pre-proline 0 C--N 1.366 1.293 0 C-N-CA 128.203 2.601 . . . . 0.0 108.455 178.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.19 -14.11 16.77 Favored 'Trans proline' 0 C--N 1.356 0.948 1 C-N-CA 126.278 4.652 . . . . 0.0 113.563 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 95.5 m -161.6 101.0 1.18 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 102.43 -3.174 . . . . 0.0 102.43 178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -83.12 134.05 35.02 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.83 2.452 . . . . 0.0 112.183 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.62 173.19 7.74 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 127.935 2.494 . . . . 0.0 110.086 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -41.12 23.61 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 120.166 3.395 . . . . 0.0 120.166 -173.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -66.95 -14.57 62.96 Favored 'General case' 0 C--N 1.366 1.317 0 C-N-CA 126.801 2.04 . . . . 0.0 115.393 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -80.42 -17.05 52.94 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 129.475 3.11 . . . . 0.0 111.559 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.86 107.88 2.79 Favored 'General case' 0 C--N 1.384 2.077 0 N-CA-C 120.45 3.5 . . . . 0.0 120.45 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.65 -154.12 19.13 Favored Glycine 0 CA--C 1.459 -3.413 0 C-N-CA 126.77 2.129 . . . . 0.0 108.935 172.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.418 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.288 19.6 m -117.64 135.49 53.95 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 114.892 -2.723 . . . . 0.0 108.296 175.335 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.475 ' CD2' HD23 ' A' ' 93' ' ' LEU . 10.1 m-85 -96.77 133.32 41.5 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 120.299 -1.501 . . . . 0.0 113.487 -171.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.418 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -146.05 149.32 33.87 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 121.573 0.702 . . . . 0.0 110.782 -173.032 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.474 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 14.6 p -142.49 142.94 26.51 Favored 'Isoleucine or valine' 0 C--N 1.372 1.56 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 175.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -105.15 118.45 36.58 Favored 'General case' 0 C--N 1.375 1.681 0 C-N-CA 129.732 3.213 . . . . 0.0 105.333 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -129.1 122.66 56.86 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 126.765 2.026 . . . . 0.0 112.347 -175.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 17.4 m -111.78 133.96 53.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 118.995 -2.315 . . . . 0.0 114.043 -177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . 0.591 4.4 p30 -134.86 -167.18 1.94 Allowed 'General case' 0 C--N 1.373 1.62 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 173.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.538 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 90.6 p -48.88 3.51 0.01 OUTLIER 'General case' 0 C--N 1.366 1.297 2 C-N-CA 134.838 5.255 . . . . 0.0 122.208 -158.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -106.75 4.87 28.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.468 164.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.397 89.3 mm-40 66.19 40.19 3.93 Favored 'General case' 0 C--N 1.375 1.696 1 C-N-CA 132.077 4.151 . . . . 0.0 110.455 -171.72 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.9 m -112.92 129.85 67.82 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.376 0 CA-C-N 111.759 -2.473 . . . . 0.0 111.362 -171.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.89 130.54 37.63 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.885 1.274 . . . . 0.0 110.027 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.93 156.99 26.45 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 128.172 2.589 . . . . 0.0 104.913 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -130.5 146.72 52.09 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 120.877 -1.139 . . . . 0.0 108.128 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.474 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.337 88.4 p -130.82 143.83 51.02 Favored 'General case' 0 C--O 1.251 1.133 0 O-C-N 121.726 -0.609 . . . . 0.0 110.734 175.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.0 m -54.35 148.02 12.49 Favored 'General case' 0 CA--C 1.481 -1.675 2 C-N-CA 137.127 6.171 . . . . 0.0 118.089 -162.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 65.5 p -68.38 110.35 4.08 Favored 'General case' 0 C--N 1.375 1.675 0 CA-C-N 111.865 -2.425 . . . . 0.0 109.136 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 109.78 22.47 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 102.172 -3.27 . . . . 0.0 102.172 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.42 114.58 27.17 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 125.125 2.393 . . . . 0.0 110.628 -174.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.4 t -117.83 117.4 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.2 m -113.45 121.01 43.01 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 103.182 -2.895 . . . . 0.0 103.182 173.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.453 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 4.5 m -135.04 102.12 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 171.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.32 156.7 37.2 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 125.055 1.342 . . . . 0.0 109.055 177.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -62.77 168.02 10.93 Favored 'Trans proline' 0 CA--C 1.551 1.35 1 C-N-CA 126.932 5.088 . . . . 0.0 110.156 154.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 17.7 p -67.05 136.2 54.85 Favored 'General case' 0 C--N 1.375 1.68 0 O-C-N 118.994 -2.316 . . . . 0.0 108.059 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 49.1 t -66.73 103.84 0.53 Allowed Pre-proline 0 C--N 1.361 1.07 1 N-CA-C 122.173 4.138 . . . . 0.0 122.173 -126.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.63 123.66 12.76 Favored 'Trans proline' 0 C--N 1.385 2.496 1 C-N-CA 126.319 4.679 . . . . 0.0 112.707 170.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 104.29 -45.16 1.35 Allowed Glycine 0 C--N 1.359 1.81 0 C-N-CA 125.913 1.72 . . . . 0.0 111.219 -177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -82.57 -42.02 8.67 Favored Glycine 0 C--N 1.361 1.953 0 C-N-CA 125.64 1.59 . . . . 0.0 113.81 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.9 90.72 3.39 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.72 71.59 0.21 Allowed 'General case' 0 C--N 1.363 1.159 0 C-N-CA 126.307 1.843 . . . . 0.0 115.575 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 . . . . . 0 C--N 1.357 0.934 0 C-N-CA 128.052 2.541 . . . . 0.0 112.897 -177.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.33 145.88 32.27 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 127.34 2.256 . . . . 0.0 110.28 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.78 140.88 34.44 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 173.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -96.65 99.67 11.28 Favored 'General case' 0 C--N 1.37 1.462 0 O-C-N 118.46 -2.65 . . . . 0.0 106.885 175.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.1 m 65.33 -74.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.687 1.995 . . . . 0.0 110.01 -168.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 119.65 19.63 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 128.301 2.64 . . . . 0.0 105.027 154.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.278 6.9 t70 -86.88 117.91 25.92 Favored 'General case' 0 C--N 1.371 1.537 0 N-CA-C 101.262 -3.607 . . . . 0.0 101.262 166.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -71.63 -36.1 70.62 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 121.003 3.705 . . . . 0.0 121.003 -157.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 m -173.78 172.37 3.54 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 102.982 -2.969 . . . . 0.0 102.982 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.01 -52.79 2.59 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.294 -1.504 . . . . 0.0 110.205 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 t -172.16 136.04 0.82 Allowed 'General case' 0 C--N 1.357 0.928 0 O-C-N 119.842 -1.786 . . . . 0.0 113.709 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 25.0 ttt -130.56 117.9 20.25 Favored 'General case' 0 C--N 1.373 1.605 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 163.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -105.5 115.61 30.55 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 119.612 -1.93 . . . . 0.0 107.496 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 86' ' ' GLU . 11.1 p -149.24 173.72 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.752 0 CA-C-O 123.255 1.502 . . . . 0.0 112.208 -168.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.402 ' O ' HG21 ' A' ' 85' ' ' VAL . 8.6 pt-20 -80.02 132.65 36.04 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 126.864 2.066 . . . . 0.0 105.455 159.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.29 0.3 OUTLIER -43.77 121.71 2.48 Favored 'General case' 0 N--CA 1.513 2.719 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 -161.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 138.44 51.66 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.226 0 CA-C-N 111.446 -2.615 . . . . 0.0 108.938 -164.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.13 163.34 17.91 Favored 'General case' 0 C--N 1.367 1.352 0 C-N-CA 125.804 1.642 . . . . 0.0 111.455 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.15 105.69 14.48 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.925 0.89 . . . . 0.0 112.755 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.7 mp -119.87 120.22 35.82 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 126.505 1.922 . . . . 0.0 115.313 -172.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.75 126.37 52.2 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 170.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.34 114.87 18.14 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 103.452 -2.795 . . . . 0.0 103.452 176.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -156.75 140.32 15.9 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.951 -1.093 . . . . 0.0 109.63 -172.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.64 172.73 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 129.395 3.078 . . . . 0.0 104.884 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.3 t -104.01 141.76 35.63 Favored 'General case' 0 C--N 1.373 1.605 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' A' ' 121' ' ' ALA . . . -125.26 149.88 47.59 Favored 'General case' 0 C--N 1.363 1.194 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.4 m -159.4 174.92 13.99 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.17 42.48 2.74 Favored Glycine 0 C--N 1.362 2.009 0 CA-C-N 122.905 2.593 . . . . 0.0 116.239 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.84 0.8 60.22 Favored Glycine 0 C--N 1.362 1.979 0 C-N-CA 125.649 1.595 . . . . 0.0 114.393 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.9 m -117.24 123.91 47.76 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.346 1.458 . . . . 0.0 110.034 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.636 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.45 -113.26 4.36 Favored Glycine 0 C--N 1.361 1.917 0 CA-C-O 116.153 -2.47 . . . . 0.0 108.798 -163.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -66.96 168.45 17.18 Favored 'Trans proline' 0 CA--C 1.564 1.985 1 C-N-CA 127.759 5.64 . . . . 0.0 117.353 163.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.401 ' CE2' ' CG ' ' A' ' 142' ' ' ASP . 27.4 m-85 -82.1 144.33 30.87 Favored 'General case' 0 C--N 1.358 0.947 1 N-CA-C 125.453 5.353 . . . . 0.0 125.453 -164.494 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.3 t -103.24 141.47 35.84 Favored 'General case' 0 C--N 1.371 1.529 0 C-N-CA 127.914 2.486 . . . . 0.0 104.525 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -137.39 160.32 39.43 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 120.354 3.464 . . . . 0.0 120.354 -166.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.08 113.69 9.09 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 110.593 -3.003 . . . . 0.0 105.112 173.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -111.98 154.77 24.8 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 120.676 -1.265 . . . . 0.0 108.595 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.383 0.2 OUTLIER -158.3 168.73 26.2 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 166.338 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.48 ' HZ2' ' HB3' ' A' ' 113' ' ' SER . 1.0 OUTLIER -144.5 105.01 4.12 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 120.138 -1.601 . . . . 0.0 114.911 -178.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.481 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.224 0.6 OUTLIER 36.39 53.75 1.01 Allowed 'General case' 0 CA--C 1.464 -2.336 1 CA-C-O 111.394 -4.145 . . . . 0.0 119.198 153.699 . . . . . . . . 5 4 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.38 -0.65 78.24 Favored Glycine 0 C--N 1.373 2.607 2 O-C-N 134.747 7.529 . . . . 0.0 118.375 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.48 ' HB3' ' HZ2' ' A' ' 110' ' ' LYS 0.268 58.2 m -124.89 148.87 61.15 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 120.304 3.446 . . . . 0.0 120.304 -167.297 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -60.22 148.75 88.69 Favored 'Trans proline' 0 N--CA 1.507 2.301 1 C-N-CA 126.231 4.62 . . . . 0.0 116.194 166.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.401 ' HB ' ' HD2' ' A' ' 116' ' ' PRO 0.325 0.8 OUTLIER -98.64 165.1 15.71 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 117.846 -3.034 . . . . 0.0 112.285 175.279 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 6.0 Cg_endo -69.2 87.92 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.739 1 C-N-CA 125.826 4.351 . . . . 0.0 113.984 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.6 t70 84.99 -57.51 0.09 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.877 3.271 . . . . 0.0 110.612 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.302 . . 102.97 -62.87 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 130.715 3.606 . . . . 0.0 115.285 171.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.301 8.0 t -73.7 80.12 1.54 Allowed 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 130.732 3.613 . . . . 0.0 113.886 -174.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.94 -71.48 0.02 OUTLIER Glycine 0 C--N 1.36 1.867 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 -172.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.4 ' HB1' ' HB1' ' A' ' 97' ' ' ALA 0.318 . . 129.4 -24.73 0.01 OUTLIER 'General case' 0 C--N 1.365 1.247 0 C-N-CA 127.265 2.226 . . . . 0.0 116.044 178.008 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.34 15.0 t -154.85 102.23 2.34 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-N 121.013 1.733 . . . . 0.0 112.657 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.313 0.1 OUTLIER -127.43 141.48 51.67 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 127.897 2.479 . . . . 0.0 111.472 176.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 60.1 m -128.32 138.65 52.48 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 118.991 -2.318 . . . . 0.0 107.28 173.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.89 102.72 52.88 Favored Pre-proline 0 C--N 1.362 1.137 0 C-N-CA 128.042 2.537 . . . . 0.0 105.209 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -77.04 -11.86 17.77 Favored 'Trans proline' 0 C--N 1.348 0.548 1 C-N-CA 126.227 4.618 . . . . 0.0 112.731 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 62.1 m -157.22 100.9 1.87 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.46 128.47 39.56 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 124.312 1.045 . . . . 0.0 112.317 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.27 179.06 5.17 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 129.462 3.105 . . . . 0.0 108.574 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.62 -53.96 13.26 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -172.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.38 0.93 3.37 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 127.234 2.213 . . . . 0.0 115.788 172.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -113.8 -13.79 12.59 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 130.362 3.465 . . . . 0.0 110.695 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.28 160.18 14.46 Favored 'General case' 0 C--N 1.4 2.775 0 N-CA-C 120.157 3.391 . . . . 0.0 120.157 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.6 -158.59 27.75 Favored Glycine 0 CA--C 1.469 -2.831 0 C-N-CA 128.585 2.993 . . . . 0.0 106.905 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.331 1.2 m -105.8 129.39 54.0 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 114.677 -2.809 . . . . 0.0 107.559 168.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.42 ' CZ ' ' HD2' ' A' ' 110' ' ' LYS . 12.7 m-85 -96.59 134.92 39.21 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 123.404 2.82 . . . . 0.0 113.159 -171.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -146.16 152.15 38.78 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 123.9 0.88 . . . . 0.0 110.385 -175.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.666 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 8.5 p -142.95 141.12 27.11 Favored 'Isoleucine or valine' 0 C--N 1.371 1.525 0 C-N-CA 117.474 -1.69 . . . . 0.0 114.928 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 61.5 m -103.64 110.98 23.26 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 129.96 3.304 . . . . 0.0 106.206 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.78 114.9 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.334 2.254 . . . . 0.0 109.87 -172.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 4.7 m -102.16 130.15 48.72 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.322 -1.486 . . . . 0.0 113.807 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.401 ' CG ' ' CE2' ' A' ' 104' ' ' TYR 0.481 7.1 p30 -138.39 -165.38 1.8 Allowed 'General case' 0 C--N 1.371 1.531 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 174.131 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.636 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 91.3 p -48.91 3.69 0.01 OUTLIER 'General case' 0 C--N 1.369 1.45 2 C-N-CA 134.986 5.315 . . . . 0.0 123.135 -163.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -105.65 5.92 31.58 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 163.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.395 6.9 mm100 64.27 39.98 6.97 Favored 'General case' 0 C--N 1.374 1.655 1 C-N-CA 133.403 4.681 . . . . 0.0 111.261 -171.164 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 141' ' ' THR . 3.1 m -113.88 134.77 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.826 0 CA-C-N 111.774 -2.466 . . . . 0.0 112.318 -170.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.14 123.45 34.61 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 129.13 2.972 . . . . 0.0 106.287 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.82 157.84 24.93 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 128.781 2.833 . . . . 0.0 105.038 -175.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.437 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 30.3 t70 -125.82 134.23 51.74 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 122.284 1.04 . . . . 0.0 109.108 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.666 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.508 54.2 p -111.79 146.8 36.99 Favored 'General case' 0 C--O 1.252 1.227 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.0 m -53.95 147.87 11.57 Favored 'General case' 0 C--N 1.375 1.702 1 C-N-CA 135.261 5.424 . . . . 0.0 120.004 -157.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.3 p -69.38 110.89 4.92 Favored 'General case' 0 C--N 1.37 1.468 0 C-N-CA 126.115 1.766 . . . . 0.0 110.192 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.36 109.46 21.1 Favored 'General case' 0 C--N 1.358 0.957 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -94.54 107.22 19.21 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-O 123.622 1.677 . . . . 0.0 110.99 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.82 115.09 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.1 m -107.99 132.09 53.87 Favored 'General case' 0 C--N 1.369 1.415 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.53 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.8 105.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.365 1.274 0 CA-C-O 124.276 1.989 . . . . 0.0 113.73 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -88.37 157.67 49.95 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.453 1.501 . . . . 0.0 109.663 175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.06 166.2 30.67 Favored 'Trans proline' 0 CA--C 1.548 1.196 1 C-N-CA 127.296 5.331 . . . . 0.0 107.596 153.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.0 p -66.97 125.65 26.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 118.361 -2.712 . . . . 0.0 110.233 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 56.9 t -67.09 112.3 9.5 Favored Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 121.068 3.729 . . . . 0.0 121.068 -123.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -62.69 148.3 93.58 Favored 'Trans proline' 0 C--N 1.381 2.275 1 C-N-CA 126.43 4.753 . . . . 0.0 114.942 173.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.82 -58.18 3.31 Favored Glycine 0 C--N 1.361 1.941 0 C-N-CA 125.497 1.522 . . . . 0.0 114.151 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.03 147.4 9.31 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 66.0 mt -96.76 59.09 1.71 Allowed 'General case' 0 C--N 1.363 1.169 0 O-C-N 120.714 -1.463 . . . . 0.0 111.763 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -76.88 64.49 2.41 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 126.85 2.06 . . . . 0.0 113.632 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 82.9 t60 . . . . . 0 C--N 1.353 0.721 0 C-N-CA 126.207 1.803 . . . . 0.0 108.742 -177.613 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.018 0 CA-C-O 121.863 0.84 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.0 tp -107.35 136.88 46.41 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 126.863 2.065 . . . . 0.0 108.665 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.4 t -94.39 172.61 8.09 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 120.074 -1.641 . . . . 0.0 111.449 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.42 0.5 OUTLIER -84.28 98.27 9.89 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.942 171.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.02 -72.51 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 117.912 -2.992 . . . . 0.0 115.418 -172.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -133.48 140.55 47.32 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 130.413 3.485 . . . . 0.0 107.07 167.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.284 0.0 OUTLIER -82.99 171.01 14.29 Favored 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 128.288 2.635 . . . . 0.0 111.201 177.208 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.428 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -71.75 -31.81 67.05 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.379 -1.737 . . . . 0.0 113.716 172.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.9 m -171.97 172.63 4.67 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 100.483 -3.895 . . . . 0.0 100.483 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.47 -51.32 1.96 Allowed 'General case' 0 C--N 1.351 0.673 0 CA-C-N 120.561 1.528 . . . . 0.0 111.117 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.4 t -172.62 145.41 1.55 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 120.35 -1.469 . . . . 0.0 114.728 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.5 ttt -135.7 128.57 31.23 Favored 'General case' 0 C--N 1.371 1.517 0 O-C-N 121.36 -0.837 . . . . 0.0 109.608 160.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 p -104.9 114.49 28.72 Favored 'General case' 0 C--N 1.373 1.611 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 86' ' ' GLU 0.252 7.4 p -149.87 174.03 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.899 -167.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 85' ' ' VAL . 1.3 pp20? -89.31 144.23 26.24 Favored 'General case' 0 C--N 1.364 1.209 0 O-C-N 119.392 -2.067 . . . . 0.0 106.813 163.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.473 3.8 pt-20 -44.39 124.91 4.35 Favored 'General case' 0 N--CA 1.516 2.847 0 O-C-N 118.121 -2.862 . . . . 0.0 117.863 -172.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.05 50.4 0.24 Allowed Glycine 0 C--N 1.345 1.049 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 -150.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.04 152.28 18.9 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 127.023 2.129 . . . . 0.0 111.663 -176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.05 113.79 26.79 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-O 122.466 1.127 . . . . 0.0 113.632 -169.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 136' ' ' TYR . 0.3 OUTLIER -121.03 138.1 54.33 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 126.343 1.857 . . . . 0.0 115.9 174.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -123.87 137.38 54.66 Favored 'General case' 0 CA--C 1.494 -1.173 1 N-CA-C 99.817 -4.142 . . . . 0.0 99.817 160.682 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.0 mp -122.29 115.13 21.79 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 101.003 -3.702 . . . . 0.0 101.003 177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.428 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 5.7 t -152.49 132.27 13.22 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -174.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.84 174.43 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.052 1 C-N-CA 132.476 4.31 . . . . 0.0 105.629 176.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.3 t -104.15 141.24 36.59 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 119.773 -1.83 . . . . 0.0 107.72 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.76 146.01 35.47 Favored 'General case' 0 C--N 1.382 2.008 1 N-CA-C 124.947 5.166 . . . . 0.0 124.947 -173.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.9 p -156.95 175.33 14.24 Favored 'General case' 0 C--N 1.369 1.414 1 C-N-CA 133.786 4.834 . . . . 0.0 104.031 177.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.06 42.91 0.79 Allowed Glycine 0 C--N 1.367 2.273 0 O-C-N 119.597 -1.939 . . . . 0.0 117.779 171.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.85 25.69 52.05 Favored Glycine 0 C--N 1.361 1.961 0 C-N-CA 128.396 2.903 . . . . 0.0 114.851 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.419 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 6.4 p -116.91 110.01 17.78 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 116.519 -1.705 . . . . 0.0 108.368 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.728 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 71.8 -90.63 0.49 Allowed Glycine 0 C--N 1.371 2.516 0 C-N-CA 129.408 3.385 . . . . 0.0 110.731 -167.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 101' ' ' THR . 38.9 Cg_exo -59.89 169.32 4.72 Favored 'Trans proline' 0 CA--C 1.564 1.975 1 C-N-CA 128.054 5.836 . . . . 0.0 117.326 160.647 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.461 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 64.7 m-85 -94.74 143.18 26.66 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 120.373 3.472 . . . . 0.0 120.373 -167.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.8 t -103.24 142.34 34.35 Favored 'General case' 0 C--N 1.382 1.999 0 C-N-CA 128.772 2.829 . . . . 0.0 104.789 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -141.48 165.99 25.98 Favored 'General case' 0 C--N 1.351 0.654 1 N-CA-C 122.282 4.178 . . . . 0.0 122.282 -160.745 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.86 121.95 12.89 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 128.187 2.595 . . . . 0.0 106.642 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -112.01 142.46 44.41 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 125.335 1.454 . . . . 0.0 111.878 -175.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.7 170.77 19.43 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 123.186 1.47 . . . . 0.0 107.187 174.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.512 ' HD3' ' CE2' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -147.68 106.12 3.78 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 177.728 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.235 1.3 t70 34.5 53.07 0.58 Allowed 'General case' 0 C--N 1.377 1.794 2 N-CA-C 123.336 4.569 . . . . 0.0 123.336 140.062 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.69 -0.74 87.77 Favored Glycine 0 C--N 1.376 2.78 2 O-C-N 134.128 7.143 . . . . 0.0 119.292 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.43 ' HB2' ' HD2' ' A' ' 110' ' ' LYS . 3.6 m -124.8 147.18 55.46 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 129.3 3.04 . . . . 0.0 118.352 -172.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.33 138.07 49.61 Favored 'Trans proline' 0 N--CA 1.495 1.577 1 C-N-CA 125.984 4.456 . . . . 0.0 115.036 171.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -91.36 163.64 27.94 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 117.816 -3.052 . . . . 0.0 115.57 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -71.22 84.4 0.91 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.703 3.602 . . . . 0.0 115.841 -178.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.3 t70 78.01 -62.5 0.36 Allowed 'General case' 0 C--N 1.362 1.137 0 C-N-CA 127.719 2.407 . . . . 0.0 114.762 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 79.64 171.63 0.16 Allowed 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 130.284 3.434 . . . . 0.0 114.791 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 75.64 72.38 0.09 Allowed 'General case' 0 C--N 1.358 0.972 0 CA-C-N 114.345 -1.298 . . . . 0.0 114.288 173.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.76 -51.93 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.967 0 N-CA-C 118.976 2.35 . . . . 0.0 118.976 -173.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.263 . . 133.4 -73.11 0.0 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.055 2.142 . . . . 0.0 107.356 -176.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.272 6.9 t -133.82 111.61 10.65 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-O 123.092 1.425 . . . . 0.0 113.459 -175.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.331 0.6 OUTLIER -127.07 141.65 51.72 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 129.042 2.937 . . . . 0.0 112.394 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.7 m -128.51 139.71 52.18 Favored 'General case' 0 C--N 1.366 1.318 0 O-C-N 120.702 -1.249 . . . . 0.0 109.302 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.7 100.08 51.16 Favored Pre-proline 0 C--N 1.355 0.81 0 C-N-CA 129.822 3.249 . . . . 0.0 105.145 176.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -77.49 -32.4 2.92 Favored 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 125.93 4.42 . . . . 0.0 113.407 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.4 m -138.45 101.29 4.33 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.75 129.6 42.93 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 127.522 2.329 . . . . 0.0 109.615 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.59 175.58 7.85 Favored 'General case' 0 C--N 1.369 1.426 0 C-N-CA 128.169 2.588 . . . . 0.0 108.457 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.18 -51.35 18.63 Favored 'General case' 0 C--N 1.368 1.397 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 -171.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -63.92 -22.89 67.12 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 126.1 1.76 . . . . 0.0 114.748 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -82.87 -10.28 58.91 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 130.103 3.361 . . . . 0.0 111.909 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -94.35 166.37 12.11 Favored 'General case' 0 C--N 1.383 2.061 0 N-CA-C 116.59 2.071 . . . . 0.0 116.59 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 144.86 -156.34 26.86 Favored Glycine 0 CA--C 1.461 -3.289 0 C-N-CA 127.603 2.525 . . . . 0.0 108.867 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.325 1.4 m -113.54 130.45 56.35 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 114.276 -2.969 . . . . 0.0 107.118 171.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.512 ' CE2' ' HD3' ' A' ' 110' ' ' LYS . 31.0 m-85 -97.16 135.02 39.72 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 126.882 2.073 . . . . 0.0 112.063 -168.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -148.83 148.79 30.32 Favored 'General case' 0 C--N 1.373 1.595 0 CA-C-O 123.449 1.595 . . . . 0.0 109.12 -174.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.291 0.8 OUTLIER -141.46 141.03 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.265 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.7 m -102.64 122.98 45.5 Favored 'General case' 0 C--N 1.377 1.8 0 C-N-CA 129.138 2.975 . . . . 0.0 107.201 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.54 126.72 48.83 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 125.816 1.646 . . . . 0.0 113.391 -174.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 8.3 m -113.83 132.59 55.83 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 119.365 -2.084 . . . . 0.0 114.296 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.461 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.428 25.6 p30 -126.93 -174.36 3.12 Favored 'General case' 0 C--N 1.377 1.78 0 O-C-N 120.729 -1.232 . . . . 0.0 112.695 176.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.728 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 63.2 p -49.62 3.3 0.01 OUTLIER 'General case' 0 C--N 1.362 1.126 1 C-N-CA 136.302 5.841 . . . . 0.0 121.775 -164.551 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -104.21 4.47 33.95 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 118.215 -1.394 . . . . 0.0 107.798 163.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.405 91.8 mm-40 66.55 40.2 3.53 Favored 'General case' 0 C--N 1.375 1.683 1 C-N-CA 132.504 4.321 . . . . 0.0 110.156 -172.204 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.48 126.67 69.9 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.39 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.591 -170.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -91.67 134.0 35.09 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 124.613 1.165 . . . . 0.0 109.724 -177.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 158.51 24.52 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 130.429 3.492 . . . . 0.0 105.686 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -127.21 136.51 52.13 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.252 0.1 OUTLIER -116.38 151.6 35.62 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.242 1.817 . . . . 0.0 110.772 -175.482 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 m -53.42 146.5 12.38 Favored 'General case' 0 CA--C 1.489 -1.399 1 C-N-CA 134.209 5.004 . . . . 0.0 119.441 -157.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.8 p -70.76 111.59 6.32 Favored 'General case' 0 C--N 1.37 1.467 0 C-N-CA 128.749 2.819 . . . . 0.0 108.867 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.19 109.93 21.87 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 102.149 -3.278 . . . . 0.0 102.149 178.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -100.06 111.83 24.12 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-O 123.893 1.806 . . . . 0.0 111.556 -173.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -122.03 123.94 70.15 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 O-C-N 119.375 -2.078 . . . . 0.0 108.882 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.4 m -111.92 127.48 55.86 Favored 'General case' 0 C--N 1.369 1.44 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.299 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 26.9 m -123.93 105.81 16.06 Favored 'Isoleucine or valine' 0 C--N 1.367 1.362 0 CA-C-O 123.586 1.66 . . . . 0.0 113.093 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -83.12 160.17 60.8 Favored Pre-proline 0 CA--C 1.556 1.208 0 O-C-N 120.545 -1.347 . . . . 0.0 109.964 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.5 166.07 30.89 Favored 'Trans proline' 0 CA--C 1.547 1.154 1 C-N-CA 126.284 4.656 . . . . 0.0 107.421 153.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.3 p -67.36 132.6 47.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 118.377 -2.702 . . . . 0.0 109.267 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.09 115.41 20.9 Favored Pre-proline 0 C--N 1.365 1.253 0 N-CA-C 120.006 3.335 . . . . 0.0 120.006 -126.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.34 151.43 82.6 Favored 'Trans proline' 0 C--N 1.383 2.353 1 C-N-CA 126.478 4.786 . . . . 0.0 115.359 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.07 55.84 1.06 Allowed Glycine 0 C--N 1.366 2.209 0 C-N-CA 127.423 2.439 . . . . 0.0 118.104 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -106.25 -36.3 2.72 Favored Glycine 0 C--N 1.356 1.676 0 C-N-CA 126.437 1.97 . . . . 0.0 113.115 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -103.16 -5.39 23.26 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.402 1.481 . . . . 0.0 112.876 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 59.72 -60.62 0.06 Allowed 'General case' 0 C--N 1.364 1.235 0 C-N-CA 129.114 2.965 . . . . 0.0 118.758 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . 0.367 1.6 p-80 . . . . . 0 C--N 1.361 1.097 0 C-N-CA 131.69 3.996 . . . . 0.0 118.169 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.7 tp -101.91 132.21 47.84 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 126.727 2.011 . . . . 0.0 111.114 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.3 t -98.91 172.79 7.2 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.875 2.47 . . . . 0.0 108.907 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.287 0.6 OUTLIER -77.67 98.89 5.61 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 120.79 -1.194 . . . . 0.0 109.298 176.745 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.9 m 59.81 -83.48 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 119.261 -2.149 . . . . 0.0 114.031 -166.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -133.33 141.1 47.78 Favored 'General case' 0 C--N 1.357 0.897 1 C-N-CA 132.251 4.22 . . . . 0.0 104.01 169.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.335 0.0 OUTLIER -82.68 173.35 11.99 Favored 'General case' 0 C--N 1.352 0.715 1 C-N-CA 132.581 4.353 . . . . 0.0 107.222 178.515 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.99 -34.27 73.12 Favored 'General case' 0 CA--C 1.577 1.996 0 O-C-N 119.515 -1.991 . . . . 0.0 113.087 176.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.428 ' CG2' ' HG ' ' A' ' 153' ' ' CYS . 8.3 m -168.09 172.24 8.92 Favored 'General case' 0 CA--C 1.519 -0.248 1 O-C-N 115.33 -4.606 . . . . 0.0 101.173 171.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.61 -48.5 1.27 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 125.842 1.657 . . . . 0.0 111.132 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.4 t -170.71 140.78 1.73 Allowed 'General case' 0 C--N 1.362 1.129 0 O-C-N 119.622 -1.924 . . . . 0.0 115.78 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.17 117.07 13.2 Favored 'General case' 0 C--N 1.377 1.769 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 161.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.0 m -114.36 116.8 29.5 Favored 'General case' 0 C--N 1.363 1.186 0 O-C-N 118.209 -2.807 . . . . 0.0 108.334 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.0 p -149.46 172.09 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 125.828 1.651 . . . . 0.0 110.37 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -82.45 129.7 34.96 Favored 'General case' 0 C--N 1.373 1.589 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 163.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.437 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.258 9.1 pt-20 -41.53 123.01 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 120.397 3.48 . . . . 0.0 120.397 -152.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 142.08 52.97 0.04 OUTLIER Glycine 0 C--N 1.359 1.833 0 CA-C-N 109.73 -3.395 . . . . 0.0 110.654 -171.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.94 163.96 21.84 Favored 'General case' 0 C--N 1.374 1.631 0 C-N-CA 125.73 1.612 . . . . 0.0 112.928 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.67 108.83 18.43 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 124.272 1.029 . . . . 0.0 110.33 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.2 mp -119.46 123.09 43.2 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 125.797 1.639 . . . . 0.0 115.247 -174.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -110.57 127.21 55.11 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 102.364 -3.198 . . . . 0.0 102.364 170.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.44 115.65 21.94 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 172.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.403 ' HG ' ' CB ' ' A' ' 122' ' ' THR . 6.6 t -154.56 134.11 12.73 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 119.947 -1.72 . . . . 0.0 112.461 -169.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.5 m -148.89 175.0 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.645 0 C-N-CA 131.637 3.975 . . . . 0.0 105.886 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.2 t -104.01 138.88 39.91 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.185 2.594 . . . . 0.0 104.625 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.35 142.19 33.8 Favored 'General case' 0 C--N 1.373 1.597 0 N-CA-C 121.642 3.942 . . . . 0.0 121.642 -174.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.3 m -158.52 174.19 15.46 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 131.092 3.757 . . . . 0.0 102.05 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.27 44.54 1.38 Allowed Glycine 0 C--N 1.367 2.292 0 CA-C-N 121.879 2.127 . . . . 0.0 117.232 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.77 28.06 52.07 Favored Glycine 0 C--N 1.358 1.754 0 C-N-CA 128.544 2.973 . . . . 0.0 115.289 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.44 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 90.7 m -117.93 110.96 18.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 114.372 -2.728 . . . . 0.0 107.114 173.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.611 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.85 -87.4 0.86 Allowed Glycine 0 C--N 1.379 2.944 0 C-N-CA 129.729 3.538 . . . . 0.0 110.144 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.44 ' HD2' ' O ' ' A' ' 101' ' ' THR . 23.5 Cg_exo -60.18 168.12 6.62 Favored 'Trans proline' 0 CA--C 1.568 2.196 1 C-N-CA 126.51 4.806 . . . . 0.0 116.167 159.053 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.505 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 71.5 m-85 -103.2 143.59 32.43 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 119.593 3.182 . . . . 0.0 119.593 -165.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -103.52 146.49 28.46 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 127.255 2.222 . . . . 0.0 105.526 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.425 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.22 166.46 24.97 Favored 'General case' 0 C--N 1.354 0.778 1 N-CA-C 123.25 4.537 . . . . 0.0 123.25 -160.857 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.07 120.52 15.0 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 128.283 2.633 . . . . 0.0 106.25 172.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -112.54 146.65 38.14 Favored 'General case' 0 C--N 1.367 1.355 0 O-C-N 120.853 -1.155 . . . . 0.0 112.145 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.2 169.72 23.87 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 171.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.518 ' HZ3' ' HH ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -143.56 105.56 4.37 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 174.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.17 1.5 t70 34.79 52.79 0.6 Allowed 'General case' 0 C--N 1.376 1.744 1 N-CA-C 122.48 4.252 . . . . 0.0 122.48 140.265 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.07 -6.21 83.81 Favored Glycine 0 C--N 1.364 2.116 2 O-C-N 133.085 6.49 . . . . 0.0 119.003 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.269 3.0 m -124.28 147.13 53.95 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 129.268 3.027 . . . . 0.0 117.671 -171.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.78 142.46 76.39 Favored 'Trans proline' 0 N--CA 1.495 1.604 1 C-N-CA 126.245 4.63 . . . . 0.0 114.973 172.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.26 158.9 31.42 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 118.462 -2.649 . . . . 0.0 112.636 178.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.04 86.9 0.18 Allowed 'Trans proline' 0 C--N 1.363 1.291 1 C-N-CA 126.336 4.691 . . . . 0.0 115.355 -177.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 73.21 -58.8 0.59 Allowed 'General case' 0 C--N 1.362 1.145 0 C-N-CA 128.268 2.627 . . . . 0.0 115.185 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 73.25 176.24 0.26 Allowed 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 130.824 3.65 . . . . 0.0 115.048 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 72.15 60.98 0.13 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-N 114.308 -1.314 . . . . 0.0 114.324 174.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.98 -82.98 0.07 OUTLIER Glycine 0 C--N 1.355 1.59 0 N-CA-C 116.316 1.287 . . . . 0.0 116.316 -170.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 165.8 -62.61 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 126.509 1.924 . . . . 0.0 106.539 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.403 ' CB ' ' HG ' ' A' ' 94' ' ' SER . 11.4 t -137.79 111.31 8.07 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.451 -1.406 . . . . 0.0 112.316 -177.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.314 31.8 p90 -127.33 140.75 51.98 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 126.111 1.764 . . . . 0.0 111.925 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.6 m -128.65 139.91 52.02 Favored 'General case' 0 C--N 1.361 1.076 0 O-C-N 120.014 -1.679 . . . . 0.0 109.017 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.404 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -114.29 98.43 48.6 Favored Pre-proline 0 C--N 1.363 1.181 0 C-N-CA 129.075 2.95 . . . . 0.0 105.289 178.632 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -77.39 -15.32 15.87 Favored 'Trans proline' 0 C--N 1.353 0.765 1 C-N-CA 126.413 4.742 . . . . 0.0 113.736 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 53.6 m -159.01 104.9 1.73 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 101.813 -3.403 . . . . 0.0 101.813 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.86 134.45 33.94 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 127.326 2.25 . . . . 0.0 111.287 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.72 175.61 6.83 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 127.997 2.519 . . . . 0.0 110.789 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.1 -48.05 33.91 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 119.611 3.189 . . . . 0.0 119.611 -173.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.16 -9.15 51.5 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 126.722 2.009 . . . . 0.0 114.603 173.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.333 2.9 m-20 -78.32 -19.86 52.65 Favored 'General case' 0 CA--C 1.572 1.816 0 C-N-CA 129.344 3.058 . . . . 0.0 111.532 168.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.88 122.71 18.74 Favored 'General case' 0 C--N 1.384 2.084 0 N-CA-C 120.546 3.536 . . . . 0.0 120.546 171.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 164.98 -155.96 27.67 Favored Glycine 0 CA--C 1.472 -2.65 0 C-N-CA 127.044 2.259 . . . . 0.0 109.254 173.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.4 m -119.33 131.82 55.78 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 115.64 -2.424 . . . . 0.0 108.441 171.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.518 ' HH ' ' HZ3' ' A' ' 110' ' ' LYS 0.296 26.5 m-85 -95.39 134.23 38.44 Favored 'General case' 0 C--N 1.369 1.44 0 C-N-CA 129.799 3.239 . . . . 0.0 111.467 -172.209 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.3 145.09 32.42 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 124.67 1.188 . . . . 0.0 107.924 -173.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.614 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 11.3 p -135.75 143.6 35.98 Favored 'Isoleucine or valine' 0 C--N 1.359 1.02 0 C-N-CA 118.817 -1.153 . . . . 0.0 113.006 179.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 m -109.71 124.1 50.64 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 128.914 2.885 . . . . 0.0 105.392 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.69 131.74 53.92 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 127.701 2.4 . . . . 0.0 111.632 -176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.5 m -119.63 134.17 55.34 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 126.479 1.912 . . . . 0.0 113.813 -177.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.505 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.389 9.1 p-10 -125.51 -174.17 3.0 Favored 'General case' 0 C--N 1.383 2.044 0 CA-C-N 120.831 1.65 . . . . 0.0 113.176 175.722 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.611 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 3.6 p -49.24 -2.09 0.01 OUTLIER 'General case' 0 C--N 1.376 1.758 1 C-N-CA 136.801 6.04 . . . . 0.0 120.015 -165.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -101.44 4.82 41.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 117.755 -1.578 . . . . 0.0 108.751 165.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.409 72.5 mm-40 66.42 40.05 3.72 Favored 'General case' 0 C--N 1.376 1.744 1 C-N-CA 133.346 4.658 . . . . 0.0 110.146 -172.911 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.8 m -112.87 129.01 69.27 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-N 111.365 -2.652 . . . . 0.0 111.362 -170.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -92.04 140.38 29.71 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 124.48 1.112 . . . . 0.0 111.113 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -117.78 156.56 28.11 Favored 'General case' 0 C--N 1.346 0.452 1 C-N-CA 132.193 4.197 . . . . 0.0 104.063 174.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -129.54 141.33 51.0 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 173.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.614 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.425 50.4 p -120.03 146.91 45.44 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 120.081 1.31 . . . . 0.0 109.05 178.059 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -54.07 148.43 10.94 Favored 'General case' 0 CA--C 1.484 -1.574 1 C-N-CA 137.304 6.242 . . . . 0.0 118.442 -160.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -68.45 109.85 3.88 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 125.553 1.541 . . . . 0.0 111.106 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.428 ' HG ' ' CG2' ' A' ' 80' ' ' THR . 0.0 OUTLIER -95.16 109.93 21.96 Favored 'General case' 0 C--N 1.366 1.298 0 N-CA-C 102.267 -3.234 . . . . 0.0 102.267 179.042 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.68 112.92 25.1 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 123.679 1.704 . . . . 0.0 111.82 -172.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.92 128.65 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 O-C-N 120.279 -1.513 . . . . 0.0 109.798 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 87.9 m -111.25 121.45 45.3 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 101.847 -3.39 . . . . 0.0 101.847 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 4.9 m -135.39 103.18 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.21 152.69 41.24 Favored Pre-proline 0 C--N 1.351 0.657 0 C-N-CA 125.547 1.539 . . . . 0.0 109.033 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -66.09 166.09 22.05 Favored 'Trans proline' 0 C--N 1.366 1.477 1 C-N-CA 127.045 5.163 . . . . 0.0 110.176 160.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.2 p -67.56 132.82 48.31 Favored 'General case' 0 C--N 1.372 1.568 0 O-C-N 119.264 -2.148 . . . . 0.0 108.898 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.11 114.71 19.67 Favored Pre-proline 0 CA--C 1.556 1.211 1 N-CA-C 121.99 4.07 . . . . 0.0 121.99 -123.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.69 154.87 62.58 Favored 'Trans proline' 0 C--N 1.388 2.614 1 C-N-CA 126.47 4.78 . . . . 0.0 114.248 171.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.51 45.94 0.04 OUTLIER Glycine 0 C--N 1.367 2.289 0 C-N-CA 128.688 3.042 . . . . 0.0 120.484 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -95.72 -13.96 48.52 Favored Glycine 0 C--N 1.358 1.799 0 C-N-CA 127.481 2.467 . . . . 0.0 111.701 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 45.4 mt -89.56 -27.23 20.39 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.963 1.705 . . . . 0.0 111.717 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 68.56 -50.63 0.57 Allowed 'General case' 0 C--N 1.365 1.25 0 C-N-CA 128.543 2.737 . . . . 0.0 116.801 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 . . . . . 0 C--N 1.357 0.908 0 C-N-CA 128.433 2.693 . . . . 0.0 111.519 179.54 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.97 0 CA-C-O 121.862 0.839 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.8 tt -107.24 120.92 43.45 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 126.553 1.941 . . . . 0.0 108.326 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.1 t -94.76 172.39 8.19 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 127.278 2.231 . . . . 0.0 110.397 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.262 1.3 pp -80.68 98.93 7.93 Favored 'General case' 0 C--N 1.366 1.296 0 O-C-N 119.75 -1.844 . . . . 0.0 109.058 174.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.7 m 59.09 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 118.119 -2.863 . . . . 0.0 114.784 -167.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -133.82 140.48 46.92 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 131.078 3.751 . . . . 0.0 106.848 167.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.304 0.0 OUTLIER -83.67 172.2 12.51 Favored 'General case' 0 C--N 1.344 0.333 1 C-N-CA 132.121 4.168 . . . . 0.0 110.53 175.178 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.425 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -69.77 -34.56 73.95 Favored 'General case' 0 CA--C 1.583 2.243 0 O-C-N 120.558 -1.339 . . . . 0.0 112.043 168.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 21.7 m -169.54 171.63 7.49 Favored 'General case' 0 N--CA 1.464 0.264 1 O-C-N 115.876 -4.265 . . . . 0.0 102.062 172.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.8 -45.79 1.74 Allowed 'General case' 0 C--N 1.365 1.255 0 C-N-CA 126.51 1.924 . . . . 0.0 114.157 176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.0 t -174.27 141.19 0.71 Allowed 'General case' 0 C--N 1.364 1.223 0 O-C-N 119.885 -1.759 . . . . 0.0 115.068 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.3 ttt -126.38 136.89 53.26 Favored 'General case' 0 C--N 1.38 1.9 0 CA-C-N 118.352 0.524 . . . . 0.0 109.927 157.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m -114.59 113.37 24.29 Favored 'General case' 0 C--N 1.377 1.764 0 O-C-N 119.84 -1.788 . . . . 0.0 108.015 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 86' ' ' GLU 0.295 11.5 p -151.56 174.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 123.569 1.652 . . . . 0.0 114.076 -170.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.445 ' O ' HG21 ' A' ' 85' ' ' VAL . 8.0 mp0 -83.19 144.5 29.76 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 127.202 2.201 . . . . 0.0 105.573 158.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.421 4.5 pt-20 -44.01 124.37 3.8 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 117.202 -3.436 . . . . 0.0 118.071 -171.678 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 122.62 52.63 0.21 Allowed Glycine 0 C--N 1.358 1.787 0 C-N-CA 127.662 2.554 . . . . 0.0 109.887 -154.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.91 161.68 15.1 Favored 'General case' 0 C--N 1.376 1.731 0 C-N-CA 124.95 1.3 . . . . 0.0 110.908 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.74 97.43 6.7 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.298 53.7 tp -120.8 114.93 22.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -169.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.01 131.77 55.21 Favored 'General case' 0 C--N 1.373 1.591 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.416 ' HB3' ' CZ3' ' A' ' 108' ' ' TRP . 1.1 mm? -129.37 115.86 18.18 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 175.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.425 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 6.9 t -151.11 134.04 15.84 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 119.419 -2.051 . . . . 0.0 112.273 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.75 173.79 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.851 0 C-N-CA 129.594 3.158 . . . . 0.0 104.786 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -104.01 141.06 36.85 Favored 'General case' 0 C--N 1.369 1.445 0 O-C-N 119.293 -2.129 . . . . 0.0 105.349 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.24 145.25 38.99 Favored 'General case' 0 C--N 1.365 1.262 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 -173.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -158.41 174.26 15.39 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 130.741 3.616 . . . . 0.0 101.561 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.15 43.2 1.46 Allowed Glycine 0 C--N 1.364 2.128 0 CA-C-N 121.879 2.127 . . . . 0.0 117.696 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.44 22.13 52.04 Favored Glycine 0 C--N 1.359 1.82 0 C-N-CA 127.785 2.612 . . . . 0.0 116.342 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.488 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 76.1 m -116.95 111.44 19.61 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 114.018 -2.896 . . . . 0.0 107.944 176.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.616 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.93 -92.5 0.93 Allowed Glycine 0 C--N 1.38 3.004 0 CA-C-N 124.628 3.376 . . . . 0.0 110.118 -175.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.436 ' HD2' ' O ' ' A' ' 101' ' ' THR . 14.9 Cg_exo -60.5 167.54 7.95 Favored 'Trans proline' 0 CA--C 1.564 1.998 1 C-N-CA 126.82 5.013 . . . . 0.0 116.19 159.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.448 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 74.1 m-85 -98.47 143.28 29.08 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 120.613 3.56 . . . . 0.0 120.613 -165.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 t -102.96 141.12 36.31 Favored 'General case' 0 C--N 1.381 1.945 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.72 156.03 49.51 Favored 'General case' 0 C--N 1.347 0.494 1 N-CA-C 122.517 4.265 . . . . 0.0 122.517 -162.107 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.06 112.79 10.84 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 111.124 -2.762 . . . . 0.0 104.768 171.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.48 ' CE3' ' HB ' ' A' ' 138' ' ' VAL . 35.2 m95 -111.96 148.0 34.69 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.327 0.2 OUTLIER -159.36 169.93 22.92 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 166.019 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.436 ' HE3' ' CE2' ' A' ' 136' ' ' TYR 0.337 33.6 mtpt -123.19 127.31 48.46 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 115.431 -2.223 . . . . 0.0 107.089 173.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.402 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.308 0.7 OUTLIER 32.35 51.04 0.21 Allowed 'General case' 0 C--N 1.373 1.61 2 N-CA-C 123.763 4.727 . . . . 0.0 123.763 123.185 . . . . . . . . 5 4 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.88 1.92 49.47 Favored Glycine 0 C--N 1.377 2.821 2 O-C-N 133.907 7.004 . . . . 0.0 120.592 -169.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.574 0.6 OUTLIER -125.73 147.83 59.94 Favored Pre-proline 0 CA--C 1.563 1.466 1 N-CA-C 123.023 4.453 . . . . 0.0 123.023 -168.346 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.26 149.32 88.68 Favored 'Trans proline' 0 N--CA 1.499 1.842 1 C-N-CA 126.088 4.526 . . . . 0.0 116.245 173.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -110.28 153.69 43.24 Favored Pre-proline 0 CA--C 1.549 0.911 0 O-C-N 119.567 -1.958 . . . . 0.0 111.545 178.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.428 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 13.3 Cg_endo -68.09 90.13 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.098 1 C-N-CA 125.969 4.446 . . . . 0.0 114.992 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 t70 76.41 -52.63 0.6 Allowed 'General case' 0 C--N 1.364 1.221 0 C-N-CA 127.883 2.473 . . . . 0.0 114.474 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 85.19 -62.89 0.06 Allowed 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 130.139 3.376 . . . . 0.0 116.282 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -58.04 55.81 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.078 1 C-N-CA 134.045 4.938 . . . . 0.0 118.13 -173.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -144.52 -78.1 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.89 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -173.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 160.93 -58.93 0.0 OUTLIER 'General case' 0 C--N 1.352 0.713 0 C-N-CA 125.172 1.389 . . . . 0.0 109.329 -177.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.9 t -135.55 112.36 10.17 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 122.537 1.161 . . . . 0.0 111.169 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . 0.428 ' CD2' ' HG2' ' A' ' 116' ' ' PRO . 35.0 p90 -127.04 139.76 52.78 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 124.627 1.171 . . . . 0.0 110.338 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.6 m -129.99 140.39 50.9 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 120.647 -1.283 . . . . 0.0 110.57 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.27 99.6 47.03 Favored Pre-proline 0 C--N 1.356 0.878 0 C-N-CA 130.213 3.405 . . . . 0.0 105.684 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -77.43 -13.28 16.75 Favored 'Trans proline' 0 CA--C 1.536 0.606 1 C-N-CA 126.04 4.493 . . . . 0.0 112.891 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -162.1 100.94 1.11 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.21 133.5 35.33 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 127.826 2.451 . . . . 0.0 111.772 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.47 173.29 8.42 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 130.141 3.376 . . . . 0.0 111.265 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.42 -45.6 25.65 Favored 'General case' 0 C--N 1.367 1.349 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.85 -17.86 65.1 Favored 'General case' 0 C--N 1.367 1.326 0 C-N-CA 126.229 1.812 . . . . 0.0 115.316 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.271 37.8 m-20 -84.09 -16.41 43.82 Favored 'General case' 0 C--N 1.362 1.144 1 C-N-CA 132.209 4.204 . . . . 0.0 110.72 171.996 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.28 156.05 35.43 Favored 'General case' 0 C--N 1.392 2.44 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 163.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 138.64 -157.36 24.61 Favored Glycine 0 CA--C 1.452 -3.865 0 C-N-CA 127.735 2.588 . . . . 0.0 106.862 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.403 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.251 3.3 m -119.73 135.73 54.72 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 114.657 -2.817 . . . . 0.0 107.27 167.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.436 ' CE2' ' HE3' ' A' ' 110' ' ' LYS . 28.8 m-85 -96.99 134.74 39.96 Favored 'General case' 0 C--N 1.373 1.589 0 C-N-CA 128.434 2.694 . . . . 0.0 111.689 -172.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -146.39 154.57 41.78 Favored 'General case' 0 C--N 1.371 1.541 0 C-N-CA 124.729 1.211 . . . . 0.0 110.419 -176.611 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.48 ' HB ' ' CE3' ' A' ' 108' ' ' TRP . 14.8 p -142.91 139.95 27.54 Favored 'Isoleucine or valine' 0 C--N 1.368 1.38 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.3 m -107.67 110.81 22.77 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 131.334 3.854 . . . . 0.0 106.388 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -127.38 116.8 45.11 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 C-N-CA 125.892 1.677 . . . . 0.0 111.918 -172.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.5 m -102.34 131.12 49.15 Favored 'General case' 0 C--N 1.358 0.959 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.448 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.35 36.4 p-10 -125.65 179.31 5.22 Favored 'General case' 0 C--N 1.376 1.718 0 CA-C-N 120.408 1.458 . . . . 0.0 111.519 174.137 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.616 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 22.0 p -49.34 3.49 0.01 OUTLIER 'General case' 0 C--N 1.371 1.503 1 C-N-CA 136.57 5.948 . . . . 0.0 120.413 -169.653 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -103.51 4.83 36.33 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 166.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.524 2.0 mp0 64.51 40.03 6.43 Favored 'General case' 0 C--N 1.376 1.726 1 C-N-CA 133.518 4.727 . . . . 0.0 112.528 -173.842 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 m -112.68 123.48 68.41 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 CA-C-N 111.127 -2.761 . . . . 0.0 111.951 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.04 123.28 34.39 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 128.555 2.742 . . . . 0.0 105.303 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.55 158.36 23.79 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 129.14 2.976 . . . . 0.0 103.218 -174.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.445 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 9.0 t70 -129.56 141.27 51.01 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.214 1.007 . . . . 0.0 109.872 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.548 22.4 p -114.79 139.66 49.54 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 m -55.0 147.84 14.81 Favored 'General case' 0 C--N 1.366 1.321 1 C-N-CA 138.044 6.538 . . . . 0.0 117.898 -163.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.8 p -68.67 110.53 4.32 Favored 'General case' 0 C--N 1.375 1.701 0 C-N-CA 125.732 1.613 . . . . 0.0 110.33 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -101.2 110.35 22.36 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 -178.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.55 115.22 27.12 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 123.954 1.835 . . . . 0.0 113.171 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.85 128.25 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 O-C-N 119.65 -1.906 . . . . 0.0 107.602 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m -114.36 122.74 47.59 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 3.0 m -133.29 104.69 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -90.29 158.79 43.13 Favored Pre-proline 0 C--N 1.356 0.89 0 C-N-CA 126.522 1.929 . . . . 0.0 109.651 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -68.86 165.19 30.69 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 124.862 3.708 . . . . 0.0 108.043 154.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.91 134.69 51.26 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 118.61 -2.556 . . . . 0.0 109.272 -172.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 95.6 t -65.36 107.96 1.79 Allowed Pre-proline 0 C--N 1.361 1.068 0 N-CA-C 120.698 3.592 . . . . 0.0 120.698 -125.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -63.48 122.78 11.04 Favored 'Trans proline' 0 C--N 1.382 2.3 1 C-N-CA 125.371 4.047 . . . . 0.0 112.778 166.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.79 -72.11 0.87 Allowed Glycine 0 C--N 1.365 2.153 0 C-N-CA 127.407 2.432 . . . . 0.0 116.214 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.78 158.39 26.34 Favored Glycine 0 CA--C 1.49 -1.479 1 N-CA-C 102.277 -4.329 . . . . 0.0 102.277 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.503 ' H ' HD23 ' A' ' 165' ' ' LEU . 0.9 OUTLIER -96.15 -5.66 40.12 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.737 1.615 . . . . 0.0 114.099 -175.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 71.55 -50.01 0.69 Allowed 'General case' 0 C--N 1.364 1.214 0 C-N-CA 129.634 3.174 . . . . 0.0 114.252 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 . . . . . 0 C--N 1.351 0.645 0 C-N-CA 131.56 3.944 . . . . 0.0 113.131 179.731 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.1 tp -102.6 119.71 39.29 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 125.318 1.447 . . . . 0.0 108.406 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.5 t -95.58 172.76 7.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 129.105 2.962 . . . . 0.0 109.927 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.9 98.63 5.7 Favored 'General case' 0 C--N 1.367 1.36 0 O-C-N 119.364 -2.085 . . . . 0.0 110.986 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.18 -79.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 118.842 -2.411 . . . . 0.0 113.823 -168.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -133.6 140.45 47.14 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 129.838 3.255 . . . . 0.0 105.077 164.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.354 3.2 t0 -83.5 174.14 10.86 Favored 'General case' 0 C--N 1.341 0.236 1 C-N-CA 133.396 4.678 . . . . 0.0 109.998 177.479 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.22 -34.66 73.16 Favored 'General case' 0 CA--C 1.586 2.329 0 O-C-N 120.854 -1.154 . . . . 0.0 112.558 170.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 m -169.79 171.97 7.0 Favored 'General case' 0 N--CA 1.467 0.412 1 O-C-N 114.69 -5.006 . . . . 0.0 101.598 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.13 -45.9 1.24 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.092 1.357 . . . . 0.0 111.159 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.9 p -171.03 125.2 0.65 Allowed 'General case' 0 C--N 1.361 1.103 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.0 ttt -130.6 118.0 20.37 Favored 'General case' 0 C--N 1.376 1.726 0 CA-C-N 120.605 1.548 . . . . 0.0 109.346 160.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -110.61 115.14 29.08 Favored 'General case' 0 C--N 1.368 1.407 0 O-C-N 119.823 -1.798 . . . . 0.0 108.181 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 86' ' ' GLU . 14.8 p -150.03 173.71 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 126.848 2.059 . . . . 0.0 112.977 -169.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.412 ' O ' HG23 ' A' ' 85' ' ' VAL . 94.8 mt-10 -73.46 144.59 46.21 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 128.042 2.537 . . . . 0.0 107.1 159.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.421 ' HA ' ' HB ' ' A' ' 157' ' ' VAL 0.536 0.7 OUTLIER -44.13 123.28 3.3 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 124.628 3.376 . . . . 0.0 118.248 -171.282 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 126.96 43.17 0.26 Allowed Glycine 0 C--N 1.358 1.755 0 CA-C-N 111.45 -2.614 . . . . 0.0 112.09 -157.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.44 164.93 20.64 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 119.707 1.753 . . . . 0.0 112.156 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.07 114.93 28.85 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 125.994 1.718 . . . . 0.0 108.556 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 7.0 mp -120.5 114.49 21.85 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 127.668 2.387 . . . . 0.0 114.693 -176.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.61 124.49 51.24 Favored 'General case' 0 C--N 1.364 1.235 0 N-CA-C 102.467 -3.16 . . . . 0.0 102.467 170.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -124.69 114.77 19.76 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.4 t -153.62 134.09 13.56 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 120.021 -1.675 . . . . 0.0 112.182 -172.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -149.12 174.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.736 0 C-N-CA 130.513 3.525 . . . . 0.0 104.591 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -103.67 140.74 37.17 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.16 142.39 34.04 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 120.588 3.551 . . . . 0.0 120.588 -173.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.3 m -158.47 174.54 14.94 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 130.337 3.455 . . . . 0.0 102.023 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.26 44.35 1.89 Allowed Glycine 0 C--N 1.366 2.2 0 CA-C-N 122.122 2.237 . . . . 0.0 117.639 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.67 20.16 62.27 Favored Glycine 0 C--N 1.358 1.806 0 C-N-CA 127.78 2.609 . . . . 0.0 114.776 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.404 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 45.2 p -116.75 110.81 18.91 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 113.948 -2.929 . . . . 0.0 108.285 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.668 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 73.03 -92.47 0.64 Allowed Glycine 0 C--N 1.376 2.762 0 C-N-CA 129.876 3.607 . . . . 0.0 111.065 -170.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.404 ' HD2' ' O ' ' A' ' 101' ' ' THR . 12.1 Cg_exo -61.86 168.75 8.26 Favored 'Trans proline' 0 CA--C 1.566 2.113 1 C-N-CA 127.128 5.219 . . . . 0.0 117.207 160.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.43 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 75.8 m-85 -93.72 141.36 28.58 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 121.186 3.772 . . . . 0.0 121.186 -167.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -103.24 147.0 27.58 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 128.19 2.596 . . . . 0.0 105.093 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -144.05 166.21 25.63 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 121.579 3.918 . . . . 0.0 121.579 -160.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.07 113.7 7.86 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 111.715 -2.493 . . . . 0.0 106.263 172.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -112.07 153.84 26.29 Favored 'General case' 0 C--N 1.376 1.722 0 O-C-N 120.149 -1.594 . . . . 0.0 107.87 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.345 0.0 OUTLIER -156.04 152.97 28.73 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 163.236 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.492 ' HZ2' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -128.27 103.86 7.41 Favored 'General case' 0 C--N 1.369 1.451 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 177.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.186 4.0 t70 37.54 54.98 1.46 Allowed 'General case' 0 CA--C 1.453 -2.76 1 CA-C-O 110.881 -4.39 . . . . 0.0 119.601 153.505 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.51 -17.0 51.62 Favored Glycine 0 C--N 1.372 2.559 2 O-C-N 134.729 7.518 . . . . 0.0 116.408 -175.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.282 48.5 m -124.12 149.48 60.56 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 130.754 3.622 . . . . 0.0 119.304 -165.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.12 154.46 51.44 Favored 'Trans proline' 0 N--CA 1.507 2.315 1 C-N-CA 126.937 5.091 . . . . 0.0 116.378 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.416 ' HB ' ' HD2' ' A' ' 116' ' ' PRO 0.274 0.8 OUTLIER -95.12 164.59 18.9 Favored Pre-proline 0 N--CA 1.484 1.23 0 O-C-N 117.967 -2.958 . . . . 0.0 111.917 174.309 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.416 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 1.9 Cg_endo -67.98 92.24 0.38 Allowed 'Trans proline' 0 C--N 1.368 1.584 1 C-N-CA 126.491 4.794 . . . . 0.0 112.585 177.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 78.7 -65.89 0.21 Allowed 'General case' 0 C--N 1.351 0.671 0 C-N-CA 128.448 2.699 . . . . 0.0 111.721 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 88.21 148.72 0.05 OUTLIER 'General case' 0 CA--C 1.466 -2.276 0 C-N-CA 128.029 2.532 . . . . 0.0 112.196 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.438 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 18.5 m 74.13 62.62 0.08 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.177 -1.828 . . . . 0.0 115.17 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.01 -77.96 0.08 OUTLIER Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 115.214 0.846 . . . . 0.0 115.214 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 160.53 -58.27 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 124.639 1.176 . . . . 0.0 109.187 -177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.4 t -141.68 112.85 7.46 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 123.367 1.556 . . . . 0.0 113.311 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.257 0.0 OUTLIER -127.47 139.72 52.62 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 124.856 1.262 . . . . 0.0 108.931 172.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 65.4 m -129.73 138.62 51.22 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.35 114.11 48.17 Favored Pre-proline 0 C--N 1.363 1.182 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 173.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.32 -14.07 16.57 Favored 'Trans proline' 0 C--N 1.354 0.852 1 C-N-CA 126.273 4.649 . . . . 0.0 112.83 174.739 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -161.83 106.41 1.25 Allowed 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -88.47 134.97 33.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.074 2.55 . . . . 0.0 113.823 177.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.16 176.64 6.89 Favored 'General case' 0 C--N 1.371 1.536 0 C-N-CA 127.878 2.471 . . . . 0.0 110.568 174.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.04 -48.97 32.8 Favored 'General case' 0 C--N 1.368 1.413 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 -173.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -64.31 -17.35 63.57 Favored 'General case' 0 C--N 1.366 1.283 0 C-N-CA 127.104 2.162 . . . . 0.0 114.685 173.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.492 ' HA ' ' HZ2' ' A' ' 110' ' ' LYS 0.35 32.7 m-20 -83.67 -19.13 35.9 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 130.894 3.678 . . . . 0.0 112.287 172.241 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.61 131.98 48.5 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 163.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 159.3 -158.82 29.89 Favored Glycine 0 CA--C 1.456 -3.616 0 C-N-CA 126.914 2.197 . . . . 0.0 107.737 167.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.333 22.8 m -116.88 136.02 53.27 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 114.964 -2.694 . . . . 0.0 108.316 170.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.429 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 22.9 m-85 -96.77 133.67 41.05 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 119.24 -2.163 . . . . 0.0 114.143 -171.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.4 141.94 37.52 Favored 'General case' 0 C--N 1.37 1.487 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -173.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.472 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 8.3 p -141.3 141.7 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 117.614 -1.635 . . . . 0.0 114.704 179.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 18.1 m -107.64 118.9 37.93 Favored 'General case' 0 C--N 1.378 1.844 0 C-N-CA 128.488 2.715 . . . . 0.0 107.187 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.33 118.98 42.25 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 126.058 1.743 . . . . 0.0 111.697 -172.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.6 m -108.24 129.36 55.21 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -178.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.43 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.402 28.9 p-10 -124.02 -177.15 3.67 Favored 'General case' 0 C--N 1.372 1.559 0 O-C-N 120.944 -1.098 . . . . 0.0 112.885 174.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.668 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 86.2 p -50.15 3.93 0.01 OUTLIER 'General case' 0 C--N 1.36 1.026 2 C-N-CA 135.742 5.617 . . . . 0.0 121.954 -168.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -101.8 4.65 40.61 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 164.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.348 3.1 mp0 66.78 39.69 3.41 Favored 'General case' 0 C--N 1.379 1.887 1 C-N-CA 133.678 4.791 . . . . 0.0 109.974 -174.367 . . . . . . . . 3 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.3 m -113.13 123.97 69.3 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.62 0 CA-C-N 112.418 -2.174 . . . . 0.0 113.021 -170.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.31 123.67 34.92 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.251 2.221 . . . . 0.0 107.034 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.13 156.54 26.26 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -130.35 147.07 52.02 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 121.382 -0.824 . . . . 0.0 110.104 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.472 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.294 58.7 p -123.64 143.7 50.08 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 m -54.93 148.24 13.78 Favored 'General case' 0 C--N 1.377 1.791 2 C-N-CA 138.807 6.843 . . . . 0.0 114.699 -168.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.8 p -67.61 109.81 3.43 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.223 1.809 . . . . 0.0 111.238 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.72 108.78 20.48 Favored 'General case' 0 C--N 1.37 1.488 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -94.63 109.22 21.17 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 120.519 1.509 . . . . 0.0 111.465 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.87 113.93 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 59.3 m -120.41 122.57 41.03 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.421 ' HB ' ' HA ' ' A' ' 87' ' ' GLU . 4.5 m -120.32 104.89 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.034 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -178.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -83.35 155.62 66.32 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.19 1.796 . . . . 0.0 110.931 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -69.65 165.83 29.53 Favored 'Trans proline' 0 C--N 1.36 1.172 1 C-N-CA 126.119 4.546 . . . . 0.0 107.6 154.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.2 p -67.31 133.35 49.48 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 118.166 -2.834 . . . . 0.0 110.3 -171.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.3 t -66.14 113.91 14.43 Favored Pre-proline 0 CA--C 1.554 1.126 0 N-CA-C 121.484 3.883 . . . . 0.0 121.484 -127.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.45 152.1 79.09 Favored 'Trans proline' 0 C--N 1.379 2.153 1 C-N-CA 126.145 4.563 . . . . 0.0 115.472 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.5 80.9 0.4 Allowed Glycine 0 C--N 1.368 2.321 0 C-N-CA 127.961 2.696 . . . . 0.0 115.078 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.99 -123.48 0.97 Allowed Glycine 0 C--N 1.348 1.198 0 N-CA-C 107.884 -2.087 . . . . 0.0 107.884 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 34.9 mt 65.65 -69.1 0.11 Allowed 'General case' 0 C--N 1.363 1.184 0 C-N-CA 128.692 2.797 . . . . 0.0 116.218 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -108.43 -15.26 14.49 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 129.042 2.937 . . . . 0.0 110.385 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 79.5 t60 . . . . . 0 C--N 1.353 0.761 0 C-N-CA 127.304 2.241 . . . . 0.0 109.175 -178.922 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.977 0 CA-C-O 121.872 0.844 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.0 tt -106.1 117.89 35.21 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.859 1.664 . . . . 0.0 106.841 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 t -94.77 173.08 7.78 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 128.097 2.559 . . . . 0.0 110.924 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 75' ' ' LEU 0.256 2.4 pt? -73.84 98.52 2.99 Favored 'General case' 0 C--N 1.365 1.25 0 O-C-N 120.702 -1.249 . . . . 0.0 110.496 171.029 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.4 t 58.08 -75.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 117.033 -3.542 . . . . 0.0 116.158 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -133.38 142.1 48.22 Favored 'General case' 0 C--N 1.36 1.056 1 C-N-CA 132.99 4.516 . . . . 0.0 106.693 168.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.441 0.4 OUTLIER -81.63 170.57 15.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 131.656 3.983 . . . . 0.0 110.595 -178.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.474 ' HG ' ' H ' ' A' ' 94' ' ' SER . 1.2 mp -72.37 -35.31 68.46 Favored 'General case' 0 CA--C 1.578 2.046 0 O-C-N 119.942 -1.724 . . . . 0.0 111.38 167.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.49 ' HB ' ' SG ' ' A' ' 153' ' ' CYS . 19.1 m -172.25 179.75 2.5 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 100.399 -3.926 . . . . 0.0 100.399 174.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.12 -42.66 0.46 Allowed 'General case' 0 C--N 1.367 1.353 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.0 m -164.63 99.63 0.79 Allowed 'General case' 0 N--CA 1.477 0.9 0 O-C-N 118.449 -2.657 . . . . 0.0 115.601 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 19.9 mmm -120.27 117.55 28.13 Favored 'General case' 0 C--N 1.369 1.449 0 CA-C-O 122.591 1.186 . . . . 0.0 109.664 168.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.5 p -115.15 114.86 25.85 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 86' ' ' GLU . 7.4 p -150.94 174.63 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 112.973 -1.921 . . . . 0.0 111.17 -171.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.417 ' O ' HG21 ' A' ' 85' ' ' VAL . 48.4 mt-10 -70.02 144.68 52.17 Favored 'General case' 0 CA--C 1.564 1.501 0 O-C-N 118.968 -2.332 . . . . 0.0 107.724 158.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.437 0.7 OUTLIER -44.14 123.17 3.26 Favored 'General case' 0 N--CA 1.523 3.176 0 O-C-N 117.675 -3.141 . . . . 0.0 117.733 -170.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 123.52 50.17 0.22 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-N 111.347 -2.661 . . . . 0.0 108.884 -154.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -95.9 139.43 32.12 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 125.298 1.439 . . . . 0.0 108.32 173.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.94 119.33 32.71 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -167.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.2 mt -121.46 129.14 52.79 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.194 2.598 . . . . 0.0 117.584 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -115.95 118.48 33.05 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 100.352 -3.944 . . . . 0.0 100.352 167.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.49 115.09 22.2 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.474 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 8.8 t -155.03 131.58 10.54 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -169.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 m -150.17 173.71 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.649 1 C-N-CA 131.748 4.019 . . . . 0.0 103.465 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.2 t -104.29 141.44 36.3 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 122.857 2.571 . . . . 0.0 106.67 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.75 145.53 48.53 Favored 'General case' 0 C--N 1.37 1.495 0 N-CA-C 119.618 3.192 . . . . 0.0 119.618 -174.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.6 m -158.29 174.29 15.38 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 131.644 3.978 . . . . 0.0 101.41 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.39 44.49 2.21 Favored Glycine 0 C--N 1.364 2.089 0 CA-C-N 122.111 2.232 . . . . 0.0 116.508 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.86 21.42 57.62 Favored Glycine 0 C--N 1.356 1.676 0 C-N-CA 127.297 2.379 . . . . 0.0 115.578 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.408 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 90.7 m -117.6 111.25 18.94 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 114.799 -2.524 . . . . 0.0 107.728 174.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.684 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 78.57 -91.22 1.16 Allowed Glycine 0 C--N 1.375 2.721 0 C-N-CA 129.546 3.451 . . . . 0.0 109.679 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.408 ' HD2' ' O ' ' A' ' 101' ' ' THR . 23.4 Cg_exo -60.61 167.22 8.61 Favored 'Trans proline' 0 CA--C 1.57 2.312 1 C-N-CA 126.566 4.844 . . . . 0.0 116.288 160.138 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.481 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 69.0 m-85 -98.94 145.33 27.14 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 120.473 3.508 . . . . 0.0 120.473 -166.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.7 t -102.7 140.06 37.47 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.426 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -114.32 148.98 36.69 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 -164.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.65 111.25 10.46 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 102.358 -3.201 . . . . 0.0 102.358 162.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.422 ' CE2' HG21 ' A' ' 138' ' ' VAL . 40.7 m95 -112.93 150.28 32.04 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 125.301 1.44 . . . . 0.0 108.661 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.65 169.64 19.92 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 165.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.406 ' NZ ' ' CZ ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -139.84 104.15 4.82 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 175.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.235 1.5 t70 34.77 52.85 0.6 Allowed 'General case' 0 CA--C 1.473 -1.994 2 N-CA-C 122.336 4.199 . . . . 0.0 122.336 142.339 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.77 -11.25 71.41 Favored Glycine 0 C--N 1.366 2.195 2 O-C-N 133.346 6.654 . . . . 0.0 118.629 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.1 m -124.14 148.17 56.74 Favored Pre-proline 0 CA--C 1.564 1.497 0 C-N-CA 131.287 3.835 . . . . 0.0 121.034 -168.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.62 148.52 92.26 Favored 'Trans proline' 0 C--N 1.378 2.122 1 C-N-CA 126.834 5.023 . . . . 0.0 115.247 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.12 162.11 20.76 Favored Pre-proline 0 C--N 1.354 0.788 0 O-C-N 119.741 -1.85 . . . . 0.0 115.482 -177.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_endo -73.82 88.96 1.02 Allowed 'Trans proline' 0 C--N 1.363 1.335 1 C-N-CA 125.923 4.415 . . . . 0.0 114.699 -177.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.1 t70 82.19 -53.71 0.23 Allowed 'General case' 0 C--N 1.361 1.098 0 C-N-CA 128.528 2.731 . . . . 0.0 113.48 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 91.55 -48.34 0.02 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 129.789 3.236 . . . . 0.0 113.639 177.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.416 ' HA ' ' CE1' ' A' ' 106' ' ' TYR 0.252 33.1 t -77.61 49.33 0.73 Allowed 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 129.479 3.112 . . . . 0.0 114.017 -174.718 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -131.0 -46.16 0.15 Allowed Glycine 0 C--N 1.367 2.267 1 N-CA-C 124.665 4.626 . . . . 0.0 124.665 -162.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.291 . . 99.72 -75.99 0.0 OUTLIER 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.734 2.267 . . . . 0.0 111.564 -177.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.298 6.5 t -130.95 102.32 6.0 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-O 123.528 1.633 . . . . 0.0 110.805 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.262 19.2 p90 -126.97 141.74 51.72 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 128.324 2.65 . . . . 0.0 111.485 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 38.0 m -128.42 139.29 52.44 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 119.645 -1.909 . . . . 0.0 107.861 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.16 92.39 35.51 Favored Pre-proline 0 C--N 1.358 0.96 0 C-N-CA 129.494 3.118 . . . . 0.0 104.362 175.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -68.47 -33.16 23.56 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.47 3.447 . . . . 0.0 112.719 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 97.5 m -127.4 104.12 7.74 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 126.008 1.723 . . . . 0.0 106.442 176.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.09 124.06 35.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.305 1.442 . . . . 0.0 110.51 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.38 170.86 13.16 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.91 2.084 . . . . 0.0 108.002 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.12 -47.51 23.37 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -170.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.65 -23.38 67.06 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 126.753 2.021 . . . . 0.0 115.061 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -83.43 -12.85 55.92 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.846 2.858 . . . . 0.0 112.574 172.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.51 155.83 19.43 Favored 'General case' 0 C--N 1.381 1.951 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 170.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 141.54 -149.39 21.07 Favored Glycine 0 CA--C 1.457 -3.554 0 N-CA-C 104.713 -3.355 . . . . 0.0 104.713 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.264 66.8 m -125.97 138.26 53.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 114.543 -2.863 . . . . 0.0 107.606 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.406 ' CZ ' ' NZ ' ' A' ' 110' ' ' LYS . 8.7 m-85 -96.96 134.64 40.06 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 126.445 1.898 . . . . 0.0 112.054 -168.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.58 143.43 30.8 Favored 'General case' 0 C--N 1.365 1.26 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.332 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.622 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 14.9 p -143.25 143.51 24.68 Favored 'Isoleucine or valine' 0 C--N 1.364 1.236 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -111.56 122.63 48.33 Favored 'General case' 0 C--N 1.375 1.705 0 C-N-CA 130.921 3.688 . . . . 0.0 105.994 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.414 ' CG2' ' HZ2' ' A' ' 148' ' ' LYS . 0.0 OUTLIER -134.55 120.37 32.35 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 124.518 1.127 . . . . 0.0 109.844 -172.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 7.9 m -105.22 132.87 50.89 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.481 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.384 23.9 p-10 -126.12 -174.45 3.11 Favored 'General case' 0 C--N 1.38 1.904 0 C-N-CA 124.589 1.155 . . . . 0.0 112.691 176.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.684 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 6.5 p -49.24 0.31 0.01 OUTLIER 'General case' 0 C--N 1.372 1.551 1 C-N-CA 136.577 5.951 . . . . 0.0 120.821 -166.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -104.04 4.54 34.52 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 118.474 -1.29 . . . . 0.0 107.836 165.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.464 94.7 mm-40 67.24 40.3 2.82 Favored 'General case' 0 C--N 1.374 1.631 1 C-N-CA 132.707 4.403 . . . . 0.0 110.56 -172.692 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.78 126.07 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.346 0 CA-C-N 111.605 -2.543 . . . . 0.0 112.845 -171.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -90.83 125.9 35.87 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 127.777 2.431 . . . . 0.0 108.109 -176.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.468 ' HZ1' ' HB3' ' A' ' 150' ' ' SER . 0.1 OUTLIER -116.24 156.74 26.05 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 -176.421 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -130.65 146.88 52.24 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 120.543 -1.348 . . . . 0.0 111.492 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.622 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.433 91.8 p -127.19 146.29 50.46 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.557 0.743 . . . . 0.0 111.807 176.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.0 m -54.61 148.59 12.19 Favored 'General case' 0 CA--C 1.488 -1.407 1 C-N-CA 138.496 6.718 . . . . 0.0 117.42 -164.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.8 p -68.56 110.2 4.1 Favored 'General case' 0 C--N 1.377 1.768 0 C-N-CA 127.764 2.426 . . . . 0.0 110.046 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.49 ' SG ' ' HB ' ' A' ' 80' ' ' THR . 1.0 OUTLIER -106.35 109.35 21.25 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 -172.308 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.54 122.46 42.64 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -168.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -123.17 115.03 44.43 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 C-N-CA 125.045 1.338 . . . . 0.0 108.128 176.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 62.7 m -114.24 122.82 47.92 Favored 'General case' 0 C--N 1.372 1.561 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.4 m -120.36 108.07 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 C-N-CA 126.358 1.863 . . . . 0.0 111.485 -175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -87.21 157.15 53.99 Favored Pre-proline 0 CA--C 1.556 1.179 0 O-C-N 121.222 -0.924 . . . . 0.0 110.065 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.55 165.89 31.23 Favored 'Trans proline' 0 CA--C 1.548 1.194 1 C-N-CA 126.182 4.588 . . . . 0.0 106.978 152.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.5 m -67.43 137.47 55.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 117.932 -2.98 . . . . 0.0 109.781 -172.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 42.3 t -65.49 107.52 1.54 Allowed Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 119.433 3.123 . . . . 0.0 119.433 -124.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -63.28 154.71 66.26 Favored 'Trans proline' 0 C--N 1.381 2.268 1 C-N-CA 126.56 4.84 . . . . 0.0 114.601 172.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.34 -57.04 2.77 Favored Glycine 0 C--N 1.358 1.77 0 C-N-CA 125.479 1.514 . . . . 0.0 112.768 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -177.12 151.3 10.94 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 82.7 mt -103.34 60.08 0.76 Allowed 'General case' 0 C--N 1.36 1.056 0 O-C-N 121.236 -1.155 . . . . 0.0 109.592 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.62 72.48 1.03 Allowed 'General case' 0 C--N 1.362 1.141 0 C-N-CA 127.181 2.192 . . . . 0.0 114.775 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 . . . . . 0 C--N 1.357 0.927 0 C-N-CA 127.74 2.416 . . . . 0.0 113.158 -177.105 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.984 0 CA-C-O 121.853 0.835 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.0 tp -86.79 129.15 34.99 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 126.384 1.874 . . . . 0.0 112.307 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 t -95.46 172.24 8.2 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 126.162 1.785 . . . . 0.0 110.621 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.437 ' H ' HD21 ' A' ' 75' ' ' LEU 0.374 0.4 OUTLIER -81.59 97.73 8.0 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.631 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.84 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 118.662 -2.524 . . . . 0.0 115.082 -168.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -133.36 141.7 48.04 Favored 'General case' 0 C--N 1.36 1.06 1 C-N-CA 132.467 4.307 . . . . 0.0 106.327 169.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.287 0.0 OUTLIER -82.39 171.79 13.79 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 128.647 2.779 . . . . 0.0 110.507 177.895 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.33 -30.63 66.43 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 113.608 -1.633 . . . . 0.0 112.405 176.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 m -171.48 172.94 4.92 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 116.726 -3.734 . . . . 0.0 101.032 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.48 -42.71 0.55 Allowed 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.467 1.485 . . . . 0.0 111.479 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.1 m -162.86 113.39 1.45 Allowed 'General case' 0 C--N 1.356 0.875 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -174.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.77 117.26 19.97 Favored 'General case' 0 C--N 1.371 1.532 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 162.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.6 m -116.41 116.81 28.38 Favored 'General case' 0 C--N 1.364 1.198 0 O-C-N 117.946 -2.971 . . . . 0.0 110.066 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 p -149.57 172.29 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.533 1.133 . . . . 0.0 113.059 -173.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -83.72 130.67 34.96 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 162.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.488 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.326 0.3 OUTLIER -41.53 123.09 2.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 120.076 3.361 . . . . 0.0 120.076 -150.492 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 141.64 48.84 0.05 OUTLIER Glycine 0 C--N 1.357 1.701 0 CA-C-N 109.941 -3.299 . . . . 0.0 111.896 -170.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.98 171.67 11.94 Favored 'General case' 0 C--N 1.37 1.471 0 C-N-CA 124.731 1.213 . . . . 0.0 112.95 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.54 115.77 30.2 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.251 1.42 . . . . 0.0 108.508 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.7 mp -120.47 113.06 19.76 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.467 2.307 . . . . 0.0 113.346 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.97 126.92 54.44 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 170.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.423 HD11 ' CG ' ' A' ' 136' ' ' TYR . 1.9 mm? -112.57 114.43 27.08 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 102.625 -3.102 . . . . 0.0 102.625 174.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.1 m -150.24 134.58 17.22 Favored 'General case' 0 C--N 1.368 1.389 0 CA-C-O 121.729 0.776 . . . . 0.0 112.043 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.17 173.03 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 C-N-CA 131.521 3.928 . . . . 0.0 103.766 174.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.9 p -103.59 137.43 41.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.48 2.712 . . . . 0.0 108.121 -173.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.6 145.82 35.5 Favored 'General case' 0 C--N 1.384 2.098 1 N-CA-C 127.602 6.149 . . . . 0.0 127.602 -170.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.7 p -156.67 175.07 14.54 Favored 'General case' 0 C--N 1.37 1.491 1 C-N-CA 134.241 5.016 . . . . 0.0 103.985 173.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.64 40.19 0.78 Allowed Glycine 0 C--N 1.367 2.27 0 O-C-N 119.279 -2.138 . . . . 0.0 117.798 170.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.5 30.73 15.06 Favored Glycine 0 C--N 1.359 1.812 0 C-N-CA 128.54 2.972 . . . . 0.0 114.648 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 33.5 p -117.35 109.67 17.1 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 114.39 -2.719 . . . . 0.0 108.79 175.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.548 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.68 -90.64 0.86 Allowed Glycine 0 C--N 1.378 2.886 0 CA-C-N 124.147 3.158 . . . . 0.0 111.591 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -62.29 169.17 8.31 Favored 'Trans proline' 0 CA--C 1.569 2.256 1 C-N-CA 126.528 4.819 . . . . 0.0 113.62 158.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.458 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 61.0 m-85 -100.68 159.79 14.88 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 119.655 3.206 . . . . 0.0 119.655 -165.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.7 t -110.14 141.49 42.95 Favored 'General case' 0 C--N 1.368 1.392 0 N-CA-C 102.393 -3.188 . . . . 0.0 102.393 171.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -138.39 151.03 47.12 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 120.501 3.519 . . . . 0.0 120.501 -165.203 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.11 124.51 34.93 Favored 'General case' 0 C--N 1.368 1.391 0 C-N-CA 128.776 2.83 . . . . 0.0 106.908 172.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.444 ' HB2' HG13 ' A' ' 115' ' ' ILE . 8.8 m95 -113.2 147.62 37.09 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 125.344 1.457 . . . . 0.0 113.76 -177.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.14 169.63 17.5 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 166.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.842 ' HZ2' ' HB2' ' A' ' 113' ' ' SER . 1.8 ptmm? -140.74 107.43 5.35 Favored 'General case' 0 N--CA 1.42 -1.97 0 O-C-N 119.92 -1.738 . . . . 0.0 108.087 173.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.205 1.7 t70 34.23 52.25 0.49 Allowed 'General case' 0 C--N 1.373 1.605 1 N-CA-C 123.649 4.685 . . . . 0.0 123.649 141.859 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.14 -5.98 84.11 Favored Glycine 0 C--N 1.367 2.271 2 O-C-N 132.724 6.265 . . . . 0.0 119.712 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.842 ' HB2' ' HZ2' ' A' ' 110' ' ' LYS 0.359 2.2 m -124.05 149.37 60.03 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 130.468 3.507 . . . . 0.0 118.115 -171.41 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.09 158.6 38.39 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 124.221 3.281 . . . . 0.0 115.161 164.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.444 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.1 OUTLIER -108.94 155.95 39.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 120.04 -1.662 . . . . 0.0 110.255 177.345 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -69.06 84.37 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.216 3.944 . . . . 0.0 115.837 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.6 t70 80.13 -54.18 0.37 Allowed 'General case' 0 C--N 1.366 1.312 0 C-N-CA 129.302 3.041 . . . . 0.0 113.131 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 88.51 -163.52 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 130.405 3.482 . . . . 0.0 110.878 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.06 4.91 5.04 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.95 -31.95 6.07 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 120.651 3.02 . . . . 0.0 120.651 -163.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.279 . . 91.52 -52.91 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 127.684 2.393 . . . . 0.0 111.317 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.319 12.1 t -140.33 97.44 3.22 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 123.022 1.392 . . . . 0.0 109.561 177.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.27 2.5 p90 -126.69 140.25 52.54 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 128.03 2.532 . . . . 0.0 111.374 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.8 m -129.58 140.26 51.26 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 119.804 -1.81 . . . . 0.0 112.802 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.313 0.7 OUTLIER -108.73 111.99 60.69 Favored Pre-proline 0 C--N 1.373 1.609 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 168.183 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -77.65 -17.3 14.32 Favored 'Trans proline' 0 CA--C 1.538 0.681 1 C-N-CA 126.373 4.715 . . . . 0.0 113.503 171.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 61.5 m -157.79 107.05 2.1 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 103.277 -2.861 . . . . 0.0 103.277 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.33 134.79 36.44 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.234 2.213 . . . . 0.0 113.822 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.07 172.2 11.45 Favored 'General case' 0 C--N 1.371 1.505 0 C-N-CA 128.444 2.697 . . . . 0.0 110.47 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.62 -45.81 28.0 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 119.817 3.265 . . . . 0.0 119.817 -171.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -62.75 -17.66 61.31 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 127.833 2.453 . . . . 0.0 114.977 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -79.55 -14.89 58.54 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 128.146 2.578 . . . . 0.0 112.713 170.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.48 38.99 Favored 'General case' 0 C--N 1.389 2.325 1 N-CA-C 122.339 4.2 . . . . 0.0 122.339 172.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.573 ' CA ' ' HZ3' ' A' ' 110' ' ' LYS . . . 150.73 -135.91 5.37 Favored Glycine 0 C--N 1.374 2.652 0 C-N-CA 130.314 3.816 . . . . 0.0 109.253 169.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.414 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 19.7 m -129.78 140.25 51.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 115.853 -2.339 . . . . 0.0 110.679 173.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.57 ' CZ ' ' HD2' ' A' ' 110' ' ' LYS . 43.2 m-85 -97.03 134.75 39.98 Favored 'General case' 0 C--N 1.366 1.323 0 C-N-CA 127.09 2.156 . . . . 0.0 113.016 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -142.45 141.54 32.21 Favored 'General case' 0 C--N 1.368 1.398 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -174.234 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.36 2.2 p -133.75 134.63 56.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.94 107.81 19.01 Favored 'General case' 0 C--N 1.377 1.773 0 C-N-CA 130.345 3.458 . . . . 0.0 106.541 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -121.62 118.67 56.58 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 C-N-CA 128.243 2.617 . . . . 0.0 112.49 -168.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 4.2 m -103.57 132.81 49.51 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 119.318 -2.114 . . . . 0.0 114.391 -177.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.458 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.327 24.4 p-10 -128.39 -178.96 4.77 Favored 'General case' 0 C--N 1.378 1.816 0 CA-C-N 120.321 1.419 . . . . 0.0 111.52 175.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.548 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 13.3 p -49.23 3.22 0.01 OUTLIER 'General case' 0 C--N 1.372 1.562 1 C-N-CA 136.515 5.926 . . . . 0.0 120.332 -169.26 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -101.01 4.78 42.7 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.618 162.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.439 0.7 OUTLIER 64.96 39.63 5.68 Favored 'General case' 0 C--N 1.372 1.569 1 C-N-CA 134.024 4.93 . . . . 0.0 111.635 -174.625 . . . . . . . . 4 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 141' ' ' THR . 3.0 m -113.19 133.7 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 CA-C-N 111.213 -2.721 . . . . 0.0 111.885 -170.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.84 125.78 35.83 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 127.65 2.38 . . . . 0.0 106.87 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.8 158.78 22.37 Favored 'General case' 0 CA--C 1.486 -1.481 0 C-N-CA 129.267 3.027 . . . . 0.0 103.123 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -126.47 135.33 51.22 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 123.836 1.779 . . . . 0.0 109.605 -174.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.283 2.8 p -121.96 146.51 47.07 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.001 -1.908 . . . . 0.0 109.952 -176.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 m -54.14 147.1 13.53 Favored 'General case' 0 CA--C 1.481 -1.682 1 C-N-CA 136.91 6.084 . . . . 0.0 118.273 -158.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.7 p -69.47 110.67 4.86 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.677 2.391 . . . . 0.0 110.549 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 109.77 21.94 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -98.22 113.44 25.37 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-O 123.844 1.783 . . . . 0.0 112.837 -173.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.18 128.35 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 O-C-N 119.187 -2.196 . . . . 0.0 109.511 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.2 m -110.81 121.62 45.8 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 103.795 -2.669 . . . . 0.0 103.795 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.488 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 5.4 m -134.3 102.99 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 173.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.92 150.25 39.53 Favored Pre-proline 0 C--N 1.348 0.531 0 O-C-N 120.168 -1.582 . . . . 0.0 108.681 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.23 166.4 27.07 Favored 'Trans proline' 0 C--N 1.357 0.978 1 C-N-CA 126.61 4.874 . . . . 0.0 109.393 161.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.47 134.14 50.81 Favored 'General case' 0 C--N 1.367 1.333 0 O-C-N 119.264 -2.148 . . . . 0.0 108.31 -176.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 58.5 t -66.47 109.36 3.26 Favored Pre-proline 0 C--N 1.362 1.143 0 N-CA-C 121.546 3.906 . . . . 0.0 121.546 -123.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -63.11 148.76 92.97 Favored 'Trans proline' 0 C--N 1.385 2.49 1 C-N-CA 125.951 4.434 . . . . 0.0 114.194 169.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.39 50.93 1.73 Allowed Glycine 0 C--N 1.365 2.157 0 C-N-CA 126.545 2.021 . . . . 0.0 117.11 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -86.67 -19.89 55.35 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 128.567 2.984 . . . . 0.0 113.184 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.84 -6.45 23.56 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 128.093 2.557 . . . . 0.0 109.336 175.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . 0.307 24.2 mt-10 64.87 -51.53 0.33 Allowed 'General case' 0 C--N 1.361 1.102 0 C-N-CA 131.26 3.824 . . . . 0.0 117.01 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 74.5 t60 . . . . . 0 C--N 1.352 0.716 0 C-N-CA 127.123 2.169 . . . . 0.0 109.168 178.1 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.994 0 CA-C-O 121.393 0.616 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.9 tp -107.25 145.92 32.1 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 126.727 2.011 . . . . 0.0 107.479 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.441 ' HA ' ' HB2' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -94.4 138.42 32.37 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 173.04 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.96 99.13 10.4 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 173.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t 64.41 -76.03 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 119.563 -1.96 . . . . 0.0 111.824 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -133.75 115.06 14.1 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.261 2.624 . . . . 0.0 105.0 159.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 74' ' ' THR 0.359 56.9 t0 -86.64 137.9 32.11 Favored 'General case' 0 C--N 1.371 1.527 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 165.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.71 -36.29 67.78 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-N 122.503 2.41 . . . . 0.0 116.939 -171.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -172.61 172.41 4.26 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 117.279 -3.388 . . . . 0.0 104.499 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.46 -48.33 1.69 Allowed 'General case' 0 C--N 1.355 0.844 0 C-N-CA 126.844 2.057 . . . . 0.0 112.061 175.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.2 t -173.68 138.07 0.64 Allowed 'General case' 0 C--N 1.362 1.117 0 O-C-N 119.36 -2.087 . . . . 0.0 115.088 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.3 ttt -141.03 116.56 10.18 Favored 'General case' 0 C--N 1.377 1.78 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 158.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.5 p -109.45 116.18 31.32 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 119.409 -2.057 . . . . 0.0 109.432 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 86' ' ' GLU . 7.1 p -149.52 172.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.794 0 C-N-CA 126.327 1.851 . . . . 0.0 110.174 -171.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.403 ' O ' HG22 ' A' ' 85' ' ' VAL . 1.0 OUTLIER -80.86 133.8 35.65 Favored 'General case' 0 C--N 1.371 1.505 0 O-C-N 119.424 -2.048 . . . . 0.0 106.561 163.213 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.288 9.5 pt-20 -42.55 122.41 2.27 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 120.232 3.419 . . . . 0.0 120.232 -156.13 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 140.37 46.09 0.06 OUTLIER Glycine 0 C--N 1.361 1.954 0 CA-C-N 110.312 -3.131 . . . . 0.0 110.979 -164.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.38 167.12 16.79 Favored 'General case' 0 C--N 1.375 1.69 0 C-N-CA 125.222 1.409 . . . . 0.0 112.984 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.31 105.8 14.19 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.419 1.087 . . . . 0.0 110.578 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.31 121.51 42.21 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.464 1.506 . . . . 0.0 113.418 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.08 131.04 53.09 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 102.221 -3.251 . . . . 0.0 102.221 172.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -120.2 113.57 20.63 Favored 'General case' 0 C--N 1.352 0.682 1 N-CA-C 98.967 -4.457 . . . . 0.0 98.967 170.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.6 m -153.67 132.79 12.59 Favored 'General case' 0 C--N 1.365 1.269 0 CA-C-N 121.093 1.769 . . . . 0.0 109.8 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.7 m -149.22 174.64 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 130.893 3.677 . . . . 0.0 104.104 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -103.89 139.65 38.78 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 128.25 2.62 . . . . 0.0 105.254 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.58 144.26 34.14 Favored 'General case' 0 C--N 1.381 1.964 1 N-CA-C 123.91 4.781 . . . . 0.0 123.91 -174.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.7 p -156.71 175.62 13.82 Favored 'General case' 0 C--N 1.364 1.212 1 C-N-CA 133.812 4.845 . . . . 0.0 104.288 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.54 40.0 0.76 Allowed Glycine 0 C--N 1.366 2.233 0 O-C-N 119.992 -1.693 . . . . 0.0 117.243 168.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.28 29.46 27.72 Favored Glycine 0 C--N 1.362 2.0 0 C-N-CA 128.199 2.809 . . . . 0.0 115.419 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.437 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 66.7 m -117.94 110.6 17.92 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 115.178 -2.344 . . . . 0.0 109.008 173.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.6 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 77.59 -87.08 1.03 Allowed Glycine 0 C--N 1.377 2.822 0 C-N-CA 129.402 3.382 . . . . 0.0 109.655 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 101' ' ' THR . 36.4 Cg_exo -59.93 168.65 5.53 Favored 'Trans proline' 0 CA--C 1.566 2.09 1 C-N-CA 126.628 4.885 . . . . 0.0 115.143 157.647 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.485 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 67.8 m-85 -103.98 146.59 28.47 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 -166.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -102.64 140.01 37.48 Favored 'General case' 0 C--N 1.373 1.619 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -122.37 157.51 31.67 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 119.862 3.282 . . . . 0.0 119.862 -164.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -131.02 119.59 22.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 110.391 -3.095 . . . . 0.0 104.273 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.412 ' CE3' HG23 ' A' ' 138' ' ' VAL . 38.1 m95 -111.01 128.54 55.88 Favored 'General case' 0 C--N 1.379 1.87 0 CA-C-N 119.606 1.094 . . . . 0.0 111.235 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.328 0.2 OUTLIER -143.58 170.83 15.08 Favored 'General case' 0 C--N 1.377 1.779 0 CA-C-N 121.462 1.937 . . . . 0.0 108.145 170.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.472 ' HZ2' ' C ' ' A' ' 132' ' ' ASP . 31.4 tttt -151.0 107.3 3.47 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 120.138 -1.601 . . . . 0.0 108.843 -178.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.268 1.3 t70 34.25 52.42 0.5 Allowed 'General case' 0 CA--C 1.467 -2.249 2 N-CA-C 122.477 4.251 . . . . 0.0 122.477 142.186 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.44 2.2 83.81 Favored Glycine 0 C--N 1.373 2.637 2 O-C-N 133.935 7.022 . . . . 0.0 118.266 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.265 3.2 m -125.06 147.1 55.85 Favored Pre-proline 0 C--N 1.349 0.553 0 C-N-CA 127.672 2.389 . . . . 0.0 116.853 -172.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.63 152.37 78.3 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 124.697 3.598 . . . . 0.0 113.842 170.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -103.76 148.83 36.42 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 120.06 -1.65 . . . . 0.0 108.296 175.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -62.61 -78.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.996 3.797 . . . . 0.0 119.384 -166.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -125.42 63.65 1.18 Allowed 'General case' 0 C--N 1.349 0.548 0 C-N-CA 124.673 1.189 . . . . 0.0 108.387 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.66 150.5 44.13 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 119.386 3.106 . . . . 0.0 119.386 -175.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 81.16 75.94 0.03 OUTLIER 'General case' 0 C--N 1.363 1.193 0 C-N-CA 125.266 1.426 . . . . 0.0 111.987 175.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -165.24 -46.85 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 117.908 1.923 . . . . 0.0 117.908 -172.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.334 . . 135.65 -68.96 0.0 OUTLIER 'General case' 0 C--N 1.351 0.67 0 C-N-CA 128.174 2.59 . . . . 0.0 108.01 -178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.256 9.0 t -138.33 115.93 11.34 Favored 'General case' 0 C--N 1.359 0.978 0 CA-C-N 120.61 1.55 . . . . 0.0 114.467 -174.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.302 4.3 p90 -127.77 140.69 51.89 Favored 'General case' 0 C--N 1.368 1.402 0 C-N-CA 129.458 3.103 . . . . 0.0 110.957 175.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.4 m -129.81 140.22 51.07 Favored 'General case' 0 C--N 1.358 0.951 0 O-C-N 118.344 -2.722 . . . . 0.0 110.368 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.37 96.42 35.61 Favored Pre-proline 0 C--N 1.367 1.355 0 C-N-CA 128.399 2.68 . . . . 0.0 106.982 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -77.38 -14.64 16.22 Favored 'Trans proline' 0 C--N 1.359 1.127 1 C-N-CA 126.946 5.097 . . . . 0.0 114.502 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -161.97 105.79 1.2 Allowed 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 176.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -94.28 133.95 37.27 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.173 2.189 . . . . 0.0 112.772 -178.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.5 177.97 7.24 Favored 'General case' 0 C--N 1.371 1.518 0 C-N-CA 128.191 2.596 . . . . 0.0 111.066 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.05 -48.6 33.11 Favored 'General case' 0 C--N 1.364 1.22 0 N-CA-C 118.955 2.946 . . . . 0.0 118.955 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.44 -14.18 62.7 Favored 'General case' 0 C--N 1.366 1.296 0 C-N-CA 126.696 1.999 . . . . 0.0 114.573 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.472 ' C ' ' HZ2' ' A' ' 110' ' ' LYS 0.332 31.5 m-20 -82.58 -14.28 55.11 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 130.354 3.462 . . . . 0.0 111.48 170.854 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.79 133.86 41.88 Favored 'General case' 0 C--N 1.383 2.059 0 N-CA-C 118.09 2.626 . . . . 0.0 118.09 165.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.9 -158.92 31.6 Favored Glycine 0 C--N 1.37 2.421 0 C-N-CA 126.793 2.139 . . . . 0.0 109.492 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.268 11.0 t -117.74 135.94 53.7 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 114.612 -2.835 . . . . 0.0 106.879 169.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.433 ' HB2' ' HB2' ' A' ' 153' ' ' CYS 0.26 13.7 m-85 -97.4 134.49 40.59 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 127.072 2.149 . . . . 0.0 112.342 -173.305 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.63 153.96 43.05 Favored 'General case' 0 C--N 1.365 1.282 0 CA-C-O 123.231 1.491 . . . . 0.0 108.851 -174.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.497 HG13 HG22 ' A' ' 140' ' ' VAL . 1.1 t -143.62 148.15 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 117.388 -1.725 . . . . 0.0 114.672 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -120.29 120.8 37.12 Favored 'General case' 0 C--N 1.381 1.96 0 C-N-CA 126.127 1.771 . . . . 0.0 106.308 171.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.497 HG22 HG13 ' A' ' 138' ' ' VAL . 0.1 OUTLIER -131.91 123.56 51.61 Favored 'Isoleucine or valine' 0 C--N 1.367 1.341 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -176.27 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.6 m -106.63 133.62 51.03 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 119.366 -2.084 . . . . 0.0 114.625 -176.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.485 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.37 18.9 p-10 -127.85 -179.05 4.75 Favored 'General case' 0 C--N 1.38 1.929 0 CA-C-N 119.962 1.256 . . . . 0.0 112.064 175.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.6 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 8.0 p -49.17 1.33 0.01 OUTLIER 'General case' 0 C--N 1.375 1.713 1 C-N-CA 136.593 5.957 . . . . 0.0 119.964 -167.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -101.29 4.81 42.03 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 118.502 -1.279 . . . . 0.0 108.271 164.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.462 1.3 tp60 64.83 39.69 5.94 Favored 'General case' 0 C--N 1.371 1.502 1 C-N-CA 134.582 5.153 . . . . 0.0 111.569 -173.6 . . . . . . . . 3 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.4 m -112.88 131.45 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 CA-C-N 111.54 -2.573 . . . . 0.0 111.632 -169.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.64 128.72 38.59 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.249 1.82 . . . . 0.0 108.425 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 147.13 41.68 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 101.246 -3.613 . . . . 0.0 101.246 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -130.36 147.09 52.03 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 119.43 -2.043 . . . . 0.0 107.051 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 54.2 p -116.94 151.96 35.56 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 120.822 -1.174 . . . . 0.0 113.273 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.3 148.04 15.61 Favored 'General case' 0 C--N 1.375 1.677 1 C-N-CA 136.782 6.033 . . . . 0.0 116.153 -172.019 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 6.1 p -68.1 111.63 4.59 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 127.034 2.134 . . . . 0.0 111.417 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 1.8 m -97.06 108.45 21.19 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 102.461 -3.163 . . . . 0.0 102.461 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.73 106.81 18.75 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-O 124.704 2.192 . . . . 0.0 109.195 -172.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.46 127.79 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 O-C-N 120.309 -1.494 . . . . 0.0 107.421 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 92.6 m -115.8 122.16 44.59 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 4.2 m -134.99 103.89 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.55 152.93 40.84 Favored Pre-proline 0 C--N 1.352 0.692 0 C-N-CA 125.469 1.507 . . . . 0.0 108.366 177.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -66.79 165.64 25.08 Favored 'Trans proline' 0 C--N 1.368 1.587 1 C-N-CA 127.102 5.201 . . . . 0.0 110.094 162.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.7 p -67.62 130.87 44.37 Favored 'General case' 0 C--N 1.369 1.446 0 O-C-N 119.559 -1.963 . . . . 0.0 109.264 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.4 111.77 8.28 Favored Pre-proline 0 CA--C 1.552 1.051 1 N-CA-C 122.976 4.435 . . . . 0.0 122.976 -121.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.69 153.72 70.22 Favored 'Trans proline' 0 C--N 1.385 2.465 1 C-N-CA 126.007 4.471 . . . . 0.0 114.934 170.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.13 59.68 1.84 Allowed Glycine 0 C--N 1.366 2.213 0 C-N-CA 126.491 1.996 . . . . 0.0 116.615 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.32 19.27 5.41 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 126.483 1.992 . . . . 0.0 111.659 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.8 mt -92.07 -24.44 19.16 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 125.065 1.346 . . . . 0.0 109.973 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . 0.27 45.9 mm-40 64.89 -50.32 0.33 Allowed 'General case' 0 C--N 1.362 1.127 0 C-N-CA 130.756 3.622 . . . . 0.0 116.473 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 78.4 t60 . . . . . 0 C--N 1.357 0.935 0 C-N-CA 128.68 2.792 . . . . 0.0 114.844 175.729 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.146 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.8 tp -86.99 133.7 33.56 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-O 123.548 1.642 . . . . 0.0 111.041 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . 0.251 1.2 t -94.55 170.41 9.49 Favored 'General case' 0 N--CA 1.418 -2.074 0 C-N-CA 127.038 2.135 . . . . 0.0 110.524 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.3 98.67 11.4 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 175.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 t 61.78 -80.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 119.724 -1.86 . . . . 0.0 112.111 -168.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -134.02 140.38 46.65 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.435 3.094 . . . . 0.0 107.029 162.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.362 0.3 OUTLIER -82.76 174.47 10.94 Favored 'General case' 0 C--N 1.351 0.65 1 C-N-CA 132.917 4.487 . . . . 0.0 108.834 175.419 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.03 -34.55 73.41 Favored 'General case' 0 CA--C 1.575 1.906 0 O-C-N 120.517 -1.364 . . . . 0.0 112.027 176.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.5 m -161.88 173.0 15.14 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 117.221 -3.424 . . . . 0.0 103.652 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.98 -47.15 0.59 Allowed 'General case' 0 C--N 1.365 1.275 0 C-N-CA 127.834 2.454 . . . . 0.0 115.468 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.7 p -172.36 116.25 0.34 Allowed 'General case' 0 C--N 1.368 1.385 0 N-CA-C 120.479 3.511 . . . . 0.0 120.479 -172.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.1 ttt -127.06 126.44 43.06 Favored 'General case' 0 C--N 1.38 1.905 0 CA-C-N 121.843 2.11 . . . . 0.0 114.267 165.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -105.5 116.44 31.94 Favored 'General case' 0 C--N 1.373 1.601 0 O-C-N 119.568 -1.957 . . . . 0.0 108.506 174.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 86' ' ' GLU . 9.1 p -149.01 172.94 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.639 0 CA-C-O 122.714 1.245 . . . . 0.0 114.251 -169.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.4 ' O ' HG21 ' A' ' 85' ' ' VAL . 40.9 mt-10 -86.1 123.99 32.02 Favored 'General case' 0 C--N 1.368 1.404 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 161.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -42.07 122.31 2.08 Favored 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 124.239 3.199 . . . . 0.0 118.234 -155.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 143.53 54.23 0.03 OUTLIER Glycine 0 C--N 1.356 1.672 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.636 -162.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.38 166.34 14.33 Favored 'General case' 0 C--N 1.363 1.152 0 C-N-CA 125.099 1.36 . . . . 0.0 112.143 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.9 111.16 22.1 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.166 0.986 . . . . 0.0 108.744 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 6.0 mp -119.75 116.01 25.06 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 125.854 1.662 . . . . 0.0 113.774 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.93 125.09 52.47 Favored 'General case' 0 C--N 1.364 1.219 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 173.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -121.24 113.61 20.2 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 101.412 -3.551 . . . . 0.0 101.412 171.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.8 m -147.92 133.38 18.66 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 119.753 -1.842 . . . . 0.0 111.387 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.13 175.48 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 130.258 3.423 . . . . 0.0 104.364 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 t -104.13 139.26 39.44 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 128.066 2.547 . . . . 0.0 105.69 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.76 147.48 37.41 Favored 'General case' 0 C--N 1.381 1.943 1 N-CA-C 123.885 4.772 . . . . 0.0 123.885 -175.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.4 p -157.04 176.06 13.26 Favored 'General case' 0 C--N 1.361 1.096 1 C-N-CA 133.999 4.92 . . . . 0.0 103.701 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.72 41.63 0.69 Allowed Glycine 0 C--N 1.367 2.288 0 N-CA-C 117.2 1.64 . . . . 0.0 117.2 167.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.1 29.0 35.25 Favored Glycine 0 C--N 1.361 1.936 0 C-N-CA 128.526 2.965 . . . . 0.0 115.476 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.435 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 26.5 p -117.02 110.15 17.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 114.334 -2.746 . . . . 0.0 108.598 176.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.659 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.09 -88.66 0.78 Allowed Glycine 0 C--N 1.38 3.003 0 C-N-CA 129.677 3.513 . . . . 0.0 110.022 -174.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.435 ' HD2' ' O ' ' A' ' 101' ' ' THR . 25.1 Cg_exo -59.97 169.1 5.03 Favored 'Trans proline' 0 CA--C 1.571 2.335 1 C-N-CA 127.223 5.282 . . . . 0.0 116.139 158.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.45 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 57.3 m-85 -101.09 143.18 31.52 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 120.616 3.561 . . . . 0.0 120.616 -166.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -102.86 141.21 36.06 Favored 'General case' 0 C--N 1.379 1.876 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.95 156.32 49.21 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 121.015 3.709 . . . . 0.0 121.015 -163.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -136.33 111.85 9.28 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 112.295 -2.23 . . . . 0.0 105.121 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.444 ' CE3' ' HB ' ' A' ' 138' ' ' VAL . 24.7 m95 -112.8 150.0 32.27 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.473 1.509 . . . . 0.0 108.68 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.295 0.1 OUTLIER -156.28 160.5 39.81 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 164.174 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.439 ' HZ1' ' HB3' ' A' ' 113' ' ' SER . 1.8 pptp? -133.93 104.98 6.51 Favored 'General case' 0 C--N 1.368 1.39 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.422 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.243 2.7 t70 37.45 55.17 1.42 Allowed 'General case' 0 CA--C 1.458 -2.585 1 CA-C-O 110.337 -4.649 . . . . 0.0 120.289 155.349 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.97 -10.15 65.89 Favored Glycine 0 C--N 1.376 2.786 2 O-C-N 134.632 7.457 . . . . 0.0 115.716 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.439 ' HB3' ' HZ1' ' A' ' 110' ' ' LYS . 73.9 m -124.68 148.86 60.45 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 129.995 3.318 . . . . 0.0 119.495 -165.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.25 43.8 Cg_endo -60.04 156.98 36.29 Favored 'Trans proline' 0 N--CA 1.5 1.909 1 C-N-CA 125.777 4.318 . . . . 0.0 116.865 167.782 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -112.13 150.02 41.81 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 119.408 -2.057 . . . . 0.0 111.301 175.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.77 -81.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.09 1 C-N-CA 127.966 5.777 . . . . 0.0 119.516 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -100.58 -42.1 6.68 Favored 'General case' 0 C--N 1.359 1.02 0 C-N-CA 125.461 1.504 . . . . 0.0 111.369 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 71.51 -68.93 0.2 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 129.045 2.938 . . . . 0.0 118.155 172.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.302 8.3 t -75.8 52.77 0.7 Allowed 'General case' 0 N--CA 1.418 -2.051 1 C-N-CA 134.517 5.127 . . . . 0.0 115.544 -169.81 . . . . . . . . 3 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.07 -60.81 0.01 OUTLIER Glycine 0 CA--C 1.476 -2.359 0 N-CA-C 119.152 2.421 . . . . 0.0 119.152 -173.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 150.49 -62.68 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -174.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.6 t -136.68 117.24 13.84 Favored 'General case' 0 C--N 1.359 0.991 0 O-C-N 120.39 -1.444 . . . . 0.0 113.003 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -127.48 138.12 52.86 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.786 2.034 . . . . 0.0 110.751 172.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 27.1 m -129.98 139.46 51.06 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 119.851 -1.781 . . . . 0.0 109.583 177.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.25 106.8 54.38 Favored Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 127.799 2.439 . . . . 0.0 106.095 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.95 -11.9 17.92 Favored 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.459 4.106 . . . . 0.0 112.738 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -161.24 111.88 1.72 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.25 126.91 45.17 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.98 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.06 -179.31 5.65 Favored 'General case' 0 C--N 1.365 1.281 0 C-N-CA 128.746 2.818 . . . . 0.0 108.584 171.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.6 -53.77 13.72 Favored 'General case' 0 C--N 1.367 1.332 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -69.2 0.14 5.23 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 127.913 2.485 . . . . 0.0 115.304 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -116.23 -7.46 11.8 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 131.423 3.889 . . . . 0.0 110.344 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.54 160.18 14.45 Favored 'General case' 0 C--N 1.397 2.643 0 N-CA-C 120.575 3.546 . . . . 0.0 120.575 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.64 -152.72 24.07 Favored Glycine 0 CA--C 1.465 -3.033 0 C-N-CA 127.643 2.544 . . . . 0.0 107.11 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.315 19.4 m -118.12 136.52 53.54 Favored 'General case' 0 N--CA 1.507 2.384 0 C-N-CA 114.001 -3.08 . . . . 0.0 109.881 171.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.438 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 14.9 m-85 -96.73 133.65 41.02 Favored 'General case' 0 C--N 1.368 1.391 0 CA-C-N 123.136 2.698 . . . . 0.0 115.283 -171.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.422 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -141.16 146.38 36.93 Favored 'General case' 0 C--N 1.373 1.596 0 CA-C-O 121.132 0.492 . . . . 0.0 110.393 -175.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.452 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 15.0 p -141.53 143.49 27.39 Favored 'Isoleucine or valine' 0 C--N 1.372 1.564 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.8 m -107.67 120.39 42.11 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 130.341 3.457 . . . . 0.0 107.14 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.54 120.23 44.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 C-N-CA 125.975 1.71 . . . . 0.0 110.752 -173.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -106.88 132.02 53.3 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.475 -1.391 . . . . 0.0 114.522 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.45 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.36 37.3 p-10 -125.93 179.35 5.25 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 119.578 1.081 . . . . 0.0 112.28 175.211 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.659 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 25.4 p -49.62 3.22 0.01 OUTLIER 'General case' 0 C--N 1.372 1.569 1 C-N-CA 135.384 5.474 . . . . 0.0 120.775 -168.906 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -101.96 4.75 40.32 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 165.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.494 0.7 OUTLIER 65.72 40.04 4.54 Favored 'General case' 0 C--N 1.37 1.482 1 C-N-CA 133.653 4.781 . . . . 0.0 111.899 -174.342 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.68 124.49 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.649 0 CA-C-N 111.36 -2.655 . . . . 0.0 112.185 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.63 123.72 35.25 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 127.623 2.369 . . . . 0.0 106.404 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.71 153.38 31.47 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 101.809 -3.404 . . . . 0.0 101.809 -175.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -130.4 146.54 51.98 Favored 'General case' 0 CA--C 1.494 -1.204 0 O-C-N 120.958 -1.089 . . . . 0.0 109.688 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.452 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.323 84.2 p -130.6 145.29 51.86 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.544 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.0 m -55.0 147.91 14.66 Favored 'General case' 0 C--N 1.376 1.734 1 C-N-CA 137.06 6.144 . . . . 0.0 117.725 -165.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.5 p -67.34 110.22 3.46 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 128.528 2.731 . . . . 0.0 111.075 -173.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.74 108.19 20.2 Favored 'General case' 0 C--N 1.372 1.557 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.85 110.33 22.53 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 123.242 1.496 . . . . 0.0 112.654 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.61 114.88 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.251 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . 0.294 0.6 OUTLIER -119.21 131.79 55.87 Favored 'General case' 0 C--N 1.368 1.371 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.5 m -123.04 115.29 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-O 123.482 1.611 . . . . 0.0 112.366 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -87.6 154.27 53.39 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.818 1.247 . . . . 0.0 108.719 174.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.36 166.64 29.17 Favored 'Trans proline' 0 C--N 1.361 1.19 1 C-N-CA 127.531 5.487 . . . . 0.0 107.15 153.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 18.7 p -66.7 131.2 45.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 118.025 -2.922 . . . . 0.0 110.293 -171.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.67 111.68 6.86 Favored Pre-proline 0 C--N 1.361 1.095 0 N-CA-C 120.814 3.635 . . . . 0.0 120.814 -128.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.35 154.48 63.42 Favored 'Trans proline' 0 C--N 1.381 2.289 1 C-N-CA 126.437 4.758 . . . . 0.0 114.658 172.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.81 48.99 0.34 Allowed Glycine 0 C--N 1.368 2.353 0 C-N-CA 128.16 2.79 . . . . 0.0 118.548 -175.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -112.28 35.1 4.83 Favored Glycine 0 C--N 1.353 1.487 0 C-N-CA 128.147 2.784 . . . . 0.0 110.726 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 71.0 mt -121.23 45.0 2.38 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 127.396 2.278 . . . . 0.0 105.814 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -66.97 64.74 0.06 Allowed 'General case' 0 C--N 1.361 1.074 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -173.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 14.6 p80 . . . . . 0 C--N 1.366 1.287 0 C-N-CA 127.562 2.345 . . . . 0.0 115.157 -177.606 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.077 0 CA-C-O 121.499 0.666 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.4 tp -107.51 129.26 54.98 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 126.874 2.07 . . . . 0.0 110.279 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.56 ' HG1' ' N ' ' A' ' 78' ' ' ASP . 9.7 t -94.75 173.22 7.71 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 127.454 2.301 . . . . 0.0 109.965 174.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.352 1.0 OUTLIER -82.3 97.6 8.38 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 123.231 1.491 . . . . 0.0 108.442 175.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 t 57.84 -72.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 116.315 -3.991 . . . . 0.0 116.135 -167.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -133.27 137.68 46.14 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 130.535 3.534 . . . . 0.0 109.025 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.56 ' N ' ' HG1' ' A' ' 74' ' ' THR 0.48 1.4 m-20 -84.8 134.13 34.32 Favored 'General case' 0 C--N 1.378 1.848 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 168.177 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.437 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -72.76 -35.68 67.51 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 125.056 3.571 . . . . 0.0 112.67 -178.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 36.6 m -171.92 171.84 4.96 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 169.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -123.24 -48.08 1.99 Allowed 'General case' 0 C--N 1.368 1.372 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 175.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.5 t -171.68 148.55 2.44 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 119.299 -2.125 . . . . 0.0 113.535 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.49 117.35 6.27 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 124.21 1.004 . . . . 0.0 108.48 166.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.8 t -110.57 115.63 29.95 Favored 'General case' 0 C--N 1.366 1.321 0 O-C-N 118.792 -2.442 . . . . 0.0 107.348 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 86' ' ' GLU 0.25 9.5 p -150.97 174.16 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 125.411 1.484 . . . . 0.0 113.757 -169.567 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.435 ' O ' HG21 ' A' ' 85' ' ' VAL . 49.4 mt-10 -77.68 132.89 38.4 Favored 'General case' 0 C--N 1.374 1.667 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 159.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.359 0.0 OUTLIER -42.97 122.61 2.48 Favored 'General case' 0 N--CA 1.514 2.763 0 N-CA-C 119.606 3.187 . . . . 0.0 119.606 -161.426 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.84 50.76 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 110.225 -3.171 . . . . 0.0 106.226 -163.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.47 145.91 24.45 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 126.72 2.008 . . . . 0.0 107.469 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.62 121.57 36.32 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 -170.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -120.84 133.82 55.3 Favored 'General case' 0 C--N 1.372 1.583 0 C-N-CA 127.172 2.189 . . . . 0.0 115.956 172.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.81 120.36 32.4 Favored 'General case' 0 C--N 1.359 0.986 1 N-CA-C 98.155 -4.757 . . . . 0.0 98.155 165.302 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -115.19 115.49 26.8 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 102.018 -3.327 . . . . 0.0 102.018 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 4.9 t -154.62 133.29 12.11 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 117.801 -1.559 . . . . 0.0 111.789 -174.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.87 174.35 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.743 0 C-N-CA 130.405 3.482 . . . . 0.0 105.573 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.8 t -104.03 141.53 36.04 Favored 'General case' 0 C--N 1.361 1.077 0 O-C-N 119.487 -2.008 . . . . 0.0 106.578 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.19 145.21 35.36 Favored 'General case' 0 C--N 1.376 1.759 1 N-CA-C 122.989 4.44 . . . . 0.0 122.989 -173.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.9 p -156.48 175.28 14.23 Favored 'General case' 0 C--N 1.364 1.223 1 C-N-CA 133.234 4.614 . . . . 0.0 103.36 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.61 41.49 1.0 Allowed Glycine 0 C--N 1.362 2.019 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.36 18.92 54.38 Favored Glycine 0 C--N 1.362 1.982 0 C-N-CA 127.14 2.305 . . . . 0.0 116.121 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.6 m -118.19 111.02 18.28 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 115.039 -2.41 . . . . 0.0 110.185 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.658 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 79.35 -93.05 1.31 Allowed Glycine 0 C--N 1.379 2.961 0 C-N-CA 129.665 3.507 . . . . 0.0 109.221 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.36 168.54 6.29 Favored 'Trans proline' 0 CA--C 1.564 1.998 1 C-N-CA 127.485 5.457 . . . . 0.0 116.316 159.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.457 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 74.0 m-85 -99.12 148.14 24.36 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 119.804 3.261 . . . . 0.0 119.804 -165.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -110.7 144.69 39.25 Favored 'General case' 0 C--N 1.381 1.938 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.439 ' CD2' ' N ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -141.09 165.95 26.14 Favored 'General case' 0 C--N 1.346 0.444 1 N-CA-C 122.345 4.202 . . . . 0.0 122.345 -159.75 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.15 118.49 12.81 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 110.723 -2.944 . . . . 0.0 105.044 172.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -111.79 134.48 53.32 Favored 'General case' 0 C--N 1.366 1.288 0 C-N-CA 125.797 1.639 . . . . 0.0 109.321 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.367 0.2 OUTLIER -155.79 170.01 23.06 Favored 'General case' 0 CA--C 1.488 -1.422 0 O-C-N 120.468 -1.395 . . . . 0.0 107.458 170.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.412 ' HD2' ' CE2' ' A' ' 136' ' ' TYR . 1.6 ptmm? -143.01 106.49 4.6 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 119.52 -1.988 . . . . 0.0 111.555 -177.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.44 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.141 2.0 t70 36.41 54.8 1.07 Allowed 'General case' 0 C--N 1.384 2.084 1 CA-C-O 109.687 -4.959 . . . . 0.0 121.53 149.042 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.33 2.83 80.81 Favored Glycine 0 C--N 1.386 3.319 2 O-C-N 135.353 7.908 . . . . 0.0 119.561 -172.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.274 1.0 OUTLIER -125.23 147.48 57.53 Favored Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 129.39 3.076 . . . . 0.0 117.936 -167.227 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.85 139.39 62.15 Favored 'Trans proline' 0 N--CA 1.504 2.103 1 C-N-CA 126.037 4.492 . . . . 0.0 117.501 169.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.413 HG12 ' HB3' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -91.63 160.02 37.36 Favored Pre-proline 0 CA--C 1.553 1.059 0 O-C-N 118.441 -2.662 . . . . 0.0 112.773 175.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -72.42 -82.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 124.959 3.773 . . . . 0.0 118.284 -172.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -117.29 60.85 0.75 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.277 1.431 . . . . 0.0 109.643 -171.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.413 ' HB3' HG12 ' A' ' 115' ' ' ILE . . . -67.65 151.79 46.69 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 129.085 2.954 . . . . 0.0 117.565 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.412 ' HA ' ' CD2' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 80.54 63.71 0.02 OUTLIER 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.73 1.612 . . . . 0.0 111.015 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.36 -85.56 0.06 OUTLIER Glycine 0 C--N 1.355 1.598 0 N-CA-C 115.474 0.949 . . . . 0.0 115.474 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . 165.74 -65.75 0.0 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 126.068 1.747 . . . . 0.0 106.712 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.263 14.8 t -133.03 110.11 10.0 Favored 'General case' 0 C--N 1.36 1.056 0 CA-C-O 122.994 1.378 . . . . 0.0 113.308 -177.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.293 9.4 p90 -127.09 141.12 51.85 Favored 'General case' 0 C--N 1.369 1.448 0 C-N-CA 128.339 2.656 . . . . 0.0 112.474 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.5 m -128.82 139.7 52.05 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 119.924 -1.735 . . . . 0.0 108.854 178.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.71 92.19 45.45 Favored Pre-proline 0 C--N 1.354 0.801 0 C-N-CA 128.748 2.819 . . . . 0.0 104.903 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -74.43 -32.89 5.92 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 124.879 3.719 . . . . 0.0 112.854 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 69.0 m -128.38 100.6 5.86 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.67 118.5 31.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.877 1.671 . . . . 0.0 113.111 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.43 -179.06 6.86 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.451 2.301 . . . . 0.0 109.438 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -51.32 23.62 Favored 'General case' 0 C--N 1.366 1.316 0 O-C-N 117.803 -3.06 . . . . 0.0 118.088 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.31 0.86 2.53 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 128.851 2.86 . . . . 0.0 115.111 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -116.36 -13.91 11.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 129.544 3.138 . . . . 0.0 111.102 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.75 154.64 17.46 Favored 'General case' 0 C--N 1.399 2.739 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 174.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.46 -157.78 27.36 Favored Glycine 0 C--N 1.382 3.095 0 C-N-CA 128.923 3.154 . . . . 0.0 109.81 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.393 5.7 m -110.66 130.83 55.47 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 112.343 -3.743 . . . . 0.0 107.545 167.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.451 ' HB2' ' HB3' ' A' ' 153' ' ' CYS . 24.5 m-85 -96.81 134.77 39.68 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-N 122.605 2.457 . . . . 0.0 113.011 -172.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.44 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -148.5 150.64 33.77 Favored 'General case' 0 C--N 1.376 1.743 0 C-N-CA 124.878 1.271 . . . . 0.0 110.456 -175.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.677 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 8.9 p -143.67 137.49 24.95 Favored 'Isoleucine or valine' 0 C--N 1.371 1.501 0 C-N-CA 117.956 -1.497 . . . . 0.0 114.314 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.23 111.77 24.65 Favored 'General case' 0 C--N 1.378 1.811 0 C-N-CA 130.34 3.456 . . . . 0.0 105.341 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.21 112.21 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 128.124 2.569 . . . . 0.0 110.73 -169.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 8.0 m -99.3 130.93 45.62 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.457 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.364 25.3 p-10 -127.7 -177.03 3.94 Favored 'General case' 0 C--N 1.372 1.584 0 CA-C-N 119.234 0.925 . . . . 0.0 112.213 174.763 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.658 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 20.4 p -49.83 3.36 0.01 OUTLIER 'General case' 0 C--N 1.369 1.414 1 C-N-CA 136.749 6.02 . . . . 0.0 120.501 -169.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -101.27 4.89 42.18 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 163.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.358 2.1 mp0 65.44 39.53 5.12 Favored 'General case' 0 C--N 1.378 1.825 1 C-N-CA 134.249 5.02 . . . . 0.0 110.678 -175.149 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 141' ' ' THR . 3.0 m -113.58 133.4 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 CA-C-N 112.137 -2.302 . . . . 0.0 111.99 -170.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 1.8 t -91.69 132.16 36.57 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 120.744 1.611 . . . . 0.0 106.883 174.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.13 157.99 23.92 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 -176.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 22.6 t70 -126.11 134.18 51.42 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.814 0.816 . . . . 0.0 109.294 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.677 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.528 59.8 p -111.13 143.9 41.12 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.8 m -54.05 146.74 13.97 Favored 'General case' 0 C--N 1.368 1.404 1 C-N-CA 136.709 6.004 . . . . 0.0 119.405 -155.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.0 p -69.06 110.1 4.33 Favored 'General case' 0 C--N 1.376 1.719 0 C-N-CA 124.264 1.026 . . . . 0.0 110.711 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 4.7 t -100.02 110.12 22.43 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.14 103.89 15.86 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 122.758 1.266 . . . . 0.0 112.267 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.2 m -112.43 115.18 49.11 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -113.41 131.58 55.95 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -174.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 13.3 m -132.98 124.31 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 124.53 1.132 . . . . 0.0 111.574 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.88 159.51 29.67 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 125.23 1.412 . . . . 0.0 107.343 166.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.38 167.24 27.48 Favored 'Trans proline' 0 C--N 1.359 1.111 1 C-N-CA 128.656 6.237 . . . . 0.0 110.022 162.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 11.9 p -67.55 127.61 33.35 Favored 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.551 -1.968 . . . . 0.0 108.789 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.75 122.05 78.69 Favored Pre-proline 0 C--N 1.364 1.223 0 N-CA-C 120.856 3.65 . . . . 0.0 120.856 -122.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.18 145.7 96.21 Favored 'Trans proline' 0 C--N 1.388 2.609 1 C-N-CA 126.107 4.538 . . . . 0.0 114.516 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.79 51.3 0.89 Allowed Glycine 0 C--N 1.366 2.206 0 C-N-CA 127.98 2.705 . . . . 0.0 117.921 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -106.67 34.69 5.54 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 127.34 2.4 . . . . 0.0 110.129 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.77 38.57 3.21 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 126.89 2.076 . . . . 0.0 109.836 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -75.46 58.38 1.01 Allowed 'General case' 0 C--N 1.36 1.029 0 C-N-CA 127.135 2.174 . . . . 0.0 115.67 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 . . . . . 0 C--N 1.353 0.72 0 C-N-CA 125.48 1.512 . . . . 0.0 108.012 179.951 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.033 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.7 tp -102.71 127.84 49.68 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 126.639 1.976 . . . . 0.0 110.676 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 t -103.3 173.73 6.18 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 127.829 2.451 . . . . 0.0 108.522 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.289 0.9 OUTLIER -72.61 99.31 2.52 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 110.185 174.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.89 -82.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 117.869 -3.02 . . . . 0.0 114.666 -170.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -133.01 140.11 47.58 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 130.713 3.605 . . . . 0.0 105.122 167.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -84.54 172.02 12.0 Favored 'General case' 0 N--CA 1.443 -0.779 1 C-N-CA 135.039 5.336 . . . . 0.0 108.303 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.22 -36.81 71.99 Favored 'General case' 0 CA--C 1.575 1.907 0 O-C-N 118.956 -2.34 . . . . 0.0 115.943 -177.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -175.93 176.21 1.84 Allowed 'General case' 0 CA--C 1.5 -0.96 1 N-CA-C 97.987 -4.82 . . . . 0.0 97.987 167.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.25 -51.24 2.92 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 121.713 2.052 . . . . 0.0 107.862 162.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.0 t -166.67 135.61 2.9 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 119.562 -1.961 . . . . 0.0 114.396 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 ttt -137.79 116.73 12.4 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-O 122.592 1.187 . . . . 0.0 109.388 161.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -108.57 115.22 29.68 Favored 'General case' 0 C--N 1.362 1.133 0 O-C-N 119.023 -2.298 . . . . 0.0 107.972 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 86' ' ' GLU . 14.4 p -149.55 173.17 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 127.535 2.334 . . . . 0.0 112.077 -169.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 85' ' ' VAL . 10.5 pt-20 -74.59 136.27 42.05 Favored 'General case' 0 C--N 1.37 1.484 0 O-C-N 118.739 -2.476 . . . . 0.0 107.175 158.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.485 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.28 5.8 pt-20 -43.34 122.08 2.45 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 -162.616 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 136.19 45.0 0.09 OUTLIER Glycine 0 C--N 1.352 1.43 0 CA-C-N 110.094 -3.23 . . . . 0.0 111.526 -162.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.23 164.57 21.11 Favored 'General case' 0 C--N 1.373 1.604 0 C-N-CA 125.07 1.348 . . . . 0.0 111.383 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.37 101.98 10.65 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 123.072 1.415 . . . . 0.0 113.897 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.2 mp -119.71 128.82 54.15 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -175.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.6 t -114.53 135.69 53.85 Favored 'General case' 0 C--N 1.358 0.953 1 N-CA-C 99.422 -4.288 . . . . 0.0 99.422 165.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.01 114.79 23.68 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 100.867 -3.753 . . . . 0.0 100.867 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -150.3 132.65 15.55 Favored 'General case' 0 C--N 1.366 1.321 0 C-N-CA 118.2 -1.4 . . . . 0.0 114.147 -168.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 m -149.59 174.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.943 1 C-N-CA 132.971 4.508 . . . . 0.0 106.198 177.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -104.37 141.52 36.18 Favored 'General case' 0 C--N 1.367 1.368 0 O-C-N 118.948 -2.345 . . . . 0.0 106.669 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.98 135.9 38.04 Favored 'General case' 0 C--N 1.374 1.654 0 N-CA-C 120.986 3.699 . . . . 0.0 120.986 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.0 m -157.69 172.11 19.11 Favored 'General case' 0 C--N 1.359 1.012 1 C-N-CA 131.789 4.035 . . . . 0.0 101.518 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.98 44.12 1.27 Allowed Glycine 0 C--N 1.367 2.301 0 CA-C-N 122.535 2.425 . . . . 0.0 117.381 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.29 25.49 57.1 Favored Glycine 0 C--N 1.355 1.596 0 C-N-CA 128.552 2.977 . . . . 0.0 115.422 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.421 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 88.2 m -117.9 110.96 18.38 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 114.444 -2.693 . . . . 0.0 107.587 173.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.615 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 78.03 -89.27 1.08 Allowed Glycine 0 C--N 1.376 2.783 0 C-N-CA 130.148 3.737 . . . . 0.0 109.953 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 101' ' ' THR . 25.1 Cg_exo -60.68 167.99 7.55 Favored 'Trans proline' 0 CA--C 1.564 2.01 1 C-N-CA 127.009 5.14 . . . . 0.0 116.258 159.633 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.467 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 82.1 m-85 -102.57 146.58 27.94 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 120.036 3.347 . . . . 0.0 120.036 -166.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 t -105.63 153.83 21.26 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 129.354 3.062 . . . . 0.0 104.083 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.02 164.9 38.25 Favored 'General case' 0 C--N 1.366 1.295 1 N-CA-C 122.231 4.16 . . . . 0.0 122.231 -161.135 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.29 114.63 14.64 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 128.614 2.766 . . . . 0.0 106.258 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -111.02 131.27 55.2 Favored 'General case' 0 C--N 1.368 1.404 0 C-N-CA 127.145 2.178 . . . . 0.0 109.807 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.313 0.0 OUTLIER -151.03 169.54 21.57 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 168.602 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.501 ' HZ1' ' HA ' ' A' ' 132' ' ' ASP . 4.0 ttpt -135.61 107.68 7.17 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.24 0.8 OUTLIER 33.25 50.83 0.27 Allowed 'General case' 0 C--N 1.374 1.658 1 N-CA-C 123.546 4.647 . . . . 0.0 123.546 135.421 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.96 -3.54 83.66 Favored Glycine 0 C--N 1.363 2.063 2 O-C-N 132.412 6.07 . . . . 0.0 120.199 -172.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.293 3.4 m -124.02 147.38 53.99 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 129.963 3.305 . . . . 0.0 118.598 -172.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -62.07 140.49 84.47 Favored 'Trans proline' 0 C--N 1.37 1.665 1 C-N-CA 126.215 4.61 . . . . 0.0 115.645 172.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.63 164.87 30.42 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 119.694 -1.879 . . . . 0.0 111.23 175.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_exo -52.21 -44.62 44.86 Favored 'Trans proline' 0 C--N 1.353 0.793 1 C-N-CA 127.785 5.657 . . . . 0.0 118.72 -171.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -169.15 -50.43 0.02 OUTLIER 'General case' 0 C--N 1.348 0.507 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 81.03 -164.17 0.02 OUTLIER 'General case' 0 C--N 1.364 1.204 0 C-N-CA 129.328 3.051 . . . . 0.0 111.401 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t 82.6 3.17 1.14 Allowed 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 119.609 3.189 . . . . 0.0 119.609 170.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.97 85.11 0.06 OUTLIER Glycine 0 CA--C 1.475 -2.467 0 C-N-CA 115.597 -3.192 . . . . 0.0 119.125 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.335 . . 87.47 -78.63 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 163.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.306 6.0 t -141.37 119.95 12.45 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 123.833 1.778 . . . . 0.0 115.153 -170.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -127.3 142.67 51.4 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 129.514 3.126 . . . . 0.0 109.883 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.7 m -126.38 139.0 53.62 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 122.345 2.339 . . . . 0.0 109.678 176.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.15 89.31 39.19 Favored Pre-proline 0 C--N 1.37 1.493 0 C-N-CA 129.056 2.942 . . . . 0.0 103.847 176.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -73.28 -31.39 9.36 Favored 'Trans proline' 0 N--CA 1.471 0.204 1 C-N-CA 125.512 4.142 . . . . 0.0 112.668 -172.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 55.2 m -143.98 100.53 3.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 177.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -86.93 134.58 33.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.312 1.845 . . . . 0.0 114.443 -177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.15 171.69 14.59 Favored 'General case' 0 C--N 1.366 1.302 0 C-N-CA 127.436 2.294 . . . . 0.0 112.343 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.1 -43.72 20.65 Favored 'General case' 0 C--N 1.37 1.477 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -172.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.2 -13.32 61.85 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 128.545 2.738 . . . . 0.0 115.07 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.501 ' HA ' ' HZ1' ' A' ' 110' ' ' LYS . 4.9 m-20 -74.31 -21.08 59.88 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 128.113 2.565 . . . . 0.0 112.239 167.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.17 119.75 9.0 Favored 'General case' 0 C--N 1.386 2.183 0 N-CA-C 120.449 3.5 . . . . 0.0 120.449 172.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.97 -155.13 26.35 Favored Glycine 0 CA--C 1.468 -2.879 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.426 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.316 6.9 m -118.3 132.01 56.31 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 115.397 -2.521 . . . . 0.0 107.214 171.473 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.468 ' CD1' ' HD3' ' A' ' 110' ' ' LYS . 2.5 m-85 -97.06 133.81 41.24 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 125.85 1.66 . . . . 0.0 110.487 -170.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -145.62 144.5 30.49 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-O 122.091 0.948 . . . . 0.0 109.647 -174.394 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.291 7.5 p -141.8 135.94 30.23 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 117.685 -1.606 . . . . 0.0 114.166 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.8 m -103.08 121.26 42.22 Favored 'General case' 0 C--N 1.38 1.915 0 C-N-CA 129.455 3.102 . . . . 0.0 106.238 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.22 120.44 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 127.127 2.171 . . . . 0.0 110.497 -169.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.404 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 14.1 m -107.78 133.35 52.3 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 119.877 -1.764 . . . . 0.0 112.816 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.467 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.373 18.3 p-10 -129.76 -176.55 3.95 Favored 'General case' 0 C--N 1.377 1.77 0 C-N-CA 124.804 1.242 . . . . 0.0 111.929 176.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.615 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 8.1 p -49.37 1.5 0.01 OUTLIER 'General case' 0 C--N 1.369 1.437 1 C-N-CA 136.332 5.853 . . . . 0.0 120.519 -167.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -99.75 4.63 45.5 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 118.262 -1.375 . . . . 0.0 107.784 163.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.437 0.8 OUTLIER 65.67 39.77 4.72 Favored 'General case' 0 C--N 1.371 1.508 1 C-N-CA 133.961 4.904 . . . . 0.0 111.623 -174.524 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 141' ' ' THR . 3.0 m -113.43 131.94 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 CA-C-N 111.023 -2.808 . . . . 0.0 112.394 -169.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.2 124.0 35.07 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 127.856 2.462 . . . . 0.0 107.477 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.36 157.69 24.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 128.798 2.839 . . . . 0.0 103.835 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -128.5 137.34 51.74 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.861 1.21 . . . . 0.0 109.672 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.385 75.1 p -113.55 143.21 44.93 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 125.405 1.482 . . . . 0.0 109.245 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.2 m -54.11 148.47 10.99 Favored 'General case' 0 C--N 1.37 1.492 1 C-N-CA 135.839 5.656 . . . . 0.0 118.887 -159.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 66.6 p -69.09 111.31 4.99 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 127.718 2.407 . . . . 0.0 110.1 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.28 109.85 22.07 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.05 105.99 18.1 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 124.433 2.063 . . . . 0.0 110.372 -174.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.1 m -118.46 128.21 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 14.9 m -119.9 124.07 45.12 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.485 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 2.5 m -126.63 103.91 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -82.79 155.71 67.97 Favored Pre-proline 0 C--N 1.358 0.97 0 C-N-CA 126.147 1.779 . . . . 0.0 111.41 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.52 165.41 27.34 Favored 'Trans proline' 0 CA--C 1.544 1.023 1 C-N-CA 125.629 4.219 . . . . 0.0 108.678 155.546 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.53 134.75 51.85 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 118.796 -2.44 . . . . 0.0 110.599 -173.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.8 t -66.64 109.08 2.9 Favored Pre-proline 0 C--N 1.359 0.999 1 N-CA-C 122.001 4.074 . . . . 0.0 122.001 -124.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -62.5 154.49 64.17 Favored 'Trans proline' 0 C--N 1.386 2.542 1 C-N-CA 126.228 4.619 . . . . 0.0 114.619 171.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.61 49.11 0.45 Allowed Glycine 0 C--N 1.368 2.329 0 C-N-CA 128.259 2.837 . . . . 0.0 118.033 -176.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.38 29.25 10.79 Favored Glycine 0 C--N 1.354 1.574 0 C-N-CA 127.675 2.56 . . . . 0.0 110.602 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 61.9 mt -115.78 46.59 1.49 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 126.982 2.113 . . . . 0.0 107.431 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -71.51 62.56 0.38 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 127.596 2.358 . . . . 0.0 115.75 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--N 1.353 0.727 0 C-N-CA 127.922 2.489 . . . . 0.0 109.693 179.051 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 tp -107.51 141.0 39.62 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.734 1.614 . . . . 0.0 110.544 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.512 ' HG1' ' N ' ' A' ' 78' ' ' ASP . 11.9 t -94.54 173.06 7.81 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 126.187 1.795 . . . . 0.0 110.613 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.363 0.6 OUTLIER -86.99 98.96 11.55 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 127.274 2.23 . . . . 0.0 107.493 171.517 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.49 -76.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 118.553 -2.592 . . . . 0.0 115.575 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -133.33 140.39 47.38 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 129.238 3.015 . . . . 0.0 104.896 166.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.512 ' N ' ' HG1' ' A' ' 74' ' ' THR 0.291 5.4 t0 -83.79 174.34 10.52 Favored 'General case' 0 CA--C 1.503 -0.858 1 C-N-CA 133.926 4.89 . . . . 0.0 110.23 178.765 . . . . . . . . 4 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 0.5 OUTLIER -70.16 -34.67 73.3 Favored 'General case' 0 CA--C 1.584 2.254 0 O-C-N 121.352 -0.842 . . . . 0.0 113.061 174.262 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -170.8 172.33 5.72 Favored 'General case' 0 N--CA 1.471 0.588 1 O-C-N 114.385 -5.197 . . . . 0.0 101.903 173.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.18 -41.94 0.57 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.588 1.555 . . . . 0.0 111.349 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.1 m -163.73 117.49 1.52 Allowed 'General case' 0 C--N 1.363 1.191 0 N-CA-C 117.754 2.501 . . . . 0.0 117.754 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.4 ttt -137.18 116.57 12.74 Favored 'General case' 0 C--N 1.377 1.791 0 CA-C-N 120.378 1.445 . . . . 0.0 109.079 155.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.1 m -113.25 117.02 30.7 Favored 'General case' 0 C--N 1.365 1.261 0 O-C-N 118.607 -2.558 . . . . 0.0 109.063 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -149.4 172.58 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.937 0 C-N-CA 126.058 1.743 . . . . 0.0 110.156 -170.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.99 130.9 35.19 Favored 'General case' 0 C--N 1.373 1.625 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.402 ' HB3' ' HB ' ' A' ' 157' ' ' VAL . 9.9 pt-20 -41.85 122.34 2.02 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -153.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 143.61 43.36 0.05 OUTLIER Glycine 0 C--N 1.356 1.662 0 CA-C-N 109.721 -3.399 . . . . 0.0 110.7 -163.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.53 168.02 14.89 Favored 'General case' 0 C--N 1.374 1.67 0 C-N-CA 124.802 1.241 . . . . 0.0 112.543 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.48 99.37 8.15 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.188 0.995 . . . . 0.0 109.595 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.03 111.78 23.38 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 125.494 1.518 . . . . 0.0 113.94 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -105.19 125.5 51.05 Favored 'General case' 0 C--N 1.371 1.534 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.67 114.87 21.17 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 103.539 -2.763 . . . . 0.0 103.539 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 t -151.14 134.3 16.01 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 120.938 -1.101 . . . . 0.0 112.197 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.03 173.85 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 130.769 3.627 . . . . 0.0 103.703 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -104.16 138.47 40.6 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.404 ' CB ' ' HB3' ' A' ' 121' ' ' ALA . . . -141.3 142.15 33.88 Favored 'General case' 0 C--N 1.366 1.301 0 N-CA-C 120.012 3.338 . . . . 0.0 120.012 -174.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.5 m -158.26 174.33 15.33 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 130.826 3.65 . . . . 0.0 102.178 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.36 44.29 1.64 Allowed Glycine 0 C--N 1.366 2.244 0 O-C-N 118.681 -2.512 . . . . 0.0 117.452 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.24 21.36 65.14 Favored Glycine 0 C--N 1.359 1.838 0 C-N-CA 128.823 3.106 . . . . 0.0 114.749 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.407 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 10.1 p -116.55 111.34 19.78 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 126.165 1.786 . . . . 0.0 106.823 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.804 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 70.51 -90.72 0.38 Allowed Glycine 0 C--N 1.364 2.115 0 C-N-CA 130.649 3.976 . . . . 0.0 111.586 -169.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 101' ' ' THR . 14.7 Cg_exo -60.74 168.39 7.05 Favored 'Trans proline' 0 CA--C 1.568 2.184 1 C-N-CA 127.457 5.438 . . . . 0.0 117.289 160.402 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.457 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 74.6 m-85 -93.64 142.32 27.49 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 121.317 3.821 . . . . 0.0 121.317 -167.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -102.96 155.13 18.57 Favored 'General case' 0 C--N 1.383 2.025 0 C-N-CA 128.23 2.612 . . . . 0.0 104.905 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.443 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -155.59 166.94 32.0 Favored 'General case' 0 C--N 1.362 1.133 1 N-CA-C 122.402 4.223 . . . . 0.0 122.402 -159.375 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.36 114.18 7.65 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-N 112.166 -2.288 . . . . 0.0 107.596 173.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -113.29 155.07 25.78 Favored 'General case' 0 C--N 1.373 1.606 0 O-C-N 119.622 -1.924 . . . . 0.0 110.965 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.0 p -149.06 159.13 44.51 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 167.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.416 ' CE ' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -123.5 102.23 7.76 Favored 'General case' 0 C--N 1.377 1.797 0 C-N-CA 114.411 -2.916 . . . . 0.0 112.673 161.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.173 1.6 t70 36.47 54.17 1.06 Allowed 'General case' 0 CA--C 1.458 -2.58 0 CA-C-O 111.972 -3.87 . . . . 0.0 120.526 149.246 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.93 -17.17 42.14 Favored Glycine 0 C--N 1.363 2.055 1 O-C-N 133.193 6.558 . . . . 0.0 116.573 -172.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m -122.73 146.41 47.95 Favored Pre-proline 0 CA--C 1.573 1.854 0 C-N-CA 131.344 3.858 . . . . 0.0 119.876 -170.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.266 65.1 Cg_endo -65.08 136.12 46.73 Favored 'Trans proline' 0 N--CA 1.509 2.43 1 C-N-CA 128.684 6.256 . . . . 0.0 116.334 176.739 . . . . . . . . 3 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.404 ' HB ' ' CD ' ' A' ' 116' ' ' PRO 0.421 0.6 OUTLIER -84.64 164.95 40.32 Favored Pre-proline 0 N--CA 1.485 1.316 2 O-C-N 116.123 -4.111 . . . . 0.0 116.846 179.889 . . . . . . . . 5 4 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.418 ' HD3' ' HH ' ' A' ' 136' ' ' TYR . 2.8 Cg_exo -67.1 80.88 0.37 Allowed 'Trans proline' 0 C--N 1.384 2.446 1 C-N-CA 127.3 5.333 . . . . 0.0 112.571 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 80.29 -62.21 0.25 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 127.874 2.47 . . . . 0.0 110.815 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 84.94 162.28 0.1 Allowed 'General case' 0 C--N 1.372 1.554 0 C-N-CA 129.207 3.003 . . . . 0.0 111.448 -179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.431 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.2 OUTLIER 74.03 59.54 0.08 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-O 122.767 1.27 . . . . 0.0 114.127 174.95 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.44 -85.51 0.09 OUTLIER Glycine 0 C--N 1.356 1.648 0 N-CA-C 117.487 1.755 . . . . 0.0 117.487 -170.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.404 ' HB3' ' CB ' ' A' ' 97' ' ' ALA 0.26 . . 160.01 -71.13 0.0 OUTLIER 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.98 1.312 . . . . 0.0 110.437 -177.589 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.1 t -136.09 104.96 5.86 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 122.859 1.314 . . . . 0.0 113.838 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.299 7.8 p90 -128.05 140.97 51.65 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 127.713 2.405 . . . . 0.0 110.563 174.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 70.9 m -129.07 139.27 52.09 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 119.931 -1.73 . . . . 0.0 109.094 177.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.259 1.3 mmmm -105.76 111.67 64.6 Favored Pre-proline 0 C--N 1.372 1.548 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 171.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.21 -16.89 15.33 Favored 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 126.37 4.713 . . . . 0.0 113.339 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -162.18 101.27 1.1 Allowed 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 177.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.425 ' HB2' ' CB ' ' A' ' 132' ' ' ASP . . . -88.53 134.59 33.82 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.395 2.278 . . . . 0.0 113.167 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.17 176.83 8.51 Favored 'General case' 0 C--N 1.372 1.579 0 C-N-CA 128.351 2.66 . . . . 0.0 112.718 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.73 -46.63 29.97 Favored 'General case' 0 C--N 1.37 1.467 0 N-CA-C 119.414 3.116 . . . . 0.0 119.414 -172.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.98 -16.88 48.01 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 129.142 2.977 . . . . 0.0 115.0 174.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.425 ' CB ' ' HB2' ' A' ' 128' ' ' ALA . 7.4 m-20 -80.43 -22.04 41.58 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 128.79 2.836 . . . . 0.0 113.855 170.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.27 124.63 22.71 Favored 'General case' 0 C--N 1.382 2.014 0 N-CA-C 120.234 3.42 . . . . 0.0 120.234 173.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.14 -159.27 31.76 Favored Glycine 0 CA--C 1.463 -3.217 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.311 50.5 m -112.6 133.78 54.47 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 115.002 -2.679 . . . . 0.0 107.775 171.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.418 ' HH ' ' HD3' ' A' ' 116' ' ' PRO . 5.9 m-85 -96.2 133.43 40.53 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 118.988 -2.32 . . . . 0.0 110.311 -171.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.61 142.98 32.22 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 125.111 1.507 . . . . 0.0 107.329 -173.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.603 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 13.1 p -133.45 143.4 39.1 Favored 'Isoleucine or valine' 0 C--N 1.36 1.031 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.781 179.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -110.86 120.75 43.42 Favored 'General case' 0 C--N 1.38 1.898 0 C-N-CA 127.71 2.404 . . . . 0.0 106.135 171.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.58 120.49 42.37 Favored 'Isoleucine or valine' 0 C--N 1.361 1.101 0 C-N-CA 126.439 1.896 . . . . 0.0 112.143 -172.154 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 11.9 m -108.75 129.63 55.37 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 119.652 -1.905 . . . . 0.0 114.338 -178.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.457 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.468 17.5 p30 -126.67 -167.84 1.78 Allowed 'General case' 0 C--N 1.376 1.735 0 CA-C-N 119.972 1.26 . . . . 0.0 113.057 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.804 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 20.2 p -49.77 -0.52 0.01 OUTLIER 'General case' 0 C--N 1.365 1.259 2 C-N-CA 135.08 5.352 . . . . 0.0 122.04 -162.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -105.91 4.68 29.84 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.119 167.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.41 87.3 mm-40 68.29 40.32 2.11 Favored 'General case' 0 C--N 1.375 1.717 0 C-N-CA 131.635 3.974 . . . . 0.0 109.819 -170.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.52 122.9 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 CA-C-N 111.991 -2.368 . . . . 0.0 112.528 -170.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.49 124.11 34.73 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 128.646 2.778 . . . . 0.0 107.254 -177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.17 157.33 24.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 129.303 3.041 . . . . 0.0 103.066 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -130.2 143.36 50.74 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.603 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.39 5.0 p -124.62 148.18 48.05 Favored 'General case' 0 C--O 1.26 1.626 0 CA-C-N 119.378 0.99 . . . . 0.0 109.509 176.569 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.2 m -54.4 147.01 14.53 Favored 'General case' 0 C--N 1.385 2.127 2 C-N-CA 137.817 6.447 . . . . 0.0 115.776 -162.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 73.5 p -68.82 109.8 4.04 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.159 -1.837 . . . . 0.0 111.721 -172.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 108.95 20.29 Favored 'General case' 0 C--N 1.368 1.412 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.31 109.02 21.6 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 123.889 1.804 . . . . 0.0 110.029 -173.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.83 128.24 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 O-C-N 120.367 -1.458 . . . . 0.0 108.676 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 98.3 m -112.79 121.54 45.01 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.402 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 4.2 m -135.03 102.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 171.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -107.37 153.07 41.43 Favored Pre-proline 0 C--N 1.349 0.545 0 O-C-N 119.983 -1.698 . . . . 0.0 108.762 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.2 166.36 27.16 Favored 'Trans proline' 0 C--N 1.361 1.204 1 C-N-CA 126.873 5.049 . . . . 0.0 109.734 161.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 8.2 p -67.42 133.19 49.11 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 119.161 -2.212 . . . . 0.0 108.643 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 32.3 t -66.56 113.15 11.55 Favored Pre-proline 0 CA--C 1.554 1.11 0 N-CA-C 121.349 3.833 . . . . 0.0 121.349 -122.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -62.51 148.46 93.29 Favored 'Trans proline' 0 C--N 1.388 2.625 1 C-N-CA 126.211 4.607 . . . . 0.0 114.32 175.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.19 48.92 0.71 Allowed Glycine 0 C--N 1.365 2.151 0 C-N-CA 128.168 2.794 . . . . 0.0 117.625 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -104.41 37.48 3.76 Favored Glycine 0 C--N 1.354 1.543 0 C-N-CA 127.55 2.5 . . . . 0.0 110.061 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.02 39.49 2.33 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 126.525 1.93 . . . . 0.0 109.652 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -76.53 62.63 1.93 Allowed 'General case' 0 C--N 1.359 0.98 0 C-N-CA 126.688 1.995 . . . . 0.0 115.611 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.3 p80 . . . . . 0 C--N 1.358 0.943 0 C-N-CA 126.977 2.111 . . . . 0.0 111.734 179.33 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.183 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.0 tp -67.15 135.72 53.98 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 127.697 2.399 . . . . 0.0 112.727 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.7 t -94.28 172.5 8.17 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 127.29 2.236 . . . . 0.0 111.192 -175.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.444 0.8 OUTLIER -82.17 97.8 8.4 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.529 -2.123 . . . . 0.0 107.558 174.025 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.54 -74.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 118.56 -2.588 . . . . 0.0 116.196 -170.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -132.85 141.15 48.28 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 131.382 3.873 . . . . 0.0 106.433 171.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.313 1.5 t70 -82.93 173.41 11.83 Favored 'General case' 0 CA--C 1.503 -0.86 1 C-N-CA 133.447 4.699 . . . . 0.0 109.232 179.871 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.657 ' HG ' ' H ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -72.05 -34.26 68.63 Favored 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 113.989 -1.46 . . . . 0.0 111.588 179.284 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.6 m -163.94 172.57 13.77 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 116.556 -3.84 . . . . 0.0 104.049 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.68 -40.83 0.78 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 128.111 2.564 . . . . 0.0 112.944 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.6 p -176.0 136.13 0.29 Allowed 'General case' 0 C--N 1.369 1.423 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 34.8 tpp -134.22 118.27 17.42 Favored 'General case' 0 C--N 1.375 1.684 0 CA-C-N 119.69 1.132 . . . . 0.0 109.855 163.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.7 t -111.18 115.65 29.74 Favored 'General case' 0 C--N 1.377 1.788 0 CA-C-O 123.553 1.644 . . . . 0.0 107.796 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 86' ' ' GLU . 9.3 p -150.75 174.4 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 127.495 2.318 . . . . 0.0 110.938 -174.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 85' ' ' VAL . 43.8 mt-10 -73.57 143.83 46.28 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 126.556 1.943 . . . . 0.0 106.643 156.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.431 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.381 0.0 OUTLIER -44.14 123.38 3.36 Favored 'General case' 0 N--CA 1.514 2.773 0 O-C-N 116.947 -3.596 . . . . 0.0 116.626 -172.668 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 124.73 48.72 0.21 Allowed Glycine 0 C--N 1.353 1.516 0 CA-C-N 111.705 -2.498 . . . . 0.0 109.338 -151.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.19 156.75 18.11 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 125.487 1.515 . . . . 0.0 111.515 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.76 105.25 13.68 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 124.609 1.164 . . . . 0.0 111.282 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.4 mp -120.31 125.52 48.27 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 127.002 2.121 . . . . 0.0 115.361 -174.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.62 122.27 46.74 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 170.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -123.46 115.48 21.65 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.657 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 86.2 p -157.29 131.57 8.41 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 120.775 -1.203 . . . . 0.0 113.967 -172.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.41 HG13 HG21 ' A' ' 140' ' ' VAL . 10.1 m -148.97 173.12 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 129.955 3.302 . . . . 0.0 105.974 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 p -103.77 124.71 49.4 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 115.082 -2.389 . . . . 0.0 109.808 -172.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.72 138.18 40.72 Favored 'General case' 0 C--N 1.386 2.154 1 N-CA-C 125.318 5.303 . . . . 0.0 125.318 -170.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.5 m -157.49 174.57 15.19 Favored 'General case' 0 C--N 1.367 1.354 1 C-N-CA 132.023 4.129 . . . . 0.0 101.678 169.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -69.27 46.99 0.5 Allowed Glycine 0 C--N 1.366 2.228 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -177.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.58 21.0 60.76 Favored Glycine 0 C--N 1.356 1.657 0 C-N-CA 127.146 2.308 . . . . 0.0 116.156 175.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.4 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 7.9 p -116.45 111.11 19.53 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 115.686 -2.102 . . . . 0.0 107.234 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.739 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 70.98 -90.43 0.41 Allowed Glycine 0 C--N 1.377 2.844 0 C-N-CA 128.105 2.764 . . . . 0.0 111.814 -170.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.4 ' HD2' ' O ' ' A' ' 101' ' ' THR . 62.4 Cg_endo -66.57 167.52 18.82 Favored 'Trans proline' 0 CA--C 1.571 2.343 1 C-N-CA 126.35 4.7 . . . . 0.0 115.211 162.454 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.421 ' CD1' ' HB3' ' A' ' 142' ' ' ASP . 67.4 m-85 -90.82 145.54 24.68 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 121.009 3.707 . . . . 0.0 121.009 -166.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 t -102.16 140.4 36.49 Favored 'General case' 0 C--N 1.38 1.895 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.421 ' HB3' ' CG1' ' A' ' 140' ' ' VAL . 0.0 OUTLIER -132.14 158.26 42.12 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 121.589 3.922 . . . . 0.0 121.589 -160.257 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.27 119.66 10.94 Favored 'General case' 0 C--N 1.36 1.029 0 CA-C-N 112.423 -2.171 . . . . 0.0 106.977 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -112.38 151.59 29.61 Favored 'General case' 0 C--N 1.367 1.335 0 O-C-N 119.943 -1.723 . . . . 0.0 107.848 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.4 0.0 OUTLIER -157.78 146.08 19.04 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 119.559 -1.963 . . . . 0.0 105.771 164.939 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.477 ' HB3' ' CD2' ' A' ' 136' ' ' TYR 0.307 65.8 mmtt -126.43 99.67 5.93 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 115.987 -2.285 . . . . 0.0 111.613 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.4 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.356 0.8 OUTLIER 36.65 53.22 1.05 Allowed 'General case' 0 CA--C 1.46 -2.489 1 CA-C-O 111.615 -4.04 . . . . 0.0 121.267 157.612 . . . . . . . . 5 4 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.45 -5.26 70.52 Favored Glycine 0 C--N 1.372 2.547 2 O-C-N 133.509 6.756 . . . . 0.0 114.965 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -124.09 148.56 57.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 131.179 3.792 . . . . 0.0 115.956 -168.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.36 161.69 19.5 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 124.244 3.296 . . . . 0.0 116.187 168.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.436 ' CG2' ' HG2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -93.27 165.57 18.07 Favored Pre-proline 0 N--CA 1.443 -0.791 0 C-N-CA 131.373 3.869 . . . . 0.0 109.305 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -51.24 -44.29 43.82 Favored 'Trans proline' 0 CA--C 1.538 0.675 1 C-N-CA 127.433 5.422 . . . . 0.0 118.757 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -158.62 -50.82 0.06 Allowed 'General case' 0 C--N 1.348 0.504 0 C-N-CA 126.245 1.818 . . . . 0.0 106.972 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.256 . . 97.49 140.52 0.02 OUTLIER 'General case' 0 CA--C 1.464 -2.352 0 C-N-CA 128.819 2.847 . . . . 0.0 110.472 -177.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 73.9 m 69.75 34.71 2.57 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.163 -1.835 . . . . 0.0 114.243 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -108.2 -18.46 9.78 Favored Glycine 0 CA--C 1.47 -2.762 0 N-CA-C 117.877 1.911 . . . . 0.0 117.877 -164.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.313 . . 81.99 -73.03 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 126.309 1.844 . . . . 0.0 111.786 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.28 13.4 t -128.62 104.22 7.54 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 123.199 1.476 . . . . 0.0 112.459 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.346 0.0 OUTLIER -127.49 140.99 51.78 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 128.192 2.597 . . . . 0.0 112.16 174.194 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.8 m -123.48 138.59 54.55 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 120.334 -1.479 . . . . 0.0 107.869 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.67 106.75 57.52 Favored Pre-proline 0 C--N 1.369 1.415 0 N-CA-C 103.449 -2.796 . . . . 0.0 103.449 170.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.72 -32.46 3.53 Favored 'Trans proline' 0 C--N 1.356 0.958 1 C-N-CA 126.925 5.083 . . . . 0.0 111.733 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -144.47 103.98 4.01 Favored 'General case' 0 N--CA 1.42 -1.928 1 N-CA-C 99.855 -4.128 . . . . 0.0 99.855 176.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -95.37 133.38 39.38 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 128.335 2.654 . . . . 0.0 107.611 176.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.42 -176.1 4.68 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 127.956 2.502 . . . . 0.0 113.084 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.29 -45.12 34.44 Favored 'General case' 0 C--N 1.369 1.419 0 N-CA-C 119.024 2.972 . . . . 0.0 119.024 -173.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -69.04 -7.58 37.03 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 126.753 2.021 . . . . 0.0 114.974 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -81.54 -17.9 46.85 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.293 2.237 . . . . 0.0 110.236 168.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.92 114.02 3.82 Favored 'General case' 0 C--N 1.386 2.158 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 171.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 165.63 -156.87 29.08 Favored Glycine 0 CA--C 1.454 -3.75 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.334 23.7 m -112.85 133.08 55.01 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 114.667 -2.813 . . . . 0.0 107.257 174.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.477 ' CD2' ' HB3' ' A' ' 110' ' ' LYS . 4.2 m-85 -96.99 132.39 42.85 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 118.506 -2.621 . . . . 0.0 113.547 -168.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -144.05 151.35 39.54 Favored 'General case' 0 C--N 1.394 2.543 0 CA-C-N 120.066 1.303 . . . . 0.0 112.138 -173.531 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.469 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 14.3 p -141.59 143.07 27.91 Favored 'Isoleucine or valine' 0 C--N 1.378 1.82 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 174.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.1 m -113.15 121.04 43.33 Favored 'General case' 0 C--N 1.373 1.623 0 C-N-CA 129.684 3.194 . . . . 0.0 107.366 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.421 ' CG1' ' HB3' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -132.8 125.37 52.38 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 C-N-CA 126.311 1.844 . . . . 0.0 113.112 -177.212 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 4.0 m -112.0 133.85 53.92 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.156 -2.215 . . . . 0.0 116.027 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.421 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.39 23.2 p30 -127.98 -173.91 3.06 Favored 'General case' 0 C--N 1.379 1.868 0 CA-C-N 120.226 1.375 . . . . 0.0 113.46 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.739 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 19.8 p -49.25 2.76 0.01 OUTLIER 'General case' 0 C--N 1.363 1.191 2 C-N-CA 136.349 5.86 . . . . 0.0 122.097 -165.466 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.89 4.62 25.57 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 164.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.447 98.3 mm-40 67.53 40.1 2.68 Favored 'General case' 0 C--N 1.371 1.526 1 C-N-CA 132.22 4.208 . . . . 0.0 110.576 -172.6 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.76 127.18 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-N 111.462 -2.608 . . . . 0.0 112.447 -171.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.419 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.9 OUTLIER -91.64 134.45 34.68 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.754 1.622 . . . . 0.0 110.318 -176.693 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -116.78 141.05 48.72 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 102.38 -3.193 . . . . 0.0 102.38 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -128.87 146.95 50.8 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.469 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.304 1.7 p -119.41 141.7 48.87 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 121.521 0.677 . . . . 0.0 110.738 175.536 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 m -54.23 148.22 11.78 Favored 'General case' 0 CA--C 1.479 -1.768 2 C-N-CA 138.253 6.621 . . . . 0.0 115.672 -168.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 78.3 p -68.19 110.17 3.89 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.594 2.758 . . . . 0.0 110.881 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.41 ' HG ' HG22 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -96.54 109.46 22.05 Favored 'General case' 0 C--N 1.363 1.193 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 -176.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.98 113.17 24.21 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 124.566 2.126 . . . . 0.0 111.086 -173.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.41 HG22 ' HG ' ' A' ' 153' ' ' CYS . 96.3 t -112.58 114.99 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -172.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 62.2 m -120.76 123.05 41.71 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.431 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 3.3 m -123.42 105.29 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -82.63 156.86 67.9 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.709 1.204 . . . . 0.0 110.477 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.0 165.75 30.21 Favored 'Trans proline' 0 CA--C 1.544 0.986 1 C-N-CA 125.665 4.244 . . . . 0.0 107.835 154.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 12.2 p -67.27 132.46 47.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 118.543 -2.598 . . . . 0.0 109.175 -173.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 65.2 t -65.13 115.52 21.98 Favored Pre-proline 0 C--N 1.366 1.285 0 N-CA-C 120.073 3.36 . . . . 0.0 120.073 -126.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.16 145.73 96.23 Favored 'Trans proline' 0 C--N 1.383 2.376 1 C-N-CA 126.519 4.813 . . . . 0.0 115.238 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.22 61.48 1.06 Allowed Glycine 0 C--N 1.365 2.158 0 C-N-CA 128.615 3.007 . . . . 0.0 117.564 -174.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -103.99 -48.84 1.12 Allowed Glycine 0 C--N 1.355 1.6 0 C-N-CA 127.364 2.411 . . . . 0.0 110.99 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.87 -12.28 45.31 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 127.388 2.275 . . . . 0.0 113.766 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 65.94 -42.05 0.36 Allowed 'General case' 0 C--N 1.367 1.359 0 C-N-CA 129.57 3.148 . . . . 0.0 116.841 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 C--N 1.351 0.653 0 C-N-CA 130.073 3.349 . . . . 0.0 113.18 -177.826 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.057 0 CA-C-O 122.303 1.049 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.1 tp -106.94 117.51 34.26 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.471 ' HG1' ' CA ' ' A' ' 78' ' ' ASP . 5.3 t -104.08 172.78 6.61 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 126.399 1.879 . . . . 0.0 110.02 -176.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.355 0.5 OUTLIER -76.14 97.48 4.12 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-O 122.473 1.13 . . . . 0.0 110.603 173.886 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.68 -77.5 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 O-C-N 119.128 -2.232 . . . . 0.0 114.466 -170.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -132.97 140.98 48.06 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 130.146 3.378 . . . . 0.0 103.376 167.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.471 ' CA ' ' HG1' ' A' ' 74' ' ' THR 0.428 45.1 t0 -83.02 171.82 13.4 Favored 'General case' 0 CA--C 1.511 -0.542 1 C-N-CA 134.279 5.032 . . . . 0.0 107.321 179.52 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.52 ' HB3' ' HA ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -72.38 -37.61 68.7 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 178.572 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m -173.86 172.5 3.46 Favored 'General case' 0 CA--C 1.504 -0.814 1 N-CA-C 99.221 -4.363 . . . . 0.0 99.221 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.43 -47.55 2.54 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 121.051 1.75 . . . . 0.0 109.599 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -170.42 132.57 1.0 Allowed 'General case' 0 C--N 1.36 1.055 0 O-C-N 119.765 -1.835 . . . . 0.0 115.878 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 12.7 tpt -130.75 116.26 17.76 Favored 'General case' 0 C--N 1.373 1.612 0 CA-C-N 120.603 1.547 . . . . 0.0 107.793 164.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 p -109.86 115.52 29.97 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 119.397 -2.065 . . . . 0.0 107.813 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -149.55 174.27 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 126.157 1.783 . . . . 0.0 111.499 -168.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -74.08 135.74 43.0 Favored 'General case' 0 C--N 1.368 1.405 0 O-C-N 118.87 -2.394 . . . . 0.0 107.087 158.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.336 0.4 OUTLIER -44.04 122.62 2.96 Favored 'General case' 0 N--CA 1.515 2.813 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -165.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 131.74 50.81 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 111.337 -2.665 . . . . 0.0 108.722 -162.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.61 160.67 19.55 Favored 'General case' 0 C--N 1.369 1.415 0 C-N-CA 126.382 1.873 . . . . 0.0 109.443 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.02 99.95 8.73 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 122.494 1.14 . . . . 0.0 110.723 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . 0.276 9.0 mp -113.27 114.24 26.41 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 126.679 1.992 . . . . 0.0 115.74 -169.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.92 137.17 45.48 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 170.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 79' ' ' LEU . 1.7 mm? -124.84 116.09 21.7 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.6 t -150.37 131.94 14.84 Favored 'General case' 0 C--N 1.38 1.908 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 -171.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.5 m -149.57 172.81 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.039 0 C-N-CA 129.926 3.29 . . . . 0.0 106.849 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.6 t -105.45 138.12 42.16 Favored 'General case' 0 C--N 1.371 1.515 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.42 143.91 37.85 Favored 'General case' 0 C--N 1.371 1.535 0 N-CA-C 119.914 3.302 . . . . 0.0 119.914 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.96 174.69 15.13 Favored 'General case' 0 C--N 1.361 1.091 1 C-N-CA 134.169 4.988 . . . . 0.0 102.881 177.521 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.19 45.57 1.75 Allowed Glycine 0 C--N 1.37 2.422 0 O-C-N 118.706 -2.496 . . . . 0.0 117.73 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.41 62.01 Favored Glycine 0 C--N 1.363 2.073 0 C-N-CA 128.073 2.749 . . . . 0.0 112.787 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.5 m -115.96 110.93 19.64 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 126.442 1.897 . . . . 0.0 107.565 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.564 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 66.95 -102.6 0.79 Allowed Glycine 0 CA--C 1.548 2.106 0 CA-C-O 116.667 -2.185 . . . . 0.0 109.783 -160.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.58 169.51 5.38 Favored 'Trans proline' 0 C--N 1.377 2.041 1 C-N-CA 129.128 6.552 . . . . 0.0 118.168 160.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.475 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 76.9 m-85 -81.74 142.3 32.77 Favored 'General case' 0 C--N 1.358 0.965 1 N-CA-C 124.301 4.926 . . . . 0.0 124.301 -164.407 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 t -102.32 141.06 35.76 Favored 'General case' 0 C--N 1.379 1.887 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -134.51 162.91 30.94 Favored 'General case' 0 C--N 1.351 0.662 1 N-CA-C 122.85 4.389 . . . . 0.0 122.85 -161.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.49 121.18 11.86 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.992 2.517 . . . . 0.0 106.951 176.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -112.16 138.2 49.16 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.577 1.951 . . . . 0.0 111.422 -175.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.1 169.97 19.46 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-O 123.119 1.438 . . . . 0.0 107.335 172.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 13.8 ttpt -145.64 104.99 3.94 Favored 'General case' 0 N--CA 1.422 -1.851 0 O-C-N 119.37 -2.081 . . . . 0.0 105.875 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.415 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.239 1.2 t70 34.76 53.47 0.63 Allowed 'General case' 0 CA--C 1.472 -2.024 2 CA-C-O 110.414 -4.613 . . . . 0.0 123.073 141.976 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.74 -1.11 84.67 Favored Glycine 0 C--N 1.377 2.859 2 O-C-N 134.349 7.28 . . . . 0.0 118.964 -173.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.5 t -124.96 145.43 50.14 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -171.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -64.79 136.24 48.36 Favored 'Trans proline' 0 N--CA 1.495 1.588 1 C-N-CA 126.158 4.572 . . . . 0.0 115.315 173.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -85.23 165.6 35.54 Favored Pre-proline 0 CA--C 1.552 1.039 0 O-C-N 119.337 -2.102 . . . . 0.0 116.319 178.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -68.1 81.45 0.5 Allowed 'Trans proline' 0 C--N 1.363 1.319 1 C-N-CA 125.406 4.071 . . . . 0.0 114.647 174.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 74.82 -62.15 0.46 Allowed 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.43 2.292 . . . . 0.0 115.033 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 85.3 162.68 0.1 Allowed 'General case' 0 CA--C 1.481 -1.703 0 C-N-CA 129.431 3.092 . . . . 0.0 112.584 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 79.16 52.98 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 CA-C-N 113.531 -1.668 . . . . 0.0 111.049 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.99 -86.44 0.84 Allowed Glycine 0 C--N 1.362 2.018 0 CA-C-N 114.172 -1.376 . . . . 0.0 116.494 -170.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.339 . . 144.45 -74.97 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.406 2.282 . . . . 0.0 111.079 177.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.3 9.0 t -126.0 93.47 3.83 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.909 1.814 . . . . 0.0 110.301 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.277 3.3 p90 -125.98 141.05 52.13 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.228 1.811 . . . . 0.0 110.319 -177.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 88.8 m -129.71 139.8 51.26 Favored 'General case' 0 CA--C 1.493 -1.238 0 O-C-N 120.389 -1.444 . . . . 0.0 110.041 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.09 103.93 55.51 Favored Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 129.485 3.114 . . . . 0.0 105.293 176.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -72.65 -32.76 9.14 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.718 3.612 . . . . 0.0 113.772 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 99.4 m -136.54 100.99 4.51 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.07 124.04 36.76 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 124.212 1.005 . . . . 0.0 113.196 177.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.93 -178.49 4.67 Favored 'General case' 0 C--N 1.364 1.234 0 C-N-CA 129.2 3.0 . . . . 0.0 109.719 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -54.19 13.39 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -173.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.13 1.03 1.65 Allowed 'General case' 0 C--N 1.365 1.241 0 C-N-CA 128.6 2.76 . . . . 0.0 115.357 172.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -116.06 -18.56 10.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 129.409 3.084 . . . . 0.0 111.266 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.18 164.55 12.81 Favored 'General case' 0 C--N 1.391 2.412 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.87 -155.86 26.74 Favored Glycine 0 C--N 1.383 3.149 0 C-N-CA 128.318 2.866 . . . . 0.0 109.734 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.356 6.9 m -109.41 130.73 55.49 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 112.974 -3.491 . . . . 0.0 107.135 164.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . 0.255 3.5 m-85 -97.01 134.49 40.31 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 125.704 1.602 . . . . 0.0 111.492 -169.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.415 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -145.49 152.61 40.05 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-N 119.459 1.027 . . . . 0.0 109.021 -175.746 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.612 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 7.7 p -141.39 142.69 28.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 C-N-CA 116.568 -2.053 . . . . 0.0 111.592 178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.5 m -105.99 119.37 39.03 Favored 'General case' 0 C--N 1.368 1.401 0 C-N-CA 129.778 3.231 . . . . 0.0 106.286 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.16 124.27 45.66 Favored 'Isoleucine or valine' 0 C--N 1.35 0.591 0 C-N-CA 124.268 1.027 . . . . 0.0 113.613 -173.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 6.0 m -109.23 131.71 54.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 119.412 -2.055 . . . . 0.0 114.599 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.475 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.444 10.2 p-10 -128.45 -170.48 2.26 Favored 'General case' 0 C--N 1.367 1.366 0 O-C-N 120.682 -1.261 . . . . 0.0 113.894 175.21 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.564 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 22.1 p -48.71 3.84 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.317 1 C-N-CA 136.218 5.807 . . . . 0.0 121.634 -164.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -106.74 4.57 27.82 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 118.286 -1.366 . . . . 0.0 107.898 163.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.433 89.9 mm-40 66.45 40.09 3.67 Favored 'General case' 0 C--N 1.373 1.62 1 C-N-CA 132.924 4.49 . . . . 0.0 110.273 -171.992 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.2 m -112.54 126.32 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 C-N-CA 128.08 2.552 . . . . 0.0 112.061 -171.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . 0.411 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.3 OUTLIER -91.83 130.24 37.64 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 124.61 1.164 . . . . 0.0 109.849 -178.203 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.62 158.89 23.84 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.755 3.222 . . . . 0.0 104.455 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -129.77 146.51 51.52 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.612 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.404 87.8 p -116.4 150.19 38.18 Favored 'General case' 0 C--O 1.254 1.303 0 C-N-CA 124.469 1.108 . . . . 0.0 110.004 177.401 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.92 148.83 12.59 Favored 'General case' 0 C--N 1.382 2.012 1 C-N-CA 134.245 5.018 . . . . 0.0 118.719 -158.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.0 p -68.74 111.13 4.66 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 127.866 2.466 . . . . 0.0 110.434 -177.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.16 109.25 22.04 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.52 107.43 19.59 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 124.84 2.257 . . . . 0.0 110.882 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.0 m -119.75 120.25 62.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 O-C-N 119.821 -1.799 . . . . 0.0 106.386 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -112.07 135.76 52.3 Favored 'General case' 0 C--N 1.364 1.235 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -174.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 29.7 m -128.17 104.96 12.69 Favored 'Isoleucine or valine' 0 C--N 1.361 1.079 0 CA-C-O 124.136 1.922 . . . . 0.0 112.672 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -85.97 161.36 50.13 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.457 1.503 . . . . 0.0 109.814 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -67.99 165.96 26.37 Favored 'Trans proline' 0 C--N 1.364 1.381 1 C-N-CA 127.788 5.659 . . . . 0.0 108.613 153.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 17.7 p -67.28 131.53 45.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 118.53 -2.606 . . . . 0.0 109.815 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.14 111.6 6.97 Favored Pre-proline 0 CA--C 1.552 1.041 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 -125.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.51 147.44 94.84 Favored 'Trans proline' 0 C--N 1.382 2.317 1 C-N-CA 126.091 4.528 . . . . 0.0 114.107 171.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.06 48.4 0.67 Allowed Glycine 0 C--N 1.365 2.161 0 C-N-CA 128.044 2.735 . . . . 0.0 117.933 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -104.25 33.68 6.38 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 127.512 2.482 . . . . 0.0 110.437 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.49 36.29 4.28 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 127.789 2.436 . . . . 0.0 110.119 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -75.01 65.54 1.46 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 127.238 2.215 . . . . 0.0 116.553 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 C--N 1.354 0.799 0 C-N-CA 126.296 1.838 . . . . 0.0 109.777 178.162 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 121.614 0.721 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.4 tp -107.28 122.29 46.27 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 126.644 1.978 . . . . 0.0 109.048 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.553 ' HG1' ' CG ' ' A' ' 78' ' ' ASP . 5.5 t -94.96 173.36 7.62 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 127.593 2.357 . . . . 0.0 110.11 176.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.28 0.6 OUTLIER -78.95 97.91 6.22 Favored 'General case' 0 C--N 1.363 1.193 0 O-C-N 120.303 -1.498 . . . . 0.0 109.547 175.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.97 -73.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 117.44 -3.287 . . . . 0.0 115.93 -167.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.98 140.37 47.75 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 130.015 3.326 . . . . 0.0 107.119 172.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.553 ' CG ' ' HG1' ' A' ' 74' ' ' THR 0.47 0.6 OUTLIER -83.9 142.35 30.62 Favored 'General case' 0 C--N 1.375 1.675 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 172.975 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 93' ' ' LEU . 0.3 OUTLIER -72.14 -26.95 62.3 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-N 124.773 3.442 . . . . 0.0 112.354 -177.569 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.9 m -172.13 175.46 3.74 Favored 'General case' 0 C--N 1.317 -0.822 1 C-N-CA 132.142 4.177 . . . . 0.0 101.478 168.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.75 -62.86 1.44 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.827 2.051 . . . . 0.0 113.065 169.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 p -179.99 125.14 0.07 Allowed 'General case' 0 C--N 1.36 1.048 0 O-C-N 118.434 -2.666 . . . . 0.0 117.636 -175.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.1 mmm -120.29 134.63 55.22 Favored 'General case' 0 C--N 1.379 1.888 0 CA-C-N 120.464 1.483 . . . . 0.0 113.198 168.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.2 p -114.54 115.66 27.56 Favored 'General case' 0 C--N 1.365 1.241 0 O-C-N 119.127 -2.233 . . . . 0.0 108.629 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.425 HG23 ' O ' ' A' ' 86' ' ' GLU . 14.9 p -150.1 173.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-N 114.011 -1.449 . . . . 0.0 113.134 -167.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.425 ' O ' HG23 ' A' ' 85' ' ' VAL . 35.6 mt-10 -81.11 131.48 35.3 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 128.01 2.524 . . . . 0.0 104.931 161.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.317 0.2 OUTLIER -43.23 122.38 2.51 Favored 'General case' 0 N--CA 1.518 2.968 0 CA-C-N 123.418 2.827 . . . . 0.0 118.55 -161.727 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 134.57 54.24 0.07 OUTLIER Glycine 0 C--N 1.35 1.354 0 CA-C-N 111.854 -2.43 . . . . 0.0 111.503 -164.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.69 172.27 10.99 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.775 1.23 . . . . 0.0 112.095 173.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.55 100.95 9.41 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.9 -1.125 . . . . 0.0 109.298 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.405 ' CD2' ' HB1' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -121.47 114.31 21.08 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.531 1.532 . . . . 0.0 111.218 -172.511 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . 0.29 2.4 t -113.84 137.54 51.52 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.405 ' HA ' ' HB2' ' A' ' 79' ' ' LEU . 7.1 mt -126.68 115.74 19.91 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 -176.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 t -152.86 132.41 13.01 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.808 1.289 . . . . 0.0 112.185 -169.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.9 175.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.665 1 C-N-CA 132.171 4.188 . . . . 0.0 106.583 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -103.98 140.97 36.98 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.853 2.461 . . . . 0.0 106.375 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' A' ' 121' ' ' ALA . . . -141.33 144.38 34.54 Favored 'General case' 0 C--N 1.381 1.978 1 N-CA-C 122.934 4.42 . . . . 0.0 122.934 -174.871 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.5 p -156.41 175.84 13.49 Favored 'General case' 0 C--N 1.364 1.199 1 C-N-CA 133.883 4.873 . . . . 0.0 104.094 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.38 40.33 0.75 Allowed Glycine 0 C--N 1.365 2.183 0 C-N-CA 125.858 1.694 . . . . 0.0 117.232 167.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.06 30.67 25.12 Favored Glycine 0 C--N 1.361 1.944 0 C-N-CA 127.616 2.531 . . . . 0.0 116.164 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.449 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 63.5 m -117.44 110.9 18.58 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 113.653 -3.07 . . . . 0.0 108.351 175.118 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.79 -86.73 0.54 Allowed Glycine 0 C--N 1.383 3.15 0 CA-C-N 124.837 3.471 . . . . 0.0 110.172 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 101' ' ' THR . 23.9 Cg_exo -59.86 168.13 6.12 Favored 'Trans proline' 0 CA--C 1.57 2.291 1 C-N-CA 126.102 4.535 . . . . 0.0 115.364 157.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.488 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 78.4 m-85 -105.97 145.13 31.72 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 119.798 3.259 . . . . 0.0 119.798 -164.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.6 t -103.02 141.51 35.68 Favored 'General case' 0 C--N 1.378 1.837 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -140.13 160.98 38.74 Favored 'General case' 0 C--N 1.347 0.466 1 N-CA-C 121.923 4.045 . . . . 0.0 121.923 -160.133 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -136.2 120.89 18.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.674 2.79 . . . . 0.0 105.796 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -112.05 132.8 54.6 Favored 'General case' 0 C--N 1.366 1.29 0 C-N-CA 125.178 1.391 . . . . 0.0 111.574 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.89 169.69 17.58 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 123.252 1.501 . . . . 0.0 107.334 172.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.429 ' HD3' ' CE1' ' A' ' 136' ' ' TYR . 13.0 ttpp -142.79 105.7 4.53 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.22 1.7 t70 34.91 53.63 0.66 Allowed 'General case' 0 CA--C 1.472 -2.035 2 CA-C-O 109.685 -4.96 . . . . 0.0 123.473 140.739 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.09 -10.43 60.74 Favored Glycine 0 C--N 1.383 3.179 2 O-C-N 135.222 7.826 . . . . 0.0 119.365 -172.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.407 9.8 p -124.89 147.15 55.6 Favored Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 130.607 3.563 . . . . 0.0 120.586 -167.724 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -63.8 139.72 70.17 Favored 'Trans proline' 0 N--CA 1.499 1.817 1 C-N-CA 126.484 4.789 . . . . 0.0 116.933 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -89.51 164.27 30.23 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 119.237 -2.164 . . . . 0.0 115.568 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -72.05 82.9 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 125.119 3.879 . . . . 0.0 115.009 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 74.52 -61.06 0.5 Allowed 'General case' 0 C--N 1.36 1.05 0 C-N-CA 126.626 1.97 . . . . 0.0 115.846 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 79.16 176.21 0.14 Allowed 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 130.3 3.44 . . . . 0.0 114.805 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 74.55 70.08 0.1 Allowed 'General case' 0 C--N 1.356 0.864 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.752 173.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -154.77 -53.11 0.01 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 120.078 2.791 . . . . 0.0 120.078 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.405 ' HB3' ' CB ' ' A' ' 97' ' ' ALA 0.292 . . 131.94 -65.87 0.0 OUTLIER 'General case' 0 C--N 1.351 0.634 0 C-N-CA 127.129 2.172 . . . . 0.0 107.777 -176.017 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.27 14.7 t -137.53 108.84 6.86 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-N 120.475 1.489 . . . . 0.0 113.688 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.289 0.2 OUTLIER -128.02 140.25 52.08 Favored 'General case' 0 C--N 1.372 1.567 0 C-N-CA 127.881 2.472 . . . . 0.0 111.846 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.8 m -129.39 139.75 51.57 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 119.909 -1.745 . . . . 0.0 111.596 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 105.27 56.68 Favored Pre-proline 0 C--N 1.358 0.949 0 C-N-CA 129.377 3.071 . . . . 0.0 105.966 173.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -75.56 -11.51 20.47 Favored 'Trans proline' 0 C--N 1.353 0.782 1 C-N-CA 125.745 4.297 . . . . 0.0 112.819 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 62.1 m -157.93 105.65 1.99 Allowed 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.405 ' HB1' ' CD2' ' A' ' 91' ' ' LEU . . . -94.17 118.9 32.22 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.313 1.045 . . . . 0.0 112.825 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.97 -176.98 6.2 Favored 'General case' 0 C--N 1.367 1.351 0 C-N-CA 127.131 2.173 . . . . 0.0 109.236 172.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.12 -54.19 14.08 Favored 'General case' 0 C--N 1.368 1.384 0 O-C-N 118.273 -2.767 . . . . 0.0 117.209 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.8 0.79 1.58 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 128.692 2.797 . . . . 0.0 115.58 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -116.43 -18.33 10.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 129.299 3.04 . . . . 0.0 111.347 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.65 164.74 13.29 Favored 'General case' 0 C--N 1.397 2.655 0 CA-C-N 122.534 2.424 . . . . 0.0 116.673 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.24 -155.08 25.42 Favored Glycine 0 CA--C 1.459 -3.446 0 C-N-CA 127.107 2.289 . . . . 0.0 109.012 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.351 9.3 m -113.49 133.41 55.23 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 111.912 -3.915 . . . . 0.0 108.595 166.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.429 ' CE1' ' HD3' ' A' ' 110' ' ' LYS 0.252 21.1 m-85 -96.26 135.2 38.41 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 122.228 2.285 . . . . 0.0 110.984 -170.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.77 147.52 31.97 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 123.982 0.913 . . . . 0.0 108.908 -176.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.656 ' CG1' ' HG ' ' A' ' 150' ' ' SER . 10.4 p -138.76 137.38 42.95 Favored 'Isoleucine or valine' 0 C--N 1.365 1.267 0 C-N-CA 118.189 -1.404 . . . . 0.0 113.402 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 113.89 27.74 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 129.29 3.036 . . . . 0.0 105.848 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.98 119.68 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.936 1.694 . . . . 0.0 110.513 -171.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' A' ' 146' ' ' VAL . 5.2 m -106.24 133.1 51.47 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.228 -1.545 . . . . 0.0 113.719 -176.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.488 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.328 15.6 p-10 -126.21 179.43 5.26 Favored 'General case' 0 C--N 1.376 1.757 0 C-N-CA 124.164 0.986 . . . . 0.0 111.971 174.923 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 13.1 p -49.18 2.29 0.01 OUTLIER 'General case' 0 C--N 1.375 1.677 1 C-N-CA 136.971 6.108 . . . . 0.0 119.306 -170.768 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -101.28 4.24 41.53 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 165.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.523 0.9 OUTLIER 62.89 39.87 10.12 Favored 'General case' 0 C--N 1.372 1.554 1 C-N-CA 134.266 5.026 . . . . 0.0 112.715 -172.692 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 141' ' ' THR . 4.6 m -112.85 128.37 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.858 0 CA-C-N 111.596 -2.547 . . . . 0.0 111.882 -170.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.02 123.0 35.06 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.456 1.902 . . . . 0.0 106.777 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 157.74 24.56 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 128.031 2.532 . . . . 0.0 104.804 -174.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.415 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 27.3 t70 -125.06 140.32 53.0 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.708 1.242 . . . . 0.0 108.205 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.656 ' HG ' ' CG1' ' A' ' 138' ' ' VAL 0.486 44.6 p -116.98 144.05 45.01 Favored 'General case' 0 C--O 1.254 1.334 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.257 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 m -54.11 147.98 11.84 Favored 'General case' 0 CA--C 1.478 -1.789 2 C-N-CA 138.798 6.839 . . . . 0.0 118.049 -159.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 73.6 p -68.29 109.77 3.76 Favored 'General case' 0 C--N 1.367 1.348 0 C-N-CA 124.486 1.114 . . . . 0.0 111.907 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . 0.403 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -95.22 108.49 20.63 Favored 'General case' 0 C--N 1.373 1.608 0 N-CA-C 102.653 -3.092 . . . . 0.0 102.653 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.53 113.72 25.48 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 123.732 1.729 . . . . 0.0 111.152 -172.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.33 116.21 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 97.7 m -111.24 128.26 55.87 Favored 'General case' 0 C--N 1.372 1.549 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.1 m -123.17 108.37 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 CA-C-O 123.78 1.752 . . . . 0.0 111.669 -176.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -85.25 155.99 60.04 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.243 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.3 166.3 29.72 Favored 'Trans proline' 0 C--N 1.359 1.124 1 C-N-CA 126.931 5.087 . . . . 0.0 107.418 154.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.3 p -66.86 132.46 48.05 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 118.515 -2.616 . . . . 0.0 109.169 -172.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.81 124.8 87.47 Favored Pre-proline 0 C--N 1.366 1.283 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 -127.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.16 154.82 60.2 Favored 'Trans proline' 0 C--N 1.386 2.518 1 C-N-CA 126.641 4.894 . . . . 0.0 114.994 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.12 50.89 0.75 Allowed Glycine 0 C--N 1.367 2.279 0 C-N-CA 127.426 2.441 . . . . 0.0 118.019 -177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -110.6 32.39 6.63 Favored Glycine 0 C--N 1.355 1.632 0 C-N-CA 127.776 2.608 . . . . 0.0 110.872 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 67.6 mt -119.21 43.52 2.57 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 127.249 2.219 . . . . 0.0 106.422 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.42 52.67 0.08 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 129.504 3.122 . . . . 0.0 117.011 -173.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.352 0.709 0 C-N-CA 128.854 2.861 . . . . 0.0 109.46 -179.569 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.262 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -108.45 121.36 44.79 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.364 1.466 . . . . 0.0 108.849 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.456 ' HG1' ' CA ' ' A' ' 78' ' ' ASP . 8.0 t -106.2 173.64 6.23 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.444 1.898 . . . . 0.0 108.844 178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.315 0.9 OUTLIER -72.05 98.14 2.03 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 122.332 1.063 . . . . 0.0 110.536 173.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.26 -77.26 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.584 0 O-C-N 117.87 -3.019 . . . . 0.0 115.487 -168.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -132.97 141.11 48.14 Favored 'General case' 0 C--N 1.362 1.137 1 C-N-CA 133.178 4.591 . . . . 0.0 105.139 172.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.456 ' CA ' ' HG1' ' A' ' 74' ' ' THR 0.293 12.1 t70 -82.85 171.56 13.78 Favored 'General case' 0 C--N 1.344 0.362 1 C-N-CA 131.88 4.072 . . . . 0.0 109.854 -179.671 . . . . . . . . 4 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.43 -27.74 63.5 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -171.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER -175.09 -177.02 1.01 Allowed 'General case' 0 N--CA 1.476 0.83 1 N-CA-C 98.716 -4.549 . . . . 0.0 98.716 162.75 . . . . . . . . 4 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.86 -53.09 2.67 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 119.567 -1.958 . . . . 0.0 106.767 162.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.0 p -168.91 128.92 1.12 Allowed 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.037 -1.664 . . . . 0.0 115.079 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.0 tpt -124.95 123.45 39.92 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-N 120.81 1.641 . . . . 0.0 111.247 167.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.2 t -112.05 116.73 31.01 Favored 'General case' 0 C--N 1.374 1.652 0 O-C-N 119.724 -1.86 . . . . 0.0 107.273 171.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.438 HG22 ' O ' ' A' ' 86' ' ' GLU . 7.8 p -149.67 173.7 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 112.065 -2.334 . . . . 0.0 109.981 -173.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.438 ' O ' HG22 ' A' ' 85' ' ' VAL . 12.0 pt-20 -76.55 144.7 39.51 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 126.302 1.841 . . . . 0.0 106.609 158.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.417 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.436 0.0 OUTLIER -44.42 121.97 2.84 Favored 'General case' 0 N--CA 1.515 2.807 0 O-C-N 117.376 -3.327 . . . . 0.0 118.339 -168.027 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 129.74 55.49 0.1 OUTLIER Glycine 0 C--N 1.36 1.866 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.651 -155.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.5 165.23 12.85 Favored 'General case' 0 C--N 1.369 1.413 0 O-C-N 120.643 -1.504 . . . . 0.0 110.487 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.93 100.96 9.84 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-O 123.17 1.462 . . . . 0.0 113.393 -173.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mp -119.36 127.23 52.96 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 125.113 1.365 . . . . 0.0 111.835 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.8 t -116.04 115.3 25.88 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 168.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.12 112.0 24.71 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 103.04 -2.948 . . . . 0.0 103.04 173.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.9 t -146.35 131.2 18.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.621 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.1 m -150.54 174.23 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.649 1 C-N-CA 131.789 4.035 . . . . 0.0 103.565 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.3 t -106.38 140.39 39.37 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 122.096 2.225 . . . . 0.0 106.976 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.71 142.61 36.85 Favored 'General case' 0 C--N 1.379 1.863 0 N-CA-C 121.021 3.712 . . . . 0.0 121.021 -174.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.2 p -156.29 175.54 13.86 Favored 'General case' 0 C--N 1.367 1.346 1 C-N-CA 134.365 5.066 . . . . 0.0 103.352 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.73 39.77 0.78 Allowed Glycine 0 C--N 1.368 2.31 0 O-C-N 119.514 -1.991 . . . . 0.0 117.649 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.19 26.08 49.49 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 128.459 2.933 . . . . 0.0 114.427 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.41 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 7.2 p -116.88 109.84 17.58 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 116.249 -1.834 . . . . 0.0 107.856 178.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.726 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.01 -91.07 0.51 Allowed Glycine 0 C--N 1.374 2.643 0 C-N-CA 129.073 3.225 . . . . 0.0 111.053 -167.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 101' ' ' THR . 22.9 Cg_exo -60.22 169.16 5.29 Favored 'Trans proline' 0 CA--C 1.566 2.111 1 C-N-CA 127.993 5.795 . . . . 0.0 116.968 160.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.449 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 75.1 m-85 -94.58 146.27 24.24 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -168.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -102.69 140.78 36.53 Favored 'General case' 0 C--N 1.382 2.013 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -135.46 139.84 44.38 Favored 'General case' 0 C--N 1.352 0.691 1 N-CA-C 123.668 4.692 . . . . 0.0 123.668 -158.356 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.07 111.56 14.83 Favored 'General case' 0 C--N 1.371 1.533 0 C-N-CA 126.403 1.881 . . . . 0.0 107.238 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TRP . . . . . 0.4 ' CE2' HG22 ' A' ' 138' ' ' VAL . 76.4 m95 -113.06 145.14 41.42 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.053 1.741 . . . . 0.0 111.405 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.32 0.0 OUTLIER -157.95 156.38 31.16 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 164.211 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.439 ' HB2' ' HZ3' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -128.05 102.84 6.91 Favored 'General case' 0 C--N 1.37 1.493 0 C-N-CA 117.271 -1.771 . . . . 0.0 113.517 175.962 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . 1.231 2.5 t70 36.94 54.53 1.19 Allowed 'General case' 0 CA--C 1.456 -2.656 1 CA-C-O 110.772 -4.442 . . . . 0.0 120.837 152.829 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.19 -11.49 63.74 Favored Glycine 0 C--N 1.37 2.462 2 O-C-N 133.928 7.018 . . . . 0.0 116.041 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.262 3.6 m -123.96 149.16 59.14 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 131.216 3.806 . . . . 0.0 117.161 -168.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.15 152.32 80.27 Favored 'Trans proline' 0 N--CA 1.494 1.544 1 C-N-CA 125.473 4.115 . . . . 0.0 116.211 169.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.04 157.76 33.51 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.469 1.508 . . . . 0.0 109.243 174.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -62.64 -75.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.839 1 C-N-CA 126.039 4.493 . . . . 0.0 116.773 -170.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -102.86 -34.46 8.97 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.267 1.427 . . . . 0.0 111.281 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 75.93 -72.36 0.11 Allowed 'General case' 0 CA--C 1.486 -1.512 0 C-N-CA 130.075 3.35 . . . . 0.0 114.393 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.348 5.2 t -81.82 72.64 8.87 Favored 'General case' 0 N--CA 1.416 -2.155 1 C-N-CA 133.627 4.771 . . . . 0.0 111.348 -175.108 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.23 -41.5 0.02 OUTLIER Glycine 0 CA--C 1.469 -2.794 0 N-CA-C 122.072 3.589 . . . . 0.0 122.072 -168.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.301 . . 105.16 -62.57 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.505 1.522 . . . . 0.0 110.151 179.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.296 15.3 t -136.49 96.33 3.33 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-O 122.622 1.201 . . . . 0.0 113.841 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -126.5 138.0 53.44 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 127.121 2.169 . . . . 0.0 107.823 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 91.5 m -128.92 133.2 47.78 Favored 'General case' 0 CA--C 1.478 -1.789 0 O-C-N 119.536 -1.977 . . . . 0.0 106.256 -176.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.83 93.22 8.49 Favored Pre-proline 0 C--N 1.359 1.018 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.69 -11.83 26.27 Favored 'Trans proline' 0 C--N 1.348 0.544 1 C-N-CA 125.525 4.15 . . . . 0.0 111.048 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' THR . . . . . . . . . . . . . 1.2 m -161.62 104.29 1.22 Allowed 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 -179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -87.16 133.48 33.63 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.253 2.621 . . . . 0.0 113.119 176.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.11 178.92 5.72 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 128.995 2.918 . . . . 0.0 110.683 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.13 -45.3 32.99 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 118.937 2.94 . . . . 0.0 118.937 -174.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -66.88 -17.59 64.97 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 126.855 2.062 . . . . 0.0 114.205 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -82.05 -14.26 56.13 Favored 'General case' 0 CA--C 1.573 1.854 0 C-N-CA 128.52 2.728 . . . . 0.0 111.361 170.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.28 127.15 32.03 Favored 'General case' 0 C--N 1.393 2.48 0 N-CA-C 119.474 3.139 . . . . 0.0 119.474 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.18 -147.9 18.01 Favored Glycine 0 CA--C 1.473 -2.542 0 C-N-CA 128.404 2.907 . . . . 0.0 108.651 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.408 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.265 21.1 m -125.46 140.08 53.09 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 114.47 -2.892 . . . . 0.0 109.533 173.317 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 16.9 m-85 -95.91 134.52 38.8 Favored 'General case' 0 C--N 1.367 1.361 0 O-C-N 118.722 -2.486 . . . . 0.0 112.456 -172.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . 0.408 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -142.45 146.68 35.07 Favored 'General case' 0 C--N 1.368 1.393 0 C-N-CA 123.993 0.917 . . . . 0.0 108.602 -174.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . 0.4 HG22 ' CE2' ' A' ' 108' ' ' TRP 0.251 13.4 p -146.99 139.95 19.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.185 0 C-N-CA 118.64 -1.224 . . . . 0.0 114.144 176.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.48 115.67 27.63 Favored 'General case' 0 C--N 1.375 1.702 0 C-N-CA 127.22 2.208 . . . . 0.0 106.321 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.09 116.46 44.51 Favored 'Isoleucine or valine' 0 C--N 1.369 1.444 0 C-N-CA 127.996 2.518 . . . . 0.0 112.155 -171.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.0 m -99.12 132.89 44.11 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.449 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.424 16.2 p-10 -126.58 -176.93 3.82 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-N 120.769 1.622 . . . . 0.0 112.171 173.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.726 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 77.5 p -49.58 3.3 0.01 OUTLIER 'General case' 0 C--N 1.36 1.025 1 C-N-CA 136.634 5.973 . . . . 0.0 121.279 -165.15 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.29 4.47 36.57 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 164.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.422 81.0 mm-40 65.52 40.01 4.79 Favored 'General case' 0 C--N 1.374 1.659 1 C-N-CA 132.874 4.47 . . . . 0.0 111.183 -172.55 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.4 m -112.64 130.09 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.754 -172.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.59 124.57 35.14 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 128.742 2.817 . . . . 0.0 107.733 -177.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.69 152.89 32.34 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 45.8 p30 -130.56 147.14 52.21 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 123.061 1.41 . . . . 0.0 112.455 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.283 9.9 p -119.15 144.75 46.49 Favored 'General case' 0 C--O 1.259 1.58 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.277 168.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.8 m -55.12 148.83 13.29 Favored 'General case' 0 CA--C 1.478 -1.804 3 C-N-CA 140.098 7.359 . . . . 0.0 115.101 -172.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 72.5 p -68.58 109.86 3.95 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 127.835 2.454 . . . . 0.0 109.49 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 108.92 21.07 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 102.274 -3.232 . . . . 0.0 102.274 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.88 112.74 24.81 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 122.426 1.108 . . . . 0.0 111.502 -172.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.0 m -121.61 118.37 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 58.5 m -119.36 122.79 42.61 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.417 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 3.8 m -123.55 105.02 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -82.72 155.94 68.06 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.756 1.622 . . . . 0.0 110.951 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.98 165.81 31.14 Favored 'Trans proline' 0 CA--C 1.547 1.126 1 C-N-CA 126.179 4.586 . . . . 0.0 107.891 154.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 10.7 p -67.2 125.12 25.04 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 118.598 -2.564 . . . . 0.0 109.063 -172.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 9.1 p -66.53 117.95 49.23 Favored Pre-proline 0 C--N 1.366 1.285 1 N-CA-C 122.696 4.332 . . . . 0.0 122.696 -125.018 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -62.73 143.56 92.36 Favored 'Trans proline' 0 C--N 1.382 2.31 1 C-N-CA 125.988 4.459 . . . . 0.0 114.604 171.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.28 56.28 0.44 Allowed Glycine 0 C--N 1.367 2.302 0 C-N-CA 128.107 2.765 . . . . 0.0 117.48 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -120.92 -120.48 2.75 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 128.201 2.81 . . . . 0.0 106.922 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 28.8 mt 68.78 42.08 1.46 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 128.342 2.657 . . . . 0.0 111.009 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -69.82 65.24 0.22 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.998 2.519 . . . . 0.0 116.5 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 . . . . . 0 C--N 1.357 0.916 0 C-N-CA 129.045 2.938 . . . . 0.0 114.152 -176.473 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.493 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.428 -1.56 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.3 m -172.57 173.38 4.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.48 -51.56 2.06 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 120.412 1.46 . . . . 0.0 112.263 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.3 t -170.6 142.66 2.07 Favored 'General case' 0 C--N 1.363 1.18 0 O-C-N 119.415 -2.053 . . . . 0.0 114.339 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.6 118.78 19.62 Favored 'General case' 0 C--N 1.377 1.772 0 O-C-N 121.417 -0.802 . . . . 0.0 109.887 167.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -105.87 114.91 29.35 Favored 'General case' 0 C--N 1.376 1.746 0 O-C-N 120.459 -1.401 . . . . 0.0 109.18 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.8 p -150.93 173.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.688 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.249 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -79.96 143.51 34.1 Favored 'General case' 0 C--N 1.369 1.456 0 C-N-CA 127.259 2.224 . . . . 0.0 105.432 157.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.433 5.1 pt-20 -44.21 122.88 3.15 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 117.338 -3.352 . . . . 0.0 118.626 -166.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.63 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 129.0 51.75 0.12 Allowed Glycine 0 C--N 1.352 1.467 0 C-N-CA 128.908 3.147 . . . . 0.0 110.741 -163.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.76 162.34 22.96 Favored 'General case' 0 C--N 1.375 1.689 0 C-N-CA 124.957 1.303 . . . . 0.0 112.339 171.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.91 105.87 14.43 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 124.628 1.171 . . . . 0.0 111.635 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.479 HD23 ' CZ ' ' A' ' 136' ' ' TYR 0.252 2.3 mp -119.73 129.88 54.72 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -173.255 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -114.87 137.93 51.39 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 166.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.623 HD11 ' CD1' ' A' ' 136' ' ' TYR . 3.9 mm? -113.69 115.62 28.15 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 102.104 -3.295 . . . . 0.0 102.104 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.493 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 2.5 t -154.62 132.47 11.52 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 120.933 1.697 . . . . 0.0 114.098 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 m -150.22 174.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.011 1 C-N-CA 133.643 4.777 . . . . 0.0 106.822 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.0 t -104.36 141.73 35.8 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 127.637 2.375 . . . . 0.0 106.734 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -139.2 145.95 39.93 Favored 'General case' 0 C--N 1.379 1.856 1 N-CA-C 123.228 4.529 . . . . 0.0 123.228 -174.25 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.4 p -156.58 175.49 13.97 Favored 'General case' 0 C--N 1.365 1.248 1 C-N-CA 133.34 4.656 . . . . 0.0 104.391 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.51 42.11 1.02 Allowed Glycine 0 C--N 1.365 2.162 0 O-C-N 119.802 -1.811 . . . . 0.0 117.318 168.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.18 28.35 28.28 Favored Glycine 0 C--N 1.361 1.966 0 C-N-CA 127.616 2.531 . . . . 0.0 115.412 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.406 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 59.3 m -117.67 110.88 18.42 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 114.217 -2.801 . . . . 0.0 108.453 174.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.91 -86.21 0.56 Allowed Glycine 0 C--N 1.38 3.007 0 C-N-CA 129.249 3.309 . . . . 0.0 110.389 -176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 101' ' ' THR . 20.0 Cg_exo -59.88 168.38 5.83 Favored 'Trans proline' 0 CA--C 1.57 2.312 1 C-N-CA 126.164 4.576 . . . . 0.0 115.676 158.107 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.559 ' HB3' HG12 ' A' ' 140' ' ' VAL . 77.7 m-85 -106.31 146.09 30.83 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 119.892 3.293 . . . . 0.0 119.892 -163.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.9 t -103.34 142.65 33.85 Favored 'General case' 0 C--N 1.38 1.928 0 C-N-CA 127.879 2.472 . . . . 0.0 104.358 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -142.43 165.4 27.5 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 122.783 4.364 . . . . 0.0 122.783 -161.555 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.42 119.06 18.09 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 128.265 2.626 . . . . 0.0 105.083 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -109.62 136.41 49.02 Favored 'General case' 0 C--N 1.368 1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 110.55 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.91 169.87 18.25 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 122.717 1.246 . . . . 0.0 107.69 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -144.73 105.64 4.17 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 175.435 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.469 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.16 1.8 t70 35.05 52.95 0.66 Allowed 'General case' 0 C--N 1.377 1.785 1 N-CA-C 122.307 4.188 . . . . 0.0 122.307 139.829 . . . . . . . . 4 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.45 -4.77 85.86 Favored Glycine 0 C--N 1.369 2.384 2 O-C-N 133.53 6.769 . . . . 0.0 119.206 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.269 3.5 m -124.45 147.46 55.42 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 129.532 3.133 . . . . 0.0 118.329 -171.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.01 145.05 84.46 Favored 'Trans proline' 0 N--CA 1.493 1.498 1 C-N-CA 125.882 4.388 . . . . 0.0 114.722 171.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.09 159.04 30.57 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 118.739 -2.476 . . . . 0.0 112.244 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -67.42 87.73 0.33 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 125.247 3.965 . . . . 0.0 116.177 -175.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 74.62 -57.22 0.62 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 127.372 2.269 . . . . 0.0 115.425 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 74.13 174.83 0.26 Allowed 'General case' 0 CA--C 1.482 -1.657 0 C-N-CA 130.189 3.396 . . . . 0.0 116.494 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.408 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.3 OUTLIER 75.6 71.87 0.09 Allowed 'General case' 0 C--N 1.356 0.867 0 CA-C-N 114.114 -1.403 . . . . 0.0 114.735 171.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.42 -67.92 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 117.382 1.713 . . . . 0.0 117.382 -172.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 150.32 -69.86 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 126.503 1.921 . . . . 0.0 106.74 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.284 13.6 t -135.38 109.87 8.51 Favored 'General case' 0 C--N 1.363 1.153 0 CA-C-O 123.35 1.548 . . . . 0.0 113.878 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.368 9.1 p90 -127.23 142.12 51.56 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 129.473 3.109 . . . . 0.0 112.716 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.5 m -128.28 139.57 52.35 Favored 'General case' 0 C--N 1.366 1.288 0 O-C-N 119.323 -2.11 . . . . 0.0 110.305 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 100.23 44.33 Favored Pre-proline 0 C--N 1.366 1.324 0 C-N-CA 128.708 2.803 . . . . 0.0 106.411 175.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.26 -17.1 15.11 Favored 'Trans proline' 0 C--N 1.353 0.814 1 C-N-CA 126.096 4.531 . . . . 0.0 114.061 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.63 HG23 ' HA2' ' A' ' 88' ' ' GLY . 52.4 m -156.11 102.48 2.14 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 102.596 -3.113 . . . . 0.0 102.596 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.549 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.79 133.33 34.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.623 1.969 . . . . 0.0 111.499 175.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.5 -179.52 4.92 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.193 2.597 . . . . 0.0 111.027 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.02 -49.0 32.57 Favored 'General case' 0 C--N 1.366 1.305 0 N-CA-C 119.194 3.035 . . . . 0.0 119.194 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.35 -10.26 57.11 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 126.335 1.854 . . . . 0.0 114.53 173.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.549 ' CB ' ' HB1' ' A' ' 128' ' ' ALA 0.366 48.7 m-20 -80.41 -18.31 49.26 Favored 'General case' 0 CA--C 1.572 1.793 0 C-N-CA 129.581 3.152 . . . . 0.0 111.84 168.092 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.64 126.49 29.1 Favored 'General case' 0 C--N 1.387 2.212 0 N-CA-C 119.536 3.161 . . . . 0.0 119.536 168.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 160.44 -157.5 28.89 Favored Glycine 0 CA--C 1.459 -3.446 0 C-N-CA 127.117 2.294 . . . . 0.0 109.694 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 m -120.63 129.7 53.84 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 115.004 -2.679 . . . . 0.0 108.235 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.623 ' CD1' HD11 ' A' ' 93' ' ' LEU 0.274 30.1 m-85 -95.21 134.85 37.5 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 130.163 3.385 . . . . 0.0 111.651 -170.083 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.469 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -147.02 153.87 40.54 Favored 'General case' 0 C--N 1.369 1.429 0 C-N-CA 125.509 1.524 . . . . 0.0 108.202 -173.515 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 150' ' ' SER 0.43 2.4 p -143.58 134.3 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 117.677 -1.609 . . . . 0.0 114.339 -178.53 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.42 109.22 21.01 Favored 'General case' 0 C--N 1.385 2.132 0 C-N-CA 129.669 3.188 . . . . 0.0 106.345 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -127.7 118.62 49.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 C-N-CA 125.482 1.513 . . . . 0.0 111.037 -168.344 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 146' ' ' VAL . 11.1 m -104.32 130.86 52.14 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 120.451 -1.406 . . . . 0.0 113.552 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.497 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.344 18.9 p-10 -124.99 -176.58 3.59 Favored 'General case' 0 C--N 1.379 1.853 0 C-N-CA 124.312 1.045 . . . . 0.0 111.909 175.653 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 6.2 p -48.84 2.73 0.01 OUTLIER 'General case' 0 C--N 1.372 1.574 1 C-N-CA 137.428 6.291 . . . . 0.0 119.867 -168.01 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.76 4.29 35.04 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 118.16 -1.416 . . . . 0.0 107.678 163.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.435 93.6 mm-40 65.54 40.3 4.63 Favored 'General case' 0 C--N 1.374 1.662 1 C-N-CA 132.736 4.414 . . . . 0.0 110.783 -172.164 . . . . . . . . 3 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.413 ' C ' HG23 ' A' ' 141' ' ' THR . 3.1 m -112.9 129.36 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 CA-C-N 111.944 -2.389 . . . . 0.0 112.201 -171.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.19 124.12 35.16 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 127.68 2.392 . . . . 0.0 108.205 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 157.43 25.23 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 128.308 2.643 . . . . 0.0 105.375 -173.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -121.46 132.09 54.53 Favored 'General case' 0 C--N 1.358 0.943 0 CA-C-O 124.611 2.148 . . . . 0.0 108.892 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.755 ' HB2' HG13 ' A' ' 138' ' ' VAL . 51.1 m -108.26 147.84 30.85 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 111.509 -2.587 . . . . 0.0 106.942 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.5 m -52.95 146.92 10.05 Favored 'General case' 0 CA--C 1.49 -1.36 1 C-N-CA 135.012 5.325 . . . . 0.0 119.477 -159.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.1 p -70.69 111.04 5.86 Favored 'General case' 0 C--N 1.368 1.403 0 C-N-CA 127.317 2.247 . . . . 0.0 109.321 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.74 110.46 22.77 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 102.214 -3.254 . . . . 0.0 102.214 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.24 113.37 25.6 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 123.247 1.499 . . . . 0.0 112.092 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.67 128.39 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 O-C-N 119.99 -1.694 . . . . 0.0 109.281 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 102.508 -3.145 . . . . 0.0 102.508 178.267 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.571 1.785 0 CA-C-O 120.828 0.347 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.0 m -161.93 172.0 16.75 Favored 'General case' 0 C--N 1.347 0.465 0 O-C-N 116.835 -3.666 . . . . 0.0 103.856 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.72 -43.24 1.0 Allowed 'General case' 0 C--N 1.363 1.187 0 C-N-CA 126.792 2.037 . . . . 0.0 113.359 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.2 p -172.24 127.98 0.57 Allowed 'General case' 0 C--N 1.366 1.319 0 N-CA-C 118.426 2.751 . . . . 0.0 118.426 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.7 tpt -142.4 116.12 9.21 Favored 'General case' 0 C--N 1.377 1.785 0 CA-C-N 120.985 1.721 . . . . 0.0 109.909 162.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.4 p -112.81 116.39 29.99 Favored 'General case' 0 C--N 1.364 1.201 0 O-C-N 118.719 -2.488 . . . . 0.0 110.178 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.59 172.04 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 125.951 1.7 . . . . 0.0 110.331 -170.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -83.27 130.21 35.06 Favored 'General case' 0 C--N 1.373 1.615 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 164.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -41.73 122.4 1.99 Allowed 'General case' 0 C--N 1.372 1.555 0 N-CA-C 120.469 3.507 . . . . 0.0 120.469 -151.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.436 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 145.57 45.75 0.04 OUTLIER Glycine 0 C--N 1.363 2.052 0 CA-C-N 110.292 -3.14 . . . . 0.0 110.993 -166.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.64 165.7 17.71 Favored 'General case' 0 C--N 1.375 1.712 0 C-N-CA 125.336 1.454 . . . . 0.0 113.527 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.99 105.68 14.16 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 124.525 1.13 . . . . 0.0 110.85 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.443 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 4.5 mp -119.58 119.92 35.19 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.87 1.668 . . . . 0.0 114.388 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.87 127.04 53.69 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 173.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -123.78 114.73 20.29 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 173.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.9 m -151.18 132.94 14.96 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 119.63 -1.919 . . . . 0.0 110.909 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 m -148.97 175.18 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.406 0 C-N-CA 130.423 3.489 . . . . 0.0 104.605 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -104.24 139.39 39.33 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 127.511 2.324 . . . . 0.0 105.555 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.59 137.03 31.62 Favored 'General case' 0 C--N 1.379 1.891 1 N-CA-C 122.502 4.26 . . . . 0.0 122.502 -173.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.1 p -156.52 174.72 15.02 Favored 'General case' 0 C--N 1.359 0.991 1 C-N-CA 133.904 4.882 . . . . 0.0 101.25 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.66 40.7 1.37 Allowed Glycine 0 C--N 1.363 2.076 0 N-CA-C 118.102 2.001 . . . . 0.0 118.102 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.53 25.1 28.93 Favored Glycine 0 C--N 1.36 1.91 0 C-N-CA 127.8 2.619 . . . . 0.0 114.458 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 29.8 p -116.55 110.32 18.4 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 113.089 -3.339 . . . . 0.0 107.876 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.574 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 69.13 -86.93 0.23 Allowed Glycine 0 C--N 1.382 3.089 0 C-N-CA 130.014 3.674 . . . . 0.0 111.117 -170.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.91 168.88 5.2 Favored 'Trans proline' 0 CA--C 1.571 2.37 1 C-N-CA 127.514 5.476 . . . . 0.0 116.957 160.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.566 ' HB3' HG12 ' A' ' 140' ' ' VAL . 66.8 m-85 -98.6 144.27 28.08 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 119.758 3.244 . . . . 0.0 119.758 -167.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 t -102.51 159.16 15.68 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.438 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.5 OUTLIER -157.17 166.32 33.55 Favored 'General case' 0 C--N 1.365 1.255 0 N-CA-C 120.508 3.521 . . . . 0.0 120.508 -164.679 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.84 112.5 10.08 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 128.398 2.679 . . . . 0.0 105.846 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.456 ' HB2' HG13 ' A' ' 115' ' ' ILE . 7.4 m95 -112.64 142.73 44.89 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 125.346 1.458 . . . . 0.0 108.041 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.29 0.0 OUTLIER -158.25 161.36 37.74 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 166.299 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HZ1' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -133.01 103.89 6.27 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 116.717 -1.993 . . . . 0.0 115.873 177.179 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.458 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.226 1.7 t70 36.99 54.68 1.21 Allowed 'General case' 0 CA--C 1.455 -2.68 1 CA-C-O 111.111 -4.28 . . . . 0.0 119.918 154.075 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.11 -15.28 58.03 Favored Glycine 0 C--N 1.369 2.365 2 O-C-N 134.153 7.158 . . . . 0.0 116.681 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.424 ' HB3' ' HE2' ' A' ' 110' ' ' LYS 0.271 26.6 m -124.23 148.92 59.27 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 129.863 3.265 . . . . 0.0 116.909 -167.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.32 155.86 43.99 Favored 'Trans proline' 0 N--CA 1.502 2.01 1 C-N-CA 126.644 4.896 . . . . 0.0 116.323 171.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.456 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -104.58 147.53 34.56 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 119.539 -1.976 . . . . 0.0 110.162 174.935 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -58.8 -76.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.919 1 C-N-CA 126.504 4.802 . . . . 0.0 120.377 -165.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -141.54 64.75 1.4 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.83 -172.72 4.13 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 126.788 2.035 . . . . 0.0 115.498 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.309 8.4 t 101.79 13.13 0.01 OUTLIER 'General case' 0 C--N 1.354 0.783 0 C-N-CA 129.076 2.95 . . . . 0.0 111.825 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.81 96.75 0.1 Allowed Glycine 0 CA--C 1.475 -2.431 0 C-N-CA 116.733 -2.651 . . . . 0.0 117.687 166.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.481 . . 84.26 -84.52 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 170.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.9 t -138.92 121.1 15.8 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 122.316 2.325 . . . . 0.0 115.609 -170.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -127.66 139.69 52.56 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 127.638 2.375 . . . . 0.0 110.745 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 91' ' ' LEU . 35.1 m -129.76 139.91 51.18 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 119.33 -2.106 . . . . 0.0 109.774 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.35 98.04 41.92 Favored Pre-proline 0 C--N 1.363 1.159 0 C-N-CA 127.638 2.375 . . . . 0.0 107.316 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.12 -16.5 15.69 Favored 'Trans proline' 0 C--N 1.363 1.31 1 C-N-CA 126.635 4.89 . . . . 0.0 113.83 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.436 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -161.69 104.32 1.21 Allowed 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 102.426 -3.176 . . . . 0.0 102.426 177.512 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.458 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -90.74 134.37 34.47 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 128.382 2.673 . . . . 0.0 113.082 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.2 176.92 6.76 Favored 'General case' 0 C--N 1.37 1.473 0 C-N-CA 128.193 2.597 . . . . 0.0 111.031 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.9 -48.59 31.45 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 -172.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.8 -12.3 60.31 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 126.493 1.917 . . . . 0.0 114.65 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.581 ' HA ' ' HZ1' ' A' ' 110' ' ' LYS 0.354 32.0 m-20 -80.84 -18.64 46.77 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 129.873 3.269 . . . . 0.0 111.977 169.575 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.79 133.31 46.43 Favored 'General case' 0 C--N 1.379 1.882 0 N-CA-C 119.448 3.129 . . . . 0.0 119.448 166.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.47 -157.08 29.16 Favored Glycine 0 CA--C 1.461 -3.341 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 170.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.456 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.31 19.2 m -114.0 134.76 54.64 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 114.632 -2.827 . . . . 0.0 107.33 170.229 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.53 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 9.2 m-85 -96.66 133.5 41.11 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 122.014 2.188 . . . . 0.0 113.351 -172.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -140.95 145.6 36.25 Favored 'General case' 0 C--N 1.37 1.477 0 O-C-N 124.035 0.834 . . . . 0.0 109.458 -173.435 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.326 7.6 p -144.94 136.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.37 1.495 0 C-N-CA 118.289 -1.364 . . . . 0.0 113.834 176.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -104.31 118.05 35.68 Favored 'General case' 0 C--N 1.375 1.692 0 C-N-CA 130.081 3.352 . . . . 0.0 106.755 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.566 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -128.41 126.08 65.03 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 C-N-CA 127.572 2.349 . . . . 0.0 113.108 -173.404 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.48 HG23 ' C ' ' A' ' 146' ' ' VAL . 11.3 m -117.24 133.68 55.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 119.401 -2.062 . . . . 0.0 113.883 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.425 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.344 29.3 p-10 -126.46 -177.76 4.1 Favored 'General case' 0 C--N 1.376 1.725 0 CA-C-N 120.301 1.41 . . . . 0.0 112.798 174.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.574 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 66.2 p -49.64 3.75 0.01 OUTLIER 'General case' 0 C--N 1.366 1.324 1 C-N-CA 137.082 6.153 . . . . 0.0 121.01 -170.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -100.73 4.63 43.22 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 163.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.378 1.9 mp0 65.23 39.77 5.25 Favored 'General case' 0 C--N 1.379 1.86 1 C-N-CA 133.46 4.704 . . . . 0.0 110.783 -174.239 . . . . . . . . 3 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.48 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.11 127.81 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 CA-C-N 111.541 -2.572 . . . . 0.0 110.974 -169.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.71 128.13 37.42 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 126.982 2.113 . . . . 0.0 107.735 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.75 156.15 27.68 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 128.083 2.553 . . . . 0.0 104.577 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -130.62 146.48 52.13 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.69 -1.256 . . . . 0.0 109.688 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.5 p -129.71 142.95 50.62 Favored 'General case' 0 C--O 1.253 1.24 0 C-N-CA 123.173 0.589 . . . . 0.0 111.627 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 m -54.57 147.24 14.66 Favored 'General case' 0 C--N 1.376 1.758 2 C-N-CA 136.582 5.953 . . . . 0.0 117.108 -163.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.3 p -68.14 110.76 4.13 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 129.754 3.222 . . . . 0.0 109.844 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.08 108.75 21.55 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -93.96 106.9 18.86 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-O 124.324 2.012 . . . . 0.0 110.838 -172.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.52 126.81 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 O-C-N 120.675 -1.266 . . . . 0.0 108.11 -173.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.5 m . . . . . 0 CA--C 1.483 -1.618 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.817 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.535 HD13 ' SG ' ' A' ' 153' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.578 2.02 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.0 m -172.04 179.53 2.64 Favored 'General case' 0 N--CA 1.468 0.434 1 N-CA-C 99.647 -4.205 . . . . 0.0 99.647 173.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.51 -48.69 1.17 Allowed 'General case' 0 C--N 1.355 0.838 0 CA-C-N 121.508 1.958 . . . . 0.0 108.773 169.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.4 t -172.07 134.52 0.75 Allowed 'General case' 0 C--N 1.356 0.876 0 O-C-N 120.396 -1.44 . . . . 0.0 113.106 174.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 54.5 ttm -134.36 116.91 15.77 Favored 'General case' 0 C--N 1.369 1.446 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 162.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 p -108.57 115.36 29.95 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 119.727 -1.858 . . . . 0.0 107.327 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 p -149.62 174.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 125.88 1.672 . . . . 0.0 111.857 -165.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -79.22 134.2 36.67 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 126.959 2.104 . . . . 0.0 105.689 161.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.39 0.0 OUTLIER -43.63 122.88 2.87 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 -164.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.537 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 135.0 52.53 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 128.372 2.892 . . . . 0.0 107.654 -165.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.423 ' HB1' HG22 ' A' ' 155' ' ' VAL . . . -91.75 153.23 19.76 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 126.577 1.951 . . . . 0.0 108.932 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.15 110.72 21.68 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -166.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.442 HD13 ' CZ ' ' A' ' 136' ' ' TYR . 4.8 mt -120.62 144.44 48.14 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -126.86 138.51 53.34 Favored 'General case' 0 CA--C 1.506 -0.734 1 N-CA-C 100.165 -4.013 . . . . 0.0 100.165 166.347 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.4 HD23 ' CE3' ' A' ' 108' ' ' TRP . 4.0 mp -121.86 113.95 20.36 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 100.608 -3.849 . . . . 0.0 100.608 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.503 ' H ' HD23 ' A' ' 79' ' ' LEU . 4.0 t -150.33 133.4 16.16 Favored 'General case' 0 C--N 1.369 1.423 0 CA-C-N 119.568 1.077 . . . . 0.0 112.717 -173.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.76 173.94 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.879 1 C-N-CA 132.191 4.196 . . . . 0.0 104.396 175.614 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.2 t -103.0 141.81 35.17 Favored 'General case' 0 C--N 1.367 1.334 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.5 140.87 46.5 Favored 'General case' 0 C--N 1.368 1.408 1 N-CA-C 122.285 4.18 . . . . 0.0 122.285 -171.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.0 m -158.24 174.26 15.44 Favored 'General case' 0 C--N 1.357 0.891 0 C-N-CA 130.797 3.639 . . . . 0.0 102.222 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.82 43.7 2.2 Favored Glycine 0 C--N 1.365 2.16 0 CA-C-N 122.763 2.529 . . . . 0.0 116.714 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.52 21.33 62.28 Favored Glycine 0 C--N 1.359 1.832 0 C-N-CA 128.413 2.911 . . . . 0.0 114.082 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.7 p -117.1 110.94 18.82 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.271 1.829 . . . . 0.0 108.457 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.659 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.34 -96.64 1.02 Allowed Glycine 0 C--N 1.371 2.488 0 C-N-CA 127.943 2.687 . . . . 0.0 110.985 -168.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.98 169.22 10.78 Favored 'Trans proline' 0 CA--C 1.556 1.579 1 C-N-CA 127.258 5.305 . . . . 0.0 116.855 159.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.49 ' HB3' HG12 ' A' ' 140' ' ' VAL . 58.5 m-85 -92.1 148.07 22.46 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 120.782 3.623 . . . . 0.0 120.782 -168.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -102.84 141.45 35.63 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 129.097 2.959 . . . . 0.0 104.439 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.402 ' HD1' ' HA ' ' A' ' 119' ' ' SER . 0.1 OUTLIER -124.72 159.47 30.81 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 120.076 3.361 . . . . 0.0 120.076 -166.184 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.0 117.53 20.19 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 101.865 -3.383 . . . . 0.0 101.865 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.437 ' HB3' HG13 ' A' ' 115' ' ' ILE . 94.8 m95 -107.23 134.76 49.85 Favored 'General case' 0 C--N 1.363 1.176 0 C-N-CA 124.664 1.185 . . . . 0.0 109.073 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.7 170.31 19.52 Favored 'General case' 0 CA--C 1.487 -1.451 0 O-C-N 120.34 -1.475 . . . . 0.0 108.311 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.5 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.5 ptmm? -148.32 106.46 3.73 Favored 'General case' 0 N--CA 1.423 -1.795 0 O-C-N 119.643 -1.91 . . . . 0.0 108.45 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.213 0.9 OUTLIER 35.27 54.31 0.77 Allowed 'General case' 0 CA--C 1.47 -2.114 2 CA-C-O 109.472 -5.061 . . . . 0.0 122.73 146.212 . . . . . . . . 5 4 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.55 -0.42 85.45 Favored Glycine 0 C--N 1.384 3.242 2 O-C-N 135.113 7.758 . . . . 0.0 118.887 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.3 0.9 OUTLIER -124.49 147.57 55.85 Favored Pre-proline 0 CA--C 1.563 1.474 0 C-N-CA 129.429 3.091 . . . . 0.0 118.812 -167.398 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.75 139.17 56.53 Favored 'Trans proline' 0 N--CA 1.5 1.887 1 C-N-CA 125.992 4.461 . . . . 0.0 117.15 170.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -89.18 162.46 37.37 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 118.374 -2.704 . . . . 0.0 114.303 177.109 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 8.3 Cg_endo -67.89 94.02 0.39 Allowed 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.564 4.176 . . . . 0.0 115.556 -178.134 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.3 t70 82.05 -72.14 0.05 OUTLIER 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.61 2.364 . . . . 0.0 110.921 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.661 ' HB2' HD11 ' A' ' 115' ' ' ILE . . . 97.06 142.45 0.02 OUTLIER 'General case' 0 CA--C 1.479 -1.767 0 C-N-CA 129.057 2.943 . . . . 0.0 111.757 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.402 ' HA ' ' HD1' ' A' ' 106' ' ' TYR 0.281 0.2 OUTLIER 82.48 53.54 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.028 -1.896 . . . . 0.0 112.709 179.056 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.58 -55.84 0.32 Allowed Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 116.305 1.282 . . . . 0.0 116.305 -168.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.304 . . 103.43 -47.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.395 0 C-N-CA 126.59 1.956 . . . . 0.0 113.953 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.4 6.4 t -145.92 92.6 2.22 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 124.135 1.921 . . . . 0.0 109.582 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.291 4.3 p90 -126.88 142.18 51.61 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 129.003 2.921 . . . . 0.0 111.332 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.5 m -124.97 139.66 53.62 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 120.096 -1.628 . . . . 0.0 109.349 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 89.5 45.97 Favored Pre-proline 0 C--N 1.354 0.799 0 C-N-CA 127.937 2.495 . . . . 0.0 107.857 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -68.16 -32.57 27.01 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 124.712 3.608 . . . . 0.0 115.335 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.537 HG23 ' HA2' ' A' ' 88' ' ' GLY . 96.3 m -130.18 100.67 5.49 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.3 118.63 29.95 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.918 1.287 . . . . 0.0 113.555 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.07 -179.84 6.54 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.348 2.659 . . . . 0.0 109.646 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.87 -51.26 23.68 Favored 'General case' 0 C--N 1.368 1.387 0 O-C-N 118.16 -2.837 . . . . 0.0 117.761 -174.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -68.08 0.17 3.89 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 128.45 2.7 . . . . 0.0 114.966 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -116.66 -12.08 10.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 130.435 3.494 . . . . 0.0 111.316 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.34 157.26 16.3 Favored 'General case' 0 C--N 1.394 2.509 0 N-CA-C 119.409 3.115 . . . . 0.0 119.409 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 152.43 -158.36 27.8 Favored Glycine 0 C--N 1.39 3.535 0 C-N-CA 128.832 3.111 . . . . 0.0 111.042 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.485 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.328 3.8 m -106.07 131.94 52.74 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 112.947 -3.501 . . . . 0.0 105.989 167.578 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.556 ' HB2' ' HB2' ' A' ' 153' ' ' CYS . 18.3 m-85 -97.23 134.96 39.84 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 122.757 2.526 . . . . 0.0 113.599 -172.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.515 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -147.97 152.3 37.25 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-O 122.422 1.106 . . . . 0.0 110.175 -174.493 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.254 8.3 p -135.91 137.69 48.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 118.471 -1.292 . . . . 0.0 113.901 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.3 m -105.69 116.61 32.23 Favored 'General case' 0 C--N 1.377 1.787 0 C-N-CA 129.098 2.959 . . . . 0.0 104.925 176.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -130.88 119.09 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 124.086 0.954 . . . . 0.0 109.67 -167.768 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 146' ' ' VAL . 10.2 m -103.73 128.8 51.06 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 120.951 -1.093 . . . . 0.0 113.497 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.465 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.488 11.1 p-10 -127.55 -174.78 3.27 Favored 'General case' 0 C--N 1.371 1.52 0 CA-C-N 119.191 0.905 . . . . 0.0 111.84 174.644 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.659 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 80.5 p -49.97 2.44 0.01 OUTLIER 'General case' 0 C--N 1.361 1.069 2 C-N-CA 135.549 5.54 . . . . 0.0 121.816 -163.18 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.52 4.37 38.5 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 164.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.394 68.8 mm-40 66.39 40.01 3.78 Favored 'General case' 0 C--N 1.375 1.678 1 C-N-CA 132.803 4.441 . . . . 0.0 110.84 -172.623 . . . . . . . . 3 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.43 ' C ' HG23 ' A' ' 141' ' ' THR . 3.9 m -113.26 129.8 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.253 -171.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.29 123.58 34.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 126.661 1.984 . . . . 0.0 107.691 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.55 157.53 25.11 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 -175.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -128.68 132.22 48.03 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.646 -1.284 . . . . 0.0 109.706 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.474 55.9 p -114.35 151.88 32.32 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 123.75 0.82 . . . . 0.0 111.13 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -53.69 146.81 12.62 Favored 'General case' 0 C--N 1.371 1.508 1 C-N-CA 133.843 4.857 . . . . 0.0 120.146 -153.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 64.5 p -70.33 110.96 5.57 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 129.745 3.218 . . . . 0.0 109.323 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 18.0 m -106.01 109.62 21.63 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.58 107.23 19.62 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 124.773 2.225 . . . . 0.0 111.308 -170.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.423 HG22 ' HB1' ' A' ' 89' ' ' ALA 0.263 1.1 t -118.0 114.95 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 -172.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.368 1.373 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -174.45 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.577 2.005 0 CA-C-O 121.756 0.788 . . . . 0.0 112.336 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.2 m -164.81 171.32 14.37 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 116.667 -3.77 . . . . 0.0 103.785 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.41 -45.41 1.51 Allowed 'General case' 0 C--N 1.366 1.315 0 C-N-CA 127.031 2.132 . . . . 0.0 112.932 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 86.1 p -176.17 134.12 0.25 Allowed 'General case' 0 C--N 1.365 1.262 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.6 ttt -134.75 117.93 16.52 Favored 'General case' 0 C--N 1.373 1.629 0 CA-C-N 119.696 1.134 . . . . 0.0 109.203 159.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.5 p -111.13 116.15 30.62 Favored 'General case' 0 C--N 1.363 1.188 0 O-C-N 119.482 -2.011 . . . . 0.0 109.789 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.74 171.98 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 126.825 2.05 . . . . 0.0 112.937 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.4 127.56 33.79 Favored 'General case' 0 C--N 1.372 1.55 0 O-C-N 118.961 -2.337 . . . . 0.0 105.258 163.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.278 8.6 pt-20 -41.83 122.57 2.07 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 120.389 3.477 . . . . 0.0 120.389 -150.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 144.34 54.71 0.03 OUTLIER Glycine 0 C--N 1.356 1.639 0 CA-C-N 109.656 -3.429 . . . . 0.0 110.55 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.11 158.79 23.56 Favored 'General case' 0 C--N 1.372 1.58 0 C-N-CA 125.482 1.513 . . . . 0.0 113.101 174.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.91 101.62 9.92 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 125.415 1.486 . . . . 0.0 112.312 -174.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.533 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 1.1 mp -119.79 130.83 55.13 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 125.943 1.697 . . . . 0.0 115.318 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.98 132.8 53.9 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 172.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.636 HD21 ' CD2' ' A' ' 136' ' ' TYR . 3.1 mp -131.83 115.16 15.58 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 170.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -148.1 133.84 18.93 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.529 -1.357 . . . . 0.0 110.981 -174.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.7 174.57 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 129.549 3.14 . . . . 0.0 104.0 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 t -104.26 141.38 36.39 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 126.948 2.099 . . . . 0.0 105.696 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.31 134.2 32.23 Favored 'General case' 0 C--N 1.37 1.472 0 N-CA-C 120.127 3.38 . . . . 0.0 120.127 -172.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.3 m -157.86 174.04 15.88 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 131.363 3.865 . . . . 0.0 100.843 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.52 44.24 2.21 Favored Glycine 0 C--N 1.363 2.045 0 CA-C-N 122.584 2.447 . . . . 0.0 117.582 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.4 12.73 81.63 Favored Glycine 0 C--N 1.362 1.991 0 C-N-CA 128.705 3.05 . . . . 0.0 113.068 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.7 p -115.87 111.17 20.05 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 126.481 1.913 . . . . 0.0 107.396 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.513 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 71.83 -101.4 1.01 Allowed Glycine 0 C--N 1.36 1.886 0 C-N-CA 127.181 2.324 . . . . 0.0 109.315 -161.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.79 168.32 7.22 Favored 'Trans proline' 0 CA--C 1.555 1.573 1 C-N-CA 129.227 6.618 . . . . 0.0 118.349 165.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.541 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.6 m-85 -82.07 138.86 34.73 Favored 'General case' 0 CA--C 1.562 1.419 1 N-CA-C 122.274 4.175 . . . . 0.0 122.274 -170.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 t -102.82 154.96 18.68 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 129.756 3.223 . . . . 0.0 104.309 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.475 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.5 OUTLIER -153.71 166.27 33.35 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -165.129 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.2 112.81 10.76 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 128.417 2.687 . . . . 0.0 105.64 170.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.407 ' HB3' HG13 ' A' ' 115' ' ' ILE . 94.1 m95 -111.94 137.5 49.85 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.349 1.859 . . . . 0.0 108.595 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.308 0.2 OUTLIER -158.61 162.77 37.35 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.32 -1.487 . . . . 0.0 107.427 168.898 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.503 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -137.31 103.59 5.14 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 116.954 -1.898 . . . . 0.0 115.412 177.9 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.153 2.3 t70 36.6 53.82 1.07 Allowed 'General case' 0 CA--C 1.467 -2.22 1 CA-C-O 111.433 -4.127 . . . . 0.0 119.609 153.898 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.71 -0.56 70.46 Favored Glycine 0 C--N 1.373 2.6 2 O-C-N 134.227 7.204 . . . . 0.0 117.38 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.4 ' HB2' ' HE3' ' A' ' 110' ' ' LYS 0.384 1.3 p -124.82 147.8 57.51 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 130.074 3.349 . . . . 0.0 119.445 -167.511 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.02 143.7 79.7 Favored 'Trans proline' 0 N--CA 1.498 1.747 1 C-N-CA 125.964 4.442 . . . . 0.0 115.817 167.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -94.99 144.91 28.6 Favored Pre-proline 0 CA--C 1.551 1.004 0 O-C-N 119.437 -2.039 . . . . 0.0 112.916 176.088 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.55 93.43 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.447 1 C-N-CA 125.938 4.425 . . . . 0.0 118.83 -172.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.3 t70 65.1 48.26 2.28 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 169.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.32 -165.64 0.9 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 127.598 2.359 . . . . 0.0 115.694 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.304 8.4 t 99.92 8.04 0.01 OUTLIER 'General case' 0 C--N 1.354 0.765 0 C-N-CA 128.959 2.904 . . . . 0.0 112.121 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.2 91.77 0.08 OUTLIER Glycine 0 CA--C 1.48 -2.129 0 C-N-CA 115.979 -3.01 . . . . 0.0 118.568 167.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.461 . . 89.6 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 167.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.0 t -139.32 118.27 12.5 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 122.106 2.23 . . . . 0.0 115.915 -169.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -127.63 140.13 52.29 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 127.381 2.272 . . . . 0.0 111.197 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 91' ' ' LEU . 89.1 m -129.25 140.55 51.41 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 119.306 -2.121 . . . . 0.0 109.68 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.411 ' HB3' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.85 95.97 31.21 Favored Pre-proline 0 C--N 1.366 1.293 0 C-N-CA 128.203 2.601 . . . . 0.0 108.455 178.051 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.19 -14.11 16.77 Favored 'Trans proline' 0 C--N 1.356 0.948 1 C-N-CA 126.278 4.652 . . . . 0.0 113.563 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.47 HG23 ' HA2' ' A' ' 88' ' ' GLY . 95.5 m -161.6 101.0 1.18 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 102.43 -3.174 . . . . 0.0 102.43 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.48 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -83.12 134.05 35.02 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.83 2.452 . . . . 0.0 112.183 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.62 173.19 7.74 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 127.935 2.494 . . . . 0.0 110.086 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -41.12 23.61 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 120.166 3.395 . . . . 0.0 120.166 -173.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -66.95 -14.57 62.96 Favored 'General case' 0 C--N 1.366 1.317 0 C-N-CA 126.801 2.04 . . . . 0.0 115.393 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.48 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 42.7 m-20 -80.42 -17.05 52.94 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 129.475 3.11 . . . . 0.0 111.559 168.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.86 107.88 2.79 Favored 'General case' 0 C--N 1.384 2.077 0 N-CA-C 120.45 3.5 . . . . 0.0 120.45 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.65 -154.12 19.13 Favored Glycine 0 CA--C 1.459 -3.413 0 C-N-CA 126.77 2.129 . . . . 0.0 108.935 172.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.433 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.288 19.6 m -117.64 135.49 53.95 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 114.892 -2.723 . . . . 0.0 108.296 175.335 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.636 ' CD2' HD21 ' A' ' 93' ' ' LEU . 10.1 m-85 -96.77 133.32 41.5 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 120.299 -1.501 . . . . 0.0 113.487 -171.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.466 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -146.05 149.32 33.87 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 121.573 0.702 . . . . 0.0 110.782 -173.032 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.6 p -142.49 142.94 26.51 Favored 'Isoleucine or valine' 0 C--N 1.372 1.56 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -105.15 118.45 36.58 Favored 'General case' 0 C--N 1.375 1.681 0 C-N-CA 129.732 3.213 . . . . 0.0 105.333 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -129.1 122.66 56.86 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 126.765 2.026 . . . . 0.0 112.347 -175.269 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.453 HG23 ' C ' ' A' ' 146' ' ' VAL . 17.4 m -111.78 133.96 53.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 118.995 -2.315 . . . . 0.0 114.043 -177.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . 0.591 4.4 p30 -134.86 -167.18 1.94 Allowed 'General case' 0 C--N 1.373 1.62 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 173.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.513 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 90.6 p -48.88 3.51 0.01 OUTLIER 'General case' 0 C--N 1.366 1.297 2 C-N-CA 134.838 5.255 . . . . 0.0 122.208 -158.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -106.75 4.87 28.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.468 164.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.397 89.3 mm-40 66.19 40.19 3.93 Favored 'General case' 0 C--N 1.375 1.696 1 C-N-CA 132.077 4.151 . . . . 0.0 110.455 -171.72 . . . . . . . . 3 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.453 ' C ' HG23 ' A' ' 141' ' ' THR . 3.9 m -112.92 129.85 67.82 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.376 0 CA-C-N 111.759 -2.473 . . . . 0.0 111.362 -171.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.6 OUTLIER -91.89 130.54 37.63 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.885 1.274 . . . . 0.0 110.027 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.93 156.99 26.45 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 128.172 2.589 . . . . 0.0 104.913 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -130.5 146.72 52.09 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 120.877 -1.139 . . . . 0.0 108.128 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.337 88.4 p -130.82 143.83 51.02 Favored 'General case' 0 C--O 1.251 1.133 0 O-C-N 121.726 -0.609 . . . . 0.0 110.734 175.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.0 m -54.35 148.02 12.49 Favored 'General case' 0 CA--C 1.481 -1.675 2 C-N-CA 137.127 6.171 . . . . 0.0 118.089 -162.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 65.5 p -68.38 110.35 4.08 Favored 'General case' 0 C--N 1.375 1.675 0 CA-C-N 111.865 -2.425 . . . . 0.0 109.136 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 109.78 22.47 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 102.172 -3.27 . . . . 0.0 102.172 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.42 114.58 27.17 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 125.125 2.393 . . . . 0.0 110.628 -174.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.4 t -117.83 117.4 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 CA--C 1.492 -1.257 0 N-CA-C 103.182 -2.895 . . . . 0.0 103.182 173.123 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.4 ' O ' HG22 ' A' ' 92' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.561 1.365 0 N-CA-C 121.003 3.705 . . . . 0.0 121.003 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 m -173.78 172.37 3.54 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 102.982 -2.969 . . . . 0.0 102.982 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.01 -52.79 2.59 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.294 -1.504 . . . . 0.0 110.205 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 t -172.16 136.04 0.82 Allowed 'General case' 0 C--N 1.357 0.928 0 O-C-N 119.842 -1.786 . . . . 0.0 113.709 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 25.0 ttt -130.56 117.9 20.25 Favored 'General case' 0 C--N 1.373 1.605 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 163.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -105.5 115.61 30.55 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 119.612 -1.93 . . . . 0.0 107.496 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.24 173.72 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.752 0 CA-C-O 123.255 1.502 . . . . 0.0 112.208 -168.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.02 132.65 36.04 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 126.864 2.066 . . . . 0.0 105.455 159.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.29 0.3 OUTLIER -43.77 121.71 2.48 Favored 'General case' 0 N--CA 1.513 2.719 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 -161.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.581 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 138.44 51.66 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.226 0 CA-C-N 111.446 -2.615 . . . . 0.0 108.938 -164.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.13 163.34 17.91 Favored 'General case' 0 C--N 1.367 1.352 0 C-N-CA 125.804 1.642 . . . . 0.0 111.455 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.15 105.69 14.48 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.925 0.89 . . . . 0.0 112.755 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.482 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 3.7 mp -119.87 120.22 35.82 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 126.505 1.922 . . . . 0.0 115.313 -172.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -106.75 126.37 52.2 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 170.352 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.34 114.87 18.14 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 103.452 -2.795 . . . . 0.0 103.452 176.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -156.75 140.32 15.9 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.951 -1.093 . . . . 0.0 109.63 -172.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.64 172.73 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 129.395 3.078 . . . . 0.0 104.884 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.3 t -104.01 141.76 35.63 Favored 'General case' 0 C--N 1.373 1.605 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . . . -125.26 149.88 47.59 Favored 'General case' 0 C--N 1.363 1.194 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.4 m -159.4 174.92 13.99 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.17 42.48 2.74 Favored Glycine 0 C--N 1.362 2.009 0 CA-C-N 122.905 2.593 . . . . 0.0 116.239 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.84 0.8 60.22 Favored Glycine 0 C--N 1.362 1.979 0 C-N-CA 125.649 1.595 . . . . 0.0 114.393 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.9 m -117.24 123.91 47.76 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.346 1.458 . . . . 0.0 110.034 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.611 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.45 -113.26 4.36 Favored Glycine 0 C--N 1.361 1.917 0 CA-C-O 116.153 -2.47 . . . . 0.0 108.798 -163.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -66.96 168.45 17.18 Favored 'Trans proline' 0 CA--C 1.564 1.985 1 C-N-CA 127.759 5.64 . . . . 0.0 117.353 163.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.469 ' HB3' HG12 ' A' ' 140' ' ' VAL . 27.4 m-85 -82.1 144.33 30.87 Favored 'General case' 0 C--N 1.358 0.947 1 N-CA-C 125.453 5.353 . . . . 0.0 125.453 -164.494 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.3 t -103.24 141.47 35.84 Favored 'General case' 0 C--N 1.371 1.529 0 C-N-CA 127.914 2.486 . . . . 0.0 104.525 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.544 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.6 OUTLIER -137.39 160.32 39.43 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 120.354 3.464 . . . . 0.0 120.354 -166.001 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.08 113.69 9.09 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 110.593 -3.003 . . . . 0.0 105.112 173.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -111.98 154.77 24.8 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 120.676 -1.265 . . . . 0.0 108.595 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.383 0.2 OUTLIER -158.3 168.73 26.2 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 166.338 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.507 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.0 OUTLIER -144.5 105.01 4.12 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 120.138 -1.601 . . . . 0.0 114.911 -178.325 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.513 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.224 0.6 OUTLIER 36.39 53.75 1.01 Allowed 'General case' 0 CA--C 1.464 -2.336 1 CA-C-O 111.394 -4.145 . . . . 0.0 119.198 153.699 . . . . . . . . 5 4 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.38 -0.65 78.24 Favored Glycine 0 C--N 1.373 2.607 2 O-C-N 134.747 7.529 . . . . 0.0 118.375 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.268 58.2 m -124.89 148.87 61.15 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 120.304 3.446 . . . . 0.0 120.304 -167.297 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -60.22 148.75 88.69 Favored 'Trans proline' 0 N--CA 1.507 2.301 1 C-N-CA 126.231 4.62 . . . . 0.0 116.194 166.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.591 ' HB ' ' HD2' ' A' ' 116' ' ' PRO 0.325 0.8 OUTLIER -98.64 165.1 15.71 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 117.846 -3.034 . . . . 0.0 112.285 175.279 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 6.0 Cg_endo -69.2 87.92 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.739 1 C-N-CA 125.826 4.351 . . . . 0.0 113.984 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.6 t70 84.99 -57.51 0.09 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.877 3.271 . . . . 0.0 110.612 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.302 . . 102.97 -62.87 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 130.715 3.606 . . . . 0.0 115.285 171.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.301 8.0 t -73.7 80.12 1.54 Allowed 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 130.732 3.613 . . . . 0.0 113.886 -174.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.94 -71.48 0.02 OUTLIER Glycine 0 C--N 1.36 1.867 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 -172.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 97' ' ' ALA 0.318 . . 129.4 -24.73 0.01 OUTLIER 'General case' 0 C--N 1.365 1.247 0 C-N-CA 127.265 2.226 . . . . 0.0 116.044 178.008 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.34 15.0 t -154.85 102.23 2.34 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-N 121.013 1.733 . . . . 0.0 112.657 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.313 0.1 OUTLIER -127.43 141.48 51.67 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 127.897 2.479 . . . . 0.0 111.472 176.355 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 91' ' ' LEU . 60.1 m -128.32 138.65 52.48 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 118.991 -2.318 . . . . 0.0 107.28 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.89 102.72 52.88 Favored Pre-proline 0 C--N 1.362 1.137 0 C-N-CA 128.042 2.537 . . . . 0.0 105.209 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -77.04 -11.86 17.77 Favored 'Trans proline' 0 C--N 1.348 0.548 1 C-N-CA 126.227 4.618 . . . . 0.0 112.731 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.581 HG23 ' HA2' ' A' ' 88' ' ' GLY . 62.1 m -157.22 100.9 1.87 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.46 128.47 39.56 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 124.312 1.045 . . . . 0.0 112.317 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.27 179.06 5.17 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 129.462 3.105 . . . . 0.0 108.574 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.62 -53.96 13.26 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -172.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.38 0.93 3.37 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 127.234 2.213 . . . . 0.0 115.788 172.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -113.8 -13.79 12.59 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 130.362 3.465 . . . . 0.0 110.695 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.28 160.18 14.46 Favored 'General case' 0 C--N 1.4 2.775 0 N-CA-C 120.157 3.391 . . . . 0.0 120.157 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.6 -158.59 27.75 Favored Glycine 0 CA--C 1.469 -2.831 0 C-N-CA 128.585 2.993 . . . . 0.0 106.905 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.416 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.331 1.2 m -105.8 129.39 54.0 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 114.677 -2.809 . . . . 0.0 107.559 168.278 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.507 ' CZ ' ' HD2' ' A' ' 110' ' ' LYS . 12.7 m-85 -96.59 134.92 39.21 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 123.404 2.82 . . . . 0.0 113.159 -171.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -146.16 152.15 38.78 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 123.9 0.88 . . . . 0.0 110.385 -175.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 149' ' ' ASP . 8.5 p -142.95 141.12 27.11 Favored 'Isoleucine or valine' 0 C--N 1.371 1.525 0 C-N-CA 117.474 -1.69 . . . . 0.0 114.928 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 61.5 m -103.64 110.98 23.26 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 129.96 3.304 . . . . 0.0 106.206 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -123.78 114.9 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.334 2.254 . . . . 0.0 109.87 -172.643 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.433 HG23 ' C ' ' A' ' 146' ' ' VAL . 4.7 m -102.16 130.15 48.72 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.322 -1.486 . . . . 0.0 113.807 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.401 ' CG ' ' CE2' ' A' ' 104' ' ' TYR 0.481 7.1 p30 -138.39 -165.38 1.8 Allowed 'General case' 0 C--N 1.371 1.531 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 174.131 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.611 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 91.3 p -48.91 3.69 0.01 OUTLIER 'General case' 0 C--N 1.369 1.45 2 C-N-CA 134.986 5.315 . . . . 0.0 123.135 -163.007 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -105.65 5.92 31.58 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 163.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.395 6.9 mm100 64.27 39.98 6.97 Favored 'General case' 0 C--N 1.374 1.655 1 C-N-CA 133.403 4.681 . . . . 0.0 111.261 -171.164 . . . . . . . . 3 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.433 ' C ' HG23 ' A' ' 141' ' ' THR . 3.1 m -113.88 134.77 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.826 0 CA-C-N 111.774 -2.466 . . . . 0.0 112.318 -170.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.14 123.45 34.61 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 129.13 2.972 . . . . 0.0 106.287 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.82 157.84 24.93 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 128.781 2.833 . . . . 0.0 105.038 -175.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 30.3 t70 -125.82 134.23 51.74 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 122.284 1.04 . . . . 0.0 109.108 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.508 54.2 p -111.79 146.8 36.99 Favored 'General case' 0 C--O 1.252 1.227 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.0 m -53.95 147.87 11.57 Favored 'General case' 0 C--N 1.375 1.702 1 C-N-CA 135.261 5.424 . . . . 0.0 120.004 -157.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.3 p -69.38 110.89 4.92 Favored 'General case' 0 C--N 1.37 1.468 0 C-N-CA 126.115 1.766 . . . . 0.0 110.192 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.36 109.46 21.1 Favored 'General case' 0 C--N 1.358 0.957 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -94.54 107.22 19.21 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-O 123.622 1.677 . . . . 0.0 110.99 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.82 115.09 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.369 1.415 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.53 -174.946 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.49 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.9 m -171.97 172.63 4.67 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 100.483 -3.895 . . . . 0.0 100.483 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.47 -51.32 1.96 Allowed 'General case' 0 C--N 1.351 0.673 0 CA-C-N 120.561 1.528 . . . . 0.0 111.117 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.4 t -172.62 145.41 1.55 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 120.35 -1.469 . . . . 0.0 114.728 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.5 ttt -135.7 128.57 31.23 Favored 'General case' 0 C--N 1.371 1.517 0 O-C-N 121.36 -0.837 . . . . 0.0 109.608 160.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 p -104.9 114.49 28.72 Favored 'General case' 0 C--N 1.373 1.611 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 86' ' ' GLU 0.252 7.4 p -149.87 174.03 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.899 -167.109 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 85' ' ' VAL . 1.3 pp20? -89.31 144.23 26.24 Favored 'General case' 0 C--N 1.364 1.209 0 O-C-N 119.392 -2.067 . . . . 0.0 106.813 163.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.473 3.8 pt-20 -44.39 124.91 4.35 Favored 'General case' 0 N--CA 1.516 2.847 0 O-C-N 118.121 -2.862 . . . . 0.0 117.863 -172.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.542 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 122.05 50.4 0.24 Allowed Glycine 0 C--N 1.345 1.049 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 -150.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 128' ' ' ALA . . . -97.04 152.28 18.9 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 127.023 2.129 . . . . 0.0 111.663 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.05 113.79 26.79 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-O 122.466 1.127 . . . . 0.0 113.632 -169.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.578 HD12 ' SG ' ' A' ' 153' ' ' CYS . 0.3 OUTLIER -121.03 138.1 54.33 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 126.343 1.857 . . . . 0.0 115.9 174.317 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -123.87 137.38 54.66 Favored 'General case' 0 CA--C 1.494 -1.173 1 N-CA-C 99.817 -4.142 . . . . 0.0 99.817 160.682 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 136' ' ' TYR . 4.0 mp -122.29 115.13 21.79 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 101.003 -3.702 . . . . 0.0 101.003 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.49 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 5.7 t -152.49 132.27 13.22 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -174.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.84 174.43 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.052 1 C-N-CA 132.476 4.31 . . . . 0.0 105.629 176.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.3 t -104.15 141.24 36.59 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 119.773 -1.83 . . . . 0.0 107.72 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.76 146.01 35.47 Favored 'General case' 0 C--N 1.382 2.008 1 N-CA-C 124.947 5.166 . . . . 0.0 124.947 -173.422 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.9 p -156.95 175.33 14.24 Favored 'General case' 0 C--N 1.369 1.414 1 C-N-CA 133.786 4.834 . . . . 0.0 104.031 177.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.06 42.91 0.79 Allowed Glycine 0 C--N 1.367 2.273 0 O-C-N 119.597 -1.939 . . . . 0.0 117.779 171.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.85 25.69 52.05 Favored Glycine 0 C--N 1.361 1.961 0 C-N-CA 128.396 2.903 . . . . 0.0 114.851 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.4 p -116.91 110.01 17.78 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 116.519 -1.705 . . . . 0.0 108.368 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.66 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 71.8 -90.63 0.49 Allowed Glycine 0 C--N 1.371 2.516 0 C-N-CA 129.408 3.385 . . . . 0.0 110.731 -167.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.89 169.32 4.72 Favored 'Trans proline' 0 CA--C 1.564 1.975 1 C-N-CA 128.054 5.836 . . . . 0.0 117.326 160.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.528 ' HB3' HG12 ' A' ' 140' ' ' VAL . 64.7 m-85 -94.74 143.18 26.66 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 120.373 3.472 . . . . 0.0 120.373 -167.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.8 t -103.24 142.34 34.35 Favored 'General case' 0 C--N 1.382 1.999 0 C-N-CA 128.772 2.829 . . . . 0.0 104.789 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.434 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -141.48 165.99 25.98 Favored 'General case' 0 C--N 1.351 0.654 1 N-CA-C 122.282 4.178 . . . . 0.0 122.282 -160.745 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.86 121.95 12.89 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 128.187 2.595 . . . . 0.0 106.642 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.409 ' CZ3' HG11 ' A' ' 138' ' ' VAL . 72.2 m95 -112.01 142.46 44.41 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 125.335 1.454 . . . . 0.0 111.878 -175.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.7 170.77 19.43 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 123.186 1.47 . . . . 0.0 107.187 174.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.568 ' HD3' ' CE2' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -147.68 106.12 3.78 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 177.728 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.47 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.235 1.3 t70 34.5 53.07 0.58 Allowed 'General case' 0 C--N 1.377 1.794 2 N-CA-C 123.336 4.569 . . . . 0.0 123.336 140.062 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.69 -0.74 87.77 Favored Glycine 0 C--N 1.376 2.78 2 O-C-N 134.128 7.143 . . . . 0.0 119.292 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.469 ' HB2' ' HD2' ' A' ' 110' ' ' LYS . 3.6 m -124.8 147.18 55.46 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 129.3 3.04 . . . . 0.0 118.352 -172.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.33 138.07 49.61 Favored 'Trans proline' 0 N--CA 1.495 1.577 1 C-N-CA 125.984 4.456 . . . . 0.0 115.036 171.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.418 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -91.36 163.64 27.94 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 117.816 -3.052 . . . . 0.0 115.57 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 9.5 Cg_endo -71.22 84.4 0.91 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.703 3.602 . . . . 0.0 115.841 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.3 t70 78.01 -62.5 0.36 Allowed 'General case' 0 C--N 1.362 1.137 0 C-N-CA 127.719 2.407 . . . . 0.0 114.762 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 79.64 171.63 0.16 Allowed 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 130.284 3.434 . . . . 0.0 114.791 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.424 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 75.64 72.38 0.09 Allowed 'General case' 0 C--N 1.358 0.972 0 CA-C-N 114.345 -1.298 . . . . 0.0 114.288 173.886 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.76 -51.93 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.967 0 N-CA-C 118.976 2.35 . . . . 0.0 118.976 -173.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.263 . . 133.4 -73.11 0.0 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.055 2.142 . . . . 0.0 107.356 -176.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.272 6.9 t -133.82 111.61 10.65 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-O 123.092 1.425 . . . . 0.0 113.459 -175.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.331 0.6 OUTLIER -127.07 141.65 51.72 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 129.042 2.937 . . . . 0.0 112.394 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.7 m -128.51 139.71 52.18 Favored 'General case' 0 C--N 1.366 1.318 0 O-C-N 120.702 -1.249 . . . . 0.0 109.302 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.7 100.08 51.16 Favored Pre-proline 0 C--N 1.355 0.81 0 C-N-CA 129.822 3.249 . . . . 0.0 105.145 176.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -77.49 -32.4 2.92 Favored 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 125.93 4.42 . . . . 0.0 113.407 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.542 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.4 m -138.45 101.29 4.33 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -95.75 129.6 42.93 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 127.522 2.329 . . . . 0.0 109.615 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.59 175.58 7.85 Favored 'General case' 0 C--N 1.369 1.426 0 C-N-CA 128.169 2.588 . . . . 0.0 108.457 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.18 -51.35 18.63 Favored 'General case' 0 C--N 1.368 1.397 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 -171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -63.92 -22.89 67.12 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 126.1 1.76 . . . . 0.0 114.748 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -82.87 -10.28 58.91 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 130.103 3.361 . . . . 0.0 111.909 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -94.35 166.37 12.11 Favored 'General case' 0 C--N 1.383 2.061 0 N-CA-C 116.59 2.071 . . . . 0.0 116.59 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 144.86 -156.34 26.86 Favored Glycine 0 CA--C 1.461 -3.289 0 C-N-CA 127.603 2.525 . . . . 0.0 108.867 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.325 1.4 m -113.54 130.45 56.35 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 114.276 -2.969 . . . . 0.0 107.118 171.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.568 ' CE2' ' HD3' ' A' ' 110' ' ' LYS . 31.0 m-85 -97.16 135.02 39.72 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 126.882 2.073 . . . . 0.0 112.063 -168.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.47 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -148.83 148.79 30.32 Favored 'General case' 0 C--N 1.373 1.595 0 CA-C-O 123.449 1.595 . . . . 0.0 109.12 -174.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.409 HG11 ' CZ3' ' A' ' 108' ' ' TRP 0.291 0.8 OUTLIER -141.46 141.03 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.265 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.7 m -102.64 122.98 45.5 Favored 'General case' 0 C--N 1.377 1.8 0 C-N-CA 129.138 2.975 . . . . 0.0 107.201 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.528 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -134.54 126.72 48.83 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 125.816 1.646 . . . . 0.0 113.391 -174.797 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 8.3 m -113.83 132.59 55.83 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 119.365 -2.084 . . . . 0.0 114.296 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.443 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.428 25.6 p30 -126.93 -174.36 3.12 Favored 'General case' 0 C--N 1.377 1.78 0 O-C-N 120.729 -1.232 . . . . 0.0 112.695 176.501 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.66 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 63.2 p -49.62 3.3 0.01 OUTLIER 'General case' 0 C--N 1.362 1.126 1 C-N-CA 136.302 5.841 . . . . 0.0 121.775 -164.551 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -104.21 4.47 33.95 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 118.215 -1.394 . . . . 0.0 107.798 163.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.405 91.8 mm-40 66.55 40.2 3.53 Favored 'General case' 0 C--N 1.375 1.683 1 C-N-CA 132.504 4.321 . . . . 0.0 110.156 -172.204 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.413 ' C ' HG23 ' A' ' 141' ' ' THR . 3.8 m -112.48 126.67 69.9 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.39 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.591 -170.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.3 OUTLIER -91.67 134.0 35.09 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 124.613 1.165 . . . . 0.0 109.724 -177.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 158.51 24.52 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 130.429 3.492 . . . . 0.0 105.686 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -127.21 136.51 52.13 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.252 0.1 OUTLIER -116.38 151.6 35.62 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.242 1.817 . . . . 0.0 110.772 -175.482 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 m -53.42 146.5 12.38 Favored 'General case' 0 CA--C 1.489 -1.399 1 C-N-CA 134.209 5.004 . . . . 0.0 119.441 -157.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.8 p -70.76 111.59 6.32 Favored 'General case' 0 C--N 1.37 1.467 0 C-N-CA 128.749 2.819 . . . . 0.0 108.867 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.578 ' SG ' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -107.19 109.93 21.87 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 102.149 -3.278 . . . . 0.0 102.149 178.27 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -100.06 111.83 24.12 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-O 123.893 1.806 . . . . 0.0 111.556 -173.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -122.03 123.94 70.15 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 O-C-N 119.375 -2.078 . . . . 0.0 108.882 -178.529 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.369 1.44 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.299 -175.768 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 92' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.577 1.996 0 CA-C-O 121.895 0.855 . . . . 0.0 113.087 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -168.09 172.24 8.92 Favored 'General case' 0 CA--C 1.519 -0.248 1 O-C-N 115.33 -4.606 . . . . 0.0 101.173 171.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.61 -48.5 1.27 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 125.842 1.657 . . . . 0.0 111.132 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.4 t -170.71 140.78 1.73 Allowed 'General case' 0 C--N 1.362 1.129 0 O-C-N 119.622 -1.924 . . . . 0.0 115.78 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.17 117.07 13.2 Favored 'General case' 0 C--N 1.377 1.769 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 161.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.0 m -114.36 116.8 29.5 Favored 'General case' 0 C--N 1.363 1.186 0 O-C-N 118.209 -2.807 . . . . 0.0 108.334 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.0 p -149.46 172.09 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 125.828 1.651 . . . . 0.0 110.37 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -82.45 129.7 34.96 Favored 'General case' 0 C--N 1.373 1.589 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 163.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.258 9.1 pt-20 -41.53 123.01 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 120.397 3.48 . . . . 0.0 120.397 -152.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.597 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 142.08 52.97 0.04 OUTLIER Glycine 0 C--N 1.359 1.833 0 CA-C-N 109.73 -3.395 . . . . 0.0 110.654 -171.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.94 163.96 21.84 Favored 'General case' 0 C--N 1.374 1.631 0 C-N-CA 125.73 1.612 . . . . 0.0 112.928 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.67 108.83 18.43 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 124.272 1.029 . . . . 0.0 110.33 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 124' ' ' THR . 4.2 mp -119.46 123.09 43.2 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 125.797 1.639 . . . . 0.0 115.247 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -110.57 127.21 55.11 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 102.364 -3.198 . . . . 0.0 102.364 170.526 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.44 115.65 21.94 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 172.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 t -154.56 134.11 12.73 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 119.947 -1.72 . . . . 0.0 112.461 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.5 m -148.89 175.0 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.645 0 C-N-CA 131.637 3.975 . . . . 0.0 105.886 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.2 t -104.01 138.88 39.91 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.185 2.594 . . . . 0.0 104.625 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.35 142.19 33.8 Favored 'General case' 0 C--N 1.373 1.597 0 N-CA-C 121.642 3.942 . . . . 0.0 121.642 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.3 m -158.52 174.19 15.46 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 131.092 3.757 . . . . 0.0 102.05 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.27 44.54 1.38 Allowed Glycine 0 C--N 1.367 2.292 0 CA-C-N 121.879 2.127 . . . . 0.0 117.232 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.77 28.06 52.07 Favored Glycine 0 C--N 1.358 1.754 0 C-N-CA 128.544 2.973 . . . . 0.0 115.289 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.7 m -117.93 110.96 18.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 114.372 -2.728 . . . . 0.0 107.114 173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.85 -87.4 0.86 Allowed Glycine 0 C--N 1.379 2.944 0 C-N-CA 129.729 3.538 . . . . 0.0 110.144 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -60.18 168.12 6.62 Favored 'Trans proline' 0 CA--C 1.568 2.196 1 C-N-CA 126.51 4.806 . . . . 0.0 116.167 159.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 71.5 m-85 -103.2 143.59 32.43 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 119.593 3.182 . . . . 0.0 119.593 -165.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -103.52 146.49 28.46 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 127.255 2.222 . . . . 0.0 105.526 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.46 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -144.22 166.46 24.97 Favored 'General case' 0 C--N 1.354 0.778 1 N-CA-C 123.25 4.537 . . . . 0.0 123.25 -160.857 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.07 120.52 15.0 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 128.283 2.633 . . . . 0.0 106.25 172.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -112.54 146.65 38.14 Favored 'General case' 0 C--N 1.367 1.355 0 O-C-N 120.853 -1.155 . . . . 0.0 112.145 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.2 169.72 23.87 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 171.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -143.56 105.56 4.37 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 174.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.453 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.17 1.5 t70 34.79 52.79 0.6 Allowed 'General case' 0 C--N 1.376 1.744 1 N-CA-C 122.48 4.252 . . . . 0.0 122.48 140.265 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.07 -6.21 83.81 Favored Glycine 0 C--N 1.364 2.116 2 O-C-N 133.085 6.49 . . . . 0.0 119.003 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.269 3.0 m -124.28 147.13 53.95 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 129.268 3.027 . . . . 0.0 117.671 -171.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.78 142.46 76.39 Favored 'Trans proline' 0 N--CA 1.495 1.604 1 C-N-CA 126.245 4.63 . . . . 0.0 114.973 172.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.406 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -99.26 158.9 31.42 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 118.462 -2.649 . . . . 0.0 112.636 178.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 2.7 Cg_endo -65.04 86.9 0.18 Allowed 'Trans proline' 0 C--N 1.363 1.291 1 C-N-CA 126.336 4.691 . . . . 0.0 115.355 -177.471 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 73.21 -58.8 0.59 Allowed 'General case' 0 C--N 1.362 1.145 0 C-N-CA 128.268 2.627 . . . . 0.0 115.185 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 73.25 176.24 0.26 Allowed 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 130.824 3.65 . . . . 0.0 115.048 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.429 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.3 OUTLIER 72.15 60.98 0.13 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-N 114.308 -1.314 . . . . 0.0 114.324 174.394 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.98 -82.98 0.07 OUTLIER Glycine 0 C--N 1.355 1.59 0 N-CA-C 116.316 1.287 . . . . 0.0 116.316 -170.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.631 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 165.8 -62.61 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 126.509 1.924 . . . . 0.0 106.539 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.4 t -137.79 111.31 8.07 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.451 -1.406 . . . . 0.0 112.316 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.314 31.8 p90 -127.33 140.75 51.98 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 126.111 1.764 . . . . 0.0 111.925 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 91' ' ' LEU . 25.6 m -128.65 139.91 52.02 Favored 'General case' 0 C--N 1.361 1.076 0 O-C-N 120.014 -1.679 . . . . 0.0 109.017 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 98.43 48.6 Favored Pre-proline 0 C--N 1.363 1.181 0 C-N-CA 129.075 2.95 . . . . 0.0 105.289 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -77.39 -15.32 15.87 Favored 'Trans proline' 0 C--N 1.353 0.765 1 C-N-CA 126.413 4.742 . . . . 0.0 113.736 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.597 HG23 ' HA2' ' A' ' 88' ' ' GLY . 53.6 m -159.01 104.9 1.73 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 101.813 -3.403 . . . . 0.0 101.813 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.86 134.45 33.94 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 127.326 2.25 . . . . 0.0 111.287 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.72 175.61 6.83 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 127.997 2.519 . . . . 0.0 110.789 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.1 -48.05 33.91 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 119.611 3.189 . . . . 0.0 119.611 -173.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.16 -9.15 51.5 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 126.722 2.009 . . . . 0.0 114.603 173.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.527 ' CB ' ' HB1' ' A' ' 128' ' ' ALA 0.333 2.9 m-20 -78.32 -19.86 52.65 Favored 'General case' 0 CA--C 1.572 1.816 0 C-N-CA 129.344 3.058 . . . . 0.0 111.532 168.264 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.88 122.71 18.74 Favored 'General case' 0 C--N 1.384 2.084 0 N-CA-C 120.546 3.536 . . . . 0.0 120.546 171.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 164.98 -155.96 27.67 Favored Glycine 0 CA--C 1.472 -2.65 0 C-N-CA 127.044 2.259 . . . . 0.0 109.254 173.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.409 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 19.4 m -119.33 131.82 55.78 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 115.64 -2.424 . . . . 0.0 108.441 171.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 110' ' ' LYS 0.296 26.5 m-85 -95.39 134.23 38.44 Favored 'General case' 0 C--N 1.369 1.44 0 C-N-CA 129.799 3.239 . . . . 0.0 111.467 -172.209 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -143.3 145.09 32.42 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 124.67 1.188 . . . . 0.0 107.924 -173.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.3 p -135.75 143.6 35.98 Favored 'Isoleucine or valine' 0 C--N 1.359 1.02 0 C-N-CA 118.817 -1.153 . . . . 0.0 113.006 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 m -109.71 124.1 50.64 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 128.914 2.885 . . . . 0.0 105.392 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -134.69 131.74 53.92 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 127.701 2.4 . . . . 0.0 111.632 -176.681 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 7.5 m -119.63 134.17 55.34 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 126.479 1.912 . . . . 0.0 113.813 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.492 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.389 9.1 p-10 -125.51 -174.17 3.0 Favored 'General case' 0 C--N 1.383 2.044 0 CA-C-N 120.831 1.65 . . . . 0.0 113.176 175.722 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 3.6 p -49.24 -2.09 0.01 OUTLIER 'General case' 0 C--N 1.376 1.758 1 C-N-CA 136.801 6.04 . . . . 0.0 120.015 -165.621 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -101.44 4.82 41.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 117.755 -1.578 . . . . 0.0 108.751 165.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.409 72.5 mm-40 66.42 40.05 3.72 Favored 'General case' 0 C--N 1.376 1.744 1 C-N-CA 133.346 4.658 . . . . 0.0 110.146 -172.911 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.411 ' C ' HG23 ' A' ' 141' ' ' THR . 2.8 m -112.87 129.01 69.27 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-N 111.365 -2.652 . . . . 0.0 111.362 -170.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.5 OUTLIER -92.04 140.38 29.71 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 124.48 1.112 . . . . 0.0 111.113 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -117.78 156.56 28.11 Favored 'General case' 0 C--N 1.346 0.452 1 C-N-CA 132.193 4.197 . . . . 0.0 104.063 174.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -129.54 141.33 51.0 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 173.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.425 50.4 p -120.03 146.91 45.44 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 120.081 1.31 . . . . 0.0 109.05 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -54.07 148.43 10.94 Favored 'General case' 0 CA--C 1.484 -1.574 1 C-N-CA 137.304 6.242 . . . . 0.0 118.442 -160.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -68.45 109.85 3.88 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 125.553 1.541 . . . . 0.0 111.106 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.16 109.93 21.96 Favored 'General case' 0 C--N 1.366 1.298 0 N-CA-C 102.267 -3.234 . . . . 0.0 102.267 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.68 112.92 25.1 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 123.679 1.704 . . . . 0.0 111.82 -172.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.92 128.65 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 O-C-N 120.279 -1.513 . . . . 0.0 109.798 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 C--N 1.361 1.097 0 N-CA-C 101.847 -3.39 . . . . 0.0 101.847 174.07 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.413 ' O ' HG22 ' A' ' 92' ' ' THR . 0.2 OUTLIER . . . . . 0 CA--C 1.583 2.243 0 CA-C-O 121.43 0.633 . . . . 0.0 112.043 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 81' ' ' ALA . 21.7 m -169.54 171.63 7.49 Favored 'General case' 0 N--CA 1.464 0.264 1 O-C-N 115.876 -4.265 . . . . 0.0 102.062 172.703 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.407 ' N ' HG22 ' A' ' 80' ' ' THR . . . -125.8 -45.79 1.74 Allowed 'General case' 0 C--N 1.365 1.255 0 C-N-CA 126.51 1.924 . . . . 0.0 114.157 176.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.0 t -174.27 141.19 0.71 Allowed 'General case' 0 C--N 1.364 1.223 0 O-C-N 119.885 -1.759 . . . . 0.0 115.068 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.3 ttt -126.38 136.89 53.26 Favored 'General case' 0 C--N 1.38 1.9 0 CA-C-N 118.352 0.524 . . . . 0.0 109.927 157.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m -114.59 113.37 24.29 Favored 'General case' 0 C--N 1.377 1.764 0 O-C-N 119.84 -1.788 . . . . 0.0 108.015 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.295 11.5 p -151.56 174.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 123.569 1.652 . . . . 0.0 114.076 -170.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -83.19 144.5 29.76 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 127.202 2.201 . . . . 0.0 105.573 158.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.421 4.5 pt-20 -44.01 124.37 3.8 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 117.202 -3.436 . . . . 0.0 118.071 -171.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.456 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 122.62 52.63 0.21 Allowed Glycine 0 C--N 1.358 1.787 0 C-N-CA 127.662 2.554 . . . . 0.0 109.887 -154.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.91 161.68 15.1 Favored 'General case' 0 C--N 1.376 1.731 0 C-N-CA 124.95 1.3 . . . . 0.0 110.908 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.74 97.43 6.7 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.787 HD21 ' CZ ' ' A' ' 136' ' ' TYR 0.298 53.7 tp -120.8 114.93 22.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -169.709 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -112.01 131.77 55.21 Favored 'General case' 0 C--N 1.373 1.591 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.412 HD21 ' HG ' ' A' ' 91' ' ' LEU . 1.1 mm? -129.37 115.86 18.18 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 175.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.4 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 6.9 t -151.11 134.04 15.84 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 119.419 -2.051 . . . . 0.0 112.273 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.75 173.79 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.851 0 C-N-CA 129.594 3.158 . . . . 0.0 104.786 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -104.01 141.06 36.85 Favored 'General case' 0 C--N 1.369 1.445 0 O-C-N 119.293 -2.129 . . . . 0.0 105.349 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -139.24 145.25 38.99 Favored 'General case' 0 C--N 1.365 1.262 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 -173.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -158.41 174.26 15.39 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 130.741 3.616 . . . . 0.0 101.561 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.15 43.2 1.46 Allowed Glycine 0 C--N 1.364 2.128 0 CA-C-N 121.879 2.127 . . . . 0.0 117.696 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.44 22.13 52.04 Favored Glycine 0 C--N 1.359 1.82 0 C-N-CA 127.785 2.612 . . . . 0.0 116.342 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 76.1 m -116.95 111.44 19.61 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 114.018 -2.896 . . . . 0.0 107.944 176.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.507 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.93 -92.5 0.93 Allowed Glycine 0 C--N 1.38 3.004 0 CA-C-N 124.628 3.376 . . . . 0.0 110.118 -175.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -60.5 167.54 7.95 Favored 'Trans proline' 0 CA--C 1.564 1.998 1 C-N-CA 126.82 5.013 . . . . 0.0 116.19 159.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.572 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.1 m-85 -98.47 143.28 29.08 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 120.613 3.56 . . . . 0.0 120.613 -165.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 t -102.96 141.12 36.31 Favored 'General case' 0 C--N 1.381 1.945 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.528 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -134.72 156.03 49.51 Favored 'General case' 0 C--N 1.347 0.494 1 N-CA-C 122.517 4.265 . . . . 0.0 122.517 -162.107 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.06 112.79 10.84 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 111.124 -2.762 . . . . 0.0 104.768 171.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.48 ' CE3' ' HB ' ' A' ' 138' ' ' VAL . 35.2 m95 -111.96 148.0 34.69 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.327 0.2 OUTLIER -159.36 169.93 22.92 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 166.019 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.454 ' HE3' ' CE2' ' A' ' 136' ' ' TYR 0.337 33.6 mtpt -123.19 127.31 48.46 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 115.431 -2.223 . . . . 0.0 107.089 173.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.437 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.308 0.7 OUTLIER 32.35 51.04 0.21 Allowed 'General case' 0 C--N 1.373 1.61 2 N-CA-C 123.763 4.727 . . . . 0.0 123.763 123.185 . . . . . . . . 5 4 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.88 1.92 49.47 Favored Glycine 0 C--N 1.377 2.821 2 O-C-N 133.907 7.004 . . . . 0.0 120.592 -169.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.574 0.6 OUTLIER -125.73 147.83 59.94 Favored Pre-proline 0 CA--C 1.563 1.466 1 N-CA-C 123.023 4.453 . . . . 0.0 123.023 -168.346 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.26 149.32 88.68 Favored 'Trans proline' 0 N--CA 1.499 1.842 1 C-N-CA 126.088 4.526 . . . . 0.0 116.245 173.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -110.28 153.69 43.24 Favored Pre-proline 0 CA--C 1.549 0.911 0 O-C-N 119.567 -1.958 . . . . 0.0 111.545 178.242 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 13.3 Cg_endo -68.09 90.13 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.098 1 C-N-CA 125.969 4.446 . . . . 0.0 114.992 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 t70 76.41 -52.63 0.6 Allowed 'General case' 0 C--N 1.364 1.221 0 C-N-CA 127.883 2.473 . . . . 0.0 114.474 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.424 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . 85.19 -62.89 0.06 Allowed 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 130.139 3.376 . . . . 0.0 116.282 173.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -58.04 55.81 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.078 1 C-N-CA 134.045 4.938 . . . . 0.0 118.13 -173.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -144.52 -78.1 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.89 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -173.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 160.93 -58.93 0.0 OUTLIER 'General case' 0 C--N 1.352 0.713 0 C-N-CA 125.172 1.389 . . . . 0.0 109.329 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.9 t -135.55 112.36 10.17 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 122.537 1.161 . . . . 0.0 111.169 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' TYR . . . . . 0.413 ' CD2' ' HG2' ' A' ' 116' ' ' PRO . 35.0 p90 -127.04 139.76 52.78 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 124.627 1.171 . . . . 0.0 110.338 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.6 m -129.99 140.39 50.9 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 120.647 -1.283 . . . . 0.0 110.57 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.425 ' CB ' HD23 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -112.27 99.6 47.03 Favored Pre-proline 0 C--N 1.356 0.878 0 C-N-CA 130.213 3.405 . . . . 0.0 105.684 177.45 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -77.43 -13.28 16.75 Favored 'Trans proline' 0 CA--C 1.536 0.606 1 C-N-CA 126.04 4.493 . . . . 0.0 112.891 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.456 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -162.1 100.94 1.11 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.21 133.5 35.33 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 127.826 2.451 . . . . 0.0 111.772 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.47 173.29 8.42 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 130.141 3.376 . . . . 0.0 111.265 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.42 -45.6 25.65 Favored 'General case' 0 C--N 1.367 1.349 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.85 -17.86 65.1 Favored 'General case' 0 C--N 1.367 1.326 0 C-N-CA 126.229 1.812 . . . . 0.0 115.316 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.271 37.8 m-20 -84.09 -16.41 43.82 Favored 'General case' 0 C--N 1.362 1.144 1 C-N-CA 132.209 4.204 . . . . 0.0 110.72 171.996 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.28 156.05 35.43 Favored 'General case' 0 C--N 1.392 2.44 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 163.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 138.64 -157.36 24.61 Favored Glycine 0 CA--C 1.452 -3.865 0 C-N-CA 127.735 2.588 . . . . 0.0 106.862 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.434 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.251 3.3 m -119.73 135.73 54.72 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 114.657 -2.817 . . . . 0.0 107.27 167.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.787 ' CZ ' HD21 ' A' ' 91' ' ' LEU . 28.8 m-85 -96.99 134.74 39.96 Favored 'General case' 0 C--N 1.373 1.589 0 C-N-CA 128.434 2.694 . . . . 0.0 111.689 -172.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -146.39 154.57 41.78 Favored 'General case' 0 C--N 1.371 1.541 0 C-N-CA 124.729 1.211 . . . . 0.0 110.419 -176.611 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.48 ' HB ' ' CE3' ' A' ' 108' ' ' TRP . 14.8 p -142.91 139.95 27.54 Favored 'Isoleucine or valine' 0 C--N 1.368 1.38 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.3 m -107.67 110.81 22.77 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 131.334 3.854 . . . . 0.0 106.388 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.572 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -127.38 116.8 45.11 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 C-N-CA 125.892 1.677 . . . . 0.0 111.918 -172.519 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.5 m -102.34 131.12 49.15 Favored 'General case' 0 C--N 1.358 0.959 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.437 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.35 36.4 p-10 -125.65 179.31 5.22 Favored 'General case' 0 C--N 1.376 1.718 0 CA-C-N 120.408 1.458 . . . . 0.0 111.519 174.137 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 22.0 p -49.34 3.49 0.01 OUTLIER 'General case' 0 C--N 1.371 1.503 1 C-N-CA 136.57 5.948 . . . . 0.0 120.413 -169.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -103.51 4.83 36.33 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 166.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.524 2.0 mp0 64.51 40.03 6.43 Favored 'General case' 0 C--N 1.376 1.726 1 C-N-CA 133.518 4.727 . . . . 0.0 112.528 -173.842 . . . . . . . . 3 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 m -112.68 123.48 68.41 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 CA-C-N 111.127 -2.761 . . . . 0.0 111.951 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.04 123.28 34.39 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 128.555 2.742 . . . . 0.0 105.303 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.55 158.36 23.79 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 129.14 2.976 . . . . 0.0 103.218 -174.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 9.0 t70 -129.56 141.27 51.01 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.214 1.007 . . . . 0.0 109.872 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.548 22.4 p -114.79 139.66 49.54 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 m -55.0 147.84 14.81 Favored 'General case' 0 C--N 1.366 1.321 1 C-N-CA 138.044 6.538 . . . . 0.0 117.898 -163.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.8 p -68.67 110.53 4.32 Favored 'General case' 0 C--N 1.375 1.701 0 C-N-CA 125.732 1.613 . . . . 0.0 110.33 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -101.2 110.35 22.36 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 -178.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.55 115.22 27.12 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 123.954 1.835 . . . . 0.0 113.171 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.85 128.25 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 O-C-N 119.65 -1.906 . . . . 0.0 107.602 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.493 -1.24 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 178.71 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.431 ' O ' HG22 ' A' ' 92' ' ' THR . 0.5 OUTLIER . . . . . 0 CA--C 1.586 2.329 0 CA-C-O 121.61 0.719 . . . . 0.0 112.558 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 m -169.79 171.97 7.0 Favored 'General case' 0 N--CA 1.467 0.412 1 O-C-N 114.69 -5.006 . . . . 0.0 101.598 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.13 -45.9 1.24 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.092 1.357 . . . . 0.0 111.159 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.9 p -171.03 125.2 0.65 Allowed 'General case' 0 C--N 1.361 1.103 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.0 ttt -130.6 118.0 20.37 Favored 'General case' 0 C--N 1.376 1.726 0 CA-C-N 120.605 1.548 . . . . 0.0 109.346 160.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -110.61 115.14 29.08 Favored 'General case' 0 C--N 1.368 1.407 0 O-C-N 119.823 -1.798 . . . . 0.0 108.181 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.8 p -150.03 173.71 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 126.848 2.059 . . . . 0.0 112.977 -169.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.46 144.59 46.21 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 128.042 2.537 . . . . 0.0 107.1 159.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.536 0.7 OUTLIER -44.13 123.28 3.3 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 124.628 3.376 . . . . 0.0 118.248 -171.282 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.431 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 126.96 43.17 0.26 Allowed Glycine 0 C--N 1.358 1.755 0 CA-C-N 111.45 -2.614 . . . . 0.0 112.09 -157.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.44 164.93 20.64 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 119.707 1.753 . . . . 0.0 112.156 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.07 114.93 28.85 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 125.994 1.718 . . . . 0.0 108.556 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 124' ' ' THR . 7.0 mp -120.5 114.49 21.85 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 127.668 2.387 . . . . 0.0 114.693 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -109.61 124.49 51.24 Favored 'General case' 0 C--N 1.364 1.235 0 N-CA-C 102.467 -3.16 . . . . 0.0 102.467 170.503 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -124.69 114.77 19.76 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.4 t -153.62 134.09 13.56 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 120.021 -1.675 . . . . 0.0 112.182 -172.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -149.12 174.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.736 0 C-N-CA 130.513 3.525 . . . . 0.0 104.591 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -103.67 140.74 37.17 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.16 142.39 34.04 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 120.588 3.551 . . . . 0.0 120.588 -173.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.3 m -158.47 174.54 14.94 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 130.337 3.455 . . . . 0.0 102.023 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.26 44.35 1.89 Allowed Glycine 0 C--N 1.366 2.2 0 CA-C-N 122.122 2.237 . . . . 0.0 117.639 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.67 20.16 62.27 Favored Glycine 0 C--N 1.358 1.806 0 C-N-CA 127.78 2.609 . . . . 0.0 114.776 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 45.2 p -116.75 110.81 18.91 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 113.948 -2.929 . . . . 0.0 108.285 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.595 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 73.03 -92.47 0.64 Allowed Glycine 0 C--N 1.376 2.762 0 C-N-CA 129.876 3.607 . . . . 0.0 111.065 -170.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -61.86 168.75 8.26 Favored 'Trans proline' 0 CA--C 1.566 2.113 1 C-N-CA 127.128 5.219 . . . . 0.0 117.207 160.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.592 ' HB3' HG12 ' A' ' 140' ' ' VAL . 75.8 m-85 -93.72 141.36 28.58 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 121.186 3.772 . . . . 0.0 121.186 -167.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -103.24 147.0 27.58 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 128.19 2.596 . . . . 0.0 105.093 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.519 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -144.05 166.21 25.63 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 121.579 3.918 . . . . 0.0 121.579 -160.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.07 113.7 7.86 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 111.715 -2.493 . . . . 0.0 106.263 172.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -112.07 153.84 26.29 Favored 'General case' 0 C--N 1.376 1.722 0 O-C-N 120.149 -1.594 . . . . 0.0 107.87 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.345 0.0 OUTLIER -156.04 152.97 28.73 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 163.236 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.859 ' HZ1' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -128.27 103.86 7.41 Favored 'General case' 0 C--N 1.369 1.451 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 177.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.456 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.186 4.0 t70 37.54 54.98 1.46 Allowed 'General case' 0 CA--C 1.453 -2.76 1 CA-C-O 110.881 -4.39 . . . . 0.0 119.601 153.505 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.51 -17.0 51.62 Favored Glycine 0 C--N 1.372 2.559 2 O-C-N 134.729 7.518 . . . . 0.0 116.408 -175.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.421 ' HB3' ' HE2' ' A' ' 110' ' ' LYS 0.282 48.5 m -124.12 149.48 60.56 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 130.754 3.622 . . . . 0.0 119.304 -165.723 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.12 154.46 51.44 Favored 'Trans proline' 0 N--CA 1.507 2.315 1 C-N-CA 126.937 5.091 . . . . 0.0 116.378 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.576 ' HB ' ' HD2' ' A' ' 116' ' ' PRO 0.274 0.8 OUTLIER -95.12 164.59 18.9 Favored Pre-proline 0 N--CA 1.484 1.23 0 O-C-N 117.967 -2.958 . . . . 0.0 111.917 174.309 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.576 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 1.9 Cg_endo -67.98 92.24 0.38 Allowed 'Trans proline' 0 C--N 1.368 1.584 1 C-N-CA 126.491 4.794 . . . . 0.0 112.585 177.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 78.7 -65.89 0.21 Allowed 'General case' 0 C--N 1.351 0.671 0 C-N-CA 128.448 2.699 . . . . 0.0 111.721 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 88.21 148.72 0.05 OUTLIER 'General case' 0 CA--C 1.466 -2.276 0 C-N-CA 128.029 2.532 . . . . 0.0 112.196 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.458 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 18.5 m 74.13 62.62 0.08 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.177 -1.828 . . . . 0.0 115.17 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.01 -77.96 0.08 OUTLIER Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 115.214 0.846 . . . . 0.0 115.214 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.599 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 160.53 -58.27 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 124.639 1.176 . . . . 0.0 109.187 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.4 t -141.68 112.85 7.46 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 123.367 1.556 . . . . 0.0 113.311 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.257 0.0 OUTLIER -127.47 139.72 52.62 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 124.856 1.262 . . . . 0.0 108.931 172.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 91' ' ' LEU . 65.4 m -129.73 138.62 51.22 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 173.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.35 114.11 48.17 Favored Pre-proline 0 C--N 1.363 1.182 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 173.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.32 -14.07 16.57 Favored 'Trans proline' 0 C--N 1.354 0.852 1 C-N-CA 126.273 4.649 . . . . 0.0 112.83 174.739 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.431 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -161.83 106.41 1.25 Allowed 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.536 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.47 134.97 33.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.074 2.55 . . . . 0.0 113.823 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.16 176.64 6.89 Favored 'General case' 0 C--N 1.371 1.536 0 C-N-CA 127.878 2.471 . . . . 0.0 110.568 174.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.04 -48.97 32.8 Favored 'General case' 0 C--N 1.368 1.413 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 -173.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -64.31 -17.35 63.57 Favored 'General case' 0 C--N 1.366 1.283 0 C-N-CA 127.104 2.162 . . . . 0.0 114.685 173.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.859 ' HA ' ' HZ1' ' A' ' 110' ' ' LYS 0.35 32.7 m-20 -83.67 -19.13 35.9 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 130.894 3.678 . . . . 0.0 112.287 172.241 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.61 131.98 48.5 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 163.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 159.3 -158.82 29.89 Favored Glycine 0 CA--C 1.456 -3.616 0 C-N-CA 126.914 2.197 . . . . 0.0 107.737 167.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.333 22.8 m -116.88 136.02 53.27 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 114.964 -2.694 . . . . 0.0 108.316 170.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.529 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 22.9 m-85 -96.77 133.67 41.05 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 119.24 -2.163 . . . . 0.0 114.143 -171.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -139.4 141.94 37.52 Favored 'General case' 0 C--N 1.37 1.487 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -173.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.3 p -141.3 141.7 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 117.614 -1.635 . . . . 0.0 114.704 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 18.1 m -107.64 118.9 37.93 Favored 'General case' 0 C--N 1.378 1.844 0 C-N-CA 128.488 2.715 . . . . 0.0 107.187 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -131.33 118.98 42.25 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 126.058 1.743 . . . . 0.0 111.697 -172.67 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.448 HG23 ' C ' ' A' ' 146' ' ' VAL . 6.6 m -108.24 129.36 55.21 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.418 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.402 28.9 p-10 -124.02 -177.15 3.67 Favored 'General case' 0 C--N 1.372 1.559 0 O-C-N 120.944 -1.098 . . . . 0.0 112.885 174.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.595 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 86.2 p -50.15 3.93 0.01 OUTLIER 'General case' 0 C--N 1.36 1.026 2 C-N-CA 135.742 5.617 . . . . 0.0 121.954 -168.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -101.8 4.65 40.61 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 164.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.348 3.1 mp0 66.78 39.69 3.41 Favored 'General case' 0 C--N 1.379 1.887 1 C-N-CA 133.678 4.791 . . . . 0.0 109.974 -174.367 . . . . . . . . 3 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.448 ' C ' HG23 ' A' ' 141' ' ' THR . 4.3 m -113.13 123.97 69.3 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.62 0 CA-C-N 112.418 -2.174 . . . . 0.0 113.021 -170.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.31 123.67 34.92 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.251 2.221 . . . . 0.0 107.034 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.13 156.54 26.26 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -130.35 147.07 52.02 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 121.382 -0.824 . . . . 0.0 110.104 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.294 58.7 p -123.64 143.7 50.08 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 m -54.93 148.24 13.78 Favored 'General case' 0 C--N 1.377 1.791 2 C-N-CA 138.807 6.843 . . . . 0.0 114.699 -168.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.8 p -67.61 109.81 3.43 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.223 1.809 . . . . 0.0 111.238 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.72 108.78 20.48 Favored 'General case' 0 C--N 1.37 1.488 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -94.63 109.22 21.17 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 120.519 1.509 . . . . 0.0 111.465 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.87 113.93 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 59.3 m . . . . . 0 CA--C 1.492 -1.28 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 -175.911 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.554 ' O ' HG22 ' A' ' 92' ' ' THR . 1.2 mp . . . . . 0 CA--C 1.578 2.046 0 CA-C-O 122.278 1.037 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.519 ' HB ' ' SG ' ' A' ' 153' ' ' CYS . 19.1 m -172.25 179.75 2.5 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 100.399 -3.926 . . . . 0.0 100.399 174.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.12 -42.66 0.46 Allowed 'General case' 0 C--N 1.367 1.353 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.0 m -164.63 99.63 0.79 Allowed 'General case' 0 N--CA 1.477 0.9 0 O-C-N 118.449 -2.657 . . . . 0.0 115.601 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 19.9 mmm -120.27 117.55 28.13 Favored 'General case' 0 C--N 1.369 1.449 0 CA-C-O 122.591 1.186 . . . . 0.0 109.664 168.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.5 p -115.15 114.86 25.85 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.94 174.63 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 112.973 -1.921 . . . . 0.0 111.17 -171.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.02 144.68 52.17 Favored 'General case' 0 CA--C 1.564 1.501 0 O-C-N 118.968 -2.332 . . . . 0.0 107.724 158.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.437 0.7 OUTLIER -44.14 123.17 3.26 Favored 'General case' 0 N--CA 1.523 3.176 0 O-C-N 117.675 -3.141 . . . . 0.0 117.733 -170.118 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.511 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 123.52 50.17 0.22 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-N 111.347 -2.661 . . . . 0.0 108.884 -154.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 155' ' ' VAL . . . -95.9 139.43 32.12 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 125.298 1.439 . . . . 0.0 108.32 173.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.94 119.33 32.71 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -167.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.551 ' HG ' HG11 ' A' ' 155' ' ' VAL . 6.2 mt -121.46 129.14 52.79 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.194 2.598 . . . . 0.0 117.584 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -115.95 118.48 33.05 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 100.352 -3.944 . . . . 0.0 100.352 167.792 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.49 115.09 22.2 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.496 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 8.8 t -155.03 131.58 10.54 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -169.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 m -150.17 173.71 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.649 1 C-N-CA 131.748 4.019 . . . . 0.0 103.465 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.2 t -104.29 141.44 36.3 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 122.857 2.571 . . . . 0.0 106.67 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.668 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -134.75 145.53 48.53 Favored 'General case' 0 C--N 1.37 1.495 0 N-CA-C 119.618 3.192 . . . . 0.0 119.618 -174.38 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.6 m -158.29 174.29 15.38 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 131.644 3.978 . . . . 0.0 101.41 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.39 44.49 2.21 Favored Glycine 0 C--N 1.364 2.089 0 CA-C-N 122.111 2.232 . . . . 0.0 116.508 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.86 21.42 57.62 Favored Glycine 0 C--N 1.356 1.676 0 C-N-CA 127.297 2.379 . . . . 0.0 115.578 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.7 m -117.6 111.25 18.94 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 114.799 -2.524 . . . . 0.0 107.728 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.621 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 78.57 -91.22 1.16 Allowed Glycine 0 C--N 1.375 2.721 0 C-N-CA 129.546 3.451 . . . . 0.0 109.679 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.61 167.22 8.61 Favored 'Trans proline' 0 CA--C 1.57 2.312 1 C-N-CA 126.566 4.844 . . . . 0.0 116.288 160.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 69.0 m-85 -98.94 145.33 27.14 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 120.473 3.508 . . . . 0.0 120.473 -166.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.7 t -102.7 140.06 37.47 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.478 ' CE1' ' HA ' ' A' ' 119' ' ' SER . 0.0 OUTLIER -114.32 148.98 36.69 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 -164.708 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.65 111.25 10.46 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 102.358 -3.201 . . . . 0.0 102.358 162.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.503 ' HB2' HG13 ' A' ' 115' ' ' ILE . 40.7 m95 -112.93 150.28 32.04 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 125.301 1.44 . . . . 0.0 108.661 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.65 169.64 19.92 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 165.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -139.84 104.15 4.82 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 175.146 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.434 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.235 1.5 t70 34.77 52.85 0.6 Allowed 'General case' 0 CA--C 1.473 -1.994 2 N-CA-C 122.336 4.199 . . . . 0.0 122.336 142.339 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.77 -11.25 71.41 Favored Glycine 0 C--N 1.366 2.195 2 O-C-N 133.346 6.654 . . . . 0.0 118.629 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.1 m -124.14 148.17 56.74 Favored Pre-proline 0 CA--C 1.564 1.497 0 C-N-CA 131.287 3.835 . . . . 0.0 121.034 -168.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.62 148.52 92.26 Favored 'Trans proline' 0 C--N 1.378 2.122 1 C-N-CA 126.834 5.023 . . . . 0.0 115.247 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.712 HD11 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -107.12 162.11 20.76 Favored Pre-proline 0 C--N 1.354 0.788 0 O-C-N 119.741 -1.85 . . . . 0.0 115.482 -177.545 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 9.0 Cg_endo -73.82 88.96 1.02 Allowed 'Trans proline' 0 C--N 1.363 1.335 1 C-N-CA 125.923 4.415 . . . . 0.0 114.699 -177.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.1 t70 82.19 -53.71 0.23 Allowed 'General case' 0 C--N 1.361 1.098 0 C-N-CA 128.528 2.731 . . . . 0.0 113.48 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.712 ' HB2' HD11 ' A' ' 115' ' ' ILE . . . 91.55 -48.34 0.02 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 129.789 3.236 . . . . 0.0 113.639 177.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.478 ' HA ' ' CE1' ' A' ' 106' ' ' TYR 0.252 33.1 t -77.61 49.33 0.73 Allowed 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 129.479 3.112 . . . . 0.0 114.017 -174.718 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -131.0 -46.16 0.15 Allowed Glycine 0 C--N 1.367 2.267 1 N-CA-C 124.665 4.626 . . . . 0.0 124.665 -162.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.668 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.291 . . 99.72 -75.99 0.0 OUTLIER 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.734 2.267 . . . . 0.0 111.564 -177.578 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.298 6.5 t -130.95 102.32 6.0 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-O 123.528 1.633 . . . . 0.0 110.805 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.262 19.2 p90 -126.97 141.74 51.72 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 128.324 2.65 . . . . 0.0 111.485 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 91' ' ' LEU . 38.0 m -128.42 139.29 52.44 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 119.645 -1.909 . . . . 0.0 107.861 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -116.16 92.39 35.51 Favored Pre-proline 0 C--N 1.358 0.96 0 C-N-CA 129.494 3.118 . . . . 0.0 104.362 175.072 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -68.47 -33.16 23.56 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.47 3.447 . . . . 0.0 112.719 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.511 HG23 ' HA2' ' A' ' 88' ' ' GLY . 97.5 m -127.4 104.12 7.74 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 126.008 1.723 . . . . 0.0 106.442 176.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.09 124.06 35.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.305 1.442 . . . . 0.0 110.51 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.38 170.86 13.16 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.91 2.084 . . . . 0.0 108.002 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.12 -47.51 23.37 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -170.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.65 -23.38 67.06 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 126.753 2.021 . . . . 0.0 115.061 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -83.43 -12.85 55.92 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.846 2.858 . . . . 0.0 112.574 172.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.51 155.83 19.43 Favored 'General case' 0 C--N 1.381 1.951 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 170.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 141.54 -149.39 21.07 Favored Glycine 0 CA--C 1.457 -3.554 0 N-CA-C 104.713 -3.355 . . . . 0.0 104.713 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.264 66.8 m -125.97 138.26 53.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 114.543 -2.863 . . . . 0.0 107.606 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 8.7 m-85 -96.96 134.64 40.06 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 126.445 1.898 . . . . 0.0 112.054 -168.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -144.58 143.43 30.8 Favored 'General case' 0 C--N 1.365 1.26 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.332 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.409 HG21 ' CE2' ' A' ' 108' ' ' TRP . 14.9 p -143.25 143.51 24.68 Favored 'Isoleucine or valine' 0 C--N 1.364 1.236 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -111.56 122.63 48.33 Favored 'General case' 0 C--N 1.375 1.705 0 C-N-CA 130.921 3.688 . . . . 0.0 105.994 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.421 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -134.55 120.37 32.35 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 124.518 1.127 . . . . 0.0 109.844 -172.366 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.412 HG23 ' C ' ' A' ' 146' ' ' VAL . 7.9 m -105.22 132.87 50.89 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -176.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.47 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.384 23.9 p-10 -126.12 -174.45 3.11 Favored 'General case' 0 C--N 1.38 1.904 0 C-N-CA 124.589 1.155 . . . . 0.0 112.691 176.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.621 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 6.5 p -49.24 0.31 0.01 OUTLIER 'General case' 0 C--N 1.372 1.551 1 C-N-CA 136.577 5.951 . . . . 0.0 120.821 -166.725 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -104.04 4.54 34.52 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 118.474 -1.29 . . . . 0.0 107.836 165.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.464 94.7 mm-40 67.24 40.3 2.82 Favored 'General case' 0 C--N 1.374 1.631 1 C-N-CA 132.707 4.403 . . . . 0.0 110.56 -172.692 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.412 ' C ' HG23 ' A' ' 141' ' ' THR . 3.5 m -112.78 126.07 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.346 0 CA-C-N 111.605 -2.543 . . . . 0.0 112.845 -171.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.7 OUTLIER -90.83 125.9 35.87 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 127.777 2.431 . . . . 0.0 108.109 -176.503 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.24 156.74 26.05 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 -176.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -130.65 146.88 52.24 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 120.543 -1.348 . . . . 0.0 111.492 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.433 91.8 p -127.19 146.29 50.46 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.557 0.743 . . . . 0.0 111.807 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.0 m -54.61 148.59 12.19 Favored 'General case' 0 CA--C 1.488 -1.407 1 C-N-CA 138.496 6.718 . . . . 0.0 117.42 -164.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.8 p -68.56 110.2 4.1 Favored 'General case' 0 C--N 1.377 1.768 0 C-N-CA 127.764 2.426 . . . . 0.0 110.046 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 80' ' ' THR . 1.0 OUTLIER -106.35 109.35 21.25 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 -172.308 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.54 122.46 42.64 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -168.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.551 HG11 ' HG ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -123.17 115.03 44.43 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 C-N-CA 125.045 1.338 . . . . 0.0 108.128 176.7 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 62.7 m . . . . . 0 C--N 1.372 1.561 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 177.627 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 m -171.48 172.94 4.92 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 116.726 -3.734 . . . . 0.0 101.032 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.48 -42.71 0.55 Allowed 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.467 1.485 . . . . 0.0 111.479 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 154' ' ' ALA . 58.1 m -162.86 113.39 1.45 Allowed 'General case' 0 C--N 1.356 0.875 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.77 117.26 19.97 Favored 'General case' 0 C--N 1.371 1.532 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 162.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.6 m -116.41 116.81 28.38 Favored 'General case' 0 C--N 1.364 1.198 0 O-C-N 117.946 -2.971 . . . . 0.0 110.066 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 p -149.57 172.29 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.533 1.133 . . . . 0.0 113.059 -173.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -83.72 130.67 34.96 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 162.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.326 0.3 OUTLIER -41.53 123.09 2.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 120.076 3.361 . . . . 0.0 120.076 -150.492 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.62 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 141.64 48.84 0.05 OUTLIER Glycine 0 C--N 1.357 1.701 0 CA-C-N 109.941 -3.299 . . . . 0.0 111.896 -170.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.98 171.67 11.94 Favored 'General case' 0 C--N 1.37 1.471 0 C-N-CA 124.731 1.213 . . . . 0.0 112.95 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.54 115.77 30.2 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.251 1.42 . . . . 0.0 108.508 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 128' ' ' ALA . 6.7 mp -120.47 113.06 19.76 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.467 2.307 . . . . 0.0 113.346 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.97 126.92 54.44 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 170.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 136' ' ' TYR . 1.9 mm? -112.57 114.43 27.08 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 102.625 -3.102 . . . . 0.0 102.625 174.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.1 m -150.24 134.58 17.22 Favored 'General case' 0 C--N 1.368 1.389 0 CA-C-O 121.729 0.776 . . . . 0.0 112.043 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.17 173.03 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 C-N-CA 131.521 3.928 . . . . 0.0 103.766 174.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.9 p -103.59 137.43 41.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.48 2.712 . . . . 0.0 108.121 -173.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.404 ' HB2' ' HE2' ' A' ' 106' ' ' TYR . . . -141.6 145.82 35.5 Favored 'General case' 0 C--N 1.384 2.098 1 N-CA-C 127.602 6.149 . . . . 0.0 127.602 -170.493 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.431 HG23 ' HG2' ' A' ' 103' ' ' PRO . 23.7 p -156.67 175.07 14.54 Favored 'General case' 0 C--N 1.37 1.491 1 C-N-CA 134.241 5.016 . . . . 0.0 103.985 173.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.64 40.19 0.78 Allowed Glycine 0 C--N 1.367 2.27 0 O-C-N 119.279 -2.138 . . . . 0.0 117.798 170.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.5 30.73 15.06 Favored Glycine 0 C--N 1.359 1.812 0 C-N-CA 128.54 2.972 . . . . 0.0 114.648 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.4 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 33.5 p -117.35 109.67 17.1 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 114.39 -2.719 . . . . 0.0 108.79 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.68 -90.64 0.86 Allowed Glycine 0 C--N 1.378 2.886 0 CA-C-N 124.147 3.158 . . . . 0.0 111.591 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HG2' HG23 ' A' ' 98' ' ' THR . 62.8 Cg_endo -62.29 169.17 8.31 Favored 'Trans proline' 0 CA--C 1.569 2.256 1 C-N-CA 126.528 4.819 . . . . 0.0 113.62 158.119 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.45 ' HB3' HG12 ' A' ' 140' ' ' VAL . 61.0 m-85 -100.68 159.79 14.88 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 119.655 3.206 . . . . 0.0 119.655 -165.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.7 t -110.14 141.49 42.95 Favored 'General case' 0 C--N 1.368 1.392 0 N-CA-C 102.393 -3.188 . . . . 0.0 102.393 171.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.563 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -138.39 151.03 47.12 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 120.501 3.519 . . . . 0.0 120.501 -165.203 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.11 124.51 34.93 Favored 'General case' 0 C--N 1.368 1.391 0 C-N-CA 128.776 2.83 . . . . 0.0 106.908 172.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.494 ' HB2' HG13 ' A' ' 115' ' ' ILE . 8.8 m95 -113.2 147.62 37.09 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 125.344 1.457 . . . . 0.0 113.76 -177.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.14 169.63 17.5 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 166.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.8 ptmm? -140.74 107.43 5.35 Favored 'General case' 0 N--CA 1.42 -1.97 0 O-C-N 119.92 -1.738 . . . . 0.0 108.087 173.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.446 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.205 1.7 t70 34.23 52.25 0.49 Allowed 'General case' 0 C--N 1.373 1.605 1 N-CA-C 123.649 4.685 . . . . 0.0 123.649 141.859 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.14 -5.98 84.11 Favored Glycine 0 C--N 1.367 2.271 2 O-C-N 132.724 6.265 . . . . 0.0 119.712 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.405 ' HB2' ' NZ ' ' A' ' 110' ' ' LYS 0.359 2.2 m -124.05 149.37 60.03 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 130.468 3.507 . . . . 0.0 118.115 -171.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.09 158.6 38.39 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 124.221 3.281 . . . . 0.0 115.161 164.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.1 OUTLIER -108.94 155.95 39.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 120.04 -1.662 . . . . 0.0 110.255 177.345 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -69.06 84.37 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.216 3.944 . . . . 0.0 115.837 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.6 t70 80.13 -54.18 0.37 Allowed 'General case' 0 C--N 1.366 1.312 0 C-N-CA 129.302 3.041 . . . . 0.0 113.131 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 88.51 -163.52 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 130.405 3.482 . . . . 0.0 110.878 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.06 4.91 5.04 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.95 -31.95 6.07 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 120.651 3.02 . . . . 0.0 120.651 -163.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.279 . . 91.52 -52.91 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 127.684 2.393 . . . . 0.0 111.317 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.319 12.1 t -140.33 97.44 3.22 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 123.022 1.392 . . . . 0.0 109.561 177.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.27 2.5 p90 -126.69 140.25 52.54 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 128.03 2.532 . . . . 0.0 111.374 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.8 m -129.58 140.26 51.26 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 119.804 -1.81 . . . . 0.0 112.802 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 125' ' ' LYS 0.313 0.7 OUTLIER -108.73 111.99 60.69 Favored Pre-proline 0 C--N 1.373 1.609 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 168.183 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -77.65 -17.3 14.32 Favored 'Trans proline' 0 CA--C 1.538 0.681 1 C-N-CA 126.373 4.715 . . . . 0.0 113.503 171.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.62 HG23 ' HA2' ' A' ' 88' ' ' GLY . 61.5 m -157.79 107.05 2.1 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 103.277 -2.861 . . . . 0.0 103.277 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.555 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -94.33 134.79 36.44 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.234 2.213 . . . . 0.0 113.822 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.07 172.2 11.45 Favored 'General case' 0 C--N 1.371 1.505 0 C-N-CA 128.444 2.697 . . . . 0.0 110.47 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.62 -45.81 28.0 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 119.817 3.265 . . . . 0.0 119.817 -171.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -62.75 -17.66 61.31 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 127.833 2.453 . . . . 0.0 114.977 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.555 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 44.0 m-20 -79.55 -14.89 58.54 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 128.146 2.578 . . . . 0.0 112.713 170.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.48 38.99 Favored 'General case' 0 C--N 1.389 2.325 1 N-CA-C 122.339 4.2 . . . . 0.0 122.339 172.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.73 -135.91 5.37 Favored Glycine 0 C--N 1.374 2.652 0 C-N-CA 130.314 3.816 . . . . 0.0 109.253 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.45 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 19.7 m -129.78 140.25 51.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 115.853 -2.339 . . . . 0.0 110.679 173.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.581 ' CZ ' ' HD2' ' A' ' 110' ' ' LYS . 43.2 m-85 -97.03 134.75 39.98 Favored 'General case' 0 C--N 1.366 1.323 0 C-N-CA 127.09 2.156 . . . . 0.0 113.016 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -142.45 141.54 32.21 Favored 'General case' 0 C--N 1.368 1.398 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -174.234 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.644 HG13 ' OG ' ' A' ' 150' ' ' SER 0.36 2.2 p -133.75 134.63 56.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -175.439 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.94 107.81 19.01 Favored 'General case' 0 C--N 1.377 1.773 0 C-N-CA 130.345 3.458 . . . . 0.0 106.541 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -121.62 118.67 56.58 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 C-N-CA 128.243 2.617 . . . . 0.0 112.49 -168.106 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.418 HG23 ' C ' ' A' ' 146' ' ' VAL . 4.2 m -103.57 132.81 49.51 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 119.318 -2.114 . . . . 0.0 114.391 -177.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.449 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.327 24.4 p-10 -128.39 -178.96 4.77 Favored 'General case' 0 C--N 1.378 1.816 0 CA-C-N 120.321 1.419 . . . . 0.0 111.52 175.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.475 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 13.3 p -49.23 3.22 0.01 OUTLIER 'General case' 0 C--N 1.372 1.562 1 C-N-CA 136.515 5.926 . . . . 0.0 120.332 -169.26 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -101.01 4.78 42.7 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.618 162.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.439 0.7 OUTLIER 64.96 39.63 5.68 Favored 'General case' 0 C--N 1.372 1.569 1 C-N-CA 134.024 4.93 . . . . 0.0 111.635 -174.625 . . . . . . . . 4 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.418 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.19 133.7 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 CA-C-N 111.213 -2.721 . . . . 0.0 111.885 -170.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.84 125.78 35.83 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 127.65 2.38 . . . . 0.0 106.87 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.8 158.78 22.37 Favored 'General case' 0 CA--C 1.486 -1.481 0 C-N-CA 129.267 3.027 . . . . 0.0 103.123 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -126.47 135.33 51.22 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 123.836 1.779 . . . . 0.0 109.605 -174.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.644 ' OG ' HG13 ' A' ' 138' ' ' VAL 0.283 2.8 p -121.96 146.51 47.07 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.001 -1.908 . . . . 0.0 109.952 -176.19 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 m -54.14 147.1 13.53 Favored 'General case' 0 CA--C 1.481 -1.682 1 C-N-CA 136.91 6.084 . . . . 0.0 118.273 -158.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.7 p -69.47 110.67 4.86 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.677 2.391 . . . . 0.0 110.549 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 109.77 21.94 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -98.22 113.44 25.37 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-O 123.844 1.783 . . . . 0.0 112.837 -173.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.18 128.35 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 O-C-N 119.187 -2.196 . . . . 0.0 109.511 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.493 -1.216 0 N-CA-C 103.795 -2.669 . . . . 0.0 103.795 175.463 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.621 ' O ' HG22 ' A' ' 92' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.211 -0.946 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -172.61 172.41 4.26 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 117.279 -3.388 . . . . 0.0 104.499 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.46 -48.33 1.69 Allowed 'General case' 0 C--N 1.355 0.844 0 C-N-CA 126.844 2.057 . . . . 0.0 112.061 175.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.2 t -173.68 138.07 0.64 Allowed 'General case' 0 C--N 1.362 1.117 0 O-C-N 119.36 -2.087 . . . . 0.0 115.088 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.3 ttt -141.03 116.56 10.18 Favored 'General case' 0 C--N 1.377 1.78 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 158.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.5 p -109.45 116.18 31.32 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 119.409 -2.057 . . . . 0.0 109.432 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.52 172.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.794 0 C-N-CA 126.327 1.851 . . . . 0.0 110.174 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.86 133.8 35.65 Favored 'General case' 0 C--N 1.371 1.505 0 O-C-N 119.424 -2.048 . . . . 0.0 106.561 163.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.288 9.5 pt-20 -42.55 122.41 2.27 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 120.232 3.419 . . . . 0.0 120.232 -156.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.455 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 140.37 46.09 0.06 OUTLIER Glycine 0 C--N 1.361 1.954 0 CA-C-N 110.312 -3.131 . . . . 0.0 110.979 -164.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.38 167.12 16.79 Favored 'General case' 0 C--N 1.375 1.69 0 C-N-CA 125.222 1.409 . . . . 0.0 112.984 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.31 105.8 14.19 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.419 1.087 . . . . 0.0 110.578 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.31 121.51 42.21 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.464 1.506 . . . . 0.0 113.418 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -105.08 131.04 53.09 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 102.221 -3.251 . . . . 0.0 102.221 172.084 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.65 HD11 ' CD2' ' A' ' 136' ' ' TYR . 4.2 mm? -120.2 113.57 20.63 Favored 'General case' 0 C--N 1.352 0.682 1 N-CA-C 98.967 -4.457 . . . . 0.0 98.967 170.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.6 m -153.67 132.79 12.59 Favored 'General case' 0 C--N 1.365 1.269 0 CA-C-N 121.093 1.769 . . . . 0.0 109.8 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.7 m -149.22 174.64 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 130.893 3.677 . . . . 0.0 104.104 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -103.89 139.65 38.78 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 128.25 2.62 . . . . 0.0 105.254 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.58 144.26 34.14 Favored 'General case' 0 C--N 1.381 1.964 1 N-CA-C 123.91 4.781 . . . . 0.0 123.91 -174.83 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.7 p -156.71 175.62 13.82 Favored 'General case' 0 C--N 1.364 1.212 1 C-N-CA 133.812 4.845 . . . . 0.0 104.288 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.54 40.0 0.76 Allowed Glycine 0 C--N 1.366 2.233 0 O-C-N 119.992 -1.693 . . . . 0.0 117.243 168.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.28 29.46 27.72 Favored Glycine 0 C--N 1.362 2.0 0 C-N-CA 128.199 2.809 . . . . 0.0 115.419 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.7 m -117.94 110.6 17.92 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 115.178 -2.344 . . . . 0.0 109.008 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.517 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 77.59 -87.08 1.03 Allowed Glycine 0 C--N 1.377 2.822 0 C-N-CA 129.402 3.382 . . . . 0.0 109.655 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.93 168.65 5.53 Favored 'Trans proline' 0 CA--C 1.566 2.09 1 C-N-CA 126.628 4.885 . . . . 0.0 115.143 157.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.491 ' HB3' HG12 ' A' ' 140' ' ' VAL . 67.8 m-85 -103.98 146.59 28.47 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 -166.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -102.64 140.01 37.48 Favored 'General case' 0 C--N 1.373 1.619 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.421 ' CD2' ' N ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -122.37 157.51 31.67 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 119.862 3.282 . . . . 0.0 119.862 -164.118 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -131.02 119.59 22.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 110.391 -3.095 . . . . 0.0 104.273 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.435 ' CE3' HG21 ' A' ' 138' ' ' VAL . 38.1 m95 -111.01 128.54 55.88 Favored 'General case' 0 C--N 1.379 1.87 0 CA-C-N 119.606 1.094 . . . . 0.0 111.235 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.328 0.2 OUTLIER -143.58 170.83 15.08 Favored 'General case' 0 C--N 1.377 1.779 0 CA-C-N 121.462 1.937 . . . . 0.0 108.145 170.539 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -151.0 107.3 3.47 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 120.138 -1.601 . . . . 0.0 108.843 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.477 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.268 1.3 t70 34.25 52.42 0.5 Allowed 'General case' 0 CA--C 1.467 -2.249 2 N-CA-C 122.477 4.251 . . . . 0.0 122.477 142.186 . . . . . . . . 4 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.44 2.2 83.81 Favored Glycine 0 C--N 1.373 2.637 2 O-C-N 133.935 7.022 . . . . 0.0 118.266 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.265 3.2 m -125.06 147.1 55.85 Favored Pre-proline 0 C--N 1.349 0.553 0 C-N-CA 127.672 2.389 . . . . 0.0 116.853 -172.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.63 152.37 78.3 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 124.697 3.598 . . . . 0.0 113.842 170.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -103.76 148.83 36.42 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 120.06 -1.65 . . . . 0.0 108.296 175.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -62.61 -78.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.996 3.797 . . . . 0.0 119.384 -166.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -125.42 63.65 1.18 Allowed 'General case' 0 C--N 1.349 0.548 0 C-N-CA 124.673 1.189 . . . . 0.0 108.387 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.418 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -63.66 150.5 44.13 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 119.386 3.106 . . . . 0.0 119.386 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 81.16 75.94 0.03 OUTLIER 'General case' 0 C--N 1.363 1.193 0 C-N-CA 125.266 1.426 . . . . 0.0 111.987 175.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -165.24 -46.85 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 117.908 1.923 . . . . 0.0 117.908 -172.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.334 . . 135.65 -68.96 0.0 OUTLIER 'General case' 0 C--N 1.351 0.67 0 C-N-CA 128.174 2.59 . . . . 0.0 108.01 -178.176 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.256 9.0 t -138.33 115.93 11.34 Favored 'General case' 0 C--N 1.359 0.978 0 CA-C-N 120.61 1.55 . . . . 0.0 114.467 -174.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.302 4.3 p90 -127.77 140.69 51.89 Favored 'General case' 0 C--N 1.368 1.402 0 C-N-CA 129.458 3.103 . . . . 0.0 110.957 175.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.4 m -129.81 140.22 51.07 Favored 'General case' 0 C--N 1.358 0.951 0 O-C-N 118.344 -2.722 . . . . 0.0 110.368 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.37 96.42 35.61 Favored Pre-proline 0 C--N 1.367 1.355 0 C-N-CA 128.399 2.68 . . . . 0.0 106.982 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -77.38 -14.64 16.22 Favored 'Trans proline' 0 C--N 1.359 1.127 1 C-N-CA 126.946 5.097 . . . . 0.0 114.502 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.455 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -161.97 105.79 1.2 Allowed 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 176.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -94.28 133.95 37.27 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.173 2.189 . . . . 0.0 112.772 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.5 177.97 7.24 Favored 'General case' 0 C--N 1.371 1.518 0 C-N-CA 128.191 2.596 . . . . 0.0 111.066 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.05 -48.6 33.11 Favored 'General case' 0 C--N 1.364 1.22 0 N-CA-C 118.955 2.946 . . . . 0.0 118.955 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.44 -14.18 62.7 Favored 'General case' 0 C--N 1.366 1.296 0 C-N-CA 126.696 1.999 . . . . 0.0 114.573 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.479 ' CB ' ' HB1' ' A' ' 128' ' ' ALA 0.332 31.5 m-20 -82.58 -14.28 55.11 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 130.354 3.462 . . . . 0.0 111.48 170.854 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.79 133.86 41.88 Favored 'General case' 0 C--N 1.383 2.059 0 N-CA-C 118.09 2.626 . . . . 0.0 118.09 165.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.9 -158.92 31.6 Favored Glycine 0 C--N 1.37 2.421 0 C-N-CA 126.793 2.139 . . . . 0.0 109.492 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.268 11.0 t -117.74 135.94 53.7 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 114.612 -2.835 . . . . 0.0 106.879 169.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.65 ' CD2' HD11 ' A' ' 93' ' ' LEU 0.26 13.7 m-85 -97.4 134.49 40.59 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 127.072 2.149 . . . . 0.0 112.342 -173.305 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.587 ' HE2' HG22 ' A' ' 152' ' ' THR . 0.0 OUTLIER -143.63 153.96 43.05 Favored 'General case' 0 C--N 1.365 1.282 0 CA-C-O 123.231 1.491 . . . . 0.0 108.851 -174.399 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.638 HG13 HG22 ' A' ' 140' ' ' VAL . 1.1 t -143.62 148.15 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 117.388 -1.725 . . . . 0.0 114.672 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -120.29 120.8 37.12 Favored 'General case' 0 C--N 1.381 1.96 0 C-N-CA 126.127 1.771 . . . . 0.0 106.308 171.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.638 HG22 HG13 ' A' ' 138' ' ' VAL . 0.1 OUTLIER -131.91 123.56 51.61 Favored 'Isoleucine or valine' 0 C--N 1.367 1.341 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -176.27 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.408 HG23 ' C ' ' A' ' 146' ' ' VAL . 3.6 m -106.63 133.62 51.03 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 119.366 -2.084 . . . . 0.0 114.625 -176.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.476 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.37 18.9 p-10 -127.85 -179.05 4.75 Favored 'General case' 0 C--N 1.38 1.929 0 CA-C-N 119.962 1.256 . . . . 0.0 112.064 175.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.517 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 8.0 p -49.17 1.33 0.01 OUTLIER 'General case' 0 C--N 1.375 1.713 1 C-N-CA 136.593 5.957 . . . . 0.0 119.964 -167.618 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -101.29 4.81 42.03 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 118.502 -1.279 . . . . 0.0 108.271 164.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.462 1.3 tp60 64.83 39.69 5.94 Favored 'General case' 0 C--N 1.371 1.502 1 C-N-CA 134.582 5.153 . . . . 0.0 111.569 -173.6 . . . . . . . . 3 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.408 ' C ' HG23 ' A' ' 141' ' ' THR . 3.4 m -112.88 131.45 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 CA-C-N 111.54 -2.573 . . . . 0.0 111.632 -169.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.64 128.72 38.59 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.249 1.82 . . . . 0.0 108.425 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 147.13 41.68 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 101.246 -3.613 . . . . 0.0 101.246 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -130.36 147.09 52.03 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 119.43 -2.043 . . . . 0.0 107.051 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 54.2 p -116.94 151.96 35.56 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 120.822 -1.174 . . . . 0.0 113.273 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.3 148.04 15.61 Favored 'General case' 0 C--N 1.375 1.677 1 C-N-CA 136.782 6.033 . . . . 0.0 116.153 -172.019 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.587 HG22 ' HE2' ' A' ' 137' ' ' LYS . 6.1 p -68.1 111.63 4.59 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 127.034 2.134 . . . . 0.0 111.417 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 1.8 m -97.06 108.45 21.19 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 102.461 -3.163 . . . . 0.0 102.461 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.73 106.81 18.75 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-O 124.704 2.192 . . . . 0.0 109.195 -172.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.46 127.79 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 O-C-N 120.309 -1.494 . . . . 0.0 107.421 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 92.6 m . . . . . 0 CA--C 1.484 -1.564 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.006 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.575 1.906 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.5 m -161.88 173.0 15.14 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 117.221 -3.424 . . . . 0.0 103.652 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.98 -47.15 0.59 Allowed 'General case' 0 C--N 1.365 1.275 0 C-N-CA 127.834 2.454 . . . . 0.0 115.468 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.7 p -172.36 116.25 0.34 Allowed 'General case' 0 C--N 1.368 1.385 0 N-CA-C 120.479 3.511 . . . . 0.0 120.479 -172.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.1 ttt -127.06 126.44 43.06 Favored 'General case' 0 C--N 1.38 1.905 0 CA-C-N 121.843 2.11 . . . . 0.0 114.267 165.595 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -105.5 116.44 31.94 Favored 'General case' 0 C--N 1.373 1.601 0 O-C-N 119.568 -1.957 . . . . 0.0 108.506 174.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.01 172.94 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.639 0 CA-C-O 122.714 1.245 . . . . 0.0 114.251 -169.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -86.1 123.99 32.02 Favored 'General case' 0 C--N 1.368 1.404 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 161.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -42.07 122.31 2.08 Favored 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 124.239 3.199 . . . . 0.0 118.234 -155.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.45 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 143.53 54.23 0.03 OUTLIER Glycine 0 C--N 1.356 1.672 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.636 -162.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.38 166.34 14.33 Favored 'General case' 0 C--N 1.363 1.152 0 C-N-CA 125.099 1.36 . . . . 0.0 112.143 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.9 111.16 22.1 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.166 0.986 . . . . 0.0 108.744 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 124' ' ' THR . 6.0 mp -119.75 116.01 25.06 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 125.854 1.662 . . . . 0.0 113.774 -173.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.93 125.09 52.47 Favored 'General case' 0 C--N 1.364 1.219 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 173.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -121.24 113.61 20.2 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 101.412 -3.551 . . . . 0.0 101.412 171.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.8 m -147.92 133.38 18.66 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 119.753 -1.842 . . . . 0.0 111.387 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.13 175.48 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 130.258 3.423 . . . . 0.0 104.364 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 t -104.13 139.26 39.44 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 128.066 2.547 . . . . 0.0 105.69 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.76 147.48 37.41 Favored 'General case' 0 C--N 1.381 1.943 1 N-CA-C 123.885 4.772 . . . . 0.0 123.885 -175.053 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.4 p -157.04 176.06 13.26 Favored 'General case' 0 C--N 1.361 1.096 1 C-N-CA 133.999 4.92 . . . . 0.0 103.701 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.72 41.63 0.69 Allowed Glycine 0 C--N 1.367 2.288 0 N-CA-C 117.2 1.64 . . . . 0.0 117.2 167.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.1 29.0 35.25 Favored Glycine 0 C--N 1.361 1.936 0 C-N-CA 128.526 2.965 . . . . 0.0 115.476 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.5 p -117.02 110.15 17.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 114.334 -2.746 . . . . 0.0 108.598 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.603 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.09 -88.66 0.78 Allowed Glycine 0 C--N 1.38 3.003 0 C-N-CA 129.677 3.513 . . . . 0.0 110.022 -174.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.97 169.1 5.03 Favored 'Trans proline' 0 CA--C 1.571 2.335 1 C-N-CA 127.223 5.282 . . . . 0.0 116.139 158.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.578 ' HB3' HG12 ' A' ' 140' ' ' VAL . 57.3 m-85 -101.09 143.18 31.52 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 120.616 3.561 . . . . 0.0 120.616 -166.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -102.86 141.21 36.06 Favored 'General case' 0 C--N 1.379 1.876 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.53 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -134.95 156.32 49.21 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 121.015 3.709 . . . . 0.0 121.015 -163.414 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -136.33 111.85 9.28 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 112.295 -2.23 . . . . 0.0 105.121 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.516 ' HB2' HG13 ' A' ' 115' ' ' ILE . 24.7 m95 -112.8 150.0 32.27 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.473 1.509 . . . . 0.0 108.68 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.295 0.1 OUTLIER -156.28 160.5 39.81 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 164.174 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.512 ' CB ' ' HA ' ' A' ' 136' ' ' TYR . 1.8 pptp? -133.93 104.98 6.51 Favored 'General case' 0 C--N 1.368 1.39 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.51 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.243 2.7 t70 37.45 55.17 1.42 Allowed 'General case' 0 CA--C 1.458 -2.585 1 CA-C-O 110.337 -4.649 . . . . 0.0 120.289 155.349 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.97 -10.15 65.89 Favored Glycine 0 C--N 1.376 2.786 2 O-C-N 134.632 7.457 . . . . 0.0 115.716 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -124.68 148.86 60.45 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 129.995 3.318 . . . . 0.0 119.495 -165.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.25 43.8 Cg_endo -60.04 156.98 36.29 Favored 'Trans proline' 0 N--CA 1.5 1.909 1 C-N-CA 125.777 4.318 . . . . 0.0 116.865 167.782 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -112.13 150.02 41.81 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 119.408 -2.057 . . . . 0.0 111.301 175.683 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.77 -81.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.09 1 C-N-CA 127.966 5.777 . . . . 0.0 119.516 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -100.58 -42.1 6.68 Favored 'General case' 0 C--N 1.359 1.02 0 C-N-CA 125.461 1.504 . . . . 0.0 111.369 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.447 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . 71.51 -68.93 0.2 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 129.045 2.938 . . . . 0.0 118.155 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.302 8.3 t -75.8 52.77 0.7 Allowed 'General case' 0 N--CA 1.418 -2.051 1 C-N-CA 134.517 5.127 . . . . 0.0 115.544 -169.81 . . . . . . . . 3 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.07 -60.81 0.01 OUTLIER Glycine 0 CA--C 1.476 -2.359 0 N-CA-C 119.152 2.421 . . . . 0.0 119.152 -173.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 150.49 -62.68 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -174.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.6 t -136.68 117.24 13.84 Favored 'General case' 0 C--N 1.359 0.991 0 O-C-N 120.39 -1.444 . . . . 0.0 113.003 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -127.48 138.12 52.86 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.786 2.034 . . . . 0.0 110.751 172.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 91' ' ' LEU . 27.1 m -129.98 139.46 51.06 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 119.851 -1.781 . . . . 0.0 109.583 177.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.25 106.8 54.38 Favored Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 127.799 2.439 . . . . 0.0 106.095 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.95 -11.9 17.92 Favored 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.459 4.106 . . . . 0.0 112.738 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.45 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -161.24 111.88 1.72 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.25 126.91 45.17 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.98 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.06 -179.31 5.65 Favored 'General case' 0 C--N 1.365 1.281 0 C-N-CA 128.746 2.818 . . . . 0.0 108.584 171.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.6 -53.77 13.72 Favored 'General case' 0 C--N 1.367 1.332 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -69.2 0.14 5.23 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 127.913 2.485 . . . . 0.0 115.304 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -116.23 -7.46 11.8 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 131.423 3.889 . . . . 0.0 110.344 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.54 160.18 14.45 Favored 'General case' 0 C--N 1.397 2.643 0 N-CA-C 120.575 3.546 . . . . 0.0 120.575 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.64 -152.72 24.07 Favored Glycine 0 CA--C 1.465 -3.033 0 C-N-CA 127.643 2.544 . . . . 0.0 107.11 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.315 19.4 m -118.12 136.52 53.54 Favored 'General case' 0 N--CA 1.507 2.384 0 C-N-CA 114.001 -3.08 . . . . 0.0 109.881 171.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.512 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 14.9 m-85 -96.73 133.65 41.02 Favored 'General case' 0 C--N 1.368 1.391 0 CA-C-N 123.136 2.698 . . . . 0.0 115.283 -171.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.51 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -141.16 146.38 36.93 Favored 'General case' 0 C--N 1.373 1.596 0 CA-C-O 121.132 0.492 . . . . 0.0 110.393 -175.569 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 108' ' ' TRP . 15.0 p -141.53 143.49 27.39 Favored 'Isoleucine or valine' 0 C--N 1.372 1.564 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.8 m -107.67 120.39 42.11 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 130.341 3.457 . . . . 0.0 107.14 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -131.54 120.23 44.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 C-N-CA 125.975 1.71 . . . . 0.0 110.752 -173.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -106.88 132.02 53.3 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.475 -1.391 . . . . 0.0 114.522 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.451 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.36 37.3 p-10 -125.93 179.35 5.25 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 119.578 1.081 . . . . 0.0 112.28 175.211 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.603 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 25.4 p -49.62 3.22 0.01 OUTLIER 'General case' 0 C--N 1.372 1.569 1 C-N-CA 135.384 5.474 . . . . 0.0 120.775 -168.906 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -101.96 4.75 40.32 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 165.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.494 0.7 OUTLIER 65.72 40.04 4.54 Favored 'General case' 0 C--N 1.37 1.482 1 C-N-CA 133.653 4.781 . . . . 0.0 111.899 -174.342 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.68 124.49 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.649 0 CA-C-N 111.36 -2.655 . . . . 0.0 112.185 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.63 123.72 35.25 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 127.623 2.369 . . . . 0.0 106.404 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.71 153.38 31.47 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 101.809 -3.404 . . . . 0.0 101.809 -175.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -130.4 146.54 51.98 Favored 'General case' 0 CA--C 1.494 -1.204 0 O-C-N 120.958 -1.089 . . . . 0.0 109.688 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.323 84.2 p -130.6 145.29 51.86 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.0 m -55.0 147.91 14.66 Favored 'General case' 0 C--N 1.376 1.734 1 C-N-CA 137.06 6.144 . . . . 0.0 117.725 -165.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 136' ' ' TYR . 70.5 p -67.34 110.22 3.46 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 128.528 2.731 . . . . 0.0 111.075 -173.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.74 108.19 20.2 Favored 'General case' 0 C--N 1.372 1.557 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.85 110.33 22.53 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 123.242 1.496 . . . . 0.0 112.654 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.61 114.88 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.251 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . 0.294 0.6 OUTLIER . . . . . 0 C--N 1.368 1.371 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.6 ' O ' HG22 ' A' ' 92' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 123.927 1.822 . . . . 0.0 112.67 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 81' ' ' ALA . 36.6 m -171.92 171.84 4.96 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 169.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.418 ' N ' HG22 ' A' ' 80' ' ' THR . . . -123.24 -48.08 1.99 Allowed 'General case' 0 C--N 1.368 1.372 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 175.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.5 t -171.68 148.55 2.44 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 119.299 -2.125 . . . . 0.0 113.535 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.49 117.35 6.27 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 124.21 1.004 . . . . 0.0 108.48 166.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.8 t -110.57 115.63 29.95 Favored 'General case' 0 C--N 1.366 1.321 0 O-C-N 118.792 -2.442 . . . . 0.0 107.348 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.25 9.5 p -150.97 174.16 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 125.411 1.484 . . . . 0.0 113.757 -169.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -77.68 132.89 38.4 Favored 'General case' 0 C--N 1.374 1.667 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 159.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.359 0.0 OUTLIER -42.97 122.61 2.48 Favored 'General case' 0 N--CA 1.514 2.763 0 N-CA-C 119.606 3.187 . . . . 0.0 119.606 -161.426 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.479 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 139.84 50.76 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 110.225 -3.171 . . . . 0.0 106.226 -163.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.47 145.91 24.45 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 126.72 2.008 . . . . 0.0 107.469 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.62 121.57 36.32 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 -170.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 124' ' ' THR . 1.1 mm? -120.84 133.82 55.3 Favored 'General case' 0 C--N 1.372 1.583 0 C-N-CA 127.172 2.189 . . . . 0.0 115.956 172.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -123.81 120.36 32.4 Favored 'General case' 0 C--N 1.359 0.986 1 N-CA-C 98.155 -4.757 . . . . 0.0 98.155 165.302 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.4 HD11 ' CD1' ' A' ' 136' ' ' TYR . 1.2 mm? -115.19 115.49 26.8 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 102.018 -3.327 . . . . 0.0 102.018 176.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 4.9 t -154.62 133.29 12.11 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 117.801 -1.559 . . . . 0.0 111.789 -174.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.87 174.35 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.743 0 C-N-CA 130.405 3.482 . . . . 0.0 105.573 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.8 t -104.03 141.53 36.04 Favored 'General case' 0 C--N 1.361 1.077 0 O-C-N 119.487 -2.008 . . . . 0.0 106.578 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.19 145.21 35.36 Favored 'General case' 0 C--N 1.376 1.759 1 N-CA-C 122.989 4.44 . . . . 0.0 122.989 -173.598 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.9 p -156.48 175.28 14.23 Favored 'General case' 0 C--N 1.364 1.223 1 C-N-CA 133.234 4.614 . . . . 0.0 103.36 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.61 41.49 1.0 Allowed Glycine 0 C--N 1.362 2.019 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.36 18.92 54.38 Favored Glycine 0 C--N 1.362 1.982 0 C-N-CA 127.14 2.305 . . . . 0.0 116.121 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.6 m -118.19 111.02 18.28 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 115.039 -2.41 . . . . 0.0 110.185 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.592 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 79.35 -93.05 1.31 Allowed Glycine 0 C--N 1.379 2.961 0 C-N-CA 129.665 3.507 . . . . 0.0 109.221 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.36 168.54 6.29 Favored 'Trans proline' 0 CA--C 1.564 1.998 1 C-N-CA 127.485 5.457 . . . . 0.0 116.316 159.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.585 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.0 m-85 -99.12 148.14 24.36 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 119.804 3.261 . . . . 0.0 119.804 -165.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -110.7 144.69 39.25 Favored 'General case' 0 C--N 1.381 1.938 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.484 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -141.09 165.95 26.14 Favored 'General case' 0 C--N 1.346 0.444 1 N-CA-C 122.345 4.202 . . . . 0.0 122.345 -159.75 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.15 118.49 12.81 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 110.723 -2.944 . . . . 0.0 105.044 172.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -111.79 134.48 53.32 Favored 'General case' 0 C--N 1.366 1.288 0 C-N-CA 125.797 1.639 . . . . 0.0 109.321 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.367 0.2 OUTLIER -155.79 170.01 23.06 Favored 'General case' 0 CA--C 1.488 -1.422 0 O-C-N 120.468 -1.395 . . . . 0.0 107.458 170.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.494 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.6 ptmm? -143.01 106.49 4.6 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 119.52 -1.988 . . . . 0.0 111.555 -177.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.508 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.141 2.0 t70 36.41 54.8 1.07 Allowed 'General case' 0 C--N 1.384 2.084 1 CA-C-O 109.687 -4.959 . . . . 0.0 121.53 149.042 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.33 2.83 80.81 Favored Glycine 0 C--N 1.386 3.319 2 O-C-N 135.353 7.908 . . . . 0.0 119.561 -172.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.274 1.0 OUTLIER -125.23 147.48 57.53 Favored Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 129.39 3.076 . . . . 0.0 117.936 -167.227 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.85 139.39 62.15 Favored 'Trans proline' 0 N--CA 1.504 2.103 1 C-N-CA 126.037 4.492 . . . . 0.0 117.501 169.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.494 HG12 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -91.63 160.02 37.36 Favored Pre-proline 0 CA--C 1.553 1.059 0 O-C-N 118.441 -2.662 . . . . 0.0 112.773 175.433 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 12.3 Cg_endo -72.42 -82.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 124.959 3.773 . . . . 0.0 118.284 -172.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -117.29 60.85 0.75 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.277 1.431 . . . . 0.0 109.643 -171.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.494 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -67.65 151.79 46.69 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 129.085 2.954 . . . . 0.0 117.565 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.464 ' HA ' ' CD2' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 80.54 63.71 0.02 OUTLIER 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.73 1.612 . . . . 0.0 111.015 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.36 -85.56 0.06 OUTLIER Glycine 0 C--N 1.355 1.598 0 N-CA-C 115.474 0.949 . . . . 0.0 115.474 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 165.74 -65.75 0.0 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 126.068 1.747 . . . . 0.0 106.712 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.263 14.8 t -133.03 110.11 10.0 Favored 'General case' 0 C--N 1.36 1.056 0 CA-C-O 122.994 1.378 . . . . 0.0 113.308 -177.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.293 9.4 p90 -127.09 141.12 51.85 Favored 'General case' 0 C--N 1.369 1.448 0 C-N-CA 128.339 2.656 . . . . 0.0 112.474 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 91' ' ' LEU . 25.5 m -128.82 139.7 52.05 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 119.924 -1.735 . . . . 0.0 108.854 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.71 92.19 45.45 Favored Pre-proline 0 C--N 1.354 0.801 0 C-N-CA 128.748 2.819 . . . . 0.0 104.903 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -74.43 -32.89 5.92 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 124.879 3.719 . . . . 0.0 112.854 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.479 HG23 ' HA2' ' A' ' 88' ' ' GLY . 69.0 m -128.38 100.6 5.86 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.67 118.5 31.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.877 1.671 . . . . 0.0 113.111 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.43 -179.06 6.86 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.451 2.301 . . . . 0.0 109.438 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -51.32 23.62 Favored 'General case' 0 C--N 1.366 1.316 0 O-C-N 117.803 -3.06 . . . . 0.0 118.088 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.31 0.86 2.53 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 128.851 2.86 . . . . 0.0 115.111 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -116.36 -13.91 11.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 129.544 3.138 . . . . 0.0 111.102 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.75 154.64 17.46 Favored 'General case' 0 C--N 1.399 2.739 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 174.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.46 -157.78 27.36 Favored Glycine 0 C--N 1.382 3.095 0 C-N-CA 128.923 3.154 . . . . 0.0 109.81 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.393 5.7 m -110.66 130.83 55.47 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 112.343 -3.743 . . . . 0.0 107.545 167.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.502 ' HB2' ' HB3' ' A' ' 153' ' ' CYS . 24.5 m-85 -96.81 134.77 39.68 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-N 122.605 2.457 . . . . 0.0 113.011 -172.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -148.5 150.64 33.77 Favored 'General case' 0 C--N 1.376 1.743 0 C-N-CA 124.878 1.271 . . . . 0.0 110.456 -175.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 149' ' ' ASP . 8.9 p -143.67 137.49 24.95 Favored 'Isoleucine or valine' 0 C--N 1.371 1.501 0 C-N-CA 117.956 -1.497 . . . . 0.0 114.314 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.23 111.77 24.65 Favored 'General case' 0 C--N 1.378 1.811 0 C-N-CA 130.34 3.456 . . . . 0.0 105.341 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.585 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -127.21 112.21 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 128.124 2.569 . . . . 0.0 110.73 -169.59 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 8.0 m -99.3 130.93 45.62 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.458 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.364 25.3 p-10 -127.7 -177.03 3.94 Favored 'General case' 0 C--N 1.372 1.584 0 CA-C-N 119.234 0.925 . . . . 0.0 112.213 174.763 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.592 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 20.4 p -49.83 3.36 0.01 OUTLIER 'General case' 0 C--N 1.369 1.414 1 C-N-CA 136.749 6.02 . . . . 0.0 120.501 -169.602 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -101.27 4.89 42.18 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 163.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.358 2.1 mp0 65.44 39.53 5.12 Favored 'General case' 0 C--N 1.378 1.825 1 C-N-CA 134.249 5.02 . . . . 0.0 110.678 -175.149 . . . . . . . . 3 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.452 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.58 133.4 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 CA-C-N 112.137 -2.302 . . . . 0.0 111.99 -170.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 1.8 t -91.69 132.16 36.57 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 120.744 1.611 . . . . 0.0 106.883 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.13 157.99 23.92 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 -176.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 22.6 t70 -126.11 134.18 51.42 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.814 0.816 . . . . 0.0 109.294 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.528 59.8 p -111.13 143.9 41.12 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.8 m -54.05 146.74 13.97 Favored 'General case' 0 C--N 1.368 1.404 1 C-N-CA 136.709 6.004 . . . . 0.0 119.405 -155.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.0 p -69.06 110.1 4.33 Favored 'General case' 0 C--N 1.376 1.719 0 C-N-CA 124.264 1.026 . . . . 0.0 110.711 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 4.7 t -100.02 110.12 22.43 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.14 103.89 15.86 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 122.758 1.266 . . . . 0.0 112.267 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.2 m -112.43 115.18 49.11 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -174.739 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.575 1.907 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -175.93 176.21 1.84 Allowed 'General case' 0 CA--C 1.5 -0.96 1 N-CA-C 97.987 -4.82 . . . . 0.0 97.987 167.545 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.25 -51.24 2.92 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 121.713 2.052 . . . . 0.0 107.862 162.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.0 t -166.67 135.61 2.9 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 119.562 -1.961 . . . . 0.0 114.396 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 ttt -137.79 116.73 12.4 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-O 122.592 1.187 . . . . 0.0 109.388 161.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -108.57 115.22 29.68 Favored 'General case' 0 C--N 1.362 1.133 0 O-C-N 119.023 -2.298 . . . . 0.0 107.972 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.4 p -149.55 173.17 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 127.535 2.334 . . . . 0.0 112.077 -169.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.59 136.27 42.05 Favored 'General case' 0 C--N 1.37 1.484 0 O-C-N 118.739 -2.476 . . . . 0.0 107.175 158.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.28 5.8 pt-20 -43.34 122.08 2.45 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 -162.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.56 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 136.19 45.0 0.09 OUTLIER Glycine 0 C--N 1.352 1.43 0 CA-C-N 110.094 -3.23 . . . . 0.0 111.526 -162.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.23 164.57 21.11 Favored 'General case' 0 C--N 1.373 1.604 0 C-N-CA 125.07 1.348 . . . . 0.0 111.383 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.37 101.98 10.65 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 123.072 1.415 . . . . 0.0 113.897 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 1.2 mp -119.71 128.82 54.15 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -175.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.6 t -114.53 135.69 53.85 Favored 'General case' 0 C--N 1.358 0.953 1 N-CA-C 99.422 -4.288 . . . . 0.0 99.422 165.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.01 114.79 23.68 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 100.867 -3.753 . . . . 0.0 100.867 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -150.3 132.65 15.55 Favored 'General case' 0 C--N 1.366 1.321 0 C-N-CA 118.2 -1.4 . . . . 0.0 114.147 -168.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 m -149.59 174.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.943 1 C-N-CA 132.971 4.508 . . . . 0.0 106.198 177.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -104.37 141.52 36.18 Favored 'General case' 0 C--N 1.367 1.368 0 O-C-N 118.948 -2.345 . . . . 0.0 106.669 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.98 135.9 38.04 Favored 'General case' 0 C--N 1.374 1.654 0 N-CA-C 120.986 3.699 . . . . 0.0 120.986 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.0 m -157.69 172.11 19.11 Favored 'General case' 0 C--N 1.359 1.012 1 C-N-CA 131.789 4.035 . . . . 0.0 101.518 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.98 44.12 1.27 Allowed Glycine 0 C--N 1.367 2.301 0 CA-C-N 122.535 2.425 . . . . 0.0 117.381 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.29 25.49 57.1 Favored Glycine 0 C--N 1.355 1.596 0 C-N-CA 128.552 2.977 . . . . 0.0 115.422 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.2 m -117.9 110.96 18.38 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 114.444 -2.693 . . . . 0.0 107.587 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.544 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 78.03 -89.27 1.08 Allowed Glycine 0 C--N 1.376 2.783 0 C-N-CA 130.148 3.737 . . . . 0.0 109.953 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -60.68 167.99 7.55 Favored 'Trans proline' 0 CA--C 1.564 2.01 1 C-N-CA 127.009 5.14 . . . . 0.0 116.258 159.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.588 ' HB3' HG12 ' A' ' 140' ' ' VAL . 82.1 m-85 -102.57 146.58 27.94 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 120.036 3.347 . . . . 0.0 120.036 -166.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 t -105.63 153.83 21.26 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 129.354 3.062 . . . . 0.0 104.083 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.02 164.9 38.25 Favored 'General case' 0 C--N 1.366 1.295 1 N-CA-C 122.231 4.16 . . . . 0.0 122.231 -161.135 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.29 114.63 14.64 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 128.614 2.766 . . . . 0.0 106.258 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -111.02 131.27 55.2 Favored 'General case' 0 C--N 1.368 1.404 0 C-N-CA 127.145 2.178 . . . . 0.0 109.807 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.313 0.0 OUTLIER -151.03 169.54 21.57 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 168.602 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HD3' ' CD1' ' A' ' 136' ' ' TYR . 4.0 ttpt -135.61 107.68 7.17 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.426 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.24 0.8 OUTLIER 33.25 50.83 0.27 Allowed 'General case' 0 C--N 1.374 1.658 1 N-CA-C 123.546 4.647 . . . . 0.0 123.546 135.421 . . . . . . . . 5 4 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.96 -3.54 83.66 Favored Glycine 0 C--N 1.363 2.063 2 O-C-N 132.412 6.07 . . . . 0.0 120.199 -172.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.293 3.4 m -124.02 147.38 53.99 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 129.963 3.305 . . . . 0.0 118.598 -172.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -62.07 140.49 84.47 Favored 'Trans proline' 0 C--N 1.37 1.665 1 C-N-CA 126.215 4.61 . . . . 0.0 115.645 172.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.522 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -88.63 164.87 30.42 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 119.694 -1.879 . . . . 0.0 111.23 175.24 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 90.6 Cg_exo -52.21 -44.62 44.86 Favored 'Trans proline' 0 C--N 1.353 0.793 1 C-N-CA 127.785 5.657 . . . . 0.0 118.72 -171.273 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -169.15 -50.43 0.02 OUTLIER 'General case' 0 C--N 1.348 0.507 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 81.03 -164.17 0.02 OUTLIER 'General case' 0 C--N 1.364 1.204 0 C-N-CA 129.328 3.051 . . . . 0.0 111.401 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t 82.6 3.17 1.14 Allowed 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 119.609 3.189 . . . . 0.0 119.609 170.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.97 85.11 0.06 OUTLIER Glycine 0 CA--C 1.475 -2.467 0 C-N-CA 115.597 -3.192 . . . . 0.0 119.125 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.335 . . 87.47 -78.63 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 163.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.306 6.0 t -141.37 119.95 12.45 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 123.833 1.778 . . . . 0.0 115.153 -170.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -127.3 142.67 51.4 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 129.514 3.126 . . . . 0.0 109.883 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.7 m -126.38 139.0 53.62 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 122.345 2.339 . . . . 0.0 109.678 176.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -119.15 89.31 39.19 Favored Pre-proline 0 C--N 1.37 1.493 0 C-N-CA 129.056 2.942 . . . . 0.0 103.847 176.625 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -73.28 -31.39 9.36 Favored 'Trans proline' 0 N--CA 1.471 0.204 1 C-N-CA 125.512 4.142 . . . . 0.0 112.668 -172.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.56 HG23 ' HA2' ' A' ' 88' ' ' GLY . 55.2 m -143.98 100.53 3.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.693 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -86.93 134.58 33.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.312 1.845 . . . . 0.0 114.443 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.15 171.69 14.59 Favored 'General case' 0 C--N 1.366 1.302 0 C-N-CA 127.436 2.294 . . . . 0.0 112.343 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.1 -43.72 20.65 Favored 'General case' 0 C--N 1.37 1.477 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -172.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.2 -13.32 61.85 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 128.545 2.738 . . . . 0.0 115.07 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.693 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 4.9 m-20 -74.31 -21.08 59.88 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 128.113 2.565 . . . . 0.0 112.239 167.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.17 119.75 9.0 Favored 'General case' 0 C--N 1.386 2.183 0 N-CA-C 120.449 3.5 . . . . 0.0 120.449 172.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.97 -155.13 26.35 Favored Glycine 0 CA--C 1.468 -2.879 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.491 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.316 6.9 m -118.3 132.01 56.31 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 115.397 -2.521 . . . . 0.0 107.214 171.473 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.464 ' CD1' ' HD3' ' A' ' 110' ' ' LYS . 2.5 m-85 -97.06 133.81 41.24 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 125.85 1.66 . . . . 0.0 110.487 -170.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.491 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -145.62 144.5 30.49 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-O 122.091 0.948 . . . . 0.0 109.647 -174.394 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.291 7.5 p -141.8 135.94 30.23 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 117.685 -1.606 . . . . 0.0 114.166 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.8 m -103.08 121.26 42.22 Favored 'General case' 0 C--N 1.38 1.915 0 C-N-CA 129.455 3.102 . . . . 0.0 106.238 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -132.22 120.44 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 127.127 2.171 . . . . 0.0 110.497 -169.501 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.467 HG23 ' C ' ' A' ' 146' ' ' VAL . 14.1 m -107.78 133.35 52.3 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 119.877 -1.764 . . . . 0.0 112.816 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.466 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.373 18.3 p-10 -129.76 -176.55 3.95 Favored 'General case' 0 C--N 1.377 1.77 0 C-N-CA 124.804 1.242 . . . . 0.0 111.929 176.271 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.544 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 8.1 p -49.37 1.5 0.01 OUTLIER 'General case' 0 C--N 1.369 1.437 1 C-N-CA 136.332 5.853 . . . . 0.0 120.519 -167.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -99.75 4.63 45.5 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 118.262 -1.375 . . . . 0.0 107.784 163.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.437 0.8 OUTLIER 65.67 39.77 4.72 Favored 'General case' 0 C--N 1.371 1.508 1 C-N-CA 133.961 4.904 . . . . 0.0 111.623 -174.524 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.467 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.43 131.94 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 CA-C-N 111.023 -2.808 . . . . 0.0 112.394 -169.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.2 124.0 35.07 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 127.856 2.462 . . . . 0.0 107.477 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.36 157.69 24.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 128.798 2.839 . . . . 0.0 103.835 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -128.5 137.34 51.74 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.861 1.21 . . . . 0.0 109.672 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.385 75.1 p -113.55 143.21 44.93 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 125.405 1.482 . . . . 0.0 109.245 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.2 m -54.11 148.47 10.99 Favored 'General case' 0 C--N 1.37 1.492 1 C-N-CA 135.839 5.656 . . . . 0.0 118.887 -159.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 66.6 p -69.09 111.31 4.99 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 127.718 2.407 . . . . 0.0 110.1 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.28 109.85 22.07 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.05 105.99 18.1 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 124.433 2.063 . . . . 0.0 110.372 -174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.1 m -118.46 128.21 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.484 -1.565 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 177.942 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.44 ' O ' HG22 ' A' ' 92' ' ' THR . 0.5 OUTLIER . . . . . 0 CA--C 1.584 2.254 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -170.8 172.33 5.72 Favored 'General case' 0 N--CA 1.471 0.588 1 O-C-N 114.385 -5.197 . . . . 0.0 101.903 173.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.18 -41.94 0.57 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.588 1.555 . . . . 0.0 111.349 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.1 m -163.73 117.49 1.52 Allowed 'General case' 0 C--N 1.363 1.191 0 N-CA-C 117.754 2.501 . . . . 0.0 117.754 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.4 ttt -137.18 116.57 12.74 Favored 'General case' 0 C--N 1.377 1.791 0 CA-C-N 120.378 1.445 . . . . 0.0 109.079 155.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.1 m -113.25 117.02 30.7 Favored 'General case' 0 C--N 1.365 1.261 0 O-C-N 118.607 -2.558 . . . . 0.0 109.063 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -149.4 172.58 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.937 0 C-N-CA 126.058 1.743 . . . . 0.0 110.156 -170.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.99 130.9 35.19 Favored 'General case' 0 C--N 1.373 1.625 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -41.85 122.34 2.02 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -153.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.484 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 143.61 43.36 0.05 OUTLIER Glycine 0 C--N 1.356 1.662 0 CA-C-N 109.721 -3.399 . . . . 0.0 110.7 -163.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.53 168.02 14.89 Favored 'General case' 0 C--N 1.374 1.67 0 C-N-CA 124.802 1.241 . . . . 0.0 112.543 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.48 99.37 8.15 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.188 0.995 . . . . 0.0 109.595 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.03 111.78 23.38 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 125.494 1.518 . . . . 0.0 113.94 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -105.19 125.5 51.05 Favored 'General case' 0 C--N 1.371 1.534 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.025 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.67 114.87 21.17 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 103.539 -2.763 . . . . 0.0 103.539 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 t -151.14 134.3 16.01 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 120.938 -1.101 . . . . 0.0 112.197 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.03 173.85 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 130.769 3.627 . . . . 0.0 103.703 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -104.16 138.47 40.6 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.3 142.15 33.88 Favored 'General case' 0 C--N 1.366 1.301 0 N-CA-C 120.012 3.338 . . . . 0.0 120.012 -174.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.5 m -158.26 174.33 15.33 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 130.826 3.65 . . . . 0.0 102.178 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.36 44.29 1.64 Allowed Glycine 0 C--N 1.366 2.244 0 O-C-N 118.681 -2.512 . . . . 0.0 117.452 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.24 21.36 65.14 Favored Glycine 0 C--N 1.359 1.838 0 C-N-CA 128.823 3.106 . . . . 0.0 114.749 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 10.1 p -116.55 111.34 19.78 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 126.165 1.786 . . . . 0.0 106.823 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.753 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 70.51 -90.72 0.38 Allowed Glycine 0 C--N 1.364 2.115 0 C-N-CA 130.649 3.976 . . . . 0.0 111.586 -169.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -60.74 168.39 7.05 Favored 'Trans proline' 0 CA--C 1.568 2.184 1 C-N-CA 127.457 5.438 . . . . 0.0 117.289 160.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.619 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.6 m-85 -93.64 142.32 27.49 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 121.317 3.821 . . . . 0.0 121.317 -167.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -102.96 155.13 18.57 Favored 'General case' 0 C--N 1.383 2.025 0 C-N-CA 128.23 2.612 . . . . 0.0 104.905 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 119' ' ' SER . 0.0 OUTLIER -155.59 166.94 32.0 Favored 'General case' 0 C--N 1.362 1.133 1 N-CA-C 122.402 4.223 . . . . 0.0 122.402 -159.375 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.36 114.18 7.65 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-N 112.166 -2.288 . . . . 0.0 107.596 173.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -113.29 155.07 25.78 Favored 'General case' 0 C--N 1.373 1.606 0 O-C-N 119.622 -1.924 . . . . 0.0 110.965 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.0 p -149.06 159.13 44.51 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 167.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' CE ' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -123.5 102.23 7.76 Favored 'General case' 0 C--N 1.377 1.797 0 C-N-CA 114.411 -2.916 . . . . 0.0 112.673 161.601 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.45 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.173 1.6 t70 36.47 54.17 1.06 Allowed 'General case' 0 CA--C 1.458 -2.58 0 CA-C-O 111.972 -3.87 . . . . 0.0 120.526 149.246 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.93 -17.17 42.14 Favored Glycine 0 C--N 1.363 2.055 1 O-C-N 133.193 6.558 . . . . 0.0 116.573 -172.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m -122.73 146.41 47.95 Favored Pre-proline 0 CA--C 1.573 1.854 0 C-N-CA 131.344 3.858 . . . . 0.0 119.876 -170.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.266 65.1 Cg_endo -65.08 136.12 46.73 Favored 'Trans proline' 0 N--CA 1.509 2.43 1 C-N-CA 128.684 6.256 . . . . 0.0 116.334 176.739 . . . . . . . . 3 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.516 ' HB ' ' CD ' ' A' ' 116' ' ' PRO 0.421 0.6 OUTLIER -84.64 164.95 40.32 Favored Pre-proline 0 N--CA 1.485 1.316 2 O-C-N 116.123 -4.111 . . . . 0.0 116.846 179.889 . . . . . . . . 5 4 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.516 ' CD ' ' HB ' ' A' ' 115' ' ' ILE . 2.8 Cg_exo -67.1 80.88 0.37 Allowed 'Trans proline' 0 C--N 1.384 2.446 1 C-N-CA 127.3 5.333 . . . . 0.0 112.571 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 80.29 -62.21 0.25 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 127.874 2.47 . . . . 0.0 110.815 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . 0.469 ' HB2' ' CG1' ' A' ' 115' ' ' ILE . . . 84.94 162.28 0.1 Allowed 'General case' 0 C--N 1.372 1.554 0 C-N-CA 129.207 3.003 . . . . 0.0 111.448 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.47 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.2 OUTLIER 74.03 59.54 0.08 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-O 122.767 1.27 . . . . 0.0 114.127 174.95 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.44 -85.51 0.09 OUTLIER Glycine 0 C--N 1.356 1.648 0 N-CA-C 117.487 1.755 . . . . 0.0 117.487 -170.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.26 . . 160.01 -71.13 0.0 OUTLIER 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.98 1.312 . . . . 0.0 110.437 -177.589 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.1 t -136.09 104.96 5.86 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 122.859 1.314 . . . . 0.0 113.838 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.299 7.8 p90 -128.05 140.97 51.65 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 127.713 2.405 . . . . 0.0 110.563 174.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 70.9 m -129.07 139.27 52.09 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 119.931 -1.73 . . . . 0.0 109.094 177.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.259 1.3 mmmm -105.76 111.67 64.6 Favored Pre-proline 0 C--N 1.372 1.548 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 171.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.21 -16.89 15.33 Favored 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 126.37 4.713 . . . . 0.0 113.339 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.484 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -162.18 101.27 1.1 Allowed 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 177.769 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.549 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.53 134.59 33.82 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.395 2.278 . . . . 0.0 113.167 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.17 176.83 8.51 Favored 'General case' 0 C--N 1.372 1.579 0 C-N-CA 128.351 2.66 . . . . 0.0 112.718 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.73 -46.63 29.97 Favored 'General case' 0 C--N 1.37 1.467 0 N-CA-C 119.414 3.116 . . . . 0.0 119.414 -172.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.98 -16.88 48.01 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 129.142 2.977 . . . . 0.0 115.0 174.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.549 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 7.4 m-20 -80.43 -22.04 41.58 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 128.79 2.836 . . . . 0.0 113.855 170.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.27 124.63 22.71 Favored 'General case' 0 C--N 1.382 2.014 0 N-CA-C 120.234 3.42 . . . . 0.0 120.234 173.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.14 -159.27 31.76 Favored Glycine 0 CA--C 1.463 -3.217 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.4 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.311 50.5 m -112.6 133.78 54.47 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 115.002 -2.679 . . . . 0.0 107.775 171.482 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.427 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 5.9 m-85 -96.2 133.43 40.53 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 118.988 -2.32 . . . . 0.0 110.311 -171.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -142.61 142.98 32.22 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 125.111 1.507 . . . . 0.0 107.329 -173.44 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.1 p -133.45 143.4 39.1 Favored 'Isoleucine or valine' 0 C--N 1.36 1.031 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.781 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -110.86 120.75 43.42 Favored 'General case' 0 C--N 1.38 1.898 0 C-N-CA 127.71 2.404 . . . . 0.0 106.135 171.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -132.58 120.49 42.37 Favored 'Isoleucine or valine' 0 C--N 1.361 1.101 0 C-N-CA 126.439 1.896 . . . . 0.0 112.143 -172.154 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 11.9 m -108.75 129.63 55.37 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 119.652 -1.905 . . . . 0.0 114.338 -178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.468 17.5 p30 -126.67 -167.84 1.78 Allowed 'General case' 0 C--N 1.376 1.735 0 CA-C-N 119.972 1.26 . . . . 0.0 113.057 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.753 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 20.2 p -49.77 -0.52 0.01 OUTLIER 'General case' 0 C--N 1.365 1.259 2 C-N-CA 135.08 5.352 . . . . 0.0 122.04 -162.507 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -105.91 4.68 29.84 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.119 167.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.41 87.3 mm-40 68.29 40.32 2.11 Favored 'General case' 0 C--N 1.375 1.717 0 C-N-CA 131.635 3.974 . . . . 0.0 109.819 -170.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.52 122.9 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 CA-C-N 111.991 -2.368 . . . . 0.0 112.528 -170.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -90.49 124.11 34.73 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 128.646 2.778 . . . . 0.0 107.254 -177.739 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.17 157.33 24.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 129.303 3.041 . . . . 0.0 103.066 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -130.2 143.36 50.74 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.39 5.0 p -124.62 148.18 48.05 Favored 'General case' 0 C--O 1.26 1.626 0 CA-C-N 119.378 0.99 . . . . 0.0 109.509 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.2 m -54.4 147.01 14.53 Favored 'General case' 0 C--N 1.385 2.127 2 C-N-CA 137.817 6.447 . . . . 0.0 115.776 -162.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 73.5 p -68.82 109.8 4.04 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.159 -1.837 . . . . 0.0 111.721 -172.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 108.95 20.29 Favored 'General case' 0 C--N 1.368 1.412 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.31 109.02 21.6 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 123.889 1.804 . . . . 0.0 110.029 -173.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.83 128.24 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 O-C-N 120.367 -1.458 . . . . 0.0 108.676 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 98.3 m . . . . . 0 CA--C 1.499 -1.012 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 175.519 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.633 ' HG ' ' H ' ' A' ' 94' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.576 1.965 0 CA-C-O 121.909 0.862 . . . . 0.0 111.588 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.6 m -163.94 172.57 13.77 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 116.556 -3.84 . . . . 0.0 104.049 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.68 -40.83 0.78 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 128.111 2.564 . . . . 0.0 112.944 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.6 p -176.0 136.13 0.29 Allowed 'General case' 0 C--N 1.369 1.423 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 34.8 tpp -134.22 118.27 17.42 Favored 'General case' 0 C--N 1.375 1.684 0 CA-C-N 119.69 1.132 . . . . 0.0 109.855 163.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.7 t -111.18 115.65 29.74 Favored 'General case' 0 C--N 1.377 1.788 0 CA-C-O 123.553 1.644 . . . . 0.0 107.796 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.75 174.4 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 127.495 2.318 . . . . 0.0 110.938 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -73.57 143.83 46.28 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 126.556 1.943 . . . . 0.0 106.643 156.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.381 0.0 OUTLIER -44.14 123.38 3.36 Favored 'General case' 0 N--CA 1.514 2.773 0 O-C-N 116.947 -3.596 . . . . 0.0 116.626 -172.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 124.73 48.72 0.21 Allowed Glycine 0 C--N 1.353 1.516 0 CA-C-N 111.705 -2.498 . . . . 0.0 109.338 -151.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.19 156.75 18.11 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 125.487 1.515 . . . . 0.0 111.515 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.76 105.25 13.68 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 124.609 1.164 . . . . 0.0 111.282 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.548 HD23 ' CE1' ' A' ' 136' ' ' TYR . 3.4 mp -120.31 125.52 48.27 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 127.002 2.121 . . . . 0.0 115.361 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.62 122.27 46.74 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 170.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -123.46 115.48 21.65 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.633 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 86.2 p -157.29 131.57 8.41 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 120.775 -1.203 . . . . 0.0 113.967 -172.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 140' ' ' VAL . 10.1 m -148.97 173.12 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 129.955 3.302 . . . . 0.0 105.974 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 p -103.77 124.71 49.4 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 115.082 -2.389 . . . . 0.0 109.808 -172.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -136.72 138.18 40.72 Favored 'General case' 0 C--N 1.386 2.154 1 N-CA-C 125.318 5.303 . . . . 0.0 125.318 -170.875 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 99' ' ' GLY . 61.5 m -157.49 174.57 15.19 Favored 'General case' 0 C--N 1.367 1.354 1 C-N-CA 132.023 4.129 . . . . 0.0 101.678 169.307 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.438 ' H ' HG22 ' A' ' 98' ' ' THR . . . -69.27 46.99 0.5 Allowed Glycine 0 C--N 1.366 2.228 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -177.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.58 21.0 60.76 Favored Glycine 0 C--N 1.356 1.657 0 C-N-CA 127.146 2.308 . . . . 0.0 116.156 175.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.412 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 7.9 p -116.45 111.11 19.53 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 115.686 -2.102 . . . . 0.0 107.234 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.678 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 70.98 -90.43 0.41 Allowed Glycine 0 C--N 1.377 2.844 0 C-N-CA 128.105 2.764 . . . . 0.0 111.814 -170.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 101' ' ' THR . 62.4 Cg_endo -66.57 167.52 18.82 Favored 'Trans proline' 0 CA--C 1.571 2.343 1 C-N-CA 126.35 4.7 . . . . 0.0 115.211 162.454 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.417 ' HB3' HG12 ' A' ' 140' ' ' VAL . 67.4 m-85 -90.82 145.54 24.68 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 121.009 3.707 . . . . 0.0 121.009 -166.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 t -102.16 140.4 36.49 Favored 'General case' 0 C--N 1.38 1.895 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.569 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -132.14 158.26 42.12 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 121.589 3.922 . . . . 0.0 121.589 -160.257 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.27 119.66 10.94 Favored 'General case' 0 C--N 1.36 1.029 0 CA-C-N 112.423 -2.171 . . . . 0.0 106.977 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -112.38 151.59 29.61 Favored 'General case' 0 C--N 1.367 1.335 0 O-C-N 119.943 -1.723 . . . . 0.0 107.848 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.4 0.0 OUTLIER -157.78 146.08 19.04 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 119.559 -1.963 . . . . 0.0 105.771 164.939 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.849 ' HG2' HG22 ' A' ' 115' ' ' ILE 0.307 65.8 mmtt -126.43 99.67 5.93 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 115.987 -2.285 . . . . 0.0 111.613 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.458 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.356 0.8 OUTLIER 36.65 53.22 1.05 Allowed 'General case' 0 CA--C 1.46 -2.489 1 CA-C-O 111.615 -4.04 . . . . 0.0 121.267 157.612 . . . . . . . . 5 4 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.45 -5.26 70.52 Favored Glycine 0 C--N 1.372 2.547 2 O-C-N 133.509 6.756 . . . . 0.0 114.965 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -124.09 148.56 57.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 131.179 3.792 . . . . 0.0 115.956 -168.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.36 161.69 19.5 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 124.244 3.296 . . . . 0.0 116.187 168.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.849 HG22 ' HG2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -93.27 165.57 18.07 Favored Pre-proline 0 N--CA 1.443 -0.791 0 C-N-CA 131.373 3.869 . . . . 0.0 109.305 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 44.6 Cg_exo -51.24 -44.29 43.82 Favored 'Trans proline' 0 CA--C 1.538 0.675 1 C-N-CA 127.433 5.422 . . . . 0.0 118.757 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -158.62 -50.82 0.06 Allowed 'General case' 0 C--N 1.348 0.504 0 C-N-CA 126.245 1.818 . . . . 0.0 106.972 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.256 . . 97.49 140.52 0.02 OUTLIER 'General case' 0 CA--C 1.464 -2.352 0 C-N-CA 128.819 2.847 . . . . 0.0 110.472 -177.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 73.9 m 69.75 34.71 2.57 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.163 -1.835 . . . . 0.0 114.243 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -108.2 -18.46 9.78 Favored Glycine 0 CA--C 1.47 -2.762 0 N-CA-C 117.877 1.911 . . . . 0.0 117.877 -164.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.313 . . 81.99 -73.03 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 126.309 1.844 . . . . 0.0 111.786 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.28 13.4 t -128.62 104.22 7.54 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 123.199 1.476 . . . . 0.0 112.459 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.346 0.0 OUTLIER -127.49 140.99 51.78 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 128.192 2.597 . . . . 0.0 112.16 174.194 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.8 m -123.48 138.59 54.55 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 120.334 -1.479 . . . . 0.0 107.869 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.67 106.75 57.52 Favored Pre-proline 0 C--N 1.369 1.415 0 N-CA-C 103.449 -2.796 . . . . 0.0 103.449 170.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.72 -32.46 3.53 Favored 'Trans proline' 0 C--N 1.356 0.958 1 C-N-CA 126.925 5.083 . . . . 0.0 111.733 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.417 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -144.47 103.98 4.01 Favored 'General case' 0 N--CA 1.42 -1.928 1 N-CA-C 99.855 -4.128 . . . . 0.0 99.855 176.689 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.586 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -95.37 133.38 39.38 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 128.335 2.654 . . . . 0.0 107.611 176.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.42 -176.1 4.68 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 127.956 2.502 . . . . 0.0 113.084 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.29 -45.12 34.44 Favored 'General case' 0 C--N 1.369 1.419 0 N-CA-C 119.024 2.972 . . . . 0.0 119.024 -173.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -69.04 -7.58 37.03 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 126.753 2.021 . . . . 0.0 114.974 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.586 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 4.9 m-20 -81.54 -17.9 46.85 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.293 2.237 . . . . 0.0 110.236 168.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.92 114.02 3.82 Favored 'General case' 0 C--N 1.386 2.158 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 171.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 165.63 -156.87 29.08 Favored Glycine 0 CA--C 1.454 -3.75 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.404 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.334 23.7 m -112.85 133.08 55.01 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 114.667 -2.813 . . . . 0.0 107.257 174.423 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.548 ' CE1' HD23 ' A' ' 91' ' ' LEU . 4.2 m-85 -96.99 132.39 42.85 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 118.506 -2.621 . . . . 0.0 113.547 -168.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -144.05 151.35 39.54 Favored 'General case' 0 C--N 1.394 2.543 0 CA-C-N 120.066 1.303 . . . . 0.0 112.138 -173.531 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.3 p -141.59 143.07 27.91 Favored 'Isoleucine or valine' 0 C--N 1.378 1.82 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.1 m -113.15 121.04 43.33 Favored 'General case' 0 C--N 1.373 1.623 0 C-N-CA 129.684 3.194 . . . . 0.0 107.366 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -132.8 125.37 52.38 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 C-N-CA 126.311 1.844 . . . . 0.0 113.112 -177.212 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 4.0 m -112.0 133.85 53.92 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.156 -2.215 . . . . 0.0 116.027 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.39 23.2 p30 -127.98 -173.91 3.06 Favored 'General case' 0 C--N 1.379 1.868 0 CA-C-N 120.226 1.375 . . . . 0.0 113.46 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.678 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 19.8 p -49.25 2.76 0.01 OUTLIER 'General case' 0 C--N 1.363 1.191 2 C-N-CA 136.349 5.86 . . . . 0.0 122.097 -165.466 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.89 4.62 25.57 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 164.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.447 98.3 mm-40 67.53 40.1 2.68 Favored 'General case' 0 C--N 1.371 1.526 1 C-N-CA 132.22 4.208 . . . . 0.0 110.576 -172.6 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.76 127.18 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-N 111.462 -2.608 . . . . 0.0 112.447 -171.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.9 OUTLIER -91.64 134.45 34.68 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.754 1.622 . . . . 0.0 110.318 -176.693 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -116.78 141.05 48.72 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 102.38 -3.193 . . . . 0.0 102.38 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -128.87 146.95 50.8 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.304 1.7 p -119.41 141.7 48.87 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 121.521 0.677 . . . . 0.0 110.738 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 m -54.23 148.22 11.78 Favored 'General case' 0 CA--C 1.479 -1.768 2 C-N-CA 138.253 6.621 . . . . 0.0 115.672 -168.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 78.3 p -68.19 110.17 3.89 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.594 2.758 . . . . 0.0 110.881 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.54 109.46 22.05 Favored 'General case' 0 C--N 1.363 1.193 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 -176.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.98 113.17 24.21 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 124.566 2.126 . . . . 0.0 111.086 -173.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.58 114.99 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -172.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 62.2 m . . . . . 0 CA--C 1.489 -1.37 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 175.057 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.697 HD22 ' H ' ' A' ' 94' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.567 1.628 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m -173.86 172.5 3.46 Favored 'General case' 0 CA--C 1.504 -0.814 1 N-CA-C 99.221 -4.363 . . . . 0.0 99.221 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.43 -47.55 2.54 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 121.051 1.75 . . . . 0.0 109.599 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -170.42 132.57 1.0 Allowed 'General case' 0 C--N 1.36 1.055 0 O-C-N 119.765 -1.835 . . . . 0.0 115.878 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 12.7 tpt -130.75 116.26 17.76 Favored 'General case' 0 C--N 1.373 1.612 0 CA-C-N 120.603 1.547 . . . . 0.0 107.793 164.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 p -109.86 115.52 29.97 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 119.397 -2.065 . . . . 0.0 107.813 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -149.55 174.27 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 126.157 1.783 . . . . 0.0 111.499 -168.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -74.08 135.74 43.0 Favored 'General case' 0 C--N 1.368 1.405 0 O-C-N 118.87 -2.394 . . . . 0.0 107.087 158.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.336 0.4 OUTLIER -44.04 122.62 2.96 Favored 'General case' 0 N--CA 1.515 2.813 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -165.55 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.587 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 131.74 50.81 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 111.337 -2.665 . . . . 0.0 108.722 -162.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.61 160.67 19.55 Favored 'General case' 0 C--N 1.369 1.415 0 C-N-CA 126.382 1.873 . . . . 0.0 109.443 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.02 99.95 8.73 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 122.494 1.14 . . . . 0.0 110.723 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 128' ' ' ALA 0.276 9.0 mp -113.27 114.24 26.41 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 126.679 1.992 . . . . 0.0 115.74 -169.602 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.92 137.17 45.48 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 170.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 79' ' ' LEU . 1.7 mm? -124.84 116.09 21.7 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.697 ' H ' HD22 ' A' ' 79' ' ' LEU . 3.6 t -150.37 131.94 14.84 Favored 'General case' 0 C--N 1.38 1.908 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.5 m -149.57 172.81 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.039 0 C-N-CA 129.926 3.29 . . . . 0.0 106.849 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.6 t -105.45 138.12 42.16 Favored 'General case' 0 C--N 1.371 1.515 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.42 143.91 37.85 Favored 'General case' 0 C--N 1.371 1.535 0 N-CA-C 119.914 3.302 . . . . 0.0 119.914 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.96 174.69 15.13 Favored 'General case' 0 C--N 1.361 1.091 1 C-N-CA 134.169 4.988 . . . . 0.0 102.881 177.521 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.19 45.57 1.75 Allowed Glycine 0 C--N 1.37 2.422 0 O-C-N 118.706 -2.496 . . . . 0.0 117.73 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.41 62.01 Favored Glycine 0 C--N 1.363 2.073 0 C-N-CA 128.073 2.749 . . . . 0.0 112.787 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.5 m -115.96 110.93 19.64 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 126.442 1.897 . . . . 0.0 107.565 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 66.95 -102.6 0.79 Allowed Glycine 0 CA--C 1.548 2.106 0 CA-C-O 116.667 -2.185 . . . . 0.0 109.783 -160.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.58 169.51 5.38 Favored 'Trans proline' 0 C--N 1.377 2.041 1 C-N-CA 129.128 6.552 . . . . 0.0 118.168 160.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.617 ' HB3' HG12 ' A' ' 140' ' ' VAL . 76.9 m-85 -81.74 142.3 32.77 Favored 'General case' 0 C--N 1.358 0.965 1 N-CA-C 124.301 4.926 . . . . 0.0 124.301 -164.407 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 t -102.32 141.06 35.76 Favored 'General case' 0 C--N 1.379 1.887 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.555 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -134.51 162.91 30.94 Favored 'General case' 0 C--N 1.351 0.662 1 N-CA-C 122.85 4.389 . . . . 0.0 122.85 -161.947 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.49 121.18 11.86 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.992 2.517 . . . . 0.0 106.951 176.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -112.16 138.2 49.16 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.577 1.951 . . . . 0.0 111.422 -175.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.1 169.97 19.46 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-O 123.119 1.438 . . . . 0.0 107.335 172.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HD3' ' CE1' ' A' ' 136' ' ' TYR . 13.8 ttpt -145.64 104.99 3.94 Favored 'General case' 0 N--CA 1.422 -1.851 0 O-C-N 119.37 -2.081 . . . . 0.0 105.875 177.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.472 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.239 1.2 t70 34.76 53.47 0.63 Allowed 'General case' 0 CA--C 1.472 -2.024 2 CA-C-O 110.414 -4.613 . . . . 0.0 123.073 141.976 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.74 -1.11 84.67 Favored Glycine 0 C--N 1.377 2.859 2 O-C-N 134.349 7.28 . . . . 0.0 118.964 -173.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.5 t -124.96 145.43 50.14 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -171.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -64.79 136.24 48.36 Favored 'Trans proline' 0 N--CA 1.495 1.588 1 C-N-CA 126.158 4.572 . . . . 0.0 115.315 173.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.447 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -85.23 165.6 35.54 Favored Pre-proline 0 CA--C 1.552 1.039 0 O-C-N 119.337 -2.102 . . . . 0.0 116.319 178.364 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 1.8 Cg_endo -68.1 81.45 0.5 Allowed 'Trans proline' 0 C--N 1.363 1.319 1 C-N-CA 125.406 4.071 . . . . 0.0 114.647 174.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 74.82 -62.15 0.46 Allowed 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.43 2.292 . . . . 0.0 115.033 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 85.3 162.68 0.1 Allowed 'General case' 0 CA--C 1.481 -1.703 0 C-N-CA 129.431 3.092 . . . . 0.0 112.584 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 79.16 52.98 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 CA-C-N 113.531 -1.668 . . . . 0.0 111.049 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.99 -86.44 0.84 Allowed Glycine 0 C--N 1.362 2.018 0 CA-C-N 114.172 -1.376 . . . . 0.0 116.494 -170.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 94' ' ' SER 0.339 . . 144.45 -74.97 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.406 2.282 . . . . 0.0 111.079 177.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.3 9.0 t -126.0 93.47 3.83 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.909 1.814 . . . . 0.0 110.301 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.277 3.3 p90 -125.98 141.05 52.13 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.228 1.811 . . . . 0.0 110.319 -177.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 88.8 m -129.71 139.8 51.26 Favored 'General case' 0 CA--C 1.493 -1.238 0 O-C-N 120.389 -1.444 . . . . 0.0 110.041 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -111.09 103.93 55.51 Favored Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 129.485 3.114 . . . . 0.0 105.293 176.484 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -72.65 -32.76 9.14 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.718 3.612 . . . . 0.0 113.772 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.587 HG23 ' HA2' ' A' ' 88' ' ' GLY . 99.4 m -136.54 100.99 4.51 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.479 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -93.07 124.04 36.76 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 124.212 1.005 . . . . 0.0 113.196 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.93 -178.49 4.67 Favored 'General case' 0 C--N 1.364 1.234 0 C-N-CA 129.2 3.0 . . . . 0.0 109.719 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -54.19 13.39 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -173.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.13 1.03 1.65 Allowed 'General case' 0 C--N 1.365 1.241 0 C-N-CA 128.6 2.76 . . . . 0.0 115.357 172.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -116.06 -18.56 10.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 129.409 3.084 . . . . 0.0 111.266 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.18 164.55 12.81 Favored 'General case' 0 C--N 1.391 2.412 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.87 -155.86 26.74 Favored Glycine 0 C--N 1.383 3.149 0 C-N-CA 128.318 2.866 . . . . 0.0 109.734 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.356 6.9 m -109.41 130.73 55.49 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 112.974 -3.491 . . . . 0.0 107.135 164.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.464 ' CE1' ' HD3' ' A' ' 110' ' ' LYS 0.255 3.5 m-85 -97.01 134.49 40.31 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 125.704 1.602 . . . . 0.0 111.492 -169.299 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -145.49 152.61 40.05 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-N 119.459 1.027 . . . . 0.0 109.021 -175.746 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.39 142.69 28.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 C-N-CA 116.568 -2.053 . . . . 0.0 111.592 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.5 m -105.99 119.37 39.03 Favored 'General case' 0 C--N 1.368 1.401 0 C-N-CA 129.778 3.231 . . . . 0.0 106.286 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.617 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -134.16 124.27 45.66 Favored 'Isoleucine or valine' 0 C--N 1.35 0.591 0 C-N-CA 124.268 1.027 . . . . 0.0 113.613 -173.36 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 6.0 m -109.23 131.71 54.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 119.412 -2.055 . . . . 0.0 114.599 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.453 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.444 10.2 p-10 -128.45 -170.48 2.26 Favored 'General case' 0 C--N 1.367 1.366 0 O-C-N 120.682 -1.261 . . . . 0.0 113.894 175.21 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.466 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 22.1 p -48.71 3.84 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.317 1 C-N-CA 136.218 5.807 . . . . 0.0 121.634 -164.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -106.74 4.57 27.82 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 118.286 -1.366 . . . . 0.0 107.898 163.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.433 89.9 mm-40 66.45 40.09 3.67 Favored 'General case' 0 C--N 1.373 1.62 1 C-N-CA 132.924 4.49 . . . . 0.0 110.273 -171.992 . . . . . . . . 3 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.418 ' C ' HG23 ' A' ' 141' ' ' THR . 4.2 m -112.54 126.32 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 C-N-CA 128.08 2.552 . . . . 0.0 112.061 -171.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.3 OUTLIER -91.83 130.24 37.64 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 124.61 1.164 . . . . 0.0 109.849 -178.203 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.62 158.89 23.84 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.755 3.222 . . . . 0.0 104.455 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -129.77 146.51 51.52 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.404 87.8 p -116.4 150.19 38.18 Favored 'General case' 0 C--O 1.254 1.303 0 C-N-CA 124.469 1.108 . . . . 0.0 110.004 177.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.92 148.83 12.59 Favored 'General case' 0 C--N 1.382 2.012 1 C-N-CA 134.245 5.018 . . . . 0.0 118.719 -158.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 136' ' ' TYR . 76.0 p -68.74 111.13 4.66 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 127.866 2.466 . . . . 0.0 110.434 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.16 109.25 22.04 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.52 107.43 19.59 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 124.84 2.257 . . . . 0.0 110.882 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.0 m -119.75 120.25 62.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 O-C-N 119.821 -1.799 . . . . 0.0 106.386 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.364 1.235 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -174.845 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 92' ' ' THR . 0.3 OUTLIER . . . . . 0 C--O 1.204 -1.298 0 CA-C-O 122.165 0.983 . . . . 0.0 112.354 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.9 m -172.13 175.46 3.74 Favored 'General case' 0 C--N 1.317 -0.822 1 C-N-CA 132.142 4.177 . . . . 0.0 101.478 168.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.75 -62.86 1.44 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.827 2.051 . . . . 0.0 113.065 169.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 p -179.99 125.14 0.07 Allowed 'General case' 0 C--N 1.36 1.048 0 O-C-N 118.434 -2.666 . . . . 0.0 117.636 -175.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.1 mmm -120.29 134.63 55.22 Favored 'General case' 0 C--N 1.379 1.888 0 CA-C-N 120.464 1.483 . . . . 0.0 113.198 168.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.2 p -114.54 115.66 27.56 Favored 'General case' 0 C--N 1.365 1.241 0 O-C-N 119.127 -2.233 . . . . 0.0 108.629 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -150.1 173.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-N 114.011 -1.449 . . . . 0.0 113.134 -167.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -81.11 131.48 35.3 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 128.01 2.524 . . . . 0.0 104.931 161.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.317 0.2 OUTLIER -43.23 122.38 2.51 Favored 'General case' 0 N--CA 1.518 2.968 0 CA-C-N 123.418 2.827 . . . . 0.0 118.55 -161.727 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.54 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 134.57 54.24 0.07 OUTLIER Glycine 0 C--N 1.35 1.354 0 CA-C-N 111.854 -2.43 . . . . 0.0 111.503 -164.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.69 172.27 10.99 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.775 1.23 . . . . 0.0 112.095 173.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.55 100.95 9.41 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.9 -1.125 . . . . 0.0 109.298 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -121.47 114.31 21.08 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.531 1.532 . . . . 0.0 111.218 -172.511 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 79' ' ' LEU 0.29 2.4 t -113.84 137.54 51.52 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.68 115.74 19.91 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 t -152.86 132.41 13.01 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.808 1.289 . . . . 0.0 112.185 -169.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.9 175.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.665 1 C-N-CA 132.171 4.188 . . . . 0.0 106.583 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -103.98 140.97 36.98 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.853 2.461 . . . . 0.0 106.375 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.33 144.38 34.54 Favored 'General case' 0 C--N 1.381 1.978 1 N-CA-C 122.934 4.42 . . . . 0.0 122.934 -174.871 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.5 p -156.41 175.84 13.49 Favored 'General case' 0 C--N 1.364 1.199 1 C-N-CA 133.883 4.873 . . . . 0.0 104.094 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.38 40.33 0.75 Allowed Glycine 0 C--N 1.365 2.183 0 C-N-CA 125.858 1.694 . . . . 0.0 117.232 167.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.06 30.67 25.12 Favored Glycine 0 C--N 1.361 1.944 0 C-N-CA 127.616 2.531 . . . . 0.0 116.164 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.41 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 63.5 m -117.44 110.9 18.58 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 113.653 -3.07 . . . . 0.0 108.351 175.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.479 ' H ' ' CB ' ' A' ' 143' ' ' SER . . . 72.79 -86.73 0.54 Allowed Glycine 0 C--N 1.383 3.15 0 CA-C-N 124.837 3.471 . . . . 0.0 110.172 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.86 168.13 6.12 Favored 'Trans proline' 0 CA--C 1.57 2.291 1 C-N-CA 126.102 4.535 . . . . 0.0 115.364 157.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.568 ' HB3' HG12 ' A' ' 140' ' ' VAL . 78.4 m-85 -105.97 145.13 31.72 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 119.798 3.259 . . . . 0.0 119.798 -164.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.6 t -103.02 141.51 35.68 Favored 'General case' 0 C--N 1.378 1.837 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.48 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -140.13 160.98 38.74 Favored 'General case' 0 C--N 1.347 0.466 1 N-CA-C 121.923 4.045 . . . . 0.0 121.923 -160.133 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -136.2 120.89 18.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.674 2.79 . . . . 0.0 105.796 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -112.05 132.8 54.6 Favored 'General case' 0 C--N 1.366 1.29 0 C-N-CA 125.178 1.391 . . . . 0.0 111.574 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.89 169.69 17.58 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 123.252 1.501 . . . . 0.0 107.334 172.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.49 ' HD3' ' CE1' ' A' ' 136' ' ' TYR . 13.0 ttpp -142.79 105.7 4.53 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.459 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.22 1.7 t70 34.91 53.63 0.66 Allowed 'General case' 0 CA--C 1.472 -2.035 2 CA-C-O 109.685 -4.96 . . . . 0.0 123.473 140.739 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.09 -10.43 60.74 Favored Glycine 0 C--N 1.383 3.179 2 O-C-N 135.222 7.826 . . . . 0.0 119.365 -172.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.407 9.8 p -124.89 147.15 55.6 Favored Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 130.607 3.563 . . . . 0.0 120.586 -167.724 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -63.8 139.72 70.17 Favored 'Trans proline' 0 N--CA 1.499 1.817 1 C-N-CA 126.484 4.789 . . . . 0.0 116.933 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -89.51 164.27 30.23 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 119.237 -2.164 . . . . 0.0 115.568 178.628 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 8.8 Cg_endo -72.05 82.9 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 125.119 3.879 . . . . 0.0 115.009 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 74.52 -61.06 0.5 Allowed 'General case' 0 C--N 1.36 1.05 0 C-N-CA 126.626 1.97 . . . . 0.0 115.846 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 79.16 176.21 0.14 Allowed 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 130.3 3.44 . . . . 0.0 114.805 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.418 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 74.55 70.08 0.1 Allowed 'General case' 0 C--N 1.356 0.864 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.752 173.355 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -154.77 -53.11 0.01 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 120.078 2.791 . . . . 0.0 120.078 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.292 . . 131.94 -65.87 0.0 OUTLIER 'General case' 0 C--N 1.351 0.634 0 C-N-CA 127.129 2.172 . . . . 0.0 107.777 -176.017 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.27 14.7 t -137.53 108.84 6.86 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-N 120.475 1.489 . . . . 0.0 113.688 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.289 0.2 OUTLIER -128.02 140.25 52.08 Favored 'General case' 0 C--N 1.372 1.567 0 C-N-CA 127.881 2.472 . . . . 0.0 111.846 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.8 m -129.39 139.75 51.57 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 119.909 -1.745 . . . . 0.0 111.596 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 105.27 56.68 Favored Pre-proline 0 C--N 1.358 0.949 0 C-N-CA 129.377 3.071 . . . . 0.0 105.966 173.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -75.56 -11.51 20.47 Favored 'Trans proline' 0 C--N 1.353 0.782 1 C-N-CA 125.745 4.297 . . . . 0.0 112.819 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.54 HG23 ' HA2' ' A' ' 88' ' ' GLY . 62.1 m -157.93 105.65 1.99 Allowed 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.791 ' HB2' HD21 ' A' ' 91' ' ' LEU . . . -94.17 118.9 32.22 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.313 1.045 . . . . 0.0 112.825 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.97 -176.98 6.2 Favored 'General case' 0 C--N 1.367 1.351 0 C-N-CA 127.131 2.173 . . . . 0.0 109.236 172.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.12 -54.19 14.08 Favored 'General case' 0 C--N 1.368 1.384 0 O-C-N 118.273 -2.767 . . . . 0.0 117.209 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.8 0.79 1.58 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 128.692 2.797 . . . . 0.0 115.58 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -116.43 -18.33 10.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 129.299 3.04 . . . . 0.0 111.347 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.65 164.74 13.29 Favored 'General case' 0 C--N 1.397 2.655 0 CA-C-N 122.534 2.424 . . . . 0.0 116.673 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.24 -155.08 25.42 Favored Glycine 0 CA--C 1.459 -3.446 0 C-N-CA 127.107 2.289 . . . . 0.0 109.012 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.351 9.3 m -113.49 133.41 55.23 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 111.912 -3.915 . . . . 0.0 108.595 166.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.49 ' CE1' ' HD3' ' A' ' 110' ' ' LYS 0.252 21.1 m-85 -96.26 135.2 38.41 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 122.228 2.285 . . . . 0.0 110.984 -170.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.459 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -145.77 147.52 31.97 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 123.982 0.913 . . . . 0.0 108.908 -176.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 149' ' ' ASP . 10.4 p -138.76 137.38 42.95 Favored 'Isoleucine or valine' 0 C--N 1.365 1.267 0 C-N-CA 118.189 -1.404 . . . . 0.0 113.402 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 113.89 27.74 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 129.29 3.036 . . . . 0.0 105.848 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.568 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -128.98 119.68 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.936 1.694 . . . . 0.0 110.513 -171.41 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.403 HG23 ' C ' ' A' ' 146' ' ' VAL . 5.2 m -106.24 133.1 51.47 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.228 -1.545 . . . . 0.0 113.719 -176.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.484 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.328 15.6 p-10 -126.21 179.43 5.26 Favored 'General case' 0 C--N 1.376 1.757 0 C-N-CA 124.164 0.986 . . . . 0.0 111.971 174.923 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.479 ' CB ' ' H ' ' A' ' 102' ' ' GLY . 13.1 p -49.18 2.29 0.01 OUTLIER 'General case' 0 C--N 1.375 1.677 1 C-N-CA 136.971 6.108 . . . . 0.0 119.306 -170.768 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -101.28 4.24 41.53 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 165.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.523 0.9 OUTLIER 62.89 39.87 10.12 Favored 'General case' 0 C--N 1.372 1.554 1 C-N-CA 134.266 5.026 . . . . 0.0 112.715 -172.692 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.403 ' C ' HG23 ' A' ' 141' ' ' THR . 4.6 m -112.85 128.37 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.858 0 CA-C-N 111.596 -2.547 . . . . 0.0 111.882 -170.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.02 123.0 35.06 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.456 1.902 . . . . 0.0 106.777 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 157.74 24.56 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 128.031 2.532 . . . . 0.0 104.804 -174.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 27.3 t70 -125.06 140.32 53.0 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.708 1.242 . . . . 0.0 108.205 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.486 44.6 p -116.98 144.05 45.01 Favored 'General case' 0 C--O 1.254 1.334 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 m -54.11 147.98 11.84 Favored 'General case' 0 CA--C 1.478 -1.789 2 C-N-CA 138.798 6.839 . . . . 0.0 118.049 -159.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 73.6 p -68.29 109.77 3.76 Favored 'General case' 0 C--N 1.367 1.348 0 C-N-CA 124.486 1.114 . . . . 0.0 111.907 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -95.22 108.49 20.63 Favored 'General case' 0 C--N 1.373 1.608 0 N-CA-C 102.653 -3.092 . . . . 0.0 102.653 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.53 113.72 25.48 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 123.732 1.729 . . . . 0.0 111.152 -172.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.33 116.21 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 C--N 1.372 1.549 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -179.556 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.566 1.568 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER -175.09 -177.02 1.01 Allowed 'General case' 0 N--CA 1.476 0.83 1 N-CA-C 98.716 -4.549 . . . . 0.0 98.716 162.75 . . . . . . . . 4 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.86 -53.09 2.67 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 119.567 -1.958 . . . . 0.0 106.767 162.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.0 p -168.91 128.92 1.12 Allowed 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.037 -1.664 . . . . 0.0 115.079 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.0 tpt -124.95 123.45 39.92 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-N 120.81 1.641 . . . . 0.0 111.247 167.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.2 t -112.05 116.73 31.01 Favored 'General case' 0 C--N 1.374 1.652 0 O-C-N 119.724 -1.86 . . . . 0.0 107.273 171.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -149.67 173.7 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 112.065 -2.334 . . . . 0.0 109.981 -173.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.55 144.7 39.51 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 126.302 1.841 . . . . 0.0 106.609 158.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.436 0.0 OUTLIER -44.42 121.97 2.84 Favored 'General case' 0 N--CA 1.515 2.807 0 O-C-N 117.376 -3.327 . . . . 0.0 118.339 -168.027 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.422 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 129.74 55.49 0.1 OUTLIER Glycine 0 C--N 1.36 1.866 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.651 -155.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.5 165.23 12.85 Favored 'General case' 0 C--N 1.369 1.413 0 O-C-N 120.643 -1.504 . . . . 0.0 110.487 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.93 100.96 9.84 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-O 123.17 1.462 . . . . 0.0 113.393 -173.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mp -119.36 127.23 52.96 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 125.113 1.365 . . . . 0.0 111.835 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.452 ' HA ' HG23 ' A' ' 124' ' ' THR . 4.8 t -116.04 115.3 25.88 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 168.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.12 112.0 24.71 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 103.04 -2.948 . . . . 0.0 103.04 173.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.9 t -146.35 131.2 18.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.621 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.1 m -150.54 174.23 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.649 1 C-N-CA 131.789 4.035 . . . . 0.0 103.565 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.3 t -106.38 140.39 39.37 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 122.096 2.225 . . . . 0.0 106.976 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -139.71 142.61 36.85 Favored 'General case' 0 C--N 1.379 1.863 0 N-CA-C 121.021 3.712 . . . . 0.0 121.021 -174.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.2 p -156.29 175.54 13.86 Favored 'General case' 0 C--N 1.367 1.346 1 C-N-CA 134.365 5.066 . . . . 0.0 103.352 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.73 39.77 0.78 Allowed Glycine 0 C--N 1.368 2.31 0 O-C-N 119.514 -1.991 . . . . 0.0 117.649 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.19 26.08 49.49 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 128.459 2.933 . . . . 0.0 114.427 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 p -116.88 109.84 17.58 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 116.249 -1.834 . . . . 0.0 107.856 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.652 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.01 -91.07 0.51 Allowed Glycine 0 C--N 1.374 2.643 0 C-N-CA 129.073 3.225 . . . . 0.0 111.053 -167.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -60.22 169.16 5.29 Favored 'Trans proline' 0 CA--C 1.566 2.111 1 C-N-CA 127.993 5.795 . . . . 0.0 116.968 160.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TYR . . . . . 0.49 ' HB3' HG12 ' A' ' 140' ' ' VAL . 75.1 m-85 -94.58 146.27 24.24 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -168.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -102.69 140.78 36.53 Favored 'General case' 0 C--N 1.382 2.013 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.429 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -135.46 139.84 44.38 Favored 'General case' 0 C--N 1.352 0.691 1 N-CA-C 123.668 4.692 . . . . 0.0 123.668 -158.356 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.07 111.56 14.83 Favored 'General case' 0 C--N 1.371 1.533 0 C-N-CA 126.403 1.881 . . . . 0.0 107.238 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TRP . . . . . 0.462 ' CE2' HG21 ' A' ' 138' ' ' VAL . 76.4 m95 -113.06 145.14 41.42 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.053 1.741 . . . . 0.0 111.405 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.32 0.0 OUTLIER -157.95 156.38 31.16 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 164.211 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.498 ' HG2' HG22 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -128.05 102.84 6.91 Favored 'General case' 0 C--N 1.37 1.493 0 C-N-CA 117.271 -1.771 . . . . 0.0 113.517 175.962 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.453 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.231 2.5 t70 36.94 54.53 1.19 Allowed 'General case' 0 CA--C 1.456 -2.656 1 CA-C-O 110.772 -4.442 . . . . 0.0 120.837 152.829 . . . . . . . . 4 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.19 -11.49 63.74 Favored Glycine 0 C--N 1.37 2.462 2 O-C-N 133.928 7.018 . . . . 0.0 116.041 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.262 3.6 m -123.96 149.16 59.14 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 131.216 3.806 . . . . 0.0 117.161 -168.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.15 152.32 80.27 Favored 'Trans proline' 0 N--CA 1.494 1.544 1 C-N-CA 125.473 4.115 . . . . 0.0 116.211 169.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.498 HG22 ' HG2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -99.04 157.76 33.51 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.469 1.508 . . . . 0.0 109.243 174.522 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 5.3 Cg_exo -62.64 -75.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.839 1 C-N-CA 126.039 4.493 . . . . 0.0 116.773 -170.036 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -102.86 -34.46 8.97 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.267 1.427 . . . . 0.0 111.281 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 75.93 -72.36 0.11 Allowed 'General case' 0 CA--C 1.486 -1.512 0 C-N-CA 130.075 3.35 . . . . 0.0 114.393 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.348 5.2 t -81.82 72.64 8.87 Favored 'General case' 0 N--CA 1.416 -2.155 1 C-N-CA 133.627 4.771 . . . . 0.0 111.348 -175.108 . . . . . . . . 3 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.23 -41.5 0.02 OUTLIER Glycine 0 CA--C 1.469 -2.794 0 N-CA-C 122.072 3.589 . . . . 0.0 122.072 -168.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.301 . . 105.16 -62.57 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.505 1.522 . . . . 0.0 110.151 179.051 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.296 15.3 t -136.49 96.33 3.33 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-O 122.622 1.201 . . . . 0.0 113.841 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -126.5 138.0 53.44 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 127.121 2.169 . . . . 0.0 107.823 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . 0.452 HG23 ' HA ' ' A' ' 92' ' ' THR . 91.5 m -128.92 133.2 47.78 Favored 'General case' 0 CA--C 1.478 -1.789 0 O-C-N 119.536 -1.977 . . . . 0.0 106.256 -176.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.83 93.22 8.49 Favored Pre-proline 0 C--N 1.359 1.018 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.69 -11.83 26.27 Favored 'Trans proline' 0 C--N 1.348 0.544 1 C-N-CA 125.525 4.15 . . . . 0.0 111.048 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' THR . . . . . 0.422 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -161.62 104.29 1.22 Allowed 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -87.16 133.48 33.63 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.253 2.621 . . . . 0.0 113.119 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.11 178.92 5.72 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 128.995 2.918 . . . . 0.0 110.683 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.13 -45.3 32.99 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 118.937 2.94 . . . . 0.0 118.937 -174.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -66.88 -17.59 64.97 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 126.855 2.062 . . . . 0.0 114.205 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.566 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 36.5 m-20 -82.05 -14.26 56.13 Favored 'General case' 0 CA--C 1.573 1.854 0 C-N-CA 128.52 2.728 . . . . 0.0 111.361 170.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.28 127.15 32.03 Favored 'General case' 0 C--N 1.393 2.48 0 N-CA-C 119.474 3.139 . . . . 0.0 119.474 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.18 -147.9 18.01 Favored Glycine 0 CA--C 1.473 -2.542 0 C-N-CA 128.404 2.907 . . . . 0.0 108.651 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.451 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.265 21.1 m -125.46 140.08 53.09 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 114.47 -2.892 . . . . 0.0 109.533 173.317 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.473 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 16.9 m-85 -95.91 134.52 38.8 Favored 'General case' 0 C--N 1.367 1.361 0 O-C-N 118.722 -2.486 . . . . 0.0 112.456 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -142.45 146.68 35.07 Favored 'General case' 0 C--N 1.368 1.393 0 C-N-CA 123.993 0.917 . . . . 0.0 108.602 -174.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' VAL . . . . . 0.462 HG21 ' CE2' ' A' ' 108' ' ' TRP 0.251 13.4 p -146.99 139.95 19.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.185 0 C-N-CA 118.64 -1.224 . . . . 0.0 114.144 176.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.48 115.67 27.63 Favored 'General case' 0 C--N 1.375 1.702 0 C-N-CA 127.22 2.208 . . . . 0.0 106.321 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -127.09 116.46 44.51 Favored 'Isoleucine or valine' 0 C--N 1.369 1.444 0 C-N-CA 127.996 2.518 . . . . 0.0 112.155 -171.345 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.415 HG23 ' C ' ' A' ' 146' ' ' VAL . 4.0 m -99.12 132.89 44.11 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -176.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.424 16.2 p-10 -126.58 -176.93 3.82 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-N 120.769 1.622 . . . . 0.0 112.171 173.887 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.652 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 77.5 p -49.58 3.3 0.01 OUTLIER 'General case' 0 C--N 1.36 1.025 1 C-N-CA 136.634 5.973 . . . . 0.0 121.279 -165.15 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.29 4.47 36.57 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 164.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.422 81.0 mm-40 65.52 40.01 4.79 Favored 'General case' 0 C--N 1.374 1.659 1 C-N-CA 132.874 4.47 . . . . 0.0 111.183 -172.55 . . . . . . . . 3 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' VAL . . . . . 0.415 ' C ' HG23 ' A' ' 141' ' ' THR . 3.4 m -112.64 130.09 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.754 -172.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -90.59 124.57 35.14 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 128.742 2.817 . . . . 0.0 107.733 -177.501 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.69 152.89 32.34 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 45.8 p30 -130.56 147.14 52.21 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 123.061 1.41 . . . . 0.0 112.455 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.283 9.9 p -119.15 144.75 46.49 Favored 'General case' 0 C--O 1.259 1.58 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.277 168.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.8 m -55.12 148.83 13.29 Favored 'General case' 0 CA--C 1.478 -1.804 3 C-N-CA 140.098 7.359 . . . . 0.0 115.101 -172.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 72.5 p -68.58 109.86 3.95 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 127.835 2.454 . . . . 0.0 109.49 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 108.92 21.07 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 102.274 -3.232 . . . . 0.0 102.274 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.88 112.74 24.81 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 122.426 1.108 . . . . 0.0 111.502 -172.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.0 m -121.61 118.37 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 58.5 m . . . . . 0 CA--C 1.489 -1.38 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 178.347 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.092 0 CA-C-O 121.747 0.784 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.9 tp -87.84 119.63 28.37 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.109 1.763 . . . . 0.0 111.354 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.9 t -98.82 172.92 7.14 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 129.841 3.257 . . . . 0.0 109.728 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 75' ' ' LEU 0.329 0.4 OUTLIER -75.13 98.4 3.69 Favored 'General case' 0 C--N 1.36 1.063 0 O-C-N 120.804 -1.185 . . . . 0.0 109.893 169.501 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 58.24 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 117.91 -2.994 . . . . 0.0 115.551 -171.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -133.0 141.03 48.06 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 131.648 3.979 . . . . 0.0 105.501 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.297 0.0 OUTLIER -82.71 171.08 14.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 125.348 2.499 . . . . 0.0 110.162 177.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.493 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -72.42 -33.31 67.03 Favored 'General case' 0 N--CA 1.428 -1.56 0 O-C-N 119.858 -1.776 . . . . 0.0 112.963 169.222 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.3 m -172.57 173.38 4.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.48 -51.56 2.06 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 120.412 1.46 . . . . 0.0 112.263 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.3 t -170.6 142.66 2.07 Favored 'General case' 0 C--N 1.363 1.18 0 O-C-N 119.415 -2.053 . . . . 0.0 114.339 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.6 118.78 19.62 Favored 'General case' 0 C--N 1.377 1.772 0 O-C-N 121.417 -0.802 . . . . 0.0 109.887 167.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -105.87 114.91 29.35 Favored 'General case' 0 C--N 1.376 1.746 0 O-C-N 120.459 -1.401 . . . . 0.0 109.18 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.8 p -150.93 173.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.688 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.249 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -79.96 143.51 34.1 Favored 'General case' 0 C--N 1.369 1.456 0 C-N-CA 127.259 2.224 . . . . 0.0 105.432 157.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.433 5.1 pt-20 -44.21 122.88 3.15 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 117.338 -3.352 . . . . 0.0 118.626 -166.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.63 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 129.0 51.75 0.12 Allowed Glycine 0 C--N 1.352 1.467 0 C-N-CA 128.908 3.147 . . . . 0.0 110.741 -163.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.76 162.34 22.96 Favored 'General case' 0 C--N 1.375 1.689 0 C-N-CA 124.957 1.303 . . . . 0.0 112.339 171.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.91 105.87 14.43 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 124.628 1.171 . . . . 0.0 111.635 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.479 HD23 ' CZ ' ' A' ' 136' ' ' TYR 0.252 2.3 mp -119.73 129.88 54.72 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -173.255 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -114.87 137.93 51.39 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 166.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.623 HD11 ' CD1' ' A' ' 136' ' ' TYR . 3.9 mm? -113.69 115.62 28.15 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 102.104 -3.295 . . . . 0.0 102.104 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.493 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 2.5 t -154.62 132.47 11.52 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 120.933 1.697 . . . . 0.0 114.098 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 m -150.22 174.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.011 1 C-N-CA 133.643 4.777 . . . . 0.0 106.822 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.0 t -104.36 141.73 35.8 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 127.637 2.375 . . . . 0.0 106.734 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -139.2 145.95 39.93 Favored 'General case' 0 C--N 1.379 1.856 1 N-CA-C 123.228 4.529 . . . . 0.0 123.228 -174.25 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.4 p -156.58 175.49 13.97 Favored 'General case' 0 C--N 1.365 1.248 1 C-N-CA 133.34 4.656 . . . . 0.0 104.391 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.51 42.11 1.02 Allowed Glycine 0 C--N 1.365 2.162 0 O-C-N 119.802 -1.811 . . . . 0.0 117.318 168.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.18 28.35 28.28 Favored Glycine 0 C--N 1.361 1.966 0 C-N-CA 127.616 2.531 . . . . 0.0 115.412 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.406 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 59.3 m -117.67 110.88 18.42 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 114.217 -2.801 . . . . 0.0 108.453 174.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.91 -86.21 0.56 Allowed Glycine 0 C--N 1.38 3.007 0 C-N-CA 129.249 3.309 . . . . 0.0 110.389 -176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 101' ' ' THR . 20.0 Cg_exo -59.88 168.38 5.83 Favored 'Trans proline' 0 CA--C 1.57 2.312 1 C-N-CA 126.164 4.576 . . . . 0.0 115.676 158.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.559 ' HB3' HG12 ' A' ' 140' ' ' VAL . 77.7 m-85 -106.31 146.09 30.83 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 119.892 3.293 . . . . 0.0 119.892 -163.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.9 t -103.34 142.65 33.85 Favored 'General case' 0 C--N 1.38 1.928 0 C-N-CA 127.879 2.472 . . . . 0.0 104.358 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -142.43 165.4 27.5 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 122.783 4.364 . . . . 0.0 122.783 -161.555 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.42 119.06 18.09 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 128.265 2.626 . . . . 0.0 105.083 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -109.62 136.41 49.02 Favored 'General case' 0 C--N 1.368 1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 110.55 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.91 169.87 18.25 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 122.717 1.246 . . . . 0.0 107.69 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -144.73 105.64 4.17 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 175.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.469 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.16 1.8 t70 35.05 52.95 0.66 Allowed 'General case' 0 C--N 1.377 1.785 1 N-CA-C 122.307 4.188 . . . . 0.0 122.307 139.829 . . . . . . . . 4 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.45 -4.77 85.86 Favored Glycine 0 C--N 1.369 2.384 2 O-C-N 133.53 6.769 . . . . 0.0 119.206 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.269 3.5 m -124.45 147.46 55.42 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 129.532 3.133 . . . . 0.0 118.329 -171.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.01 145.05 84.46 Favored 'Trans proline' 0 N--CA 1.493 1.498 1 C-N-CA 125.882 4.388 . . . . 0.0 114.722 171.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.09 159.04 30.57 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 118.739 -2.476 . . . . 0.0 112.244 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -67.42 87.73 0.33 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 125.247 3.965 . . . . 0.0 116.177 -175.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 74.62 -57.22 0.62 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 127.372 2.269 . . . . 0.0 115.425 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 74.13 174.83 0.26 Allowed 'General case' 0 CA--C 1.482 -1.657 0 C-N-CA 130.189 3.396 . . . . 0.0 116.494 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.408 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.3 OUTLIER 75.6 71.87 0.09 Allowed 'General case' 0 C--N 1.356 0.867 0 CA-C-N 114.114 -1.403 . . . . 0.0 114.735 171.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.42 -67.92 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 117.382 1.713 . . . . 0.0 117.382 -172.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 150.32 -69.86 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 126.503 1.921 . . . . 0.0 106.74 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.284 13.6 t -135.38 109.87 8.51 Favored 'General case' 0 C--N 1.363 1.153 0 CA-C-O 123.35 1.548 . . . . 0.0 113.878 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.368 9.1 p90 -127.23 142.12 51.56 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 129.473 3.109 . . . . 0.0 112.716 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.5 m -128.28 139.57 52.35 Favored 'General case' 0 C--N 1.366 1.288 0 O-C-N 119.323 -2.11 . . . . 0.0 110.305 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 100.23 44.33 Favored Pre-proline 0 C--N 1.366 1.324 0 C-N-CA 128.708 2.803 . . . . 0.0 106.411 175.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.26 -17.1 15.11 Favored 'Trans proline' 0 C--N 1.353 0.814 1 C-N-CA 126.096 4.531 . . . . 0.0 114.061 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.63 HG23 ' HA2' ' A' ' 88' ' ' GLY . 52.4 m -156.11 102.48 2.14 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 102.596 -3.113 . . . . 0.0 102.596 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.549 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.79 133.33 34.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.623 1.969 . . . . 0.0 111.499 175.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.5 -179.52 4.92 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.193 2.597 . . . . 0.0 111.027 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.02 -49.0 32.57 Favored 'General case' 0 C--N 1.366 1.305 0 N-CA-C 119.194 3.035 . . . . 0.0 119.194 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.35 -10.26 57.11 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 126.335 1.854 . . . . 0.0 114.53 173.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.549 ' CB ' ' HB1' ' A' ' 128' ' ' ALA 0.366 48.7 m-20 -80.41 -18.31 49.26 Favored 'General case' 0 CA--C 1.572 1.793 0 C-N-CA 129.581 3.152 . . . . 0.0 111.84 168.092 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.64 126.49 29.1 Favored 'General case' 0 C--N 1.387 2.212 0 N-CA-C 119.536 3.161 . . . . 0.0 119.536 168.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 160.44 -157.5 28.89 Favored Glycine 0 CA--C 1.459 -3.446 0 C-N-CA 127.117 2.294 . . . . 0.0 109.694 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 m -120.63 129.7 53.84 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 115.004 -2.679 . . . . 0.0 108.235 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.623 ' CD1' HD11 ' A' ' 93' ' ' LEU 0.274 30.1 m-85 -95.21 134.85 37.5 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 130.163 3.385 . . . . 0.0 111.651 -170.083 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.469 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -147.02 153.87 40.54 Favored 'General case' 0 C--N 1.369 1.429 0 C-N-CA 125.509 1.524 . . . . 0.0 108.202 -173.515 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 150' ' ' SER 0.43 2.4 p -143.58 134.3 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 117.677 -1.609 . . . . 0.0 114.339 -178.53 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.42 109.22 21.01 Favored 'General case' 0 C--N 1.385 2.132 0 C-N-CA 129.669 3.188 . . . . 0.0 106.345 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -127.7 118.62 49.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 C-N-CA 125.482 1.513 . . . . 0.0 111.037 -168.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 146' ' ' VAL . 11.1 m -104.32 130.86 52.14 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 120.451 -1.406 . . . . 0.0 113.552 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.497 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.344 18.9 p-10 -124.99 -176.58 3.59 Favored 'General case' 0 C--N 1.379 1.853 0 C-N-CA 124.312 1.045 . . . . 0.0 111.909 175.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 6.2 p -48.84 2.73 0.01 OUTLIER 'General case' 0 C--N 1.372 1.574 1 C-N-CA 137.428 6.291 . . . . 0.0 119.867 -168.01 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.76 4.29 35.04 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 118.16 -1.416 . . . . 0.0 107.678 163.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.435 93.6 mm-40 65.54 40.3 4.63 Favored 'General case' 0 C--N 1.374 1.662 1 C-N-CA 132.736 4.414 . . . . 0.0 110.783 -172.164 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.413 ' C ' HG23 ' A' ' 141' ' ' THR . 3.1 m -112.9 129.36 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 CA-C-N 111.944 -2.389 . . . . 0.0 112.201 -171.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.19 124.12 35.16 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 127.68 2.392 . . . . 0.0 108.205 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 157.43 25.23 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 128.308 2.643 . . . . 0.0 105.375 -173.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -121.46 132.09 54.53 Favored 'General case' 0 C--N 1.358 0.943 0 CA-C-O 124.611 2.148 . . . . 0.0 108.892 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.755 ' HB2' HG13 ' A' ' 138' ' ' VAL . 51.1 m -108.26 147.84 30.85 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 111.509 -2.587 . . . . 0.0 106.942 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.5 m -52.95 146.92 10.05 Favored 'General case' 0 CA--C 1.49 -1.36 1 C-N-CA 135.012 5.325 . . . . 0.0 119.477 -159.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.1 p -70.69 111.04 5.86 Favored 'General case' 0 C--N 1.368 1.403 0 C-N-CA 127.317 2.247 . . . . 0.0 109.321 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.74 110.46 22.77 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 102.214 -3.254 . . . . 0.0 102.214 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.24 113.37 25.6 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 123.247 1.499 . . . . 0.0 112.092 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.67 128.39 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 O-C-N 119.99 -1.694 . . . . 0.0 109.281 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 34.6 m -122.23 122.77 39.91 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 102.508 -3.145 . . . . 0.0 102.508 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 2.7 m -124.43 104.41 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -85.75 157.96 57.16 Favored Pre-proline 0 C--N 1.356 0.875 0 C-N-CA 124.662 1.185 . . . . 0.0 111.454 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -68.87 165.8 28.61 Favored 'Trans proline' 0 CA--C 1.55 1.278 1 C-N-CA 125.986 4.458 . . . . 0.0 108.782 154.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 20.9 p -67.32 127.01 31.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 119.089 -2.257 . . . . 0.0 108.95 -173.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.06 125.2 89.67 Favored Pre-proline 0 C--N 1.366 1.318 0 N-CA-C 121.648 3.944 . . . . 0.0 121.648 -123.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.63 141.09 84.49 Favored 'Trans proline' 0 C--N 1.386 2.519 1 C-N-CA 125.811 4.341 . . . . 0.0 111.873 168.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -52.71 60.93 0.0 OUTLIER Glycine 0 C--N 1.366 2.221 0 N-CA-C 121.728 3.451 . . . . 0.0 121.728 -168.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -125.42 -40.27 0.4 Allowed Glycine 0 C--N 1.353 1.513 0 C-N-CA 125.701 1.62 . . . . 0.0 113.673 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 9.6 mp -86.37 -64.45 1.15 Allowed 'General case' 0 C--N 1.357 0.93 0 C-N-CA 125.5 1.52 . . . . 0.0 113.907 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.11 13.4 4.71 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 125.205 1.402 . . . . 0.0 112.704 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 75.4 t60 . . . . . 0 C--N 1.351 0.652 0 O-C-N 120.906 -1.121 . . . . 0.0 110.801 -175.308 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.3 tp -106.82 132.2 53.06 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-O 123.585 1.659 . . . . 0.0 108.507 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . 0.269 1.2 t -105.11 170.16 8.03 Favored 'General case' 0 N--CA 1.414 -2.253 0 C-N-CA 125.474 1.51 . . . . 0.0 107.146 177.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 75' ' ' LEU 0.256 0.3 OUTLIER -88.96 98.44 11.76 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 119.808 -1.808 . . . . 0.0 107.963 175.73 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.14 -79.45 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.025 -1.672 . . . . 0.0 111.815 -168.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -133.81 140.61 47.01 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.086 3.355 . . . . 0.0 107.012 161.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.378 0.3 OUTLIER -82.39 174.21 11.32 Favored 'General case' 0 C--N 1.356 0.866 1 C-N-CA 132.109 4.164 . . . . 0.0 109.129 175.242 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -34.83 74.34 Favored 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.912 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.0 m -161.93 172.0 16.75 Favored 'General case' 0 C--N 1.347 0.465 0 O-C-N 116.835 -3.666 . . . . 0.0 103.856 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.72 -43.24 1.0 Allowed 'General case' 0 C--N 1.363 1.187 0 C-N-CA 126.792 2.037 . . . . 0.0 113.359 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.2 p -172.24 127.98 0.57 Allowed 'General case' 0 C--N 1.366 1.319 0 N-CA-C 118.426 2.751 . . . . 0.0 118.426 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.7 tpt -142.4 116.12 9.21 Favored 'General case' 0 C--N 1.377 1.785 0 CA-C-N 120.985 1.721 . . . . 0.0 109.909 162.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.4 p -112.81 116.39 29.99 Favored 'General case' 0 C--N 1.364 1.201 0 O-C-N 118.719 -2.488 . . . . 0.0 110.178 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.59 172.04 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 125.951 1.7 . . . . 0.0 110.331 -170.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -83.27 130.21 35.06 Favored 'General case' 0 C--N 1.373 1.615 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 164.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -41.73 122.4 1.99 Allowed 'General case' 0 C--N 1.372 1.555 0 N-CA-C 120.469 3.507 . . . . 0.0 120.469 -151.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.436 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 145.57 45.75 0.04 OUTLIER Glycine 0 C--N 1.363 2.052 0 CA-C-N 110.292 -3.14 . . . . 0.0 110.993 -166.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.64 165.7 17.71 Favored 'General case' 0 C--N 1.375 1.712 0 C-N-CA 125.336 1.454 . . . . 0.0 113.527 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.99 105.68 14.16 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 124.525 1.13 . . . . 0.0 110.85 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.443 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 4.5 mp -119.58 119.92 35.19 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.87 1.668 . . . . 0.0 114.388 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.87 127.04 53.69 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 173.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -123.78 114.73 20.29 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 173.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.9 m -151.18 132.94 14.96 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 119.63 -1.919 . . . . 0.0 110.909 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 m -148.97 175.18 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.406 0 C-N-CA 130.423 3.489 . . . . 0.0 104.605 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -104.24 139.39 39.33 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 127.511 2.324 . . . . 0.0 105.555 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.59 137.03 31.62 Favored 'General case' 0 C--N 1.379 1.891 1 N-CA-C 122.502 4.26 . . . . 0.0 122.502 -173.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.1 p -156.52 174.72 15.02 Favored 'General case' 0 C--N 1.359 0.991 1 C-N-CA 133.904 4.882 . . . . 0.0 101.25 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.66 40.7 1.37 Allowed Glycine 0 C--N 1.363 2.076 0 N-CA-C 118.102 2.001 . . . . 0.0 118.102 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.53 25.1 28.93 Favored Glycine 0 C--N 1.36 1.91 0 C-N-CA 127.8 2.619 . . . . 0.0 114.458 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 29.8 p -116.55 110.32 18.4 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 113.089 -3.339 . . . . 0.0 107.876 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.574 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 69.13 -86.93 0.23 Allowed Glycine 0 C--N 1.382 3.089 0 C-N-CA 130.014 3.674 . . . . 0.0 111.117 -170.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.91 168.88 5.2 Favored 'Trans proline' 0 CA--C 1.571 2.37 1 C-N-CA 127.514 5.476 . . . . 0.0 116.957 160.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.566 ' HB3' HG12 ' A' ' 140' ' ' VAL . 66.8 m-85 -98.6 144.27 28.08 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 119.758 3.244 . . . . 0.0 119.758 -167.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 t -102.51 159.16 15.68 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.438 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.5 OUTLIER -157.17 166.32 33.55 Favored 'General case' 0 C--N 1.365 1.255 0 N-CA-C 120.508 3.521 . . . . 0.0 120.508 -164.679 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.84 112.5 10.08 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 128.398 2.679 . . . . 0.0 105.846 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.456 ' HB2' HG13 ' A' ' 115' ' ' ILE . 7.4 m95 -112.64 142.73 44.89 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 125.346 1.458 . . . . 0.0 108.041 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.29 0.0 OUTLIER -158.25 161.36 37.74 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 166.299 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HZ1' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -133.01 103.89 6.27 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 116.717 -1.993 . . . . 0.0 115.873 177.179 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.458 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.226 1.7 t70 36.99 54.68 1.21 Allowed 'General case' 0 CA--C 1.455 -2.68 1 CA-C-O 111.111 -4.28 . . . . 0.0 119.918 154.075 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.11 -15.28 58.03 Favored Glycine 0 C--N 1.369 2.365 2 O-C-N 134.153 7.158 . . . . 0.0 116.681 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.424 ' HB3' ' HE2' ' A' ' 110' ' ' LYS 0.271 26.6 m -124.23 148.92 59.27 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 129.863 3.265 . . . . 0.0 116.909 -167.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.32 155.86 43.99 Favored 'Trans proline' 0 N--CA 1.502 2.01 1 C-N-CA 126.644 4.896 . . . . 0.0 116.323 171.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.456 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -104.58 147.53 34.56 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 119.539 -1.976 . . . . 0.0 110.162 174.935 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -58.8 -76.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.919 1 C-N-CA 126.504 4.802 . . . . 0.0 120.377 -165.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -141.54 64.75 1.4 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.83 -172.72 4.13 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 126.788 2.035 . . . . 0.0 115.498 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.309 8.4 t 101.79 13.13 0.01 OUTLIER 'General case' 0 C--N 1.354 0.783 0 C-N-CA 129.076 2.95 . . . . 0.0 111.825 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.81 96.75 0.1 Allowed Glycine 0 CA--C 1.475 -2.431 0 C-N-CA 116.733 -2.651 . . . . 0.0 117.687 166.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.481 . . 84.26 -84.52 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 170.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.9 t -138.92 121.1 15.8 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 122.316 2.325 . . . . 0.0 115.609 -170.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -127.66 139.69 52.56 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 127.638 2.375 . . . . 0.0 110.745 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 91' ' ' LEU . 35.1 m -129.76 139.91 51.18 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 119.33 -2.106 . . . . 0.0 109.774 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.35 98.04 41.92 Favored Pre-proline 0 C--N 1.363 1.159 0 C-N-CA 127.638 2.375 . . . . 0.0 107.316 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.12 -16.5 15.69 Favored 'Trans proline' 0 C--N 1.363 1.31 1 C-N-CA 126.635 4.89 . . . . 0.0 113.83 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.436 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -161.69 104.32 1.21 Allowed 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 102.426 -3.176 . . . . 0.0 102.426 177.512 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.458 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -90.74 134.37 34.47 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 128.382 2.673 . . . . 0.0 113.082 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.2 176.92 6.76 Favored 'General case' 0 C--N 1.37 1.473 0 C-N-CA 128.193 2.597 . . . . 0.0 111.031 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.9 -48.59 31.45 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 -172.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.8 -12.3 60.31 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 126.493 1.917 . . . . 0.0 114.65 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.581 ' HA ' ' HZ1' ' A' ' 110' ' ' LYS 0.354 32.0 m-20 -80.84 -18.64 46.77 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 129.873 3.269 . . . . 0.0 111.977 169.575 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.533 ' HB2' ' H ' ' A' ' 157' ' ' VAL . . . -70.79 133.31 46.43 Favored 'General case' 0 C--N 1.379 1.882 0 N-CA-C 119.448 3.129 . . . . 0.0 119.448 166.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.47 -157.08 29.16 Favored Glycine 0 CA--C 1.461 -3.341 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 170.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.456 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.31 19.2 m -114.0 134.76 54.64 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 114.632 -2.827 . . . . 0.0 107.33 170.229 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.53 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 9.2 m-85 -96.66 133.5 41.11 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 122.014 2.188 . . . . 0.0 113.351 -172.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -140.95 145.6 36.25 Favored 'General case' 0 C--N 1.37 1.477 0 O-C-N 124.035 0.834 . . . . 0.0 109.458 -173.435 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.326 7.6 p -144.94 136.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.37 1.495 0 C-N-CA 118.289 -1.364 . . . . 0.0 113.834 176.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -104.31 118.05 35.68 Favored 'General case' 0 C--N 1.375 1.692 0 C-N-CA 130.081 3.352 . . . . 0.0 106.755 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.566 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -128.41 126.08 65.03 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 C-N-CA 127.572 2.349 . . . . 0.0 113.108 -173.404 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.48 HG23 ' C ' ' A' ' 146' ' ' VAL . 11.3 m -117.24 133.68 55.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 119.401 -2.062 . . . . 0.0 113.883 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.425 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.344 29.3 p-10 -126.46 -177.76 4.1 Favored 'General case' 0 C--N 1.376 1.725 0 CA-C-N 120.301 1.41 . . . . 0.0 112.798 174.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.574 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 66.2 p -49.64 3.75 0.01 OUTLIER 'General case' 0 C--N 1.366 1.324 1 C-N-CA 137.082 6.153 . . . . 0.0 121.01 -170.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -100.73 4.63 43.22 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 163.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.378 1.9 mp0 65.23 39.77 5.25 Favored 'General case' 0 C--N 1.379 1.86 1 C-N-CA 133.46 4.704 . . . . 0.0 110.783 -174.239 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.48 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.11 127.81 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 CA-C-N 111.541 -2.572 . . . . 0.0 110.974 -169.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.71 128.13 37.42 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 126.982 2.113 . . . . 0.0 107.735 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.75 156.15 27.68 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 128.083 2.553 . . . . 0.0 104.577 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -130.62 146.48 52.13 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.69 -1.256 . . . . 0.0 109.688 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.5 p -129.71 142.95 50.62 Favored 'General case' 0 C--O 1.253 1.24 0 C-N-CA 123.173 0.589 . . . . 0.0 111.627 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 m -54.57 147.24 14.66 Favored 'General case' 0 C--N 1.376 1.758 2 C-N-CA 136.582 5.953 . . . . 0.0 117.108 -163.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.3 p -68.14 110.76 4.13 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 129.754 3.222 . . . . 0.0 109.844 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.08 108.75 21.55 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -93.96 106.9 18.86 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-O 124.324 2.012 . . . . 0.0 110.838 -172.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.52 126.81 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 O-C-N 120.675 -1.266 . . . . 0.0 108.11 -173.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.5 m -116.64 122.08 43.54 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.533 ' H ' ' HB2' ' A' ' 133' ' ' ALA . 4.0 m -135.07 103.36 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 103.773 -2.676 . . . . 0.0 103.773 172.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.98 155.67 38.77 Favored Pre-proline 0 C--N 1.349 0.585 0 C-N-CA 125.096 1.358 . . . . 0.0 108.264 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -66.5 165.67 24.32 Favored 'Trans proline' 0 C--N 1.363 1.324 1 C-N-CA 127.472 5.448 . . . . 0.0 110.672 160.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 10.5 p -67.86 126.63 30.05 Favored 'General case' 0 C--N 1.374 1.667 0 O-C-N 119.594 -1.941 . . . . 0.0 107.894 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.413 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 9.0 p -67.34 114.38 18.62 Favored Pre-proline 0 C--N 1.365 1.261 1 N-CA-C 124.392 4.96 . . . . 0.0 124.392 -121.112 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 58.6 Cg_endo -63.03 123.13 11.69 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 124.894 3.729 . . . . 0.0 111.395 166.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.94 -85.27 1.57 Allowed Glycine 0 C--N 1.358 1.781 0 C-N-CA 125.2 1.381 . . . . 0.0 112.592 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.49 177.08 39.28 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 75.8 mt -93.36 60.54 3.15 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 125.38 1.472 . . . . 0.0 110.176 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -70.25 63.06 0.23 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 127.916 2.486 . . . . 0.0 116.202 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 85.7 t60 . . . . . 0 C--N 1.355 0.81 0 C-N-CA 127.086 2.155 . . . . 0.0 109.138 179.394 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.992 0 CA-C-O 121.574 0.702 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.77 144.89 27.5 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.19 2.196 . . . . 0.0 111.228 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 t -94.09 173.44 7.65 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 129.79 3.236 . . . . 0.0 112.266 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.486 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.2 pt? -81.44 98.77 8.39 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 120.993 -1.067 . . . . 0.0 109.656 171.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.62 -76.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 117.583 -3.198 . . . . 0.0 114.856 -171.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.7 tptm -133.33 140.44 47.41 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 130.864 3.665 . . . . 0.0 106.312 167.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.266 0.0 OUTLIER -82.86 172.05 13.25 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 130.074 3.35 . . . . 0.0 110.559 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.596 ' H ' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -70.07 -28.14 65.19 Favored 'General case' 0 CA--C 1.578 2.02 0 C-N-CA 126.476 1.91 . . . . 0.0 114.602 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.0 m -172.04 179.53 2.64 Favored 'General case' 0 N--CA 1.468 0.434 1 N-CA-C 99.647 -4.205 . . . . 0.0 99.647 173.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.51 -48.69 1.17 Allowed 'General case' 0 C--N 1.355 0.838 0 CA-C-N 121.508 1.958 . . . . 0.0 108.773 169.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.4 t -172.07 134.52 0.75 Allowed 'General case' 0 C--N 1.356 0.876 0 O-C-N 120.396 -1.44 . . . . 0.0 113.106 174.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 54.5 ttm -134.36 116.91 15.77 Favored 'General case' 0 C--N 1.369 1.446 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 162.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 p -108.57 115.36 29.95 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 119.727 -1.858 . . . . 0.0 107.327 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 p -149.62 174.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 125.88 1.672 . . . . 0.0 111.857 -165.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -79.22 134.2 36.67 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 126.959 2.104 . . . . 0.0 105.689 161.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.39 0.0 OUTLIER -43.63 122.88 2.87 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 -164.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.537 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 135.0 52.53 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 128.372 2.892 . . . . 0.0 107.654 -165.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.423 ' HB1' HG22 ' A' ' 155' ' ' VAL . . . -91.75 153.23 19.76 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 126.577 1.951 . . . . 0.0 108.932 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.15 110.72 21.68 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -166.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.442 HD13 ' CZ ' ' A' ' 136' ' ' TYR . 4.8 mt -120.62 144.44 48.14 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -126.86 138.51 53.34 Favored 'General case' 0 CA--C 1.506 -0.734 1 N-CA-C 100.165 -4.013 . . . . 0.0 100.165 166.347 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.4 HD23 ' CE3' ' A' ' 108' ' ' TRP . 4.0 mp -121.86 113.95 20.36 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 100.608 -3.849 . . . . 0.0 100.608 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.503 ' H ' HD23 ' A' ' 79' ' ' LEU . 4.0 t -150.33 133.4 16.16 Favored 'General case' 0 C--N 1.369 1.423 0 CA-C-N 119.568 1.077 . . . . 0.0 112.717 -173.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.76 173.94 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.879 1 C-N-CA 132.191 4.196 . . . . 0.0 104.396 175.614 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.2 t -103.0 141.81 35.17 Favored 'General case' 0 C--N 1.367 1.334 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.5 140.87 46.5 Favored 'General case' 0 C--N 1.368 1.408 1 N-CA-C 122.285 4.18 . . . . 0.0 122.285 -171.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.0 m -158.24 174.26 15.44 Favored 'General case' 0 C--N 1.357 0.891 0 C-N-CA 130.797 3.639 . . . . 0.0 102.222 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.82 43.7 2.2 Favored Glycine 0 C--N 1.365 2.16 0 CA-C-N 122.763 2.529 . . . . 0.0 116.714 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.52 21.33 62.28 Favored Glycine 0 C--N 1.359 1.832 0 C-N-CA 128.413 2.911 . . . . 0.0 114.082 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.7 p -117.1 110.94 18.82 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.271 1.829 . . . . 0.0 108.457 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.659 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.34 -96.64 1.02 Allowed Glycine 0 C--N 1.371 2.488 0 C-N-CA 127.943 2.687 . . . . 0.0 110.985 -168.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.98 169.22 10.78 Favored 'Trans proline' 0 CA--C 1.556 1.579 1 C-N-CA 127.258 5.305 . . . . 0.0 116.855 159.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.49 ' HB3' HG12 ' A' ' 140' ' ' VAL . 58.5 m-85 -92.1 148.07 22.46 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 120.782 3.623 . . . . 0.0 120.782 -168.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -102.84 141.45 35.63 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 129.097 2.959 . . . . 0.0 104.439 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.402 ' HD1' ' HA ' ' A' ' 119' ' ' SER . 0.1 OUTLIER -124.72 159.47 30.81 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 120.076 3.361 . . . . 0.0 120.076 -166.184 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.0 117.53 20.19 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 101.865 -3.383 . . . . 0.0 101.865 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.437 ' HB3' HG13 ' A' ' 115' ' ' ILE . 94.8 m95 -107.23 134.76 49.85 Favored 'General case' 0 C--N 1.363 1.176 0 C-N-CA 124.664 1.185 . . . . 0.0 109.073 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.7 170.31 19.52 Favored 'General case' 0 CA--C 1.487 -1.451 0 O-C-N 120.34 -1.475 . . . . 0.0 108.311 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.5 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.5 ptmm? -148.32 106.46 3.73 Favored 'General case' 0 N--CA 1.423 -1.795 0 O-C-N 119.643 -1.91 . . . . 0.0 108.45 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.213 0.9 OUTLIER 35.27 54.31 0.77 Allowed 'General case' 0 CA--C 1.47 -2.114 2 CA-C-O 109.472 -5.061 . . . . 0.0 122.73 146.212 . . . . . . . . 5 4 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.55 -0.42 85.45 Favored Glycine 0 C--N 1.384 3.242 2 O-C-N 135.113 7.758 . . . . 0.0 118.887 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.3 0.9 OUTLIER -124.49 147.57 55.85 Favored Pre-proline 0 CA--C 1.563 1.474 0 C-N-CA 129.429 3.091 . . . . 0.0 118.812 -167.398 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.75 139.17 56.53 Favored 'Trans proline' 0 N--CA 1.5 1.887 1 C-N-CA 125.992 4.461 . . . . 0.0 117.15 170.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -89.18 162.46 37.37 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 118.374 -2.704 . . . . 0.0 114.303 177.109 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 8.3 Cg_endo -67.89 94.02 0.39 Allowed 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.564 4.176 . . . . 0.0 115.556 -178.134 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.3 t70 82.05 -72.14 0.05 OUTLIER 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.61 2.364 . . . . 0.0 110.921 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.661 ' HB2' HD11 ' A' ' 115' ' ' ILE . . . 97.06 142.45 0.02 OUTLIER 'General case' 0 CA--C 1.479 -1.767 0 C-N-CA 129.057 2.943 . . . . 0.0 111.757 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.402 ' HA ' ' HD1' ' A' ' 106' ' ' TYR 0.281 0.2 OUTLIER 82.48 53.54 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.028 -1.896 . . . . 0.0 112.709 179.056 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.58 -55.84 0.32 Allowed Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 116.305 1.282 . . . . 0.0 116.305 -168.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.304 . . 103.43 -47.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.395 0 C-N-CA 126.59 1.956 . . . . 0.0 113.953 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.4 6.4 t -145.92 92.6 2.22 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 124.135 1.921 . . . . 0.0 109.582 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.291 4.3 p90 -126.88 142.18 51.61 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 129.003 2.921 . . . . 0.0 111.332 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.5 m -124.97 139.66 53.62 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 120.096 -1.628 . . . . 0.0 109.349 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 89.5 45.97 Favored Pre-proline 0 C--N 1.354 0.799 0 C-N-CA 127.937 2.495 . . . . 0.0 107.857 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -68.16 -32.57 27.01 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 124.712 3.608 . . . . 0.0 115.335 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.537 HG23 ' HA2' ' A' ' 88' ' ' GLY . 96.3 m -130.18 100.67 5.49 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.3 118.63 29.95 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.918 1.287 . . . . 0.0 113.555 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.07 -179.84 6.54 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.348 2.659 . . . . 0.0 109.646 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.87 -51.26 23.68 Favored 'General case' 0 C--N 1.368 1.387 0 O-C-N 118.16 -2.837 . . . . 0.0 117.761 -174.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -68.08 0.17 3.89 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 128.45 2.7 . . . . 0.0 114.966 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -116.66 -12.08 10.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 130.435 3.494 . . . . 0.0 111.316 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.504 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -98.34 157.26 16.3 Favored 'General case' 0 C--N 1.394 2.509 0 N-CA-C 119.409 3.115 . . . . 0.0 119.409 174.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 152.43 -158.36 27.8 Favored Glycine 0 C--N 1.39 3.535 0 C-N-CA 128.832 3.111 . . . . 0.0 111.042 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.485 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.328 3.8 m -106.07 131.94 52.74 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 112.947 -3.501 . . . . 0.0 105.989 167.578 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.556 ' HB2' ' HB2' ' A' ' 153' ' ' CYS . 18.3 m-85 -97.23 134.96 39.84 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 122.757 2.526 . . . . 0.0 113.599 -172.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.515 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -147.97 152.3 37.25 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-O 122.422 1.106 . . . . 0.0 110.175 -174.493 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.254 8.3 p -135.91 137.69 48.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 118.471 -1.292 . . . . 0.0 113.901 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.3 m -105.69 116.61 32.23 Favored 'General case' 0 C--N 1.377 1.787 0 C-N-CA 129.098 2.959 . . . . 0.0 104.925 176.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -130.88 119.09 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 124.086 0.954 . . . . 0.0 109.67 -167.768 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 146' ' ' VAL . 10.2 m -103.73 128.8 51.06 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 120.951 -1.093 . . . . 0.0 113.497 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.465 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.488 11.1 p-10 -127.55 -174.78 3.27 Favored 'General case' 0 C--N 1.371 1.52 0 CA-C-N 119.191 0.905 . . . . 0.0 111.84 174.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.659 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 80.5 p -49.97 2.44 0.01 OUTLIER 'General case' 0 C--N 1.361 1.069 2 C-N-CA 135.549 5.54 . . . . 0.0 121.816 -163.18 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.52 4.37 38.5 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 164.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.394 68.8 mm-40 66.39 40.01 3.78 Favored 'General case' 0 C--N 1.375 1.678 1 C-N-CA 132.803 4.441 . . . . 0.0 110.84 -172.623 . . . . . . . . 3 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.43 ' C ' HG23 ' A' ' 141' ' ' THR . 3.9 m -113.26 129.8 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.253 -171.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.29 123.58 34.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 126.661 1.984 . . . . 0.0 107.691 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.55 157.53 25.11 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 -175.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -128.68 132.22 48.03 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.646 -1.284 . . . . 0.0 109.706 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.474 55.9 p -114.35 151.88 32.32 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 123.75 0.82 . . . . 0.0 111.13 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -53.69 146.81 12.62 Favored 'General case' 0 C--N 1.371 1.508 1 C-N-CA 133.843 4.857 . . . . 0.0 120.146 -153.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 64.5 p -70.33 110.96 5.57 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 129.745 3.218 . . . . 0.0 109.323 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 18.0 m -106.01 109.62 21.63 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.58 107.23 19.62 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 124.773 2.225 . . . . 0.0 111.308 -170.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.423 HG22 ' HB1' ' A' ' 89' ' ' ALA 0.263 1.1 t -118.0 114.95 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 -172.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m -110.37 133.63 53.08 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.504 HG22 ' CB ' ' A' ' 133' ' ' ALA . 33.4 m -128.8 105.77 13.41 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 CA-C-O 124.023 1.868 . . . . 0.0 112.802 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -87.31 157.69 53.03 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 124.594 1.158 . . . . 0.0 109.086 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.82 165.91 30.43 Favored 'Trans proline' 0 C--N 1.358 1.059 1 C-N-CA 126.835 5.023 . . . . 0.0 107.02 153.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.9 p -67.29 133.57 49.93 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 118.506 -2.621 . . . . 0.0 110.784 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.498 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 14.9 t -65.72 104.47 0.58 Allowed Pre-proline 0 C--N 1.36 1.045 0 N-CA-C 121.218 3.784 . . . . 0.0 121.218 -124.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 61.4 Cg_endo -62.77 122.86 11.34 Favored 'Trans proline' 0 C--N 1.386 2.529 1 C-N-CA 125.972 4.448 . . . . 0.0 111.544 170.007 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.58 -21.01 48.06 Favored Glycine 0 C--N 1.357 1.707 0 C-N-CA 125.559 1.552 . . . . 0.0 112.734 -170.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -101.83 -49.0 1.31 Allowed Glycine 0 C--N 1.361 1.938 0 C-N-CA 125.272 1.415 . . . . 0.0 114.986 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 19.3 mt -88.55 -5.88 57.92 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 58.94 -35.52 0.06 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 130.389 3.475 . . . . 0.0 120.126 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 1.3 p80 . . . . . 0 C--N 1.358 0.938 0 C-N-CA 129.431 3.092 . . . . 0.0 117.398 -176.489 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.132 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.1 tp -107.24 132.67 52.82 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 122.784 1.278 . . . . 0.0 108.903 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 t -104.8 171.18 7.46 Favored 'General case' 0 N--CA 1.416 -2.159 0 C-N-CA 125.463 1.505 . . . . 0.0 112.632 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' H ' HD23 ' A' ' 75' ' ' LEU 0.29 0.5 OUTLIER -92.46 97.85 11.1 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.299 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 t 61.16 -78.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 119.06 -2.275 . . . . 0.0 112.877 -169.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -133.68 138.72 46.02 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 128.82 2.848 . . . . 0.0 107.764 164.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.34 0.0 OUTLIER -83.53 172.66 12.16 Favored 'General case' 0 C--N 1.356 0.877 1 C-N-CA 132.911 4.485 . . . . 0.0 109.123 175.866 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -32.26 70.22 Favored 'General case' 0 CA--C 1.577 2.005 0 O-C-N 119.651 -1.906 . . . . 0.0 112.336 173.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.2 m -164.81 171.32 14.37 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 116.667 -3.77 . . . . 0.0 103.785 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.41 -45.41 1.51 Allowed 'General case' 0 C--N 1.366 1.315 0 C-N-CA 127.031 2.132 . . . . 0.0 112.932 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 86.1 p -176.17 134.12 0.25 Allowed 'General case' 0 C--N 1.365 1.262 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.6 ttt -134.75 117.93 16.52 Favored 'General case' 0 C--N 1.373 1.629 0 CA-C-N 119.696 1.134 . . . . 0.0 109.203 159.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.5 p -111.13 116.15 30.62 Favored 'General case' 0 C--N 1.363 1.188 0 O-C-N 119.482 -2.011 . . . . 0.0 109.789 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.74 171.98 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 126.825 2.05 . . . . 0.0 112.937 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.4 127.56 33.79 Favored 'General case' 0 C--N 1.372 1.55 0 O-C-N 118.961 -2.337 . . . . 0.0 105.258 163.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.456 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.278 8.6 pt-20 -41.83 122.57 2.07 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 120.389 3.477 . . . . 0.0 120.389 -150.211 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 144.34 54.71 0.03 OUTLIER Glycine 0 C--N 1.356 1.639 0 CA-C-N 109.656 -3.429 . . . . 0.0 110.55 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.11 158.79 23.56 Favored 'General case' 0 C--N 1.372 1.58 0 C-N-CA 125.482 1.513 . . . . 0.0 113.101 174.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.91 101.62 9.92 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 125.415 1.486 . . . . 0.0 112.312 -174.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.533 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 1.1 mp -119.79 130.83 55.13 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 125.943 1.697 . . . . 0.0 115.318 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.98 132.8 53.9 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 172.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.636 HD21 ' CD2' ' A' ' 136' ' ' TYR . 3.1 mp -131.83 115.16 15.58 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 170.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -148.1 133.84 18.93 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.529 -1.357 . . . . 0.0 110.981 -174.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.7 174.57 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 129.549 3.14 . . . . 0.0 104.0 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 t -104.26 141.38 36.39 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 126.948 2.099 . . . . 0.0 105.696 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.31 134.2 32.23 Favored 'General case' 0 C--N 1.37 1.472 0 N-CA-C 120.127 3.38 . . . . 0.0 120.127 -172.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.3 m -157.86 174.04 15.88 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 131.363 3.865 . . . . 0.0 100.843 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.52 44.24 2.21 Favored Glycine 0 C--N 1.363 2.045 0 CA-C-N 122.584 2.447 . . . . 0.0 117.582 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.4 12.73 81.63 Favored Glycine 0 C--N 1.362 1.991 0 C-N-CA 128.705 3.05 . . . . 0.0 113.068 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.7 p -115.87 111.17 20.05 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 126.481 1.913 . . . . 0.0 107.396 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.513 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 71.83 -101.4 1.01 Allowed Glycine 0 C--N 1.36 1.886 0 C-N-CA 127.181 2.324 . . . . 0.0 109.315 -161.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.79 168.32 7.22 Favored 'Trans proline' 0 CA--C 1.555 1.573 1 C-N-CA 129.227 6.618 . . . . 0.0 118.349 165.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.541 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.6 m-85 -82.07 138.86 34.73 Favored 'General case' 0 CA--C 1.562 1.419 1 N-CA-C 122.274 4.175 . . . . 0.0 122.274 -170.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 t -102.82 154.96 18.68 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 129.756 3.223 . . . . 0.0 104.309 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.475 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.5 OUTLIER -153.71 166.27 33.35 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -165.129 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.2 112.81 10.76 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 128.417 2.687 . . . . 0.0 105.64 170.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.407 ' HB3' HG13 ' A' ' 115' ' ' ILE . 94.1 m95 -111.94 137.5 49.85 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.349 1.859 . . . . 0.0 108.595 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.308 0.2 OUTLIER -158.61 162.77 37.35 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.32 -1.487 . . . . 0.0 107.427 168.898 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.503 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -137.31 103.59 5.14 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 116.954 -1.898 . . . . 0.0 115.412 177.9 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.153 2.3 t70 36.6 53.82 1.07 Allowed 'General case' 0 CA--C 1.467 -2.22 1 CA-C-O 111.433 -4.127 . . . . 0.0 119.609 153.898 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.71 -0.56 70.46 Favored Glycine 0 C--N 1.373 2.6 2 O-C-N 134.227 7.204 . . . . 0.0 117.38 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.4 ' HB2' ' HE3' ' A' ' 110' ' ' LYS 0.384 1.3 p -124.82 147.8 57.51 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 130.074 3.349 . . . . 0.0 119.445 -167.511 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.02 143.7 79.7 Favored 'Trans proline' 0 N--CA 1.498 1.747 1 C-N-CA 125.964 4.442 . . . . 0.0 115.817 167.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -94.99 144.91 28.6 Favored Pre-proline 0 CA--C 1.551 1.004 0 O-C-N 119.437 -2.039 . . . . 0.0 112.916 176.088 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.55 93.43 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.447 1 C-N-CA 125.938 4.425 . . . . 0.0 118.83 -172.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.3 t70 65.1 48.26 2.28 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 169.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.32 -165.64 0.9 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 127.598 2.359 . . . . 0.0 115.694 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.304 8.4 t 99.92 8.04 0.01 OUTLIER 'General case' 0 C--N 1.354 0.765 0 C-N-CA 128.959 2.904 . . . . 0.0 112.121 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.2 91.77 0.08 OUTLIER Glycine 0 CA--C 1.48 -2.129 0 C-N-CA 115.979 -3.01 . . . . 0.0 118.568 167.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.461 . . 89.6 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 167.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.0 t -139.32 118.27 12.5 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 122.106 2.23 . . . . 0.0 115.915 -169.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -127.63 140.13 52.29 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 127.381 2.272 . . . . 0.0 111.197 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 91' ' ' LEU . 89.1 m -129.25 140.55 51.41 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 119.306 -2.121 . . . . 0.0 109.68 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.411 ' HB3' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.85 95.97 31.21 Favored Pre-proline 0 C--N 1.366 1.293 0 C-N-CA 128.203 2.601 . . . . 0.0 108.455 178.051 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.19 -14.11 16.77 Favored 'Trans proline' 0 C--N 1.356 0.948 1 C-N-CA 126.278 4.652 . . . . 0.0 113.563 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.47 HG23 ' HA2' ' A' ' 88' ' ' GLY . 95.5 m -161.6 101.0 1.18 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 102.43 -3.174 . . . . 0.0 102.43 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.488 ' HB3' HG11 ' A' ' 157' ' ' VAL . . . -83.12 134.05 35.02 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.83 2.452 . . . . 0.0 112.183 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.62 173.19 7.74 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 127.935 2.494 . . . . 0.0 110.086 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -41.12 23.61 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 120.166 3.395 . . . . 0.0 120.166 -173.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -66.95 -14.57 62.96 Favored 'General case' 0 C--N 1.366 1.317 0 C-N-CA 126.801 2.04 . . . . 0.0 115.393 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.48 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 42.7 m-20 -80.42 -17.05 52.94 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 129.475 3.11 . . . . 0.0 111.559 168.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.86 107.88 2.79 Favored 'General case' 0 C--N 1.384 2.077 0 N-CA-C 120.45 3.5 . . . . 0.0 120.45 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.65 -154.12 19.13 Favored Glycine 0 CA--C 1.459 -3.413 0 C-N-CA 126.77 2.129 . . . . 0.0 108.935 172.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.433 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.288 19.6 m -117.64 135.49 53.95 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 114.892 -2.723 . . . . 0.0 108.296 175.335 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.636 ' CD2' HD21 ' A' ' 93' ' ' LEU . 10.1 m-85 -96.77 133.32 41.5 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 120.299 -1.501 . . . . 0.0 113.487 -171.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.466 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -146.05 149.32 33.87 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 121.573 0.702 . . . . 0.0 110.782 -173.032 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.6 p -142.49 142.94 26.51 Favored 'Isoleucine or valine' 0 C--N 1.372 1.56 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -105.15 118.45 36.58 Favored 'General case' 0 C--N 1.375 1.681 0 C-N-CA 129.732 3.213 . . . . 0.0 105.333 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -129.1 122.66 56.86 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 126.765 2.026 . . . . 0.0 112.347 -175.269 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.453 HG23 ' C ' ' A' ' 146' ' ' VAL . 17.4 m -111.78 133.96 53.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 118.995 -2.315 . . . . 0.0 114.043 -177.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . 0.591 4.4 p30 -134.86 -167.18 1.94 Allowed 'General case' 0 C--N 1.373 1.62 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 173.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.513 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 90.6 p -48.88 3.51 0.01 OUTLIER 'General case' 0 C--N 1.366 1.297 2 C-N-CA 134.838 5.255 . . . . 0.0 122.208 -158.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -106.75 4.87 28.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.468 164.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.397 89.3 mm-40 66.19 40.19 3.93 Favored 'General case' 0 C--N 1.375 1.696 1 C-N-CA 132.077 4.151 . . . . 0.0 110.455 -171.72 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.453 ' C ' HG23 ' A' ' 141' ' ' THR . 3.9 m -112.92 129.85 67.82 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.376 0 CA-C-N 111.759 -2.473 . . . . 0.0 111.362 -171.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.6 OUTLIER -91.89 130.54 37.63 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.885 1.274 . . . . 0.0 110.027 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.93 156.99 26.45 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 128.172 2.589 . . . . 0.0 104.913 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -130.5 146.72 52.09 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 120.877 -1.139 . . . . 0.0 108.128 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.337 88.4 p -130.82 143.83 51.02 Favored 'General case' 0 C--O 1.251 1.133 0 O-C-N 121.726 -0.609 . . . . 0.0 110.734 175.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.0 m -54.35 148.02 12.49 Favored 'General case' 0 CA--C 1.481 -1.675 2 C-N-CA 137.127 6.171 . . . . 0.0 118.089 -162.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 65.5 p -68.38 110.35 4.08 Favored 'General case' 0 C--N 1.375 1.675 0 CA-C-N 111.865 -2.425 . . . . 0.0 109.136 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 109.78 22.47 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 102.172 -3.27 . . . . 0.0 102.172 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.42 114.58 27.17 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 125.125 2.393 . . . . 0.0 110.628 -174.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.4 t -117.83 117.4 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.2 m -113.45 121.01 43.01 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 103.182 -2.895 . . . . 0.0 103.182 173.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' A' ' 128' ' ' ALA . 4.5 m -135.04 102.12 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 171.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.32 156.7 37.2 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 125.055 1.342 . . . . 0.0 109.055 177.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -62.77 168.02 10.93 Favored 'Trans proline' 0 CA--C 1.551 1.35 1 C-N-CA 126.932 5.088 . . . . 0.0 110.156 154.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 17.7 p -67.05 136.2 54.85 Favored 'General case' 0 C--N 1.375 1.68 0 O-C-N 118.994 -2.316 . . . . 0.0 108.059 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.511 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 49.1 t -66.73 103.84 0.53 Allowed Pre-proline 0 C--N 1.361 1.07 1 N-CA-C 122.173 4.138 . . . . 0.0 122.173 -126.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.511 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 57.8 Cg_endo -62.63 123.66 12.76 Favored 'Trans proline' 0 C--N 1.385 2.496 1 C-N-CA 126.319 4.679 . . . . 0.0 112.707 170.376 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 104.29 -45.16 1.35 Allowed Glycine 0 C--N 1.359 1.81 0 C-N-CA 125.913 1.72 . . . . 0.0 111.219 -177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -82.57 -42.02 8.67 Favored Glycine 0 C--N 1.361 1.953 0 C-N-CA 125.64 1.59 . . . . 0.0 113.81 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.9 90.72 3.39 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.72 71.59 0.21 Allowed 'General case' 0 C--N 1.363 1.159 0 C-N-CA 126.307 1.843 . . . . 0.0 115.575 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 . . . . . 0 C--N 1.357 0.934 0 C-N-CA 128.052 2.541 . . . . 0.0 112.897 -177.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.33 145.88 32.27 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 127.34 2.256 . . . . 0.0 110.28 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.78 140.88 34.44 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 173.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -96.65 99.67 11.28 Favored 'General case' 0 C--N 1.37 1.462 0 O-C-N 118.46 -2.65 . . . . 0.0 106.885 175.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.1 m 65.33 -74.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.687 1.995 . . . . 0.0 110.01 -168.25 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 119.65 19.63 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 128.301 2.64 . . . . 0.0 105.027 154.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.278 6.9 t70 -86.88 117.91 25.92 Favored 'General case' 0 C--N 1.371 1.537 0 N-CA-C 101.262 -3.607 . . . . 0.0 101.262 166.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.508 ' H ' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -71.63 -36.1 70.62 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 121.003 3.705 . . . . 0.0 121.003 -157.542 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 m -173.78 172.37 3.54 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 102.982 -2.969 . . . . 0.0 102.982 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.01 -52.79 2.59 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.294 -1.504 . . . . 0.0 110.205 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 t -172.16 136.04 0.82 Allowed 'General case' 0 C--N 1.357 0.928 0 O-C-N 119.842 -1.786 . . . . 0.0 113.709 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 25.0 ttt -130.56 117.9 20.25 Favored 'General case' 0 C--N 1.373 1.605 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 163.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -105.5 115.61 30.55 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 119.612 -1.93 . . . . 0.0 107.496 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.24 173.72 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.752 0 CA-C-O 123.255 1.502 . . . . 0.0 112.208 -168.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.02 132.65 36.04 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 126.864 2.066 . . . . 0.0 105.455 159.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.29 0.3 OUTLIER -43.77 121.71 2.48 Favored 'General case' 0 N--CA 1.513 2.719 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 -161.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.581 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 138.44 51.66 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.226 0 CA-C-N 111.446 -2.615 . . . . 0.0 108.938 -164.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.13 163.34 17.91 Favored 'General case' 0 C--N 1.367 1.352 0 C-N-CA 125.804 1.642 . . . . 0.0 111.455 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.15 105.69 14.48 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.925 0.89 . . . . 0.0 112.755 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.482 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 3.7 mp -119.87 120.22 35.82 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 126.505 1.922 . . . . 0.0 115.313 -172.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -106.75 126.37 52.2 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 170.352 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.34 114.87 18.14 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 103.452 -2.795 . . . . 0.0 103.452 176.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -156.75 140.32 15.9 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.951 -1.093 . . . . 0.0 109.63 -172.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.64 172.73 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 129.395 3.078 . . . . 0.0 104.884 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.3 t -104.01 141.76 35.63 Favored 'General case' 0 C--N 1.373 1.605 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . . . -125.26 149.88 47.59 Favored 'General case' 0 C--N 1.363 1.194 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.4 m -159.4 174.92 13.99 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.17 42.48 2.74 Favored Glycine 0 C--N 1.362 2.009 0 CA-C-N 122.905 2.593 . . . . 0.0 116.239 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.84 0.8 60.22 Favored Glycine 0 C--N 1.362 1.979 0 C-N-CA 125.649 1.595 . . . . 0.0 114.393 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.9 m -117.24 123.91 47.76 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.346 1.458 . . . . 0.0 110.034 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.611 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.45 -113.26 4.36 Favored Glycine 0 C--N 1.361 1.917 0 CA-C-O 116.153 -2.47 . . . . 0.0 108.798 -163.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -66.96 168.45 17.18 Favored 'Trans proline' 0 CA--C 1.564 1.985 1 C-N-CA 127.759 5.64 . . . . 0.0 117.353 163.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.469 ' HB3' HG12 ' A' ' 140' ' ' VAL . 27.4 m-85 -82.1 144.33 30.87 Favored 'General case' 0 C--N 1.358 0.947 1 N-CA-C 125.453 5.353 . . . . 0.0 125.453 -164.494 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.3 t -103.24 141.47 35.84 Favored 'General case' 0 C--N 1.371 1.529 0 C-N-CA 127.914 2.486 . . . . 0.0 104.525 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.544 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.6 OUTLIER -137.39 160.32 39.43 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 120.354 3.464 . . . . 0.0 120.354 -166.001 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.08 113.69 9.09 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 110.593 -3.003 . . . . 0.0 105.112 173.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -111.98 154.77 24.8 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 120.676 -1.265 . . . . 0.0 108.595 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.383 0.2 OUTLIER -158.3 168.73 26.2 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 166.338 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.507 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.0 OUTLIER -144.5 105.01 4.12 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 120.138 -1.601 . . . . 0.0 114.911 -178.325 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.513 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.224 0.6 OUTLIER 36.39 53.75 1.01 Allowed 'General case' 0 CA--C 1.464 -2.336 1 CA-C-O 111.394 -4.145 . . . . 0.0 119.198 153.699 . . . . . . . . 5 4 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.38 -0.65 78.24 Favored Glycine 0 C--N 1.373 2.607 2 O-C-N 134.747 7.529 . . . . 0.0 118.375 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.268 58.2 m -124.89 148.87 61.15 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 120.304 3.446 . . . . 0.0 120.304 -167.297 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -60.22 148.75 88.69 Favored 'Trans proline' 0 N--CA 1.507 2.301 1 C-N-CA 126.231 4.62 . . . . 0.0 116.194 166.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.591 ' HB ' ' HD2' ' A' ' 116' ' ' PRO 0.325 0.8 OUTLIER -98.64 165.1 15.71 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 117.846 -3.034 . . . . 0.0 112.285 175.279 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 6.0 Cg_endo -69.2 87.92 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.739 1 C-N-CA 125.826 4.351 . . . . 0.0 113.984 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.6 t70 84.99 -57.51 0.09 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.877 3.271 . . . . 0.0 110.612 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.302 . . 102.97 -62.87 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 130.715 3.606 . . . . 0.0 115.285 171.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.301 8.0 t -73.7 80.12 1.54 Allowed 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 130.732 3.613 . . . . 0.0 113.886 -174.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.94 -71.48 0.02 OUTLIER Glycine 0 C--N 1.36 1.867 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 -172.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 97' ' ' ALA 0.318 . . 129.4 -24.73 0.01 OUTLIER 'General case' 0 C--N 1.365 1.247 0 C-N-CA 127.265 2.226 . . . . 0.0 116.044 178.008 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.34 15.0 t -154.85 102.23 2.34 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-N 121.013 1.733 . . . . 0.0 112.657 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.313 0.1 OUTLIER -127.43 141.48 51.67 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 127.897 2.479 . . . . 0.0 111.472 176.355 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 91' ' ' LEU . 60.1 m -128.32 138.65 52.48 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 118.991 -2.318 . . . . 0.0 107.28 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.89 102.72 52.88 Favored Pre-proline 0 C--N 1.362 1.137 0 C-N-CA 128.042 2.537 . . . . 0.0 105.209 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -77.04 -11.86 17.77 Favored 'Trans proline' 0 C--N 1.348 0.548 1 C-N-CA 126.227 4.618 . . . . 0.0 112.731 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.581 HG23 ' HA2' ' A' ' 88' ' ' GLY . 62.1 m -157.22 100.9 1.87 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.46 128.47 39.56 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 124.312 1.045 . . . . 0.0 112.317 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.27 179.06 5.17 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 129.462 3.105 . . . . 0.0 108.574 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.62 -53.96 13.26 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -172.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.38 0.93 3.37 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 127.234 2.213 . . . . 0.0 115.788 172.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -113.8 -13.79 12.59 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 130.362 3.465 . . . . 0.0 110.695 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.463 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -98.28 160.18 14.46 Favored 'General case' 0 C--N 1.4 2.775 0 N-CA-C 120.157 3.391 . . . . 0.0 120.157 171.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.6 -158.59 27.75 Favored Glycine 0 CA--C 1.469 -2.831 0 C-N-CA 128.585 2.993 . . . . 0.0 106.905 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.416 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.331 1.2 m -105.8 129.39 54.0 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 114.677 -2.809 . . . . 0.0 107.559 168.278 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.507 ' CZ ' ' HD2' ' A' ' 110' ' ' LYS . 12.7 m-85 -96.59 134.92 39.21 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 123.404 2.82 . . . . 0.0 113.159 -171.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -146.16 152.15 38.78 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 123.9 0.88 . . . . 0.0 110.385 -175.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 149' ' ' ASP . 8.5 p -142.95 141.12 27.11 Favored 'Isoleucine or valine' 0 C--N 1.371 1.525 0 C-N-CA 117.474 -1.69 . . . . 0.0 114.928 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 61.5 m -103.64 110.98 23.26 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 129.96 3.304 . . . . 0.0 106.206 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -123.78 114.9 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.334 2.254 . . . . 0.0 109.87 -172.643 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.433 HG23 ' C ' ' A' ' 146' ' ' VAL . 4.7 m -102.16 130.15 48.72 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.322 -1.486 . . . . 0.0 113.807 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.401 ' CG ' ' CE2' ' A' ' 104' ' ' TYR 0.481 7.1 p30 -138.39 -165.38 1.8 Allowed 'General case' 0 C--N 1.371 1.531 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 174.131 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.611 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 91.3 p -48.91 3.69 0.01 OUTLIER 'General case' 0 C--N 1.369 1.45 2 C-N-CA 134.986 5.315 . . . . 0.0 123.135 -163.007 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -105.65 5.92 31.58 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 163.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.395 6.9 mm100 64.27 39.98 6.97 Favored 'General case' 0 C--N 1.374 1.655 1 C-N-CA 133.403 4.681 . . . . 0.0 111.261 -171.164 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.433 ' C ' HG23 ' A' ' 141' ' ' THR . 3.1 m -113.88 134.77 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.826 0 CA-C-N 111.774 -2.466 . . . . 0.0 112.318 -170.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.14 123.45 34.61 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 129.13 2.972 . . . . 0.0 106.287 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.82 157.84 24.93 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 128.781 2.833 . . . . 0.0 105.038 -175.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 30.3 t70 -125.82 134.23 51.74 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 122.284 1.04 . . . . 0.0 109.108 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.508 54.2 p -111.79 146.8 36.99 Favored 'General case' 0 C--O 1.252 1.227 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.0 m -53.95 147.87 11.57 Favored 'General case' 0 C--N 1.375 1.702 1 C-N-CA 135.261 5.424 . . . . 0.0 120.004 -157.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.3 p -69.38 110.89 4.92 Favored 'General case' 0 C--N 1.37 1.468 0 C-N-CA 126.115 1.766 . . . . 0.0 110.192 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.36 109.46 21.1 Favored 'General case' 0 C--N 1.358 0.957 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -94.54 107.22 19.21 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-O 123.622 1.677 . . . . 0.0 110.99 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.82 115.09 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.1 m -107.99 132.09 53.87 Favored 'General case' 0 C--N 1.369 1.415 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.53 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.463 HG22 ' CB ' ' A' ' 133' ' ' ALA . 34.8 m -128.8 105.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.365 1.274 0 CA-C-O 124.276 1.989 . . . . 0.0 113.73 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -88.37 157.67 49.95 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.453 1.501 . . . . 0.0 109.663 175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.06 166.2 30.67 Favored 'Trans proline' 0 CA--C 1.548 1.196 1 C-N-CA 127.296 5.331 . . . . 0.0 107.596 153.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.0 p -66.97 125.65 26.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 118.361 -2.712 . . . . 0.0 110.233 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.52 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 56.9 t -67.09 112.3 9.5 Favored Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 121.068 3.729 . . . . 0.0 121.068 -123.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.52 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 63.7 Cg_endo -62.69 148.3 93.58 Favored 'Trans proline' 0 C--N 1.381 2.275 1 C-N-CA 126.43 4.753 . . . . 0.0 114.942 173.181 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.82 -58.18 3.31 Favored Glycine 0 C--N 1.361 1.941 0 C-N-CA 125.497 1.522 . . . . 0.0 114.151 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.03 147.4 9.31 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 66.0 mt -96.76 59.09 1.71 Allowed 'General case' 0 C--N 1.363 1.169 0 O-C-N 120.714 -1.463 . . . . 0.0 111.763 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -76.88 64.49 2.41 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 126.85 2.06 . . . . 0.0 113.632 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 82.9 t60 . . . . . 0 C--N 1.353 0.721 0 C-N-CA 126.207 1.803 . . . . 0.0 108.742 -177.613 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.018 0 CA-C-O 121.863 0.84 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.0 tp -107.35 136.88 46.41 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 126.863 2.065 . . . . 0.0 108.665 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.4 t -94.39 172.61 8.09 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 120.074 -1.641 . . . . 0.0 111.449 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 150' ' ' SER 0.42 0.5 OUTLIER -84.28 98.27 9.89 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.942 171.631 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.02 -72.51 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 117.912 -2.992 . . . . 0.0 115.418 -172.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -133.48 140.55 47.32 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 130.413 3.485 . . . . 0.0 107.07 167.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.284 0.0 OUTLIER -82.99 171.01 14.29 Favored 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 128.288 2.635 . . . . 0.0 111.201 177.208 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.49 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -71.75 -31.81 67.05 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.379 -1.737 . . . . 0.0 113.716 172.077 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.9 m -171.97 172.63 4.67 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 100.483 -3.895 . . . . 0.0 100.483 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.47 -51.32 1.96 Allowed 'General case' 0 C--N 1.351 0.673 0 CA-C-N 120.561 1.528 . . . . 0.0 111.117 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.4 t -172.62 145.41 1.55 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 120.35 -1.469 . . . . 0.0 114.728 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.5 ttt -135.7 128.57 31.23 Favored 'General case' 0 C--N 1.371 1.517 0 O-C-N 121.36 -0.837 . . . . 0.0 109.608 160.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 p -104.9 114.49 28.72 Favored 'General case' 0 C--N 1.373 1.611 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 86' ' ' GLU 0.252 7.4 p -149.87 174.03 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.899 -167.109 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 85' ' ' VAL . 1.3 pp20? -89.31 144.23 26.24 Favored 'General case' 0 C--N 1.364 1.209 0 O-C-N 119.392 -2.067 . . . . 0.0 106.813 163.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.473 3.8 pt-20 -44.39 124.91 4.35 Favored 'General case' 0 N--CA 1.516 2.847 0 O-C-N 118.121 -2.862 . . . . 0.0 117.863 -172.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.542 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 122.05 50.4 0.24 Allowed Glycine 0 C--N 1.345 1.049 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 -150.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 128' ' ' ALA . . . -97.04 152.28 18.9 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 127.023 2.129 . . . . 0.0 111.663 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.05 113.79 26.79 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-O 122.466 1.127 . . . . 0.0 113.632 -169.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.578 HD12 ' SG ' ' A' ' 153' ' ' CYS . 0.3 OUTLIER -121.03 138.1 54.33 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 126.343 1.857 . . . . 0.0 115.9 174.317 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -123.87 137.38 54.66 Favored 'General case' 0 CA--C 1.494 -1.173 1 N-CA-C 99.817 -4.142 . . . . 0.0 99.817 160.682 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 136' ' ' TYR . 4.0 mp -122.29 115.13 21.79 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 101.003 -3.702 . . . . 0.0 101.003 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.49 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 5.7 t -152.49 132.27 13.22 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -174.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.84 174.43 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.052 1 C-N-CA 132.476 4.31 . . . . 0.0 105.629 176.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.3 t -104.15 141.24 36.59 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 119.773 -1.83 . . . . 0.0 107.72 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.76 146.01 35.47 Favored 'General case' 0 C--N 1.382 2.008 1 N-CA-C 124.947 5.166 . . . . 0.0 124.947 -173.422 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.9 p -156.95 175.33 14.24 Favored 'General case' 0 C--N 1.369 1.414 1 C-N-CA 133.786 4.834 . . . . 0.0 104.031 177.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.06 42.91 0.79 Allowed Glycine 0 C--N 1.367 2.273 0 O-C-N 119.597 -1.939 . . . . 0.0 117.779 171.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.85 25.69 52.05 Favored Glycine 0 C--N 1.361 1.961 0 C-N-CA 128.396 2.903 . . . . 0.0 114.851 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.4 p -116.91 110.01 17.78 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 116.519 -1.705 . . . . 0.0 108.368 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.66 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 71.8 -90.63 0.49 Allowed Glycine 0 C--N 1.371 2.516 0 C-N-CA 129.408 3.385 . . . . 0.0 110.731 -167.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.89 169.32 4.72 Favored 'Trans proline' 0 CA--C 1.564 1.975 1 C-N-CA 128.054 5.836 . . . . 0.0 117.326 160.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.528 ' HB3' HG12 ' A' ' 140' ' ' VAL . 64.7 m-85 -94.74 143.18 26.66 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 120.373 3.472 . . . . 0.0 120.373 -167.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.8 t -103.24 142.34 34.35 Favored 'General case' 0 C--N 1.382 1.999 0 C-N-CA 128.772 2.829 . . . . 0.0 104.789 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.434 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -141.48 165.99 25.98 Favored 'General case' 0 C--N 1.351 0.654 1 N-CA-C 122.282 4.178 . . . . 0.0 122.282 -160.745 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.86 121.95 12.89 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 128.187 2.595 . . . . 0.0 106.642 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.409 ' CZ3' HG11 ' A' ' 138' ' ' VAL . 72.2 m95 -112.01 142.46 44.41 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 125.335 1.454 . . . . 0.0 111.878 -175.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.7 170.77 19.43 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 123.186 1.47 . . . . 0.0 107.187 174.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.568 ' HD3' ' CE2' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -147.68 106.12 3.78 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 177.728 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.235 1.3 t70 34.5 53.07 0.58 Allowed 'General case' 0 C--N 1.377 1.794 2 N-CA-C 123.336 4.569 . . . . 0.0 123.336 140.062 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.69 -0.74 87.77 Favored Glycine 0 C--N 1.376 2.78 2 O-C-N 134.128 7.143 . . . . 0.0 119.292 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.469 ' HB2' ' HD2' ' A' ' 110' ' ' LYS . 3.6 m -124.8 147.18 55.46 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 129.3 3.04 . . . . 0.0 118.352 -172.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.33 138.07 49.61 Favored 'Trans proline' 0 N--CA 1.495 1.577 1 C-N-CA 125.984 4.456 . . . . 0.0 115.036 171.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.418 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -91.36 163.64 27.94 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 117.816 -3.052 . . . . 0.0 115.57 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 9.5 Cg_endo -71.22 84.4 0.91 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.703 3.602 . . . . 0.0 115.841 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.3 t70 78.01 -62.5 0.36 Allowed 'General case' 0 C--N 1.362 1.137 0 C-N-CA 127.719 2.407 . . . . 0.0 114.762 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 79.64 171.63 0.16 Allowed 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 130.284 3.434 . . . . 0.0 114.791 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.424 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 75.64 72.38 0.09 Allowed 'General case' 0 C--N 1.358 0.972 0 CA-C-N 114.345 -1.298 . . . . 0.0 114.288 173.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.76 -51.93 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.967 0 N-CA-C 118.976 2.35 . . . . 0.0 118.976 -173.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.263 . . 133.4 -73.11 0.0 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.055 2.142 . . . . 0.0 107.356 -176.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.272 6.9 t -133.82 111.61 10.65 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-O 123.092 1.425 . . . . 0.0 113.459 -175.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.331 0.6 OUTLIER -127.07 141.65 51.72 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 129.042 2.937 . . . . 0.0 112.394 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.7 m -128.51 139.71 52.18 Favored 'General case' 0 C--N 1.366 1.318 0 O-C-N 120.702 -1.249 . . . . 0.0 109.302 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.7 100.08 51.16 Favored Pre-proline 0 C--N 1.355 0.81 0 C-N-CA 129.822 3.249 . . . . 0.0 105.145 176.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -77.49 -32.4 2.92 Favored 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 125.93 4.42 . . . . 0.0 113.407 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.542 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.4 m -138.45 101.29 4.33 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -95.75 129.6 42.93 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 127.522 2.329 . . . . 0.0 109.615 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.59 175.58 7.85 Favored 'General case' 0 C--N 1.369 1.426 0 C-N-CA 128.169 2.588 . . . . 0.0 108.457 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.18 -51.35 18.63 Favored 'General case' 0 C--N 1.368 1.397 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 -171.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -63.92 -22.89 67.12 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 126.1 1.76 . . . . 0.0 114.748 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -82.87 -10.28 58.91 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 130.103 3.361 . . . . 0.0 111.909 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.583 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -94.35 166.37 12.11 Favored 'General case' 0 C--N 1.383 2.061 0 N-CA-C 116.59 2.071 . . . . 0.0 116.59 167.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 144.86 -156.34 26.86 Favored Glycine 0 CA--C 1.461 -3.289 0 C-N-CA 127.603 2.525 . . . . 0.0 108.867 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.325 1.4 m -113.54 130.45 56.35 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 114.276 -2.969 . . . . 0.0 107.118 171.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.568 ' CE2' ' HD3' ' A' ' 110' ' ' LYS . 31.0 m-85 -97.16 135.02 39.72 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 126.882 2.073 . . . . 0.0 112.063 -168.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.47 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -148.83 148.79 30.32 Favored 'General case' 0 C--N 1.373 1.595 0 CA-C-O 123.449 1.595 . . . . 0.0 109.12 -174.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.409 HG11 ' CZ3' ' A' ' 108' ' ' TRP 0.291 0.8 OUTLIER -141.46 141.03 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.265 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.7 m -102.64 122.98 45.5 Favored 'General case' 0 C--N 1.377 1.8 0 C-N-CA 129.138 2.975 . . . . 0.0 107.201 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.528 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -134.54 126.72 48.83 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 125.816 1.646 . . . . 0.0 113.391 -174.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 8.3 m -113.83 132.59 55.83 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 119.365 -2.084 . . . . 0.0 114.296 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.443 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.428 25.6 p30 -126.93 -174.36 3.12 Favored 'General case' 0 C--N 1.377 1.78 0 O-C-N 120.729 -1.232 . . . . 0.0 112.695 176.501 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.66 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 63.2 p -49.62 3.3 0.01 OUTLIER 'General case' 0 C--N 1.362 1.126 1 C-N-CA 136.302 5.841 . . . . 0.0 121.775 -164.551 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -104.21 4.47 33.95 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 118.215 -1.394 . . . . 0.0 107.798 163.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.405 91.8 mm-40 66.55 40.2 3.53 Favored 'General case' 0 C--N 1.375 1.683 1 C-N-CA 132.504 4.321 . . . . 0.0 110.156 -172.204 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.413 ' C ' HG23 ' A' ' 141' ' ' THR . 3.8 m -112.48 126.67 69.9 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.39 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.591 -170.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.3 OUTLIER -91.67 134.0 35.09 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 124.613 1.165 . . . . 0.0 109.724 -177.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 158.51 24.52 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 130.429 3.492 . . . . 0.0 105.686 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -127.21 136.51 52.13 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.449 ' HB3' HD22 ' A' ' 75' ' ' LEU 0.252 0.1 OUTLIER -116.38 151.6 35.62 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.242 1.817 . . . . 0.0 110.772 -175.482 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 m -53.42 146.5 12.38 Favored 'General case' 0 CA--C 1.489 -1.399 1 C-N-CA 134.209 5.004 . . . . 0.0 119.441 -157.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.8 p -70.76 111.59 6.32 Favored 'General case' 0 C--N 1.37 1.467 0 C-N-CA 128.749 2.819 . . . . 0.0 108.867 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.578 ' SG ' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -107.19 109.93 21.87 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 102.149 -3.278 . . . . 0.0 102.149 178.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -100.06 111.83 24.12 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-O 123.893 1.806 . . . . 0.0 111.556 -173.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -122.03 123.94 70.15 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 O-C-N 119.375 -2.078 . . . . 0.0 108.882 -178.529 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.4 m -111.92 127.48 55.86 Favored 'General case' 0 C--N 1.369 1.44 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.299 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.583 HG22 ' CB ' ' A' ' 133' ' ' ALA . 26.9 m -123.93 105.81 16.06 Favored 'Isoleucine or valine' 0 C--N 1.367 1.362 0 CA-C-O 123.586 1.66 . . . . 0.0 113.093 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -83.12 160.17 60.8 Favored Pre-proline 0 CA--C 1.556 1.208 0 O-C-N 120.545 -1.347 . . . . 0.0 109.964 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.5 166.07 30.89 Favored 'Trans proline' 0 CA--C 1.547 1.154 1 C-N-CA 126.284 4.656 . . . . 0.0 107.421 153.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.3 p -67.36 132.6 47.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 118.377 -2.702 . . . . 0.0 109.267 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.09 115.41 20.9 Favored Pre-proline 0 C--N 1.365 1.253 0 N-CA-C 120.006 3.335 . . . . 0.0 120.006 -126.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.34 151.43 82.6 Favored 'Trans proline' 0 C--N 1.383 2.353 1 C-N-CA 126.478 4.786 . . . . 0.0 115.359 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.07 55.84 1.06 Allowed Glycine 0 C--N 1.366 2.209 0 C-N-CA 127.423 2.439 . . . . 0.0 118.104 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -106.25 -36.3 2.72 Favored Glycine 0 C--N 1.356 1.676 0 C-N-CA 126.437 1.97 . . . . 0.0 113.115 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -103.16 -5.39 23.26 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.402 1.481 . . . . 0.0 112.876 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 59.72 -60.62 0.06 Allowed 'General case' 0 C--N 1.364 1.235 0 C-N-CA 129.114 2.965 . . . . 0.0 118.758 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . 0.367 1.6 p-80 . . . . . 0 C--N 1.361 1.097 0 C-N-CA 131.69 3.996 . . . . 0.0 118.169 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.7 tp -101.91 132.21 47.84 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 126.727 2.011 . . . . 0.0 111.114 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.3 t -98.91 172.79 7.2 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.875 2.47 . . . . 0.0 108.907 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.287 0.6 OUTLIER -77.67 98.89 5.61 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 120.79 -1.194 . . . . 0.0 109.298 176.745 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.9 m 59.81 -83.48 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 119.261 -2.149 . . . . 0.0 114.031 -166.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -133.33 141.1 47.78 Favored 'General case' 0 C--N 1.357 0.897 1 C-N-CA 132.251 4.22 . . . . 0.0 104.01 169.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.335 0.0 OUTLIER -82.68 173.35 11.99 Favored 'General case' 0 C--N 1.352 0.715 1 C-N-CA 132.581 4.353 . . . . 0.0 107.222 178.515 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 92' ' ' THR . 0.3 OUTLIER -69.99 -34.27 73.12 Favored 'General case' 0 CA--C 1.577 1.996 0 O-C-N 119.515 -1.991 . . . . 0.0 113.087 176.69 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -168.09 172.24 8.92 Favored 'General case' 0 CA--C 1.519 -0.248 1 O-C-N 115.33 -4.606 . . . . 0.0 101.173 171.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.61 -48.5 1.27 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 125.842 1.657 . . . . 0.0 111.132 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.4 t -170.71 140.78 1.73 Allowed 'General case' 0 C--N 1.362 1.129 0 O-C-N 119.622 -1.924 . . . . 0.0 115.78 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.17 117.07 13.2 Favored 'General case' 0 C--N 1.377 1.769 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 161.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.0 m -114.36 116.8 29.5 Favored 'General case' 0 C--N 1.363 1.186 0 O-C-N 118.209 -2.807 . . . . 0.0 108.334 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.0 p -149.46 172.09 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 125.828 1.651 . . . . 0.0 110.37 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -82.45 129.7 34.96 Favored 'General case' 0 C--N 1.373 1.589 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 163.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.258 9.1 pt-20 -41.53 123.01 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 120.397 3.48 . . . . 0.0 120.397 -152.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.597 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 142.08 52.97 0.04 OUTLIER Glycine 0 C--N 1.359 1.833 0 CA-C-N 109.73 -3.395 . . . . 0.0 110.654 -171.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.94 163.96 21.84 Favored 'General case' 0 C--N 1.374 1.631 0 C-N-CA 125.73 1.612 . . . . 0.0 112.928 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.67 108.83 18.43 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 124.272 1.029 . . . . 0.0 110.33 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 124' ' ' THR . 4.2 mp -119.46 123.09 43.2 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 125.797 1.639 . . . . 0.0 115.247 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -110.57 127.21 55.11 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 102.364 -3.198 . . . . 0.0 102.364 170.526 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.44 115.65 21.94 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 172.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 t -154.56 134.11 12.73 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 119.947 -1.72 . . . . 0.0 112.461 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.5 m -148.89 175.0 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.645 0 C-N-CA 131.637 3.975 . . . . 0.0 105.886 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.2 t -104.01 138.88 39.91 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.185 2.594 . . . . 0.0 104.625 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.35 142.19 33.8 Favored 'General case' 0 C--N 1.373 1.597 0 N-CA-C 121.642 3.942 . . . . 0.0 121.642 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.3 m -158.52 174.19 15.46 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 131.092 3.757 . . . . 0.0 102.05 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.27 44.54 1.38 Allowed Glycine 0 C--N 1.367 2.292 0 CA-C-N 121.879 2.127 . . . . 0.0 117.232 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.77 28.06 52.07 Favored Glycine 0 C--N 1.358 1.754 0 C-N-CA 128.544 2.973 . . . . 0.0 115.289 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.7 m -117.93 110.96 18.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 114.372 -2.728 . . . . 0.0 107.114 173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.85 -87.4 0.86 Allowed Glycine 0 C--N 1.379 2.944 0 C-N-CA 129.729 3.538 . . . . 0.0 110.144 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -60.18 168.12 6.62 Favored 'Trans proline' 0 CA--C 1.568 2.196 1 C-N-CA 126.51 4.806 . . . . 0.0 116.167 159.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 71.5 m-85 -103.2 143.59 32.43 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 119.593 3.182 . . . . 0.0 119.593 -165.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -103.52 146.49 28.46 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 127.255 2.222 . . . . 0.0 105.526 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.46 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -144.22 166.46 24.97 Favored 'General case' 0 C--N 1.354 0.778 1 N-CA-C 123.25 4.537 . . . . 0.0 123.25 -160.857 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.07 120.52 15.0 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 128.283 2.633 . . . . 0.0 106.25 172.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -112.54 146.65 38.14 Favored 'General case' 0 C--N 1.367 1.355 0 O-C-N 120.853 -1.155 . . . . 0.0 112.145 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.2 169.72 23.87 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 171.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -143.56 105.56 4.37 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 174.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.453 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.17 1.5 t70 34.79 52.79 0.6 Allowed 'General case' 0 C--N 1.376 1.744 1 N-CA-C 122.48 4.252 . . . . 0.0 122.48 140.265 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.07 -6.21 83.81 Favored Glycine 0 C--N 1.364 2.116 2 O-C-N 133.085 6.49 . . . . 0.0 119.003 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.269 3.0 m -124.28 147.13 53.95 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 129.268 3.027 . . . . 0.0 117.671 -171.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.78 142.46 76.39 Favored 'Trans proline' 0 N--CA 1.495 1.604 1 C-N-CA 126.245 4.63 . . . . 0.0 114.973 172.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.406 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -99.26 158.9 31.42 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 118.462 -2.649 . . . . 0.0 112.636 178.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 2.7 Cg_endo -65.04 86.9 0.18 Allowed 'Trans proline' 0 C--N 1.363 1.291 1 C-N-CA 126.336 4.691 . . . . 0.0 115.355 -177.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 73.21 -58.8 0.59 Allowed 'General case' 0 C--N 1.362 1.145 0 C-N-CA 128.268 2.627 . . . . 0.0 115.185 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 73.25 176.24 0.26 Allowed 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 130.824 3.65 . . . . 0.0 115.048 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.429 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.3 OUTLIER 72.15 60.98 0.13 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-N 114.308 -1.314 . . . . 0.0 114.324 174.394 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.98 -82.98 0.07 OUTLIER Glycine 0 C--N 1.355 1.59 0 N-CA-C 116.316 1.287 . . . . 0.0 116.316 -170.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.631 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 165.8 -62.61 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 126.509 1.924 . . . . 0.0 106.539 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.4 t -137.79 111.31 8.07 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.451 -1.406 . . . . 0.0 112.316 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.314 31.8 p90 -127.33 140.75 51.98 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 126.111 1.764 . . . . 0.0 111.925 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 91' ' ' LEU . 25.6 m -128.65 139.91 52.02 Favored 'General case' 0 C--N 1.361 1.076 0 O-C-N 120.014 -1.679 . . . . 0.0 109.017 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 98.43 48.6 Favored Pre-proline 0 C--N 1.363 1.181 0 C-N-CA 129.075 2.95 . . . . 0.0 105.289 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -77.39 -15.32 15.87 Favored 'Trans proline' 0 C--N 1.353 0.765 1 C-N-CA 126.413 4.742 . . . . 0.0 113.736 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.597 HG23 ' HA2' ' A' ' 88' ' ' GLY . 53.6 m -159.01 104.9 1.73 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 101.813 -3.403 . . . . 0.0 101.813 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.86 134.45 33.94 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 127.326 2.25 . . . . 0.0 111.287 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.72 175.61 6.83 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 127.997 2.519 . . . . 0.0 110.789 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.1 -48.05 33.91 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 119.611 3.189 . . . . 0.0 119.611 -173.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.16 -9.15 51.5 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 126.722 2.009 . . . . 0.0 114.603 173.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.527 ' CB ' ' HB1' ' A' ' 128' ' ' ALA 0.333 2.9 m-20 -78.32 -19.86 52.65 Favored 'General case' 0 CA--C 1.572 1.816 0 C-N-CA 129.344 3.058 . . . . 0.0 111.532 168.264 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.88 122.71 18.74 Favored 'General case' 0 C--N 1.384 2.084 0 N-CA-C 120.546 3.536 . . . . 0.0 120.546 171.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 164.98 -155.96 27.67 Favored Glycine 0 CA--C 1.472 -2.65 0 C-N-CA 127.044 2.259 . . . . 0.0 109.254 173.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.409 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 19.4 m -119.33 131.82 55.78 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 115.64 -2.424 . . . . 0.0 108.441 171.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 110' ' ' LYS 0.296 26.5 m-85 -95.39 134.23 38.44 Favored 'General case' 0 C--N 1.369 1.44 0 C-N-CA 129.799 3.239 . . . . 0.0 111.467 -172.209 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -143.3 145.09 32.42 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 124.67 1.188 . . . . 0.0 107.924 -173.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.3 p -135.75 143.6 35.98 Favored 'Isoleucine or valine' 0 C--N 1.359 1.02 0 C-N-CA 118.817 -1.153 . . . . 0.0 113.006 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 m -109.71 124.1 50.64 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 128.914 2.885 . . . . 0.0 105.392 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -134.69 131.74 53.92 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 127.701 2.4 . . . . 0.0 111.632 -176.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 7.5 m -119.63 134.17 55.34 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 126.479 1.912 . . . . 0.0 113.813 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.492 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.389 9.1 p-10 -125.51 -174.17 3.0 Favored 'General case' 0 C--N 1.383 2.044 0 CA-C-N 120.831 1.65 . . . . 0.0 113.176 175.722 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 3.6 p -49.24 -2.09 0.01 OUTLIER 'General case' 0 C--N 1.376 1.758 1 C-N-CA 136.801 6.04 . . . . 0.0 120.015 -165.621 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -101.44 4.82 41.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 117.755 -1.578 . . . . 0.0 108.751 165.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.409 72.5 mm-40 66.42 40.05 3.72 Favored 'General case' 0 C--N 1.376 1.744 1 C-N-CA 133.346 4.658 . . . . 0.0 110.146 -172.911 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.411 ' C ' HG23 ' A' ' 141' ' ' THR . 2.8 m -112.87 129.01 69.27 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-N 111.365 -2.652 . . . . 0.0 111.362 -170.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.5 OUTLIER -92.04 140.38 29.71 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 124.48 1.112 . . . . 0.0 111.113 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -117.78 156.56 28.11 Favored 'General case' 0 C--N 1.346 0.452 1 C-N-CA 132.193 4.197 . . . . 0.0 104.063 174.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -129.54 141.33 51.0 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 173.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.425 50.4 p -120.03 146.91 45.44 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 120.081 1.31 . . . . 0.0 109.05 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -54.07 148.43 10.94 Favored 'General case' 0 CA--C 1.484 -1.574 1 C-N-CA 137.304 6.242 . . . . 0.0 118.442 -160.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -68.45 109.85 3.88 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 125.553 1.541 . . . . 0.0 111.106 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.16 109.93 21.96 Favored 'General case' 0 C--N 1.366 1.298 0 N-CA-C 102.267 -3.234 . . . . 0.0 102.267 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.68 112.92 25.1 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 123.679 1.704 . . . . 0.0 111.82 -172.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.92 128.65 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 O-C-N 120.279 -1.513 . . . . 0.0 109.798 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 87.9 m -111.25 121.45 45.3 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 101.847 -3.39 . . . . 0.0 101.847 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 4.9 m -135.39 103.18 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.21 152.69 41.24 Favored Pre-proline 0 C--N 1.351 0.657 0 C-N-CA 125.547 1.539 . . . . 0.0 109.033 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -66.09 166.09 22.05 Favored 'Trans proline' 0 C--N 1.366 1.477 1 C-N-CA 127.045 5.163 . . . . 0.0 110.176 160.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.2 p -67.56 132.82 48.31 Favored 'General case' 0 C--N 1.372 1.568 0 O-C-N 119.264 -2.148 . . . . 0.0 108.898 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.11 114.71 19.67 Favored Pre-proline 0 CA--C 1.556 1.211 1 N-CA-C 121.99 4.07 . . . . 0.0 121.99 -123.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.69 154.87 62.58 Favored 'Trans proline' 0 C--N 1.388 2.614 1 C-N-CA 126.47 4.78 . . . . 0.0 114.248 171.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.51 45.94 0.04 OUTLIER Glycine 0 C--N 1.367 2.289 0 C-N-CA 128.688 3.042 . . . . 0.0 120.484 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -95.72 -13.96 48.52 Favored Glycine 0 C--N 1.358 1.799 0 C-N-CA 127.481 2.467 . . . . 0.0 111.701 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 45.4 mt -89.56 -27.23 20.39 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.963 1.705 . . . . 0.0 111.717 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 68.56 -50.63 0.57 Allowed 'General case' 0 C--N 1.365 1.25 0 C-N-CA 128.543 2.737 . . . . 0.0 116.801 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 . . . . . 0 C--N 1.357 0.908 0 C-N-CA 128.433 2.693 . . . . 0.0 111.519 179.54 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.97 0 CA-C-O 121.862 0.839 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.8 tt -107.24 120.92 43.45 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 126.553 1.941 . . . . 0.0 108.326 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.1 t -94.76 172.39 8.19 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 127.278 2.231 . . . . 0.0 110.397 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.262 1.3 pp -80.68 98.93 7.93 Favored 'General case' 0 C--N 1.366 1.296 0 O-C-N 119.75 -1.844 . . . . 0.0 109.058 174.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.7 m 59.09 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 118.119 -2.863 . . . . 0.0 114.784 -167.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -133.82 140.48 46.92 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 131.078 3.751 . . . . 0.0 106.848 167.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.304 0.0 OUTLIER -83.67 172.2 12.51 Favored 'General case' 0 C--N 1.344 0.333 1 C-N-CA 132.121 4.168 . . . . 0.0 110.53 175.178 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.413 ' O ' HG22 ' A' ' 92' ' ' THR . 0.2 OUTLIER -69.77 -34.56 73.95 Favored 'General case' 0 CA--C 1.583 2.243 0 O-C-N 120.558 -1.339 . . . . 0.0 112.043 168.456 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 81' ' ' ALA . 21.7 m -169.54 171.63 7.49 Favored 'General case' 0 N--CA 1.464 0.264 1 O-C-N 115.876 -4.265 . . . . 0.0 102.062 172.703 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.407 ' N ' HG22 ' A' ' 80' ' ' THR . . . -125.8 -45.79 1.74 Allowed 'General case' 0 C--N 1.365 1.255 0 C-N-CA 126.51 1.924 . . . . 0.0 114.157 176.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.0 t -174.27 141.19 0.71 Allowed 'General case' 0 C--N 1.364 1.223 0 O-C-N 119.885 -1.759 . . . . 0.0 115.068 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.3 ttt -126.38 136.89 53.26 Favored 'General case' 0 C--N 1.38 1.9 0 CA-C-N 118.352 0.524 . . . . 0.0 109.927 157.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m -114.59 113.37 24.29 Favored 'General case' 0 C--N 1.377 1.764 0 O-C-N 119.84 -1.788 . . . . 0.0 108.015 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.295 11.5 p -151.56 174.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 123.569 1.652 . . . . 0.0 114.076 -170.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -83.19 144.5 29.76 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 127.202 2.201 . . . . 0.0 105.573 158.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.421 4.5 pt-20 -44.01 124.37 3.8 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 117.202 -3.436 . . . . 0.0 118.071 -171.678 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.456 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 122.62 52.63 0.21 Allowed Glycine 0 C--N 1.358 1.787 0 C-N-CA 127.662 2.554 . . . . 0.0 109.887 -154.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.91 161.68 15.1 Favored 'General case' 0 C--N 1.376 1.731 0 C-N-CA 124.95 1.3 . . . . 0.0 110.908 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.74 97.43 6.7 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.787 HD21 ' CZ ' ' A' ' 136' ' ' TYR 0.298 53.7 tp -120.8 114.93 22.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -169.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -112.01 131.77 55.21 Favored 'General case' 0 C--N 1.373 1.591 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.412 HD21 ' HG ' ' A' ' 91' ' ' LEU . 1.1 mm? -129.37 115.86 18.18 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 175.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.4 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 6.9 t -151.11 134.04 15.84 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 119.419 -2.051 . . . . 0.0 112.273 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.75 173.79 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.851 0 C-N-CA 129.594 3.158 . . . . 0.0 104.786 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -104.01 141.06 36.85 Favored 'General case' 0 C--N 1.369 1.445 0 O-C-N 119.293 -2.129 . . . . 0.0 105.349 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -139.24 145.25 38.99 Favored 'General case' 0 C--N 1.365 1.262 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 -173.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -158.41 174.26 15.39 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 130.741 3.616 . . . . 0.0 101.561 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.15 43.2 1.46 Allowed Glycine 0 C--N 1.364 2.128 0 CA-C-N 121.879 2.127 . . . . 0.0 117.696 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.44 22.13 52.04 Favored Glycine 0 C--N 1.359 1.82 0 C-N-CA 127.785 2.612 . . . . 0.0 116.342 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 76.1 m -116.95 111.44 19.61 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 114.018 -2.896 . . . . 0.0 107.944 176.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.507 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.93 -92.5 0.93 Allowed Glycine 0 C--N 1.38 3.004 0 CA-C-N 124.628 3.376 . . . . 0.0 110.118 -175.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -60.5 167.54 7.95 Favored 'Trans proline' 0 CA--C 1.564 1.998 1 C-N-CA 126.82 5.013 . . . . 0.0 116.19 159.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.572 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.1 m-85 -98.47 143.28 29.08 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 120.613 3.56 . . . . 0.0 120.613 -165.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 t -102.96 141.12 36.31 Favored 'General case' 0 C--N 1.381 1.945 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.528 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -134.72 156.03 49.51 Favored 'General case' 0 C--N 1.347 0.494 1 N-CA-C 122.517 4.265 . . . . 0.0 122.517 -162.107 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.06 112.79 10.84 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 111.124 -2.762 . . . . 0.0 104.768 171.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.48 ' CE3' ' HB ' ' A' ' 138' ' ' VAL . 35.2 m95 -111.96 148.0 34.69 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.327 0.2 OUTLIER -159.36 169.93 22.92 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 166.019 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.454 ' HE3' ' CE2' ' A' ' 136' ' ' TYR 0.337 33.6 mtpt -123.19 127.31 48.46 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 115.431 -2.223 . . . . 0.0 107.089 173.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.437 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.308 0.7 OUTLIER 32.35 51.04 0.21 Allowed 'General case' 0 C--N 1.373 1.61 2 N-CA-C 123.763 4.727 . . . . 0.0 123.763 123.185 . . . . . . . . 5 4 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.88 1.92 49.47 Favored Glycine 0 C--N 1.377 2.821 2 O-C-N 133.907 7.004 . . . . 0.0 120.592 -169.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.574 0.6 OUTLIER -125.73 147.83 59.94 Favored Pre-proline 0 CA--C 1.563 1.466 1 N-CA-C 123.023 4.453 . . . . 0.0 123.023 -168.346 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.26 149.32 88.68 Favored 'Trans proline' 0 N--CA 1.499 1.842 1 C-N-CA 126.088 4.526 . . . . 0.0 116.245 173.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -110.28 153.69 43.24 Favored Pre-proline 0 CA--C 1.549 0.911 0 O-C-N 119.567 -1.958 . . . . 0.0 111.545 178.242 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 13.3 Cg_endo -68.09 90.13 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.098 1 C-N-CA 125.969 4.446 . . . . 0.0 114.992 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 t70 76.41 -52.63 0.6 Allowed 'General case' 0 C--N 1.364 1.221 0 C-N-CA 127.883 2.473 . . . . 0.0 114.474 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.424 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . 85.19 -62.89 0.06 Allowed 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 130.139 3.376 . . . . 0.0 116.282 173.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -58.04 55.81 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.078 1 C-N-CA 134.045 4.938 . . . . 0.0 118.13 -173.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -144.52 -78.1 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.89 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -173.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 160.93 -58.93 0.0 OUTLIER 'General case' 0 C--N 1.352 0.713 0 C-N-CA 125.172 1.389 . . . . 0.0 109.329 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.9 t -135.55 112.36 10.17 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 122.537 1.161 . . . . 0.0 111.169 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TYR . . . . . 0.413 ' CD2' ' HG2' ' A' ' 116' ' ' PRO . 35.0 p90 -127.04 139.76 52.78 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 124.627 1.171 . . . . 0.0 110.338 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.6 m -129.99 140.39 50.9 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 120.647 -1.283 . . . . 0.0 110.57 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.425 ' CB ' HD23 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -112.27 99.6 47.03 Favored Pre-proline 0 C--N 1.356 0.878 0 C-N-CA 130.213 3.405 . . . . 0.0 105.684 177.45 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -77.43 -13.28 16.75 Favored 'Trans proline' 0 CA--C 1.536 0.606 1 C-N-CA 126.04 4.493 . . . . 0.0 112.891 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.456 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -162.1 100.94 1.11 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.21 133.5 35.33 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 127.826 2.451 . . . . 0.0 111.772 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.47 173.29 8.42 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 130.141 3.376 . . . . 0.0 111.265 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.42 -45.6 25.65 Favored 'General case' 0 C--N 1.367 1.349 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.85 -17.86 65.1 Favored 'General case' 0 C--N 1.367 1.326 0 C-N-CA 126.229 1.812 . . . . 0.0 115.316 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.271 37.8 m-20 -84.09 -16.41 43.82 Favored 'General case' 0 C--N 1.362 1.144 1 C-N-CA 132.209 4.204 . . . . 0.0 110.72 171.996 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.28 156.05 35.43 Favored 'General case' 0 C--N 1.392 2.44 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 163.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 138.64 -157.36 24.61 Favored Glycine 0 CA--C 1.452 -3.865 0 C-N-CA 127.735 2.588 . . . . 0.0 106.862 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.434 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.251 3.3 m -119.73 135.73 54.72 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 114.657 -2.817 . . . . 0.0 107.27 167.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.787 ' CZ ' HD21 ' A' ' 91' ' ' LEU . 28.8 m-85 -96.99 134.74 39.96 Favored 'General case' 0 C--N 1.373 1.589 0 C-N-CA 128.434 2.694 . . . . 0.0 111.689 -172.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -146.39 154.57 41.78 Favored 'General case' 0 C--N 1.371 1.541 0 C-N-CA 124.729 1.211 . . . . 0.0 110.419 -176.611 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.48 ' HB ' ' CE3' ' A' ' 108' ' ' TRP . 14.8 p -142.91 139.95 27.54 Favored 'Isoleucine or valine' 0 C--N 1.368 1.38 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.3 m -107.67 110.81 22.77 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 131.334 3.854 . . . . 0.0 106.388 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.572 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -127.38 116.8 45.11 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 C-N-CA 125.892 1.677 . . . . 0.0 111.918 -172.519 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.5 m -102.34 131.12 49.15 Favored 'General case' 0 C--N 1.358 0.959 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.437 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.35 36.4 p-10 -125.65 179.31 5.22 Favored 'General case' 0 C--N 1.376 1.718 0 CA-C-N 120.408 1.458 . . . . 0.0 111.519 174.137 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 22.0 p -49.34 3.49 0.01 OUTLIER 'General case' 0 C--N 1.371 1.503 1 C-N-CA 136.57 5.948 . . . . 0.0 120.413 -169.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -103.51 4.83 36.33 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 166.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.524 2.0 mp0 64.51 40.03 6.43 Favored 'General case' 0 C--N 1.376 1.726 1 C-N-CA 133.518 4.727 . . . . 0.0 112.528 -173.842 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 m -112.68 123.48 68.41 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 CA-C-N 111.127 -2.761 . . . . 0.0 111.951 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.04 123.28 34.39 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 128.555 2.742 . . . . 0.0 105.303 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.55 158.36 23.79 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 129.14 2.976 . . . . 0.0 103.218 -174.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 9.0 t70 -129.56 141.27 51.01 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.214 1.007 . . . . 0.0 109.872 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.548 22.4 p -114.79 139.66 49.54 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 m -55.0 147.84 14.81 Favored 'General case' 0 C--N 1.366 1.321 1 C-N-CA 138.044 6.538 . . . . 0.0 117.898 -163.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.8 p -68.67 110.53 4.32 Favored 'General case' 0 C--N 1.375 1.701 0 C-N-CA 125.732 1.613 . . . . 0.0 110.33 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -101.2 110.35 22.36 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 -178.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.55 115.22 27.12 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 123.954 1.835 . . . . 0.0 113.171 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.85 128.25 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 O-C-N 119.65 -1.906 . . . . 0.0 107.602 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m -114.36 122.74 47.59 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 3.0 m -133.29 104.69 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -90.29 158.79 43.13 Favored Pre-proline 0 C--N 1.356 0.89 0 C-N-CA 126.522 1.929 . . . . 0.0 109.651 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -68.86 165.19 30.69 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 124.862 3.708 . . . . 0.0 108.043 154.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.91 134.69 51.26 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 118.61 -2.556 . . . . 0.0 109.272 -172.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.423 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 95.6 t -65.36 107.96 1.79 Allowed Pre-proline 0 C--N 1.361 1.068 0 N-CA-C 120.698 3.592 . . . . 0.0 120.698 -125.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 48.5 Cg_endo -63.48 122.78 11.04 Favored 'Trans proline' 0 C--N 1.382 2.3 1 C-N-CA 125.371 4.047 . . . . 0.0 112.778 166.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.79 -72.11 0.87 Allowed Glycine 0 C--N 1.365 2.153 0 C-N-CA 127.407 2.432 . . . . 0.0 116.214 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.78 158.39 26.34 Favored Glycine 0 CA--C 1.49 -1.479 1 N-CA-C 102.277 -4.329 . . . . 0.0 102.277 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.561 ' H ' HD23 ' A' ' 165' ' ' LEU . 0.9 OUTLIER -96.15 -5.66 40.12 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.737 1.615 . . . . 0.0 114.099 -175.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 71.55 -50.01 0.69 Allowed 'General case' 0 C--N 1.364 1.214 0 C-N-CA 129.634 3.174 . . . . 0.0 114.252 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 . . . . . 0 C--N 1.351 0.645 0 C-N-CA 131.56 3.944 . . . . 0.0 113.131 179.731 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.1 tp -102.6 119.71 39.29 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 125.318 1.447 . . . . 0.0 108.406 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.5 t -95.58 172.76 7.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 129.105 2.962 . . . . 0.0 109.927 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.9 98.63 5.7 Favored 'General case' 0 C--N 1.367 1.36 0 O-C-N 119.364 -2.085 . . . . 0.0 110.986 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.18 -79.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 118.842 -2.411 . . . . 0.0 113.823 -168.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -133.6 140.45 47.14 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 129.838 3.255 . . . . 0.0 105.077 164.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.354 3.2 t0 -83.5 174.14 10.86 Favored 'General case' 0 C--N 1.341 0.236 1 C-N-CA 133.396 4.678 . . . . 0.0 109.998 177.479 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.431 ' O ' HG22 ' A' ' 92' ' ' THR . 0.5 OUTLIER -70.22 -34.66 73.16 Favored 'General case' 0 CA--C 1.586 2.329 0 O-C-N 120.854 -1.154 . . . . 0.0 112.558 170.102 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 m -169.79 171.97 7.0 Favored 'General case' 0 N--CA 1.467 0.412 1 O-C-N 114.69 -5.006 . . . . 0.0 101.598 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.13 -45.9 1.24 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.092 1.357 . . . . 0.0 111.159 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.9 p -171.03 125.2 0.65 Allowed 'General case' 0 C--N 1.361 1.103 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.0 ttt -130.6 118.0 20.37 Favored 'General case' 0 C--N 1.376 1.726 0 CA-C-N 120.605 1.548 . . . . 0.0 109.346 160.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -110.61 115.14 29.08 Favored 'General case' 0 C--N 1.368 1.407 0 O-C-N 119.823 -1.798 . . . . 0.0 108.181 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.8 p -150.03 173.71 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 126.848 2.059 . . . . 0.0 112.977 -169.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.46 144.59 46.21 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 128.042 2.537 . . . . 0.0 107.1 159.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.536 0.7 OUTLIER -44.13 123.28 3.3 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 124.628 3.376 . . . . 0.0 118.248 -171.282 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.431 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 126.96 43.17 0.26 Allowed Glycine 0 C--N 1.358 1.755 0 CA-C-N 111.45 -2.614 . . . . 0.0 112.09 -157.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.44 164.93 20.64 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 119.707 1.753 . . . . 0.0 112.156 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.07 114.93 28.85 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 125.994 1.718 . . . . 0.0 108.556 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 124' ' ' THR . 7.0 mp -120.5 114.49 21.85 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 127.668 2.387 . . . . 0.0 114.693 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -109.61 124.49 51.24 Favored 'General case' 0 C--N 1.364 1.235 0 N-CA-C 102.467 -3.16 . . . . 0.0 102.467 170.503 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -124.69 114.77 19.76 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.4 t -153.62 134.09 13.56 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 120.021 -1.675 . . . . 0.0 112.182 -172.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -149.12 174.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.736 0 C-N-CA 130.513 3.525 . . . . 0.0 104.591 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -103.67 140.74 37.17 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.16 142.39 34.04 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 120.588 3.551 . . . . 0.0 120.588 -173.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.3 m -158.47 174.54 14.94 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 130.337 3.455 . . . . 0.0 102.023 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.26 44.35 1.89 Allowed Glycine 0 C--N 1.366 2.2 0 CA-C-N 122.122 2.237 . . . . 0.0 117.639 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.67 20.16 62.27 Favored Glycine 0 C--N 1.358 1.806 0 C-N-CA 127.78 2.609 . . . . 0.0 114.776 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 45.2 p -116.75 110.81 18.91 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 113.948 -2.929 . . . . 0.0 108.285 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.595 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 73.03 -92.47 0.64 Allowed Glycine 0 C--N 1.376 2.762 0 C-N-CA 129.876 3.607 . . . . 0.0 111.065 -170.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -61.86 168.75 8.26 Favored 'Trans proline' 0 CA--C 1.566 2.113 1 C-N-CA 127.128 5.219 . . . . 0.0 117.207 160.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.592 ' HB3' HG12 ' A' ' 140' ' ' VAL . 75.8 m-85 -93.72 141.36 28.58 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 121.186 3.772 . . . . 0.0 121.186 -167.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -103.24 147.0 27.58 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 128.19 2.596 . . . . 0.0 105.093 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.519 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -144.05 166.21 25.63 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 121.579 3.918 . . . . 0.0 121.579 -160.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.07 113.7 7.86 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 111.715 -2.493 . . . . 0.0 106.263 172.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -112.07 153.84 26.29 Favored 'General case' 0 C--N 1.376 1.722 0 O-C-N 120.149 -1.594 . . . . 0.0 107.87 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.345 0.0 OUTLIER -156.04 152.97 28.73 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 163.236 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.859 ' HZ1' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -128.27 103.86 7.41 Favored 'General case' 0 C--N 1.369 1.451 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 177.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.456 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.186 4.0 t70 37.54 54.98 1.46 Allowed 'General case' 0 CA--C 1.453 -2.76 1 CA-C-O 110.881 -4.39 . . . . 0.0 119.601 153.505 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.51 -17.0 51.62 Favored Glycine 0 C--N 1.372 2.559 2 O-C-N 134.729 7.518 . . . . 0.0 116.408 -175.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.421 ' HB3' ' HE2' ' A' ' 110' ' ' LYS 0.282 48.5 m -124.12 149.48 60.56 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 130.754 3.622 . . . . 0.0 119.304 -165.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.12 154.46 51.44 Favored 'Trans proline' 0 N--CA 1.507 2.315 1 C-N-CA 126.937 5.091 . . . . 0.0 116.378 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.576 ' HB ' ' HD2' ' A' ' 116' ' ' PRO 0.274 0.8 OUTLIER -95.12 164.59 18.9 Favored Pre-proline 0 N--CA 1.484 1.23 0 O-C-N 117.967 -2.958 . . . . 0.0 111.917 174.309 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.576 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 1.9 Cg_endo -67.98 92.24 0.38 Allowed 'Trans proline' 0 C--N 1.368 1.584 1 C-N-CA 126.491 4.794 . . . . 0.0 112.585 177.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 78.7 -65.89 0.21 Allowed 'General case' 0 C--N 1.351 0.671 0 C-N-CA 128.448 2.699 . . . . 0.0 111.721 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 88.21 148.72 0.05 OUTLIER 'General case' 0 CA--C 1.466 -2.276 0 C-N-CA 128.029 2.532 . . . . 0.0 112.196 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.458 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 18.5 m 74.13 62.62 0.08 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.177 -1.828 . . . . 0.0 115.17 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.01 -77.96 0.08 OUTLIER Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 115.214 0.846 . . . . 0.0 115.214 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.599 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 160.53 -58.27 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 124.639 1.176 . . . . 0.0 109.187 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.4 t -141.68 112.85 7.46 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 123.367 1.556 . . . . 0.0 113.311 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.257 0.0 OUTLIER -127.47 139.72 52.62 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 124.856 1.262 . . . . 0.0 108.931 172.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 91' ' ' LEU . 65.4 m -129.73 138.62 51.22 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 173.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.35 114.11 48.17 Favored Pre-proline 0 C--N 1.363 1.182 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 173.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.32 -14.07 16.57 Favored 'Trans proline' 0 C--N 1.354 0.852 1 C-N-CA 126.273 4.649 . . . . 0.0 112.83 174.739 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.431 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -161.83 106.41 1.25 Allowed 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.536 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.47 134.97 33.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.074 2.55 . . . . 0.0 113.823 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.16 176.64 6.89 Favored 'General case' 0 C--N 1.371 1.536 0 C-N-CA 127.878 2.471 . . . . 0.0 110.568 174.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.04 -48.97 32.8 Favored 'General case' 0 C--N 1.368 1.413 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 -173.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -64.31 -17.35 63.57 Favored 'General case' 0 C--N 1.366 1.283 0 C-N-CA 127.104 2.162 . . . . 0.0 114.685 173.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.859 ' HA ' ' HZ1' ' A' ' 110' ' ' LYS 0.35 32.7 m-20 -83.67 -19.13 35.9 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 130.894 3.678 . . . . 0.0 112.287 172.241 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.61 131.98 48.5 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 163.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 159.3 -158.82 29.89 Favored Glycine 0 CA--C 1.456 -3.616 0 C-N-CA 126.914 2.197 . . . . 0.0 107.737 167.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.333 22.8 m -116.88 136.02 53.27 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 114.964 -2.694 . . . . 0.0 108.316 170.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.529 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 22.9 m-85 -96.77 133.67 41.05 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 119.24 -2.163 . . . . 0.0 114.143 -171.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -139.4 141.94 37.52 Favored 'General case' 0 C--N 1.37 1.487 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -173.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.3 p -141.3 141.7 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 117.614 -1.635 . . . . 0.0 114.704 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 18.1 m -107.64 118.9 37.93 Favored 'General case' 0 C--N 1.378 1.844 0 C-N-CA 128.488 2.715 . . . . 0.0 107.187 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -131.33 118.98 42.25 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 126.058 1.743 . . . . 0.0 111.697 -172.67 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.448 HG23 ' C ' ' A' ' 146' ' ' VAL . 6.6 m -108.24 129.36 55.21 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.418 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.402 28.9 p-10 -124.02 -177.15 3.67 Favored 'General case' 0 C--N 1.372 1.559 0 O-C-N 120.944 -1.098 . . . . 0.0 112.885 174.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.595 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 86.2 p -50.15 3.93 0.01 OUTLIER 'General case' 0 C--N 1.36 1.026 2 C-N-CA 135.742 5.617 . . . . 0.0 121.954 -168.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -101.8 4.65 40.61 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 164.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.348 3.1 mp0 66.78 39.69 3.41 Favored 'General case' 0 C--N 1.379 1.887 1 C-N-CA 133.678 4.791 . . . . 0.0 109.974 -174.367 . . . . . . . . 3 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.448 ' C ' HG23 ' A' ' 141' ' ' THR . 4.3 m -113.13 123.97 69.3 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.62 0 CA-C-N 112.418 -2.174 . . . . 0.0 113.021 -170.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.31 123.67 34.92 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.251 2.221 . . . . 0.0 107.034 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.13 156.54 26.26 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -130.35 147.07 52.02 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 121.382 -0.824 . . . . 0.0 110.104 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.294 58.7 p -123.64 143.7 50.08 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 m -54.93 148.24 13.78 Favored 'General case' 0 C--N 1.377 1.791 2 C-N-CA 138.807 6.843 . . . . 0.0 114.699 -168.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.8 p -67.61 109.81 3.43 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.223 1.809 . . . . 0.0 111.238 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.72 108.78 20.48 Favored 'General case' 0 C--N 1.37 1.488 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -94.63 109.22 21.17 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 120.519 1.509 . . . . 0.0 111.465 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.87 113.93 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 59.3 m -120.41 122.57 41.03 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 4.5 m -120.32 104.89 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.034 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -178.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -83.35 155.62 66.32 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.19 1.796 . . . . 0.0 110.931 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -69.65 165.83 29.53 Favored 'Trans proline' 0 C--N 1.36 1.172 1 C-N-CA 126.119 4.546 . . . . 0.0 107.6 154.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.2 p -67.31 133.35 49.48 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 118.166 -2.834 . . . . 0.0 110.3 -171.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.3 t -66.14 113.91 14.43 Favored Pre-proline 0 CA--C 1.554 1.126 0 N-CA-C 121.484 3.883 . . . . 0.0 121.484 -127.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.45 152.1 79.09 Favored 'Trans proline' 0 C--N 1.379 2.153 1 C-N-CA 126.145 4.563 . . . . 0.0 115.472 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.5 80.9 0.4 Allowed Glycine 0 C--N 1.368 2.321 0 C-N-CA 127.961 2.696 . . . . 0.0 115.078 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.99 -123.48 0.97 Allowed Glycine 0 C--N 1.348 1.198 0 N-CA-C 107.884 -2.087 . . . . 0.0 107.884 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 34.9 mt 65.65 -69.1 0.11 Allowed 'General case' 0 C--N 1.363 1.184 0 C-N-CA 128.692 2.797 . . . . 0.0 116.218 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -108.43 -15.26 14.49 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 129.042 2.937 . . . . 0.0 110.385 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 79.5 t60 . . . . . 0 C--N 1.353 0.761 0 C-N-CA 127.304 2.241 . . . . 0.0 109.175 -178.922 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.977 0 CA-C-O 121.872 0.844 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.0 tt -106.1 117.89 35.21 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.859 1.664 . . . . 0.0 106.841 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 t -94.77 173.08 7.78 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 128.097 2.559 . . . . 0.0 110.924 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 75' ' ' LEU 0.256 2.4 pt? -73.84 98.52 2.99 Favored 'General case' 0 C--N 1.365 1.25 0 O-C-N 120.702 -1.249 . . . . 0.0 110.496 171.029 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.4 t 58.08 -75.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 117.033 -3.542 . . . . 0.0 116.158 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -133.38 142.1 48.22 Favored 'General case' 0 C--N 1.36 1.056 1 C-N-CA 132.99 4.516 . . . . 0.0 106.693 168.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.441 0.4 OUTLIER -81.63 170.57 15.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 131.656 3.983 . . . . 0.0 110.595 -178.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.554 ' O ' HG22 ' A' ' 92' ' ' THR . 1.2 mp -72.37 -35.31 68.46 Favored 'General case' 0 CA--C 1.578 2.046 0 O-C-N 119.942 -1.724 . . . . 0.0 111.38 167.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.519 ' HB ' ' SG ' ' A' ' 153' ' ' CYS . 19.1 m -172.25 179.75 2.5 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 100.399 -3.926 . . . . 0.0 100.399 174.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.12 -42.66 0.46 Allowed 'General case' 0 C--N 1.367 1.353 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.0 m -164.63 99.63 0.79 Allowed 'General case' 0 N--CA 1.477 0.9 0 O-C-N 118.449 -2.657 . . . . 0.0 115.601 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 19.9 mmm -120.27 117.55 28.13 Favored 'General case' 0 C--N 1.369 1.449 0 CA-C-O 122.591 1.186 . . . . 0.0 109.664 168.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.5 p -115.15 114.86 25.85 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.94 174.63 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 112.973 -1.921 . . . . 0.0 111.17 -171.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.02 144.68 52.17 Favored 'General case' 0 CA--C 1.564 1.501 0 O-C-N 118.968 -2.332 . . . . 0.0 107.724 158.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.437 0.7 OUTLIER -44.14 123.17 3.26 Favored 'General case' 0 N--CA 1.523 3.176 0 O-C-N 117.675 -3.141 . . . . 0.0 117.733 -170.118 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.511 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 123.52 50.17 0.22 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-N 111.347 -2.661 . . . . 0.0 108.884 -154.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 155' ' ' VAL . . . -95.9 139.43 32.12 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 125.298 1.439 . . . . 0.0 108.32 173.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.94 119.33 32.71 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -167.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.551 ' HG ' HG11 ' A' ' 155' ' ' VAL . 6.2 mt -121.46 129.14 52.79 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.194 2.598 . . . . 0.0 117.584 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -115.95 118.48 33.05 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 100.352 -3.944 . . . . 0.0 100.352 167.792 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.49 115.09 22.2 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.496 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 8.8 t -155.03 131.58 10.54 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -169.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 m -150.17 173.71 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.649 1 C-N-CA 131.748 4.019 . . . . 0.0 103.465 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.2 t -104.29 141.44 36.3 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 122.857 2.571 . . . . 0.0 106.67 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.668 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -134.75 145.53 48.53 Favored 'General case' 0 C--N 1.37 1.495 0 N-CA-C 119.618 3.192 . . . . 0.0 119.618 -174.38 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.6 m -158.29 174.29 15.38 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 131.644 3.978 . . . . 0.0 101.41 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.39 44.49 2.21 Favored Glycine 0 C--N 1.364 2.089 0 CA-C-N 122.111 2.232 . . . . 0.0 116.508 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.86 21.42 57.62 Favored Glycine 0 C--N 1.356 1.676 0 C-N-CA 127.297 2.379 . . . . 0.0 115.578 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.7 m -117.6 111.25 18.94 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 114.799 -2.524 . . . . 0.0 107.728 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.621 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 78.57 -91.22 1.16 Allowed Glycine 0 C--N 1.375 2.721 0 C-N-CA 129.546 3.451 . . . . 0.0 109.679 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.61 167.22 8.61 Favored 'Trans proline' 0 CA--C 1.57 2.312 1 C-N-CA 126.566 4.844 . . . . 0.0 116.288 160.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 69.0 m-85 -98.94 145.33 27.14 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 120.473 3.508 . . . . 0.0 120.473 -166.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.7 t -102.7 140.06 37.47 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.478 ' CE1' ' HA ' ' A' ' 119' ' ' SER . 0.0 OUTLIER -114.32 148.98 36.69 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 -164.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.65 111.25 10.46 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 102.358 -3.201 . . . . 0.0 102.358 162.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.503 ' HB2' HG13 ' A' ' 115' ' ' ILE . 40.7 m95 -112.93 150.28 32.04 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 125.301 1.44 . . . . 0.0 108.661 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.65 169.64 19.92 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 165.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -139.84 104.15 4.82 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 175.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.434 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.235 1.5 t70 34.77 52.85 0.6 Allowed 'General case' 0 CA--C 1.473 -1.994 2 N-CA-C 122.336 4.199 . . . . 0.0 122.336 142.339 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.77 -11.25 71.41 Favored Glycine 0 C--N 1.366 2.195 2 O-C-N 133.346 6.654 . . . . 0.0 118.629 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.1 m -124.14 148.17 56.74 Favored Pre-proline 0 CA--C 1.564 1.497 0 C-N-CA 131.287 3.835 . . . . 0.0 121.034 -168.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.62 148.52 92.26 Favored 'Trans proline' 0 C--N 1.378 2.122 1 C-N-CA 126.834 5.023 . . . . 0.0 115.247 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.712 HD11 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -107.12 162.11 20.76 Favored Pre-proline 0 C--N 1.354 0.788 0 O-C-N 119.741 -1.85 . . . . 0.0 115.482 -177.545 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 9.0 Cg_endo -73.82 88.96 1.02 Allowed 'Trans proline' 0 C--N 1.363 1.335 1 C-N-CA 125.923 4.415 . . . . 0.0 114.699 -177.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.1 t70 82.19 -53.71 0.23 Allowed 'General case' 0 C--N 1.361 1.098 0 C-N-CA 128.528 2.731 . . . . 0.0 113.48 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.712 ' HB2' HD11 ' A' ' 115' ' ' ILE . . . 91.55 -48.34 0.02 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 129.789 3.236 . . . . 0.0 113.639 177.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.478 ' HA ' ' CE1' ' A' ' 106' ' ' TYR 0.252 33.1 t -77.61 49.33 0.73 Allowed 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 129.479 3.112 . . . . 0.0 114.017 -174.718 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -131.0 -46.16 0.15 Allowed Glycine 0 C--N 1.367 2.267 1 N-CA-C 124.665 4.626 . . . . 0.0 124.665 -162.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.668 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.291 . . 99.72 -75.99 0.0 OUTLIER 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.734 2.267 . . . . 0.0 111.564 -177.578 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.298 6.5 t -130.95 102.32 6.0 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-O 123.528 1.633 . . . . 0.0 110.805 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.262 19.2 p90 -126.97 141.74 51.72 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 128.324 2.65 . . . . 0.0 111.485 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 91' ' ' LEU . 38.0 m -128.42 139.29 52.44 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 119.645 -1.909 . . . . 0.0 107.861 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -116.16 92.39 35.51 Favored Pre-proline 0 C--N 1.358 0.96 0 C-N-CA 129.494 3.118 . . . . 0.0 104.362 175.072 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -68.47 -33.16 23.56 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.47 3.447 . . . . 0.0 112.719 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.511 HG23 ' HA2' ' A' ' 88' ' ' GLY . 97.5 m -127.4 104.12 7.74 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 126.008 1.723 . . . . 0.0 106.442 176.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.09 124.06 35.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.305 1.442 . . . . 0.0 110.51 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.38 170.86 13.16 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.91 2.084 . . . . 0.0 108.002 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.12 -47.51 23.37 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -170.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.65 -23.38 67.06 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 126.753 2.021 . . . . 0.0 115.061 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -83.43 -12.85 55.92 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.846 2.858 . . . . 0.0 112.574 172.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.634 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -88.51 155.83 19.43 Favored 'General case' 0 C--N 1.381 1.951 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 170.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 141.54 -149.39 21.07 Favored Glycine 0 CA--C 1.457 -3.554 0 N-CA-C 104.713 -3.355 . . . . 0.0 104.713 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.264 66.8 m -125.97 138.26 53.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 114.543 -2.863 . . . . 0.0 107.606 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 8.7 m-85 -96.96 134.64 40.06 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 126.445 1.898 . . . . 0.0 112.054 -168.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -144.58 143.43 30.8 Favored 'General case' 0 C--N 1.365 1.26 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.332 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.409 HG21 ' CE2' ' A' ' 108' ' ' TRP . 14.9 p -143.25 143.51 24.68 Favored 'Isoleucine or valine' 0 C--N 1.364 1.236 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -111.56 122.63 48.33 Favored 'General case' 0 C--N 1.375 1.705 0 C-N-CA 130.921 3.688 . . . . 0.0 105.994 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.421 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -134.55 120.37 32.35 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 124.518 1.127 . . . . 0.0 109.844 -172.366 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.412 HG23 ' C ' ' A' ' 146' ' ' VAL . 7.9 m -105.22 132.87 50.89 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -176.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.47 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.384 23.9 p-10 -126.12 -174.45 3.11 Favored 'General case' 0 C--N 1.38 1.904 0 C-N-CA 124.589 1.155 . . . . 0.0 112.691 176.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.621 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 6.5 p -49.24 0.31 0.01 OUTLIER 'General case' 0 C--N 1.372 1.551 1 C-N-CA 136.577 5.951 . . . . 0.0 120.821 -166.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -104.04 4.54 34.52 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 118.474 -1.29 . . . . 0.0 107.836 165.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.464 94.7 mm-40 67.24 40.3 2.82 Favored 'General case' 0 C--N 1.374 1.631 1 C-N-CA 132.707 4.403 . . . . 0.0 110.56 -172.692 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.412 ' C ' HG23 ' A' ' 141' ' ' THR . 3.5 m -112.78 126.07 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.346 0 CA-C-N 111.605 -2.543 . . . . 0.0 112.845 -171.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.7 OUTLIER -90.83 125.9 35.87 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 127.777 2.431 . . . . 0.0 108.109 -176.503 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.24 156.74 26.05 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 -176.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -130.65 146.88 52.24 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 120.543 -1.348 . . . . 0.0 111.492 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.433 91.8 p -127.19 146.29 50.46 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.557 0.743 . . . . 0.0 111.807 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.0 m -54.61 148.59 12.19 Favored 'General case' 0 CA--C 1.488 -1.407 1 C-N-CA 138.496 6.718 . . . . 0.0 117.42 -164.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.8 p -68.56 110.2 4.1 Favored 'General case' 0 C--N 1.377 1.768 0 C-N-CA 127.764 2.426 . . . . 0.0 110.046 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 80' ' ' THR . 1.0 OUTLIER -106.35 109.35 21.25 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 -172.308 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.54 122.46 42.64 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -168.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.551 HG11 ' HG ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -123.17 115.03 44.43 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 C-N-CA 125.045 1.338 . . . . 0.0 108.128 176.7 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 62.7 m -114.24 122.82 47.92 Favored 'General case' 0 C--N 1.372 1.561 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.634 HG22 ' CB ' ' A' ' 133' ' ' ALA . 33.4 m -120.36 108.07 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 C-N-CA 126.358 1.863 . . . . 0.0 111.485 -175.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -87.21 157.15 53.99 Favored Pre-proline 0 CA--C 1.556 1.179 0 O-C-N 121.222 -0.924 . . . . 0.0 110.065 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.55 165.89 31.23 Favored 'Trans proline' 0 CA--C 1.548 1.194 1 C-N-CA 126.182 4.588 . . . . 0.0 106.978 152.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.5 m -67.43 137.47 55.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 117.932 -2.98 . . . . 0.0 109.781 -172.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.47 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 42.3 t -65.49 107.52 1.54 Allowed Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 119.433 3.123 . . . . 0.0 119.433 -124.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 92.8 Cg_endo -63.28 154.71 66.26 Favored 'Trans proline' 0 C--N 1.381 2.268 1 C-N-CA 126.56 4.84 . . . . 0.0 114.601 172.063 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.34 -57.04 2.77 Favored Glycine 0 C--N 1.358 1.77 0 C-N-CA 125.479 1.514 . . . . 0.0 112.768 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -177.12 151.3 10.94 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 82.7 mt -103.34 60.08 0.76 Allowed 'General case' 0 C--N 1.36 1.056 0 O-C-N 121.236 -1.155 . . . . 0.0 109.592 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.62 72.48 1.03 Allowed 'General case' 0 C--N 1.362 1.141 0 C-N-CA 127.181 2.192 . . . . 0.0 114.775 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 . . . . . 0 C--N 1.357 0.927 0 C-N-CA 127.74 2.416 . . . . 0.0 113.158 -177.105 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.984 0 CA-C-O 121.853 0.835 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.0 tp -86.79 129.15 34.99 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 126.384 1.874 . . . . 0.0 112.307 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 t -95.46 172.24 8.2 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 126.162 1.785 . . . . 0.0 110.621 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.567 ' H ' HD23 ' A' ' 75' ' ' LEU 0.374 0.4 OUTLIER -81.59 97.73 8.0 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.631 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.84 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 118.662 -2.524 . . . . 0.0 115.082 -168.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -133.36 141.7 48.04 Favored 'General case' 0 C--N 1.36 1.06 1 C-N-CA 132.467 4.307 . . . . 0.0 106.327 169.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.287 0.0 OUTLIER -82.39 171.79 13.79 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 128.647 2.779 . . . . 0.0 110.507 177.895 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -71.33 -30.63 66.43 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 113.608 -1.633 . . . . 0.0 112.405 176.653 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 m -171.48 172.94 4.92 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 116.726 -3.734 . . . . 0.0 101.032 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.48 -42.71 0.55 Allowed 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.467 1.485 . . . . 0.0 111.479 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 154' ' ' ALA . 58.1 m -162.86 113.39 1.45 Allowed 'General case' 0 C--N 1.356 0.875 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.77 117.26 19.97 Favored 'General case' 0 C--N 1.371 1.532 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 162.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.6 m -116.41 116.81 28.38 Favored 'General case' 0 C--N 1.364 1.198 0 O-C-N 117.946 -2.971 . . . . 0.0 110.066 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 p -149.57 172.29 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.533 1.133 . . . . 0.0 113.059 -173.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -83.72 130.67 34.96 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 162.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.326 0.3 OUTLIER -41.53 123.09 2.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 120.076 3.361 . . . . 0.0 120.076 -150.492 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.62 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 141.64 48.84 0.05 OUTLIER Glycine 0 C--N 1.357 1.701 0 CA-C-N 109.941 -3.299 . . . . 0.0 111.896 -170.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.98 171.67 11.94 Favored 'General case' 0 C--N 1.37 1.471 0 C-N-CA 124.731 1.213 . . . . 0.0 112.95 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.54 115.77 30.2 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.251 1.42 . . . . 0.0 108.508 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 128' ' ' ALA . 6.7 mp -120.47 113.06 19.76 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.467 2.307 . . . . 0.0 113.346 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.97 126.92 54.44 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 170.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.465 HD11 ' CG ' ' A' ' 136' ' ' TYR . 1.9 mm? -112.57 114.43 27.08 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 102.625 -3.102 . . . . 0.0 102.625 174.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.1 m -150.24 134.58 17.22 Favored 'General case' 0 C--N 1.368 1.389 0 CA-C-O 121.729 0.776 . . . . 0.0 112.043 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.17 173.03 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 C-N-CA 131.521 3.928 . . . . 0.0 103.766 174.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.9 p -103.59 137.43 41.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.48 2.712 . . . . 0.0 108.121 -173.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.404 ' HB2' ' HE2' ' A' ' 106' ' ' TYR . . . -141.6 145.82 35.5 Favored 'General case' 0 C--N 1.384 2.098 1 N-CA-C 127.602 6.149 . . . . 0.0 127.602 -170.493 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.431 HG23 ' HG2' ' A' ' 103' ' ' PRO . 23.7 p -156.67 175.07 14.54 Favored 'General case' 0 C--N 1.37 1.491 1 C-N-CA 134.241 5.016 . . . . 0.0 103.985 173.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.64 40.19 0.78 Allowed Glycine 0 C--N 1.367 2.27 0 O-C-N 119.279 -2.138 . . . . 0.0 117.798 170.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.5 30.73 15.06 Favored Glycine 0 C--N 1.359 1.812 0 C-N-CA 128.54 2.972 . . . . 0.0 114.648 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.4 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 33.5 p -117.35 109.67 17.1 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 114.39 -2.719 . . . . 0.0 108.79 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.68 -90.64 0.86 Allowed Glycine 0 C--N 1.378 2.886 0 CA-C-N 124.147 3.158 . . . . 0.0 111.591 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HG2' HG23 ' A' ' 98' ' ' THR . 62.8 Cg_endo -62.29 169.17 8.31 Favored 'Trans proline' 0 CA--C 1.569 2.256 1 C-N-CA 126.528 4.819 . . . . 0.0 113.62 158.119 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.45 ' HB3' HG12 ' A' ' 140' ' ' VAL . 61.0 m-85 -100.68 159.79 14.88 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 119.655 3.206 . . . . 0.0 119.655 -165.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.7 t -110.14 141.49 42.95 Favored 'General case' 0 C--N 1.368 1.392 0 N-CA-C 102.393 -3.188 . . . . 0.0 102.393 171.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.563 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -138.39 151.03 47.12 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 120.501 3.519 . . . . 0.0 120.501 -165.203 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.11 124.51 34.93 Favored 'General case' 0 C--N 1.368 1.391 0 C-N-CA 128.776 2.83 . . . . 0.0 106.908 172.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.494 ' HB2' HG13 ' A' ' 115' ' ' ILE . 8.8 m95 -113.2 147.62 37.09 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 125.344 1.457 . . . . 0.0 113.76 -177.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.14 169.63 17.5 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 166.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.8 ptmm? -140.74 107.43 5.35 Favored 'General case' 0 N--CA 1.42 -1.97 0 O-C-N 119.92 -1.738 . . . . 0.0 108.087 173.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.446 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.205 1.7 t70 34.23 52.25 0.49 Allowed 'General case' 0 C--N 1.373 1.605 1 N-CA-C 123.649 4.685 . . . . 0.0 123.649 141.859 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.14 -5.98 84.11 Favored Glycine 0 C--N 1.367 2.271 2 O-C-N 132.724 6.265 . . . . 0.0 119.712 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.405 ' HB2' ' NZ ' ' A' ' 110' ' ' LYS 0.359 2.2 m -124.05 149.37 60.03 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 130.468 3.507 . . . . 0.0 118.115 -171.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.09 158.6 38.39 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 124.221 3.281 . . . . 0.0 115.161 164.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.1 OUTLIER -108.94 155.95 39.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 120.04 -1.662 . . . . 0.0 110.255 177.345 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -69.06 84.37 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.216 3.944 . . . . 0.0 115.837 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.6 t70 80.13 -54.18 0.37 Allowed 'General case' 0 C--N 1.366 1.312 0 C-N-CA 129.302 3.041 . . . . 0.0 113.131 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 88.51 -163.52 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 130.405 3.482 . . . . 0.0 110.878 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.06 4.91 5.04 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.95 -31.95 6.07 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 120.651 3.02 . . . . 0.0 120.651 -163.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.279 . . 91.52 -52.91 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 127.684 2.393 . . . . 0.0 111.317 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.319 12.1 t -140.33 97.44 3.22 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 123.022 1.392 . . . . 0.0 109.561 177.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.27 2.5 p90 -126.69 140.25 52.54 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 128.03 2.532 . . . . 0.0 111.374 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.8 m -129.58 140.26 51.26 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 119.804 -1.81 . . . . 0.0 112.802 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.45 ' HE2' ' HA ' ' A' ' 125' ' ' LYS 0.313 0.7 OUTLIER -108.73 111.99 60.69 Favored Pre-proline 0 C--N 1.373 1.609 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 168.183 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -77.65 -17.3 14.32 Favored 'Trans proline' 0 CA--C 1.538 0.681 1 C-N-CA 126.373 4.715 . . . . 0.0 113.503 171.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.62 HG23 ' HA2' ' A' ' 88' ' ' GLY . 61.5 m -157.79 107.05 2.1 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 103.277 -2.861 . . . . 0.0 103.277 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.555 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -94.33 134.79 36.44 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.234 2.213 . . . . 0.0 113.822 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.07 172.2 11.45 Favored 'General case' 0 C--N 1.371 1.505 0 C-N-CA 128.444 2.697 . . . . 0.0 110.47 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.62 -45.81 28.0 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 119.817 3.265 . . . . 0.0 119.817 -171.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -62.75 -17.66 61.31 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 127.833 2.453 . . . . 0.0 114.977 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.555 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 44.0 m-20 -79.55 -14.89 58.54 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 128.146 2.578 . . . . 0.0 112.713 170.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.4 ' HB2' ' H ' ' A' ' 157' ' ' VAL . . . -71.24 129.48 38.99 Favored 'General case' 0 C--N 1.389 2.325 1 N-CA-C 122.339 4.2 . . . . 0.0 122.339 172.379 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.73 -135.91 5.37 Favored Glycine 0 C--N 1.374 2.652 0 C-N-CA 130.314 3.816 . . . . 0.0 109.253 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.45 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 19.7 m -129.78 140.25 51.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 115.853 -2.339 . . . . 0.0 110.679 173.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.581 ' CZ ' ' HD2' ' A' ' 110' ' ' LYS . 43.2 m-85 -97.03 134.75 39.98 Favored 'General case' 0 C--N 1.366 1.323 0 C-N-CA 127.09 2.156 . . . . 0.0 113.016 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -142.45 141.54 32.21 Favored 'General case' 0 C--N 1.368 1.398 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -174.234 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.644 HG13 ' OG ' ' A' ' 150' ' ' SER 0.36 2.2 p -133.75 134.63 56.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -175.439 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.94 107.81 19.01 Favored 'General case' 0 C--N 1.377 1.773 0 C-N-CA 130.345 3.458 . . . . 0.0 106.541 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -121.62 118.67 56.58 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 C-N-CA 128.243 2.617 . . . . 0.0 112.49 -168.106 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.418 HG23 ' C ' ' A' ' 146' ' ' VAL . 4.2 m -103.57 132.81 49.51 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 119.318 -2.114 . . . . 0.0 114.391 -177.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.449 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.327 24.4 p-10 -128.39 -178.96 4.77 Favored 'General case' 0 C--N 1.378 1.816 0 CA-C-N 120.321 1.419 . . . . 0.0 111.52 175.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.475 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 13.3 p -49.23 3.22 0.01 OUTLIER 'General case' 0 C--N 1.372 1.562 1 C-N-CA 136.515 5.926 . . . . 0.0 120.332 -169.26 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -101.01 4.78 42.7 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.618 162.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.439 0.7 OUTLIER 64.96 39.63 5.68 Favored 'General case' 0 C--N 1.372 1.569 1 C-N-CA 134.024 4.93 . . . . 0.0 111.635 -174.625 . . . . . . . . 4 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.418 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.19 133.7 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 CA-C-N 111.213 -2.721 . . . . 0.0 111.885 -170.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.84 125.78 35.83 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 127.65 2.38 . . . . 0.0 106.87 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.8 158.78 22.37 Favored 'General case' 0 CA--C 1.486 -1.481 0 C-N-CA 129.267 3.027 . . . . 0.0 103.123 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -126.47 135.33 51.22 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 123.836 1.779 . . . . 0.0 109.605 -174.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.644 ' OG ' HG13 ' A' ' 138' ' ' VAL 0.283 2.8 p -121.96 146.51 47.07 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.001 -1.908 . . . . 0.0 109.952 -176.19 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 m -54.14 147.1 13.53 Favored 'General case' 0 CA--C 1.481 -1.682 1 C-N-CA 136.91 6.084 . . . . 0.0 118.273 -158.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.7 p -69.47 110.67 4.86 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.677 2.391 . . . . 0.0 110.549 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 109.77 21.94 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -98.22 113.44 25.37 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-O 123.844 1.783 . . . . 0.0 112.837 -173.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.18 128.35 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 O-C-N 119.187 -2.196 . . . . 0.0 109.511 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.2 m -110.81 121.62 45.8 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 103.795 -2.669 . . . . 0.0 103.795 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 5.4 m -134.3 102.99 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 173.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.92 150.25 39.53 Favored Pre-proline 0 C--N 1.348 0.531 0 O-C-N 120.168 -1.582 . . . . 0.0 108.681 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.23 166.4 27.07 Favored 'Trans proline' 0 C--N 1.357 0.978 1 C-N-CA 126.61 4.874 . . . . 0.0 109.393 161.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.47 134.14 50.81 Favored 'General case' 0 C--N 1.367 1.333 0 O-C-N 119.264 -2.148 . . . . 0.0 108.31 -176.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.451 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 58.5 t -66.47 109.36 3.26 Favored Pre-proline 0 C--N 1.362 1.143 0 N-CA-C 121.546 3.906 . . . . 0.0 121.546 -123.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 56.6 Cg_endo -63.11 148.76 92.97 Favored 'Trans proline' 0 C--N 1.385 2.49 1 C-N-CA 125.951 4.434 . . . . 0.0 114.194 169.323 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.39 50.93 1.73 Allowed Glycine 0 C--N 1.365 2.157 0 C-N-CA 126.545 2.021 . . . . 0.0 117.11 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -86.67 -19.89 55.35 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 128.567 2.984 . . . . 0.0 113.184 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.84 -6.45 23.56 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 128.093 2.557 . . . . 0.0 109.336 175.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . 0.307 24.2 mt-10 64.87 -51.53 0.33 Allowed 'General case' 0 C--N 1.361 1.102 0 C-N-CA 131.26 3.824 . . . . 0.0 117.01 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 74.5 t60 . . . . . 0 C--N 1.352 0.716 0 C-N-CA 127.123 2.169 . . . . 0.0 109.168 178.1 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.994 0 CA-C-O 121.393 0.616 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.9 tp -107.25 145.92 32.1 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 126.727 2.011 . . . . 0.0 107.479 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.516 ' HA ' ' HB2' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -94.4 138.42 32.37 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 173.04 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -97.96 99.13 10.4 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 173.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t 64.41 -76.03 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 119.563 -1.96 . . . . 0.0 111.824 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -133.75 115.06 14.1 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.261 2.624 . . . . 0.0 105.0 159.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' HB2' ' HA ' ' A' ' 74' ' ' THR 0.359 56.9 t0 -86.64 137.9 32.11 Favored 'General case' 0 C--N 1.371 1.527 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 165.201 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.621 ' O ' HG22 ' A' ' 92' ' ' THR . 0.1 OUTLIER -72.71 -36.29 67.78 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-N 122.503 2.41 . . . . 0.0 116.939 -171.643 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -172.61 172.41 4.26 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 117.279 -3.388 . . . . 0.0 104.499 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.46 -48.33 1.69 Allowed 'General case' 0 C--N 1.355 0.844 0 C-N-CA 126.844 2.057 . . . . 0.0 112.061 175.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.2 t -173.68 138.07 0.64 Allowed 'General case' 0 C--N 1.362 1.117 0 O-C-N 119.36 -2.087 . . . . 0.0 115.088 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.3 ttt -141.03 116.56 10.18 Favored 'General case' 0 C--N 1.377 1.78 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 158.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.5 p -109.45 116.18 31.32 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 119.409 -2.057 . . . . 0.0 109.432 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.52 172.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.794 0 C-N-CA 126.327 1.851 . . . . 0.0 110.174 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.86 133.8 35.65 Favored 'General case' 0 C--N 1.371 1.505 0 O-C-N 119.424 -2.048 . . . . 0.0 106.561 163.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.288 9.5 pt-20 -42.55 122.41 2.27 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 120.232 3.419 . . . . 0.0 120.232 -156.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.455 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 140.37 46.09 0.06 OUTLIER Glycine 0 C--N 1.361 1.954 0 CA-C-N 110.312 -3.131 . . . . 0.0 110.979 -164.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.38 167.12 16.79 Favored 'General case' 0 C--N 1.375 1.69 0 C-N-CA 125.222 1.409 . . . . 0.0 112.984 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.31 105.8 14.19 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.419 1.087 . . . . 0.0 110.578 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.31 121.51 42.21 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.464 1.506 . . . . 0.0 113.418 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -105.08 131.04 53.09 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 102.221 -3.251 . . . . 0.0 102.221 172.084 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.65 HD11 ' CD2' ' A' ' 136' ' ' TYR . 4.2 mm? -120.2 113.57 20.63 Favored 'General case' 0 C--N 1.352 0.682 1 N-CA-C 98.967 -4.457 . . . . 0.0 98.967 170.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.6 m -153.67 132.79 12.59 Favored 'General case' 0 C--N 1.365 1.269 0 CA-C-N 121.093 1.769 . . . . 0.0 109.8 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.7 m -149.22 174.64 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 130.893 3.677 . . . . 0.0 104.104 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -103.89 139.65 38.78 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 128.25 2.62 . . . . 0.0 105.254 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.58 144.26 34.14 Favored 'General case' 0 C--N 1.381 1.964 1 N-CA-C 123.91 4.781 . . . . 0.0 123.91 -174.83 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.7 p -156.71 175.62 13.82 Favored 'General case' 0 C--N 1.364 1.212 1 C-N-CA 133.812 4.845 . . . . 0.0 104.288 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.54 40.0 0.76 Allowed Glycine 0 C--N 1.366 2.233 0 O-C-N 119.992 -1.693 . . . . 0.0 117.243 168.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.28 29.46 27.72 Favored Glycine 0 C--N 1.362 2.0 0 C-N-CA 128.199 2.809 . . . . 0.0 115.419 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.7 m -117.94 110.6 17.92 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 115.178 -2.344 . . . . 0.0 109.008 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.517 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 77.59 -87.08 1.03 Allowed Glycine 0 C--N 1.377 2.822 0 C-N-CA 129.402 3.382 . . . . 0.0 109.655 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.93 168.65 5.53 Favored 'Trans proline' 0 CA--C 1.566 2.09 1 C-N-CA 126.628 4.885 . . . . 0.0 115.143 157.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.491 ' HB3' HG12 ' A' ' 140' ' ' VAL . 67.8 m-85 -103.98 146.59 28.47 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 -166.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -102.64 140.01 37.48 Favored 'General case' 0 C--N 1.373 1.619 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.421 ' CD2' ' N ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -122.37 157.51 31.67 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 119.862 3.282 . . . . 0.0 119.862 -164.118 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -131.02 119.59 22.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 110.391 -3.095 . . . . 0.0 104.273 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.435 ' CE3' HG21 ' A' ' 138' ' ' VAL . 38.1 m95 -111.01 128.54 55.88 Favored 'General case' 0 C--N 1.379 1.87 0 CA-C-N 119.606 1.094 . . . . 0.0 111.235 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.328 0.2 OUTLIER -143.58 170.83 15.08 Favored 'General case' 0 C--N 1.377 1.779 0 CA-C-N 121.462 1.937 . . . . 0.0 108.145 170.539 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -151.0 107.3 3.47 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 120.138 -1.601 . . . . 0.0 108.843 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.477 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.268 1.3 t70 34.25 52.42 0.5 Allowed 'General case' 0 CA--C 1.467 -2.249 2 N-CA-C 122.477 4.251 . . . . 0.0 122.477 142.186 . . . . . . . . 4 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.44 2.2 83.81 Favored Glycine 0 C--N 1.373 2.637 2 O-C-N 133.935 7.022 . . . . 0.0 118.266 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.265 3.2 m -125.06 147.1 55.85 Favored Pre-proline 0 C--N 1.349 0.553 0 C-N-CA 127.672 2.389 . . . . 0.0 116.853 -172.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.63 152.37 78.3 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 124.697 3.598 . . . . 0.0 113.842 170.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -103.76 148.83 36.42 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 120.06 -1.65 . . . . 0.0 108.296 175.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -62.61 -78.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.996 3.797 . . . . 0.0 119.384 -166.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -125.42 63.65 1.18 Allowed 'General case' 0 C--N 1.349 0.548 0 C-N-CA 124.673 1.189 . . . . 0.0 108.387 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.418 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -63.66 150.5 44.13 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 119.386 3.106 . . . . 0.0 119.386 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 81.16 75.94 0.03 OUTLIER 'General case' 0 C--N 1.363 1.193 0 C-N-CA 125.266 1.426 . . . . 0.0 111.987 175.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -165.24 -46.85 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 117.908 1.923 . . . . 0.0 117.908 -172.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.334 . . 135.65 -68.96 0.0 OUTLIER 'General case' 0 C--N 1.351 0.67 0 C-N-CA 128.174 2.59 . . . . 0.0 108.01 -178.176 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.256 9.0 t -138.33 115.93 11.34 Favored 'General case' 0 C--N 1.359 0.978 0 CA-C-N 120.61 1.55 . . . . 0.0 114.467 -174.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.302 4.3 p90 -127.77 140.69 51.89 Favored 'General case' 0 C--N 1.368 1.402 0 C-N-CA 129.458 3.103 . . . . 0.0 110.957 175.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.4 m -129.81 140.22 51.07 Favored 'General case' 0 C--N 1.358 0.951 0 O-C-N 118.344 -2.722 . . . . 0.0 110.368 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.37 96.42 35.61 Favored Pre-proline 0 C--N 1.367 1.355 0 C-N-CA 128.399 2.68 . . . . 0.0 106.982 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -77.38 -14.64 16.22 Favored 'Trans proline' 0 C--N 1.359 1.127 1 C-N-CA 126.946 5.097 . . . . 0.0 114.502 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.455 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -161.97 105.79 1.2 Allowed 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 176.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -94.28 133.95 37.27 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.173 2.189 . . . . 0.0 112.772 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.5 177.97 7.24 Favored 'General case' 0 C--N 1.371 1.518 0 C-N-CA 128.191 2.596 . . . . 0.0 111.066 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.05 -48.6 33.11 Favored 'General case' 0 C--N 1.364 1.22 0 N-CA-C 118.955 2.946 . . . . 0.0 118.955 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.44 -14.18 62.7 Favored 'General case' 0 C--N 1.366 1.296 0 C-N-CA 126.696 1.999 . . . . 0.0 114.573 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.479 ' CB ' ' HB1' ' A' ' 128' ' ' ALA 0.332 31.5 m-20 -82.58 -14.28 55.11 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 130.354 3.462 . . . . 0.0 111.48 170.854 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.52 ' HB2' ' H ' ' A' ' 157' ' ' VAL . . . -74.79 133.86 41.88 Favored 'General case' 0 C--N 1.383 2.059 0 N-CA-C 118.09 2.626 . . . . 0.0 118.09 165.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.9 -158.92 31.6 Favored Glycine 0 C--N 1.37 2.421 0 C-N-CA 126.793 2.139 . . . . 0.0 109.492 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.268 11.0 t -117.74 135.94 53.7 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 114.612 -2.835 . . . . 0.0 106.879 169.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.65 ' CD2' HD11 ' A' ' 93' ' ' LEU 0.26 13.7 m-85 -97.4 134.49 40.59 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 127.072 2.149 . . . . 0.0 112.342 -173.305 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.587 ' HE2' HG22 ' A' ' 152' ' ' THR . 0.0 OUTLIER -143.63 153.96 43.05 Favored 'General case' 0 C--N 1.365 1.282 0 CA-C-O 123.231 1.491 . . . . 0.0 108.851 -174.399 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.638 HG13 HG22 ' A' ' 140' ' ' VAL . 1.1 t -143.62 148.15 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 117.388 -1.725 . . . . 0.0 114.672 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -120.29 120.8 37.12 Favored 'General case' 0 C--N 1.381 1.96 0 C-N-CA 126.127 1.771 . . . . 0.0 106.308 171.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.638 HG22 HG13 ' A' ' 138' ' ' VAL . 0.1 OUTLIER -131.91 123.56 51.61 Favored 'Isoleucine or valine' 0 C--N 1.367 1.341 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -176.27 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.408 HG23 ' C ' ' A' ' 146' ' ' VAL . 3.6 m -106.63 133.62 51.03 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 119.366 -2.084 . . . . 0.0 114.625 -176.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.476 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.37 18.9 p-10 -127.85 -179.05 4.75 Favored 'General case' 0 C--N 1.38 1.929 0 CA-C-N 119.962 1.256 . . . . 0.0 112.064 175.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.517 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 8.0 p -49.17 1.33 0.01 OUTLIER 'General case' 0 C--N 1.375 1.713 1 C-N-CA 136.593 5.957 . . . . 0.0 119.964 -167.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -101.29 4.81 42.03 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 118.502 -1.279 . . . . 0.0 108.271 164.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.462 1.3 tp60 64.83 39.69 5.94 Favored 'General case' 0 C--N 1.371 1.502 1 C-N-CA 134.582 5.153 . . . . 0.0 111.569 -173.6 . . . . . . . . 3 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.408 ' C ' HG23 ' A' ' 141' ' ' THR . 3.4 m -112.88 131.45 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 CA-C-N 111.54 -2.573 . . . . 0.0 111.632 -169.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.64 128.72 38.59 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.249 1.82 . . . . 0.0 108.425 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 147.13 41.68 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 101.246 -3.613 . . . . 0.0 101.246 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -130.36 147.09 52.03 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 119.43 -2.043 . . . . 0.0 107.051 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 54.2 p -116.94 151.96 35.56 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 120.822 -1.174 . . . . 0.0 113.273 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.3 148.04 15.61 Favored 'General case' 0 C--N 1.375 1.677 1 C-N-CA 136.782 6.033 . . . . 0.0 116.153 -172.019 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.587 HG22 ' HE2' ' A' ' 137' ' ' LYS . 6.1 p -68.1 111.63 4.59 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 127.034 2.134 . . . . 0.0 111.417 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 1.8 m -97.06 108.45 21.19 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 102.461 -3.163 . . . . 0.0 102.461 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.73 106.81 18.75 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-O 124.704 2.192 . . . . 0.0 109.195 -172.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.46 127.79 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 O-C-N 120.309 -1.494 . . . . 0.0 107.421 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 92.6 m -115.8 122.16 44.59 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.52 ' H ' ' HB2' ' A' ' 133' ' ' ALA . 4.2 m -134.99 103.89 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.55 152.93 40.84 Favored Pre-proline 0 C--N 1.352 0.692 0 C-N-CA 125.469 1.507 . . . . 0.0 108.366 177.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -66.79 165.64 25.08 Favored 'Trans proline' 0 C--N 1.368 1.587 1 C-N-CA 127.102 5.201 . . . . 0.0 110.094 162.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.7 p -67.62 130.87 44.37 Favored 'General case' 0 C--N 1.369 1.446 0 O-C-N 119.559 -1.963 . . . . 0.0 109.264 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.4 111.77 8.28 Favored Pre-proline 0 CA--C 1.552 1.051 1 N-CA-C 122.976 4.435 . . . . 0.0 122.976 -121.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.69 153.72 70.22 Favored 'Trans proline' 0 C--N 1.385 2.465 1 C-N-CA 126.007 4.471 . . . . 0.0 114.934 170.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.13 59.68 1.84 Allowed Glycine 0 C--N 1.366 2.213 0 C-N-CA 126.491 1.996 . . . . 0.0 116.615 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.32 19.27 5.41 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 126.483 1.992 . . . . 0.0 111.659 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.8 mt -92.07 -24.44 19.16 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 125.065 1.346 . . . . 0.0 109.973 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . 0.27 45.9 mm-40 64.89 -50.32 0.33 Allowed 'General case' 0 C--N 1.362 1.127 0 C-N-CA 130.756 3.622 . . . . 0.0 116.473 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 78.4 t60 . . . . . 0 C--N 1.357 0.935 0 C-N-CA 128.68 2.792 . . . . 0.0 114.844 175.729 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.146 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.8 tp -86.99 133.7 33.56 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-O 123.548 1.642 . . . . 0.0 111.041 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . 0.251 1.2 t -94.55 170.41 9.49 Favored 'General case' 0 N--CA 1.418 -2.074 0 C-N-CA 127.038 2.135 . . . . 0.0 110.524 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.408 HD23 ' H ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -93.3 98.67 11.4 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 175.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 t 61.78 -80.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 119.724 -1.86 . . . . 0.0 112.111 -168.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -134.02 140.38 46.65 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.435 3.094 . . . . 0.0 107.029 162.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.362 0.3 OUTLIER -82.76 174.47 10.94 Favored 'General case' 0 C--N 1.351 0.65 1 C-N-CA 132.917 4.487 . . . . 0.0 108.834 175.419 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -70.03 -34.55 73.41 Favored 'General case' 0 CA--C 1.575 1.906 0 O-C-N 120.517 -1.364 . . . . 0.0 112.027 176.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.5 m -161.88 173.0 15.14 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 117.221 -3.424 . . . . 0.0 103.652 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.98 -47.15 0.59 Allowed 'General case' 0 C--N 1.365 1.275 0 C-N-CA 127.834 2.454 . . . . 0.0 115.468 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.7 p -172.36 116.25 0.34 Allowed 'General case' 0 C--N 1.368 1.385 0 N-CA-C 120.479 3.511 . . . . 0.0 120.479 -172.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.1 ttt -127.06 126.44 43.06 Favored 'General case' 0 C--N 1.38 1.905 0 CA-C-N 121.843 2.11 . . . . 0.0 114.267 165.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -105.5 116.44 31.94 Favored 'General case' 0 C--N 1.373 1.601 0 O-C-N 119.568 -1.957 . . . . 0.0 108.506 174.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.01 172.94 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.639 0 CA-C-O 122.714 1.245 . . . . 0.0 114.251 -169.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -86.1 123.99 32.02 Favored 'General case' 0 C--N 1.368 1.404 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 161.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -42.07 122.31 2.08 Favored 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 124.239 3.199 . . . . 0.0 118.234 -155.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.45 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 143.53 54.23 0.03 OUTLIER Glycine 0 C--N 1.356 1.672 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.636 -162.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.38 166.34 14.33 Favored 'General case' 0 C--N 1.363 1.152 0 C-N-CA 125.099 1.36 . . . . 0.0 112.143 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.9 111.16 22.1 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.166 0.986 . . . . 0.0 108.744 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 124' ' ' THR . 6.0 mp -119.75 116.01 25.06 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 125.854 1.662 . . . . 0.0 113.774 -173.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.93 125.09 52.47 Favored 'General case' 0 C--N 1.364 1.219 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 173.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -121.24 113.61 20.2 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 101.412 -3.551 . . . . 0.0 101.412 171.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.8 m -147.92 133.38 18.66 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 119.753 -1.842 . . . . 0.0 111.387 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.13 175.48 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 130.258 3.423 . . . . 0.0 104.364 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 t -104.13 139.26 39.44 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 128.066 2.547 . . . . 0.0 105.69 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.76 147.48 37.41 Favored 'General case' 0 C--N 1.381 1.943 1 N-CA-C 123.885 4.772 . . . . 0.0 123.885 -175.053 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.4 p -157.04 176.06 13.26 Favored 'General case' 0 C--N 1.361 1.096 1 C-N-CA 133.999 4.92 . . . . 0.0 103.701 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.72 41.63 0.69 Allowed Glycine 0 C--N 1.367 2.288 0 N-CA-C 117.2 1.64 . . . . 0.0 117.2 167.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.1 29.0 35.25 Favored Glycine 0 C--N 1.361 1.936 0 C-N-CA 128.526 2.965 . . . . 0.0 115.476 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.5 p -117.02 110.15 17.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 114.334 -2.746 . . . . 0.0 108.598 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.603 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.09 -88.66 0.78 Allowed Glycine 0 C--N 1.38 3.003 0 C-N-CA 129.677 3.513 . . . . 0.0 110.022 -174.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.97 169.1 5.03 Favored 'Trans proline' 0 CA--C 1.571 2.335 1 C-N-CA 127.223 5.282 . . . . 0.0 116.139 158.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.578 ' HB3' HG12 ' A' ' 140' ' ' VAL . 57.3 m-85 -101.09 143.18 31.52 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 120.616 3.561 . . . . 0.0 120.616 -166.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -102.86 141.21 36.06 Favored 'General case' 0 C--N 1.379 1.876 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.53 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -134.95 156.32 49.21 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 121.015 3.709 . . . . 0.0 121.015 -163.414 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -136.33 111.85 9.28 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 112.295 -2.23 . . . . 0.0 105.121 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.516 ' HB2' HG13 ' A' ' 115' ' ' ILE . 24.7 m95 -112.8 150.0 32.27 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.473 1.509 . . . . 0.0 108.68 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.295 0.1 OUTLIER -156.28 160.5 39.81 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 164.174 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.512 ' CB ' ' HA ' ' A' ' 136' ' ' TYR . 1.8 pptp? -133.93 104.98 6.51 Favored 'General case' 0 C--N 1.368 1.39 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.51 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.243 2.7 t70 37.45 55.17 1.42 Allowed 'General case' 0 CA--C 1.458 -2.585 1 CA-C-O 110.337 -4.649 . . . . 0.0 120.289 155.349 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.97 -10.15 65.89 Favored Glycine 0 C--N 1.376 2.786 2 O-C-N 134.632 7.457 . . . . 0.0 115.716 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -124.68 148.86 60.45 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 129.995 3.318 . . . . 0.0 119.495 -165.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.25 43.8 Cg_endo -60.04 156.98 36.29 Favored 'Trans proline' 0 N--CA 1.5 1.909 1 C-N-CA 125.777 4.318 . . . . 0.0 116.865 167.782 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -112.13 150.02 41.81 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 119.408 -2.057 . . . . 0.0 111.301 175.683 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.77 -81.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.09 1 C-N-CA 127.966 5.777 . . . . 0.0 119.516 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -100.58 -42.1 6.68 Favored 'General case' 0 C--N 1.359 1.02 0 C-N-CA 125.461 1.504 . . . . 0.0 111.369 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.447 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . 71.51 -68.93 0.2 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 129.045 2.938 . . . . 0.0 118.155 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.302 8.3 t -75.8 52.77 0.7 Allowed 'General case' 0 N--CA 1.418 -2.051 1 C-N-CA 134.517 5.127 . . . . 0.0 115.544 -169.81 . . . . . . . . 3 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.07 -60.81 0.01 OUTLIER Glycine 0 CA--C 1.476 -2.359 0 N-CA-C 119.152 2.421 . . . . 0.0 119.152 -173.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 150.49 -62.68 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -174.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.6 t -136.68 117.24 13.84 Favored 'General case' 0 C--N 1.359 0.991 0 O-C-N 120.39 -1.444 . . . . 0.0 113.003 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -127.48 138.12 52.86 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.786 2.034 . . . . 0.0 110.751 172.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 91' ' ' LEU . 27.1 m -129.98 139.46 51.06 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 119.851 -1.781 . . . . 0.0 109.583 177.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.25 106.8 54.38 Favored Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 127.799 2.439 . . . . 0.0 106.095 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.95 -11.9 17.92 Favored 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.459 4.106 . . . . 0.0 112.738 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.45 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -161.24 111.88 1.72 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.25 126.91 45.17 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.98 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.06 -179.31 5.65 Favored 'General case' 0 C--N 1.365 1.281 0 C-N-CA 128.746 2.818 . . . . 0.0 108.584 171.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.6 -53.77 13.72 Favored 'General case' 0 C--N 1.367 1.332 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -69.2 0.14 5.23 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 127.913 2.485 . . . . 0.0 115.304 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -116.23 -7.46 11.8 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 131.423 3.889 . . . . 0.0 110.344 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.54 160.18 14.45 Favored 'General case' 0 C--N 1.397 2.643 0 N-CA-C 120.575 3.546 . . . . 0.0 120.575 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.64 -152.72 24.07 Favored Glycine 0 CA--C 1.465 -3.033 0 C-N-CA 127.643 2.544 . . . . 0.0 107.11 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.315 19.4 m -118.12 136.52 53.54 Favored 'General case' 0 N--CA 1.507 2.384 0 C-N-CA 114.001 -3.08 . . . . 0.0 109.881 171.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.512 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 14.9 m-85 -96.73 133.65 41.02 Favored 'General case' 0 C--N 1.368 1.391 0 CA-C-N 123.136 2.698 . . . . 0.0 115.283 -171.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.51 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -141.16 146.38 36.93 Favored 'General case' 0 C--N 1.373 1.596 0 CA-C-O 121.132 0.492 . . . . 0.0 110.393 -175.569 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 108' ' ' TRP . 15.0 p -141.53 143.49 27.39 Favored 'Isoleucine or valine' 0 C--N 1.372 1.564 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.8 m -107.67 120.39 42.11 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 130.341 3.457 . . . . 0.0 107.14 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -131.54 120.23 44.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 C-N-CA 125.975 1.71 . . . . 0.0 110.752 -173.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -106.88 132.02 53.3 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.475 -1.391 . . . . 0.0 114.522 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.451 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.36 37.3 p-10 -125.93 179.35 5.25 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 119.578 1.081 . . . . 0.0 112.28 175.211 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.603 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 25.4 p -49.62 3.22 0.01 OUTLIER 'General case' 0 C--N 1.372 1.569 1 C-N-CA 135.384 5.474 . . . . 0.0 120.775 -168.906 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -101.96 4.75 40.32 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 165.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.494 0.7 OUTLIER 65.72 40.04 4.54 Favored 'General case' 0 C--N 1.37 1.482 1 C-N-CA 133.653 4.781 . . . . 0.0 111.899 -174.342 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.68 124.49 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.649 0 CA-C-N 111.36 -2.655 . . . . 0.0 112.185 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.63 123.72 35.25 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 127.623 2.369 . . . . 0.0 106.404 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.71 153.38 31.47 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 101.809 -3.404 . . . . 0.0 101.809 -175.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -130.4 146.54 51.98 Favored 'General case' 0 CA--C 1.494 -1.204 0 O-C-N 120.958 -1.089 . . . . 0.0 109.688 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.323 84.2 p -130.6 145.29 51.86 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.0 m -55.0 147.91 14.66 Favored 'General case' 0 C--N 1.376 1.734 1 C-N-CA 137.06 6.144 . . . . 0.0 117.725 -165.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 136' ' ' TYR . 70.5 p -67.34 110.22 3.46 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 128.528 2.731 . . . . 0.0 111.075 -173.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.74 108.19 20.2 Favored 'General case' 0 C--N 1.372 1.557 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.85 110.33 22.53 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 123.242 1.496 . . . . 0.0 112.654 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.61 114.88 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.251 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . 0.294 0.6 OUTLIER -119.21 131.79 55.87 Favored 'General case' 0 C--N 1.368 1.371 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.5 m -123.04 115.29 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-O 123.482 1.611 . . . . 0.0 112.366 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -87.6 154.27 53.39 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.818 1.247 . . . . 0.0 108.719 174.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.36 166.64 29.17 Favored 'Trans proline' 0 C--N 1.361 1.19 1 C-N-CA 127.531 5.487 . . . . 0.0 107.15 153.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 18.7 p -66.7 131.2 45.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 118.025 -2.922 . . . . 0.0 110.293 -171.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.67 111.68 6.86 Favored Pre-proline 0 C--N 1.361 1.095 0 N-CA-C 120.814 3.635 . . . . 0.0 120.814 -128.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.35 154.48 63.42 Favored 'Trans proline' 0 C--N 1.381 2.289 1 C-N-CA 126.437 4.758 . . . . 0.0 114.658 172.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.81 48.99 0.34 Allowed Glycine 0 C--N 1.368 2.353 0 C-N-CA 128.16 2.79 . . . . 0.0 118.548 -175.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -112.28 35.1 4.83 Favored Glycine 0 C--N 1.353 1.487 0 C-N-CA 128.147 2.784 . . . . 0.0 110.726 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 71.0 mt -121.23 45.0 2.38 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 127.396 2.278 . . . . 0.0 105.814 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -66.97 64.74 0.06 Allowed 'General case' 0 C--N 1.361 1.074 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -173.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 14.6 p80 . . . . . 0 C--N 1.366 1.287 0 C-N-CA 127.562 2.345 . . . . 0.0 115.157 -177.606 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.077 0 CA-C-O 121.499 0.666 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.4 tp -107.51 129.26 54.98 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 126.874 2.07 . . . . 0.0 110.279 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -94.75 173.22 7.71 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 127.454 2.301 . . . . 0.0 109.965 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 75' ' ' LEU 0.352 1.0 OUTLIER -82.3 97.6 8.38 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 123.231 1.491 . . . . 0.0 108.442 175.467 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 t 57.84 -72.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 116.315 -3.991 . . . . 0.0 116.135 -167.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -133.27 137.68 46.14 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 130.535 3.534 . . . . 0.0 109.025 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.48 1.4 m-20 -84.8 134.13 34.32 Favored 'General case' 0 C--N 1.378 1.848 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 168.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.6 ' O ' HG22 ' A' ' 92' ' ' THR . 0.2 OUTLIER -72.76 -35.68 67.51 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 125.056 3.571 . . . . 0.0 112.67 -178.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 81' ' ' ALA . 36.6 m -171.92 171.84 4.96 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 169.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.418 ' N ' HG22 ' A' ' 80' ' ' THR . . . -123.24 -48.08 1.99 Allowed 'General case' 0 C--N 1.368 1.372 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 175.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.5 t -171.68 148.55 2.44 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 119.299 -2.125 . . . . 0.0 113.535 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.49 117.35 6.27 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 124.21 1.004 . . . . 0.0 108.48 166.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.8 t -110.57 115.63 29.95 Favored 'General case' 0 C--N 1.366 1.321 0 O-C-N 118.792 -2.442 . . . . 0.0 107.348 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.25 9.5 p -150.97 174.16 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 125.411 1.484 . . . . 0.0 113.757 -169.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -77.68 132.89 38.4 Favored 'General case' 0 C--N 1.374 1.667 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 159.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.359 0.0 OUTLIER -42.97 122.61 2.48 Favored 'General case' 0 N--CA 1.514 2.763 0 N-CA-C 119.606 3.187 . . . . 0.0 119.606 -161.426 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.479 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 139.84 50.76 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 110.225 -3.171 . . . . 0.0 106.226 -163.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.47 145.91 24.45 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 126.72 2.008 . . . . 0.0 107.469 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.62 121.57 36.32 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 -170.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 124' ' ' THR . 1.1 mm? -120.84 133.82 55.3 Favored 'General case' 0 C--N 1.372 1.583 0 C-N-CA 127.172 2.189 . . . . 0.0 115.956 172.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -123.81 120.36 32.4 Favored 'General case' 0 C--N 1.359 0.986 1 N-CA-C 98.155 -4.757 . . . . 0.0 98.155 165.302 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.4 HD11 ' CD1' ' A' ' 136' ' ' TYR . 1.2 mm? -115.19 115.49 26.8 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 102.018 -3.327 . . . . 0.0 102.018 176.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 4.9 t -154.62 133.29 12.11 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 117.801 -1.559 . . . . 0.0 111.789 -174.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.87 174.35 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.743 0 C-N-CA 130.405 3.482 . . . . 0.0 105.573 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.8 t -104.03 141.53 36.04 Favored 'General case' 0 C--N 1.361 1.077 0 O-C-N 119.487 -2.008 . . . . 0.0 106.578 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.19 145.21 35.36 Favored 'General case' 0 C--N 1.376 1.759 1 N-CA-C 122.989 4.44 . . . . 0.0 122.989 -173.598 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.9 p -156.48 175.28 14.23 Favored 'General case' 0 C--N 1.364 1.223 1 C-N-CA 133.234 4.614 . . . . 0.0 103.36 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.61 41.49 1.0 Allowed Glycine 0 C--N 1.362 2.019 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.36 18.92 54.38 Favored Glycine 0 C--N 1.362 1.982 0 C-N-CA 127.14 2.305 . . . . 0.0 116.121 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.6 m -118.19 111.02 18.28 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 115.039 -2.41 . . . . 0.0 110.185 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.592 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 79.35 -93.05 1.31 Allowed Glycine 0 C--N 1.379 2.961 0 C-N-CA 129.665 3.507 . . . . 0.0 109.221 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.36 168.54 6.29 Favored 'Trans proline' 0 CA--C 1.564 1.998 1 C-N-CA 127.485 5.457 . . . . 0.0 116.316 159.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.585 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.0 m-85 -99.12 148.14 24.36 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 119.804 3.261 . . . . 0.0 119.804 -165.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -110.7 144.69 39.25 Favored 'General case' 0 C--N 1.381 1.938 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.484 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -141.09 165.95 26.14 Favored 'General case' 0 C--N 1.346 0.444 1 N-CA-C 122.345 4.202 . . . . 0.0 122.345 -159.75 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.15 118.49 12.81 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 110.723 -2.944 . . . . 0.0 105.044 172.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -111.79 134.48 53.32 Favored 'General case' 0 C--N 1.366 1.288 0 C-N-CA 125.797 1.639 . . . . 0.0 109.321 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.367 0.2 OUTLIER -155.79 170.01 23.06 Favored 'General case' 0 CA--C 1.488 -1.422 0 O-C-N 120.468 -1.395 . . . . 0.0 107.458 170.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.494 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.6 ptmm? -143.01 106.49 4.6 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 119.52 -1.988 . . . . 0.0 111.555 -177.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.508 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.141 2.0 t70 36.41 54.8 1.07 Allowed 'General case' 0 C--N 1.384 2.084 1 CA-C-O 109.687 -4.959 . . . . 0.0 121.53 149.042 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.33 2.83 80.81 Favored Glycine 0 C--N 1.386 3.319 2 O-C-N 135.353 7.908 . . . . 0.0 119.561 -172.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.274 1.0 OUTLIER -125.23 147.48 57.53 Favored Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 129.39 3.076 . . . . 0.0 117.936 -167.227 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.85 139.39 62.15 Favored 'Trans proline' 0 N--CA 1.504 2.103 1 C-N-CA 126.037 4.492 . . . . 0.0 117.501 169.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.494 HG12 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -91.63 160.02 37.36 Favored Pre-proline 0 CA--C 1.553 1.059 0 O-C-N 118.441 -2.662 . . . . 0.0 112.773 175.433 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 12.3 Cg_endo -72.42 -82.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 124.959 3.773 . . . . 0.0 118.284 -172.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -117.29 60.85 0.75 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.277 1.431 . . . . 0.0 109.643 -171.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.494 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -67.65 151.79 46.69 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 129.085 2.954 . . . . 0.0 117.565 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.464 ' HA ' ' CD2' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 80.54 63.71 0.02 OUTLIER 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.73 1.612 . . . . 0.0 111.015 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.36 -85.56 0.06 OUTLIER Glycine 0 C--N 1.355 1.598 0 N-CA-C 115.474 0.949 . . . . 0.0 115.474 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 165.74 -65.75 0.0 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 126.068 1.747 . . . . 0.0 106.712 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.263 14.8 t -133.03 110.11 10.0 Favored 'General case' 0 C--N 1.36 1.056 0 CA-C-O 122.994 1.378 . . . . 0.0 113.308 -177.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.293 9.4 p90 -127.09 141.12 51.85 Favored 'General case' 0 C--N 1.369 1.448 0 C-N-CA 128.339 2.656 . . . . 0.0 112.474 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 91' ' ' LEU . 25.5 m -128.82 139.7 52.05 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 119.924 -1.735 . . . . 0.0 108.854 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.71 92.19 45.45 Favored Pre-proline 0 C--N 1.354 0.801 0 C-N-CA 128.748 2.819 . . . . 0.0 104.903 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -74.43 -32.89 5.92 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 124.879 3.719 . . . . 0.0 112.854 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.479 HG23 ' HA2' ' A' ' 88' ' ' GLY . 69.0 m -128.38 100.6 5.86 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.67 118.5 31.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.877 1.671 . . . . 0.0 113.111 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.43 -179.06 6.86 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.451 2.301 . . . . 0.0 109.438 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -51.32 23.62 Favored 'General case' 0 C--N 1.366 1.316 0 O-C-N 117.803 -3.06 . . . . 0.0 118.088 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.31 0.86 2.53 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 128.851 2.86 . . . . 0.0 115.111 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -116.36 -13.91 11.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 129.544 3.138 . . . . 0.0 111.102 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.458 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -97.75 154.64 17.46 Favored 'General case' 0 C--N 1.399 2.739 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.46 -157.78 27.36 Favored Glycine 0 C--N 1.382 3.095 0 C-N-CA 128.923 3.154 . . . . 0.0 109.81 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.393 5.7 m -110.66 130.83 55.47 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 112.343 -3.743 . . . . 0.0 107.545 167.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.502 ' HB2' ' HB3' ' A' ' 153' ' ' CYS . 24.5 m-85 -96.81 134.77 39.68 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-N 122.605 2.457 . . . . 0.0 113.011 -172.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -148.5 150.64 33.77 Favored 'General case' 0 C--N 1.376 1.743 0 C-N-CA 124.878 1.271 . . . . 0.0 110.456 -175.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 149' ' ' ASP . 8.9 p -143.67 137.49 24.95 Favored 'Isoleucine or valine' 0 C--N 1.371 1.501 0 C-N-CA 117.956 -1.497 . . . . 0.0 114.314 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.23 111.77 24.65 Favored 'General case' 0 C--N 1.378 1.811 0 C-N-CA 130.34 3.456 . . . . 0.0 105.341 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.585 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -127.21 112.21 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 128.124 2.569 . . . . 0.0 110.73 -169.59 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 8.0 m -99.3 130.93 45.62 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.458 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.364 25.3 p-10 -127.7 -177.03 3.94 Favored 'General case' 0 C--N 1.372 1.584 0 CA-C-N 119.234 0.925 . . . . 0.0 112.213 174.763 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.592 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 20.4 p -49.83 3.36 0.01 OUTLIER 'General case' 0 C--N 1.369 1.414 1 C-N-CA 136.749 6.02 . . . . 0.0 120.501 -169.602 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -101.27 4.89 42.18 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 163.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.358 2.1 mp0 65.44 39.53 5.12 Favored 'General case' 0 C--N 1.378 1.825 1 C-N-CA 134.249 5.02 . . . . 0.0 110.678 -175.149 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.452 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.58 133.4 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 CA-C-N 112.137 -2.302 . . . . 0.0 111.99 -170.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 1.8 t -91.69 132.16 36.57 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 120.744 1.611 . . . . 0.0 106.883 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.13 157.99 23.92 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 -176.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 22.6 t70 -126.11 134.18 51.42 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.814 0.816 . . . . 0.0 109.294 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.528 59.8 p -111.13 143.9 41.12 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.8 m -54.05 146.74 13.97 Favored 'General case' 0 C--N 1.368 1.404 1 C-N-CA 136.709 6.004 . . . . 0.0 119.405 -155.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.0 p -69.06 110.1 4.33 Favored 'General case' 0 C--N 1.376 1.719 0 C-N-CA 124.264 1.026 . . . . 0.0 110.711 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 4.7 t -100.02 110.12 22.43 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.14 103.89 15.86 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 122.758 1.266 . . . . 0.0 112.267 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.2 m -112.43 115.18 49.11 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -113.41 131.58 55.95 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -174.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.458 HG22 ' CB ' ' A' ' 133' ' ' ALA . 13.3 m -132.98 124.31 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 124.53 1.132 . . . . 0.0 111.574 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.88 159.51 29.67 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 125.23 1.412 . . . . 0.0 107.343 166.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.38 167.24 27.48 Favored 'Trans proline' 0 C--N 1.359 1.111 1 C-N-CA 128.656 6.237 . . . . 0.0 110.022 162.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 11.9 p -67.55 127.61 33.35 Favored 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.551 -1.968 . . . . 0.0 108.789 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.75 122.05 78.69 Favored Pre-proline 0 C--N 1.364 1.223 0 N-CA-C 120.856 3.65 . . . . 0.0 120.856 -122.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.18 145.7 96.21 Favored 'Trans proline' 0 C--N 1.388 2.609 1 C-N-CA 126.107 4.538 . . . . 0.0 114.516 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.79 51.3 0.89 Allowed Glycine 0 C--N 1.366 2.206 0 C-N-CA 127.98 2.705 . . . . 0.0 117.921 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -106.67 34.69 5.54 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 127.34 2.4 . . . . 0.0 110.129 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.77 38.57 3.21 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 126.89 2.076 . . . . 0.0 109.836 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -75.46 58.38 1.01 Allowed 'General case' 0 C--N 1.36 1.029 0 C-N-CA 127.135 2.174 . . . . 0.0 115.67 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 . . . . . 0 C--N 1.353 0.72 0 C-N-CA 125.48 1.512 . . . . 0.0 108.012 179.951 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.033 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.7 tp -102.71 127.84 49.68 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 126.639 1.976 . . . . 0.0 110.676 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 t -103.3 173.73 6.18 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 127.829 2.451 . . . . 0.0 108.522 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.289 0.9 OUTLIER -72.61 99.31 2.52 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 110.185 174.099 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.89 -82.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 117.869 -3.02 . . . . 0.0 114.666 -170.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -133.01 140.11 47.58 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 130.713 3.605 . . . . 0.0 105.122 167.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -84.54 172.02 12.0 Favored 'General case' 0 N--CA 1.443 -0.779 1 C-N-CA 135.039 5.336 . . . . 0.0 108.303 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -71.22 -36.81 71.99 Favored 'General case' 0 CA--C 1.575 1.907 0 O-C-N 118.956 -2.34 . . . . 0.0 115.943 -177.096 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -175.93 176.21 1.84 Allowed 'General case' 0 CA--C 1.5 -0.96 1 N-CA-C 97.987 -4.82 . . . . 0.0 97.987 167.545 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.25 -51.24 2.92 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 121.713 2.052 . . . . 0.0 107.862 162.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.0 t -166.67 135.61 2.9 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 119.562 -1.961 . . . . 0.0 114.396 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 ttt -137.79 116.73 12.4 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-O 122.592 1.187 . . . . 0.0 109.388 161.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -108.57 115.22 29.68 Favored 'General case' 0 C--N 1.362 1.133 0 O-C-N 119.023 -2.298 . . . . 0.0 107.972 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.4 p -149.55 173.17 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 127.535 2.334 . . . . 0.0 112.077 -169.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.59 136.27 42.05 Favored 'General case' 0 C--N 1.37 1.484 0 O-C-N 118.739 -2.476 . . . . 0.0 107.175 158.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.28 5.8 pt-20 -43.34 122.08 2.45 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 -162.616 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.56 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 136.19 45.0 0.09 OUTLIER Glycine 0 C--N 1.352 1.43 0 CA-C-N 110.094 -3.23 . . . . 0.0 111.526 -162.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.23 164.57 21.11 Favored 'General case' 0 C--N 1.373 1.604 0 C-N-CA 125.07 1.348 . . . . 0.0 111.383 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.37 101.98 10.65 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 123.072 1.415 . . . . 0.0 113.897 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 1.2 mp -119.71 128.82 54.15 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -175.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.6 t -114.53 135.69 53.85 Favored 'General case' 0 C--N 1.358 0.953 1 N-CA-C 99.422 -4.288 . . . . 0.0 99.422 165.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.01 114.79 23.68 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 100.867 -3.753 . . . . 0.0 100.867 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -150.3 132.65 15.55 Favored 'General case' 0 C--N 1.366 1.321 0 C-N-CA 118.2 -1.4 . . . . 0.0 114.147 -168.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 m -149.59 174.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.943 1 C-N-CA 132.971 4.508 . . . . 0.0 106.198 177.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -104.37 141.52 36.18 Favored 'General case' 0 C--N 1.367 1.368 0 O-C-N 118.948 -2.345 . . . . 0.0 106.669 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.98 135.9 38.04 Favored 'General case' 0 C--N 1.374 1.654 0 N-CA-C 120.986 3.699 . . . . 0.0 120.986 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.0 m -157.69 172.11 19.11 Favored 'General case' 0 C--N 1.359 1.012 1 C-N-CA 131.789 4.035 . . . . 0.0 101.518 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.98 44.12 1.27 Allowed Glycine 0 C--N 1.367 2.301 0 CA-C-N 122.535 2.425 . . . . 0.0 117.381 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.29 25.49 57.1 Favored Glycine 0 C--N 1.355 1.596 0 C-N-CA 128.552 2.977 . . . . 0.0 115.422 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.2 m -117.9 110.96 18.38 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 114.444 -2.693 . . . . 0.0 107.587 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.544 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 78.03 -89.27 1.08 Allowed Glycine 0 C--N 1.376 2.783 0 C-N-CA 130.148 3.737 . . . . 0.0 109.953 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -60.68 167.99 7.55 Favored 'Trans proline' 0 CA--C 1.564 2.01 1 C-N-CA 127.009 5.14 . . . . 0.0 116.258 159.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.588 ' HB3' HG12 ' A' ' 140' ' ' VAL . 82.1 m-85 -102.57 146.58 27.94 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 120.036 3.347 . . . . 0.0 120.036 -166.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 t -105.63 153.83 21.26 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 129.354 3.062 . . . . 0.0 104.083 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.02 164.9 38.25 Favored 'General case' 0 C--N 1.366 1.295 1 N-CA-C 122.231 4.16 . . . . 0.0 122.231 -161.135 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.29 114.63 14.64 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 128.614 2.766 . . . . 0.0 106.258 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -111.02 131.27 55.2 Favored 'General case' 0 C--N 1.368 1.404 0 C-N-CA 127.145 2.178 . . . . 0.0 109.807 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.313 0.0 OUTLIER -151.03 169.54 21.57 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 168.602 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HD3' ' CD1' ' A' ' 136' ' ' TYR . 4.0 ttpt -135.61 107.68 7.17 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.426 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.24 0.8 OUTLIER 33.25 50.83 0.27 Allowed 'General case' 0 C--N 1.374 1.658 1 N-CA-C 123.546 4.647 . . . . 0.0 123.546 135.421 . . . . . . . . 5 4 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.96 -3.54 83.66 Favored Glycine 0 C--N 1.363 2.063 2 O-C-N 132.412 6.07 . . . . 0.0 120.199 -172.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.293 3.4 m -124.02 147.38 53.99 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 129.963 3.305 . . . . 0.0 118.598 -172.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -62.07 140.49 84.47 Favored 'Trans proline' 0 C--N 1.37 1.665 1 C-N-CA 126.215 4.61 . . . . 0.0 115.645 172.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.522 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -88.63 164.87 30.42 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 119.694 -1.879 . . . . 0.0 111.23 175.24 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 90.6 Cg_exo -52.21 -44.62 44.86 Favored 'Trans proline' 0 C--N 1.353 0.793 1 C-N-CA 127.785 5.657 . . . . 0.0 118.72 -171.273 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -169.15 -50.43 0.02 OUTLIER 'General case' 0 C--N 1.348 0.507 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 81.03 -164.17 0.02 OUTLIER 'General case' 0 C--N 1.364 1.204 0 C-N-CA 129.328 3.051 . . . . 0.0 111.401 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t 82.6 3.17 1.14 Allowed 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 119.609 3.189 . . . . 0.0 119.609 170.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.97 85.11 0.06 OUTLIER Glycine 0 CA--C 1.475 -2.467 0 C-N-CA 115.597 -3.192 . . . . 0.0 119.125 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.335 . . 87.47 -78.63 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 163.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.306 6.0 t -141.37 119.95 12.45 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 123.833 1.778 . . . . 0.0 115.153 -170.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -127.3 142.67 51.4 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 129.514 3.126 . . . . 0.0 109.883 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.7 m -126.38 139.0 53.62 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 122.345 2.339 . . . . 0.0 109.678 176.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -119.15 89.31 39.19 Favored Pre-proline 0 C--N 1.37 1.493 0 C-N-CA 129.056 2.942 . . . . 0.0 103.847 176.625 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -73.28 -31.39 9.36 Favored 'Trans proline' 0 N--CA 1.471 0.204 1 C-N-CA 125.512 4.142 . . . . 0.0 112.668 -172.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.56 HG23 ' HA2' ' A' ' 88' ' ' GLY . 55.2 m -143.98 100.53 3.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.693 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -86.93 134.58 33.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.312 1.845 . . . . 0.0 114.443 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.15 171.69 14.59 Favored 'General case' 0 C--N 1.366 1.302 0 C-N-CA 127.436 2.294 . . . . 0.0 112.343 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.1 -43.72 20.65 Favored 'General case' 0 C--N 1.37 1.477 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -172.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.2 -13.32 61.85 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 128.545 2.738 . . . . 0.0 115.07 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.693 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 4.9 m-20 -74.31 -21.08 59.88 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 128.113 2.565 . . . . 0.0 112.239 167.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.17 119.75 9.0 Favored 'General case' 0 C--N 1.386 2.183 0 N-CA-C 120.449 3.5 . . . . 0.0 120.449 172.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.97 -155.13 26.35 Favored Glycine 0 CA--C 1.468 -2.879 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.491 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.316 6.9 m -118.3 132.01 56.31 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 115.397 -2.521 . . . . 0.0 107.214 171.473 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.464 ' CD1' ' HD3' ' A' ' 110' ' ' LYS . 2.5 m-85 -97.06 133.81 41.24 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 125.85 1.66 . . . . 0.0 110.487 -170.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.491 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -145.62 144.5 30.49 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-O 122.091 0.948 . . . . 0.0 109.647 -174.394 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.291 7.5 p -141.8 135.94 30.23 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 117.685 -1.606 . . . . 0.0 114.166 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.8 m -103.08 121.26 42.22 Favored 'General case' 0 C--N 1.38 1.915 0 C-N-CA 129.455 3.102 . . . . 0.0 106.238 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -132.22 120.44 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 127.127 2.171 . . . . 0.0 110.497 -169.501 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.467 HG23 ' C ' ' A' ' 146' ' ' VAL . 14.1 m -107.78 133.35 52.3 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 119.877 -1.764 . . . . 0.0 112.816 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.466 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.373 18.3 p-10 -129.76 -176.55 3.95 Favored 'General case' 0 C--N 1.377 1.77 0 C-N-CA 124.804 1.242 . . . . 0.0 111.929 176.271 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.544 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 8.1 p -49.37 1.5 0.01 OUTLIER 'General case' 0 C--N 1.369 1.437 1 C-N-CA 136.332 5.853 . . . . 0.0 120.519 -167.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -99.75 4.63 45.5 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 118.262 -1.375 . . . . 0.0 107.784 163.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.437 0.8 OUTLIER 65.67 39.77 4.72 Favored 'General case' 0 C--N 1.371 1.508 1 C-N-CA 133.961 4.904 . . . . 0.0 111.623 -174.524 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.467 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.43 131.94 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 CA-C-N 111.023 -2.808 . . . . 0.0 112.394 -169.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.2 124.0 35.07 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 127.856 2.462 . . . . 0.0 107.477 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.36 157.69 24.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 128.798 2.839 . . . . 0.0 103.835 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -128.5 137.34 51.74 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.861 1.21 . . . . 0.0 109.672 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.385 75.1 p -113.55 143.21 44.93 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 125.405 1.482 . . . . 0.0 109.245 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.2 m -54.11 148.47 10.99 Favored 'General case' 0 C--N 1.37 1.492 1 C-N-CA 135.839 5.656 . . . . 0.0 118.887 -159.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 66.6 p -69.09 111.31 4.99 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 127.718 2.407 . . . . 0.0 110.1 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.28 109.85 22.07 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.05 105.99 18.1 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 124.433 2.063 . . . . 0.0 110.372 -174.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.1 m -118.46 128.21 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 14.9 m -119.9 124.07 45.12 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 2.5 m -126.63 103.91 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -82.79 155.71 67.97 Favored Pre-proline 0 C--N 1.358 0.97 0 C-N-CA 126.147 1.779 . . . . 0.0 111.41 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.52 165.41 27.34 Favored 'Trans proline' 0 CA--C 1.544 1.023 1 C-N-CA 125.629 4.219 . . . . 0.0 108.678 155.546 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.53 134.75 51.85 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 118.796 -2.44 . . . . 0.0 110.599 -173.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.452 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 3.8 t -66.64 109.08 2.9 Favored Pre-proline 0 C--N 1.359 0.999 1 N-CA-C 122.001 4.074 . . . . 0.0 122.001 -124.244 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 32.2 Cg_endo -62.5 154.49 64.17 Favored 'Trans proline' 0 C--N 1.386 2.542 1 C-N-CA 126.228 4.619 . . . . 0.0 114.619 171.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.61 49.11 0.45 Allowed Glycine 0 C--N 1.368 2.329 0 C-N-CA 128.259 2.837 . . . . 0.0 118.033 -176.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.38 29.25 10.79 Favored Glycine 0 C--N 1.354 1.574 0 C-N-CA 127.675 2.56 . . . . 0.0 110.602 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 61.9 mt -115.78 46.59 1.49 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 126.982 2.113 . . . . 0.0 107.431 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -71.51 62.56 0.38 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 127.596 2.358 . . . . 0.0 115.75 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--N 1.353 0.727 0 C-N-CA 127.922 2.489 . . . . 0.0 109.693 179.051 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 tp -107.51 141.0 39.62 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.734 1.614 . . . . 0.0 110.544 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.9 t -94.54 173.06 7.81 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 126.187 1.795 . . . . 0.0 110.613 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.363 0.6 OUTLIER -86.99 98.96 11.55 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 127.274 2.23 . . . . 0.0 107.493 171.517 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.49 -76.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 118.553 -2.592 . . . . 0.0 115.575 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -133.33 140.39 47.38 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 129.238 3.015 . . . . 0.0 104.896 166.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.291 5.4 t0 -83.79 174.34 10.52 Favored 'General case' 0 CA--C 1.503 -0.858 1 C-N-CA 133.926 4.89 . . . . 0.0 110.23 178.765 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.521 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 0.5 OUTLIER -70.16 -34.67 73.3 Favored 'General case' 0 CA--C 1.584 2.254 0 O-C-N 121.352 -0.842 . . . . 0.0 113.061 174.262 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -170.8 172.33 5.72 Favored 'General case' 0 N--CA 1.471 0.588 1 O-C-N 114.385 -5.197 . . . . 0.0 101.903 173.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.18 -41.94 0.57 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.588 1.555 . . . . 0.0 111.349 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.1 m -163.73 117.49 1.52 Allowed 'General case' 0 C--N 1.363 1.191 0 N-CA-C 117.754 2.501 . . . . 0.0 117.754 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.4 ttt -137.18 116.57 12.74 Favored 'General case' 0 C--N 1.377 1.791 0 CA-C-N 120.378 1.445 . . . . 0.0 109.079 155.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.1 m -113.25 117.02 30.7 Favored 'General case' 0 C--N 1.365 1.261 0 O-C-N 118.607 -2.558 . . . . 0.0 109.063 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -149.4 172.58 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.937 0 C-N-CA 126.058 1.743 . . . . 0.0 110.156 -170.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.99 130.9 35.19 Favored 'General case' 0 C--N 1.373 1.625 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -41.85 122.34 2.02 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -153.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.484 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 143.61 43.36 0.05 OUTLIER Glycine 0 C--N 1.356 1.662 0 CA-C-N 109.721 -3.399 . . . . 0.0 110.7 -163.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.53 168.02 14.89 Favored 'General case' 0 C--N 1.374 1.67 0 C-N-CA 124.802 1.241 . . . . 0.0 112.543 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.48 99.37 8.15 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.188 0.995 . . . . 0.0 109.595 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.03 111.78 23.38 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 125.494 1.518 . . . . 0.0 113.94 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -105.19 125.5 51.05 Favored 'General case' 0 C--N 1.371 1.534 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.025 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.67 114.87 21.17 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 103.539 -2.763 . . . . 0.0 103.539 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 t -151.14 134.3 16.01 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 120.938 -1.101 . . . . 0.0 112.197 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.03 173.85 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 130.769 3.627 . . . . 0.0 103.703 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -104.16 138.47 40.6 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.3 142.15 33.88 Favored 'General case' 0 C--N 1.366 1.301 0 N-CA-C 120.012 3.338 . . . . 0.0 120.012 -174.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.5 m -158.26 174.33 15.33 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 130.826 3.65 . . . . 0.0 102.178 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.36 44.29 1.64 Allowed Glycine 0 C--N 1.366 2.244 0 O-C-N 118.681 -2.512 . . . . 0.0 117.452 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.24 21.36 65.14 Favored Glycine 0 C--N 1.359 1.838 0 C-N-CA 128.823 3.106 . . . . 0.0 114.749 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 10.1 p -116.55 111.34 19.78 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 126.165 1.786 . . . . 0.0 106.823 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.753 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 70.51 -90.72 0.38 Allowed Glycine 0 C--N 1.364 2.115 0 C-N-CA 130.649 3.976 . . . . 0.0 111.586 -169.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -60.74 168.39 7.05 Favored 'Trans proline' 0 CA--C 1.568 2.184 1 C-N-CA 127.457 5.438 . . . . 0.0 117.289 160.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.619 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.6 m-85 -93.64 142.32 27.49 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 121.317 3.821 . . . . 0.0 121.317 -167.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -102.96 155.13 18.57 Favored 'General case' 0 C--N 1.383 2.025 0 C-N-CA 128.23 2.612 . . . . 0.0 104.905 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 119' ' ' SER . 0.0 OUTLIER -155.59 166.94 32.0 Favored 'General case' 0 C--N 1.362 1.133 1 N-CA-C 122.402 4.223 . . . . 0.0 122.402 -159.375 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.36 114.18 7.65 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-N 112.166 -2.288 . . . . 0.0 107.596 173.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -113.29 155.07 25.78 Favored 'General case' 0 C--N 1.373 1.606 0 O-C-N 119.622 -1.924 . . . . 0.0 110.965 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.0 p -149.06 159.13 44.51 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 167.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' CE ' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -123.5 102.23 7.76 Favored 'General case' 0 C--N 1.377 1.797 0 C-N-CA 114.411 -2.916 . . . . 0.0 112.673 161.601 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.45 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.173 1.6 t70 36.47 54.17 1.06 Allowed 'General case' 0 CA--C 1.458 -2.58 0 CA-C-O 111.972 -3.87 . . . . 0.0 120.526 149.246 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.93 -17.17 42.14 Favored Glycine 0 C--N 1.363 2.055 1 O-C-N 133.193 6.558 . . . . 0.0 116.573 -172.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m -122.73 146.41 47.95 Favored Pre-proline 0 CA--C 1.573 1.854 0 C-N-CA 131.344 3.858 . . . . 0.0 119.876 -170.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.266 65.1 Cg_endo -65.08 136.12 46.73 Favored 'Trans proline' 0 N--CA 1.509 2.43 1 C-N-CA 128.684 6.256 . . . . 0.0 116.334 176.739 . . . . . . . . 3 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.516 ' HB ' ' CD ' ' A' ' 116' ' ' PRO 0.421 0.6 OUTLIER -84.64 164.95 40.32 Favored Pre-proline 0 N--CA 1.485 1.316 2 O-C-N 116.123 -4.111 . . . . 0.0 116.846 179.889 . . . . . . . . 5 4 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.516 ' CD ' ' HB ' ' A' ' 115' ' ' ILE . 2.8 Cg_exo -67.1 80.88 0.37 Allowed 'Trans proline' 0 C--N 1.384 2.446 1 C-N-CA 127.3 5.333 . . . . 0.0 112.571 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 80.29 -62.21 0.25 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 127.874 2.47 . . . . 0.0 110.815 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.469 ' HB2' ' CG1' ' A' ' 115' ' ' ILE . . . 84.94 162.28 0.1 Allowed 'General case' 0 C--N 1.372 1.554 0 C-N-CA 129.207 3.003 . . . . 0.0 111.448 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.47 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.2 OUTLIER 74.03 59.54 0.08 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-O 122.767 1.27 . . . . 0.0 114.127 174.95 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.44 -85.51 0.09 OUTLIER Glycine 0 C--N 1.356 1.648 0 N-CA-C 117.487 1.755 . . . . 0.0 117.487 -170.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.26 . . 160.01 -71.13 0.0 OUTLIER 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.98 1.312 . . . . 0.0 110.437 -177.589 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.1 t -136.09 104.96 5.86 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 122.859 1.314 . . . . 0.0 113.838 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.299 7.8 p90 -128.05 140.97 51.65 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 127.713 2.405 . . . . 0.0 110.563 174.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 70.9 m -129.07 139.27 52.09 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 119.931 -1.73 . . . . 0.0 109.094 177.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.259 1.3 mmmm -105.76 111.67 64.6 Favored Pre-proline 0 C--N 1.372 1.548 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 171.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.21 -16.89 15.33 Favored 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 126.37 4.713 . . . . 0.0 113.339 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.484 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -162.18 101.27 1.1 Allowed 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 177.769 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.549 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.53 134.59 33.82 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.395 2.278 . . . . 0.0 113.167 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.17 176.83 8.51 Favored 'General case' 0 C--N 1.372 1.579 0 C-N-CA 128.351 2.66 . . . . 0.0 112.718 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.73 -46.63 29.97 Favored 'General case' 0 C--N 1.37 1.467 0 N-CA-C 119.414 3.116 . . . . 0.0 119.414 -172.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.98 -16.88 48.01 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 129.142 2.977 . . . . 0.0 115.0 174.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.549 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 7.4 m-20 -80.43 -22.04 41.58 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 128.79 2.836 . . . . 0.0 113.855 170.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.518 ' HB2' ' H ' ' A' ' 157' ' ' VAL . . . -65.27 124.63 22.71 Favored 'General case' 0 C--N 1.382 2.014 0 N-CA-C 120.234 3.42 . . . . 0.0 120.234 173.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.14 -159.27 31.76 Favored Glycine 0 CA--C 1.463 -3.217 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.4 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.311 50.5 m -112.6 133.78 54.47 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 115.002 -2.679 . . . . 0.0 107.775 171.482 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.427 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 5.9 m-85 -96.2 133.43 40.53 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 118.988 -2.32 . . . . 0.0 110.311 -171.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -142.61 142.98 32.22 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 125.111 1.507 . . . . 0.0 107.329 -173.44 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.1 p -133.45 143.4 39.1 Favored 'Isoleucine or valine' 0 C--N 1.36 1.031 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.781 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -110.86 120.75 43.42 Favored 'General case' 0 C--N 1.38 1.898 0 C-N-CA 127.71 2.404 . . . . 0.0 106.135 171.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -132.58 120.49 42.37 Favored 'Isoleucine or valine' 0 C--N 1.361 1.101 0 C-N-CA 126.439 1.896 . . . . 0.0 112.143 -172.154 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 11.9 m -108.75 129.63 55.37 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 119.652 -1.905 . . . . 0.0 114.338 -178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.468 17.5 p30 -126.67 -167.84 1.78 Allowed 'General case' 0 C--N 1.376 1.735 0 CA-C-N 119.972 1.26 . . . . 0.0 113.057 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.753 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 20.2 p -49.77 -0.52 0.01 OUTLIER 'General case' 0 C--N 1.365 1.259 2 C-N-CA 135.08 5.352 . . . . 0.0 122.04 -162.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -105.91 4.68 29.84 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.119 167.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.41 87.3 mm-40 68.29 40.32 2.11 Favored 'General case' 0 C--N 1.375 1.717 0 C-N-CA 131.635 3.974 . . . . 0.0 109.819 -170.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.52 122.9 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 CA-C-N 111.991 -2.368 . . . . 0.0 112.528 -170.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -90.49 124.11 34.73 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 128.646 2.778 . . . . 0.0 107.254 -177.739 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.17 157.33 24.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 129.303 3.041 . . . . 0.0 103.066 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -130.2 143.36 50.74 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.39 5.0 p -124.62 148.18 48.05 Favored 'General case' 0 C--O 1.26 1.626 0 CA-C-N 119.378 0.99 . . . . 0.0 109.509 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.2 m -54.4 147.01 14.53 Favored 'General case' 0 C--N 1.385 2.127 2 C-N-CA 137.817 6.447 . . . . 0.0 115.776 -162.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 73.5 p -68.82 109.8 4.04 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.159 -1.837 . . . . 0.0 111.721 -172.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 108.95 20.29 Favored 'General case' 0 C--N 1.368 1.412 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.31 109.02 21.6 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 123.889 1.804 . . . . 0.0 110.029 -173.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.83 128.24 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 O-C-N 120.367 -1.458 . . . . 0.0 108.676 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 98.3 m -112.79 121.54 45.01 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.518 ' H ' ' HB2' ' A' ' 133' ' ' ALA . 4.2 m -135.03 102.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 171.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -107.37 153.07 41.43 Favored Pre-proline 0 C--N 1.349 0.545 0 O-C-N 119.983 -1.698 . . . . 0.0 108.762 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.2 166.36 27.16 Favored 'Trans proline' 0 C--N 1.361 1.204 1 C-N-CA 126.873 5.049 . . . . 0.0 109.734 161.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 8.2 p -67.42 133.19 49.11 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 119.161 -2.212 . . . . 0.0 108.643 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.403 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 32.3 t -66.56 113.15 11.55 Favored Pre-proline 0 CA--C 1.554 1.11 0 N-CA-C 121.349 3.833 . . . . 0.0 121.349 -122.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 19.8 Cg_endo -62.51 148.46 93.29 Favored 'Trans proline' 0 C--N 1.388 2.625 1 C-N-CA 126.211 4.607 . . . . 0.0 114.32 175.086 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.19 48.92 0.71 Allowed Glycine 0 C--N 1.365 2.151 0 C-N-CA 128.168 2.794 . . . . 0.0 117.625 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -104.41 37.48 3.76 Favored Glycine 0 C--N 1.354 1.543 0 C-N-CA 127.55 2.5 . . . . 0.0 110.061 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.02 39.49 2.33 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 126.525 1.93 . . . . 0.0 109.652 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -76.53 62.63 1.93 Allowed 'General case' 0 C--N 1.359 0.98 0 C-N-CA 126.688 1.995 . . . . 0.0 115.611 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.3 p80 . . . . . 0 C--N 1.358 0.943 0 C-N-CA 126.977 2.111 . . . . 0.0 111.734 179.33 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.183 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.0 tp -67.15 135.72 53.98 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 127.697 2.399 . . . . 0.0 112.727 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.7 t -94.28 172.5 8.17 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 127.29 2.236 . . . . 0.0 111.192 -175.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.444 0.8 OUTLIER -82.17 97.8 8.4 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.529 -2.123 . . . . 0.0 107.558 174.025 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.54 -74.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 118.56 -2.588 . . . . 0.0 116.196 -170.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -132.85 141.15 48.28 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 131.382 3.873 . . . . 0.0 106.433 171.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.313 1.5 t70 -82.93 173.41 11.83 Favored 'General case' 0 CA--C 1.503 -0.86 1 C-N-CA 133.447 4.699 . . . . 0.0 109.232 179.871 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.633 ' HG ' ' H ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -72.05 -34.26 68.63 Favored 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 113.989 -1.46 . . . . 0.0 111.588 179.284 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.6 m -163.94 172.57 13.77 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 116.556 -3.84 . . . . 0.0 104.049 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.68 -40.83 0.78 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 128.111 2.564 . . . . 0.0 112.944 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.6 p -176.0 136.13 0.29 Allowed 'General case' 0 C--N 1.369 1.423 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 34.8 tpp -134.22 118.27 17.42 Favored 'General case' 0 C--N 1.375 1.684 0 CA-C-N 119.69 1.132 . . . . 0.0 109.855 163.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.7 t -111.18 115.65 29.74 Favored 'General case' 0 C--N 1.377 1.788 0 CA-C-O 123.553 1.644 . . . . 0.0 107.796 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.75 174.4 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 127.495 2.318 . . . . 0.0 110.938 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -73.57 143.83 46.28 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 126.556 1.943 . . . . 0.0 106.643 156.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.381 0.0 OUTLIER -44.14 123.38 3.36 Favored 'General case' 0 N--CA 1.514 2.773 0 O-C-N 116.947 -3.596 . . . . 0.0 116.626 -172.668 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 124.73 48.72 0.21 Allowed Glycine 0 C--N 1.353 1.516 0 CA-C-N 111.705 -2.498 . . . . 0.0 109.338 -151.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.19 156.75 18.11 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 125.487 1.515 . . . . 0.0 111.515 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.76 105.25 13.68 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 124.609 1.164 . . . . 0.0 111.282 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.548 HD23 ' CE1' ' A' ' 136' ' ' TYR . 3.4 mp -120.31 125.52 48.27 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 127.002 2.121 . . . . 0.0 115.361 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.62 122.27 46.74 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 170.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -123.46 115.48 21.65 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.633 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 86.2 p -157.29 131.57 8.41 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 120.775 -1.203 . . . . 0.0 113.967 -172.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 140' ' ' VAL . 10.1 m -148.97 173.12 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 129.955 3.302 . . . . 0.0 105.974 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 p -103.77 124.71 49.4 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 115.082 -2.389 . . . . 0.0 109.808 -172.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -136.72 138.18 40.72 Favored 'General case' 0 C--N 1.386 2.154 1 N-CA-C 125.318 5.303 . . . . 0.0 125.318 -170.875 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 99' ' ' GLY . 61.5 m -157.49 174.57 15.19 Favored 'General case' 0 C--N 1.367 1.354 1 C-N-CA 132.023 4.129 . . . . 0.0 101.678 169.307 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.438 ' H ' HG22 ' A' ' 98' ' ' THR . . . -69.27 46.99 0.5 Allowed Glycine 0 C--N 1.366 2.228 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -177.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.58 21.0 60.76 Favored Glycine 0 C--N 1.356 1.657 0 C-N-CA 127.146 2.308 . . . . 0.0 116.156 175.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.412 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 7.9 p -116.45 111.11 19.53 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 115.686 -2.102 . . . . 0.0 107.234 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.678 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 70.98 -90.43 0.41 Allowed Glycine 0 C--N 1.377 2.844 0 C-N-CA 128.105 2.764 . . . . 0.0 111.814 -170.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 101' ' ' THR . 62.4 Cg_endo -66.57 167.52 18.82 Favored 'Trans proline' 0 CA--C 1.571 2.343 1 C-N-CA 126.35 4.7 . . . . 0.0 115.211 162.454 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.417 ' HB3' HG12 ' A' ' 140' ' ' VAL . 67.4 m-85 -90.82 145.54 24.68 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 121.009 3.707 . . . . 0.0 121.009 -166.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 t -102.16 140.4 36.49 Favored 'General case' 0 C--N 1.38 1.895 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.569 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -132.14 158.26 42.12 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 121.589 3.922 . . . . 0.0 121.589 -160.257 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.27 119.66 10.94 Favored 'General case' 0 C--N 1.36 1.029 0 CA-C-N 112.423 -2.171 . . . . 0.0 106.977 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -112.38 151.59 29.61 Favored 'General case' 0 C--N 1.367 1.335 0 O-C-N 119.943 -1.723 . . . . 0.0 107.848 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.4 0.0 OUTLIER -157.78 146.08 19.04 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 119.559 -1.963 . . . . 0.0 105.771 164.939 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.849 ' HG2' HG22 ' A' ' 115' ' ' ILE 0.307 65.8 mmtt -126.43 99.67 5.93 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 115.987 -2.285 . . . . 0.0 111.613 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.458 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.356 0.8 OUTLIER 36.65 53.22 1.05 Allowed 'General case' 0 CA--C 1.46 -2.489 1 CA-C-O 111.615 -4.04 . . . . 0.0 121.267 157.612 . . . . . . . . 5 4 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.45 -5.26 70.52 Favored Glycine 0 C--N 1.372 2.547 2 O-C-N 133.509 6.756 . . . . 0.0 114.965 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -124.09 148.56 57.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 131.179 3.792 . . . . 0.0 115.956 -168.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.36 161.69 19.5 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 124.244 3.296 . . . . 0.0 116.187 168.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.849 HG22 ' HG2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -93.27 165.57 18.07 Favored Pre-proline 0 N--CA 1.443 -0.791 0 C-N-CA 131.373 3.869 . . . . 0.0 109.305 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 44.6 Cg_exo -51.24 -44.29 43.82 Favored 'Trans proline' 0 CA--C 1.538 0.675 1 C-N-CA 127.433 5.422 . . . . 0.0 118.757 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -158.62 -50.82 0.06 Allowed 'General case' 0 C--N 1.348 0.504 0 C-N-CA 126.245 1.818 . . . . 0.0 106.972 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.256 . . 97.49 140.52 0.02 OUTLIER 'General case' 0 CA--C 1.464 -2.352 0 C-N-CA 128.819 2.847 . . . . 0.0 110.472 -177.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 73.9 m 69.75 34.71 2.57 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.163 -1.835 . . . . 0.0 114.243 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -108.2 -18.46 9.78 Favored Glycine 0 CA--C 1.47 -2.762 0 N-CA-C 117.877 1.911 . . . . 0.0 117.877 -164.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.313 . . 81.99 -73.03 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 126.309 1.844 . . . . 0.0 111.786 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.28 13.4 t -128.62 104.22 7.54 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 123.199 1.476 . . . . 0.0 112.459 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.346 0.0 OUTLIER -127.49 140.99 51.78 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 128.192 2.597 . . . . 0.0 112.16 174.194 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.8 m -123.48 138.59 54.55 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 120.334 -1.479 . . . . 0.0 107.869 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.67 106.75 57.52 Favored Pre-proline 0 C--N 1.369 1.415 0 N-CA-C 103.449 -2.796 . . . . 0.0 103.449 170.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.72 -32.46 3.53 Favored 'Trans proline' 0 C--N 1.356 0.958 1 C-N-CA 126.925 5.083 . . . . 0.0 111.733 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.417 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -144.47 103.98 4.01 Favored 'General case' 0 N--CA 1.42 -1.928 1 N-CA-C 99.855 -4.128 . . . . 0.0 99.855 176.689 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.586 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -95.37 133.38 39.38 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 128.335 2.654 . . . . 0.0 107.611 176.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.42 -176.1 4.68 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 127.956 2.502 . . . . 0.0 113.084 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.29 -45.12 34.44 Favored 'General case' 0 C--N 1.369 1.419 0 N-CA-C 119.024 2.972 . . . . 0.0 119.024 -173.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -69.04 -7.58 37.03 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 126.753 2.021 . . . . 0.0 114.974 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.586 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 4.9 m-20 -81.54 -17.9 46.85 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.293 2.237 . . . . 0.0 110.236 168.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.92 114.02 3.82 Favored 'General case' 0 C--N 1.386 2.158 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 171.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 165.63 -156.87 29.08 Favored Glycine 0 CA--C 1.454 -3.75 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.404 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.334 23.7 m -112.85 133.08 55.01 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 114.667 -2.813 . . . . 0.0 107.257 174.423 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.548 ' CE1' HD23 ' A' ' 91' ' ' LEU . 4.2 m-85 -96.99 132.39 42.85 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 118.506 -2.621 . . . . 0.0 113.547 -168.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -144.05 151.35 39.54 Favored 'General case' 0 C--N 1.394 2.543 0 CA-C-N 120.066 1.303 . . . . 0.0 112.138 -173.531 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.3 p -141.59 143.07 27.91 Favored 'Isoleucine or valine' 0 C--N 1.378 1.82 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.1 m -113.15 121.04 43.33 Favored 'General case' 0 C--N 1.373 1.623 0 C-N-CA 129.684 3.194 . . . . 0.0 107.366 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -132.8 125.37 52.38 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 C-N-CA 126.311 1.844 . . . . 0.0 113.112 -177.212 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 4.0 m -112.0 133.85 53.92 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.156 -2.215 . . . . 0.0 116.027 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.39 23.2 p30 -127.98 -173.91 3.06 Favored 'General case' 0 C--N 1.379 1.868 0 CA-C-N 120.226 1.375 . . . . 0.0 113.46 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.678 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 19.8 p -49.25 2.76 0.01 OUTLIER 'General case' 0 C--N 1.363 1.191 2 C-N-CA 136.349 5.86 . . . . 0.0 122.097 -165.466 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.89 4.62 25.57 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 164.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.447 98.3 mm-40 67.53 40.1 2.68 Favored 'General case' 0 C--N 1.371 1.526 1 C-N-CA 132.22 4.208 . . . . 0.0 110.576 -172.6 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.76 127.18 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-N 111.462 -2.608 . . . . 0.0 112.447 -171.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.9 OUTLIER -91.64 134.45 34.68 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.754 1.622 . . . . 0.0 110.318 -176.693 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -116.78 141.05 48.72 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 102.38 -3.193 . . . . 0.0 102.38 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -128.87 146.95 50.8 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.304 1.7 p -119.41 141.7 48.87 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 121.521 0.677 . . . . 0.0 110.738 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 m -54.23 148.22 11.78 Favored 'General case' 0 CA--C 1.479 -1.768 2 C-N-CA 138.253 6.621 . . . . 0.0 115.672 -168.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 78.3 p -68.19 110.17 3.89 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.594 2.758 . . . . 0.0 110.881 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.54 109.46 22.05 Favored 'General case' 0 C--N 1.363 1.193 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 -176.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.98 113.17 24.21 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 124.566 2.126 . . . . 0.0 111.086 -173.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.58 114.99 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -172.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 62.2 m -120.76 123.05 41.71 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 3.3 m -123.42 105.29 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -82.63 156.86 67.9 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.709 1.204 . . . . 0.0 110.477 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.0 165.75 30.21 Favored 'Trans proline' 0 CA--C 1.544 0.986 1 C-N-CA 125.665 4.244 . . . . 0.0 107.835 154.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 12.2 p -67.27 132.46 47.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 118.543 -2.598 . . . . 0.0 109.175 -173.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 65.2 t -65.13 115.52 21.98 Favored Pre-proline 0 C--N 1.366 1.285 0 N-CA-C 120.073 3.36 . . . . 0.0 120.073 -126.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.16 145.73 96.23 Favored 'Trans proline' 0 C--N 1.383 2.376 1 C-N-CA 126.519 4.813 . . . . 0.0 115.238 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.22 61.48 1.06 Allowed Glycine 0 C--N 1.365 2.158 0 C-N-CA 128.615 3.007 . . . . 0.0 117.564 -174.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -103.99 -48.84 1.12 Allowed Glycine 0 C--N 1.355 1.6 0 C-N-CA 127.364 2.411 . . . . 0.0 110.99 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.87 -12.28 45.31 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 127.388 2.275 . . . . 0.0 113.766 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 65.94 -42.05 0.36 Allowed 'General case' 0 C--N 1.367 1.359 0 C-N-CA 129.57 3.148 . . . . 0.0 116.841 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 C--N 1.351 0.653 0 C-N-CA 130.073 3.349 . . . . 0.0 113.18 -177.826 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.057 0 CA-C-O 122.303 1.049 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.1 tp -106.94 117.51 34.26 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.3 t -104.08 172.78 6.61 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 126.399 1.879 . . . . 0.0 110.02 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.453 HD23 ' H ' ' A' ' 75' ' ' LEU 0.355 0.5 OUTLIER -76.14 97.48 4.12 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-O 122.473 1.13 . . . . 0.0 110.603 173.886 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.68 -77.5 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 O-C-N 119.128 -2.232 . . . . 0.0 114.466 -170.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -132.97 140.98 48.06 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 130.146 3.378 . . . . 0.0 103.376 167.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.428 45.1 t0 -83.02 171.82 13.4 Favored 'General case' 0 CA--C 1.511 -0.542 1 C-N-CA 134.279 5.032 . . . . 0.0 107.321 179.52 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.697 HD22 ' H ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -72.38 -37.61 68.7 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 178.572 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m -173.86 172.5 3.46 Favored 'General case' 0 CA--C 1.504 -0.814 1 N-CA-C 99.221 -4.363 . . . . 0.0 99.221 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.43 -47.55 2.54 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 121.051 1.75 . . . . 0.0 109.599 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -170.42 132.57 1.0 Allowed 'General case' 0 C--N 1.36 1.055 0 O-C-N 119.765 -1.835 . . . . 0.0 115.878 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 12.7 tpt -130.75 116.26 17.76 Favored 'General case' 0 C--N 1.373 1.612 0 CA-C-N 120.603 1.547 . . . . 0.0 107.793 164.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 p -109.86 115.52 29.97 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 119.397 -2.065 . . . . 0.0 107.813 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -149.55 174.27 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 126.157 1.783 . . . . 0.0 111.499 -168.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -74.08 135.74 43.0 Favored 'General case' 0 C--N 1.368 1.405 0 O-C-N 118.87 -2.394 . . . . 0.0 107.087 158.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.336 0.4 OUTLIER -44.04 122.62 2.96 Favored 'General case' 0 N--CA 1.515 2.813 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -165.55 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.587 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 131.74 50.81 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 111.337 -2.665 . . . . 0.0 108.722 -162.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.61 160.67 19.55 Favored 'General case' 0 C--N 1.369 1.415 0 C-N-CA 126.382 1.873 . . . . 0.0 109.443 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.02 99.95 8.73 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 122.494 1.14 . . . . 0.0 110.723 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 128' ' ' ALA 0.276 9.0 mp -113.27 114.24 26.41 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 126.679 1.992 . . . . 0.0 115.74 -169.602 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.92 137.17 45.48 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 170.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 79' ' ' LEU . 1.7 mm? -124.84 116.09 21.7 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.697 ' H ' HD22 ' A' ' 79' ' ' LEU . 3.6 t -150.37 131.94 14.84 Favored 'General case' 0 C--N 1.38 1.908 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.5 m -149.57 172.81 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.039 0 C-N-CA 129.926 3.29 . . . . 0.0 106.849 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.6 t -105.45 138.12 42.16 Favored 'General case' 0 C--N 1.371 1.515 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.42 143.91 37.85 Favored 'General case' 0 C--N 1.371 1.535 0 N-CA-C 119.914 3.302 . . . . 0.0 119.914 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.96 174.69 15.13 Favored 'General case' 0 C--N 1.361 1.091 1 C-N-CA 134.169 4.988 . . . . 0.0 102.881 177.521 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.19 45.57 1.75 Allowed Glycine 0 C--N 1.37 2.422 0 O-C-N 118.706 -2.496 . . . . 0.0 117.73 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.41 62.01 Favored Glycine 0 C--N 1.363 2.073 0 C-N-CA 128.073 2.749 . . . . 0.0 112.787 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.5 m -115.96 110.93 19.64 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 126.442 1.897 . . . . 0.0 107.565 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 66.95 -102.6 0.79 Allowed Glycine 0 CA--C 1.548 2.106 0 CA-C-O 116.667 -2.185 . . . . 0.0 109.783 -160.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.58 169.51 5.38 Favored 'Trans proline' 0 C--N 1.377 2.041 1 C-N-CA 129.128 6.552 . . . . 0.0 118.168 160.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.617 ' HB3' HG12 ' A' ' 140' ' ' VAL . 76.9 m-85 -81.74 142.3 32.77 Favored 'General case' 0 C--N 1.358 0.965 1 N-CA-C 124.301 4.926 . . . . 0.0 124.301 -164.407 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 t -102.32 141.06 35.76 Favored 'General case' 0 C--N 1.379 1.887 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.555 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -134.51 162.91 30.94 Favored 'General case' 0 C--N 1.351 0.662 1 N-CA-C 122.85 4.389 . . . . 0.0 122.85 -161.947 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.49 121.18 11.86 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.992 2.517 . . . . 0.0 106.951 176.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -112.16 138.2 49.16 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.577 1.951 . . . . 0.0 111.422 -175.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.1 169.97 19.46 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-O 123.119 1.438 . . . . 0.0 107.335 172.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HD3' ' CE1' ' A' ' 136' ' ' TYR . 13.8 ttpt -145.64 104.99 3.94 Favored 'General case' 0 N--CA 1.422 -1.851 0 O-C-N 119.37 -2.081 . . . . 0.0 105.875 177.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.472 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.239 1.2 t70 34.76 53.47 0.63 Allowed 'General case' 0 CA--C 1.472 -2.024 2 CA-C-O 110.414 -4.613 . . . . 0.0 123.073 141.976 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.74 -1.11 84.67 Favored Glycine 0 C--N 1.377 2.859 2 O-C-N 134.349 7.28 . . . . 0.0 118.964 -173.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.5 t -124.96 145.43 50.14 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -171.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -64.79 136.24 48.36 Favored 'Trans proline' 0 N--CA 1.495 1.588 1 C-N-CA 126.158 4.572 . . . . 0.0 115.315 173.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.447 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -85.23 165.6 35.54 Favored Pre-proline 0 CA--C 1.552 1.039 0 O-C-N 119.337 -2.102 . . . . 0.0 116.319 178.364 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 1.8 Cg_endo -68.1 81.45 0.5 Allowed 'Trans proline' 0 C--N 1.363 1.319 1 C-N-CA 125.406 4.071 . . . . 0.0 114.647 174.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 74.82 -62.15 0.46 Allowed 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.43 2.292 . . . . 0.0 115.033 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 85.3 162.68 0.1 Allowed 'General case' 0 CA--C 1.481 -1.703 0 C-N-CA 129.431 3.092 . . . . 0.0 112.584 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 79.16 52.98 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 CA-C-N 113.531 -1.668 . . . . 0.0 111.049 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.99 -86.44 0.84 Allowed Glycine 0 C--N 1.362 2.018 0 CA-C-N 114.172 -1.376 . . . . 0.0 116.494 -170.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 94' ' ' SER 0.339 . . 144.45 -74.97 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.406 2.282 . . . . 0.0 111.079 177.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.3 9.0 t -126.0 93.47 3.83 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.909 1.814 . . . . 0.0 110.301 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.277 3.3 p90 -125.98 141.05 52.13 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.228 1.811 . . . . 0.0 110.319 -177.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 88.8 m -129.71 139.8 51.26 Favored 'General case' 0 CA--C 1.493 -1.238 0 O-C-N 120.389 -1.444 . . . . 0.0 110.041 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -111.09 103.93 55.51 Favored Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 129.485 3.114 . . . . 0.0 105.293 176.484 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -72.65 -32.76 9.14 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.718 3.612 . . . . 0.0 113.772 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.587 HG23 ' HA2' ' A' ' 88' ' ' GLY . 99.4 m -136.54 100.99 4.51 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.479 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -93.07 124.04 36.76 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 124.212 1.005 . . . . 0.0 113.196 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.93 -178.49 4.67 Favored 'General case' 0 C--N 1.364 1.234 0 C-N-CA 129.2 3.0 . . . . 0.0 109.719 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -54.19 13.39 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -173.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.13 1.03 1.65 Allowed 'General case' 0 C--N 1.365 1.241 0 C-N-CA 128.6 2.76 . . . . 0.0 115.357 172.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -116.06 -18.56 10.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 129.409 3.084 . . . . 0.0 111.266 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.407 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -95.18 164.55 12.81 Favored 'General case' 0 C--N 1.391 2.412 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 175.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.87 -155.86 26.74 Favored Glycine 0 C--N 1.383 3.149 0 C-N-CA 128.318 2.866 . . . . 0.0 109.734 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.356 6.9 m -109.41 130.73 55.49 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 112.974 -3.491 . . . . 0.0 107.135 164.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.464 ' CE1' ' HD3' ' A' ' 110' ' ' LYS 0.255 3.5 m-85 -97.01 134.49 40.31 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 125.704 1.602 . . . . 0.0 111.492 -169.299 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -145.49 152.61 40.05 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-N 119.459 1.027 . . . . 0.0 109.021 -175.746 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.39 142.69 28.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 C-N-CA 116.568 -2.053 . . . . 0.0 111.592 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.5 m -105.99 119.37 39.03 Favored 'General case' 0 C--N 1.368 1.401 0 C-N-CA 129.778 3.231 . . . . 0.0 106.286 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.617 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -134.16 124.27 45.66 Favored 'Isoleucine or valine' 0 C--N 1.35 0.591 0 C-N-CA 124.268 1.027 . . . . 0.0 113.613 -173.36 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 6.0 m -109.23 131.71 54.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 119.412 -2.055 . . . . 0.0 114.599 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.453 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.444 10.2 p-10 -128.45 -170.48 2.26 Favored 'General case' 0 C--N 1.367 1.366 0 O-C-N 120.682 -1.261 . . . . 0.0 113.894 175.21 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.466 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 22.1 p -48.71 3.84 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.317 1 C-N-CA 136.218 5.807 . . . . 0.0 121.634 -164.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -106.74 4.57 27.82 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 118.286 -1.366 . . . . 0.0 107.898 163.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.433 89.9 mm-40 66.45 40.09 3.67 Favored 'General case' 0 C--N 1.373 1.62 1 C-N-CA 132.924 4.49 . . . . 0.0 110.273 -171.992 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.418 ' C ' HG23 ' A' ' 141' ' ' THR . 4.2 m -112.54 126.32 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 C-N-CA 128.08 2.552 . . . . 0.0 112.061 -171.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.3 OUTLIER -91.83 130.24 37.64 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 124.61 1.164 . . . . 0.0 109.849 -178.203 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.62 158.89 23.84 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.755 3.222 . . . . 0.0 104.455 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -129.77 146.51 51.52 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.404 87.8 p -116.4 150.19 38.18 Favored 'General case' 0 C--O 1.254 1.303 0 C-N-CA 124.469 1.108 . . . . 0.0 110.004 177.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.92 148.83 12.59 Favored 'General case' 0 C--N 1.382 2.012 1 C-N-CA 134.245 5.018 . . . . 0.0 118.719 -158.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 136' ' ' TYR . 76.0 p -68.74 111.13 4.66 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 127.866 2.466 . . . . 0.0 110.434 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.16 109.25 22.04 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.52 107.43 19.59 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 124.84 2.257 . . . . 0.0 110.882 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.0 m -119.75 120.25 62.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 O-C-N 119.821 -1.799 . . . . 0.0 106.386 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -112.07 135.76 52.3 Favored 'General case' 0 C--N 1.364 1.235 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -174.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.407 HG22 ' CB ' ' A' ' 133' ' ' ALA . 29.7 m -128.17 104.96 12.69 Favored 'Isoleucine or valine' 0 C--N 1.361 1.079 0 CA-C-O 124.136 1.922 . . . . 0.0 112.672 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -85.97 161.36 50.13 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.457 1.503 . . . . 0.0 109.814 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -67.99 165.96 26.37 Favored 'Trans proline' 0 C--N 1.364 1.381 1 C-N-CA 127.788 5.659 . . . . 0.0 108.613 153.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 17.7 p -67.28 131.53 45.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 118.53 -2.606 . . . . 0.0 109.815 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.14 111.6 6.97 Favored Pre-proline 0 CA--C 1.552 1.041 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 -125.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.51 147.44 94.84 Favored 'Trans proline' 0 C--N 1.382 2.317 1 C-N-CA 126.091 4.528 . . . . 0.0 114.107 171.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.06 48.4 0.67 Allowed Glycine 0 C--N 1.365 2.161 0 C-N-CA 128.044 2.735 . . . . 0.0 117.933 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -104.25 33.68 6.38 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 127.512 2.482 . . . . 0.0 110.437 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.49 36.29 4.28 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 127.789 2.436 . . . . 0.0 110.119 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -75.01 65.54 1.46 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 127.238 2.215 . . . . 0.0 116.553 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 C--N 1.354 0.799 0 C-N-CA 126.296 1.838 . . . . 0.0 109.777 178.162 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 121.614 0.721 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.4 tp -107.28 122.29 46.27 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 126.644 1.978 . . . . 0.0 109.048 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.5 t -94.96 173.36 7.62 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 127.593 2.357 . . . . 0.0 110.11 176.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 75' ' ' LEU 0.28 0.6 OUTLIER -78.95 97.91 6.22 Favored 'General case' 0 C--N 1.363 1.193 0 O-C-N 120.303 -1.498 . . . . 0.0 109.547 175.971 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.97 -73.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 117.44 -3.287 . . . . 0.0 115.93 -167.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.98 140.37 47.75 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 130.015 3.326 . . . . 0.0 107.119 172.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.47 0.6 OUTLIER -83.9 142.35 30.62 Favored 'General case' 0 C--N 1.375 1.675 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 172.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 92' ' ' THR . 0.3 OUTLIER -72.14 -26.95 62.3 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-N 124.773 3.442 . . . . 0.0 112.354 -177.569 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.9 m -172.13 175.46 3.74 Favored 'General case' 0 C--N 1.317 -0.822 1 C-N-CA 132.142 4.177 . . . . 0.0 101.478 168.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.75 -62.86 1.44 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.827 2.051 . . . . 0.0 113.065 169.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 p -179.99 125.14 0.07 Allowed 'General case' 0 C--N 1.36 1.048 0 O-C-N 118.434 -2.666 . . . . 0.0 117.636 -175.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.1 mmm -120.29 134.63 55.22 Favored 'General case' 0 C--N 1.379 1.888 0 CA-C-N 120.464 1.483 . . . . 0.0 113.198 168.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.2 p -114.54 115.66 27.56 Favored 'General case' 0 C--N 1.365 1.241 0 O-C-N 119.127 -2.233 . . . . 0.0 108.629 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -150.1 173.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-N 114.011 -1.449 . . . . 0.0 113.134 -167.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -81.11 131.48 35.3 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 128.01 2.524 . . . . 0.0 104.931 161.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.317 0.2 OUTLIER -43.23 122.38 2.51 Favored 'General case' 0 N--CA 1.518 2.968 0 CA-C-N 123.418 2.827 . . . . 0.0 118.55 -161.727 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.54 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 134.57 54.24 0.07 OUTLIER Glycine 0 C--N 1.35 1.354 0 CA-C-N 111.854 -2.43 . . . . 0.0 111.503 -164.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.69 172.27 10.99 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.775 1.23 . . . . 0.0 112.095 173.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.55 100.95 9.41 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.9 -1.125 . . . . 0.0 109.298 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -121.47 114.31 21.08 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.531 1.532 . . . . 0.0 111.218 -172.511 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 79' ' ' LEU 0.29 2.4 t -113.84 137.54 51.52 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.68 115.74 19.91 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 t -152.86 132.41 13.01 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.808 1.289 . . . . 0.0 112.185 -169.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.9 175.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.665 1 C-N-CA 132.171 4.188 . . . . 0.0 106.583 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -103.98 140.97 36.98 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.853 2.461 . . . . 0.0 106.375 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.33 144.38 34.54 Favored 'General case' 0 C--N 1.381 1.978 1 N-CA-C 122.934 4.42 . . . . 0.0 122.934 -174.871 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.5 p -156.41 175.84 13.49 Favored 'General case' 0 C--N 1.364 1.199 1 C-N-CA 133.883 4.873 . . . . 0.0 104.094 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.38 40.33 0.75 Allowed Glycine 0 C--N 1.365 2.183 0 C-N-CA 125.858 1.694 . . . . 0.0 117.232 167.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.06 30.67 25.12 Favored Glycine 0 C--N 1.361 1.944 0 C-N-CA 127.616 2.531 . . . . 0.0 116.164 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.41 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 63.5 m -117.44 110.9 18.58 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 113.653 -3.07 . . . . 0.0 108.351 175.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.479 ' H ' ' CB ' ' A' ' 143' ' ' SER . . . 72.79 -86.73 0.54 Allowed Glycine 0 C--N 1.383 3.15 0 CA-C-N 124.837 3.471 . . . . 0.0 110.172 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.86 168.13 6.12 Favored 'Trans proline' 0 CA--C 1.57 2.291 1 C-N-CA 126.102 4.535 . . . . 0.0 115.364 157.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.568 ' HB3' HG12 ' A' ' 140' ' ' VAL . 78.4 m-85 -105.97 145.13 31.72 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 119.798 3.259 . . . . 0.0 119.798 -164.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.6 t -103.02 141.51 35.68 Favored 'General case' 0 C--N 1.378 1.837 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.48 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -140.13 160.98 38.74 Favored 'General case' 0 C--N 1.347 0.466 1 N-CA-C 121.923 4.045 . . . . 0.0 121.923 -160.133 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -136.2 120.89 18.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.674 2.79 . . . . 0.0 105.796 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -112.05 132.8 54.6 Favored 'General case' 0 C--N 1.366 1.29 0 C-N-CA 125.178 1.391 . . . . 0.0 111.574 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.89 169.69 17.58 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 123.252 1.501 . . . . 0.0 107.334 172.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.49 ' HD3' ' CE1' ' A' ' 136' ' ' TYR . 13.0 ttpp -142.79 105.7 4.53 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.459 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.22 1.7 t70 34.91 53.63 0.66 Allowed 'General case' 0 CA--C 1.472 -2.035 2 CA-C-O 109.685 -4.96 . . . . 0.0 123.473 140.739 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.09 -10.43 60.74 Favored Glycine 0 C--N 1.383 3.179 2 O-C-N 135.222 7.826 . . . . 0.0 119.365 -172.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.407 9.8 p -124.89 147.15 55.6 Favored Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 130.607 3.563 . . . . 0.0 120.586 -167.724 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -63.8 139.72 70.17 Favored 'Trans proline' 0 N--CA 1.499 1.817 1 C-N-CA 126.484 4.789 . . . . 0.0 116.933 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -89.51 164.27 30.23 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 119.237 -2.164 . . . . 0.0 115.568 178.628 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 8.8 Cg_endo -72.05 82.9 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 125.119 3.879 . . . . 0.0 115.009 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 74.52 -61.06 0.5 Allowed 'General case' 0 C--N 1.36 1.05 0 C-N-CA 126.626 1.97 . . . . 0.0 115.846 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 79.16 176.21 0.14 Allowed 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 130.3 3.44 . . . . 0.0 114.805 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.418 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 74.55 70.08 0.1 Allowed 'General case' 0 C--N 1.356 0.864 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.752 173.355 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -154.77 -53.11 0.01 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 120.078 2.791 . . . . 0.0 120.078 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.292 . . 131.94 -65.87 0.0 OUTLIER 'General case' 0 C--N 1.351 0.634 0 C-N-CA 127.129 2.172 . . . . 0.0 107.777 -176.017 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.27 14.7 t -137.53 108.84 6.86 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-N 120.475 1.489 . . . . 0.0 113.688 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.289 0.2 OUTLIER -128.02 140.25 52.08 Favored 'General case' 0 C--N 1.372 1.567 0 C-N-CA 127.881 2.472 . . . . 0.0 111.846 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.8 m -129.39 139.75 51.57 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 119.909 -1.745 . . . . 0.0 111.596 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 105.27 56.68 Favored Pre-proline 0 C--N 1.358 0.949 0 C-N-CA 129.377 3.071 . . . . 0.0 105.966 173.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -75.56 -11.51 20.47 Favored 'Trans proline' 0 C--N 1.353 0.782 1 C-N-CA 125.745 4.297 . . . . 0.0 112.819 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.54 HG23 ' HA2' ' A' ' 88' ' ' GLY . 62.1 m -157.93 105.65 1.99 Allowed 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.791 ' HB2' HD21 ' A' ' 91' ' ' LEU . . . -94.17 118.9 32.22 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.313 1.045 . . . . 0.0 112.825 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.97 -176.98 6.2 Favored 'General case' 0 C--N 1.367 1.351 0 C-N-CA 127.131 2.173 . . . . 0.0 109.236 172.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.12 -54.19 14.08 Favored 'General case' 0 C--N 1.368 1.384 0 O-C-N 118.273 -2.767 . . . . 0.0 117.209 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.8 0.79 1.58 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 128.692 2.797 . . . . 0.0 115.58 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -116.43 -18.33 10.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 129.299 3.04 . . . . 0.0 111.347 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.65 164.74 13.29 Favored 'General case' 0 C--N 1.397 2.655 0 CA-C-N 122.534 2.424 . . . . 0.0 116.673 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.24 -155.08 25.42 Favored Glycine 0 CA--C 1.459 -3.446 0 C-N-CA 127.107 2.289 . . . . 0.0 109.012 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.351 9.3 m -113.49 133.41 55.23 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 111.912 -3.915 . . . . 0.0 108.595 166.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.49 ' CE1' ' HD3' ' A' ' 110' ' ' LYS 0.252 21.1 m-85 -96.26 135.2 38.41 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 122.228 2.285 . . . . 0.0 110.984 -170.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.459 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -145.77 147.52 31.97 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 123.982 0.913 . . . . 0.0 108.908 -176.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 149' ' ' ASP . 10.4 p -138.76 137.38 42.95 Favored 'Isoleucine or valine' 0 C--N 1.365 1.267 0 C-N-CA 118.189 -1.404 . . . . 0.0 113.402 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 113.89 27.74 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 129.29 3.036 . . . . 0.0 105.848 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.568 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -128.98 119.68 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.936 1.694 . . . . 0.0 110.513 -171.41 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.403 HG23 ' C ' ' A' ' 146' ' ' VAL . 5.2 m -106.24 133.1 51.47 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.228 -1.545 . . . . 0.0 113.719 -176.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.484 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.328 15.6 p-10 -126.21 179.43 5.26 Favored 'General case' 0 C--N 1.376 1.757 0 C-N-CA 124.164 0.986 . . . . 0.0 111.971 174.923 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.479 ' CB ' ' H ' ' A' ' 102' ' ' GLY . 13.1 p -49.18 2.29 0.01 OUTLIER 'General case' 0 C--N 1.375 1.677 1 C-N-CA 136.971 6.108 . . . . 0.0 119.306 -170.768 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -101.28 4.24 41.53 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 165.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.523 0.9 OUTLIER 62.89 39.87 10.12 Favored 'General case' 0 C--N 1.372 1.554 1 C-N-CA 134.266 5.026 . . . . 0.0 112.715 -172.692 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.403 ' C ' HG23 ' A' ' 141' ' ' THR . 4.6 m -112.85 128.37 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.858 0 CA-C-N 111.596 -2.547 . . . . 0.0 111.882 -170.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.02 123.0 35.06 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.456 1.902 . . . . 0.0 106.777 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 157.74 24.56 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 128.031 2.532 . . . . 0.0 104.804 -174.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 27.3 t70 -125.06 140.32 53.0 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.708 1.242 . . . . 0.0 108.205 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.486 44.6 p -116.98 144.05 45.01 Favored 'General case' 0 C--O 1.254 1.334 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 m -54.11 147.98 11.84 Favored 'General case' 0 CA--C 1.478 -1.789 2 C-N-CA 138.798 6.839 . . . . 0.0 118.049 -159.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 73.6 p -68.29 109.77 3.76 Favored 'General case' 0 C--N 1.367 1.348 0 C-N-CA 124.486 1.114 . . . . 0.0 111.907 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -95.22 108.49 20.63 Favored 'General case' 0 C--N 1.373 1.608 0 N-CA-C 102.653 -3.092 . . . . 0.0 102.653 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.53 113.72 25.48 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 123.732 1.729 . . . . 0.0 111.152 -172.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.33 116.21 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 97.7 m -111.24 128.26 55.87 Favored 'General case' 0 C--N 1.372 1.549 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.1 m -123.17 108.37 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 CA-C-O 123.78 1.752 . . . . 0.0 111.669 -176.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -85.25 155.99 60.04 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.243 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.3 166.3 29.72 Favored 'Trans proline' 0 C--N 1.359 1.124 1 C-N-CA 126.931 5.087 . . . . 0.0 107.418 154.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.3 p -66.86 132.46 48.05 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 118.515 -2.616 . . . . 0.0 109.169 -172.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.81 124.8 87.47 Favored Pre-proline 0 C--N 1.366 1.283 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 -127.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.16 154.82 60.2 Favored 'Trans proline' 0 C--N 1.386 2.518 1 C-N-CA 126.641 4.894 . . . . 0.0 114.994 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.12 50.89 0.75 Allowed Glycine 0 C--N 1.367 2.279 0 C-N-CA 127.426 2.441 . . . . 0.0 118.019 -177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -110.6 32.39 6.63 Favored Glycine 0 C--N 1.355 1.632 0 C-N-CA 127.776 2.608 . . . . 0.0 110.872 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 67.6 mt -119.21 43.52 2.57 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 127.249 2.219 . . . . 0.0 106.422 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.42 52.67 0.08 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 129.504 3.122 . . . . 0.0 117.011 -173.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.352 0.709 0 C-N-CA 128.854 2.861 . . . . 0.0 109.46 -179.569 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.262 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -108.45 121.36 44.79 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.364 1.466 . . . . 0.0 108.849 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.0 t -106.2 173.64 6.23 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.444 1.898 . . . . 0.0 108.844 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.315 0.9 OUTLIER -72.05 98.14 2.03 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 122.332 1.063 . . . . 0.0 110.536 173.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.26 -77.26 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.584 0 O-C-N 117.87 -3.019 . . . . 0.0 115.487 -168.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -132.97 141.11 48.14 Favored 'General case' 0 C--N 1.362 1.137 1 C-N-CA 133.178 4.591 . . . . 0.0 105.139 172.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.293 12.1 t70 -82.85 171.56 13.78 Favored 'General case' 0 C--N 1.344 0.362 1 C-N-CA 131.88 4.072 . . . . 0.0 109.854 -179.671 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.43 -27.74 63.5 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -171.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER -175.09 -177.02 1.01 Allowed 'General case' 0 N--CA 1.476 0.83 1 N-CA-C 98.716 -4.549 . . . . 0.0 98.716 162.75 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.86 -53.09 2.67 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 119.567 -1.958 . . . . 0.0 106.767 162.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.0 p -168.91 128.92 1.12 Allowed 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.037 -1.664 . . . . 0.0 115.079 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.0 tpt -124.95 123.45 39.92 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-N 120.81 1.641 . . . . 0.0 111.247 167.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.2 t -112.05 116.73 31.01 Favored 'General case' 0 C--N 1.374 1.652 0 O-C-N 119.724 -1.86 . . . . 0.0 107.273 171.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -149.67 173.7 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 112.065 -2.334 . . . . 0.0 109.981 -173.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.55 144.7 39.51 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 126.302 1.841 . . . . 0.0 106.609 158.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.436 0.0 OUTLIER -44.42 121.97 2.84 Favored 'General case' 0 N--CA 1.515 2.807 0 O-C-N 117.376 -3.327 . . . . 0.0 118.339 -168.027 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.422 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 129.74 55.49 0.1 OUTLIER Glycine 0 C--N 1.36 1.866 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.651 -155.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.5 165.23 12.85 Favored 'General case' 0 C--N 1.369 1.413 0 O-C-N 120.643 -1.504 . . . . 0.0 110.487 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.93 100.96 9.84 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-O 123.17 1.462 . . . . 0.0 113.393 -173.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mp -119.36 127.23 52.96 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 125.113 1.365 . . . . 0.0 111.835 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.452 ' HA ' HG23 ' A' ' 124' ' ' THR . 4.8 t -116.04 115.3 25.88 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 168.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.12 112.0 24.71 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 103.04 -2.948 . . . . 0.0 103.04 173.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.9 t -146.35 131.2 18.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.621 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.1 m -150.54 174.23 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.649 1 C-N-CA 131.789 4.035 . . . . 0.0 103.565 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.3 t -106.38 140.39 39.37 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 122.096 2.225 . . . . 0.0 106.976 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -139.71 142.61 36.85 Favored 'General case' 0 C--N 1.379 1.863 0 N-CA-C 121.021 3.712 . . . . 0.0 121.021 -174.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.2 p -156.29 175.54 13.86 Favored 'General case' 0 C--N 1.367 1.346 1 C-N-CA 134.365 5.066 . . . . 0.0 103.352 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.73 39.77 0.78 Allowed Glycine 0 C--N 1.368 2.31 0 O-C-N 119.514 -1.991 . . . . 0.0 117.649 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.19 26.08 49.49 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 128.459 2.933 . . . . 0.0 114.427 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 p -116.88 109.84 17.58 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 116.249 -1.834 . . . . 0.0 107.856 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.652 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.01 -91.07 0.51 Allowed Glycine 0 C--N 1.374 2.643 0 C-N-CA 129.073 3.225 . . . . 0.0 111.053 -167.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -60.22 169.16 5.29 Favored 'Trans proline' 0 CA--C 1.566 2.111 1 C-N-CA 127.993 5.795 . . . . 0.0 116.968 160.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.49 ' HB3' HG12 ' A' ' 140' ' ' VAL . 75.1 m-85 -94.58 146.27 24.24 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -168.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -102.69 140.78 36.53 Favored 'General case' 0 C--N 1.382 2.013 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.429 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -135.46 139.84 44.38 Favored 'General case' 0 C--N 1.352 0.691 1 N-CA-C 123.668 4.692 . . . . 0.0 123.668 -158.356 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.07 111.56 14.83 Favored 'General case' 0 C--N 1.371 1.533 0 C-N-CA 126.403 1.881 . . . . 0.0 107.238 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TRP . . . . . 0.462 ' CE2' HG21 ' A' ' 138' ' ' VAL . 76.4 m95 -113.06 145.14 41.42 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.053 1.741 . . . . 0.0 111.405 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.32 0.0 OUTLIER -157.95 156.38 31.16 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 164.211 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.498 ' HG2' HG22 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -128.05 102.84 6.91 Favored 'General case' 0 C--N 1.37 1.493 0 C-N-CA 117.271 -1.771 . . . . 0.0 113.517 175.962 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.453 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.231 2.5 t70 36.94 54.53 1.19 Allowed 'General case' 0 CA--C 1.456 -2.656 1 CA-C-O 110.772 -4.442 . . . . 0.0 120.837 152.829 . . . . . . . . 4 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.19 -11.49 63.74 Favored Glycine 0 C--N 1.37 2.462 2 O-C-N 133.928 7.018 . . . . 0.0 116.041 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.262 3.6 m -123.96 149.16 59.14 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 131.216 3.806 . . . . 0.0 117.161 -168.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.15 152.32 80.27 Favored 'Trans proline' 0 N--CA 1.494 1.544 1 C-N-CA 125.473 4.115 . . . . 0.0 116.211 169.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.498 HG22 ' HG2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -99.04 157.76 33.51 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.469 1.508 . . . . 0.0 109.243 174.522 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 5.3 Cg_exo -62.64 -75.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.839 1 C-N-CA 126.039 4.493 . . . . 0.0 116.773 -170.036 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -102.86 -34.46 8.97 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.267 1.427 . . . . 0.0 111.281 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 75.93 -72.36 0.11 Allowed 'General case' 0 CA--C 1.486 -1.512 0 C-N-CA 130.075 3.35 . . . . 0.0 114.393 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.348 5.2 t -81.82 72.64 8.87 Favored 'General case' 0 N--CA 1.416 -2.155 1 C-N-CA 133.627 4.771 . . . . 0.0 111.348 -175.108 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.23 -41.5 0.02 OUTLIER Glycine 0 CA--C 1.469 -2.794 0 N-CA-C 122.072 3.589 . . . . 0.0 122.072 -168.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.301 . . 105.16 -62.57 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.505 1.522 . . . . 0.0 110.151 179.051 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.296 15.3 t -136.49 96.33 3.33 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-O 122.622 1.201 . . . . 0.0 113.841 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -126.5 138.0 53.44 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 127.121 2.169 . . . . 0.0 107.823 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.452 HG23 ' HA ' ' A' ' 92' ' ' THR . 91.5 m -128.92 133.2 47.78 Favored 'General case' 0 CA--C 1.478 -1.789 0 O-C-N 119.536 -1.977 . . . . 0.0 106.256 -176.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.83 93.22 8.49 Favored Pre-proline 0 C--N 1.359 1.018 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.69 -11.83 26.27 Favored 'Trans proline' 0 C--N 1.348 0.544 1 C-N-CA 125.525 4.15 . . . . 0.0 111.048 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' THR . . . . . 0.422 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -161.62 104.29 1.22 Allowed 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -87.16 133.48 33.63 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.253 2.621 . . . . 0.0 113.119 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.11 178.92 5.72 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 128.995 2.918 . . . . 0.0 110.683 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.13 -45.3 32.99 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 118.937 2.94 . . . . 0.0 118.937 -174.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -66.88 -17.59 64.97 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 126.855 2.062 . . . . 0.0 114.205 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.566 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 36.5 m-20 -82.05 -14.26 56.13 Favored 'General case' 0 CA--C 1.573 1.854 0 C-N-CA 128.52 2.728 . . . . 0.0 111.361 170.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.28 127.15 32.03 Favored 'General case' 0 C--N 1.393 2.48 0 N-CA-C 119.474 3.139 . . . . 0.0 119.474 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.18 -147.9 18.01 Favored Glycine 0 CA--C 1.473 -2.542 0 C-N-CA 128.404 2.907 . . . . 0.0 108.651 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.451 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.265 21.1 m -125.46 140.08 53.09 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 114.47 -2.892 . . . . 0.0 109.533 173.317 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.473 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 16.9 m-85 -95.91 134.52 38.8 Favored 'General case' 0 C--N 1.367 1.361 0 O-C-N 118.722 -2.486 . . . . 0.0 112.456 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -142.45 146.68 35.07 Favored 'General case' 0 C--N 1.368 1.393 0 C-N-CA 123.993 0.917 . . . . 0.0 108.602 -174.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' VAL . . . . . 0.462 HG21 ' CE2' ' A' ' 108' ' ' TRP 0.251 13.4 p -146.99 139.95 19.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.185 0 C-N-CA 118.64 -1.224 . . . . 0.0 114.144 176.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.48 115.67 27.63 Favored 'General case' 0 C--N 1.375 1.702 0 C-N-CA 127.22 2.208 . . . . 0.0 106.321 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -127.09 116.46 44.51 Favored 'Isoleucine or valine' 0 C--N 1.369 1.444 0 C-N-CA 127.996 2.518 . . . . 0.0 112.155 -171.345 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.415 HG23 ' C ' ' A' ' 146' ' ' VAL . 4.0 m -99.12 132.89 44.11 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -176.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.424 16.2 p-10 -126.58 -176.93 3.82 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-N 120.769 1.622 . . . . 0.0 112.171 173.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.652 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 77.5 p -49.58 3.3 0.01 OUTLIER 'General case' 0 C--N 1.36 1.025 1 C-N-CA 136.634 5.973 . . . . 0.0 121.279 -165.15 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.29 4.47 36.57 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 164.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.422 81.0 mm-40 65.52 40.01 4.79 Favored 'General case' 0 C--N 1.374 1.659 1 C-N-CA 132.874 4.47 . . . . 0.0 111.183 -172.55 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' VAL . . . . . 0.415 ' C ' HG23 ' A' ' 141' ' ' THR . 3.4 m -112.64 130.09 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.754 -172.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -90.59 124.57 35.14 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 128.742 2.817 . . . . 0.0 107.733 -177.501 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.69 152.89 32.34 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 45.8 p30 -130.56 147.14 52.21 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 123.061 1.41 . . . . 0.0 112.455 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.283 9.9 p -119.15 144.75 46.49 Favored 'General case' 0 C--O 1.259 1.58 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.277 168.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.8 m -55.12 148.83 13.29 Favored 'General case' 0 CA--C 1.478 -1.804 3 C-N-CA 140.098 7.359 . . . . 0.0 115.101 -172.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 72.5 p -68.58 109.86 3.95 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 127.835 2.454 . . . . 0.0 109.49 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 108.92 21.07 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 102.274 -3.232 . . . . 0.0 102.274 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.88 112.74 24.81 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 122.426 1.108 . . . . 0.0 111.502 -172.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.0 m -121.61 118.37 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 58.5 m -119.36 122.79 42.61 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 3.8 m -123.55 105.02 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -82.72 155.94 68.06 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.756 1.622 . . . . 0.0 110.951 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.98 165.81 31.14 Favored 'Trans proline' 0 CA--C 1.547 1.126 1 C-N-CA 126.179 4.586 . . . . 0.0 107.891 154.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 10.7 p -67.2 125.12 25.04 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 118.598 -2.564 . . . . 0.0 109.063 -172.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 9.1 p -66.53 117.95 49.23 Favored Pre-proline 0 C--N 1.366 1.285 1 N-CA-C 122.696 4.332 . . . . 0.0 122.696 -125.018 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 31.0 Cg_endo -62.73 143.56 92.36 Favored 'Trans proline' 0 C--N 1.382 2.31 1 C-N-CA 125.988 4.459 . . . . 0.0 114.604 171.284 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.28 56.28 0.44 Allowed Glycine 0 C--N 1.367 2.302 0 C-N-CA 128.107 2.765 . . . . 0.0 117.48 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -120.92 -120.48 2.75 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 128.201 2.81 . . . . 0.0 106.922 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 28.8 mt 68.78 42.08 1.46 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 128.342 2.657 . . . . 0.0 111.009 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -69.82 65.24 0.22 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.998 2.519 . . . . 0.0 116.5 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 . . . . . 0 C--N 1.357 0.916 0 C-N-CA 129.045 2.938 . . . . 0.0 114.152 -176.473 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.493 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.428 -1.56 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.3 m -172.57 173.38 4.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.48 -51.56 2.06 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 120.412 1.46 . . . . 0.0 112.263 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.3 t -170.6 142.66 2.07 Favored 'General case' 0 C--N 1.363 1.18 0 O-C-N 119.415 -2.053 . . . . 0.0 114.339 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.6 118.78 19.62 Favored 'General case' 0 C--N 1.377 1.772 0 O-C-N 121.417 -0.802 . . . . 0.0 109.887 167.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -105.87 114.91 29.35 Favored 'General case' 0 C--N 1.376 1.746 0 O-C-N 120.459 -1.401 . . . . 0.0 109.18 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.8 p -150.93 173.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.688 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.249 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -79.96 143.51 34.1 Favored 'General case' 0 C--N 1.369 1.456 0 C-N-CA 127.259 2.224 . . . . 0.0 105.432 157.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.433 5.1 pt-20 -44.21 122.88 3.15 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 117.338 -3.352 . . . . 0.0 118.626 -166.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.63 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 129.0 51.75 0.12 Allowed Glycine 0 C--N 1.352 1.467 0 C-N-CA 128.908 3.147 . . . . 0.0 110.741 -163.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.76 162.34 22.96 Favored 'General case' 0 C--N 1.375 1.689 0 C-N-CA 124.957 1.303 . . . . 0.0 112.339 171.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.91 105.87 14.43 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 124.628 1.171 . . . . 0.0 111.635 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.479 HD23 ' CZ ' ' A' ' 136' ' ' TYR 0.252 2.3 mp -119.73 129.88 54.72 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -173.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -114.87 137.93 51.39 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 166.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.623 HD11 ' CD1' ' A' ' 136' ' ' TYR . 3.9 mm? -113.69 115.62 28.15 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 102.104 -3.295 . . . . 0.0 102.104 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.493 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 2.5 t -154.62 132.47 11.52 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 120.933 1.697 . . . . 0.0 114.098 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 m -150.22 174.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.011 1 C-N-CA 133.643 4.777 . . . . 0.0 106.822 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.0 t -104.36 141.73 35.8 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 127.637 2.375 . . . . 0.0 106.734 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -139.2 145.95 39.93 Favored 'General case' 0 C--N 1.379 1.856 1 N-CA-C 123.228 4.529 . . . . 0.0 123.228 -174.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.4 p -156.58 175.49 13.97 Favored 'General case' 0 C--N 1.365 1.248 1 C-N-CA 133.34 4.656 . . . . 0.0 104.391 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.51 42.11 1.02 Allowed Glycine 0 C--N 1.365 2.162 0 O-C-N 119.802 -1.811 . . . . 0.0 117.318 168.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.18 28.35 28.28 Favored Glycine 0 C--N 1.361 1.966 0 C-N-CA 127.616 2.531 . . . . 0.0 115.412 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.406 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 59.3 m -117.67 110.88 18.42 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 114.217 -2.801 . . . . 0.0 108.453 174.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.91 -86.21 0.56 Allowed Glycine 0 C--N 1.38 3.007 0 C-N-CA 129.249 3.309 . . . . 0.0 110.389 -176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 101' ' ' THR . 20.0 Cg_exo -59.88 168.38 5.83 Favored 'Trans proline' 0 CA--C 1.57 2.312 1 C-N-CA 126.164 4.576 . . . . 0.0 115.676 158.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.559 ' HB3' HG12 ' A' ' 140' ' ' VAL . 77.7 m-85 -106.31 146.09 30.83 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 119.892 3.293 . . . . 0.0 119.892 -163.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.9 t -103.34 142.65 33.85 Favored 'General case' 0 C--N 1.38 1.928 0 C-N-CA 127.879 2.472 . . . . 0.0 104.358 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -142.43 165.4 27.5 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 122.783 4.364 . . . . 0.0 122.783 -161.555 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.42 119.06 18.09 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 128.265 2.626 . . . . 0.0 105.083 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -109.62 136.41 49.02 Favored 'General case' 0 C--N 1.368 1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 110.55 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.91 169.87 18.25 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 122.717 1.246 . . . . 0.0 107.69 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -144.73 105.64 4.17 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 175.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.469 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.16 1.8 t70 35.05 52.95 0.66 Allowed 'General case' 0 C--N 1.377 1.785 1 N-CA-C 122.307 4.188 . . . . 0.0 122.307 139.829 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.45 -4.77 85.86 Favored Glycine 0 C--N 1.369 2.384 2 O-C-N 133.53 6.769 . . . . 0.0 119.206 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.269 3.5 m -124.45 147.46 55.42 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 129.532 3.133 . . . . 0.0 118.329 -171.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.01 145.05 84.46 Favored 'Trans proline' 0 N--CA 1.493 1.498 1 C-N-CA 125.882 4.388 . . . . 0.0 114.722 171.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.09 159.04 30.57 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 118.739 -2.476 . . . . 0.0 112.244 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -67.42 87.73 0.33 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 125.247 3.965 . . . . 0.0 116.177 -175.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 74.62 -57.22 0.62 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 127.372 2.269 . . . . 0.0 115.425 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 74.13 174.83 0.26 Allowed 'General case' 0 CA--C 1.482 -1.657 0 C-N-CA 130.189 3.396 . . . . 0.0 116.494 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.408 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.3 OUTLIER 75.6 71.87 0.09 Allowed 'General case' 0 C--N 1.356 0.867 0 CA-C-N 114.114 -1.403 . . . . 0.0 114.735 171.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.42 -67.92 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 117.382 1.713 . . . . 0.0 117.382 -172.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 150.32 -69.86 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 126.503 1.921 . . . . 0.0 106.74 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.284 13.6 t -135.38 109.87 8.51 Favored 'General case' 0 C--N 1.363 1.153 0 CA-C-O 123.35 1.548 . . . . 0.0 113.878 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.368 9.1 p90 -127.23 142.12 51.56 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 129.473 3.109 . . . . 0.0 112.716 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.5 m -128.28 139.57 52.35 Favored 'General case' 0 C--N 1.366 1.288 0 O-C-N 119.323 -2.11 . . . . 0.0 110.305 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 100.23 44.33 Favored Pre-proline 0 C--N 1.366 1.324 0 C-N-CA 128.708 2.803 . . . . 0.0 106.411 175.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.26 -17.1 15.11 Favored 'Trans proline' 0 C--N 1.353 0.814 1 C-N-CA 126.096 4.531 . . . . 0.0 114.061 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.63 HG23 ' HA2' ' A' ' 88' ' ' GLY . 52.4 m -156.11 102.48 2.14 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 102.596 -3.113 . . . . 0.0 102.596 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.549 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.79 133.33 34.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.623 1.969 . . . . 0.0 111.499 175.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.5 -179.52 4.92 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.193 2.597 . . . . 0.0 111.027 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.02 -49.0 32.57 Favored 'General case' 0 C--N 1.366 1.305 0 N-CA-C 119.194 3.035 . . . . 0.0 119.194 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.35 -10.26 57.11 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 126.335 1.854 . . . . 0.0 114.53 173.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.549 ' CB ' ' HB1' ' A' ' 128' ' ' ALA 0.366 48.7 m-20 -80.41 -18.31 49.26 Favored 'General case' 0 CA--C 1.572 1.793 0 C-N-CA 129.581 3.152 . . . . 0.0 111.84 168.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.64 126.49 29.1 Favored 'General case' 0 C--N 1.387 2.212 0 N-CA-C 119.536 3.161 . . . . 0.0 119.536 168.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 160.44 -157.5 28.89 Favored Glycine 0 CA--C 1.459 -3.446 0 C-N-CA 127.117 2.294 . . . . 0.0 109.694 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 m -120.63 129.7 53.84 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 115.004 -2.679 . . . . 0.0 108.235 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.623 ' CD1' HD11 ' A' ' 93' ' ' LEU 0.274 30.1 m-85 -95.21 134.85 37.5 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 130.163 3.385 . . . . 0.0 111.651 -170.083 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.469 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -147.02 153.87 40.54 Favored 'General case' 0 C--N 1.369 1.429 0 C-N-CA 125.509 1.524 . . . . 0.0 108.202 -173.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 150' ' ' SER 0.43 2.4 p -143.58 134.3 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 117.677 -1.609 . . . . 0.0 114.339 -178.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.42 109.22 21.01 Favored 'General case' 0 C--N 1.385 2.132 0 C-N-CA 129.669 3.188 . . . . 0.0 106.345 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -127.7 118.62 49.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 C-N-CA 125.482 1.513 . . . . 0.0 111.037 -168.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 146' ' ' VAL . 11.1 m -104.32 130.86 52.14 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 120.451 -1.406 . . . . 0.0 113.552 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.497 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.344 18.9 p-10 -124.99 -176.58 3.59 Favored 'General case' 0 C--N 1.379 1.853 0 C-N-CA 124.312 1.045 . . . . 0.0 111.909 175.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 6.2 p -48.84 2.73 0.01 OUTLIER 'General case' 0 C--N 1.372 1.574 1 C-N-CA 137.428 6.291 . . . . 0.0 119.867 -168.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.76 4.29 35.04 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 118.16 -1.416 . . . . 0.0 107.678 163.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.435 93.6 mm-40 65.54 40.3 4.63 Favored 'General case' 0 C--N 1.374 1.662 1 C-N-CA 132.736 4.414 . . . . 0.0 110.783 -172.164 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.413 ' C ' HG23 ' A' ' 141' ' ' THR . 3.1 m -112.9 129.36 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 CA-C-N 111.944 -2.389 . . . . 0.0 112.201 -171.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.19 124.12 35.16 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 127.68 2.392 . . . . 0.0 108.205 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 157.43 25.23 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 128.308 2.643 . . . . 0.0 105.375 -173.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -121.46 132.09 54.53 Favored 'General case' 0 C--N 1.358 0.943 0 CA-C-O 124.611 2.148 . . . . 0.0 108.892 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.755 ' HB2' HG13 ' A' ' 138' ' ' VAL . 51.1 m -108.26 147.84 30.85 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 111.509 -2.587 . . . . 0.0 106.942 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.5 m -52.95 146.92 10.05 Favored 'General case' 0 CA--C 1.49 -1.36 1 C-N-CA 135.012 5.325 . . . . 0.0 119.477 -159.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.1 p -70.69 111.04 5.86 Favored 'General case' 0 C--N 1.368 1.403 0 C-N-CA 127.317 2.247 . . . . 0.0 109.321 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.74 110.46 22.77 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 102.214 -3.254 . . . . 0.0 102.214 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.24 113.37 25.6 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 123.247 1.499 . . . . 0.0 112.092 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.67 128.39 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 O-C-N 119.99 -1.694 . . . . 0.0 109.281 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 34.6 m . . . . . 0 CA--C 1.49 -1.362 0 N-CA-C 102.508 -3.145 . . . . 0.0 102.508 178.267 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.571 1.785 0 CA-C-O 120.828 0.347 . . . . 0.0 111.912 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.0 m -161.93 172.0 16.75 Favored 'General case' 0 C--N 1.347 0.465 0 O-C-N 116.835 -3.666 . . . . 0.0 103.856 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.72 -43.24 1.0 Allowed 'General case' 0 C--N 1.363 1.187 0 C-N-CA 126.792 2.037 . . . . 0.0 113.359 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.2 p -172.24 127.98 0.57 Allowed 'General case' 0 C--N 1.366 1.319 0 N-CA-C 118.426 2.751 . . . . 0.0 118.426 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.7 tpt -142.4 116.12 9.21 Favored 'General case' 0 C--N 1.377 1.785 0 CA-C-N 120.985 1.721 . . . . 0.0 109.909 162.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.4 p -112.81 116.39 29.99 Favored 'General case' 0 C--N 1.364 1.201 0 O-C-N 118.719 -2.488 . . . . 0.0 110.178 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.59 172.04 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 125.951 1.7 . . . . 0.0 110.331 -170.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -83.27 130.21 35.06 Favored 'General case' 0 C--N 1.373 1.615 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 164.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -41.73 122.4 1.99 Allowed 'General case' 0 C--N 1.372 1.555 0 N-CA-C 120.469 3.507 . . . . 0.0 120.469 -151.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.436 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 145.57 45.75 0.04 OUTLIER Glycine 0 C--N 1.363 2.052 0 CA-C-N 110.292 -3.14 . . . . 0.0 110.993 -166.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.64 165.7 17.71 Favored 'General case' 0 C--N 1.375 1.712 0 C-N-CA 125.336 1.454 . . . . 0.0 113.527 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.99 105.68 14.16 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 124.525 1.13 . . . . 0.0 110.85 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.443 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 4.5 mp -119.58 119.92 35.19 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.87 1.668 . . . . 0.0 114.388 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.87 127.04 53.69 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 173.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -123.78 114.73 20.29 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 173.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.9 m -151.18 132.94 14.96 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 119.63 -1.919 . . . . 0.0 110.909 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 m -148.97 175.18 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.406 0 C-N-CA 130.423 3.489 . . . . 0.0 104.605 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -104.24 139.39 39.33 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 127.511 2.324 . . . . 0.0 105.555 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.59 137.03 31.62 Favored 'General case' 0 C--N 1.379 1.891 1 N-CA-C 122.502 4.26 . . . . 0.0 122.502 -173.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.1 p -156.52 174.72 15.02 Favored 'General case' 0 C--N 1.359 0.991 1 C-N-CA 133.904 4.882 . . . . 0.0 101.25 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.66 40.7 1.37 Allowed Glycine 0 C--N 1.363 2.076 0 N-CA-C 118.102 2.001 . . . . 0.0 118.102 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.53 25.1 28.93 Favored Glycine 0 C--N 1.36 1.91 0 C-N-CA 127.8 2.619 . . . . 0.0 114.458 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 29.8 p -116.55 110.32 18.4 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 113.089 -3.339 . . . . 0.0 107.876 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.574 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 69.13 -86.93 0.23 Allowed Glycine 0 C--N 1.382 3.089 0 C-N-CA 130.014 3.674 . . . . 0.0 111.117 -170.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.91 168.88 5.2 Favored 'Trans proline' 0 CA--C 1.571 2.37 1 C-N-CA 127.514 5.476 . . . . 0.0 116.957 160.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.566 ' HB3' HG12 ' A' ' 140' ' ' VAL . 66.8 m-85 -98.6 144.27 28.08 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 119.758 3.244 . . . . 0.0 119.758 -167.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 t -102.51 159.16 15.68 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.438 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.5 OUTLIER -157.17 166.32 33.55 Favored 'General case' 0 C--N 1.365 1.255 0 N-CA-C 120.508 3.521 . . . . 0.0 120.508 -164.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.84 112.5 10.08 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 128.398 2.679 . . . . 0.0 105.846 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.456 ' HB2' HG13 ' A' ' 115' ' ' ILE . 7.4 m95 -112.64 142.73 44.89 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 125.346 1.458 . . . . 0.0 108.041 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.29 0.0 OUTLIER -158.25 161.36 37.74 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 166.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HZ1' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -133.01 103.89 6.27 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 116.717 -1.993 . . . . 0.0 115.873 177.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.458 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.226 1.7 t70 36.99 54.68 1.21 Allowed 'General case' 0 CA--C 1.455 -2.68 1 CA-C-O 111.111 -4.28 . . . . 0.0 119.918 154.075 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.11 -15.28 58.03 Favored Glycine 0 C--N 1.369 2.365 2 O-C-N 134.153 7.158 . . . . 0.0 116.681 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.424 ' HB3' ' HE2' ' A' ' 110' ' ' LYS 0.271 26.6 m -124.23 148.92 59.27 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 129.863 3.265 . . . . 0.0 116.909 -167.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.32 155.86 43.99 Favored 'Trans proline' 0 N--CA 1.502 2.01 1 C-N-CA 126.644 4.896 . . . . 0.0 116.323 171.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.456 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -104.58 147.53 34.56 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 119.539 -1.976 . . . . 0.0 110.162 174.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -58.8 -76.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.919 1 C-N-CA 126.504 4.802 . . . . 0.0 120.377 -165.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -141.54 64.75 1.4 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.83 -172.72 4.13 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 126.788 2.035 . . . . 0.0 115.498 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.309 8.4 t 101.79 13.13 0.01 OUTLIER 'General case' 0 C--N 1.354 0.783 0 C-N-CA 129.076 2.95 . . . . 0.0 111.825 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.81 96.75 0.1 Allowed Glycine 0 CA--C 1.475 -2.431 0 C-N-CA 116.733 -2.651 . . . . 0.0 117.687 166.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.481 . . 84.26 -84.52 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 170.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.9 t -138.92 121.1 15.8 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 122.316 2.325 . . . . 0.0 115.609 -170.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -127.66 139.69 52.56 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 127.638 2.375 . . . . 0.0 110.745 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 91' ' ' LEU . 35.1 m -129.76 139.91 51.18 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 119.33 -2.106 . . . . 0.0 109.774 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.35 98.04 41.92 Favored Pre-proline 0 C--N 1.363 1.159 0 C-N-CA 127.638 2.375 . . . . 0.0 107.316 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.12 -16.5 15.69 Favored 'Trans proline' 0 C--N 1.363 1.31 1 C-N-CA 126.635 4.89 . . . . 0.0 113.83 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.436 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -161.69 104.32 1.21 Allowed 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 102.426 -3.176 . . . . 0.0 102.426 177.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.458 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -90.74 134.37 34.47 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 128.382 2.673 . . . . 0.0 113.082 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.2 176.92 6.76 Favored 'General case' 0 C--N 1.37 1.473 0 C-N-CA 128.193 2.597 . . . . 0.0 111.031 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.9 -48.59 31.45 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 -172.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.8 -12.3 60.31 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 126.493 1.917 . . . . 0.0 114.65 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.581 ' HA ' ' HZ1' ' A' ' 110' ' ' LYS 0.354 32.0 m-20 -80.84 -18.64 46.77 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 129.873 3.269 . . . . 0.0 111.977 169.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.79 133.31 46.43 Favored 'General case' 0 C--N 1.379 1.882 0 N-CA-C 119.448 3.129 . . . . 0.0 119.448 166.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.47 -157.08 29.16 Favored Glycine 0 CA--C 1.461 -3.341 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 170.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.456 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.31 19.2 m -114.0 134.76 54.64 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 114.632 -2.827 . . . . 0.0 107.33 170.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.53 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 9.2 m-85 -96.66 133.5 41.11 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 122.014 2.188 . . . . 0.0 113.351 -172.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -140.95 145.6 36.25 Favored 'General case' 0 C--N 1.37 1.477 0 O-C-N 124.035 0.834 . . . . 0.0 109.458 -173.435 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.326 7.6 p -144.94 136.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.37 1.495 0 C-N-CA 118.289 -1.364 . . . . 0.0 113.834 176.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -104.31 118.05 35.68 Favored 'General case' 0 C--N 1.375 1.692 0 C-N-CA 130.081 3.352 . . . . 0.0 106.755 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.566 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -128.41 126.08 65.03 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 C-N-CA 127.572 2.349 . . . . 0.0 113.108 -173.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.48 HG23 ' C ' ' A' ' 146' ' ' VAL . 11.3 m -117.24 133.68 55.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 119.401 -2.062 . . . . 0.0 113.883 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.425 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.344 29.3 p-10 -126.46 -177.76 4.1 Favored 'General case' 0 C--N 1.376 1.725 0 CA-C-N 120.301 1.41 . . . . 0.0 112.798 174.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.574 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 66.2 p -49.64 3.75 0.01 OUTLIER 'General case' 0 C--N 1.366 1.324 1 C-N-CA 137.082 6.153 . . . . 0.0 121.01 -170.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -100.73 4.63 43.22 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 163.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.378 1.9 mp0 65.23 39.77 5.25 Favored 'General case' 0 C--N 1.379 1.86 1 C-N-CA 133.46 4.704 . . . . 0.0 110.783 -174.239 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.48 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.11 127.81 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 CA-C-N 111.541 -2.572 . . . . 0.0 110.974 -169.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.71 128.13 37.42 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 126.982 2.113 . . . . 0.0 107.735 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.75 156.15 27.68 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 128.083 2.553 . . . . 0.0 104.577 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -130.62 146.48 52.13 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.69 -1.256 . . . . 0.0 109.688 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.5 p -129.71 142.95 50.62 Favored 'General case' 0 C--O 1.253 1.24 0 C-N-CA 123.173 0.589 . . . . 0.0 111.627 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 m -54.57 147.24 14.66 Favored 'General case' 0 C--N 1.376 1.758 2 C-N-CA 136.582 5.953 . . . . 0.0 117.108 -163.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.3 p -68.14 110.76 4.13 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 129.754 3.222 . . . . 0.0 109.844 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.08 108.75 21.55 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -93.96 106.9 18.86 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-O 124.324 2.012 . . . . 0.0 110.838 -172.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.52 126.81 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 O-C-N 120.675 -1.266 . . . . 0.0 108.11 -173.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.5 m . . . . . 0 CA--C 1.483 -1.618 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.817 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.535 HD13 ' SG ' ' A' ' 153' ' ' CYS . 0.0 OUTLIER . . . . . 0 CA--C 1.578 2.02 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.0 m -172.04 179.53 2.64 Favored 'General case' 0 N--CA 1.468 0.434 1 N-CA-C 99.647 -4.205 . . . . 0.0 99.647 173.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.51 -48.69 1.17 Allowed 'General case' 0 C--N 1.355 0.838 0 CA-C-N 121.508 1.958 . . . . 0.0 108.773 169.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.4 t -172.07 134.52 0.75 Allowed 'General case' 0 C--N 1.356 0.876 0 O-C-N 120.396 -1.44 . . . . 0.0 113.106 174.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 54.5 ttm -134.36 116.91 15.77 Favored 'General case' 0 C--N 1.369 1.446 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 162.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 p -108.57 115.36 29.95 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 119.727 -1.858 . . . . 0.0 107.327 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 p -149.62 174.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 125.88 1.672 . . . . 0.0 111.857 -165.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -79.22 134.2 36.67 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 126.959 2.104 . . . . 0.0 105.689 161.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.39 0.0 OUTLIER -43.63 122.88 2.87 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 -164.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.537 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 135.0 52.53 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 128.372 2.892 . . . . 0.0 107.654 -165.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.423 ' HB1' HG22 ' A' ' 155' ' ' VAL . . . -91.75 153.23 19.76 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 126.577 1.951 . . . . 0.0 108.932 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.15 110.72 21.68 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -166.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.442 HD13 ' CZ ' ' A' ' 136' ' ' TYR . 4.8 mt -120.62 144.44 48.14 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -126.86 138.51 53.34 Favored 'General case' 0 CA--C 1.506 -0.734 1 N-CA-C 100.165 -4.013 . . . . 0.0 100.165 166.347 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.4 HD23 ' CE3' ' A' ' 108' ' ' TRP . 4.0 mp -121.86 113.95 20.36 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 100.608 -3.849 . . . . 0.0 100.608 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.503 ' H ' HD23 ' A' ' 79' ' ' LEU . 4.0 t -150.33 133.4 16.16 Favored 'General case' 0 C--N 1.369 1.423 0 CA-C-N 119.568 1.077 . . . . 0.0 112.717 -173.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.76 173.94 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.879 1 C-N-CA 132.191 4.196 . . . . 0.0 104.396 175.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.2 t -103.0 141.81 35.17 Favored 'General case' 0 C--N 1.367 1.334 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.5 140.87 46.5 Favored 'General case' 0 C--N 1.368 1.408 1 N-CA-C 122.285 4.18 . . . . 0.0 122.285 -171.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.0 m -158.24 174.26 15.44 Favored 'General case' 0 C--N 1.357 0.891 0 C-N-CA 130.797 3.639 . . . . 0.0 102.222 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.82 43.7 2.2 Favored Glycine 0 C--N 1.365 2.16 0 CA-C-N 122.763 2.529 . . . . 0.0 116.714 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.52 21.33 62.28 Favored Glycine 0 C--N 1.359 1.832 0 C-N-CA 128.413 2.911 . . . . 0.0 114.082 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.7 p -117.1 110.94 18.82 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.271 1.829 . . . . 0.0 108.457 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.659 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.34 -96.64 1.02 Allowed Glycine 0 C--N 1.371 2.488 0 C-N-CA 127.943 2.687 . . . . 0.0 110.985 -168.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.98 169.22 10.78 Favored 'Trans proline' 0 CA--C 1.556 1.579 1 C-N-CA 127.258 5.305 . . . . 0.0 116.855 159.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.49 ' HB3' HG12 ' A' ' 140' ' ' VAL . 58.5 m-85 -92.1 148.07 22.46 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 120.782 3.623 . . . . 0.0 120.782 -168.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -102.84 141.45 35.63 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 129.097 2.959 . . . . 0.0 104.439 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.402 ' HD1' ' HA ' ' A' ' 119' ' ' SER . 0.1 OUTLIER -124.72 159.47 30.81 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 120.076 3.361 . . . . 0.0 120.076 -166.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.0 117.53 20.19 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 101.865 -3.383 . . . . 0.0 101.865 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.437 ' HB3' HG13 ' A' ' 115' ' ' ILE . 94.8 m95 -107.23 134.76 49.85 Favored 'General case' 0 C--N 1.363 1.176 0 C-N-CA 124.664 1.185 . . . . 0.0 109.073 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.7 170.31 19.52 Favored 'General case' 0 CA--C 1.487 -1.451 0 O-C-N 120.34 -1.475 . . . . 0.0 108.311 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.5 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.5 ptmm? -148.32 106.46 3.73 Favored 'General case' 0 N--CA 1.423 -1.795 0 O-C-N 119.643 -1.91 . . . . 0.0 108.45 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.213 0.9 OUTLIER 35.27 54.31 0.77 Allowed 'General case' 0 CA--C 1.47 -2.114 2 CA-C-O 109.472 -5.061 . . . . 0.0 122.73 146.212 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.55 -0.42 85.45 Favored Glycine 0 C--N 1.384 3.242 2 O-C-N 135.113 7.758 . . . . 0.0 118.887 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.3 0.9 OUTLIER -124.49 147.57 55.85 Favored Pre-proline 0 CA--C 1.563 1.474 0 C-N-CA 129.429 3.091 . . . . 0.0 118.812 -167.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.75 139.17 56.53 Favored 'Trans proline' 0 N--CA 1.5 1.887 1 C-N-CA 125.992 4.461 . . . . 0.0 117.15 170.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -89.18 162.46 37.37 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 118.374 -2.704 . . . . 0.0 114.303 177.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 8.3 Cg_endo -67.89 94.02 0.39 Allowed 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.564 4.176 . . . . 0.0 115.556 -178.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.3 t70 82.05 -72.14 0.05 OUTLIER 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.61 2.364 . . . . 0.0 110.921 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.661 ' HB2' HD11 ' A' ' 115' ' ' ILE . . . 97.06 142.45 0.02 OUTLIER 'General case' 0 CA--C 1.479 -1.767 0 C-N-CA 129.057 2.943 . . . . 0.0 111.757 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.402 ' HA ' ' HD1' ' A' ' 106' ' ' TYR 0.281 0.2 OUTLIER 82.48 53.54 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.028 -1.896 . . . . 0.0 112.709 179.056 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.58 -55.84 0.32 Allowed Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 116.305 1.282 . . . . 0.0 116.305 -168.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.304 . . 103.43 -47.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.395 0 C-N-CA 126.59 1.956 . . . . 0.0 113.953 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.4 6.4 t -145.92 92.6 2.22 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 124.135 1.921 . . . . 0.0 109.582 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.291 4.3 p90 -126.88 142.18 51.61 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 129.003 2.921 . . . . 0.0 111.332 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.5 m -124.97 139.66 53.62 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 120.096 -1.628 . . . . 0.0 109.349 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 89.5 45.97 Favored Pre-proline 0 C--N 1.354 0.799 0 C-N-CA 127.937 2.495 . . . . 0.0 107.857 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -68.16 -32.57 27.01 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 124.712 3.608 . . . . 0.0 115.335 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.537 HG23 ' HA2' ' A' ' 88' ' ' GLY . 96.3 m -130.18 100.67 5.49 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.3 118.63 29.95 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.918 1.287 . . . . 0.0 113.555 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.07 -179.84 6.54 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.348 2.659 . . . . 0.0 109.646 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.87 -51.26 23.68 Favored 'General case' 0 C--N 1.368 1.387 0 O-C-N 118.16 -2.837 . . . . 0.0 117.761 -174.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -68.08 0.17 3.89 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 128.45 2.7 . . . . 0.0 114.966 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -116.66 -12.08 10.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 130.435 3.494 . . . . 0.0 111.316 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.34 157.26 16.3 Favored 'General case' 0 C--N 1.394 2.509 0 N-CA-C 119.409 3.115 . . . . 0.0 119.409 174.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 152.43 -158.36 27.8 Favored Glycine 0 C--N 1.39 3.535 0 C-N-CA 128.832 3.111 . . . . 0.0 111.042 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.485 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.328 3.8 m -106.07 131.94 52.74 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 112.947 -3.501 . . . . 0.0 105.989 167.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.556 ' HB2' ' HB2' ' A' ' 153' ' ' CYS . 18.3 m-85 -97.23 134.96 39.84 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 122.757 2.526 . . . . 0.0 113.599 -172.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.515 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -147.97 152.3 37.25 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-O 122.422 1.106 . . . . 0.0 110.175 -174.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.254 8.3 p -135.91 137.69 48.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 118.471 -1.292 . . . . 0.0 113.901 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.3 m -105.69 116.61 32.23 Favored 'General case' 0 C--N 1.377 1.787 0 C-N-CA 129.098 2.959 . . . . 0.0 104.925 176.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -130.88 119.09 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 124.086 0.954 . . . . 0.0 109.67 -167.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 146' ' ' VAL . 10.2 m -103.73 128.8 51.06 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 120.951 -1.093 . . . . 0.0 113.497 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.465 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.488 11.1 p-10 -127.55 -174.78 3.27 Favored 'General case' 0 C--N 1.371 1.52 0 CA-C-N 119.191 0.905 . . . . 0.0 111.84 174.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.659 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 80.5 p -49.97 2.44 0.01 OUTLIER 'General case' 0 C--N 1.361 1.069 2 C-N-CA 135.549 5.54 . . . . 0.0 121.816 -163.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.52 4.37 38.5 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 164.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.394 68.8 mm-40 66.39 40.01 3.78 Favored 'General case' 0 C--N 1.375 1.678 1 C-N-CA 132.803 4.441 . . . . 0.0 110.84 -172.623 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.43 ' C ' HG23 ' A' ' 141' ' ' THR . 3.9 m -113.26 129.8 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.253 -171.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.29 123.58 34.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 126.661 1.984 . . . . 0.0 107.691 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.55 157.53 25.11 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 -175.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -128.68 132.22 48.03 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.646 -1.284 . . . . 0.0 109.706 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.474 55.9 p -114.35 151.88 32.32 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 123.75 0.82 . . . . 0.0 111.13 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -53.69 146.81 12.62 Favored 'General case' 0 C--N 1.371 1.508 1 C-N-CA 133.843 4.857 . . . . 0.0 120.146 -153.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 64.5 p -70.33 110.96 5.57 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 129.745 3.218 . . . . 0.0 109.323 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 18.0 m -106.01 109.62 21.63 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.58 107.23 19.62 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 124.773 2.225 . . . . 0.0 111.308 -170.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.423 HG22 ' HB1' ' A' ' 89' ' ' ALA 0.263 1.1 t -118.0 114.95 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 -172.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 C--N 1.368 1.373 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -174.45 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.577 2.005 0 CA-C-O 121.756 0.788 . . . . 0.0 112.336 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.2 m -164.81 171.32 14.37 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 116.667 -3.77 . . . . 0.0 103.785 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.41 -45.41 1.51 Allowed 'General case' 0 C--N 1.366 1.315 0 C-N-CA 127.031 2.132 . . . . 0.0 112.932 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 86.1 p -176.17 134.12 0.25 Allowed 'General case' 0 C--N 1.365 1.262 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.6 ttt -134.75 117.93 16.52 Favored 'General case' 0 C--N 1.373 1.629 0 CA-C-N 119.696 1.134 . . . . 0.0 109.203 159.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.5 p -111.13 116.15 30.62 Favored 'General case' 0 C--N 1.363 1.188 0 O-C-N 119.482 -2.011 . . . . 0.0 109.789 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.74 171.98 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 126.825 2.05 . . . . 0.0 112.937 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.4 127.56 33.79 Favored 'General case' 0 C--N 1.372 1.55 0 O-C-N 118.961 -2.337 . . . . 0.0 105.258 163.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.278 8.6 pt-20 -41.83 122.57 2.07 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 120.389 3.477 . . . . 0.0 120.389 -150.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 144.34 54.71 0.03 OUTLIER Glycine 0 C--N 1.356 1.639 0 CA-C-N 109.656 -3.429 . . . . 0.0 110.55 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.11 158.79 23.56 Favored 'General case' 0 C--N 1.372 1.58 0 C-N-CA 125.482 1.513 . . . . 0.0 113.101 174.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.91 101.62 9.92 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 125.415 1.486 . . . . 0.0 112.312 -174.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.533 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 1.1 mp -119.79 130.83 55.13 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 125.943 1.697 . . . . 0.0 115.318 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.98 132.8 53.9 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 172.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.636 HD21 ' CD2' ' A' ' 136' ' ' TYR . 3.1 mp -131.83 115.16 15.58 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 170.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -148.1 133.84 18.93 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.529 -1.357 . . . . 0.0 110.981 -174.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.7 174.57 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 129.549 3.14 . . . . 0.0 104.0 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 t -104.26 141.38 36.39 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 126.948 2.099 . . . . 0.0 105.696 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.31 134.2 32.23 Favored 'General case' 0 C--N 1.37 1.472 0 N-CA-C 120.127 3.38 . . . . 0.0 120.127 -172.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.3 m -157.86 174.04 15.88 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 131.363 3.865 . . . . 0.0 100.843 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.52 44.24 2.21 Favored Glycine 0 C--N 1.363 2.045 0 CA-C-N 122.584 2.447 . . . . 0.0 117.582 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.4 12.73 81.63 Favored Glycine 0 C--N 1.362 1.991 0 C-N-CA 128.705 3.05 . . . . 0.0 113.068 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.7 p -115.87 111.17 20.05 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 126.481 1.913 . . . . 0.0 107.396 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.513 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 71.83 -101.4 1.01 Allowed Glycine 0 C--N 1.36 1.886 0 C-N-CA 127.181 2.324 . . . . 0.0 109.315 -161.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.79 168.32 7.22 Favored 'Trans proline' 0 CA--C 1.555 1.573 1 C-N-CA 129.227 6.618 . . . . 0.0 118.349 165.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.541 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.6 m-85 -82.07 138.86 34.73 Favored 'General case' 0 CA--C 1.562 1.419 1 N-CA-C 122.274 4.175 . . . . 0.0 122.274 -170.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 t -102.82 154.96 18.68 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 129.756 3.223 . . . . 0.0 104.309 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.475 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.5 OUTLIER -153.71 166.27 33.35 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -165.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.2 112.81 10.76 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 128.417 2.687 . . . . 0.0 105.64 170.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.407 ' HB3' HG13 ' A' ' 115' ' ' ILE . 94.1 m95 -111.94 137.5 49.85 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.349 1.859 . . . . 0.0 108.595 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.308 0.2 OUTLIER -158.61 162.77 37.35 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.32 -1.487 . . . . 0.0 107.427 168.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.503 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -137.31 103.59 5.14 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 116.954 -1.898 . . . . 0.0 115.412 177.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.153 2.3 t70 36.6 53.82 1.07 Allowed 'General case' 0 CA--C 1.467 -2.22 1 CA-C-O 111.433 -4.127 . . . . 0.0 119.609 153.898 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.71 -0.56 70.46 Favored Glycine 0 C--N 1.373 2.6 2 O-C-N 134.227 7.204 . . . . 0.0 117.38 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.4 ' HB2' ' HE3' ' A' ' 110' ' ' LYS 0.384 1.3 p -124.82 147.8 57.51 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 130.074 3.349 . . . . 0.0 119.445 -167.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.02 143.7 79.7 Favored 'Trans proline' 0 N--CA 1.498 1.747 1 C-N-CA 125.964 4.442 . . . . 0.0 115.817 167.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -94.99 144.91 28.6 Favored Pre-proline 0 CA--C 1.551 1.004 0 O-C-N 119.437 -2.039 . . . . 0.0 112.916 176.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.55 93.43 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.447 1 C-N-CA 125.938 4.425 . . . . 0.0 118.83 -172.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.3 t70 65.1 48.26 2.28 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 169.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.32 -165.64 0.9 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 127.598 2.359 . . . . 0.0 115.694 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.304 8.4 t 99.92 8.04 0.01 OUTLIER 'General case' 0 C--N 1.354 0.765 0 C-N-CA 128.959 2.904 . . . . 0.0 112.121 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.2 91.77 0.08 OUTLIER Glycine 0 CA--C 1.48 -2.129 0 C-N-CA 115.979 -3.01 . . . . 0.0 118.568 167.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.461 . . 89.6 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 167.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.0 t -139.32 118.27 12.5 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 122.106 2.23 . . . . 0.0 115.915 -169.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -127.63 140.13 52.29 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 127.381 2.272 . . . . 0.0 111.197 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 91' ' ' LEU . 89.1 m -129.25 140.55 51.41 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 119.306 -2.121 . . . . 0.0 109.68 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.411 ' HB3' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.85 95.97 31.21 Favored Pre-proline 0 C--N 1.366 1.293 0 C-N-CA 128.203 2.601 . . . . 0.0 108.455 178.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.19 -14.11 16.77 Favored 'Trans proline' 0 C--N 1.356 0.948 1 C-N-CA 126.278 4.652 . . . . 0.0 113.563 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.47 HG23 ' HA2' ' A' ' 88' ' ' GLY . 95.5 m -161.6 101.0 1.18 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 102.43 -3.174 . . . . 0.0 102.43 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.48 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -83.12 134.05 35.02 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.83 2.452 . . . . 0.0 112.183 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.62 173.19 7.74 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 127.935 2.494 . . . . 0.0 110.086 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -41.12 23.61 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 120.166 3.395 . . . . 0.0 120.166 -173.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -66.95 -14.57 62.96 Favored 'General case' 0 C--N 1.366 1.317 0 C-N-CA 126.801 2.04 . . . . 0.0 115.393 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.48 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 42.7 m-20 -80.42 -17.05 52.94 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 129.475 3.11 . . . . 0.0 111.559 168.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.86 107.88 2.79 Favored 'General case' 0 C--N 1.384 2.077 0 N-CA-C 120.45 3.5 . . . . 0.0 120.45 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.65 -154.12 19.13 Favored Glycine 0 CA--C 1.459 -3.413 0 C-N-CA 126.77 2.129 . . . . 0.0 108.935 172.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.433 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.288 19.6 m -117.64 135.49 53.95 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 114.892 -2.723 . . . . 0.0 108.296 175.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.636 ' CD2' HD21 ' A' ' 93' ' ' LEU . 10.1 m-85 -96.77 133.32 41.5 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 120.299 -1.501 . . . . 0.0 113.487 -171.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.466 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -146.05 149.32 33.87 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 121.573 0.702 . . . . 0.0 110.782 -173.032 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.6 p -142.49 142.94 26.51 Favored 'Isoleucine or valine' 0 C--N 1.372 1.56 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -105.15 118.45 36.58 Favored 'General case' 0 C--N 1.375 1.681 0 C-N-CA 129.732 3.213 . . . . 0.0 105.333 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -129.1 122.66 56.86 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 126.765 2.026 . . . . 0.0 112.347 -175.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.453 HG23 ' C ' ' A' ' 146' ' ' VAL . 17.4 m -111.78 133.96 53.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 118.995 -2.315 . . . . 0.0 114.043 -177.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . 0.591 4.4 p30 -134.86 -167.18 1.94 Allowed 'General case' 0 C--N 1.373 1.62 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 173.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.513 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 90.6 p -48.88 3.51 0.01 OUTLIER 'General case' 0 C--N 1.366 1.297 2 C-N-CA 134.838 5.255 . . . . 0.0 122.208 -158.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -106.75 4.87 28.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.468 164.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.397 89.3 mm-40 66.19 40.19 3.93 Favored 'General case' 0 C--N 1.375 1.696 1 C-N-CA 132.077 4.151 . . . . 0.0 110.455 -171.72 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.453 ' C ' HG23 ' A' ' 141' ' ' THR . 3.9 m -112.92 129.85 67.82 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.376 0 CA-C-N 111.759 -2.473 . . . . 0.0 111.362 -171.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.6 OUTLIER -91.89 130.54 37.63 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.885 1.274 . . . . 0.0 110.027 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.93 156.99 26.45 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 128.172 2.589 . . . . 0.0 104.913 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -130.5 146.72 52.09 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 120.877 -1.139 . . . . 0.0 108.128 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.337 88.4 p -130.82 143.83 51.02 Favored 'General case' 0 C--O 1.251 1.133 0 O-C-N 121.726 -0.609 . . . . 0.0 110.734 175.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.0 m -54.35 148.02 12.49 Favored 'General case' 0 CA--C 1.481 -1.675 2 C-N-CA 137.127 6.171 . . . . 0.0 118.089 -162.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 65.5 p -68.38 110.35 4.08 Favored 'General case' 0 C--N 1.375 1.675 0 CA-C-N 111.865 -2.425 . . . . 0.0 109.136 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 109.78 22.47 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 102.172 -3.27 . . . . 0.0 102.172 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.42 114.58 27.17 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 125.125 2.393 . . . . 0.0 110.628 -174.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.4 t -117.83 117.4 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.2 m . . . . . 0 CA--C 1.492 -1.257 0 N-CA-C 103.182 -2.895 . . . . 0.0 103.182 173.123 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.4 ' O ' HG22 ' A' ' 92' ' ' THR . 0.0 OUTLIER . . . . . 0 CA--C 1.561 1.365 0 N-CA-C 121.003 3.705 . . . . 0.0 121.003 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 m -173.78 172.37 3.54 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 102.982 -2.969 . . . . 0.0 102.982 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.01 -52.79 2.59 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.294 -1.504 . . . . 0.0 110.205 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 t -172.16 136.04 0.82 Allowed 'General case' 0 C--N 1.357 0.928 0 O-C-N 119.842 -1.786 . . . . 0.0 113.709 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 25.0 ttt -130.56 117.9 20.25 Favored 'General case' 0 C--N 1.373 1.605 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 163.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -105.5 115.61 30.55 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 119.612 -1.93 . . . . 0.0 107.496 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.24 173.72 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.752 0 CA-C-O 123.255 1.502 . . . . 0.0 112.208 -168.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.02 132.65 36.04 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 126.864 2.066 . . . . 0.0 105.455 159.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.29 0.3 OUTLIER -43.77 121.71 2.48 Favored 'General case' 0 N--CA 1.513 2.719 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 -161.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.581 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 138.44 51.66 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.226 0 CA-C-N 111.446 -2.615 . . . . 0.0 108.938 -164.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.13 163.34 17.91 Favored 'General case' 0 C--N 1.367 1.352 0 C-N-CA 125.804 1.642 . . . . 0.0 111.455 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.15 105.69 14.48 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.925 0.89 . . . . 0.0 112.755 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.482 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 3.7 mp -119.87 120.22 35.82 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 126.505 1.922 . . . . 0.0 115.313 -172.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -106.75 126.37 52.2 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 170.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.34 114.87 18.14 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 103.452 -2.795 . . . . 0.0 103.452 176.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -156.75 140.32 15.9 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.951 -1.093 . . . . 0.0 109.63 -172.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.64 172.73 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 129.395 3.078 . . . . 0.0 104.884 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.3 t -104.01 141.76 35.63 Favored 'General case' 0 C--N 1.373 1.605 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . . . -125.26 149.88 47.59 Favored 'General case' 0 C--N 1.363 1.194 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.4 m -159.4 174.92 13.99 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.17 42.48 2.74 Favored Glycine 0 C--N 1.362 2.009 0 CA-C-N 122.905 2.593 . . . . 0.0 116.239 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.84 0.8 60.22 Favored Glycine 0 C--N 1.362 1.979 0 C-N-CA 125.649 1.595 . . . . 0.0 114.393 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.9 m -117.24 123.91 47.76 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.346 1.458 . . . . 0.0 110.034 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.611 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.45 -113.26 4.36 Favored Glycine 0 C--N 1.361 1.917 0 CA-C-O 116.153 -2.47 . . . . 0.0 108.798 -163.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -66.96 168.45 17.18 Favored 'Trans proline' 0 CA--C 1.564 1.985 1 C-N-CA 127.759 5.64 . . . . 0.0 117.353 163.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.469 ' HB3' HG12 ' A' ' 140' ' ' VAL . 27.4 m-85 -82.1 144.33 30.87 Favored 'General case' 0 C--N 1.358 0.947 1 N-CA-C 125.453 5.353 . . . . 0.0 125.453 -164.494 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.3 t -103.24 141.47 35.84 Favored 'General case' 0 C--N 1.371 1.529 0 C-N-CA 127.914 2.486 . . . . 0.0 104.525 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.544 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.6 OUTLIER -137.39 160.32 39.43 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 120.354 3.464 . . . . 0.0 120.354 -166.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.08 113.69 9.09 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 110.593 -3.003 . . . . 0.0 105.112 173.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -111.98 154.77 24.8 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 120.676 -1.265 . . . . 0.0 108.595 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.383 0.2 OUTLIER -158.3 168.73 26.2 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 166.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.507 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.0 OUTLIER -144.5 105.01 4.12 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 120.138 -1.601 . . . . 0.0 114.911 -178.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.513 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.224 0.6 OUTLIER 36.39 53.75 1.01 Allowed 'General case' 0 CA--C 1.464 -2.336 1 CA-C-O 111.394 -4.145 . . . . 0.0 119.198 153.699 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.38 -0.65 78.24 Favored Glycine 0 C--N 1.373 2.607 2 O-C-N 134.747 7.529 . . . . 0.0 118.375 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.268 58.2 m -124.89 148.87 61.15 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 120.304 3.446 . . . . 0.0 120.304 -167.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -60.22 148.75 88.69 Favored 'Trans proline' 0 N--CA 1.507 2.301 1 C-N-CA 126.231 4.62 . . . . 0.0 116.194 166.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.591 ' HB ' ' HD2' ' A' ' 116' ' ' PRO 0.325 0.8 OUTLIER -98.64 165.1 15.71 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 117.846 -3.034 . . . . 0.0 112.285 175.279 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 6.0 Cg_endo -69.2 87.92 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.739 1 C-N-CA 125.826 4.351 . . . . 0.0 113.984 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.6 t70 84.99 -57.51 0.09 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.877 3.271 . . . . 0.0 110.612 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.302 . . 102.97 -62.87 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 130.715 3.606 . . . . 0.0 115.285 171.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.301 8.0 t -73.7 80.12 1.54 Allowed 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 130.732 3.613 . . . . 0.0 113.886 -174.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.94 -71.48 0.02 OUTLIER Glycine 0 C--N 1.36 1.867 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 -172.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 97' ' ' ALA 0.318 . . 129.4 -24.73 0.01 OUTLIER 'General case' 0 C--N 1.365 1.247 0 C-N-CA 127.265 2.226 . . . . 0.0 116.044 178.008 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.34 15.0 t -154.85 102.23 2.34 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-N 121.013 1.733 . . . . 0.0 112.657 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.313 0.1 OUTLIER -127.43 141.48 51.67 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 127.897 2.479 . . . . 0.0 111.472 176.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 91' ' ' LEU . 60.1 m -128.32 138.65 52.48 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 118.991 -2.318 . . . . 0.0 107.28 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.89 102.72 52.88 Favored Pre-proline 0 C--N 1.362 1.137 0 C-N-CA 128.042 2.537 . . . . 0.0 105.209 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -77.04 -11.86 17.77 Favored 'Trans proline' 0 C--N 1.348 0.548 1 C-N-CA 126.227 4.618 . . . . 0.0 112.731 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.581 HG23 ' HA2' ' A' ' 88' ' ' GLY . 62.1 m -157.22 100.9 1.87 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.46 128.47 39.56 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 124.312 1.045 . . . . 0.0 112.317 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.27 179.06 5.17 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 129.462 3.105 . . . . 0.0 108.574 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.62 -53.96 13.26 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -172.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.38 0.93 3.37 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 127.234 2.213 . . . . 0.0 115.788 172.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -113.8 -13.79 12.59 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 130.362 3.465 . . . . 0.0 110.695 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.28 160.18 14.46 Favored 'General case' 0 C--N 1.4 2.775 0 N-CA-C 120.157 3.391 . . . . 0.0 120.157 171.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.6 -158.59 27.75 Favored Glycine 0 CA--C 1.469 -2.831 0 C-N-CA 128.585 2.993 . . . . 0.0 106.905 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.416 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.331 1.2 m -105.8 129.39 54.0 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 114.677 -2.809 . . . . 0.0 107.559 168.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.507 ' CZ ' ' HD2' ' A' ' 110' ' ' LYS . 12.7 m-85 -96.59 134.92 39.21 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 123.404 2.82 . . . . 0.0 113.159 -171.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -146.16 152.15 38.78 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 123.9 0.88 . . . . 0.0 110.385 -175.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 149' ' ' ASP . 8.5 p -142.95 141.12 27.11 Favored 'Isoleucine or valine' 0 C--N 1.371 1.525 0 C-N-CA 117.474 -1.69 . . . . 0.0 114.928 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 61.5 m -103.64 110.98 23.26 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 129.96 3.304 . . . . 0.0 106.206 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -123.78 114.9 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.334 2.254 . . . . 0.0 109.87 -172.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.433 HG23 ' C ' ' A' ' 146' ' ' VAL . 4.7 m -102.16 130.15 48.72 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.322 -1.486 . . . . 0.0 113.807 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.401 ' CG ' ' CE2' ' A' ' 104' ' ' TYR 0.481 7.1 p30 -138.39 -165.38 1.8 Allowed 'General case' 0 C--N 1.371 1.531 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 174.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.611 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 91.3 p -48.91 3.69 0.01 OUTLIER 'General case' 0 C--N 1.369 1.45 2 C-N-CA 134.986 5.315 . . . . 0.0 123.135 -163.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -105.65 5.92 31.58 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 163.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.395 6.9 mm100 64.27 39.98 6.97 Favored 'General case' 0 C--N 1.374 1.655 1 C-N-CA 133.403 4.681 . . . . 0.0 111.261 -171.164 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.433 ' C ' HG23 ' A' ' 141' ' ' THR . 3.1 m -113.88 134.77 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.826 0 CA-C-N 111.774 -2.466 . . . . 0.0 112.318 -170.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.14 123.45 34.61 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 129.13 2.972 . . . . 0.0 106.287 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.82 157.84 24.93 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 128.781 2.833 . . . . 0.0 105.038 -175.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 30.3 t70 -125.82 134.23 51.74 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 122.284 1.04 . . . . 0.0 109.108 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.508 54.2 p -111.79 146.8 36.99 Favored 'General case' 0 C--O 1.252 1.227 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.0 m -53.95 147.87 11.57 Favored 'General case' 0 C--N 1.375 1.702 1 C-N-CA 135.261 5.424 . . . . 0.0 120.004 -157.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.3 p -69.38 110.89 4.92 Favored 'General case' 0 C--N 1.37 1.468 0 C-N-CA 126.115 1.766 . . . . 0.0 110.192 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.36 109.46 21.1 Favored 'General case' 0 C--N 1.358 0.957 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -94.54 107.22 19.21 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-O 123.622 1.677 . . . . 0.0 110.99 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.82 115.09 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.369 1.415 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.53 -174.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.49 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.9 m -171.97 172.63 4.67 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 100.483 -3.895 . . . . 0.0 100.483 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.47 -51.32 1.96 Allowed 'General case' 0 C--N 1.351 0.673 0 CA-C-N 120.561 1.528 . . . . 0.0 111.117 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.4 t -172.62 145.41 1.55 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 120.35 -1.469 . . . . 0.0 114.728 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.5 ttt -135.7 128.57 31.23 Favored 'General case' 0 C--N 1.371 1.517 0 O-C-N 121.36 -0.837 . . . . 0.0 109.608 160.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 p -104.9 114.49 28.72 Favored 'General case' 0 C--N 1.373 1.611 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 86' ' ' GLU 0.252 7.4 p -149.87 174.03 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.899 -167.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 85' ' ' VAL . 1.3 pp20? -89.31 144.23 26.24 Favored 'General case' 0 C--N 1.364 1.209 0 O-C-N 119.392 -2.067 . . . . 0.0 106.813 163.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.473 3.8 pt-20 -44.39 124.91 4.35 Favored 'General case' 0 N--CA 1.516 2.847 0 O-C-N 118.121 -2.862 . . . . 0.0 117.863 -172.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.542 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 122.05 50.4 0.24 Allowed Glycine 0 C--N 1.345 1.049 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 -150.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 128' ' ' ALA . . . -97.04 152.28 18.9 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 127.023 2.129 . . . . 0.0 111.663 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.05 113.79 26.79 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-O 122.466 1.127 . . . . 0.0 113.632 -169.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.578 HD12 ' SG ' ' A' ' 153' ' ' CYS . 0.3 OUTLIER -121.03 138.1 54.33 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 126.343 1.857 . . . . 0.0 115.9 174.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -123.87 137.38 54.66 Favored 'General case' 0 CA--C 1.494 -1.173 1 N-CA-C 99.817 -4.142 . . . . 0.0 99.817 160.682 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 136' ' ' TYR . 4.0 mp -122.29 115.13 21.79 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 101.003 -3.702 . . . . 0.0 101.003 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.49 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 5.7 t -152.49 132.27 13.22 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -174.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.84 174.43 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.052 1 C-N-CA 132.476 4.31 . . . . 0.0 105.629 176.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.3 t -104.15 141.24 36.59 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 119.773 -1.83 . . . . 0.0 107.72 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.76 146.01 35.47 Favored 'General case' 0 C--N 1.382 2.008 1 N-CA-C 124.947 5.166 . . . . 0.0 124.947 -173.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.9 p -156.95 175.33 14.24 Favored 'General case' 0 C--N 1.369 1.414 1 C-N-CA 133.786 4.834 . . . . 0.0 104.031 177.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.06 42.91 0.79 Allowed Glycine 0 C--N 1.367 2.273 0 O-C-N 119.597 -1.939 . . . . 0.0 117.779 171.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.85 25.69 52.05 Favored Glycine 0 C--N 1.361 1.961 0 C-N-CA 128.396 2.903 . . . . 0.0 114.851 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.4 p -116.91 110.01 17.78 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 116.519 -1.705 . . . . 0.0 108.368 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.66 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 71.8 -90.63 0.49 Allowed Glycine 0 C--N 1.371 2.516 0 C-N-CA 129.408 3.385 . . . . 0.0 110.731 -167.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.89 169.32 4.72 Favored 'Trans proline' 0 CA--C 1.564 1.975 1 C-N-CA 128.054 5.836 . . . . 0.0 117.326 160.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.528 ' HB3' HG12 ' A' ' 140' ' ' VAL . 64.7 m-85 -94.74 143.18 26.66 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 120.373 3.472 . . . . 0.0 120.373 -167.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.8 t -103.24 142.34 34.35 Favored 'General case' 0 C--N 1.382 1.999 0 C-N-CA 128.772 2.829 . . . . 0.0 104.789 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.434 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -141.48 165.99 25.98 Favored 'General case' 0 C--N 1.351 0.654 1 N-CA-C 122.282 4.178 . . . . 0.0 122.282 -160.745 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.86 121.95 12.89 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 128.187 2.595 . . . . 0.0 106.642 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.409 ' CZ3' HG11 ' A' ' 138' ' ' VAL . 72.2 m95 -112.01 142.46 44.41 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 125.335 1.454 . . . . 0.0 111.878 -175.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.7 170.77 19.43 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 123.186 1.47 . . . . 0.0 107.187 174.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.568 ' HD3' ' CE2' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -147.68 106.12 3.78 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 177.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.47 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.235 1.3 t70 34.5 53.07 0.58 Allowed 'General case' 0 C--N 1.377 1.794 2 N-CA-C 123.336 4.569 . . . . 0.0 123.336 140.062 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.69 -0.74 87.77 Favored Glycine 0 C--N 1.376 2.78 2 O-C-N 134.128 7.143 . . . . 0.0 119.292 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.469 ' HB2' ' HD2' ' A' ' 110' ' ' LYS . 3.6 m -124.8 147.18 55.46 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 129.3 3.04 . . . . 0.0 118.352 -172.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.33 138.07 49.61 Favored 'Trans proline' 0 N--CA 1.495 1.577 1 C-N-CA 125.984 4.456 . . . . 0.0 115.036 171.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.418 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -91.36 163.64 27.94 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 117.816 -3.052 . . . . 0.0 115.57 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 9.5 Cg_endo -71.22 84.4 0.91 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.703 3.602 . . . . 0.0 115.841 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.3 t70 78.01 -62.5 0.36 Allowed 'General case' 0 C--N 1.362 1.137 0 C-N-CA 127.719 2.407 . . . . 0.0 114.762 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 79.64 171.63 0.16 Allowed 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 130.284 3.434 . . . . 0.0 114.791 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.424 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 75.64 72.38 0.09 Allowed 'General case' 0 C--N 1.358 0.972 0 CA-C-N 114.345 -1.298 . . . . 0.0 114.288 173.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.76 -51.93 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.967 0 N-CA-C 118.976 2.35 . . . . 0.0 118.976 -173.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.263 . . 133.4 -73.11 0.0 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.055 2.142 . . . . 0.0 107.356 -176.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.272 6.9 t -133.82 111.61 10.65 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-O 123.092 1.425 . . . . 0.0 113.459 -175.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.331 0.6 OUTLIER -127.07 141.65 51.72 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 129.042 2.937 . . . . 0.0 112.394 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.7 m -128.51 139.71 52.18 Favored 'General case' 0 C--N 1.366 1.318 0 O-C-N 120.702 -1.249 . . . . 0.0 109.302 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.7 100.08 51.16 Favored Pre-proline 0 C--N 1.355 0.81 0 C-N-CA 129.822 3.249 . . . . 0.0 105.145 176.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -77.49 -32.4 2.92 Favored 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 125.93 4.42 . . . . 0.0 113.407 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.542 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.4 m -138.45 101.29 4.33 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -95.75 129.6 42.93 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 127.522 2.329 . . . . 0.0 109.615 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.59 175.58 7.85 Favored 'General case' 0 C--N 1.369 1.426 0 C-N-CA 128.169 2.588 . . . . 0.0 108.457 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.18 -51.35 18.63 Favored 'General case' 0 C--N 1.368 1.397 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 -171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -63.92 -22.89 67.12 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 126.1 1.76 . . . . 0.0 114.748 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -82.87 -10.28 58.91 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 130.103 3.361 . . . . 0.0 111.909 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -94.35 166.37 12.11 Favored 'General case' 0 C--N 1.383 2.061 0 N-CA-C 116.59 2.071 . . . . 0.0 116.59 167.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 144.86 -156.34 26.86 Favored Glycine 0 CA--C 1.461 -3.289 0 C-N-CA 127.603 2.525 . . . . 0.0 108.867 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.325 1.4 m -113.54 130.45 56.35 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 114.276 -2.969 . . . . 0.0 107.118 171.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.568 ' CE2' ' HD3' ' A' ' 110' ' ' LYS . 31.0 m-85 -97.16 135.02 39.72 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 126.882 2.073 . . . . 0.0 112.063 -168.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.47 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -148.83 148.79 30.32 Favored 'General case' 0 C--N 1.373 1.595 0 CA-C-O 123.449 1.595 . . . . 0.0 109.12 -174.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.409 HG11 ' CZ3' ' A' ' 108' ' ' TRP 0.291 0.8 OUTLIER -141.46 141.03 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.265 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.7 m -102.64 122.98 45.5 Favored 'General case' 0 C--N 1.377 1.8 0 C-N-CA 129.138 2.975 . . . . 0.0 107.201 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.528 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -134.54 126.72 48.83 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 125.816 1.646 . . . . 0.0 113.391 -174.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 8.3 m -113.83 132.59 55.83 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 119.365 -2.084 . . . . 0.0 114.296 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.443 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.428 25.6 p30 -126.93 -174.36 3.12 Favored 'General case' 0 C--N 1.377 1.78 0 O-C-N 120.729 -1.232 . . . . 0.0 112.695 176.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.66 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 63.2 p -49.62 3.3 0.01 OUTLIER 'General case' 0 C--N 1.362 1.126 1 C-N-CA 136.302 5.841 . . . . 0.0 121.775 -164.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -104.21 4.47 33.95 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 118.215 -1.394 . . . . 0.0 107.798 163.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.405 91.8 mm-40 66.55 40.2 3.53 Favored 'General case' 0 C--N 1.375 1.683 1 C-N-CA 132.504 4.321 . . . . 0.0 110.156 -172.204 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.413 ' C ' HG23 ' A' ' 141' ' ' THR . 3.8 m -112.48 126.67 69.9 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.39 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.591 -170.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.3 OUTLIER -91.67 134.0 35.09 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 124.613 1.165 . . . . 0.0 109.724 -177.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 158.51 24.52 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 130.429 3.492 . . . . 0.0 105.686 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -127.21 136.51 52.13 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.252 0.1 OUTLIER -116.38 151.6 35.62 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.242 1.817 . . . . 0.0 110.772 -175.482 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 m -53.42 146.5 12.38 Favored 'General case' 0 CA--C 1.489 -1.399 1 C-N-CA 134.209 5.004 . . . . 0.0 119.441 -157.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.8 p -70.76 111.59 6.32 Favored 'General case' 0 C--N 1.37 1.467 0 C-N-CA 128.749 2.819 . . . . 0.0 108.867 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.578 ' SG ' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -107.19 109.93 21.87 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 102.149 -3.278 . . . . 0.0 102.149 178.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -100.06 111.83 24.12 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-O 123.893 1.806 . . . . 0.0 111.556 -173.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -122.03 123.94 70.15 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 O-C-N 119.375 -2.078 . . . . 0.0 108.882 -178.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--N 1.369 1.44 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.299 -175.768 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 92' ' ' THR . 0.3 OUTLIER . . . . . 0 CA--C 1.577 1.996 0 CA-C-O 121.895 0.855 . . . . 0.0 113.087 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -168.09 172.24 8.92 Favored 'General case' 0 CA--C 1.519 -0.248 1 O-C-N 115.33 -4.606 . . . . 0.0 101.173 171.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.61 -48.5 1.27 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 125.842 1.657 . . . . 0.0 111.132 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.4 t -170.71 140.78 1.73 Allowed 'General case' 0 C--N 1.362 1.129 0 O-C-N 119.622 -1.924 . . . . 0.0 115.78 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.17 117.07 13.2 Favored 'General case' 0 C--N 1.377 1.769 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 161.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.0 m -114.36 116.8 29.5 Favored 'General case' 0 C--N 1.363 1.186 0 O-C-N 118.209 -2.807 . . . . 0.0 108.334 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.0 p -149.46 172.09 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 125.828 1.651 . . . . 0.0 110.37 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -82.45 129.7 34.96 Favored 'General case' 0 C--N 1.373 1.589 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 163.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.258 9.1 pt-20 -41.53 123.01 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 120.397 3.48 . . . . 0.0 120.397 -152.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.597 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 142.08 52.97 0.04 OUTLIER Glycine 0 C--N 1.359 1.833 0 CA-C-N 109.73 -3.395 . . . . 0.0 110.654 -171.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.94 163.96 21.84 Favored 'General case' 0 C--N 1.374 1.631 0 C-N-CA 125.73 1.612 . . . . 0.0 112.928 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.67 108.83 18.43 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 124.272 1.029 . . . . 0.0 110.33 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 124' ' ' THR . 4.2 mp -119.46 123.09 43.2 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 125.797 1.639 . . . . 0.0 115.247 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -110.57 127.21 55.11 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 102.364 -3.198 . . . . 0.0 102.364 170.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.44 115.65 21.94 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 172.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 t -154.56 134.11 12.73 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 119.947 -1.72 . . . . 0.0 112.461 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.5 m -148.89 175.0 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.645 0 C-N-CA 131.637 3.975 . . . . 0.0 105.886 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.2 t -104.01 138.88 39.91 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.185 2.594 . . . . 0.0 104.625 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.35 142.19 33.8 Favored 'General case' 0 C--N 1.373 1.597 0 N-CA-C 121.642 3.942 . . . . 0.0 121.642 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.3 m -158.52 174.19 15.46 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 131.092 3.757 . . . . 0.0 102.05 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.27 44.54 1.38 Allowed Glycine 0 C--N 1.367 2.292 0 CA-C-N 121.879 2.127 . . . . 0.0 117.232 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.77 28.06 52.07 Favored Glycine 0 C--N 1.358 1.754 0 C-N-CA 128.544 2.973 . . . . 0.0 115.289 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.7 m -117.93 110.96 18.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 114.372 -2.728 . . . . 0.0 107.114 173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.85 -87.4 0.86 Allowed Glycine 0 C--N 1.379 2.944 0 C-N-CA 129.729 3.538 . . . . 0.0 110.144 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -60.18 168.12 6.62 Favored 'Trans proline' 0 CA--C 1.568 2.196 1 C-N-CA 126.51 4.806 . . . . 0.0 116.167 159.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 71.5 m-85 -103.2 143.59 32.43 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 119.593 3.182 . . . . 0.0 119.593 -165.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -103.52 146.49 28.46 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 127.255 2.222 . . . . 0.0 105.526 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.46 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -144.22 166.46 24.97 Favored 'General case' 0 C--N 1.354 0.778 1 N-CA-C 123.25 4.537 . . . . 0.0 123.25 -160.857 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.07 120.52 15.0 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 128.283 2.633 . . . . 0.0 106.25 172.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -112.54 146.65 38.14 Favored 'General case' 0 C--N 1.367 1.355 0 O-C-N 120.853 -1.155 . . . . 0.0 112.145 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.2 169.72 23.87 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 171.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -143.56 105.56 4.37 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 174.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.453 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.17 1.5 t70 34.79 52.79 0.6 Allowed 'General case' 0 C--N 1.376 1.744 1 N-CA-C 122.48 4.252 . . . . 0.0 122.48 140.265 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.07 -6.21 83.81 Favored Glycine 0 C--N 1.364 2.116 2 O-C-N 133.085 6.49 . . . . 0.0 119.003 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.269 3.0 m -124.28 147.13 53.95 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 129.268 3.027 . . . . 0.0 117.671 -171.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.78 142.46 76.39 Favored 'Trans proline' 0 N--CA 1.495 1.604 1 C-N-CA 126.245 4.63 . . . . 0.0 114.973 172.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.406 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -99.26 158.9 31.42 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 118.462 -2.649 . . . . 0.0 112.636 178.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 2.7 Cg_endo -65.04 86.9 0.18 Allowed 'Trans proline' 0 C--N 1.363 1.291 1 C-N-CA 126.336 4.691 . . . . 0.0 115.355 -177.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 73.21 -58.8 0.59 Allowed 'General case' 0 C--N 1.362 1.145 0 C-N-CA 128.268 2.627 . . . . 0.0 115.185 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 73.25 176.24 0.26 Allowed 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 130.824 3.65 . . . . 0.0 115.048 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.429 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.3 OUTLIER 72.15 60.98 0.13 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-N 114.308 -1.314 . . . . 0.0 114.324 174.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.98 -82.98 0.07 OUTLIER Glycine 0 C--N 1.355 1.59 0 N-CA-C 116.316 1.287 . . . . 0.0 116.316 -170.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.631 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 165.8 -62.61 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 126.509 1.924 . . . . 0.0 106.539 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.4 t -137.79 111.31 8.07 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.451 -1.406 . . . . 0.0 112.316 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.314 31.8 p90 -127.33 140.75 51.98 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 126.111 1.764 . . . . 0.0 111.925 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 91' ' ' LEU . 25.6 m -128.65 139.91 52.02 Favored 'General case' 0 C--N 1.361 1.076 0 O-C-N 120.014 -1.679 . . . . 0.0 109.017 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 98.43 48.6 Favored Pre-proline 0 C--N 1.363 1.181 0 C-N-CA 129.075 2.95 . . . . 0.0 105.289 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -77.39 -15.32 15.87 Favored 'Trans proline' 0 C--N 1.353 0.765 1 C-N-CA 126.413 4.742 . . . . 0.0 113.736 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.597 HG23 ' HA2' ' A' ' 88' ' ' GLY . 53.6 m -159.01 104.9 1.73 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 101.813 -3.403 . . . . 0.0 101.813 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.86 134.45 33.94 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 127.326 2.25 . . . . 0.0 111.287 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.72 175.61 6.83 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 127.997 2.519 . . . . 0.0 110.789 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.1 -48.05 33.91 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 119.611 3.189 . . . . 0.0 119.611 -173.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.16 -9.15 51.5 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 126.722 2.009 . . . . 0.0 114.603 173.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.527 ' CB ' ' HB1' ' A' ' 128' ' ' ALA 0.333 2.9 m-20 -78.32 -19.86 52.65 Favored 'General case' 0 CA--C 1.572 1.816 0 C-N-CA 129.344 3.058 . . . . 0.0 111.532 168.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.88 122.71 18.74 Favored 'General case' 0 C--N 1.384 2.084 0 N-CA-C 120.546 3.536 . . . . 0.0 120.546 171.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 164.98 -155.96 27.67 Favored Glycine 0 CA--C 1.472 -2.65 0 C-N-CA 127.044 2.259 . . . . 0.0 109.254 173.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.409 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 19.4 m -119.33 131.82 55.78 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 115.64 -2.424 . . . . 0.0 108.441 171.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 110' ' ' LYS 0.296 26.5 m-85 -95.39 134.23 38.44 Favored 'General case' 0 C--N 1.369 1.44 0 C-N-CA 129.799 3.239 . . . . 0.0 111.467 -172.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -143.3 145.09 32.42 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 124.67 1.188 . . . . 0.0 107.924 -173.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.3 p -135.75 143.6 35.98 Favored 'Isoleucine or valine' 0 C--N 1.359 1.02 0 C-N-CA 118.817 -1.153 . . . . 0.0 113.006 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 m -109.71 124.1 50.64 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 128.914 2.885 . . . . 0.0 105.392 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -134.69 131.74 53.92 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 127.701 2.4 . . . . 0.0 111.632 -176.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 7.5 m -119.63 134.17 55.34 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 126.479 1.912 . . . . 0.0 113.813 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.492 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.389 9.1 p-10 -125.51 -174.17 3.0 Favored 'General case' 0 C--N 1.383 2.044 0 CA-C-N 120.831 1.65 . . . . 0.0 113.176 175.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 3.6 p -49.24 -2.09 0.01 OUTLIER 'General case' 0 C--N 1.376 1.758 1 C-N-CA 136.801 6.04 . . . . 0.0 120.015 -165.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -101.44 4.82 41.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 117.755 -1.578 . . . . 0.0 108.751 165.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.409 72.5 mm-40 66.42 40.05 3.72 Favored 'General case' 0 C--N 1.376 1.744 1 C-N-CA 133.346 4.658 . . . . 0.0 110.146 -172.911 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.411 ' C ' HG23 ' A' ' 141' ' ' THR . 2.8 m -112.87 129.01 69.27 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-N 111.365 -2.652 . . . . 0.0 111.362 -170.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.5 OUTLIER -92.04 140.38 29.71 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 124.48 1.112 . . . . 0.0 111.113 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -117.78 156.56 28.11 Favored 'General case' 0 C--N 1.346 0.452 1 C-N-CA 132.193 4.197 . . . . 0.0 104.063 174.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -129.54 141.33 51.0 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 173.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.425 50.4 p -120.03 146.91 45.44 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 120.081 1.31 . . . . 0.0 109.05 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -54.07 148.43 10.94 Favored 'General case' 0 CA--C 1.484 -1.574 1 C-N-CA 137.304 6.242 . . . . 0.0 118.442 -160.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -68.45 109.85 3.88 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 125.553 1.541 . . . . 0.0 111.106 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.16 109.93 21.96 Favored 'General case' 0 C--N 1.366 1.298 0 N-CA-C 102.267 -3.234 . . . . 0.0 102.267 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.68 112.92 25.1 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 123.679 1.704 . . . . 0.0 111.82 -172.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.92 128.65 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 O-C-N 120.279 -1.513 . . . . 0.0 109.798 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 87.9 m . . . . . 0 C--N 1.361 1.097 0 N-CA-C 101.847 -3.39 . . . . 0.0 101.847 174.07 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.413 ' O ' HG22 ' A' ' 92' ' ' THR . 0.2 OUTLIER . . . . . 0 CA--C 1.583 2.243 0 CA-C-O 121.43 0.633 . . . . 0.0 112.043 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 81' ' ' ALA . 21.7 m -169.54 171.63 7.49 Favored 'General case' 0 N--CA 1.464 0.264 1 O-C-N 115.876 -4.265 . . . . 0.0 102.062 172.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.407 ' N ' HG22 ' A' ' 80' ' ' THR . . . -125.8 -45.79 1.74 Allowed 'General case' 0 C--N 1.365 1.255 0 C-N-CA 126.51 1.924 . . . . 0.0 114.157 176.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.0 t -174.27 141.19 0.71 Allowed 'General case' 0 C--N 1.364 1.223 0 O-C-N 119.885 -1.759 . . . . 0.0 115.068 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.3 ttt -126.38 136.89 53.26 Favored 'General case' 0 C--N 1.38 1.9 0 CA-C-N 118.352 0.524 . . . . 0.0 109.927 157.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m -114.59 113.37 24.29 Favored 'General case' 0 C--N 1.377 1.764 0 O-C-N 119.84 -1.788 . . . . 0.0 108.015 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.295 11.5 p -151.56 174.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 123.569 1.652 . . . . 0.0 114.076 -170.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -83.19 144.5 29.76 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 127.202 2.201 . . . . 0.0 105.573 158.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.421 4.5 pt-20 -44.01 124.37 3.8 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 117.202 -3.436 . . . . 0.0 118.071 -171.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.456 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 122.62 52.63 0.21 Allowed Glycine 0 C--N 1.358 1.787 0 C-N-CA 127.662 2.554 . . . . 0.0 109.887 -154.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.91 161.68 15.1 Favored 'General case' 0 C--N 1.376 1.731 0 C-N-CA 124.95 1.3 . . . . 0.0 110.908 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.74 97.43 6.7 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.787 HD21 ' CZ ' ' A' ' 136' ' ' TYR 0.298 53.7 tp -120.8 114.93 22.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -169.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -112.01 131.77 55.21 Favored 'General case' 0 C--N 1.373 1.591 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.412 HD21 ' HG ' ' A' ' 91' ' ' LEU . 1.1 mm? -129.37 115.86 18.18 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 175.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.4 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 6.9 t -151.11 134.04 15.84 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 119.419 -2.051 . . . . 0.0 112.273 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.75 173.79 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.851 0 C-N-CA 129.594 3.158 . . . . 0.0 104.786 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -104.01 141.06 36.85 Favored 'General case' 0 C--N 1.369 1.445 0 O-C-N 119.293 -2.129 . . . . 0.0 105.349 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -139.24 145.25 38.99 Favored 'General case' 0 C--N 1.365 1.262 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 -173.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -158.41 174.26 15.39 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 130.741 3.616 . . . . 0.0 101.561 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.15 43.2 1.46 Allowed Glycine 0 C--N 1.364 2.128 0 CA-C-N 121.879 2.127 . . . . 0.0 117.696 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.44 22.13 52.04 Favored Glycine 0 C--N 1.359 1.82 0 C-N-CA 127.785 2.612 . . . . 0.0 116.342 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 76.1 m -116.95 111.44 19.61 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 114.018 -2.896 . . . . 0.0 107.944 176.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.507 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.93 -92.5 0.93 Allowed Glycine 0 C--N 1.38 3.004 0 CA-C-N 124.628 3.376 . . . . 0.0 110.118 -175.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -60.5 167.54 7.95 Favored 'Trans proline' 0 CA--C 1.564 1.998 1 C-N-CA 126.82 5.013 . . . . 0.0 116.19 159.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.572 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.1 m-85 -98.47 143.28 29.08 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 120.613 3.56 . . . . 0.0 120.613 -165.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 t -102.96 141.12 36.31 Favored 'General case' 0 C--N 1.381 1.945 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.528 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -134.72 156.03 49.51 Favored 'General case' 0 C--N 1.347 0.494 1 N-CA-C 122.517 4.265 . . . . 0.0 122.517 -162.107 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.06 112.79 10.84 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 111.124 -2.762 . . . . 0.0 104.768 171.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.48 ' CE3' ' HB ' ' A' ' 138' ' ' VAL . 35.2 m95 -111.96 148.0 34.69 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.327 0.2 OUTLIER -159.36 169.93 22.92 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 166.019 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.454 ' HE3' ' CE2' ' A' ' 136' ' ' TYR 0.337 33.6 mtpt -123.19 127.31 48.46 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 115.431 -2.223 . . . . 0.0 107.089 173.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.437 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.308 0.7 OUTLIER 32.35 51.04 0.21 Allowed 'General case' 0 C--N 1.373 1.61 2 N-CA-C 123.763 4.727 . . . . 0.0 123.763 123.185 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.88 1.92 49.47 Favored Glycine 0 C--N 1.377 2.821 2 O-C-N 133.907 7.004 . . . . 0.0 120.592 -169.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.574 0.6 OUTLIER -125.73 147.83 59.94 Favored Pre-proline 0 CA--C 1.563 1.466 1 N-CA-C 123.023 4.453 . . . . 0.0 123.023 -168.346 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.26 149.32 88.68 Favored 'Trans proline' 0 N--CA 1.499 1.842 1 C-N-CA 126.088 4.526 . . . . 0.0 116.245 173.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -110.28 153.69 43.24 Favored Pre-proline 0 CA--C 1.549 0.911 0 O-C-N 119.567 -1.958 . . . . 0.0 111.545 178.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 13.3 Cg_endo -68.09 90.13 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.098 1 C-N-CA 125.969 4.446 . . . . 0.0 114.992 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 t70 76.41 -52.63 0.6 Allowed 'General case' 0 C--N 1.364 1.221 0 C-N-CA 127.883 2.473 . . . . 0.0 114.474 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.424 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . 85.19 -62.89 0.06 Allowed 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 130.139 3.376 . . . . 0.0 116.282 173.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -58.04 55.81 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.078 1 C-N-CA 134.045 4.938 . . . . 0.0 118.13 -173.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -144.52 -78.1 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.89 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 160.93 -58.93 0.0 OUTLIER 'General case' 0 C--N 1.352 0.713 0 C-N-CA 125.172 1.389 . . . . 0.0 109.329 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.9 t -135.55 112.36 10.17 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 122.537 1.161 . . . . 0.0 111.169 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . 0.413 ' CD2' ' HG2' ' A' ' 116' ' ' PRO . 35.0 p90 -127.04 139.76 52.78 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 124.627 1.171 . . . . 0.0 110.338 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.6 m -129.99 140.39 50.9 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 120.647 -1.283 . . . . 0.0 110.57 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.425 ' CB ' HD23 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -112.27 99.6 47.03 Favored Pre-proline 0 C--N 1.356 0.878 0 C-N-CA 130.213 3.405 . . . . 0.0 105.684 177.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -77.43 -13.28 16.75 Favored 'Trans proline' 0 CA--C 1.536 0.606 1 C-N-CA 126.04 4.493 . . . . 0.0 112.891 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.456 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -162.1 100.94 1.11 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.21 133.5 35.33 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 127.826 2.451 . . . . 0.0 111.772 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.47 173.29 8.42 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 130.141 3.376 . . . . 0.0 111.265 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.42 -45.6 25.65 Favored 'General case' 0 C--N 1.367 1.349 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.85 -17.86 65.1 Favored 'General case' 0 C--N 1.367 1.326 0 C-N-CA 126.229 1.812 . . . . 0.0 115.316 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.271 37.8 m-20 -84.09 -16.41 43.82 Favored 'General case' 0 C--N 1.362 1.144 1 C-N-CA 132.209 4.204 . . . . 0.0 110.72 171.996 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.28 156.05 35.43 Favored 'General case' 0 C--N 1.392 2.44 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 163.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 138.64 -157.36 24.61 Favored Glycine 0 CA--C 1.452 -3.865 0 C-N-CA 127.735 2.588 . . . . 0.0 106.862 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.434 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.251 3.3 m -119.73 135.73 54.72 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 114.657 -2.817 . . . . 0.0 107.27 167.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.787 ' CZ ' HD21 ' A' ' 91' ' ' LEU . 28.8 m-85 -96.99 134.74 39.96 Favored 'General case' 0 C--N 1.373 1.589 0 C-N-CA 128.434 2.694 . . . . 0.0 111.689 -172.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -146.39 154.57 41.78 Favored 'General case' 0 C--N 1.371 1.541 0 C-N-CA 124.729 1.211 . . . . 0.0 110.419 -176.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.48 ' HB ' ' CE3' ' A' ' 108' ' ' TRP . 14.8 p -142.91 139.95 27.54 Favored 'Isoleucine or valine' 0 C--N 1.368 1.38 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.3 m -107.67 110.81 22.77 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 131.334 3.854 . . . . 0.0 106.388 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.572 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -127.38 116.8 45.11 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 C-N-CA 125.892 1.677 . . . . 0.0 111.918 -172.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.5 m -102.34 131.12 49.15 Favored 'General case' 0 C--N 1.358 0.959 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.437 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.35 36.4 p-10 -125.65 179.31 5.22 Favored 'General case' 0 C--N 1.376 1.718 0 CA-C-N 120.408 1.458 . . . . 0.0 111.519 174.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 22.0 p -49.34 3.49 0.01 OUTLIER 'General case' 0 C--N 1.371 1.503 1 C-N-CA 136.57 5.948 . . . . 0.0 120.413 -169.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -103.51 4.83 36.33 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 166.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.524 2.0 mp0 64.51 40.03 6.43 Favored 'General case' 0 C--N 1.376 1.726 1 C-N-CA 133.518 4.727 . . . . 0.0 112.528 -173.842 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 m -112.68 123.48 68.41 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 CA-C-N 111.127 -2.761 . . . . 0.0 111.951 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.04 123.28 34.39 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 128.555 2.742 . . . . 0.0 105.303 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.55 158.36 23.79 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 129.14 2.976 . . . . 0.0 103.218 -174.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 9.0 t70 -129.56 141.27 51.01 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.214 1.007 . . . . 0.0 109.872 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.548 22.4 p -114.79 139.66 49.54 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 m -55.0 147.84 14.81 Favored 'General case' 0 C--N 1.366 1.321 1 C-N-CA 138.044 6.538 . . . . 0.0 117.898 -163.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.8 p -68.67 110.53 4.32 Favored 'General case' 0 C--N 1.375 1.701 0 C-N-CA 125.732 1.613 . . . . 0.0 110.33 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -101.2 110.35 22.36 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 -178.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.55 115.22 27.12 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 123.954 1.835 . . . . 0.0 113.171 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.85 128.25 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 O-C-N 119.65 -1.906 . . . . 0.0 107.602 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.493 -1.24 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 178.71 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.431 ' O ' HG22 ' A' ' 92' ' ' THR . 0.5 OUTLIER . . . . . 0 CA--C 1.586 2.329 0 CA-C-O 121.61 0.719 . . . . 0.0 112.558 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 m -169.79 171.97 7.0 Favored 'General case' 0 N--CA 1.467 0.412 1 O-C-N 114.69 -5.006 . . . . 0.0 101.598 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.13 -45.9 1.24 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.092 1.357 . . . . 0.0 111.159 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.9 p -171.03 125.2 0.65 Allowed 'General case' 0 C--N 1.361 1.103 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.0 ttt -130.6 118.0 20.37 Favored 'General case' 0 C--N 1.376 1.726 0 CA-C-N 120.605 1.548 . . . . 0.0 109.346 160.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -110.61 115.14 29.08 Favored 'General case' 0 C--N 1.368 1.407 0 O-C-N 119.823 -1.798 . . . . 0.0 108.181 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.8 p -150.03 173.71 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 126.848 2.059 . . . . 0.0 112.977 -169.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.46 144.59 46.21 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 128.042 2.537 . . . . 0.0 107.1 159.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.536 0.7 OUTLIER -44.13 123.28 3.3 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 124.628 3.376 . . . . 0.0 118.248 -171.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.431 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 126.96 43.17 0.26 Allowed Glycine 0 C--N 1.358 1.755 0 CA-C-N 111.45 -2.614 . . . . 0.0 112.09 -157.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.44 164.93 20.64 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 119.707 1.753 . . . . 0.0 112.156 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.07 114.93 28.85 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 125.994 1.718 . . . . 0.0 108.556 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 124' ' ' THR . 7.0 mp -120.5 114.49 21.85 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 127.668 2.387 . . . . 0.0 114.693 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -109.61 124.49 51.24 Favored 'General case' 0 C--N 1.364 1.235 0 N-CA-C 102.467 -3.16 . . . . 0.0 102.467 170.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -124.69 114.77 19.76 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.4 t -153.62 134.09 13.56 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 120.021 -1.675 . . . . 0.0 112.182 -172.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -149.12 174.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.736 0 C-N-CA 130.513 3.525 . . . . 0.0 104.591 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -103.67 140.74 37.17 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.16 142.39 34.04 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 120.588 3.551 . . . . 0.0 120.588 -173.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.3 m -158.47 174.54 14.94 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 130.337 3.455 . . . . 0.0 102.023 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.26 44.35 1.89 Allowed Glycine 0 C--N 1.366 2.2 0 CA-C-N 122.122 2.237 . . . . 0.0 117.639 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.67 20.16 62.27 Favored Glycine 0 C--N 1.358 1.806 0 C-N-CA 127.78 2.609 . . . . 0.0 114.776 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 45.2 p -116.75 110.81 18.91 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 113.948 -2.929 . . . . 0.0 108.285 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.595 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 73.03 -92.47 0.64 Allowed Glycine 0 C--N 1.376 2.762 0 C-N-CA 129.876 3.607 . . . . 0.0 111.065 -170.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -61.86 168.75 8.26 Favored 'Trans proline' 0 CA--C 1.566 2.113 1 C-N-CA 127.128 5.219 . . . . 0.0 117.207 160.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.592 ' HB3' HG12 ' A' ' 140' ' ' VAL . 75.8 m-85 -93.72 141.36 28.58 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 121.186 3.772 . . . . 0.0 121.186 -167.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -103.24 147.0 27.58 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 128.19 2.596 . . . . 0.0 105.093 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.519 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -144.05 166.21 25.63 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 121.579 3.918 . . . . 0.0 121.579 -160.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.07 113.7 7.86 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 111.715 -2.493 . . . . 0.0 106.263 172.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -112.07 153.84 26.29 Favored 'General case' 0 C--N 1.376 1.722 0 O-C-N 120.149 -1.594 . . . . 0.0 107.87 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.345 0.0 OUTLIER -156.04 152.97 28.73 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 163.236 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.859 ' HZ1' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -128.27 103.86 7.41 Favored 'General case' 0 C--N 1.369 1.451 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 177.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.456 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.186 4.0 t70 37.54 54.98 1.46 Allowed 'General case' 0 CA--C 1.453 -2.76 1 CA-C-O 110.881 -4.39 . . . . 0.0 119.601 153.505 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.51 -17.0 51.62 Favored Glycine 0 C--N 1.372 2.559 2 O-C-N 134.729 7.518 . . . . 0.0 116.408 -175.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.421 ' HB3' ' HE2' ' A' ' 110' ' ' LYS 0.282 48.5 m -124.12 149.48 60.56 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 130.754 3.622 . . . . 0.0 119.304 -165.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.12 154.46 51.44 Favored 'Trans proline' 0 N--CA 1.507 2.315 1 C-N-CA 126.937 5.091 . . . . 0.0 116.378 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.576 ' HB ' ' HD2' ' A' ' 116' ' ' PRO 0.274 0.8 OUTLIER -95.12 164.59 18.9 Favored Pre-proline 0 N--CA 1.484 1.23 0 O-C-N 117.967 -2.958 . . . . 0.0 111.917 174.309 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.576 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 1.9 Cg_endo -67.98 92.24 0.38 Allowed 'Trans proline' 0 C--N 1.368 1.584 1 C-N-CA 126.491 4.794 . . . . 0.0 112.585 177.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 78.7 -65.89 0.21 Allowed 'General case' 0 C--N 1.351 0.671 0 C-N-CA 128.448 2.699 . . . . 0.0 111.721 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 88.21 148.72 0.05 OUTLIER 'General case' 0 CA--C 1.466 -2.276 0 C-N-CA 128.029 2.532 . . . . 0.0 112.196 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.458 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 18.5 m 74.13 62.62 0.08 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.177 -1.828 . . . . 0.0 115.17 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.01 -77.96 0.08 OUTLIER Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 115.214 0.846 . . . . 0.0 115.214 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.599 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 160.53 -58.27 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 124.639 1.176 . . . . 0.0 109.187 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.4 t -141.68 112.85 7.46 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 123.367 1.556 . . . . 0.0 113.311 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.257 0.0 OUTLIER -127.47 139.72 52.62 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 124.856 1.262 . . . . 0.0 108.931 172.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 91' ' ' LEU . 65.4 m -129.73 138.62 51.22 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 173.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.35 114.11 48.17 Favored Pre-proline 0 C--N 1.363 1.182 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 173.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.32 -14.07 16.57 Favored 'Trans proline' 0 C--N 1.354 0.852 1 C-N-CA 126.273 4.649 . . . . 0.0 112.83 174.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.431 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -161.83 106.41 1.25 Allowed 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.536 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.47 134.97 33.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.074 2.55 . . . . 0.0 113.823 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.16 176.64 6.89 Favored 'General case' 0 C--N 1.371 1.536 0 C-N-CA 127.878 2.471 . . . . 0.0 110.568 174.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.04 -48.97 32.8 Favored 'General case' 0 C--N 1.368 1.413 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 -173.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -64.31 -17.35 63.57 Favored 'General case' 0 C--N 1.366 1.283 0 C-N-CA 127.104 2.162 . . . . 0.0 114.685 173.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.859 ' HA ' ' HZ1' ' A' ' 110' ' ' LYS 0.35 32.7 m-20 -83.67 -19.13 35.9 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 130.894 3.678 . . . . 0.0 112.287 172.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.61 131.98 48.5 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 163.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 159.3 -158.82 29.89 Favored Glycine 0 CA--C 1.456 -3.616 0 C-N-CA 126.914 2.197 . . . . 0.0 107.737 167.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.333 22.8 m -116.88 136.02 53.27 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 114.964 -2.694 . . . . 0.0 108.316 170.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.529 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 22.9 m-85 -96.77 133.67 41.05 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 119.24 -2.163 . . . . 0.0 114.143 -171.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -139.4 141.94 37.52 Favored 'General case' 0 C--N 1.37 1.487 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -173.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.3 p -141.3 141.7 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 117.614 -1.635 . . . . 0.0 114.704 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 18.1 m -107.64 118.9 37.93 Favored 'General case' 0 C--N 1.378 1.844 0 C-N-CA 128.488 2.715 . . . . 0.0 107.187 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -131.33 118.98 42.25 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 126.058 1.743 . . . . 0.0 111.697 -172.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.448 HG23 ' C ' ' A' ' 146' ' ' VAL . 6.6 m -108.24 129.36 55.21 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.418 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.402 28.9 p-10 -124.02 -177.15 3.67 Favored 'General case' 0 C--N 1.372 1.559 0 O-C-N 120.944 -1.098 . . . . 0.0 112.885 174.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.595 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 86.2 p -50.15 3.93 0.01 OUTLIER 'General case' 0 C--N 1.36 1.026 2 C-N-CA 135.742 5.617 . . . . 0.0 121.954 -168.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -101.8 4.65 40.61 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 164.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.348 3.1 mp0 66.78 39.69 3.41 Favored 'General case' 0 C--N 1.379 1.887 1 C-N-CA 133.678 4.791 . . . . 0.0 109.974 -174.367 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.448 ' C ' HG23 ' A' ' 141' ' ' THR . 4.3 m -113.13 123.97 69.3 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.62 0 CA-C-N 112.418 -2.174 . . . . 0.0 113.021 -170.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.31 123.67 34.92 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.251 2.221 . . . . 0.0 107.034 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.13 156.54 26.26 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -130.35 147.07 52.02 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 121.382 -0.824 . . . . 0.0 110.104 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.294 58.7 p -123.64 143.7 50.08 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 m -54.93 148.24 13.78 Favored 'General case' 0 C--N 1.377 1.791 2 C-N-CA 138.807 6.843 . . . . 0.0 114.699 -168.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.8 p -67.61 109.81 3.43 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.223 1.809 . . . . 0.0 111.238 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.72 108.78 20.48 Favored 'General case' 0 C--N 1.37 1.488 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -94.63 109.22 21.17 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 120.519 1.509 . . . . 0.0 111.465 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.87 113.93 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 59.3 m . . . . . 0 CA--C 1.492 -1.28 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 -175.911 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.554 ' O ' HG22 ' A' ' 92' ' ' THR . 1.2 mp . . . . . 0 CA--C 1.578 2.046 0 CA-C-O 122.278 1.037 . . . . 0.0 111.38 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.519 ' HB ' ' SG ' ' A' ' 153' ' ' CYS . 19.1 m -172.25 179.75 2.5 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 100.399 -3.926 . . . . 0.0 100.399 174.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.12 -42.66 0.46 Allowed 'General case' 0 C--N 1.367 1.353 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.0 m -164.63 99.63 0.79 Allowed 'General case' 0 N--CA 1.477 0.9 0 O-C-N 118.449 -2.657 . . . . 0.0 115.601 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 19.9 mmm -120.27 117.55 28.13 Favored 'General case' 0 C--N 1.369 1.449 0 CA-C-O 122.591 1.186 . . . . 0.0 109.664 168.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.5 p -115.15 114.86 25.85 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.94 174.63 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 112.973 -1.921 . . . . 0.0 111.17 -171.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.02 144.68 52.17 Favored 'General case' 0 CA--C 1.564 1.501 0 O-C-N 118.968 -2.332 . . . . 0.0 107.724 158.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.437 0.7 OUTLIER -44.14 123.17 3.26 Favored 'General case' 0 N--CA 1.523 3.176 0 O-C-N 117.675 -3.141 . . . . 0.0 117.733 -170.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.511 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 123.52 50.17 0.22 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-N 111.347 -2.661 . . . . 0.0 108.884 -154.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 155' ' ' VAL . . . -95.9 139.43 32.12 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 125.298 1.439 . . . . 0.0 108.32 173.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.94 119.33 32.71 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -167.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.551 ' HG ' HG11 ' A' ' 155' ' ' VAL . 6.2 mt -121.46 129.14 52.79 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.194 2.598 . . . . 0.0 117.584 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -115.95 118.48 33.05 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 100.352 -3.944 . . . . 0.0 100.352 167.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.49 115.09 22.2 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.496 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 8.8 t -155.03 131.58 10.54 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -169.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 m -150.17 173.71 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.649 1 C-N-CA 131.748 4.019 . . . . 0.0 103.465 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.2 t -104.29 141.44 36.3 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 122.857 2.571 . . . . 0.0 106.67 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.668 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -134.75 145.53 48.53 Favored 'General case' 0 C--N 1.37 1.495 0 N-CA-C 119.618 3.192 . . . . 0.0 119.618 -174.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.6 m -158.29 174.29 15.38 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 131.644 3.978 . . . . 0.0 101.41 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.39 44.49 2.21 Favored Glycine 0 C--N 1.364 2.089 0 CA-C-N 122.111 2.232 . . . . 0.0 116.508 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.86 21.42 57.62 Favored Glycine 0 C--N 1.356 1.676 0 C-N-CA 127.297 2.379 . . . . 0.0 115.578 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.7 m -117.6 111.25 18.94 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 114.799 -2.524 . . . . 0.0 107.728 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.621 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 78.57 -91.22 1.16 Allowed Glycine 0 C--N 1.375 2.721 0 C-N-CA 129.546 3.451 . . . . 0.0 109.679 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.61 167.22 8.61 Favored 'Trans proline' 0 CA--C 1.57 2.312 1 C-N-CA 126.566 4.844 . . . . 0.0 116.288 160.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 69.0 m-85 -98.94 145.33 27.14 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 120.473 3.508 . . . . 0.0 120.473 -166.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.7 t -102.7 140.06 37.47 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.478 ' CE1' ' HA ' ' A' ' 119' ' ' SER . 0.0 OUTLIER -114.32 148.98 36.69 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 -164.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.65 111.25 10.46 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 102.358 -3.201 . . . . 0.0 102.358 162.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.503 ' HB2' HG13 ' A' ' 115' ' ' ILE . 40.7 m95 -112.93 150.28 32.04 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 125.301 1.44 . . . . 0.0 108.661 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.65 169.64 19.92 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 165.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -139.84 104.15 4.82 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 175.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.434 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.235 1.5 t70 34.77 52.85 0.6 Allowed 'General case' 0 CA--C 1.473 -1.994 2 N-CA-C 122.336 4.199 . . . . 0.0 122.336 142.339 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.77 -11.25 71.41 Favored Glycine 0 C--N 1.366 2.195 2 O-C-N 133.346 6.654 . . . . 0.0 118.629 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.1 m -124.14 148.17 56.74 Favored Pre-proline 0 CA--C 1.564 1.497 0 C-N-CA 131.287 3.835 . . . . 0.0 121.034 -168.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.62 148.52 92.26 Favored 'Trans proline' 0 C--N 1.378 2.122 1 C-N-CA 126.834 5.023 . . . . 0.0 115.247 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.712 HD11 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -107.12 162.11 20.76 Favored Pre-proline 0 C--N 1.354 0.788 0 O-C-N 119.741 -1.85 . . . . 0.0 115.482 -177.545 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 9.0 Cg_endo -73.82 88.96 1.02 Allowed 'Trans proline' 0 C--N 1.363 1.335 1 C-N-CA 125.923 4.415 . . . . 0.0 114.699 -177.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.1 t70 82.19 -53.71 0.23 Allowed 'General case' 0 C--N 1.361 1.098 0 C-N-CA 128.528 2.731 . . . . 0.0 113.48 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.712 ' HB2' HD11 ' A' ' 115' ' ' ILE . . . 91.55 -48.34 0.02 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 129.789 3.236 . . . . 0.0 113.639 177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.478 ' HA ' ' CE1' ' A' ' 106' ' ' TYR 0.252 33.1 t -77.61 49.33 0.73 Allowed 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 129.479 3.112 . . . . 0.0 114.017 -174.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -131.0 -46.16 0.15 Allowed Glycine 0 C--N 1.367 2.267 1 N-CA-C 124.665 4.626 . . . . 0.0 124.665 -162.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.668 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.291 . . 99.72 -75.99 0.0 OUTLIER 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.734 2.267 . . . . 0.0 111.564 -177.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.298 6.5 t -130.95 102.32 6.0 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-O 123.528 1.633 . . . . 0.0 110.805 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.262 19.2 p90 -126.97 141.74 51.72 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 128.324 2.65 . . . . 0.0 111.485 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 91' ' ' LEU . 38.0 m -128.42 139.29 52.44 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 119.645 -1.909 . . . . 0.0 107.861 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -116.16 92.39 35.51 Favored Pre-proline 0 C--N 1.358 0.96 0 C-N-CA 129.494 3.118 . . . . 0.0 104.362 175.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -68.47 -33.16 23.56 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.47 3.447 . . . . 0.0 112.719 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.511 HG23 ' HA2' ' A' ' 88' ' ' GLY . 97.5 m -127.4 104.12 7.74 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 126.008 1.723 . . . . 0.0 106.442 176.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.09 124.06 35.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.305 1.442 . . . . 0.0 110.51 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.38 170.86 13.16 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.91 2.084 . . . . 0.0 108.002 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.12 -47.51 23.37 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -170.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.65 -23.38 67.06 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 126.753 2.021 . . . . 0.0 115.061 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -83.43 -12.85 55.92 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.846 2.858 . . . . 0.0 112.574 172.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -88.51 155.83 19.43 Favored 'General case' 0 C--N 1.381 1.951 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 170.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 141.54 -149.39 21.07 Favored Glycine 0 CA--C 1.457 -3.554 0 N-CA-C 104.713 -3.355 . . . . 0.0 104.713 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.264 66.8 m -125.97 138.26 53.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 114.543 -2.863 . . . . 0.0 107.606 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 8.7 m-85 -96.96 134.64 40.06 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 126.445 1.898 . . . . 0.0 112.054 -168.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -144.58 143.43 30.8 Favored 'General case' 0 C--N 1.365 1.26 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.409 HG21 ' CE2' ' A' ' 108' ' ' TRP . 14.9 p -143.25 143.51 24.68 Favored 'Isoleucine or valine' 0 C--N 1.364 1.236 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -111.56 122.63 48.33 Favored 'General case' 0 C--N 1.375 1.705 0 C-N-CA 130.921 3.688 . . . . 0.0 105.994 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.421 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -134.55 120.37 32.35 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 124.518 1.127 . . . . 0.0 109.844 -172.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.412 HG23 ' C ' ' A' ' 146' ' ' VAL . 7.9 m -105.22 132.87 50.89 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -176.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.47 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.384 23.9 p-10 -126.12 -174.45 3.11 Favored 'General case' 0 C--N 1.38 1.904 0 C-N-CA 124.589 1.155 . . . . 0.0 112.691 176.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.621 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 6.5 p -49.24 0.31 0.01 OUTLIER 'General case' 0 C--N 1.372 1.551 1 C-N-CA 136.577 5.951 . . . . 0.0 120.821 -166.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -104.04 4.54 34.52 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 118.474 -1.29 . . . . 0.0 107.836 165.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.464 94.7 mm-40 67.24 40.3 2.82 Favored 'General case' 0 C--N 1.374 1.631 1 C-N-CA 132.707 4.403 . . . . 0.0 110.56 -172.692 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.412 ' C ' HG23 ' A' ' 141' ' ' THR . 3.5 m -112.78 126.07 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.346 0 CA-C-N 111.605 -2.543 . . . . 0.0 112.845 -171.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.7 OUTLIER -90.83 125.9 35.87 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 127.777 2.431 . . . . 0.0 108.109 -176.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.24 156.74 26.05 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 -176.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -130.65 146.88 52.24 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 120.543 -1.348 . . . . 0.0 111.492 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.433 91.8 p -127.19 146.29 50.46 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.557 0.743 . . . . 0.0 111.807 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.0 m -54.61 148.59 12.19 Favored 'General case' 0 CA--C 1.488 -1.407 1 C-N-CA 138.496 6.718 . . . . 0.0 117.42 -164.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.8 p -68.56 110.2 4.1 Favored 'General case' 0 C--N 1.377 1.768 0 C-N-CA 127.764 2.426 . . . . 0.0 110.046 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 80' ' ' THR . 1.0 OUTLIER -106.35 109.35 21.25 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 -172.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.54 122.46 42.64 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -168.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.551 HG11 ' HG ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -123.17 115.03 44.43 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 C-N-CA 125.045 1.338 . . . . 0.0 108.128 176.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 62.7 m . . . . . 0 C--N 1.372 1.561 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 177.627 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.425 -1.68 0 N-CA-C 112.405 0.52 . . . . 0.0 112.405 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 m -171.48 172.94 4.92 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 116.726 -3.734 . . . . 0.0 101.032 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.48 -42.71 0.55 Allowed 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.467 1.485 . . . . 0.0 111.479 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 154' ' ' ALA . 58.1 m -162.86 113.39 1.45 Allowed 'General case' 0 C--N 1.356 0.875 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.77 117.26 19.97 Favored 'General case' 0 C--N 1.371 1.532 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 162.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.6 m -116.41 116.81 28.38 Favored 'General case' 0 C--N 1.364 1.198 0 O-C-N 117.946 -2.971 . . . . 0.0 110.066 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 p -149.57 172.29 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.533 1.133 . . . . 0.0 113.059 -173.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -83.72 130.67 34.96 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 162.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.326 0.3 OUTLIER -41.53 123.09 2.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 120.076 3.361 . . . . 0.0 120.076 -150.492 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.62 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 141.64 48.84 0.05 OUTLIER Glycine 0 C--N 1.357 1.701 0 CA-C-N 109.941 -3.299 . . . . 0.0 111.896 -170.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.98 171.67 11.94 Favored 'General case' 0 C--N 1.37 1.471 0 C-N-CA 124.731 1.213 . . . . 0.0 112.95 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.54 115.77 30.2 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.251 1.42 . . . . 0.0 108.508 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 128' ' ' ALA . 6.7 mp -120.47 113.06 19.76 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.467 2.307 . . . . 0.0 113.346 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.97 126.92 54.44 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 170.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.465 HD11 ' CD2' ' A' ' 136' ' ' TYR . 1.9 mm? -112.57 114.43 27.08 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 102.625 -3.102 . . . . 0.0 102.625 174.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.1 m -150.24 134.58 17.22 Favored 'General case' 0 C--N 1.368 1.389 0 CA-C-O 121.729 0.776 . . . . 0.0 112.043 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.17 173.03 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 C-N-CA 131.521 3.928 . . . . 0.0 103.766 174.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.9 p -103.59 137.43 41.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.48 2.712 . . . . 0.0 108.121 -173.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.404 ' HB2' ' HE2' ' A' ' 106' ' ' TYR . . . -141.6 145.82 35.5 Favored 'General case' 0 C--N 1.384 2.098 1 N-CA-C 127.602 6.149 . . . . 0.0 127.602 -170.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.431 HG23 ' HG2' ' A' ' 103' ' ' PRO . 23.7 p -156.67 175.07 14.54 Favored 'General case' 0 C--N 1.37 1.491 1 C-N-CA 134.241 5.016 . . . . 0.0 103.985 173.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.64 40.19 0.78 Allowed Glycine 0 C--N 1.367 2.27 0 O-C-N 119.279 -2.138 . . . . 0.0 117.798 170.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.5 30.73 15.06 Favored Glycine 0 C--N 1.359 1.812 0 C-N-CA 128.54 2.972 . . . . 0.0 114.648 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.4 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 33.5 p -117.35 109.67 17.1 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 114.39 -2.719 . . . . 0.0 108.79 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.68 -90.64 0.86 Allowed Glycine 0 C--N 1.378 2.886 0 CA-C-N 124.147 3.158 . . . . 0.0 111.591 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HG2' HG23 ' A' ' 98' ' ' THR . 62.8 Cg_endo -62.29 169.17 8.31 Favored 'Trans proline' 0 CA--C 1.569 2.256 1 C-N-CA 126.528 4.819 . . . . 0.0 113.62 158.119 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.45 ' HB3' HG12 ' A' ' 140' ' ' VAL . 61.0 m-85 -100.68 159.79 14.88 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 119.655 3.206 . . . . 0.0 119.655 -165.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.7 t -110.14 141.49 42.95 Favored 'General case' 0 C--N 1.368 1.392 0 N-CA-C 102.393 -3.188 . . . . 0.0 102.393 171.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.563 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -138.39 151.03 47.12 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 120.501 3.519 . . . . 0.0 120.501 -165.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.11 124.51 34.93 Favored 'General case' 0 C--N 1.368 1.391 0 C-N-CA 128.776 2.83 . . . . 0.0 106.908 172.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.494 ' HB2' HG13 ' A' ' 115' ' ' ILE . 8.8 m95 -113.2 147.62 37.09 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 125.344 1.457 . . . . 0.0 113.76 -177.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.14 169.63 17.5 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 166.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.8 ptmm? -140.74 107.43 5.35 Favored 'General case' 0 N--CA 1.42 -1.97 0 O-C-N 119.92 -1.738 . . . . 0.0 108.087 173.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.446 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.205 1.7 t70 34.23 52.25 0.49 Allowed 'General case' 0 C--N 1.373 1.605 1 N-CA-C 123.649 4.685 . . . . 0.0 123.649 141.859 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.14 -5.98 84.11 Favored Glycine 0 C--N 1.367 2.271 2 O-C-N 132.724 6.265 . . . . 0.0 119.712 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.405 ' HB2' ' NZ ' ' A' ' 110' ' ' LYS 0.359 2.2 m -124.05 149.37 60.03 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 130.468 3.507 . . . . 0.0 118.115 -171.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.09 158.6 38.39 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 124.221 3.281 . . . . 0.0 115.161 164.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.1 OUTLIER -108.94 155.95 39.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 120.04 -1.662 . . . . 0.0 110.255 177.345 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -69.06 84.37 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.216 3.944 . . . . 0.0 115.837 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.6 t70 80.13 -54.18 0.37 Allowed 'General case' 0 C--N 1.366 1.312 0 C-N-CA 129.302 3.041 . . . . 0.0 113.131 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 88.51 -163.52 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 130.405 3.482 . . . . 0.0 110.878 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.06 4.91 5.04 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.95 -31.95 6.07 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 120.651 3.02 . . . . 0.0 120.651 -163.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.279 . . 91.52 -52.91 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 127.684 2.393 . . . . 0.0 111.317 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.319 12.1 t -140.33 97.44 3.22 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 123.022 1.392 . . . . 0.0 109.561 177.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.27 2.5 p90 -126.69 140.25 52.54 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 128.03 2.532 . . . . 0.0 111.374 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.8 m -129.58 140.26 51.26 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 119.804 -1.81 . . . . 0.0 112.802 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.45 ' HA ' ' HE2' ' A' ' 125' ' ' LYS 0.313 0.7 OUTLIER -108.73 111.99 60.69 Favored Pre-proline 0 C--N 1.373 1.609 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 168.183 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -77.65 -17.3 14.32 Favored 'Trans proline' 0 CA--C 1.538 0.681 1 C-N-CA 126.373 4.715 . . . . 0.0 113.503 171.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.62 HG23 ' HA2' ' A' ' 88' ' ' GLY . 61.5 m -157.79 107.05 2.1 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 103.277 -2.861 . . . . 0.0 103.277 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.555 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -94.33 134.79 36.44 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.234 2.213 . . . . 0.0 113.822 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.07 172.2 11.45 Favored 'General case' 0 C--N 1.371 1.505 0 C-N-CA 128.444 2.697 . . . . 0.0 110.47 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.62 -45.81 28.0 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 119.817 3.265 . . . . 0.0 119.817 -171.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -62.75 -17.66 61.31 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 127.833 2.453 . . . . 0.0 114.977 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.555 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 44.0 m-20 -79.55 -14.89 58.54 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 128.146 2.578 . . . . 0.0 112.713 170.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.24 129.48 38.99 Favored 'General case' 0 C--N 1.389 2.325 1 N-CA-C 122.339 4.2 . . . . 0.0 122.339 172.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.73 -135.91 5.37 Favored Glycine 0 C--N 1.374 2.652 0 C-N-CA 130.314 3.816 . . . . 0.0 109.253 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.45 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 19.7 m -129.78 140.25 51.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 115.853 -2.339 . . . . 0.0 110.679 173.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.581 ' CZ ' ' HD2' ' A' ' 110' ' ' LYS . 43.2 m-85 -97.03 134.75 39.98 Favored 'General case' 0 C--N 1.366 1.323 0 C-N-CA 127.09 2.156 . . . . 0.0 113.016 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -142.45 141.54 32.21 Favored 'General case' 0 C--N 1.368 1.398 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -174.234 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.644 HG13 ' OG ' ' A' ' 150' ' ' SER 0.36 2.2 p -133.75 134.63 56.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -175.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.94 107.81 19.01 Favored 'General case' 0 C--N 1.377 1.773 0 C-N-CA 130.345 3.458 . . . . 0.0 106.541 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -121.62 118.67 56.58 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 C-N-CA 128.243 2.617 . . . . 0.0 112.49 -168.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.418 HG23 ' C ' ' A' ' 146' ' ' VAL . 4.2 m -103.57 132.81 49.51 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 119.318 -2.114 . . . . 0.0 114.391 -177.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.449 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.327 24.4 p-10 -128.39 -178.96 4.77 Favored 'General case' 0 C--N 1.378 1.816 0 CA-C-N 120.321 1.419 . . . . 0.0 111.52 175.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.475 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 13.3 p -49.23 3.22 0.01 OUTLIER 'General case' 0 C--N 1.372 1.562 1 C-N-CA 136.515 5.926 . . . . 0.0 120.332 -169.26 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -101.01 4.78 42.7 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.618 162.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.439 0.7 OUTLIER 64.96 39.63 5.68 Favored 'General case' 0 C--N 1.372 1.569 1 C-N-CA 134.024 4.93 . . . . 0.0 111.635 -174.625 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.418 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.19 133.7 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 CA-C-N 111.213 -2.721 . . . . 0.0 111.885 -170.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.84 125.78 35.83 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 127.65 2.38 . . . . 0.0 106.87 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.8 158.78 22.37 Favored 'General case' 0 CA--C 1.486 -1.481 0 C-N-CA 129.267 3.027 . . . . 0.0 103.123 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -126.47 135.33 51.22 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 123.836 1.779 . . . . 0.0 109.605 -174.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.644 ' OG ' HG13 ' A' ' 138' ' ' VAL 0.283 2.8 p -121.96 146.51 47.07 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.001 -1.908 . . . . 0.0 109.952 -176.19 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 m -54.14 147.1 13.53 Favored 'General case' 0 CA--C 1.481 -1.682 1 C-N-CA 136.91 6.084 . . . . 0.0 118.273 -158.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.7 p -69.47 110.67 4.86 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.677 2.391 . . . . 0.0 110.549 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 109.77 21.94 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -98.22 113.44 25.37 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-O 123.844 1.783 . . . . 0.0 112.837 -173.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.18 128.35 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 O-C-N 119.187 -2.196 . . . . 0.0 109.511 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.2 m . . . . . 0 CA--C 1.493 -1.216 0 N-CA-C 103.795 -2.669 . . . . 0.0 103.795 175.463 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.621 ' O ' HG22 ' A' ' 92' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.211 -0.946 0 N-CA-C 116.939 2.199 . . . . 0.0 116.939 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -172.61 172.41 4.26 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 117.279 -3.388 . . . . 0.0 104.499 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.46 -48.33 1.69 Allowed 'General case' 0 C--N 1.355 0.844 0 C-N-CA 126.844 2.057 . . . . 0.0 112.061 175.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.2 t -173.68 138.07 0.64 Allowed 'General case' 0 C--N 1.362 1.117 0 O-C-N 119.36 -2.087 . . . . 0.0 115.088 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.3 ttt -141.03 116.56 10.18 Favored 'General case' 0 C--N 1.377 1.78 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 158.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.5 p -109.45 116.18 31.32 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 119.409 -2.057 . . . . 0.0 109.432 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.52 172.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.794 0 C-N-CA 126.327 1.851 . . . . 0.0 110.174 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.86 133.8 35.65 Favored 'General case' 0 C--N 1.371 1.505 0 O-C-N 119.424 -2.048 . . . . 0.0 106.561 163.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.288 9.5 pt-20 -42.55 122.41 2.27 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 120.232 3.419 . . . . 0.0 120.232 -156.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.455 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 140.37 46.09 0.06 OUTLIER Glycine 0 C--N 1.361 1.954 0 CA-C-N 110.312 -3.131 . . . . 0.0 110.979 -164.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.38 167.12 16.79 Favored 'General case' 0 C--N 1.375 1.69 0 C-N-CA 125.222 1.409 . . . . 0.0 112.984 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.31 105.8 14.19 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.419 1.087 . . . . 0.0 110.578 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.31 121.51 42.21 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.464 1.506 . . . . 0.0 113.418 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -105.08 131.04 53.09 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 102.221 -3.251 . . . . 0.0 102.221 172.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.65 HD11 ' CD2' ' A' ' 136' ' ' TYR . 4.2 mm? -120.2 113.57 20.63 Favored 'General case' 0 C--N 1.352 0.682 1 N-CA-C 98.967 -4.457 . . . . 0.0 98.967 170.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.6 m -153.67 132.79 12.59 Favored 'General case' 0 C--N 1.365 1.269 0 CA-C-N 121.093 1.769 . . . . 0.0 109.8 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.7 m -149.22 174.64 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 130.893 3.677 . . . . 0.0 104.104 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -103.89 139.65 38.78 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 128.25 2.62 . . . . 0.0 105.254 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.58 144.26 34.14 Favored 'General case' 0 C--N 1.381 1.964 1 N-CA-C 123.91 4.781 . . . . 0.0 123.91 -174.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.7 p -156.71 175.62 13.82 Favored 'General case' 0 C--N 1.364 1.212 1 C-N-CA 133.812 4.845 . . . . 0.0 104.288 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.54 40.0 0.76 Allowed Glycine 0 C--N 1.366 2.233 0 O-C-N 119.992 -1.693 . . . . 0.0 117.243 168.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.28 29.46 27.72 Favored Glycine 0 C--N 1.362 2.0 0 C-N-CA 128.199 2.809 . . . . 0.0 115.419 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.7 m -117.94 110.6 17.92 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 115.178 -2.344 . . . . 0.0 109.008 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.517 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 77.59 -87.08 1.03 Allowed Glycine 0 C--N 1.377 2.822 0 C-N-CA 129.402 3.382 . . . . 0.0 109.655 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.93 168.65 5.53 Favored 'Trans proline' 0 CA--C 1.566 2.09 1 C-N-CA 126.628 4.885 . . . . 0.0 115.143 157.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.491 ' HB3' HG12 ' A' ' 140' ' ' VAL . 67.8 m-85 -103.98 146.59 28.47 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 -166.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -102.64 140.01 37.48 Favored 'General case' 0 C--N 1.373 1.619 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.421 ' CD2' ' N ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -122.37 157.51 31.67 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 119.862 3.282 . . . . 0.0 119.862 -164.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -131.02 119.59 22.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 110.391 -3.095 . . . . 0.0 104.273 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.435 ' CE3' HG21 ' A' ' 138' ' ' VAL . 38.1 m95 -111.01 128.54 55.88 Favored 'General case' 0 C--N 1.379 1.87 0 CA-C-N 119.606 1.094 . . . . 0.0 111.235 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.328 0.2 OUTLIER -143.58 170.83 15.08 Favored 'General case' 0 C--N 1.377 1.779 0 CA-C-N 121.462 1.937 . . . . 0.0 108.145 170.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -151.0 107.3 3.47 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 120.138 -1.601 . . . . 0.0 108.843 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.477 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.268 1.3 t70 34.25 52.42 0.5 Allowed 'General case' 0 CA--C 1.467 -2.249 2 N-CA-C 122.477 4.251 . . . . 0.0 122.477 142.186 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.44 2.2 83.81 Favored Glycine 0 C--N 1.373 2.637 2 O-C-N 133.935 7.022 . . . . 0.0 118.266 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.265 3.2 m -125.06 147.1 55.85 Favored Pre-proline 0 C--N 1.349 0.553 0 C-N-CA 127.672 2.389 . . . . 0.0 116.853 -172.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.63 152.37 78.3 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 124.697 3.598 . . . . 0.0 113.842 170.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -103.76 148.83 36.42 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 120.06 -1.65 . . . . 0.0 108.296 175.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -62.61 -78.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.996 3.797 . . . . 0.0 119.384 -166.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -125.42 63.65 1.18 Allowed 'General case' 0 C--N 1.349 0.548 0 C-N-CA 124.673 1.189 . . . . 0.0 108.387 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.418 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -63.66 150.5 44.13 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 119.386 3.106 . . . . 0.0 119.386 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 81.16 75.94 0.03 OUTLIER 'General case' 0 C--N 1.363 1.193 0 C-N-CA 125.266 1.426 . . . . 0.0 111.987 175.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -165.24 -46.85 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 117.908 1.923 . . . . 0.0 117.908 -172.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.334 . . 135.65 -68.96 0.0 OUTLIER 'General case' 0 C--N 1.351 0.67 0 C-N-CA 128.174 2.59 . . . . 0.0 108.01 -178.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.256 9.0 t -138.33 115.93 11.34 Favored 'General case' 0 C--N 1.359 0.978 0 CA-C-N 120.61 1.55 . . . . 0.0 114.467 -174.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.302 4.3 p90 -127.77 140.69 51.89 Favored 'General case' 0 C--N 1.368 1.402 0 C-N-CA 129.458 3.103 . . . . 0.0 110.957 175.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.4 m -129.81 140.22 51.07 Favored 'General case' 0 C--N 1.358 0.951 0 O-C-N 118.344 -2.722 . . . . 0.0 110.368 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.37 96.42 35.61 Favored Pre-proline 0 C--N 1.367 1.355 0 C-N-CA 128.399 2.68 . . . . 0.0 106.982 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -77.38 -14.64 16.22 Favored 'Trans proline' 0 C--N 1.359 1.127 1 C-N-CA 126.946 5.097 . . . . 0.0 114.502 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.455 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -161.97 105.79 1.2 Allowed 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 176.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -94.28 133.95 37.27 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.173 2.189 . . . . 0.0 112.772 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.5 177.97 7.24 Favored 'General case' 0 C--N 1.371 1.518 0 C-N-CA 128.191 2.596 . . . . 0.0 111.066 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.05 -48.6 33.11 Favored 'General case' 0 C--N 1.364 1.22 0 N-CA-C 118.955 2.946 . . . . 0.0 118.955 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.44 -14.18 62.7 Favored 'General case' 0 C--N 1.366 1.296 0 C-N-CA 126.696 1.999 . . . . 0.0 114.573 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.479 ' CB ' ' HB1' ' A' ' 128' ' ' ALA 0.332 31.5 m-20 -82.58 -14.28 55.11 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 130.354 3.462 . . . . 0.0 111.48 170.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -74.79 133.86 41.88 Favored 'General case' 0 C--N 1.383 2.059 0 N-CA-C 118.09 2.626 . . . . 0.0 118.09 165.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.9 -158.92 31.6 Favored Glycine 0 C--N 1.37 2.421 0 C-N-CA 126.793 2.139 . . . . 0.0 109.492 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.268 11.0 t -117.74 135.94 53.7 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 114.612 -2.835 . . . . 0.0 106.879 169.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.65 ' CD2' HD11 ' A' ' 93' ' ' LEU 0.26 13.7 m-85 -97.4 134.49 40.59 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 127.072 2.149 . . . . 0.0 112.342 -173.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.587 ' HE2' HG22 ' A' ' 152' ' ' THR . 0.0 OUTLIER -143.63 153.96 43.05 Favored 'General case' 0 C--N 1.365 1.282 0 CA-C-O 123.231 1.491 . . . . 0.0 108.851 -174.399 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.638 HG13 HG22 ' A' ' 140' ' ' VAL . 1.1 t -143.62 148.15 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 117.388 -1.725 . . . . 0.0 114.672 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -120.29 120.8 37.12 Favored 'General case' 0 C--N 1.381 1.96 0 C-N-CA 126.127 1.771 . . . . 0.0 106.308 171.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.638 HG22 HG13 ' A' ' 138' ' ' VAL . 0.1 OUTLIER -131.91 123.56 51.61 Favored 'Isoleucine or valine' 0 C--N 1.367 1.341 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -176.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.408 HG23 ' C ' ' A' ' 146' ' ' VAL . 3.6 m -106.63 133.62 51.03 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 119.366 -2.084 . . . . 0.0 114.625 -176.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.476 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.37 18.9 p-10 -127.85 -179.05 4.75 Favored 'General case' 0 C--N 1.38 1.929 0 CA-C-N 119.962 1.256 . . . . 0.0 112.064 175.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.517 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 8.0 p -49.17 1.33 0.01 OUTLIER 'General case' 0 C--N 1.375 1.713 1 C-N-CA 136.593 5.957 . . . . 0.0 119.964 -167.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -101.29 4.81 42.03 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 118.502 -1.279 . . . . 0.0 108.271 164.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.462 1.3 tp60 64.83 39.69 5.94 Favored 'General case' 0 C--N 1.371 1.502 1 C-N-CA 134.582 5.153 . . . . 0.0 111.569 -173.6 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.408 ' C ' HG23 ' A' ' 141' ' ' THR . 3.4 m -112.88 131.45 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 CA-C-N 111.54 -2.573 . . . . 0.0 111.632 -169.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.64 128.72 38.59 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.249 1.82 . . . . 0.0 108.425 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 147.13 41.68 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 101.246 -3.613 . . . . 0.0 101.246 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -130.36 147.09 52.03 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 119.43 -2.043 . . . . 0.0 107.051 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 54.2 p -116.94 151.96 35.56 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 120.822 -1.174 . . . . 0.0 113.273 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.3 148.04 15.61 Favored 'General case' 0 C--N 1.375 1.677 1 C-N-CA 136.782 6.033 . . . . 0.0 116.153 -172.019 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.587 HG22 ' HE2' ' A' ' 137' ' ' LYS . 6.1 p -68.1 111.63 4.59 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 127.034 2.134 . . . . 0.0 111.417 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 1.8 m -97.06 108.45 21.19 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 102.461 -3.163 . . . . 0.0 102.461 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.73 106.81 18.75 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-O 124.704 2.192 . . . . 0.0 109.195 -172.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.46 127.79 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 O-C-N 120.309 -1.494 . . . . 0.0 107.421 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 92.6 m . . . . . 0 CA--C 1.484 -1.564 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.006 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.575 1.906 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.5 m -161.88 173.0 15.14 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 117.221 -3.424 . . . . 0.0 103.652 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.98 -47.15 0.59 Allowed 'General case' 0 C--N 1.365 1.275 0 C-N-CA 127.834 2.454 . . . . 0.0 115.468 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.7 p -172.36 116.25 0.34 Allowed 'General case' 0 C--N 1.368 1.385 0 N-CA-C 120.479 3.511 . . . . 0.0 120.479 -172.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.1 ttt -127.06 126.44 43.06 Favored 'General case' 0 C--N 1.38 1.905 0 CA-C-N 121.843 2.11 . . . . 0.0 114.267 165.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -105.5 116.44 31.94 Favored 'General case' 0 C--N 1.373 1.601 0 O-C-N 119.568 -1.957 . . . . 0.0 108.506 174.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.01 172.94 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.639 0 CA-C-O 122.714 1.245 . . . . 0.0 114.251 -169.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -86.1 123.99 32.02 Favored 'General case' 0 C--N 1.368 1.404 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 161.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -42.07 122.31 2.08 Favored 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 124.239 3.199 . . . . 0.0 118.234 -155.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.45 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 143.53 54.23 0.03 OUTLIER Glycine 0 C--N 1.356 1.672 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.636 -162.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.38 166.34 14.33 Favored 'General case' 0 C--N 1.363 1.152 0 C-N-CA 125.099 1.36 . . . . 0.0 112.143 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.9 111.16 22.1 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.166 0.986 . . . . 0.0 108.744 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 124' ' ' THR . 6.0 mp -119.75 116.01 25.06 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 125.854 1.662 . . . . 0.0 113.774 -173.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.93 125.09 52.47 Favored 'General case' 0 C--N 1.364 1.219 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 173.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -121.24 113.61 20.2 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 101.412 -3.551 . . . . 0.0 101.412 171.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.8 m -147.92 133.38 18.66 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 119.753 -1.842 . . . . 0.0 111.387 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.13 175.48 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 130.258 3.423 . . . . 0.0 104.364 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 t -104.13 139.26 39.44 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 128.066 2.547 . . . . 0.0 105.69 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.76 147.48 37.41 Favored 'General case' 0 C--N 1.381 1.943 1 N-CA-C 123.885 4.772 . . . . 0.0 123.885 -175.053 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.4 p -157.04 176.06 13.26 Favored 'General case' 0 C--N 1.361 1.096 1 C-N-CA 133.999 4.92 . . . . 0.0 103.701 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.72 41.63 0.69 Allowed Glycine 0 C--N 1.367 2.288 0 N-CA-C 117.2 1.64 . . . . 0.0 117.2 167.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.1 29.0 35.25 Favored Glycine 0 C--N 1.361 1.936 0 C-N-CA 128.526 2.965 . . . . 0.0 115.476 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.5 p -117.02 110.15 17.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 114.334 -2.746 . . . . 0.0 108.598 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.603 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.09 -88.66 0.78 Allowed Glycine 0 C--N 1.38 3.003 0 C-N-CA 129.677 3.513 . . . . 0.0 110.022 -174.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.97 169.1 5.03 Favored 'Trans proline' 0 CA--C 1.571 2.335 1 C-N-CA 127.223 5.282 . . . . 0.0 116.139 158.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.578 ' HB3' HG12 ' A' ' 140' ' ' VAL . 57.3 m-85 -101.09 143.18 31.52 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 120.616 3.561 . . . . 0.0 120.616 -166.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -102.86 141.21 36.06 Favored 'General case' 0 C--N 1.379 1.876 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.53 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -134.95 156.32 49.21 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 121.015 3.709 . . . . 0.0 121.015 -163.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -136.33 111.85 9.28 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 112.295 -2.23 . . . . 0.0 105.121 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.516 ' HB2' HG13 ' A' ' 115' ' ' ILE . 24.7 m95 -112.8 150.0 32.27 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.473 1.509 . . . . 0.0 108.68 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.295 0.1 OUTLIER -156.28 160.5 39.81 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 164.174 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.512 ' CB ' ' HA ' ' A' ' 136' ' ' TYR . 1.8 pptp? -133.93 104.98 6.51 Favored 'General case' 0 C--N 1.368 1.39 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.51 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.243 2.7 t70 37.45 55.17 1.42 Allowed 'General case' 0 CA--C 1.458 -2.585 1 CA-C-O 110.337 -4.649 . . . . 0.0 120.289 155.349 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.97 -10.15 65.89 Favored Glycine 0 C--N 1.376 2.786 2 O-C-N 134.632 7.457 . . . . 0.0 115.716 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -124.68 148.86 60.45 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 129.995 3.318 . . . . 0.0 119.495 -165.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.25 43.8 Cg_endo -60.04 156.98 36.29 Favored 'Trans proline' 0 N--CA 1.5 1.909 1 C-N-CA 125.777 4.318 . . . . 0.0 116.865 167.782 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -112.13 150.02 41.81 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 119.408 -2.057 . . . . 0.0 111.301 175.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.77 -81.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.09 1 C-N-CA 127.966 5.777 . . . . 0.0 119.516 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -100.58 -42.1 6.68 Favored 'General case' 0 C--N 1.359 1.02 0 C-N-CA 125.461 1.504 . . . . 0.0 111.369 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.447 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . 71.51 -68.93 0.2 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 129.045 2.938 . . . . 0.0 118.155 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.302 8.3 t -75.8 52.77 0.7 Allowed 'General case' 0 N--CA 1.418 -2.051 1 C-N-CA 134.517 5.127 . . . . 0.0 115.544 -169.81 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.07 -60.81 0.01 OUTLIER Glycine 0 CA--C 1.476 -2.359 0 N-CA-C 119.152 2.421 . . . . 0.0 119.152 -173.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 150.49 -62.68 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -174.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.6 t -136.68 117.24 13.84 Favored 'General case' 0 C--N 1.359 0.991 0 O-C-N 120.39 -1.444 . . . . 0.0 113.003 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -127.48 138.12 52.86 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.786 2.034 . . . . 0.0 110.751 172.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 91' ' ' LEU . 27.1 m -129.98 139.46 51.06 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 119.851 -1.781 . . . . 0.0 109.583 177.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.25 106.8 54.38 Favored Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 127.799 2.439 . . . . 0.0 106.095 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.95 -11.9 17.92 Favored 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.459 4.106 . . . . 0.0 112.738 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.45 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -161.24 111.88 1.72 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.25 126.91 45.17 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.98 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.06 -179.31 5.65 Favored 'General case' 0 C--N 1.365 1.281 0 C-N-CA 128.746 2.818 . . . . 0.0 108.584 171.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.6 -53.77 13.72 Favored 'General case' 0 C--N 1.367 1.332 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -69.2 0.14 5.23 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 127.913 2.485 . . . . 0.0 115.304 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -116.23 -7.46 11.8 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 131.423 3.889 . . . . 0.0 110.344 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.54 160.18 14.45 Favored 'General case' 0 C--N 1.397 2.643 0 N-CA-C 120.575 3.546 . . . . 0.0 120.575 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.64 -152.72 24.07 Favored Glycine 0 CA--C 1.465 -3.033 0 C-N-CA 127.643 2.544 . . . . 0.0 107.11 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.315 19.4 m -118.12 136.52 53.54 Favored 'General case' 0 N--CA 1.507 2.384 0 C-N-CA 114.001 -3.08 . . . . 0.0 109.881 171.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.512 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 14.9 m-85 -96.73 133.65 41.02 Favored 'General case' 0 C--N 1.368 1.391 0 CA-C-N 123.136 2.698 . . . . 0.0 115.283 -171.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.51 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -141.16 146.38 36.93 Favored 'General case' 0 C--N 1.373 1.596 0 CA-C-O 121.132 0.492 . . . . 0.0 110.393 -175.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 108' ' ' TRP . 15.0 p -141.53 143.49 27.39 Favored 'Isoleucine or valine' 0 C--N 1.372 1.564 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.8 m -107.67 120.39 42.11 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 130.341 3.457 . . . . 0.0 107.14 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -131.54 120.23 44.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 C-N-CA 125.975 1.71 . . . . 0.0 110.752 -173.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -106.88 132.02 53.3 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.475 -1.391 . . . . 0.0 114.522 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.451 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.36 37.3 p-10 -125.93 179.35 5.25 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 119.578 1.081 . . . . 0.0 112.28 175.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.603 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 25.4 p -49.62 3.22 0.01 OUTLIER 'General case' 0 C--N 1.372 1.569 1 C-N-CA 135.384 5.474 . . . . 0.0 120.775 -168.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -101.96 4.75 40.32 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 165.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.494 0.7 OUTLIER 65.72 40.04 4.54 Favored 'General case' 0 C--N 1.37 1.482 1 C-N-CA 133.653 4.781 . . . . 0.0 111.899 -174.342 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.68 124.49 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.649 0 CA-C-N 111.36 -2.655 . . . . 0.0 112.185 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.63 123.72 35.25 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 127.623 2.369 . . . . 0.0 106.404 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.71 153.38 31.47 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 101.809 -3.404 . . . . 0.0 101.809 -175.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -130.4 146.54 51.98 Favored 'General case' 0 CA--C 1.494 -1.204 0 O-C-N 120.958 -1.089 . . . . 0.0 109.688 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.323 84.2 p -130.6 145.29 51.86 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.0 m -55.0 147.91 14.66 Favored 'General case' 0 C--N 1.376 1.734 1 C-N-CA 137.06 6.144 . . . . 0.0 117.725 -165.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 136' ' ' TYR . 70.5 p -67.34 110.22 3.46 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 128.528 2.731 . . . . 0.0 111.075 -173.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.74 108.19 20.2 Favored 'General case' 0 C--N 1.372 1.557 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.85 110.33 22.53 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 123.242 1.496 . . . . 0.0 112.654 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.61 114.88 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.251 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . 0.294 0.6 OUTLIER . . . . . 0 C--N 1.368 1.371 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.6 ' O ' HG22 ' A' ' 92' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 123.927 1.822 . . . . 0.0 112.67 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 81' ' ' ALA . 36.6 m -171.92 171.84 4.96 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 169.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.418 ' N ' HG22 ' A' ' 80' ' ' THR . . . -123.24 -48.08 1.99 Allowed 'General case' 0 C--N 1.368 1.372 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 175.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.5 t -171.68 148.55 2.44 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 119.299 -2.125 . . . . 0.0 113.535 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.49 117.35 6.27 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 124.21 1.004 . . . . 0.0 108.48 166.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.8 t -110.57 115.63 29.95 Favored 'General case' 0 C--N 1.366 1.321 0 O-C-N 118.792 -2.442 . . . . 0.0 107.348 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.25 9.5 p -150.97 174.16 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 125.411 1.484 . . . . 0.0 113.757 -169.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -77.68 132.89 38.4 Favored 'General case' 0 C--N 1.374 1.667 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 159.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.359 0.0 OUTLIER -42.97 122.61 2.48 Favored 'General case' 0 N--CA 1.514 2.763 0 N-CA-C 119.606 3.187 . . . . 0.0 119.606 -161.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.479 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 139.84 50.76 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 110.225 -3.171 . . . . 0.0 106.226 -163.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.47 145.91 24.45 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 126.72 2.008 . . . . 0.0 107.469 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.62 121.57 36.32 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 -170.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 124' ' ' THR . 1.1 mm? -120.84 133.82 55.3 Favored 'General case' 0 C--N 1.372 1.583 0 C-N-CA 127.172 2.189 . . . . 0.0 115.956 172.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -123.81 120.36 32.4 Favored 'General case' 0 C--N 1.359 0.986 1 N-CA-C 98.155 -4.757 . . . . 0.0 98.155 165.302 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.4 HD11 ' CD1' ' A' ' 136' ' ' TYR . 1.2 mm? -115.19 115.49 26.8 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 102.018 -3.327 . . . . 0.0 102.018 176.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 4.9 t -154.62 133.29 12.11 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 117.801 -1.559 . . . . 0.0 111.789 -174.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.87 174.35 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.743 0 C-N-CA 130.405 3.482 . . . . 0.0 105.573 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.8 t -104.03 141.53 36.04 Favored 'General case' 0 C--N 1.361 1.077 0 O-C-N 119.487 -2.008 . . . . 0.0 106.578 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.19 145.21 35.36 Favored 'General case' 0 C--N 1.376 1.759 1 N-CA-C 122.989 4.44 . . . . 0.0 122.989 -173.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.9 p -156.48 175.28 14.23 Favored 'General case' 0 C--N 1.364 1.223 1 C-N-CA 133.234 4.614 . . . . 0.0 103.36 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.61 41.49 1.0 Allowed Glycine 0 C--N 1.362 2.019 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.36 18.92 54.38 Favored Glycine 0 C--N 1.362 1.982 0 C-N-CA 127.14 2.305 . . . . 0.0 116.121 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.6 m -118.19 111.02 18.28 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 115.039 -2.41 . . . . 0.0 110.185 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.592 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 79.35 -93.05 1.31 Allowed Glycine 0 C--N 1.379 2.961 0 C-N-CA 129.665 3.507 . . . . 0.0 109.221 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.36 168.54 6.29 Favored 'Trans proline' 0 CA--C 1.564 1.998 1 C-N-CA 127.485 5.457 . . . . 0.0 116.316 159.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.585 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.0 m-85 -99.12 148.14 24.36 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 119.804 3.261 . . . . 0.0 119.804 -165.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -110.7 144.69 39.25 Favored 'General case' 0 C--N 1.381 1.938 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.484 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -141.09 165.95 26.14 Favored 'General case' 0 C--N 1.346 0.444 1 N-CA-C 122.345 4.202 . . . . 0.0 122.345 -159.75 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.15 118.49 12.81 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 110.723 -2.944 . . . . 0.0 105.044 172.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -111.79 134.48 53.32 Favored 'General case' 0 C--N 1.366 1.288 0 C-N-CA 125.797 1.639 . . . . 0.0 109.321 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.367 0.2 OUTLIER -155.79 170.01 23.06 Favored 'General case' 0 CA--C 1.488 -1.422 0 O-C-N 120.468 -1.395 . . . . 0.0 107.458 170.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.494 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.6 ptmm? -143.01 106.49 4.6 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 119.52 -1.988 . . . . 0.0 111.555 -177.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.508 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.141 2.0 t70 36.41 54.8 1.07 Allowed 'General case' 0 C--N 1.384 2.084 1 CA-C-O 109.687 -4.959 . . . . 0.0 121.53 149.042 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.33 2.83 80.81 Favored Glycine 0 C--N 1.386 3.319 2 O-C-N 135.353 7.908 . . . . 0.0 119.561 -172.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.274 1.0 OUTLIER -125.23 147.48 57.53 Favored Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 129.39 3.076 . . . . 0.0 117.936 -167.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.85 139.39 62.15 Favored 'Trans proline' 0 N--CA 1.504 2.103 1 C-N-CA 126.037 4.492 . . . . 0.0 117.501 169.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.494 HG12 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -91.63 160.02 37.36 Favored Pre-proline 0 CA--C 1.553 1.059 0 O-C-N 118.441 -2.662 . . . . 0.0 112.773 175.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 12.3 Cg_endo -72.42 -82.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 124.959 3.773 . . . . 0.0 118.284 -172.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -117.29 60.85 0.75 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.277 1.431 . . . . 0.0 109.643 -171.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.494 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -67.65 151.79 46.69 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 129.085 2.954 . . . . 0.0 117.565 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.464 ' HA ' ' CD2' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 80.54 63.71 0.02 OUTLIER 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.73 1.612 . . . . 0.0 111.015 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.36 -85.56 0.06 OUTLIER Glycine 0 C--N 1.355 1.598 0 N-CA-C 115.474 0.949 . . . . 0.0 115.474 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 165.74 -65.75 0.0 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 126.068 1.747 . . . . 0.0 106.712 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.263 14.8 t -133.03 110.11 10.0 Favored 'General case' 0 C--N 1.36 1.056 0 CA-C-O 122.994 1.378 . . . . 0.0 113.308 -177.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.293 9.4 p90 -127.09 141.12 51.85 Favored 'General case' 0 C--N 1.369 1.448 0 C-N-CA 128.339 2.656 . . . . 0.0 112.474 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 91' ' ' LEU . 25.5 m -128.82 139.7 52.05 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 119.924 -1.735 . . . . 0.0 108.854 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.71 92.19 45.45 Favored Pre-proline 0 C--N 1.354 0.801 0 C-N-CA 128.748 2.819 . . . . 0.0 104.903 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -74.43 -32.89 5.92 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 124.879 3.719 . . . . 0.0 112.854 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.479 HG23 ' HA2' ' A' ' 88' ' ' GLY . 69.0 m -128.38 100.6 5.86 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.67 118.5 31.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.877 1.671 . . . . 0.0 113.111 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.43 -179.06 6.86 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.451 2.301 . . . . 0.0 109.438 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -51.32 23.62 Favored 'General case' 0 C--N 1.366 1.316 0 O-C-N 117.803 -3.06 . . . . 0.0 118.088 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.31 0.86 2.53 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 128.851 2.86 . . . . 0.0 115.111 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -116.36 -13.91 11.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 129.544 3.138 . . . . 0.0 111.102 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.75 154.64 17.46 Favored 'General case' 0 C--N 1.399 2.739 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 174.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.46 -157.78 27.36 Favored Glycine 0 C--N 1.382 3.095 0 C-N-CA 128.923 3.154 . . . . 0.0 109.81 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.393 5.7 m -110.66 130.83 55.47 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 112.343 -3.743 . . . . 0.0 107.545 167.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.502 ' HB2' ' HB3' ' A' ' 153' ' ' CYS . 24.5 m-85 -96.81 134.77 39.68 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-N 122.605 2.457 . . . . 0.0 113.011 -172.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -148.5 150.64 33.77 Favored 'General case' 0 C--N 1.376 1.743 0 C-N-CA 124.878 1.271 . . . . 0.0 110.456 -175.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 149' ' ' ASP . 8.9 p -143.67 137.49 24.95 Favored 'Isoleucine or valine' 0 C--N 1.371 1.501 0 C-N-CA 117.956 -1.497 . . . . 0.0 114.314 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.23 111.77 24.65 Favored 'General case' 0 C--N 1.378 1.811 0 C-N-CA 130.34 3.456 . . . . 0.0 105.341 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.585 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -127.21 112.21 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 128.124 2.569 . . . . 0.0 110.73 -169.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 8.0 m -99.3 130.93 45.62 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.458 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.364 25.3 p-10 -127.7 -177.03 3.94 Favored 'General case' 0 C--N 1.372 1.584 0 CA-C-N 119.234 0.925 . . . . 0.0 112.213 174.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.592 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 20.4 p -49.83 3.36 0.01 OUTLIER 'General case' 0 C--N 1.369 1.414 1 C-N-CA 136.749 6.02 . . . . 0.0 120.501 -169.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -101.27 4.89 42.18 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 163.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.358 2.1 mp0 65.44 39.53 5.12 Favored 'General case' 0 C--N 1.378 1.825 1 C-N-CA 134.249 5.02 . . . . 0.0 110.678 -175.149 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.452 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.58 133.4 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 CA-C-N 112.137 -2.302 . . . . 0.0 111.99 -170.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 1.8 t -91.69 132.16 36.57 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 120.744 1.611 . . . . 0.0 106.883 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.13 157.99 23.92 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 -176.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 22.6 t70 -126.11 134.18 51.42 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.814 0.816 . . . . 0.0 109.294 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.528 59.8 p -111.13 143.9 41.12 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.8 m -54.05 146.74 13.97 Favored 'General case' 0 C--N 1.368 1.404 1 C-N-CA 136.709 6.004 . . . . 0.0 119.405 -155.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.0 p -69.06 110.1 4.33 Favored 'General case' 0 C--N 1.376 1.719 0 C-N-CA 124.264 1.026 . . . . 0.0 110.711 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 4.7 t -100.02 110.12 22.43 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.14 103.89 15.86 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 122.758 1.266 . . . . 0.0 112.267 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.2 m -112.43 115.18 49.11 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.489 -1.381 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -174.739 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.575 1.907 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -175.93 176.21 1.84 Allowed 'General case' 0 CA--C 1.5 -0.96 1 N-CA-C 97.987 -4.82 . . . . 0.0 97.987 167.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.25 -51.24 2.92 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 121.713 2.052 . . . . 0.0 107.862 162.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.0 t -166.67 135.61 2.9 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 119.562 -1.961 . . . . 0.0 114.396 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 ttt -137.79 116.73 12.4 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-O 122.592 1.187 . . . . 0.0 109.388 161.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -108.57 115.22 29.68 Favored 'General case' 0 C--N 1.362 1.133 0 O-C-N 119.023 -2.298 . . . . 0.0 107.972 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.4 p -149.55 173.17 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 127.535 2.334 . . . . 0.0 112.077 -169.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.59 136.27 42.05 Favored 'General case' 0 C--N 1.37 1.484 0 O-C-N 118.739 -2.476 . . . . 0.0 107.175 158.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.28 5.8 pt-20 -43.34 122.08 2.45 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 -162.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.56 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 136.19 45.0 0.09 OUTLIER Glycine 0 C--N 1.352 1.43 0 CA-C-N 110.094 -3.23 . . . . 0.0 111.526 -162.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.23 164.57 21.11 Favored 'General case' 0 C--N 1.373 1.604 0 C-N-CA 125.07 1.348 . . . . 0.0 111.383 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.37 101.98 10.65 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 123.072 1.415 . . . . 0.0 113.897 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 1.2 mp -119.71 128.82 54.15 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -175.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.6 t -114.53 135.69 53.85 Favored 'General case' 0 C--N 1.358 0.953 1 N-CA-C 99.422 -4.288 . . . . 0.0 99.422 165.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.01 114.79 23.68 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 100.867 -3.753 . . . . 0.0 100.867 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -150.3 132.65 15.55 Favored 'General case' 0 C--N 1.366 1.321 0 C-N-CA 118.2 -1.4 . . . . 0.0 114.147 -168.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 m -149.59 174.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.943 1 C-N-CA 132.971 4.508 . . . . 0.0 106.198 177.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -104.37 141.52 36.18 Favored 'General case' 0 C--N 1.367 1.368 0 O-C-N 118.948 -2.345 . . . . 0.0 106.669 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.98 135.9 38.04 Favored 'General case' 0 C--N 1.374 1.654 0 N-CA-C 120.986 3.699 . . . . 0.0 120.986 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.0 m -157.69 172.11 19.11 Favored 'General case' 0 C--N 1.359 1.012 1 C-N-CA 131.789 4.035 . . . . 0.0 101.518 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.98 44.12 1.27 Allowed Glycine 0 C--N 1.367 2.301 0 CA-C-N 122.535 2.425 . . . . 0.0 117.381 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.29 25.49 57.1 Favored Glycine 0 C--N 1.355 1.596 0 C-N-CA 128.552 2.977 . . . . 0.0 115.422 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.2 m -117.9 110.96 18.38 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 114.444 -2.693 . . . . 0.0 107.587 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.544 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 78.03 -89.27 1.08 Allowed Glycine 0 C--N 1.376 2.783 0 C-N-CA 130.148 3.737 . . . . 0.0 109.953 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -60.68 167.99 7.55 Favored 'Trans proline' 0 CA--C 1.564 2.01 1 C-N-CA 127.009 5.14 . . . . 0.0 116.258 159.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.588 ' HB3' HG12 ' A' ' 140' ' ' VAL . 82.1 m-85 -102.57 146.58 27.94 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 120.036 3.347 . . . . 0.0 120.036 -166.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 t -105.63 153.83 21.26 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 129.354 3.062 . . . . 0.0 104.083 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.02 164.9 38.25 Favored 'General case' 0 C--N 1.366 1.295 1 N-CA-C 122.231 4.16 . . . . 0.0 122.231 -161.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.29 114.63 14.64 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 128.614 2.766 . . . . 0.0 106.258 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -111.02 131.27 55.2 Favored 'General case' 0 C--N 1.368 1.404 0 C-N-CA 127.145 2.178 . . . . 0.0 109.807 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.313 0.0 OUTLIER -151.03 169.54 21.57 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 168.602 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HD3' ' CD1' ' A' ' 136' ' ' TYR . 4.0 ttpt -135.61 107.68 7.17 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.426 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.24 0.8 OUTLIER 33.25 50.83 0.27 Allowed 'General case' 0 C--N 1.374 1.658 1 N-CA-C 123.546 4.647 . . . . 0.0 123.546 135.421 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.96 -3.54 83.66 Favored Glycine 0 C--N 1.363 2.063 2 O-C-N 132.412 6.07 . . . . 0.0 120.199 -172.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.293 3.4 m -124.02 147.38 53.99 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 129.963 3.305 . . . . 0.0 118.598 -172.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -62.07 140.49 84.47 Favored 'Trans proline' 0 C--N 1.37 1.665 1 C-N-CA 126.215 4.61 . . . . 0.0 115.645 172.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.522 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -88.63 164.87 30.42 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 119.694 -1.879 . . . . 0.0 111.23 175.24 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 90.6 Cg_exo -52.21 -44.62 44.86 Favored 'Trans proline' 0 C--N 1.353 0.793 1 C-N-CA 127.785 5.657 . . . . 0.0 118.72 -171.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -169.15 -50.43 0.02 OUTLIER 'General case' 0 C--N 1.348 0.507 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 81.03 -164.17 0.02 OUTLIER 'General case' 0 C--N 1.364 1.204 0 C-N-CA 129.328 3.051 . . . . 0.0 111.401 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t 82.6 3.17 1.14 Allowed 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 119.609 3.189 . . . . 0.0 119.609 170.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.97 85.11 0.06 OUTLIER Glycine 0 CA--C 1.475 -2.467 0 C-N-CA 115.597 -3.192 . . . . 0.0 119.125 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.335 . . 87.47 -78.63 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 163.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.306 6.0 t -141.37 119.95 12.45 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 123.833 1.778 . . . . 0.0 115.153 -170.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -127.3 142.67 51.4 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 129.514 3.126 . . . . 0.0 109.883 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.7 m -126.38 139.0 53.62 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 122.345 2.339 . . . . 0.0 109.678 176.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -119.15 89.31 39.19 Favored Pre-proline 0 C--N 1.37 1.493 0 C-N-CA 129.056 2.942 . . . . 0.0 103.847 176.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -73.28 -31.39 9.36 Favored 'Trans proline' 0 N--CA 1.471 0.204 1 C-N-CA 125.512 4.142 . . . . 0.0 112.668 -172.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.56 HG23 ' HA2' ' A' ' 88' ' ' GLY . 55.2 m -143.98 100.53 3.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.693 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -86.93 134.58 33.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.312 1.845 . . . . 0.0 114.443 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.15 171.69 14.59 Favored 'General case' 0 C--N 1.366 1.302 0 C-N-CA 127.436 2.294 . . . . 0.0 112.343 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.1 -43.72 20.65 Favored 'General case' 0 C--N 1.37 1.477 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -172.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.2 -13.32 61.85 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 128.545 2.738 . . . . 0.0 115.07 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.693 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 4.9 m-20 -74.31 -21.08 59.88 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 128.113 2.565 . . . . 0.0 112.239 167.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.17 119.75 9.0 Favored 'General case' 0 C--N 1.386 2.183 0 N-CA-C 120.449 3.5 . . . . 0.0 120.449 172.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.97 -155.13 26.35 Favored Glycine 0 CA--C 1.468 -2.879 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.491 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.316 6.9 m -118.3 132.01 56.31 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 115.397 -2.521 . . . . 0.0 107.214 171.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.464 ' CD1' ' HD3' ' A' ' 110' ' ' LYS . 2.5 m-85 -97.06 133.81 41.24 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 125.85 1.66 . . . . 0.0 110.487 -170.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.491 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -145.62 144.5 30.49 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-O 122.091 0.948 . . . . 0.0 109.647 -174.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.291 7.5 p -141.8 135.94 30.23 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 117.685 -1.606 . . . . 0.0 114.166 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.8 m -103.08 121.26 42.22 Favored 'General case' 0 C--N 1.38 1.915 0 C-N-CA 129.455 3.102 . . . . 0.0 106.238 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -132.22 120.44 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 127.127 2.171 . . . . 0.0 110.497 -169.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.467 HG23 ' C ' ' A' ' 146' ' ' VAL . 14.1 m -107.78 133.35 52.3 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 119.877 -1.764 . . . . 0.0 112.816 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.466 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.373 18.3 p-10 -129.76 -176.55 3.95 Favored 'General case' 0 C--N 1.377 1.77 0 C-N-CA 124.804 1.242 . . . . 0.0 111.929 176.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.544 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 8.1 p -49.37 1.5 0.01 OUTLIER 'General case' 0 C--N 1.369 1.437 1 C-N-CA 136.332 5.853 . . . . 0.0 120.519 -167.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -99.75 4.63 45.5 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 118.262 -1.375 . . . . 0.0 107.784 163.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.437 0.8 OUTLIER 65.67 39.77 4.72 Favored 'General case' 0 C--N 1.371 1.508 1 C-N-CA 133.961 4.904 . . . . 0.0 111.623 -174.524 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.467 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.43 131.94 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 CA-C-N 111.023 -2.808 . . . . 0.0 112.394 -169.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.2 124.0 35.07 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 127.856 2.462 . . . . 0.0 107.477 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.36 157.69 24.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 128.798 2.839 . . . . 0.0 103.835 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -128.5 137.34 51.74 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.861 1.21 . . . . 0.0 109.672 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.385 75.1 p -113.55 143.21 44.93 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 125.405 1.482 . . . . 0.0 109.245 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.2 m -54.11 148.47 10.99 Favored 'General case' 0 C--N 1.37 1.492 1 C-N-CA 135.839 5.656 . . . . 0.0 118.887 -159.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 66.6 p -69.09 111.31 4.99 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 127.718 2.407 . . . . 0.0 110.1 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.28 109.85 22.07 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.05 105.99 18.1 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 124.433 2.063 . . . . 0.0 110.372 -174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.1 m -118.46 128.21 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 14.9 m . . . . . 0 CA--C 1.484 -1.565 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 177.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.44 ' O ' HG22 ' A' ' 92' ' ' THR . 0.5 OUTLIER . . . . . 0 CA--C 1.584 2.254 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -170.8 172.33 5.72 Favored 'General case' 0 N--CA 1.471 0.588 1 O-C-N 114.385 -5.197 . . . . 0.0 101.903 173.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.18 -41.94 0.57 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.588 1.555 . . . . 0.0 111.349 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.1 m -163.73 117.49 1.52 Allowed 'General case' 0 C--N 1.363 1.191 0 N-CA-C 117.754 2.501 . . . . 0.0 117.754 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.4 ttt -137.18 116.57 12.74 Favored 'General case' 0 C--N 1.377 1.791 0 CA-C-N 120.378 1.445 . . . . 0.0 109.079 155.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.1 m -113.25 117.02 30.7 Favored 'General case' 0 C--N 1.365 1.261 0 O-C-N 118.607 -2.558 . . . . 0.0 109.063 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -149.4 172.58 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.937 0 C-N-CA 126.058 1.743 . . . . 0.0 110.156 -170.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.99 130.9 35.19 Favored 'General case' 0 C--N 1.373 1.625 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -41.85 122.34 2.02 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -153.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.484 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 143.61 43.36 0.05 OUTLIER Glycine 0 C--N 1.356 1.662 0 CA-C-N 109.721 -3.399 . . . . 0.0 110.7 -163.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.53 168.02 14.89 Favored 'General case' 0 C--N 1.374 1.67 0 C-N-CA 124.802 1.241 . . . . 0.0 112.543 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.48 99.37 8.15 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.188 0.995 . . . . 0.0 109.595 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.03 111.78 23.38 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 125.494 1.518 . . . . 0.0 113.94 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -105.19 125.5 51.05 Favored 'General case' 0 C--N 1.371 1.534 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.025 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.67 114.87 21.17 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 103.539 -2.763 . . . . 0.0 103.539 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 t -151.14 134.3 16.01 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 120.938 -1.101 . . . . 0.0 112.197 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.03 173.85 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 130.769 3.627 . . . . 0.0 103.703 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -104.16 138.47 40.6 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.3 142.15 33.88 Favored 'General case' 0 C--N 1.366 1.301 0 N-CA-C 120.012 3.338 . . . . 0.0 120.012 -174.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.5 m -158.26 174.33 15.33 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 130.826 3.65 . . . . 0.0 102.178 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.36 44.29 1.64 Allowed Glycine 0 C--N 1.366 2.244 0 O-C-N 118.681 -2.512 . . . . 0.0 117.452 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.24 21.36 65.14 Favored Glycine 0 C--N 1.359 1.838 0 C-N-CA 128.823 3.106 . . . . 0.0 114.749 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 10.1 p -116.55 111.34 19.78 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 126.165 1.786 . . . . 0.0 106.823 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.753 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 70.51 -90.72 0.38 Allowed Glycine 0 C--N 1.364 2.115 0 C-N-CA 130.649 3.976 . . . . 0.0 111.586 -169.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -60.74 168.39 7.05 Favored 'Trans proline' 0 CA--C 1.568 2.184 1 C-N-CA 127.457 5.438 . . . . 0.0 117.289 160.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.619 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.6 m-85 -93.64 142.32 27.49 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 121.317 3.821 . . . . 0.0 121.317 -167.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -102.96 155.13 18.57 Favored 'General case' 0 C--N 1.383 2.025 0 C-N-CA 128.23 2.612 . . . . 0.0 104.905 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 119' ' ' SER . 0.0 OUTLIER -155.59 166.94 32.0 Favored 'General case' 0 C--N 1.362 1.133 1 N-CA-C 122.402 4.223 . . . . 0.0 122.402 -159.375 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.36 114.18 7.65 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-N 112.166 -2.288 . . . . 0.0 107.596 173.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -113.29 155.07 25.78 Favored 'General case' 0 C--N 1.373 1.606 0 O-C-N 119.622 -1.924 . . . . 0.0 110.965 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.0 p -149.06 159.13 44.51 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 167.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' CE ' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -123.5 102.23 7.76 Favored 'General case' 0 C--N 1.377 1.797 0 C-N-CA 114.411 -2.916 . . . . 0.0 112.673 161.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.45 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.173 1.6 t70 36.47 54.17 1.06 Allowed 'General case' 0 CA--C 1.458 -2.58 0 CA-C-O 111.972 -3.87 . . . . 0.0 120.526 149.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.93 -17.17 42.14 Favored Glycine 0 C--N 1.363 2.055 1 O-C-N 133.193 6.558 . . . . 0.0 116.573 -172.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m -122.73 146.41 47.95 Favored Pre-proline 0 CA--C 1.573 1.854 0 C-N-CA 131.344 3.858 . . . . 0.0 119.876 -170.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.266 65.1 Cg_endo -65.08 136.12 46.73 Favored 'Trans proline' 0 N--CA 1.509 2.43 1 C-N-CA 128.684 6.256 . . . . 0.0 116.334 176.739 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.516 ' HB ' ' CD ' ' A' ' 116' ' ' PRO 0.421 0.6 OUTLIER -84.64 164.95 40.32 Favored Pre-proline 0 N--CA 1.485 1.316 2 O-C-N 116.123 -4.111 . . . . 0.0 116.846 179.889 . . . . . . . . 5 4 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.516 ' CD ' ' HB ' ' A' ' 115' ' ' ILE . 2.8 Cg_exo -67.1 80.88 0.37 Allowed 'Trans proline' 0 C--N 1.384 2.446 1 C-N-CA 127.3 5.333 . . . . 0.0 112.571 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 80.29 -62.21 0.25 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 127.874 2.47 . . . . 0.0 110.815 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . 0.469 ' HB2' ' CG1' ' A' ' 115' ' ' ILE . . . 84.94 162.28 0.1 Allowed 'General case' 0 C--N 1.372 1.554 0 C-N-CA 129.207 3.003 . . . . 0.0 111.448 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.47 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.2 OUTLIER 74.03 59.54 0.08 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-O 122.767 1.27 . . . . 0.0 114.127 174.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.44 -85.51 0.09 OUTLIER Glycine 0 C--N 1.356 1.648 0 N-CA-C 117.487 1.755 . . . . 0.0 117.487 -170.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.26 . . 160.01 -71.13 0.0 OUTLIER 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.98 1.312 . . . . 0.0 110.437 -177.589 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.1 t -136.09 104.96 5.86 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 122.859 1.314 . . . . 0.0 113.838 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.299 7.8 p90 -128.05 140.97 51.65 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 127.713 2.405 . . . . 0.0 110.563 174.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 70.9 m -129.07 139.27 52.09 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 119.931 -1.73 . . . . 0.0 109.094 177.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.259 1.3 mmmm -105.76 111.67 64.6 Favored Pre-proline 0 C--N 1.372 1.548 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 171.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.21 -16.89 15.33 Favored 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 126.37 4.713 . . . . 0.0 113.339 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.484 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -162.18 101.27 1.1 Allowed 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 177.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.549 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.53 134.59 33.82 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.395 2.278 . . . . 0.0 113.167 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.17 176.83 8.51 Favored 'General case' 0 C--N 1.372 1.579 0 C-N-CA 128.351 2.66 . . . . 0.0 112.718 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.73 -46.63 29.97 Favored 'General case' 0 C--N 1.37 1.467 0 N-CA-C 119.414 3.116 . . . . 0.0 119.414 -172.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.98 -16.88 48.01 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 129.142 2.977 . . . . 0.0 115.0 174.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.549 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 7.4 m-20 -80.43 -22.04 41.58 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 128.79 2.836 . . . . 0.0 113.855 170.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -65.27 124.63 22.71 Favored 'General case' 0 C--N 1.382 2.014 0 N-CA-C 120.234 3.42 . . . . 0.0 120.234 173.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.14 -159.27 31.76 Favored Glycine 0 CA--C 1.463 -3.217 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.4 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.311 50.5 m -112.6 133.78 54.47 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 115.002 -2.679 . . . . 0.0 107.775 171.482 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.427 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 5.9 m-85 -96.2 133.43 40.53 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 118.988 -2.32 . . . . 0.0 110.311 -171.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -142.61 142.98 32.22 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 125.111 1.507 . . . . 0.0 107.329 -173.44 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.1 p -133.45 143.4 39.1 Favored 'Isoleucine or valine' 0 C--N 1.36 1.031 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.781 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -110.86 120.75 43.42 Favored 'General case' 0 C--N 1.38 1.898 0 C-N-CA 127.71 2.404 . . . . 0.0 106.135 171.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -132.58 120.49 42.37 Favored 'Isoleucine or valine' 0 C--N 1.361 1.101 0 C-N-CA 126.439 1.896 . . . . 0.0 112.143 -172.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 11.9 m -108.75 129.63 55.37 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 119.652 -1.905 . . . . 0.0 114.338 -178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.468 17.5 p30 -126.67 -167.84 1.78 Allowed 'General case' 0 C--N 1.376 1.735 0 CA-C-N 119.972 1.26 . . . . 0.0 113.057 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.753 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 20.2 p -49.77 -0.52 0.01 OUTLIER 'General case' 0 C--N 1.365 1.259 2 C-N-CA 135.08 5.352 . . . . 0.0 122.04 -162.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -105.91 4.68 29.84 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.119 167.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.41 87.3 mm-40 68.29 40.32 2.11 Favored 'General case' 0 C--N 1.375 1.717 0 C-N-CA 131.635 3.974 . . . . 0.0 109.819 -170.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.52 122.9 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 CA-C-N 111.991 -2.368 . . . . 0.0 112.528 -170.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -90.49 124.11 34.73 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 128.646 2.778 . . . . 0.0 107.254 -177.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.17 157.33 24.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 129.303 3.041 . . . . 0.0 103.066 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -130.2 143.36 50.74 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.39 5.0 p -124.62 148.18 48.05 Favored 'General case' 0 C--O 1.26 1.626 0 CA-C-N 119.378 0.99 . . . . 0.0 109.509 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.2 m -54.4 147.01 14.53 Favored 'General case' 0 C--N 1.385 2.127 2 C-N-CA 137.817 6.447 . . . . 0.0 115.776 -162.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 73.5 p -68.82 109.8 4.04 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.159 -1.837 . . . . 0.0 111.721 -172.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 108.95 20.29 Favored 'General case' 0 C--N 1.368 1.412 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.31 109.02 21.6 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 123.889 1.804 . . . . 0.0 110.029 -173.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.83 128.24 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 O-C-N 120.367 -1.458 . . . . 0.0 108.676 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 98.3 m . . . . . 0 CA--C 1.499 -1.012 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 175.519 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.633 ' HG ' ' H ' ' A' ' 94' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.576 1.965 0 CA-C-O 121.909 0.862 . . . . 0.0 111.588 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.6 m -163.94 172.57 13.77 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 116.556 -3.84 . . . . 0.0 104.049 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.68 -40.83 0.78 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 128.111 2.564 . . . . 0.0 112.944 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.6 p -176.0 136.13 0.29 Allowed 'General case' 0 C--N 1.369 1.423 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 34.8 tpp -134.22 118.27 17.42 Favored 'General case' 0 C--N 1.375 1.684 0 CA-C-N 119.69 1.132 . . . . 0.0 109.855 163.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.7 t -111.18 115.65 29.74 Favored 'General case' 0 C--N 1.377 1.788 0 CA-C-O 123.553 1.644 . . . . 0.0 107.796 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.75 174.4 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 127.495 2.318 . . . . 0.0 110.938 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -73.57 143.83 46.28 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 126.556 1.943 . . . . 0.0 106.643 156.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.381 0.0 OUTLIER -44.14 123.38 3.36 Favored 'General case' 0 N--CA 1.514 2.773 0 O-C-N 116.947 -3.596 . . . . 0.0 116.626 -172.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 124.73 48.72 0.21 Allowed Glycine 0 C--N 1.353 1.516 0 CA-C-N 111.705 -2.498 . . . . 0.0 109.338 -151.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.19 156.75 18.11 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 125.487 1.515 . . . . 0.0 111.515 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.76 105.25 13.68 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 124.609 1.164 . . . . 0.0 111.282 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.548 HD23 ' CE1' ' A' ' 136' ' ' TYR . 3.4 mp -120.31 125.52 48.27 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 127.002 2.121 . . . . 0.0 115.361 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.62 122.27 46.74 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 170.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -123.46 115.48 21.65 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.633 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 86.2 p -157.29 131.57 8.41 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 120.775 -1.203 . . . . 0.0 113.967 -172.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 140' ' ' VAL . 10.1 m -148.97 173.12 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 129.955 3.302 . . . . 0.0 105.974 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 p -103.77 124.71 49.4 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 115.082 -2.389 . . . . 0.0 109.808 -172.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -136.72 138.18 40.72 Favored 'General case' 0 C--N 1.386 2.154 1 N-CA-C 125.318 5.303 . . . . 0.0 125.318 -170.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 99' ' ' GLY . 61.5 m -157.49 174.57 15.19 Favored 'General case' 0 C--N 1.367 1.354 1 C-N-CA 132.023 4.129 . . . . 0.0 101.678 169.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.438 ' H ' HG22 ' A' ' 98' ' ' THR . . . -69.27 46.99 0.5 Allowed Glycine 0 C--N 1.366 2.228 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -177.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.58 21.0 60.76 Favored Glycine 0 C--N 1.356 1.657 0 C-N-CA 127.146 2.308 . . . . 0.0 116.156 175.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.412 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 7.9 p -116.45 111.11 19.53 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 115.686 -2.102 . . . . 0.0 107.234 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.678 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 70.98 -90.43 0.41 Allowed Glycine 0 C--N 1.377 2.844 0 C-N-CA 128.105 2.764 . . . . 0.0 111.814 -170.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 101' ' ' THR . 62.4 Cg_endo -66.57 167.52 18.82 Favored 'Trans proline' 0 CA--C 1.571 2.343 1 C-N-CA 126.35 4.7 . . . . 0.0 115.211 162.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.417 ' HB3' HG12 ' A' ' 140' ' ' VAL . 67.4 m-85 -90.82 145.54 24.68 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 121.009 3.707 . . . . 0.0 121.009 -166.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 t -102.16 140.4 36.49 Favored 'General case' 0 C--N 1.38 1.895 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.569 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -132.14 158.26 42.12 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 121.589 3.922 . . . . 0.0 121.589 -160.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.27 119.66 10.94 Favored 'General case' 0 C--N 1.36 1.029 0 CA-C-N 112.423 -2.171 . . . . 0.0 106.977 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -112.38 151.59 29.61 Favored 'General case' 0 C--N 1.367 1.335 0 O-C-N 119.943 -1.723 . . . . 0.0 107.848 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.4 0.0 OUTLIER -157.78 146.08 19.04 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 119.559 -1.963 . . . . 0.0 105.771 164.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.849 ' HG2' HG22 ' A' ' 115' ' ' ILE 0.307 65.8 mmtt -126.43 99.67 5.93 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 115.987 -2.285 . . . . 0.0 111.613 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.458 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.356 0.8 OUTLIER 36.65 53.22 1.05 Allowed 'General case' 0 CA--C 1.46 -2.489 1 CA-C-O 111.615 -4.04 . . . . 0.0 121.267 157.612 . . . . . . . . 5 4 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.45 -5.26 70.52 Favored Glycine 0 C--N 1.372 2.547 2 O-C-N 133.509 6.756 . . . . 0.0 114.965 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -124.09 148.56 57.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 131.179 3.792 . . . . 0.0 115.956 -168.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.36 161.69 19.5 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 124.244 3.296 . . . . 0.0 116.187 168.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.849 HG22 ' HG2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -93.27 165.57 18.07 Favored Pre-proline 0 N--CA 1.443 -0.791 0 C-N-CA 131.373 3.869 . . . . 0.0 109.305 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 44.6 Cg_exo -51.24 -44.29 43.82 Favored 'Trans proline' 0 CA--C 1.538 0.675 1 C-N-CA 127.433 5.422 . . . . 0.0 118.757 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -158.62 -50.82 0.06 Allowed 'General case' 0 C--N 1.348 0.504 0 C-N-CA 126.245 1.818 . . . . 0.0 106.972 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.256 . . 97.49 140.52 0.02 OUTLIER 'General case' 0 CA--C 1.464 -2.352 0 C-N-CA 128.819 2.847 . . . . 0.0 110.472 -177.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 73.9 m 69.75 34.71 2.57 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.163 -1.835 . . . . 0.0 114.243 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -108.2 -18.46 9.78 Favored Glycine 0 CA--C 1.47 -2.762 0 N-CA-C 117.877 1.911 . . . . 0.0 117.877 -164.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.313 . . 81.99 -73.03 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 126.309 1.844 . . . . 0.0 111.786 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.28 13.4 t -128.62 104.22 7.54 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 123.199 1.476 . . . . 0.0 112.459 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.346 0.0 OUTLIER -127.49 140.99 51.78 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 128.192 2.597 . . . . 0.0 112.16 174.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.8 m -123.48 138.59 54.55 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 120.334 -1.479 . . . . 0.0 107.869 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.67 106.75 57.52 Favored Pre-proline 0 C--N 1.369 1.415 0 N-CA-C 103.449 -2.796 . . . . 0.0 103.449 170.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.72 -32.46 3.53 Favored 'Trans proline' 0 C--N 1.356 0.958 1 C-N-CA 126.925 5.083 . . . . 0.0 111.733 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.417 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -144.47 103.98 4.01 Favored 'General case' 0 N--CA 1.42 -1.928 1 N-CA-C 99.855 -4.128 . . . . 0.0 99.855 176.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.586 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -95.37 133.38 39.38 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 128.335 2.654 . . . . 0.0 107.611 176.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.42 -176.1 4.68 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 127.956 2.502 . . . . 0.0 113.084 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.29 -45.12 34.44 Favored 'General case' 0 C--N 1.369 1.419 0 N-CA-C 119.024 2.972 . . . . 0.0 119.024 -173.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -69.04 -7.58 37.03 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 126.753 2.021 . . . . 0.0 114.974 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.586 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 4.9 m-20 -81.54 -17.9 46.85 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.293 2.237 . . . . 0.0 110.236 168.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.92 114.02 3.82 Favored 'General case' 0 C--N 1.386 2.158 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 171.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 165.63 -156.87 29.08 Favored Glycine 0 CA--C 1.454 -3.75 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.404 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.334 23.7 m -112.85 133.08 55.01 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 114.667 -2.813 . . . . 0.0 107.257 174.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.548 ' CE1' HD23 ' A' ' 91' ' ' LEU . 4.2 m-85 -96.99 132.39 42.85 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 118.506 -2.621 . . . . 0.0 113.547 -168.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -144.05 151.35 39.54 Favored 'General case' 0 C--N 1.394 2.543 0 CA-C-N 120.066 1.303 . . . . 0.0 112.138 -173.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.3 p -141.59 143.07 27.91 Favored 'Isoleucine or valine' 0 C--N 1.378 1.82 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.1 m -113.15 121.04 43.33 Favored 'General case' 0 C--N 1.373 1.623 0 C-N-CA 129.684 3.194 . . . . 0.0 107.366 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -132.8 125.37 52.38 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 C-N-CA 126.311 1.844 . . . . 0.0 113.112 -177.212 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 4.0 m -112.0 133.85 53.92 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.156 -2.215 . . . . 0.0 116.027 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.39 23.2 p30 -127.98 -173.91 3.06 Favored 'General case' 0 C--N 1.379 1.868 0 CA-C-N 120.226 1.375 . . . . 0.0 113.46 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.678 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 19.8 p -49.25 2.76 0.01 OUTLIER 'General case' 0 C--N 1.363 1.191 2 C-N-CA 136.349 5.86 . . . . 0.0 122.097 -165.466 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.89 4.62 25.57 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 164.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.447 98.3 mm-40 67.53 40.1 2.68 Favored 'General case' 0 C--N 1.371 1.526 1 C-N-CA 132.22 4.208 . . . . 0.0 110.576 -172.6 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.76 127.18 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-N 111.462 -2.608 . . . . 0.0 112.447 -171.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.9 OUTLIER -91.64 134.45 34.68 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.754 1.622 . . . . 0.0 110.318 -176.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -116.78 141.05 48.72 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 102.38 -3.193 . . . . 0.0 102.38 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -128.87 146.95 50.8 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.304 1.7 p -119.41 141.7 48.87 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 121.521 0.677 . . . . 0.0 110.738 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 m -54.23 148.22 11.78 Favored 'General case' 0 CA--C 1.479 -1.768 2 C-N-CA 138.253 6.621 . . . . 0.0 115.672 -168.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 78.3 p -68.19 110.17 3.89 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.594 2.758 . . . . 0.0 110.881 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.54 109.46 22.05 Favored 'General case' 0 C--N 1.363 1.193 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 -176.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.98 113.17 24.21 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 124.566 2.126 . . . . 0.0 111.086 -173.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.58 114.99 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -172.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 62.2 m . . . . . 0 CA--C 1.489 -1.37 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 175.057 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.697 HD22 ' H ' ' A' ' 94' ' ' SER . 0.0 OUTLIER . . . . . 0 CA--C 1.567 1.628 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m -173.86 172.5 3.46 Favored 'General case' 0 CA--C 1.504 -0.814 1 N-CA-C 99.221 -4.363 . . . . 0.0 99.221 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.43 -47.55 2.54 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 121.051 1.75 . . . . 0.0 109.599 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -170.42 132.57 1.0 Allowed 'General case' 0 C--N 1.36 1.055 0 O-C-N 119.765 -1.835 . . . . 0.0 115.878 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 12.7 tpt -130.75 116.26 17.76 Favored 'General case' 0 C--N 1.373 1.612 0 CA-C-N 120.603 1.547 . . . . 0.0 107.793 164.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 p -109.86 115.52 29.97 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 119.397 -2.065 . . . . 0.0 107.813 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -149.55 174.27 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 126.157 1.783 . . . . 0.0 111.499 -168.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -74.08 135.74 43.0 Favored 'General case' 0 C--N 1.368 1.405 0 O-C-N 118.87 -2.394 . . . . 0.0 107.087 158.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.336 0.4 OUTLIER -44.04 122.62 2.96 Favored 'General case' 0 N--CA 1.515 2.813 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -165.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.587 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 131.74 50.81 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 111.337 -2.665 . . . . 0.0 108.722 -162.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.61 160.67 19.55 Favored 'General case' 0 C--N 1.369 1.415 0 C-N-CA 126.382 1.873 . . . . 0.0 109.443 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.02 99.95 8.73 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 122.494 1.14 . . . . 0.0 110.723 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 128' ' ' ALA 0.276 9.0 mp -113.27 114.24 26.41 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 126.679 1.992 . . . . 0.0 115.74 -169.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.92 137.17 45.48 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 170.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 79' ' ' LEU . 1.7 mm? -124.84 116.09 21.7 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.697 ' H ' HD22 ' A' ' 79' ' ' LEU . 3.6 t -150.37 131.94 14.84 Favored 'General case' 0 C--N 1.38 1.908 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.5 m -149.57 172.81 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.039 0 C-N-CA 129.926 3.29 . . . . 0.0 106.849 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.6 t -105.45 138.12 42.16 Favored 'General case' 0 C--N 1.371 1.515 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.42 143.91 37.85 Favored 'General case' 0 C--N 1.371 1.535 0 N-CA-C 119.914 3.302 . . . . 0.0 119.914 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.96 174.69 15.13 Favored 'General case' 0 C--N 1.361 1.091 1 C-N-CA 134.169 4.988 . . . . 0.0 102.881 177.521 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.19 45.57 1.75 Allowed Glycine 0 C--N 1.37 2.422 0 O-C-N 118.706 -2.496 . . . . 0.0 117.73 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.41 62.01 Favored Glycine 0 C--N 1.363 2.073 0 C-N-CA 128.073 2.749 . . . . 0.0 112.787 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.5 m -115.96 110.93 19.64 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 126.442 1.897 . . . . 0.0 107.565 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 66.95 -102.6 0.79 Allowed Glycine 0 CA--C 1.548 2.106 0 CA-C-O 116.667 -2.185 . . . . 0.0 109.783 -160.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.58 169.51 5.38 Favored 'Trans proline' 0 C--N 1.377 2.041 1 C-N-CA 129.128 6.552 . . . . 0.0 118.168 160.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.617 ' HB3' HG12 ' A' ' 140' ' ' VAL . 76.9 m-85 -81.74 142.3 32.77 Favored 'General case' 0 C--N 1.358 0.965 1 N-CA-C 124.301 4.926 . . . . 0.0 124.301 -164.407 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 t -102.32 141.06 35.76 Favored 'General case' 0 C--N 1.379 1.887 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.555 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -134.51 162.91 30.94 Favored 'General case' 0 C--N 1.351 0.662 1 N-CA-C 122.85 4.389 . . . . 0.0 122.85 -161.947 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.49 121.18 11.86 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.992 2.517 . . . . 0.0 106.951 176.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -112.16 138.2 49.16 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.577 1.951 . . . . 0.0 111.422 -175.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.1 169.97 19.46 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-O 123.119 1.438 . . . . 0.0 107.335 172.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HD3' ' CE1' ' A' ' 136' ' ' TYR . 13.8 ttpt -145.64 104.99 3.94 Favored 'General case' 0 N--CA 1.422 -1.851 0 O-C-N 119.37 -2.081 . . . . 0.0 105.875 177.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.472 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.239 1.2 t70 34.76 53.47 0.63 Allowed 'General case' 0 CA--C 1.472 -2.024 2 CA-C-O 110.414 -4.613 . . . . 0.0 123.073 141.976 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.74 -1.11 84.67 Favored Glycine 0 C--N 1.377 2.859 2 O-C-N 134.349 7.28 . . . . 0.0 118.964 -173.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.5 t -124.96 145.43 50.14 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -171.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -64.79 136.24 48.36 Favored 'Trans proline' 0 N--CA 1.495 1.588 1 C-N-CA 126.158 4.572 . . . . 0.0 115.315 173.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.447 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -85.23 165.6 35.54 Favored Pre-proline 0 CA--C 1.552 1.039 0 O-C-N 119.337 -2.102 . . . . 0.0 116.319 178.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 1.8 Cg_endo -68.1 81.45 0.5 Allowed 'Trans proline' 0 C--N 1.363 1.319 1 C-N-CA 125.406 4.071 . . . . 0.0 114.647 174.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 74.82 -62.15 0.46 Allowed 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.43 2.292 . . . . 0.0 115.033 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 85.3 162.68 0.1 Allowed 'General case' 0 CA--C 1.481 -1.703 0 C-N-CA 129.431 3.092 . . . . 0.0 112.584 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 79.16 52.98 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 CA-C-N 113.531 -1.668 . . . . 0.0 111.049 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.99 -86.44 0.84 Allowed Glycine 0 C--N 1.362 2.018 0 CA-C-N 114.172 -1.376 . . . . 0.0 116.494 -170.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 94' ' ' SER 0.339 . . 144.45 -74.97 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.406 2.282 . . . . 0.0 111.079 177.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.3 9.0 t -126.0 93.47 3.83 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.909 1.814 . . . . 0.0 110.301 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.277 3.3 p90 -125.98 141.05 52.13 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.228 1.811 . . . . 0.0 110.319 -177.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 88.8 m -129.71 139.8 51.26 Favored 'General case' 0 CA--C 1.493 -1.238 0 O-C-N 120.389 -1.444 . . . . 0.0 110.041 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -111.09 103.93 55.51 Favored Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 129.485 3.114 . . . . 0.0 105.293 176.484 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -72.65 -32.76 9.14 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.718 3.612 . . . . 0.0 113.772 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.587 HG23 ' HA2' ' A' ' 88' ' ' GLY . 99.4 m -136.54 100.99 4.51 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.479 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -93.07 124.04 36.76 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 124.212 1.005 . . . . 0.0 113.196 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.93 -178.49 4.67 Favored 'General case' 0 C--N 1.364 1.234 0 C-N-CA 129.2 3.0 . . . . 0.0 109.719 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -54.19 13.39 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -173.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.13 1.03 1.65 Allowed 'General case' 0 C--N 1.365 1.241 0 C-N-CA 128.6 2.76 . . . . 0.0 115.357 172.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -116.06 -18.56 10.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 129.409 3.084 . . . . 0.0 111.266 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -95.18 164.55 12.81 Favored 'General case' 0 C--N 1.391 2.412 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 175.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.87 -155.86 26.74 Favored Glycine 0 C--N 1.383 3.149 0 C-N-CA 128.318 2.866 . . . . 0.0 109.734 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.356 6.9 m -109.41 130.73 55.49 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 112.974 -3.491 . . . . 0.0 107.135 164.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.464 ' CE1' ' HD3' ' A' ' 110' ' ' LYS 0.255 3.5 m-85 -97.01 134.49 40.31 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 125.704 1.602 . . . . 0.0 111.492 -169.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -145.49 152.61 40.05 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-N 119.459 1.027 . . . . 0.0 109.021 -175.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.39 142.69 28.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 C-N-CA 116.568 -2.053 . . . . 0.0 111.592 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.5 m -105.99 119.37 39.03 Favored 'General case' 0 C--N 1.368 1.401 0 C-N-CA 129.778 3.231 . . . . 0.0 106.286 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.617 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -134.16 124.27 45.66 Favored 'Isoleucine or valine' 0 C--N 1.35 0.591 0 C-N-CA 124.268 1.027 . . . . 0.0 113.613 -173.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 6.0 m -109.23 131.71 54.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 119.412 -2.055 . . . . 0.0 114.599 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.453 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.444 10.2 p-10 -128.45 -170.48 2.26 Favored 'General case' 0 C--N 1.367 1.366 0 O-C-N 120.682 -1.261 . . . . 0.0 113.894 175.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.466 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 22.1 p -48.71 3.84 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.317 1 C-N-CA 136.218 5.807 . . . . 0.0 121.634 -164.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -106.74 4.57 27.82 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 118.286 -1.366 . . . . 0.0 107.898 163.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.433 89.9 mm-40 66.45 40.09 3.67 Favored 'General case' 0 C--N 1.373 1.62 1 C-N-CA 132.924 4.49 . . . . 0.0 110.273 -171.992 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.418 ' C ' HG23 ' A' ' 141' ' ' THR . 4.2 m -112.54 126.32 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 C-N-CA 128.08 2.552 . . . . 0.0 112.061 -171.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.3 OUTLIER -91.83 130.24 37.64 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 124.61 1.164 . . . . 0.0 109.849 -178.203 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.62 158.89 23.84 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.755 3.222 . . . . 0.0 104.455 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -129.77 146.51 51.52 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.404 87.8 p -116.4 150.19 38.18 Favored 'General case' 0 C--O 1.254 1.303 0 C-N-CA 124.469 1.108 . . . . 0.0 110.004 177.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.92 148.83 12.59 Favored 'General case' 0 C--N 1.382 2.012 1 C-N-CA 134.245 5.018 . . . . 0.0 118.719 -158.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 136' ' ' TYR . 76.0 p -68.74 111.13 4.66 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 127.866 2.466 . . . . 0.0 110.434 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.16 109.25 22.04 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.52 107.43 19.59 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 124.84 2.257 . . . . 0.0 110.882 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.0 m -119.75 120.25 62.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 O-C-N 119.821 -1.799 . . . . 0.0 106.386 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.364 1.235 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -174.845 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 92' ' ' THR . 0.3 OUTLIER . . . . . 0 C--O 1.204 -1.298 0 CA-C-O 122.165 0.983 . . . . 0.0 112.354 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.9 m -172.13 175.46 3.74 Favored 'General case' 0 C--N 1.317 -0.822 1 C-N-CA 132.142 4.177 . . . . 0.0 101.478 168.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.75 -62.86 1.44 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.827 2.051 . . . . 0.0 113.065 169.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 p -179.99 125.14 0.07 Allowed 'General case' 0 C--N 1.36 1.048 0 O-C-N 118.434 -2.666 . . . . 0.0 117.636 -175.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.1 mmm -120.29 134.63 55.22 Favored 'General case' 0 C--N 1.379 1.888 0 CA-C-N 120.464 1.483 . . . . 0.0 113.198 168.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.2 p -114.54 115.66 27.56 Favored 'General case' 0 C--N 1.365 1.241 0 O-C-N 119.127 -2.233 . . . . 0.0 108.629 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -150.1 173.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-N 114.011 -1.449 . . . . 0.0 113.134 -167.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -81.11 131.48 35.3 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 128.01 2.524 . . . . 0.0 104.931 161.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.317 0.2 OUTLIER -43.23 122.38 2.51 Favored 'General case' 0 N--CA 1.518 2.968 0 CA-C-N 123.418 2.827 . . . . 0.0 118.55 -161.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.54 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 134.57 54.24 0.07 OUTLIER Glycine 0 C--N 1.35 1.354 0 CA-C-N 111.854 -2.43 . . . . 0.0 111.503 -164.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.69 172.27 10.99 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.775 1.23 . . . . 0.0 112.095 173.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.55 100.95 9.41 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.9 -1.125 . . . . 0.0 109.298 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -121.47 114.31 21.08 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.531 1.532 . . . . 0.0 111.218 -172.511 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 79' ' ' LEU 0.29 2.4 t -113.84 137.54 51.52 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.68 115.74 19.91 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 t -152.86 132.41 13.01 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.808 1.289 . . . . 0.0 112.185 -169.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.9 175.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.665 1 C-N-CA 132.171 4.188 . . . . 0.0 106.583 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -103.98 140.97 36.98 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.853 2.461 . . . . 0.0 106.375 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.33 144.38 34.54 Favored 'General case' 0 C--N 1.381 1.978 1 N-CA-C 122.934 4.42 . . . . 0.0 122.934 -174.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.5 p -156.41 175.84 13.49 Favored 'General case' 0 C--N 1.364 1.199 1 C-N-CA 133.883 4.873 . . . . 0.0 104.094 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.38 40.33 0.75 Allowed Glycine 0 C--N 1.365 2.183 0 C-N-CA 125.858 1.694 . . . . 0.0 117.232 167.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.06 30.67 25.12 Favored Glycine 0 C--N 1.361 1.944 0 C-N-CA 127.616 2.531 . . . . 0.0 116.164 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.41 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 63.5 m -117.44 110.9 18.58 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 113.653 -3.07 . . . . 0.0 108.351 175.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.479 ' H ' ' CB ' ' A' ' 143' ' ' SER . . . 72.79 -86.73 0.54 Allowed Glycine 0 C--N 1.383 3.15 0 CA-C-N 124.837 3.471 . . . . 0.0 110.172 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.86 168.13 6.12 Favored 'Trans proline' 0 CA--C 1.57 2.291 1 C-N-CA 126.102 4.535 . . . . 0.0 115.364 157.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.568 ' HB3' HG12 ' A' ' 140' ' ' VAL . 78.4 m-85 -105.97 145.13 31.72 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 119.798 3.259 . . . . 0.0 119.798 -164.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.6 t -103.02 141.51 35.68 Favored 'General case' 0 C--N 1.378 1.837 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.48 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -140.13 160.98 38.74 Favored 'General case' 0 C--N 1.347 0.466 1 N-CA-C 121.923 4.045 . . . . 0.0 121.923 -160.133 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -136.2 120.89 18.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.674 2.79 . . . . 0.0 105.796 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -112.05 132.8 54.6 Favored 'General case' 0 C--N 1.366 1.29 0 C-N-CA 125.178 1.391 . . . . 0.0 111.574 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.89 169.69 17.58 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 123.252 1.501 . . . . 0.0 107.334 172.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.49 ' HD3' ' CE1' ' A' ' 136' ' ' TYR . 13.0 ttpp -142.79 105.7 4.53 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.459 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.22 1.7 t70 34.91 53.63 0.66 Allowed 'General case' 0 CA--C 1.472 -2.035 2 CA-C-O 109.685 -4.96 . . . . 0.0 123.473 140.739 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.09 -10.43 60.74 Favored Glycine 0 C--N 1.383 3.179 2 O-C-N 135.222 7.826 . . . . 0.0 119.365 -172.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.407 9.8 p -124.89 147.15 55.6 Favored Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 130.607 3.563 . . . . 0.0 120.586 -167.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -63.8 139.72 70.17 Favored 'Trans proline' 0 N--CA 1.499 1.817 1 C-N-CA 126.484 4.789 . . . . 0.0 116.933 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -89.51 164.27 30.23 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 119.237 -2.164 . . . . 0.0 115.568 178.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 8.8 Cg_endo -72.05 82.9 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 125.119 3.879 . . . . 0.0 115.009 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 74.52 -61.06 0.5 Allowed 'General case' 0 C--N 1.36 1.05 0 C-N-CA 126.626 1.97 . . . . 0.0 115.846 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 79.16 176.21 0.14 Allowed 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 130.3 3.44 . . . . 0.0 114.805 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.418 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 74.55 70.08 0.1 Allowed 'General case' 0 C--N 1.356 0.864 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.752 173.355 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -154.77 -53.11 0.01 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 120.078 2.791 . . . . 0.0 120.078 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.292 . . 131.94 -65.87 0.0 OUTLIER 'General case' 0 C--N 1.351 0.634 0 C-N-CA 127.129 2.172 . . . . 0.0 107.777 -176.017 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.27 14.7 t -137.53 108.84 6.86 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-N 120.475 1.489 . . . . 0.0 113.688 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.289 0.2 OUTLIER -128.02 140.25 52.08 Favored 'General case' 0 C--N 1.372 1.567 0 C-N-CA 127.881 2.472 . . . . 0.0 111.846 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.8 m -129.39 139.75 51.57 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 119.909 -1.745 . . . . 0.0 111.596 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 105.27 56.68 Favored Pre-proline 0 C--N 1.358 0.949 0 C-N-CA 129.377 3.071 . . . . 0.0 105.966 173.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -75.56 -11.51 20.47 Favored 'Trans proline' 0 C--N 1.353 0.782 1 C-N-CA 125.745 4.297 . . . . 0.0 112.819 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.54 HG23 ' HA2' ' A' ' 88' ' ' GLY . 62.1 m -157.93 105.65 1.99 Allowed 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.791 ' HB2' HD21 ' A' ' 91' ' ' LEU . . . -94.17 118.9 32.22 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.313 1.045 . . . . 0.0 112.825 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.97 -176.98 6.2 Favored 'General case' 0 C--N 1.367 1.351 0 C-N-CA 127.131 2.173 . . . . 0.0 109.236 172.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.12 -54.19 14.08 Favored 'General case' 0 C--N 1.368 1.384 0 O-C-N 118.273 -2.767 . . . . 0.0 117.209 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.8 0.79 1.58 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 128.692 2.797 . . . . 0.0 115.58 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -116.43 -18.33 10.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 129.299 3.04 . . . . 0.0 111.347 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.65 164.74 13.29 Favored 'General case' 0 C--N 1.397 2.655 0 CA-C-N 122.534 2.424 . . . . 0.0 116.673 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.24 -155.08 25.42 Favored Glycine 0 CA--C 1.459 -3.446 0 C-N-CA 127.107 2.289 . . . . 0.0 109.012 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.351 9.3 m -113.49 133.41 55.23 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 111.912 -3.915 . . . . 0.0 108.595 166.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.49 ' CE1' ' HD3' ' A' ' 110' ' ' LYS 0.252 21.1 m-85 -96.26 135.2 38.41 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 122.228 2.285 . . . . 0.0 110.984 -170.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.459 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -145.77 147.52 31.97 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 123.982 0.913 . . . . 0.0 108.908 -176.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 149' ' ' ASP . 10.4 p -138.76 137.38 42.95 Favored 'Isoleucine or valine' 0 C--N 1.365 1.267 0 C-N-CA 118.189 -1.404 . . . . 0.0 113.402 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 113.89 27.74 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 129.29 3.036 . . . . 0.0 105.848 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.568 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -128.98 119.68 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.936 1.694 . . . . 0.0 110.513 -171.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.403 HG23 ' C ' ' A' ' 146' ' ' VAL . 5.2 m -106.24 133.1 51.47 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.228 -1.545 . . . . 0.0 113.719 -176.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.484 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.328 15.6 p-10 -126.21 179.43 5.26 Favored 'General case' 0 C--N 1.376 1.757 0 C-N-CA 124.164 0.986 . . . . 0.0 111.971 174.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.479 ' CB ' ' H ' ' A' ' 102' ' ' GLY . 13.1 p -49.18 2.29 0.01 OUTLIER 'General case' 0 C--N 1.375 1.677 1 C-N-CA 136.971 6.108 . . . . 0.0 119.306 -170.768 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -101.28 4.24 41.53 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 165.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.523 0.9 OUTLIER 62.89 39.87 10.12 Favored 'General case' 0 C--N 1.372 1.554 1 C-N-CA 134.266 5.026 . . . . 0.0 112.715 -172.692 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.403 ' C ' HG23 ' A' ' 141' ' ' THR . 4.6 m -112.85 128.37 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.858 0 CA-C-N 111.596 -2.547 . . . . 0.0 111.882 -170.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.02 123.0 35.06 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.456 1.902 . . . . 0.0 106.777 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 157.74 24.56 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 128.031 2.532 . . . . 0.0 104.804 -174.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 27.3 t70 -125.06 140.32 53.0 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.708 1.242 . . . . 0.0 108.205 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.486 44.6 p -116.98 144.05 45.01 Favored 'General case' 0 C--O 1.254 1.334 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 m -54.11 147.98 11.84 Favored 'General case' 0 CA--C 1.478 -1.789 2 C-N-CA 138.798 6.839 . . . . 0.0 118.049 -159.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 73.6 p -68.29 109.77 3.76 Favored 'General case' 0 C--N 1.367 1.348 0 C-N-CA 124.486 1.114 . . . . 0.0 111.907 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -95.22 108.49 20.63 Favored 'General case' 0 C--N 1.373 1.608 0 N-CA-C 102.653 -3.092 . . . . 0.0 102.653 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.53 113.72 25.48 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 123.732 1.729 . . . . 0.0 111.152 -172.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.33 116.21 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 97.7 m . . . . . 0 C--N 1.372 1.549 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -179.556 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.566 1.568 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER -175.09 -177.02 1.01 Allowed 'General case' 0 N--CA 1.476 0.83 1 N-CA-C 98.716 -4.549 . . . . 0.0 98.716 162.75 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.86 -53.09 2.67 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 119.567 -1.958 . . . . 0.0 106.767 162.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.0 p -168.91 128.92 1.12 Allowed 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.037 -1.664 . . . . 0.0 115.079 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.0 tpt -124.95 123.45 39.92 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-N 120.81 1.641 . . . . 0.0 111.247 167.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.2 t -112.05 116.73 31.01 Favored 'General case' 0 C--N 1.374 1.652 0 O-C-N 119.724 -1.86 . . . . 0.0 107.273 171.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -149.67 173.7 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 112.065 -2.334 . . . . 0.0 109.981 -173.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.55 144.7 39.51 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 126.302 1.841 . . . . 0.0 106.609 158.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.436 0.0 OUTLIER -44.42 121.97 2.84 Favored 'General case' 0 N--CA 1.515 2.807 0 O-C-N 117.376 -3.327 . . . . 0.0 118.339 -168.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.422 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 129.74 55.49 0.1 OUTLIER Glycine 0 C--N 1.36 1.866 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.651 -155.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.5 165.23 12.85 Favored 'General case' 0 C--N 1.369 1.413 0 O-C-N 120.643 -1.504 . . . . 0.0 110.487 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.93 100.96 9.84 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-O 123.17 1.462 . . . . 0.0 113.393 -173.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mp -119.36 127.23 52.96 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 125.113 1.365 . . . . 0.0 111.835 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.452 ' HA ' HG23 ' A' ' 124' ' ' THR . 4.8 t -116.04 115.3 25.88 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 168.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.12 112.0 24.71 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 103.04 -2.948 . . . . 0.0 103.04 173.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.9 t -146.35 131.2 18.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.621 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.1 m -150.54 174.23 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.649 1 C-N-CA 131.789 4.035 . . . . 0.0 103.565 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.3 t -106.38 140.39 39.37 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 122.096 2.225 . . . . 0.0 106.976 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -139.71 142.61 36.85 Favored 'General case' 0 C--N 1.379 1.863 0 N-CA-C 121.021 3.712 . . . . 0.0 121.021 -174.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.2 p -156.29 175.54 13.86 Favored 'General case' 0 C--N 1.367 1.346 1 C-N-CA 134.365 5.066 . . . . 0.0 103.352 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.73 39.77 0.78 Allowed Glycine 0 C--N 1.368 2.31 0 O-C-N 119.514 -1.991 . . . . 0.0 117.649 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.19 26.08 49.49 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 128.459 2.933 . . . . 0.0 114.427 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 p -116.88 109.84 17.58 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 116.249 -1.834 . . . . 0.0 107.856 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.652 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.01 -91.07 0.51 Allowed Glycine 0 C--N 1.374 2.643 0 C-N-CA 129.073 3.225 . . . . 0.0 111.053 -167.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -60.22 169.16 5.29 Favored 'Trans proline' 0 CA--C 1.566 2.111 1 C-N-CA 127.993 5.795 . . . . 0.0 116.968 160.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TYR . . . . . 0.49 ' HB3' HG12 ' A' ' 140' ' ' VAL . 75.1 m-85 -94.58 146.27 24.24 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -168.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -102.69 140.78 36.53 Favored 'General case' 0 C--N 1.382 2.013 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.429 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -135.46 139.84 44.38 Favored 'General case' 0 C--N 1.352 0.691 1 N-CA-C 123.668 4.692 . . . . 0.0 123.668 -158.356 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.07 111.56 14.83 Favored 'General case' 0 C--N 1.371 1.533 0 C-N-CA 126.403 1.881 . . . . 0.0 107.238 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TRP . . . . . 0.462 ' CE2' HG21 ' A' ' 138' ' ' VAL . 76.4 m95 -113.06 145.14 41.42 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.053 1.741 . . . . 0.0 111.405 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.32 0.0 OUTLIER -157.95 156.38 31.16 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 164.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.498 ' HG2' HG22 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -128.05 102.84 6.91 Favored 'General case' 0 C--N 1.37 1.493 0 C-N-CA 117.271 -1.771 . . . . 0.0 113.517 175.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.453 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.231 2.5 t70 36.94 54.53 1.19 Allowed 'General case' 0 CA--C 1.456 -2.656 1 CA-C-O 110.772 -4.442 . . . . 0.0 120.837 152.829 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.19 -11.49 63.74 Favored Glycine 0 C--N 1.37 2.462 2 O-C-N 133.928 7.018 . . . . 0.0 116.041 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.262 3.6 m -123.96 149.16 59.14 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 131.216 3.806 . . . . 0.0 117.161 -168.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.15 152.32 80.27 Favored 'Trans proline' 0 N--CA 1.494 1.544 1 C-N-CA 125.473 4.115 . . . . 0.0 116.211 169.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.498 HG22 ' HG2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -99.04 157.76 33.51 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.469 1.508 . . . . 0.0 109.243 174.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 5.3 Cg_exo -62.64 -75.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.839 1 C-N-CA 126.039 4.493 . . . . 0.0 116.773 -170.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -102.86 -34.46 8.97 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.267 1.427 . . . . 0.0 111.281 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 75.93 -72.36 0.11 Allowed 'General case' 0 CA--C 1.486 -1.512 0 C-N-CA 130.075 3.35 . . . . 0.0 114.393 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.348 5.2 t -81.82 72.64 8.87 Favored 'General case' 0 N--CA 1.416 -2.155 1 C-N-CA 133.627 4.771 . . . . 0.0 111.348 -175.108 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.23 -41.5 0.02 OUTLIER Glycine 0 CA--C 1.469 -2.794 0 N-CA-C 122.072 3.589 . . . . 0.0 122.072 -168.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.301 . . 105.16 -62.57 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.505 1.522 . . . . 0.0 110.151 179.051 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.296 15.3 t -136.49 96.33 3.33 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-O 122.622 1.201 . . . . 0.0 113.841 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -126.5 138.0 53.44 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 127.121 2.169 . . . . 0.0 107.823 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . 0.452 HG23 ' HA ' ' A' ' 92' ' ' THR . 91.5 m -128.92 133.2 47.78 Favored 'General case' 0 CA--C 1.478 -1.789 0 O-C-N 119.536 -1.977 . . . . 0.0 106.256 -176.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.83 93.22 8.49 Favored Pre-proline 0 C--N 1.359 1.018 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.69 -11.83 26.27 Favored 'Trans proline' 0 C--N 1.348 0.544 1 C-N-CA 125.525 4.15 . . . . 0.0 111.048 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' THR . . . . . 0.422 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -161.62 104.29 1.22 Allowed 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -87.16 133.48 33.63 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.253 2.621 . . . . 0.0 113.119 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.11 178.92 5.72 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 128.995 2.918 . . . . 0.0 110.683 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.13 -45.3 32.99 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 118.937 2.94 . . . . 0.0 118.937 -174.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -66.88 -17.59 64.97 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 126.855 2.062 . . . . 0.0 114.205 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.566 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 36.5 m-20 -82.05 -14.26 56.13 Favored 'General case' 0 CA--C 1.573 1.854 0 C-N-CA 128.52 2.728 . . . . 0.0 111.361 170.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.28 127.15 32.03 Favored 'General case' 0 C--N 1.393 2.48 0 N-CA-C 119.474 3.139 . . . . 0.0 119.474 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.18 -147.9 18.01 Favored Glycine 0 CA--C 1.473 -2.542 0 C-N-CA 128.404 2.907 . . . . 0.0 108.651 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.451 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.265 21.1 m -125.46 140.08 53.09 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 114.47 -2.892 . . . . 0.0 109.533 173.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.473 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 16.9 m-85 -95.91 134.52 38.8 Favored 'General case' 0 C--N 1.367 1.361 0 O-C-N 118.722 -2.486 . . . . 0.0 112.456 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -142.45 146.68 35.07 Favored 'General case' 0 C--N 1.368 1.393 0 C-N-CA 123.993 0.917 . . . . 0.0 108.602 -174.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . 0.462 HG21 ' CE2' ' A' ' 108' ' ' TRP 0.251 13.4 p -146.99 139.95 19.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.185 0 C-N-CA 118.64 -1.224 . . . . 0.0 114.144 176.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.48 115.67 27.63 Favored 'General case' 0 C--N 1.375 1.702 0 C-N-CA 127.22 2.208 . . . . 0.0 106.321 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -127.09 116.46 44.51 Favored 'Isoleucine or valine' 0 C--N 1.369 1.444 0 C-N-CA 127.996 2.518 . . . . 0.0 112.155 -171.345 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.415 HG23 ' C ' ' A' ' 146' ' ' VAL . 4.0 m -99.12 132.89 44.11 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -176.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.424 16.2 p-10 -126.58 -176.93 3.82 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-N 120.769 1.622 . . . . 0.0 112.171 173.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.652 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 77.5 p -49.58 3.3 0.01 OUTLIER 'General case' 0 C--N 1.36 1.025 1 C-N-CA 136.634 5.973 . . . . 0.0 121.279 -165.15 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.29 4.47 36.57 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 164.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.422 81.0 mm-40 65.52 40.01 4.79 Favored 'General case' 0 C--N 1.374 1.659 1 C-N-CA 132.874 4.47 . . . . 0.0 111.183 -172.55 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' VAL . . . . . 0.415 ' C ' HG23 ' A' ' 141' ' ' THR . 3.4 m -112.64 130.09 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.754 -172.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -90.59 124.57 35.14 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 128.742 2.817 . . . . 0.0 107.733 -177.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.69 152.89 32.34 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 45.8 p30 -130.56 147.14 52.21 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 123.061 1.41 . . . . 0.0 112.455 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.283 9.9 p -119.15 144.75 46.49 Favored 'General case' 0 C--O 1.259 1.58 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.277 168.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.8 m -55.12 148.83 13.29 Favored 'General case' 0 CA--C 1.478 -1.804 3 C-N-CA 140.098 7.359 . . . . 0.0 115.101 -172.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 72.5 p -68.58 109.86 3.95 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 127.835 2.454 . . . . 0.0 109.49 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 108.92 21.07 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 102.274 -3.232 . . . . 0.0 102.274 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.88 112.74 24.81 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 122.426 1.108 . . . . 0.0 111.502 -172.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.0 m -121.61 118.37 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 58.5 m . . . . . 0 CA--C 1.489 -1.38 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 178.347 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.092 0 CA-C-O 121.747 0.784 . . . . 0.0 108.991 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.9 tp -87.84 119.63 28.37 Favored 'General case' 0 C--N 1.358 0.958 0 C-N-CA 126.109 1.763 . . . . 0.0 111.354 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.9 t -98.82 172.92 7.14 Favored 'General case' 0 N--CA 1.432 -1.34 0 C-N-CA 129.841 3.257 . . . . 0.0 109.728 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 75' ' ' LEU 0.329 0.4 OUTLIER -75.13 98.4 3.69 Favored 'General case' 0 C--N 1.36 1.063 0 O-C-N 120.804 -1.185 . . . . 0.0 109.893 169.501 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 58.24 -76.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 117.91 -2.994 . . . . 0.0 115.551 -171.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -133.0 141.03 48.06 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 131.648 3.979 . . . . 0.0 105.501 167.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.297 0.0 OUTLIER -82.71 171.08 14.37 Favored 'General case' 0 CA--C 1.506 -0.725 0 CA-C-O 125.348 2.499 . . . . 0.0 110.162 177.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.493 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -72.42 -33.31 67.03 Favored 'General case' 0 N--CA 1.428 -1.56 0 O-C-N 119.858 -1.776 . . . . 0.0 112.963 169.222 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.3 m -172.57 173.38 4.02 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 101.704 -3.443 . . . . 0.0 101.704 176.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -121.48 -51.56 2.06 Favored 'General case' 0 C--N 1.356 0.888 0 CA-C-N 120.412 1.46 . . . . 0.0 112.263 171.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.3 t -170.6 142.66 2.07 Favored 'General case' 0 C--N 1.363 1.18 0 O-C-N 119.415 -2.053 . . . . 0.0 114.339 178.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.6 118.78 19.62 Favored 'General case' 0 C--N 1.377 1.772 0 O-C-N 121.417 -0.802 . . . . 0.0 109.887 167.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.6 m -105.87 114.91 29.35 Favored 'General case' 0 C--N 1.376 1.746 0 O-C-N 120.459 -1.401 . . . . 0.0 109.18 174.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.8 p -150.93 173.47 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.688 0 CA-C-N 114.353 -1.294 . . . . 0.0 113.249 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -79.96 143.51 34.1 Favored 'General case' 0 C--N 1.369 1.456 0 C-N-CA 127.259 2.224 . . . . 0.0 105.432 157.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.487 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.433 5.1 pt-20 -44.21 122.88 3.15 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 117.338 -3.352 . . . . 0.0 118.626 -166.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.63 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 129.0 51.75 0.12 Allowed Glycine 0 C--N 1.352 1.467 0 C-N-CA 128.908 3.147 . . . . 0.0 110.741 -163.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.76 162.34 22.96 Favored 'General case' 0 C--N 1.375 1.689 0 C-N-CA 124.957 1.303 . . . . 0.0 112.339 171.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.91 105.87 14.43 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 124.628 1.171 . . . . 0.0 111.635 -176.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.479 HD23 ' CZ ' ' A' ' 136' ' ' TYR 0.252 2.3 mp -119.73 129.88 54.72 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -173.255 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.426 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -114.87 137.93 51.39 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 103.93 -2.618 . . . . 0.0 103.93 166.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.623 HD11 ' CD1' ' A' ' 136' ' ' TYR . 3.9 mm? -113.69 115.62 28.15 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 102.104 -3.295 . . . . 0.0 102.104 173.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.493 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 2.5 t -154.62 132.47 11.52 Favored 'General case' 0 C--N 1.367 1.34 0 CA-C-N 120.933 1.697 . . . . 0.0 114.098 -175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 m -150.22 174.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.359 1.011 1 C-N-CA 133.643 4.777 . . . . 0.0 106.822 176.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.0 t -104.36 141.73 35.8 Favored 'General case' 0 C--N 1.363 1.168 0 C-N-CA 127.637 2.375 . . . . 0.0 106.734 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.433 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -139.2 145.95 39.93 Favored 'General case' 0 C--N 1.379 1.856 1 N-CA-C 123.228 4.529 . . . . 0.0 123.228 -174.25 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 70.4 p -156.58 175.49 13.97 Favored 'General case' 0 C--N 1.365 1.248 1 C-N-CA 133.34 4.656 . . . . 0.0 104.391 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.51 42.11 1.02 Allowed Glycine 0 C--N 1.365 2.162 0 O-C-N 119.802 -1.811 . . . . 0.0 117.318 168.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 86.18 28.35 28.28 Favored Glycine 0 C--N 1.361 1.966 0 C-N-CA 127.616 2.531 . . . . 0.0 115.412 176.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.406 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 59.3 m -117.67 110.88 18.42 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-O 114.217 -2.801 . . . . 0.0 108.453 174.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.91 -86.21 0.56 Allowed Glycine 0 C--N 1.38 3.007 0 C-N-CA 129.249 3.309 . . . . 0.0 110.389 -176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.406 ' HD2' ' O ' ' A' ' 101' ' ' THR . 20.0 Cg_exo -59.88 168.38 5.83 Favored 'Trans proline' 0 CA--C 1.57 2.312 1 C-N-CA 126.164 4.576 . . . . 0.0 115.676 158.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.559 ' HB3' HG12 ' A' ' 140' ' ' VAL . 77.7 m-85 -106.31 146.09 30.83 Favored 'General case' 0 CA--C 1.549 0.929 0 N-CA-C 119.892 3.293 . . . . 0.0 119.892 -163.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.9 t -103.34 142.65 33.85 Favored 'General case' 0 C--N 1.38 1.928 0 C-N-CA 127.879 2.472 . . . . 0.0 104.358 172.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -142.43 165.4 27.5 Favored 'General case' 0 C--N 1.356 0.853 1 N-CA-C 122.783 4.364 . . . . 0.0 122.783 -161.555 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -134.42 119.06 18.09 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 128.265 2.626 . . . . 0.0 105.083 171.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -109.62 136.41 49.02 Favored 'General case' 0 C--N 1.368 1.409 0 O-C-N 121.384 -0.822 . . . . 0.0 110.55 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -146.91 169.87 18.25 Favored 'General case' 0 CA--C 1.489 -1.387 0 CA-C-O 122.717 1.246 . . . . 0.0 107.69 174.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.531 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -144.73 105.64 4.17 Favored 'General case' 0 N--CA 1.425 -1.716 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 175.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.469 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.16 1.8 t70 35.05 52.95 0.66 Allowed 'General case' 0 C--N 1.377 1.785 1 N-CA-C 122.307 4.188 . . . . 0.0 122.307 139.829 . . . . . . . . 4 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 87.45 -4.77 85.86 Favored Glycine 0 C--N 1.369 2.384 2 O-C-N 133.53 6.769 . . . . 0.0 119.206 -177.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.269 3.5 m -124.45 147.46 55.42 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 129.532 3.133 . . . . 0.0 118.329 -171.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -65.01 145.05 84.46 Favored 'Trans proline' 0 N--CA 1.493 1.498 1 C-N-CA 125.882 4.388 . . . . 0.0 114.722 171.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -102.09 159.04 30.57 Favored Pre-proline 0 CA--C 1.538 0.496 0 O-C-N 118.739 -2.476 . . . . 0.0 112.244 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_endo -67.42 87.73 0.33 Allowed 'Trans proline' 0 C--N 1.358 1.074 0 C-N-CA 125.247 3.965 . . . . 0.0 116.177 -175.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 74.62 -57.22 0.62 Allowed 'General case' 0 C--N 1.362 1.113 0 C-N-CA 127.372 2.269 . . . . 0.0 115.425 176.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 74.13 174.83 0.26 Allowed 'General case' 0 CA--C 1.482 -1.657 0 C-N-CA 130.189 3.396 . . . . 0.0 116.494 176.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.408 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.3 OUTLIER 75.6 71.87 0.09 Allowed 'General case' 0 C--N 1.356 0.867 0 CA-C-N 114.114 -1.403 . . . . 0.0 114.735 171.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.42 -67.92 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.961 0 N-CA-C 117.382 1.713 . . . . 0.0 117.382 -172.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 150.32 -69.86 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.542 0 C-N-CA 126.503 1.921 . . . . 0.0 106.74 -176.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.284 13.6 t -135.38 109.87 8.51 Favored 'General case' 0 C--N 1.363 1.153 0 CA-C-O 123.35 1.548 . . . . 0.0 113.878 -175.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.368 9.1 p90 -127.23 142.12 51.56 Favored 'General case' 0 C--N 1.369 1.435 0 C-N-CA 129.473 3.109 . . . . 0.0 112.716 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.5 m -128.28 139.57 52.35 Favored 'General case' 0 C--N 1.366 1.288 0 O-C-N 119.323 -2.11 . . . . 0.0 110.305 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.54 100.23 44.33 Favored Pre-proline 0 C--N 1.366 1.324 0 C-N-CA 128.708 2.803 . . . . 0.0 106.411 175.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.26 -17.1 15.11 Favored 'Trans proline' 0 C--N 1.353 0.814 1 C-N-CA 126.096 4.531 . . . . 0.0 114.061 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.63 HG23 ' HA2' ' A' ' 88' ' ' GLY . 52.4 m -156.11 102.48 2.14 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 102.596 -3.113 . . . . 0.0 102.596 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.549 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.79 133.33 34.29 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 126.623 1.969 . . . . 0.0 111.499 175.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.5 -179.52 4.92 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.193 2.597 . . . . 0.0 111.027 178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.02 -49.0 32.57 Favored 'General case' 0 C--N 1.366 1.305 0 N-CA-C 119.194 3.035 . . . . 0.0 119.194 -173.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.35 -10.26 57.11 Favored 'General case' 0 C--N 1.368 1.378 0 C-N-CA 126.335 1.854 . . . . 0.0 114.53 173.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.549 ' CB ' ' HB1' ' A' ' 128' ' ' ALA 0.366 48.7 m-20 -80.41 -18.31 49.26 Favored 'General case' 0 CA--C 1.572 1.793 0 C-N-CA 129.581 3.152 . . . . 0.0 111.84 168.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.64 126.49 29.1 Favored 'General case' 0 C--N 1.387 2.212 0 N-CA-C 119.536 3.161 . . . . 0.0 119.536 168.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 160.44 -157.5 28.89 Favored Glycine 0 CA--C 1.459 -3.446 0 C-N-CA 127.117 2.294 . . . . 0.0 109.694 172.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.4 m -120.63 129.7 53.84 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 115.004 -2.679 . . . . 0.0 108.235 174.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.623 ' CD1' HD11 ' A' ' 93' ' ' LEU 0.274 30.1 m-85 -95.21 134.85 37.5 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 130.163 3.385 . . . . 0.0 111.651 -170.083 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.469 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -147.02 153.87 40.54 Favored 'General case' 0 C--N 1.369 1.429 0 C-N-CA 125.509 1.524 . . . . 0.0 108.202 -173.515 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.755 HG13 ' HB2' ' A' ' 150' ' ' SER 0.43 2.4 p -143.58 134.3 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 117.677 -1.609 . . . . 0.0 114.339 -178.53 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -101.42 109.22 21.01 Favored 'General case' 0 C--N 1.385 2.132 0 C-N-CA 129.669 3.188 . . . . 0.0 106.345 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.559 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -127.7 118.62 49.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.814 0 C-N-CA 125.482 1.513 . . . . 0.0 111.037 -168.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.413 HG23 ' C ' ' A' ' 146' ' ' VAL . 11.1 m -104.32 130.86 52.14 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 120.451 -1.406 . . . . 0.0 113.552 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.497 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.344 18.9 p-10 -124.99 -176.58 3.59 Favored 'General case' 0 C--N 1.379 1.853 0 C-N-CA 124.312 1.045 . . . . 0.0 111.909 175.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 6.2 p -48.84 2.73 0.01 OUTLIER 'General case' 0 C--N 1.372 1.574 1 C-N-CA 137.428 6.291 . . . . 0.0 119.867 -168.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.76 4.29 35.04 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 118.16 -1.416 . . . . 0.0 107.678 163.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.435 93.6 mm-40 65.54 40.3 4.63 Favored 'General case' 0 C--N 1.374 1.662 1 C-N-CA 132.736 4.414 . . . . 0.0 110.783 -172.164 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.413 ' C ' HG23 ' A' ' 141' ' ' THR . 3.1 m -112.9 129.36 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.506 0 CA-C-N 111.944 -2.389 . . . . 0.0 112.201 -171.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.19 124.12 35.16 Favored 'General case' 0 C--N 1.359 0.982 0 C-N-CA 127.68 2.392 . . . . 0.0 108.205 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.51 157.43 25.23 Favored 'General case' 0 CA--C 1.498 -1.04 0 C-N-CA 128.308 2.643 . . . . 0.0 105.375 -173.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -121.46 132.09 54.53 Favored 'General case' 0 C--N 1.358 0.943 0 CA-C-O 124.611 2.148 . . . . 0.0 108.892 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.755 ' HB2' HG13 ' A' ' 138' ' ' VAL . 51.1 m -108.26 147.84 30.85 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 111.509 -2.587 . . . . 0.0 106.942 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.5 m -52.95 146.92 10.05 Favored 'General case' 0 CA--C 1.49 -1.36 1 C-N-CA 135.012 5.325 . . . . 0.0 119.477 -159.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 32.1 p -70.69 111.04 5.86 Favored 'General case' 0 C--N 1.368 1.403 0 C-N-CA 127.317 2.247 . . . . 0.0 109.321 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -105.74 110.46 22.77 Favored 'General case' 0 C--N 1.35 0.619 0 N-CA-C 102.214 -3.254 . . . . 0.0 102.214 176.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.24 113.37 25.6 Favored 'General case' 0 C--O 1.243 0.721 0 CA-C-O 123.247 1.499 . . . . 0.0 112.092 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 4.8 m -119.67 128.39 75.89 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.435 0 O-C-N 119.99 -1.694 . . . . 0.0 109.281 179.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 34.6 m -122.23 122.77 39.91 Favored 'General case' 0 CA--C 1.49 -1.362 0 N-CA-C 102.508 -3.145 . . . . 0.0 102.508 178.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 2.7 m -124.43 104.41 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.774 0 N-CA-C 104.428 -2.434 . . . . 0.0 104.428 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 56.3 m-20 -85.75 157.96 57.16 Favored Pre-proline 0 C--N 1.356 0.875 0 C-N-CA 124.662 1.185 . . . . 0.0 111.454 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -68.87 165.8 28.61 Favored 'Trans proline' 0 CA--C 1.55 1.278 1 C-N-CA 125.986 4.458 . . . . 0.0 108.782 154.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 20.9 p -67.32 127.01 31.08 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 119.089 -2.257 . . . . 0.0 108.95 -173.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.06 125.2 89.67 Favored Pre-proline 0 C--N 1.366 1.318 0 N-CA-C 121.648 3.944 . . . . 0.0 121.648 -123.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -62.63 141.09 84.49 Favored 'Trans proline' 0 C--N 1.386 2.519 1 C-N-CA 125.811 4.341 . . . . 0.0 111.873 168.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -52.71 60.93 0.0 OUTLIER Glycine 0 C--N 1.366 2.221 0 N-CA-C 121.728 3.451 . . . . 0.0 121.728 -168.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -125.42 -40.27 0.4 Allowed Glycine 0 C--N 1.353 1.513 0 C-N-CA 125.701 1.62 . . . . 0.0 113.673 -178.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 9.6 mp -86.37 -64.45 1.15 Allowed 'General case' 0 C--N 1.357 0.93 0 C-N-CA 125.5 1.52 . . . . 0.0 113.907 -177.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -132.11 13.4 4.71 Favored 'General case' 0 C--N 1.35 0.62 0 C-N-CA 125.205 1.402 . . . . 0.0 112.704 -172.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 75.4 t60 . . . . . 0 C--N 1.351 0.652 0 O-C-N 120.906 -1.121 . . . . 0.0 110.801 -175.308 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.079 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 52.3 tp -106.82 132.2 53.06 Favored 'General case' 0 C--N 1.356 0.868 0 CA-C-O 123.585 1.659 . . . . 0.0 108.507 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . 0.269 1.2 t -105.11 170.16 8.03 Favored 'General case' 0 N--CA 1.414 -2.253 0 C-N-CA 125.474 1.51 . . . . 0.0 107.146 177.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 75' ' ' LEU 0.256 0.3 OUTLIER -88.96 98.44 11.76 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 119.808 -1.808 . . . . 0.0 107.963 175.73 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 62.14 -79.45 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.025 -1.672 . . . . 0.0 111.815 -168.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -133.81 140.61 47.01 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 130.086 3.355 . . . . 0.0 107.012 161.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.378 0.3 OUTLIER -82.39 174.21 11.32 Favored 'General case' 0 C--N 1.356 0.866 1 C-N-CA 132.109 4.164 . . . . 0.0 109.129 175.242 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -34.83 74.34 Favored 'General case' 0 CA--C 1.571 1.785 0 CA-C-N 114.451 -1.25 . . . . 0.0 111.912 176.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 20.0 m -161.93 172.0 16.75 Favored 'General case' 0 C--N 1.347 0.465 0 O-C-N 116.835 -3.666 . . . . 0.0 103.856 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.72 -43.24 1.0 Allowed 'General case' 0 C--N 1.363 1.187 0 C-N-CA 126.792 2.037 . . . . 0.0 113.359 175.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 28.2 p -172.24 127.98 0.57 Allowed 'General case' 0 C--N 1.366 1.319 0 N-CA-C 118.426 2.751 . . . . 0.0 118.426 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 10.7 tpt -142.4 116.12 9.21 Favored 'General case' 0 C--N 1.377 1.785 0 CA-C-N 120.985 1.721 . . . . 0.0 109.909 162.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.4 p -112.81 116.39 29.99 Favored 'General case' 0 C--N 1.364 1.201 0 O-C-N 118.719 -2.488 . . . . 0.0 110.178 177.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -149.59 172.04 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.713 0 C-N-CA 125.951 1.7 . . . . 0.0 110.331 -170.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -83.27 130.21 35.06 Favored 'General case' 0 C--N 1.373 1.615 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 164.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -41.73 122.4 1.99 Allowed 'General case' 0 C--N 1.372 1.555 0 N-CA-C 120.469 3.507 . . . . 0.0 120.469 -151.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.436 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 145.57 45.75 0.04 OUTLIER Glycine 0 C--N 1.363 2.052 0 CA-C-N 110.292 -3.14 . . . . 0.0 110.993 -166.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.64 165.7 17.71 Favored 'General case' 0 C--N 1.375 1.712 0 C-N-CA 125.336 1.454 . . . . 0.0 113.527 176.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.99 105.68 14.16 Favored 'General case' 0 C--N 1.355 0.848 0 C-N-CA 124.525 1.13 . . . . 0.0 110.85 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.443 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 4.5 mp -119.58 119.92 35.19 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 125.87 1.668 . . . . 0.0 114.388 -176.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.87 127.04 53.69 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 103.474 -2.787 . . . . 0.0 103.474 173.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -123.78 114.73 20.29 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 173.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 52.9 m -151.18 132.94 14.96 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 119.63 -1.919 . . . . 0.0 110.909 -173.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 m -148.97 175.18 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.406 0 C-N-CA 130.423 3.489 . . . . 0.0 104.605 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -104.24 139.39 39.33 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 127.511 2.324 . . . . 0.0 105.555 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -141.59 137.03 31.62 Favored 'General case' 0 C--N 1.379 1.891 1 N-CA-C 122.502 4.26 . . . . 0.0 122.502 -173.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.1 p -156.52 174.72 15.02 Favored 'General case' 0 C--N 1.359 0.991 1 C-N-CA 133.904 4.882 . . . . 0.0 101.25 177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.66 40.7 1.37 Allowed Glycine 0 C--N 1.363 2.076 0 N-CA-C 118.102 2.001 . . . . 0.0 118.102 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 89.53 25.1 28.93 Favored Glycine 0 C--N 1.36 1.91 0 C-N-CA 127.8 2.619 . . . . 0.0 114.458 177.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.43 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 29.8 p -116.55 110.32 18.4 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 113.089 -3.339 . . . . 0.0 107.876 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.574 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 69.13 -86.93 0.23 Allowed Glycine 0 C--N 1.382 3.089 0 C-N-CA 130.014 3.674 . . . . 0.0 111.117 -170.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.91 168.88 5.2 Favored 'Trans proline' 0 CA--C 1.571 2.37 1 C-N-CA 127.514 5.476 . . . . 0.0 116.957 160.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.566 ' HB3' HG12 ' A' ' 140' ' ' VAL . 66.8 m-85 -98.6 144.27 28.08 Favored 'General case' 0 CA--C 1.554 1.128 0 N-CA-C 119.758 3.244 . . . . 0.0 119.758 -167.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.6 t -102.51 159.16 15.68 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 171.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.438 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.5 OUTLIER -157.17 166.32 33.55 Favored 'General case' 0 C--N 1.365 1.255 0 N-CA-C 120.508 3.521 . . . . 0.0 120.508 -164.679 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.84 112.5 10.08 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 128.398 2.679 . . . . 0.0 105.846 169.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.456 ' HB2' HG13 ' A' ' 115' ' ' ILE . 7.4 m95 -112.64 142.73 44.89 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 125.346 1.458 . . . . 0.0 108.041 177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.29 0.0 OUTLIER -158.25 161.36 37.74 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 166.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HZ1' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -133.01 103.89 6.27 Favored 'General case' 0 C--N 1.37 1.488 0 C-N-CA 116.717 -1.993 . . . . 0.0 115.873 177.179 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.458 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.226 1.7 t70 36.99 54.68 1.21 Allowed 'General case' 0 CA--C 1.455 -2.68 1 CA-C-O 111.111 -4.28 . . . . 0.0 119.918 154.075 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 101.11 -15.28 58.03 Favored Glycine 0 C--N 1.369 2.365 2 O-C-N 134.153 7.158 . . . . 0.0 116.681 -176.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.424 ' HB3' ' HE2' ' A' ' 110' ' ' LYS 0.271 26.6 m -124.23 148.92 59.27 Favored Pre-proline 0 CA--C 1.563 1.476 0 C-N-CA 129.863 3.265 . . . . 0.0 116.909 -167.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -60.32 155.86 43.99 Favored 'Trans proline' 0 N--CA 1.502 2.01 1 C-N-CA 126.644 4.896 . . . . 0.0 116.323 171.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.456 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -104.58 147.53 34.56 Favored Pre-proline 0 CA--C 1.541 0.627 0 O-C-N 119.539 -1.976 . . . . 0.0 110.162 174.935 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -58.8 -76.62 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.919 1 C-N-CA 126.504 4.802 . . . . 0.0 120.377 -165.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -141.54 64.75 1.4 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -173.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -86.83 -172.72 4.13 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 126.788 2.035 . . . . 0.0 115.498 -178.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.309 8.4 t 101.79 13.13 0.01 OUTLIER 'General case' 0 C--N 1.354 0.783 0 C-N-CA 129.076 2.95 . . . . 0.0 111.825 178.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 171.81 96.75 0.1 Allowed Glycine 0 CA--C 1.475 -2.431 0 C-N-CA 116.733 -2.651 . . . . 0.0 117.687 166.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.481 . . 84.26 -84.52 0.02 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 118.361 2.726 . . . . 0.0 118.361 170.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 8.9 t -138.92 121.1 15.8 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 122.316 2.325 . . . . 0.0 115.609 -170.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 29.2 p90 -127.66 139.69 52.56 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 127.638 2.375 . . . . 0.0 110.745 173.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 91' ' ' LEU . 35.1 m -129.76 139.91 51.18 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 119.33 -2.106 . . . . 0.0 109.774 176.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.35 98.04 41.92 Favored Pre-proline 0 C--N 1.363 1.159 0 C-N-CA 127.638 2.375 . . . . 0.0 107.316 176.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.12 -16.5 15.69 Favored 'Trans proline' 0 C--N 1.363 1.31 1 C-N-CA 126.635 4.89 . . . . 0.0 113.83 -179.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.436 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -161.69 104.32 1.21 Allowed 'General case' 0 N--CA 1.435 -1.183 0 N-CA-C 102.426 -3.176 . . . . 0.0 102.426 177.512 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.458 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -90.74 134.37 34.47 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 128.382 2.673 . . . . 0.0 113.082 -178.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.2 176.92 6.76 Favored 'General case' 0 C--N 1.37 1.473 0 C-N-CA 128.193 2.597 . . . . 0.0 111.031 175.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.9 -48.59 31.45 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 119.546 3.165 . . . . 0.0 119.546 -172.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -67.8 -12.3 60.31 Favored 'General case' 0 C--N 1.366 1.322 0 C-N-CA 126.493 1.917 . . . . 0.0 114.65 174.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.581 ' HA ' ' HZ1' ' A' ' 110' ' ' LYS 0.354 32.0 m-20 -80.84 -18.64 46.77 Favored 'General case' 0 CA--C 1.565 1.538 0 C-N-CA 129.873 3.269 . . . . 0.0 111.977 169.575 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.533 ' HB2' ' H ' ' A' ' 157' ' ' VAL . . . -70.79 133.31 46.43 Favored 'General case' 0 C--N 1.379 1.882 0 N-CA-C 119.448 3.129 . . . . 0.0 119.448 166.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.47 -157.08 29.16 Favored Glycine 0 CA--C 1.461 -3.341 0 N-CA-C 107.458 -2.257 . . . . 0.0 107.458 170.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.456 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.31 19.2 m -114.0 134.76 54.64 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 114.632 -2.827 . . . . 0.0 107.33 170.229 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.53 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 9.2 m-85 -96.66 133.5 41.11 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-N 122.014 2.188 . . . . 0.0 113.351 -172.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -140.95 145.6 36.25 Favored 'General case' 0 C--N 1.37 1.477 0 O-C-N 124.035 0.834 . . . . 0.0 109.458 -173.435 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.326 7.6 p -144.94 136.92 21.07 Favored 'Isoleucine or valine' 0 C--N 1.37 1.495 0 C-N-CA 118.289 -1.364 . . . . 0.0 113.834 176.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -104.31 118.05 35.68 Favored 'General case' 0 C--N 1.375 1.692 0 C-N-CA 130.081 3.352 . . . . 0.0 106.755 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.566 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -128.41 126.08 65.03 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 C-N-CA 127.572 2.349 . . . . 0.0 113.108 -173.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.48 HG23 ' C ' ' A' ' 146' ' ' VAL . 11.3 m -117.24 133.68 55.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 119.401 -2.062 . . . . 0.0 113.883 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.425 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.344 29.3 p-10 -126.46 -177.76 4.1 Favored 'General case' 0 C--N 1.376 1.725 0 CA-C-N 120.301 1.41 . . . . 0.0 112.798 174.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.574 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 66.2 p -49.64 3.75 0.01 OUTLIER 'General case' 0 C--N 1.366 1.324 1 C-N-CA 137.082 6.153 . . . . 0.0 121.01 -170.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -100.73 4.63 43.22 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 163.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.378 1.9 mp0 65.23 39.77 5.25 Favored 'General case' 0 C--N 1.379 1.86 1 C-N-CA 133.46 4.704 . . . . 0.0 110.783 -174.239 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.48 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.11 127.81 70.19 Favored 'Isoleucine or valine' 0 CA--C 1.479 -1.756 0 CA-C-N 111.541 -2.572 . . . . 0.0 110.974 -169.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.71 128.13 37.42 Favored 'General case' 0 C--N 1.354 0.803 0 C-N-CA 126.982 2.113 . . . . 0.0 107.735 178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.75 156.15 27.68 Favored 'General case' 0 CA--C 1.515 -0.394 0 C-N-CA 128.083 2.553 . . . . 0.0 104.577 178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -130.62 146.48 52.13 Favored 'General case' 0 CA--C 1.504 -0.789 0 O-C-N 120.69 -1.256 . . . . 0.0 109.688 -177.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 86.5 p -129.71 142.95 50.62 Favored 'General case' 0 C--O 1.253 1.24 0 C-N-CA 123.173 0.589 . . . . 0.0 111.627 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 m -54.57 147.24 14.66 Favored 'General case' 0 C--N 1.376 1.758 2 C-N-CA 136.582 5.953 . . . . 0.0 117.108 -163.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 76.3 p -68.14 110.76 4.13 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 129.754 3.222 . . . . 0.0 109.844 -174.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.08 108.75 21.55 Favored 'General case' 0 C--N 1.363 1.16 0 N-CA-C 103.217 -2.883 . . . . 0.0 103.217 -177.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -93.96 106.9 18.86 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-O 124.324 2.012 . . . . 0.0 110.838 -172.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.9 m -121.52 126.81 75.3 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 O-C-N 120.675 -1.266 . . . . 0.0 108.11 -173.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.5 m -116.64 122.08 43.54 Favored 'General case' 0 CA--C 1.483 -1.618 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.533 ' H ' ' HB2' ' A' ' 133' ' ' ALA . 4.0 m -135.07 103.36 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.295 0 N-CA-C 103.773 -2.676 . . . . 0.0 103.773 172.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.98 155.67 38.77 Favored Pre-proline 0 C--N 1.349 0.585 0 C-N-CA 125.096 1.358 . . . . 0.0 108.264 175.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -66.5 165.67 24.32 Favored 'Trans proline' 0 C--N 1.363 1.324 1 C-N-CA 127.472 5.448 . . . . 0.0 110.672 160.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 10.5 p -67.86 126.63 30.05 Favored 'General case' 0 C--N 1.374 1.667 0 O-C-N 119.594 -1.941 . . . . 0.0 107.894 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.413 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 9.0 p -67.34 114.38 18.62 Favored Pre-proline 0 C--N 1.365 1.261 1 N-CA-C 124.392 4.96 . . . . 0.0 124.392 -121.112 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 58.6 Cg_endo -63.03 123.13 11.69 Favored 'Trans proline' 0 C--N 1.388 2.656 0 C-N-CA 124.894 3.729 . . . . 0.0 111.395 166.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 84.94 -85.27 1.57 Allowed Glycine 0 C--N 1.358 1.781 0 C-N-CA 125.2 1.381 . . . . 0.0 112.592 -174.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 168.49 177.08 39.28 Favored Glycine 0 C--N 1.352 1.418 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 75.8 mt -93.36 60.54 3.15 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 125.38 1.472 . . . . 0.0 110.176 178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -70.25 63.06 0.23 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 127.916 2.486 . . . . 0.0 116.202 -177.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 85.7 t60 . . . . . 0 C--N 1.355 0.81 0 C-N-CA 127.086 2.155 . . . . 0.0 109.138 179.394 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.992 0 CA-C-O 121.574 0.702 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.3 tp -98.77 144.89 27.5 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 127.19 2.196 . . . . 0.0 111.228 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.1 t -94.09 173.44 7.65 Favored 'General case' 0 N--CA 1.432 -1.333 0 C-N-CA 129.79 3.236 . . . . 0.0 112.266 -178.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.486 ' H ' HD23 ' A' ' 75' ' ' LEU . 1.2 pt? -81.44 98.77 8.39 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 120.993 -1.067 . . . . 0.0 109.656 171.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.62 -76.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 117.583 -3.198 . . . . 0.0 114.856 -171.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.7 tptm -133.33 140.44 47.41 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 130.864 3.665 . . . . 0.0 106.312 167.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.266 0.0 OUTLIER -82.86 172.05 13.25 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 130.074 3.35 . . . . 0.0 110.559 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.596 HD12 ' H ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -70.07 -28.14 65.19 Favored 'General case' 0 CA--C 1.578 2.02 0 C-N-CA 126.476 1.91 . . . . 0.0 114.602 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.0 m -172.04 179.53 2.64 Favored 'General case' 0 N--CA 1.468 0.434 1 N-CA-C 99.647 -4.205 . . . . 0.0 99.647 173.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.51 -48.69 1.17 Allowed 'General case' 0 C--N 1.355 0.838 0 CA-C-N 121.508 1.958 . . . . 0.0 108.773 169.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 20.4 t -172.07 134.52 0.75 Allowed 'General case' 0 C--N 1.356 0.876 0 O-C-N 120.396 -1.44 . . . . 0.0 113.106 174.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 54.5 ttm -134.36 116.91 15.77 Favored 'General case' 0 C--N 1.369 1.446 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 162.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 p -108.57 115.36 29.95 Favored 'General case' 0 C--N 1.361 1.084 0 O-C-N 119.727 -1.858 . . . . 0.0 107.327 175.368 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.7 p -149.62 174.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.609 0 C-N-CA 125.88 1.672 . . . . 0.0 111.857 -165.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 7.5 mp0 -79.22 134.2 36.67 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 126.959 2.104 . . . . 0.0 105.689 161.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.39 0.0 OUTLIER -43.63 122.88 2.87 Favored 'General case' 0 N--CA 1.516 2.847 0 N-CA-C 118.515 2.783 . . . . 0.0 118.515 -164.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.537 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 135.0 52.53 0.07 OUTLIER Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 128.372 2.892 . . . . 0.0 107.654 -165.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.423 ' HB1' HG22 ' A' ' 155' ' ' VAL . . . -91.75 153.23 19.76 Favored 'General case' 0 C--N 1.364 1.233 0 C-N-CA 126.577 1.951 . . . . 0.0 108.932 177.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.15 110.72 21.68 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 -166.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.442 HD13 ' CZ ' ' A' ' 136' ' ' TYR . 4.8 mt -120.62 144.44 48.14 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 -178.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.444 HG22 ' HA ' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -126.86 138.51 53.34 Favored 'General case' 0 CA--C 1.506 -0.734 1 N-CA-C 100.165 -4.013 . . . . 0.0 100.165 166.347 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.4 HD23 ' CE3' ' A' ' 108' ' ' TRP . 4.0 mp -121.86 113.95 20.36 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 100.608 -3.849 . . . . 0.0 100.608 175.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.503 ' H ' HD23 ' A' ' 79' ' ' LEU . 4.0 t -150.33 133.4 16.16 Favored 'General case' 0 C--N 1.369 1.423 0 CA-C-N 119.568 1.077 . . . . 0.0 112.717 -173.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -149.76 173.94 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.879 1 C-N-CA 132.191 4.196 . . . . 0.0 104.396 175.614 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 8.2 t -103.0 141.81 35.17 Favored 'General case' 0 C--N 1.367 1.334 0 N-CA-C 106.214 -1.772 . . . . 0.0 106.214 177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -134.5 140.87 46.5 Favored 'General case' 0 C--N 1.368 1.408 1 N-CA-C 122.285 4.18 . . . . 0.0 122.285 -171.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 97.0 m -158.24 174.26 15.44 Favored 'General case' 0 C--N 1.357 0.891 0 C-N-CA 130.797 3.639 . . . . 0.0 102.222 176.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.82 43.7 2.2 Favored Glycine 0 C--N 1.365 2.16 0 CA-C-N 122.763 2.529 . . . . 0.0 116.714 178.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.52 21.33 62.28 Favored Glycine 0 C--N 1.359 1.832 0 C-N-CA 128.413 2.911 . . . . 0.0 114.082 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.7 p -117.1 110.94 18.82 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 126.271 1.829 . . . . 0.0 108.457 178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.659 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.34 -96.64 1.02 Allowed Glycine 0 C--N 1.371 2.488 0 C-N-CA 127.943 2.687 . . . . 0.0 110.985 -168.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -63.98 169.22 10.78 Favored 'Trans proline' 0 CA--C 1.556 1.579 1 C-N-CA 127.258 5.305 . . . . 0.0 116.855 159.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.49 ' HB3' HG12 ' A' ' 140' ' ' VAL . 58.5 m-85 -92.1 148.07 22.46 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 120.782 3.623 . . . . 0.0 120.782 -168.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.2 t -102.84 141.45 35.63 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 129.097 2.959 . . . . 0.0 104.439 172.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.402 ' HD1' ' HA ' ' A' ' 119' ' ' SER . 0.1 OUTLIER -124.72 159.47 30.81 Favored 'General case' 0 C--N 1.364 1.198 0 N-CA-C 120.076 3.361 . . . . 0.0 120.076 -166.184 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -130.0 117.53 20.19 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 101.865 -3.383 . . . . 0.0 101.865 165.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.437 ' HB3' HG13 ' A' ' 115' ' ' ILE . 94.8 m95 -107.23 134.76 49.85 Favored 'General case' 0 C--N 1.363 1.176 0 C-N-CA 124.664 1.185 . . . . 0.0 109.073 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -150.7 170.31 19.52 Favored 'General case' 0 CA--C 1.487 -1.451 0 O-C-N 120.34 -1.475 . . . . 0.0 108.311 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.5 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.5 ptmm? -148.32 106.46 3.73 Favored 'General case' 0 N--CA 1.423 -1.795 0 O-C-N 119.643 -1.91 . . . . 0.0 108.45 176.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.515 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.213 0.9 OUTLIER 35.27 54.31 0.77 Allowed 'General case' 0 CA--C 1.47 -2.114 2 CA-C-O 109.472 -5.061 . . . . 0.0 122.73 146.212 . . . . . . . . 5 4 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.55 -0.42 85.45 Favored Glycine 0 C--N 1.384 3.242 2 O-C-N 135.113 7.758 . . . . 0.0 118.887 -174.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.3 0.9 OUTLIER -124.49 147.57 55.85 Favored Pre-proline 0 CA--C 1.563 1.474 0 C-N-CA 129.429 3.091 . . . . 0.0 118.812 -167.398 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -65.75 139.17 56.53 Favored 'Trans proline' 0 N--CA 1.5 1.887 1 C-N-CA 125.992 4.461 . . . . 0.0 117.15 170.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -89.18 162.46 37.37 Favored Pre-proline 0 CA--C 1.547 0.863 0 O-C-N 118.374 -2.704 . . . . 0.0 114.303 177.109 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 8.3 Cg_endo -67.89 94.02 0.39 Allowed 'Trans proline' 0 C--N 1.364 1.39 1 C-N-CA 125.564 4.176 . . . . 0.0 115.556 -178.134 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.3 t70 82.05 -72.14 0.05 OUTLIER 'General case' 0 C--N 1.358 0.945 0 C-N-CA 127.61 2.364 . . . . 0.0 110.921 -179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.661 ' HB2' HD11 ' A' ' 115' ' ' ILE . . . 97.06 142.45 0.02 OUTLIER 'General case' 0 CA--C 1.479 -1.767 0 C-N-CA 129.057 2.943 . . . . 0.0 111.757 176.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.402 ' HA ' ' HD1' ' A' ' 106' ' ' TYR 0.281 0.2 OUTLIER 82.48 53.54 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.028 -1.896 . . . . 0.0 112.709 179.056 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -116.58 -55.84 0.32 Allowed Glycine 0 CA--C 1.489 -1.57 0 N-CA-C 116.305 1.282 . . . . 0.0 116.305 -168.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.304 . . 103.43 -47.84 0.0 OUTLIER 'General case' 0 C--N 1.345 0.395 0 C-N-CA 126.59 1.956 . . . . 0.0 113.953 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.4 6.4 t -145.92 92.6 2.22 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 124.135 1.921 . . . . 0.0 109.582 174.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.291 4.3 p90 -126.88 142.18 51.61 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 129.003 2.921 . . . . 0.0 111.332 -177.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 34.5 m -124.97 139.66 53.62 Favored 'General case' 0 C--N 1.357 0.918 0 O-C-N 120.096 -1.628 . . . . 0.0 109.349 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.96 89.5 45.97 Favored Pre-proline 0 C--N 1.354 0.799 0 C-N-CA 127.937 2.495 . . . . 0.0 107.857 177.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -68.16 -32.57 27.01 Favored 'Trans proline' 0 C--N 1.36 1.162 0 C-N-CA 124.712 3.608 . . . . 0.0 115.335 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.537 HG23 ' HA2' ' A' ' 88' ' ' GLY . 96.3 m -130.18 100.67 5.49 Favored 'General case' 0 C--N 1.354 0.773 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -90.3 118.63 29.95 Favored 'General case' 0 C--N 1.349 0.563 0 C-N-CA 124.918 1.287 . . . . 0.0 113.555 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.07 -179.84 6.54 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.348 2.659 . . . . 0.0 109.646 173.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.87 -51.26 23.68 Favored 'General case' 0 C--N 1.368 1.387 0 O-C-N 118.16 -2.837 . . . . 0.0 117.761 -174.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -68.08 0.17 3.89 Favored 'General case' 0 C--N 1.366 1.311 0 C-N-CA 128.45 2.7 . . . . 0.0 114.966 173.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -116.66 -12.08 10.94 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 130.435 3.494 . . . . 0.0 111.316 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.504 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -98.34 157.26 16.3 Favored 'General case' 0 C--N 1.394 2.509 0 N-CA-C 119.409 3.115 . . . . 0.0 119.409 174.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 152.43 -158.36 27.8 Favored Glycine 0 C--N 1.39 3.535 0 C-N-CA 128.832 3.111 . . . . 0.0 111.042 -175.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.485 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.328 3.8 m -106.07 131.94 52.74 Favored 'General case' 0 N--CA 1.506 2.36 0 C-N-CA 112.947 -3.501 . . . . 0.0 105.989 167.578 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.556 ' HB2' ' HB2' ' A' ' 153' ' ' CYS . 18.3 m-85 -97.23 134.96 39.84 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-N 122.757 2.526 . . . . 0.0 113.599 -172.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.515 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -147.97 152.3 37.25 Favored 'General case' 0 C--N 1.37 1.498 0 CA-C-O 122.422 1.106 . . . . 0.0 110.175 -174.493 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.254 8.3 p -135.91 137.69 48.57 Favored 'Isoleucine or valine' 0 C--N 1.363 1.173 0 C-N-CA 118.471 -1.292 . . . . 0.0 113.901 177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.3 m -105.69 116.61 32.23 Favored 'General case' 0 C--N 1.377 1.787 0 C-N-CA 129.098 2.959 . . . . 0.0 104.925 176.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -130.88 119.09 44.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 C-N-CA 124.086 0.954 . . . . 0.0 109.67 -167.768 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.43 HG23 ' C ' ' A' ' 146' ' ' VAL . 10.2 m -103.73 128.8 51.06 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 120.951 -1.093 . . . . 0.0 113.497 -177.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.465 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.488 11.1 p-10 -127.55 -174.78 3.27 Favored 'General case' 0 C--N 1.371 1.52 0 CA-C-N 119.191 0.905 . . . . 0.0 111.84 174.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.659 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 80.5 p -49.97 2.44 0.01 OUTLIER 'General case' 0 C--N 1.361 1.069 2 C-N-CA 135.549 5.54 . . . . 0.0 121.816 -163.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.52 4.37 38.5 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.383 -1.339 . . . . 0.0 107.383 164.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.394 68.8 mm-40 66.39 40.01 3.78 Favored 'General case' 0 C--N 1.375 1.678 1 C-N-CA 132.803 4.441 . . . . 0.0 110.84 -172.623 . . . . . . . . 3 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.43 ' C ' HG23 ' A' ' 141' ' ' THR . 3.9 m -113.26 129.8 68.33 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.602 0 CA-C-N 112.324 -2.216 . . . . 0.0 112.253 -171.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.29 123.58 34.84 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 126.661 1.984 . . . . 0.0 107.691 -179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.55 157.53 25.11 Favored 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 103.618 -2.734 . . . . 0.0 103.618 -175.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -128.68 132.22 48.03 Favored 'General case' 0 CA--C 1.502 -0.875 0 O-C-N 120.646 -1.284 . . . . 0.0 109.706 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.474 55.9 p -114.35 151.88 32.32 Favored 'General case' 0 C--N 1.361 1.086 0 C-N-CA 123.75 0.82 . . . . 0.0 111.13 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -53.69 146.81 12.62 Favored 'General case' 0 C--N 1.371 1.508 1 C-N-CA 133.843 4.857 . . . . 0.0 120.146 -153.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 64.5 p -70.33 110.96 5.57 Favored 'General case' 0 C--N 1.374 1.635 0 C-N-CA 129.745 3.218 . . . . 0.0 109.323 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.556 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 18.0 m -106.01 109.62 21.63 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 -176.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.58 107.23 19.62 Favored 'General case' 0 C--N 1.352 0.678 0 CA-C-O 124.773 2.225 . . . . 0.0 111.308 -170.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.423 HG22 ' HB1' ' A' ' 89' ' ' ALA 0.263 1.1 t -118.0 114.95 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 -172.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m -110.37 133.63 53.08 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 -174.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.504 HG22 ' CB ' ' A' ' 133' ' ' ALA . 33.4 m -128.8 105.77 13.41 Favored 'Isoleucine or valine' 0 C--N 1.362 1.128 0 CA-C-O 124.023 1.868 . . . . 0.0 112.802 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 18.4 m-20 -87.31 157.69 53.03 Favored Pre-proline 0 CA--C 1.556 1.178 0 C-N-CA 124.594 1.158 . . . . 0.0 109.086 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -74.82 165.91 30.43 Favored 'Trans proline' 0 C--N 1.358 1.059 1 C-N-CA 126.835 5.023 . . . . 0.0 107.02 153.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 2.9 p -67.29 133.57 49.93 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 118.506 -2.621 . . . . 0.0 110.784 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.498 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 14.9 t -65.72 104.47 0.58 Allowed Pre-proline 0 C--N 1.36 1.045 0 N-CA-C 121.218 3.784 . . . . 0.0 121.218 -124.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.498 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 61.4 Cg_endo -62.77 122.86 11.34 Favored 'Trans proline' 0 C--N 1.386 2.529 1 C-N-CA 125.972 4.448 . . . . 0.0 111.544 170.007 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 96.58 -21.01 48.06 Favored Glycine 0 C--N 1.357 1.707 0 C-N-CA 125.559 1.552 . . . . 0.0 112.734 -170.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -101.83 -49.0 1.31 Allowed Glycine 0 C--N 1.361 1.938 0 C-N-CA 125.272 1.415 . . . . 0.0 114.986 -176.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 19.3 mt -88.55 -5.88 57.92 Favored 'General case' 0 C--N 1.363 1.154 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -175.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 58.94 -35.52 0.06 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 130.389 3.475 . . . . 0.0 120.126 174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 1.3 p80 . . . . . 0 C--N 1.358 0.938 0 C-N-CA 129.431 3.092 . . . . 0.0 117.398 -176.489 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.132 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 10.1 tp -107.24 132.67 52.82 Favored 'General case' 0 C--N 1.359 0.997 0 CA-C-O 122.784 1.278 . . . . 0.0 108.903 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 t -104.8 171.18 7.46 Favored 'General case' 0 N--CA 1.416 -2.159 0 C-N-CA 125.463 1.505 . . . . 0.0 112.632 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' H ' HD23 ' A' ' 75' ' ' LEU 0.29 0.5 OUTLIER -92.46 97.85 11.1 Favored 'General case' 0 C--N 1.362 1.139 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 173.299 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.6 t 61.16 -78.91 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 119.06 -2.275 . . . . 0.0 112.877 -169.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 8.4 tptm -133.68 138.72 46.02 Favored 'General case' 0 C--N 1.362 1.151 0 C-N-CA 128.82 2.848 . . . . 0.0 107.764 164.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.34 0.0 OUTLIER -83.53 172.66 12.16 Favored 'General case' 0 C--N 1.356 0.877 1 C-N-CA 132.911 4.485 . . . . 0.0 109.123 175.866 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.1 -32.26 70.22 Favored 'General case' 0 CA--C 1.577 2.005 0 O-C-N 119.651 -1.906 . . . . 0.0 112.336 173.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 23.2 m -164.81 171.32 14.37 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 116.667 -3.77 . . . . 0.0 103.785 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -127.41 -45.41 1.51 Allowed 'General case' 0 C--N 1.366 1.315 0 C-N-CA 127.031 2.132 . . . . 0.0 112.932 176.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 86.1 p -176.17 134.12 0.25 Allowed 'General case' 0 C--N 1.365 1.262 0 N-CA-C 116.458 2.021 . . . . 0.0 116.458 176.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.6 ttt -134.75 117.93 16.52 Favored 'General case' 0 C--N 1.373 1.629 0 CA-C-N 119.696 1.134 . . . . 0.0 109.203 159.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.5 p -111.13 116.15 30.62 Favored 'General case' 0 C--N 1.363 1.188 0 O-C-N 119.482 -2.011 . . . . 0.0 109.789 175.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.0 p -149.74 171.98 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.051 0 C-N-CA 126.825 2.05 . . . . 0.0 112.937 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.4 127.56 33.79 Favored 'General case' 0 C--N 1.372 1.55 0 O-C-N 118.961 -2.337 . . . . 0.0 105.258 163.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.456 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.278 8.6 pt-20 -41.83 122.57 2.07 Favored 'General case' 0 C--N 1.371 1.525 0 N-CA-C 120.389 3.477 . . . . 0.0 120.389 -150.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.47 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 144.34 54.71 0.03 OUTLIER Glycine 0 C--N 1.356 1.639 0 CA-C-N 109.656 -3.429 . . . . 0.0 110.55 -172.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.11 158.79 23.56 Favored 'General case' 0 C--N 1.372 1.58 0 C-N-CA 125.482 1.513 . . . . 0.0 113.101 174.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.91 101.62 9.92 Favored 'General case' 0 C--N 1.361 1.067 0 C-N-CA 125.415 1.486 . . . . 0.0 112.312 -174.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.533 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 1.1 mp -119.79 130.83 55.13 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 125.943 1.697 . . . . 0.0 115.318 -173.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.98 132.8 53.9 Favored 'General case' 0 CA--C 1.491 -1.296 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 172.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.636 HD21 ' CD2' ' A' ' 136' ' ' TYR . 3.1 mp -131.83 115.16 15.58 Favored 'General case' 0 C--N 1.355 0.835 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 170.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.5 t -148.1 133.84 18.93 Favored 'General case' 0 CA--C 1.513 -0.449 0 O-C-N 120.529 -1.357 . . . . 0.0 110.981 -174.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -148.7 174.57 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.336 0 C-N-CA 129.549 3.14 . . . . 0.0 104.0 178.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.7 t -104.26 141.38 36.39 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 126.948 2.099 . . . . 0.0 105.696 177.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.31 134.2 32.23 Favored 'General case' 0 C--N 1.37 1.472 0 N-CA-C 120.127 3.38 . . . . 0.0 120.127 -172.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 63.3 m -157.86 174.04 15.88 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 131.363 3.865 . . . . 0.0 100.843 178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.52 44.24 2.21 Favored Glycine 0 C--N 1.363 2.045 0 CA-C-N 122.584 2.447 . . . . 0.0 117.582 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.4 12.73 81.63 Favored Glycine 0 C--N 1.362 1.991 0 C-N-CA 128.705 3.05 . . . . 0.0 113.068 -179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.7 p -115.87 111.17 20.05 Favored 'General case' 0 CA--C 1.506 -0.718 0 C-N-CA 126.481 1.913 . . . . 0.0 107.396 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.513 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 71.83 -101.4 1.01 Allowed Glycine 0 C--N 1.36 1.886 0 C-N-CA 127.181 2.324 . . . . 0.0 109.315 -161.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -60.79 168.32 7.22 Favored 'Trans proline' 0 CA--C 1.555 1.573 1 C-N-CA 129.227 6.618 . . . . 0.0 118.349 165.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.541 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.6 m-85 -82.07 138.86 34.73 Favored 'General case' 0 CA--C 1.562 1.419 1 N-CA-C 122.274 4.175 . . . . 0.0 122.274 -170.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.5 t -102.82 154.96 18.68 Favored 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 129.756 3.223 . . . . 0.0 104.309 171.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.475 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.5 OUTLIER -153.71 166.27 33.35 Favored 'General case' 0 C--N 1.364 1.223 0 N-CA-C 119.889 3.292 . . . . 0.0 119.889 -165.129 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.2 112.81 10.76 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 128.417 2.687 . . . . 0.0 105.64 170.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.407 ' HB3' HG13 ' A' ' 115' ' ' ILE . 94.1 m95 -111.94 137.5 49.85 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 126.349 1.859 . . . . 0.0 108.595 -178.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.308 0.2 OUTLIER -158.61 162.77 37.35 Favored 'General case' 0 N--CA 1.483 1.223 0 O-C-N 120.32 -1.487 . . . . 0.0 107.427 168.898 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.503 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -137.31 103.59 5.14 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 116.954 -1.898 . . . . 0.0 115.412 177.9 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.153 2.3 t70 36.6 53.82 1.07 Allowed 'General case' 0 CA--C 1.467 -2.22 1 CA-C-O 111.433 -4.127 . . . . 0.0 119.609 153.898 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 92.71 -0.56 70.46 Favored Glycine 0 C--N 1.373 2.6 2 O-C-N 134.227 7.204 . . . . 0.0 117.38 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.4 ' HB2' ' HE3' ' A' ' 110' ' ' LYS 0.384 1.3 p -124.82 147.8 57.51 Favored Pre-proline 0 CA--C 1.564 1.492 0 C-N-CA 130.074 3.349 . . . . 0.0 119.445 -167.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -65.02 143.7 79.7 Favored 'Trans proline' 0 N--CA 1.498 1.747 1 C-N-CA 125.964 4.442 . . . . 0.0 115.817 167.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.407 HG13 ' HB3' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -94.99 144.91 28.6 Favored Pre-proline 0 CA--C 1.551 1.004 0 O-C-N 119.437 -2.039 . . . . 0.0 112.916 176.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -80.55 93.43 1.03 Allowed 'Trans proline' 0 CA--C 1.533 0.447 1 C-N-CA 125.938 4.425 . . . . 0.0 118.83 -172.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 7.3 t70 65.1 48.26 2.28 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 116.897 2.184 . . . . 0.0 116.897 169.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -80.32 -165.64 0.9 Allowed 'General case' 0 C--N 1.35 0.587 0 C-N-CA 127.598 2.359 . . . . 0.0 115.694 178.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.304 8.4 t 99.92 8.04 0.01 OUTLIER 'General case' 0 C--N 1.354 0.765 0 C-N-CA 128.959 2.904 . . . . 0.0 112.121 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.2 91.77 0.08 OUTLIER Glycine 0 CA--C 1.48 -2.129 0 C-N-CA 115.979 -3.01 . . . . 0.0 118.568 167.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.461 . . 89.6 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 117.697 2.48 . . . . 0.0 117.697 167.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 12.0 t -139.32 118.27 12.5 Favored 'General case' 0 C--N 1.357 0.914 0 CA-C-N 122.106 2.23 . . . . 0.0 115.915 -169.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 36.2 p90 -127.63 140.13 52.29 Favored 'General case' 0 C--N 1.367 1.349 0 C-N-CA 127.381 2.272 . . . . 0.0 111.197 174.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 91' ' ' LEU . 89.1 m -129.25 140.55 51.41 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 119.306 -2.121 . . . . 0.0 109.68 177.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.411 ' HB3' HD22 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -111.85 95.97 31.21 Favored Pre-proline 0 C--N 1.366 1.293 0 C-N-CA 128.203 2.601 . . . . 0.0 108.455 178.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.19 -14.11 16.77 Favored 'Trans proline' 0 C--N 1.356 0.948 1 C-N-CA 126.278 4.652 . . . . 0.0 113.563 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.47 HG23 ' HA2' ' A' ' 88' ' ' GLY . 95.5 m -161.6 101.0 1.18 Allowed 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 102.43 -3.174 . . . . 0.0 102.43 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.488 ' HB3' HG11 ' A' ' 157' ' ' VAL . . . -83.12 134.05 35.02 Favored 'General case' 0 N--CA 1.444 -0.738 0 C-N-CA 127.83 2.452 . . . . 0.0 112.183 178.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -94.62 173.19 7.74 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 127.935 2.494 . . . . 0.0 110.086 179.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -41.12 23.61 Favored 'General case' 0 C--N 1.366 1.308 0 N-CA-C 120.166 3.395 . . . . 0.0 120.166 -173.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -66.95 -14.57 62.96 Favored 'General case' 0 C--N 1.366 1.317 0 C-N-CA 126.801 2.04 . . . . 0.0 115.393 173.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.48 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 42.7 m-20 -80.42 -17.05 52.94 Favored 'General case' 0 CA--C 1.565 1.553 0 C-N-CA 129.475 3.11 . . . . 0.0 111.559 168.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.86 107.88 2.79 Favored 'General case' 0 C--N 1.384 2.077 0 N-CA-C 120.45 3.5 . . . . 0.0 120.45 168.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 173.65 -154.12 19.13 Favored Glycine 0 CA--C 1.459 -3.413 0 C-N-CA 126.77 2.129 . . . . 0.0 108.935 172.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.433 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.288 19.6 m -117.64 135.49 53.95 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 114.892 -2.723 . . . . 0.0 108.296 175.335 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.636 ' CD2' HD21 ' A' ' 93' ' ' LEU . 10.1 m-85 -96.77 133.32 41.5 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 120.299 -1.501 . . . . 0.0 113.487 -171.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.466 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -146.05 149.32 33.87 Favored 'General case' 0 C--N 1.376 1.731 0 CA-C-O 121.573 0.702 . . . . 0.0 110.782 -173.032 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.6 p -142.49 142.94 26.51 Favored 'Isoleucine or valine' 0 C--N 1.372 1.56 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 175.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 m -105.15 118.45 36.58 Favored 'General case' 0 C--N 1.375 1.681 0 C-N-CA 129.732 3.213 . . . . 0.0 105.333 171.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.541 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -129.1 122.66 56.86 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 126.765 2.026 . . . . 0.0 112.347 -175.269 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.453 HG23 ' C ' ' A' ' 146' ' ' VAL . 17.4 m -111.78 133.96 53.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 118.995 -2.315 . . . . 0.0 114.043 -177.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . 0.591 4.4 p30 -134.86 -167.18 1.94 Allowed 'General case' 0 C--N 1.373 1.62 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 173.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.513 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 90.6 p -48.88 3.51 0.01 OUTLIER 'General case' 0 C--N 1.366 1.297 2 C-N-CA 134.838 5.255 . . . . 0.0 122.208 -158.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -106.75 4.87 28.12 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 119.035 -1.066 . . . . 0.0 108.468 164.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.397 89.3 mm-40 66.19 40.19 3.93 Favored 'General case' 0 C--N 1.375 1.696 1 C-N-CA 132.077 4.151 . . . . 0.0 110.455 -171.72 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.453 ' C ' HG23 ' A' ' 141' ' ' THR . 3.9 m -112.92 129.85 67.82 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.376 0 CA-C-N 111.759 -2.473 . . . . 0.0 111.362 -171.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.45 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.6 OUTLIER -91.89 130.54 37.63 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 124.885 1.274 . . . . 0.0 110.027 -177.371 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.93 156.99 26.45 Favored 'General case' 0 CA--C 1.511 -0.548 0 C-N-CA 128.172 2.589 . . . . 0.0 104.913 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -130.5 146.72 52.09 Favored 'General case' 0 CA--C 1.496 -1.112 0 O-C-N 120.877 -1.139 . . . . 0.0 108.128 -176.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.337 88.4 p -130.82 143.83 51.02 Favored 'General case' 0 C--O 1.251 1.133 0 O-C-N 121.726 -0.609 . . . . 0.0 110.734 175.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.0 m -54.35 148.02 12.49 Favored 'General case' 0 CA--C 1.481 -1.675 2 C-N-CA 137.127 6.171 . . . . 0.0 118.089 -162.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 65.5 p -68.38 110.35 4.08 Favored 'General case' 0 C--N 1.375 1.675 0 CA-C-N 111.865 -2.425 . . . . 0.0 109.136 -175.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -97.21 109.78 22.47 Favored 'General case' 0 C--N 1.359 0.978 0 N-CA-C 102.172 -3.27 . . . . 0.0 102.172 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.42 114.58 27.17 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-O 125.125 2.393 . . . . 0.0 110.628 -174.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 67.4 t -117.83 117.4 54.83 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 -170.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 86.2 m -113.45 121.01 43.01 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 103.182 -2.895 . . . . 0.0 103.182 173.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' A' ' 128' ' ' ALA . 4.5 m -135.04 102.12 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 103.967 -2.605 . . . . 0.0 103.967 171.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.32 156.7 37.2 Favored Pre-proline 0 CA--C 1.533 0.298 0 C-N-CA 125.055 1.342 . . . . 0.0 109.055 177.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -62.77 168.02 10.93 Favored 'Trans proline' 0 CA--C 1.551 1.35 1 C-N-CA 126.932 5.088 . . . . 0.0 110.156 154.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 17.7 p -67.05 136.2 54.85 Favored 'General case' 0 C--N 1.375 1.68 0 O-C-N 118.994 -2.316 . . . . 0.0 108.059 -177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.511 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 49.1 t -66.73 103.84 0.53 Allowed Pre-proline 0 C--N 1.361 1.07 1 N-CA-C 122.173 4.138 . . . . 0.0 122.173 -126.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.511 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 57.8 Cg_endo -62.63 123.66 12.76 Favored 'Trans proline' 0 C--N 1.385 2.496 1 C-N-CA 126.319 4.679 . . . . 0.0 112.707 170.376 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 104.29 -45.16 1.35 Allowed Glycine 0 C--N 1.359 1.81 0 C-N-CA 125.913 1.72 . . . . 0.0 111.219 -177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -82.57 -42.02 8.67 Favored Glycine 0 C--N 1.361 1.953 0 C-N-CA 125.64 1.59 . . . . 0.0 113.81 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 5.3 mp -116.9 90.72 3.39 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 104.423 -2.436 . . . . 0.0 104.423 174.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -68.72 71.59 0.21 Allowed 'General case' 0 C--N 1.363 1.159 0 C-N-CA 126.307 1.843 . . . . 0.0 115.575 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 54.4 p-80 . . . . . 0 C--N 1.357 0.934 0 C-N-CA 128.052 2.541 . . . . 0.0 112.897 -177.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.2 tp -107.33 145.88 32.27 Favored 'General case' 0 C--N 1.353 0.726 0 C-N-CA 127.34 2.256 . . . . 0.0 110.28 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -100.78 140.88 34.44 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 173.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.477 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -96.65 99.67 11.28 Favored 'General case' 0 C--N 1.37 1.462 0 O-C-N 118.46 -2.65 . . . . 0.0 106.885 175.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.1 m 65.33 -74.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.687 1.995 . . . . 0.0 110.01 -168.25 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.68 119.65 19.63 Favored 'General case' 0 C--N 1.356 0.891 0 C-N-CA 128.301 2.64 . . . . 0.0 105.027 154.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.278 6.9 t70 -86.88 117.91 25.92 Favored 'General case' 0 C--N 1.371 1.537 0 N-CA-C 101.262 -3.607 . . . . 0.0 101.262 166.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.508 HD12 ' H ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -71.63 -36.1 70.62 Favored 'General case' 0 CA--C 1.561 1.365 0 N-CA-C 121.003 3.705 . . . . 0.0 121.003 -157.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 m -173.78 172.37 3.54 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 102.982 -2.969 . . . . 0.0 102.982 176.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.01 -52.79 2.59 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 120.294 -1.504 . . . . 0.0 110.205 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 22.9 t -172.16 136.04 0.82 Allowed 'General case' 0 C--N 1.357 0.928 0 O-C-N 119.842 -1.786 . . . . 0.0 113.709 175.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 25.0 ttt -130.56 117.9 20.25 Favored 'General case' 0 C--N 1.373 1.605 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 163.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -105.5 115.61 30.55 Favored 'General case' 0 C--N 1.365 1.282 0 O-C-N 119.612 -1.93 . . . . 0.0 107.496 175.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.1 p -149.24 173.72 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.752 0 CA-C-O 123.255 1.502 . . . . 0.0 112.208 -168.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -80.02 132.65 36.04 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 126.864 2.066 . . . . 0.0 105.455 159.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.29 0.3 OUTLIER -43.77 121.71 2.48 Favored 'General case' 0 N--CA 1.513 2.719 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 -161.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.581 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 138.44 51.66 0.06 OUTLIER Glycine 0 N--CA 1.438 -1.226 0 CA-C-N 111.446 -2.615 . . . . 0.0 108.938 -164.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.13 163.34 17.91 Favored 'General case' 0 C--N 1.367 1.352 0 C-N-CA 125.804 1.642 . . . . 0.0 111.455 175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.15 105.69 14.48 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.925 0.89 . . . . 0.0 112.755 -174.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.482 HD23 ' CZ ' ' A' ' 136' ' ' TYR . 3.7 mp -119.87 120.22 35.82 Favored 'General case' 0 C--N 1.359 0.997 0 C-N-CA 126.505 1.922 . . . . 0.0 115.313 -172.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.6 OUTLIER -106.75 126.37 52.2 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 102.626 -3.102 . . . . 0.0 102.626 170.352 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -127.34 114.87 18.14 Favored 'General case' 0 C--N 1.353 0.721 0 N-CA-C 103.452 -2.795 . . . . 0.0 103.452 176.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.1 t -156.75 140.32 15.9 Favored 'General case' 0 CA--C 1.506 -0.749 0 O-C-N 120.951 -1.093 . . . . 0.0 109.63 -172.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.64 172.73 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 129.395 3.078 . . . . 0.0 104.884 175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.3 t -104.01 141.76 35.63 Favored 'General case' 0 C--N 1.373 1.605 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 176.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . . . -125.26 149.88 47.59 Favored 'General case' 0 C--N 1.363 1.194 0 N-CA-C 119.56 3.17 . . . . 0.0 119.56 -176.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.4 m -159.4 174.92 13.99 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 100.64 -3.837 . . . . 0.0 100.64 170.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -81.17 42.48 2.74 Favored Glycine 0 C--N 1.362 2.009 0 CA-C-N 122.905 2.593 . . . . 0.0 116.239 178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 96.84 0.8 60.22 Favored Glycine 0 C--N 1.362 1.979 0 C-N-CA 125.649 1.595 . . . . 0.0 114.393 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.9 m -117.24 123.91 47.76 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.346 1.458 . . . . 0.0 110.034 179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.611 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.45 -113.26 4.36 Favored Glycine 0 C--N 1.361 1.917 0 CA-C-O 116.153 -2.47 . . . . 0.0 108.798 -163.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -66.96 168.45 17.18 Favored 'Trans proline' 0 CA--C 1.564 1.985 1 C-N-CA 127.759 5.64 . . . . 0.0 117.353 163.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.469 ' HB3' HG12 ' A' ' 140' ' ' VAL . 27.4 m-85 -82.1 144.33 30.87 Favored 'General case' 0 C--N 1.358 0.947 1 N-CA-C 125.453 5.353 . . . . 0.0 125.453 -164.494 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.3 t -103.24 141.47 35.84 Favored 'General case' 0 C--N 1.371 1.529 0 C-N-CA 127.914 2.486 . . . . 0.0 104.525 170.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.544 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.6 OUTLIER -137.39 160.32 39.43 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 120.354 3.464 . . . . 0.0 120.354 -166.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.08 113.69 9.09 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 110.593 -3.003 . . . . 0.0 105.112 173.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -111.98 154.77 24.8 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 120.676 -1.265 . . . . 0.0 108.595 -178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.383 0.2 OUTLIER -158.3 168.73 26.2 Favored 'General case' 0 CA--C 1.498 -1.05 0 N-CA-C 106.531 -1.655 . . . . 0.0 106.531 166.338 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.507 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.0 OUTLIER -144.5 105.01 4.12 Favored 'General case' 0 CA--C 1.498 -1.055 0 O-C-N 120.138 -1.601 . . . . 0.0 114.911 -178.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.513 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.224 0.6 OUTLIER 36.39 53.75 1.01 Allowed 'General case' 0 CA--C 1.464 -2.336 1 CA-C-O 111.394 -4.145 . . . . 0.0 119.198 153.699 . . . . . . . . 5 4 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 90.38 -0.65 78.24 Favored Glycine 0 C--N 1.373 2.607 2 O-C-N 134.747 7.529 . . . . 0.0 118.375 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.268 58.2 m -124.89 148.87 61.15 Favored Pre-proline 0 CA--C 1.556 1.174 0 N-CA-C 120.304 3.446 . . . . 0.0 120.304 -167.297 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -60.22 148.75 88.69 Favored 'Trans proline' 0 N--CA 1.507 2.301 1 C-N-CA 126.231 4.62 . . . . 0.0 116.194 166.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.591 ' HB ' ' HD2' ' A' ' 116' ' ' PRO 0.325 0.8 OUTLIER -98.64 165.1 15.71 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 117.846 -3.034 . . . . 0.0 112.285 175.279 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.591 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 6.0 Cg_endo -69.2 87.92 0.48 Allowed 'Trans proline' 0 C--N 1.371 1.739 1 C-N-CA 125.826 4.351 . . . . 0.0 113.984 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 16.6 t70 84.99 -57.51 0.09 Allowed 'General case' 0 C--N 1.363 1.167 0 C-N-CA 129.877 3.271 . . . . 0.0 110.612 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.302 . . 102.97 -62.87 0.0 OUTLIER 'General case' 0 CA--C 1.479 -1.764 0 C-N-CA 130.715 3.606 . . . . 0.0 115.285 171.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.301 8.0 t -73.7 80.12 1.54 Allowed 'General case' 0 N--CA 1.432 -1.347 0 C-N-CA 130.732 3.613 . . . . 0.0 113.886 -174.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -161.94 -71.48 0.02 OUTLIER Glycine 0 C--N 1.36 1.867 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 -172.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.437 ' HB2' ' HB2' ' A' ' 97' ' ' ALA 0.318 . . 129.4 -24.73 0.01 OUTLIER 'General case' 0 C--N 1.365 1.247 0 C-N-CA 127.265 2.226 . . . . 0.0 116.044 178.008 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.34 15.0 t -154.85 102.23 2.34 Favored 'General case' 0 C--N 1.36 1.043 0 CA-C-N 121.013 1.733 . . . . 0.0 112.657 178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.313 0.1 OUTLIER -127.43 141.48 51.67 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 127.897 2.479 . . . . 0.0 111.472 176.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 91' ' ' LEU . 60.1 m -128.32 138.65 52.48 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 118.991 -2.318 . . . . 0.0 107.28 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -116.89 102.72 52.88 Favored Pre-proline 0 C--N 1.362 1.137 0 C-N-CA 128.042 2.537 . . . . 0.0 105.209 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -77.04 -11.86 17.77 Favored 'Trans proline' 0 C--N 1.348 0.548 1 C-N-CA 126.227 4.618 . . . . 0.0 112.731 178.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.581 HG23 ' HA2' ' A' ' 88' ' ' GLY . 62.1 m -157.22 100.9 1.87 Allowed 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 104.057 -2.571 . . . . 0.0 104.057 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.46 128.47 39.56 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 124.312 1.045 . . . . 0.0 112.317 176.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -96.27 179.06 5.17 Favored 'General case' 0 C--N 1.361 1.092 0 C-N-CA 129.462 3.105 . . . . 0.0 108.574 175.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.62 -53.96 13.26 Favored 'General case' 0 C--N 1.367 1.367 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -172.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.38 0.93 3.37 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 127.234 2.213 . . . . 0.0 115.788 172.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -113.8 -13.79 12.59 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 130.362 3.465 . . . . 0.0 110.695 175.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.463 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -98.28 160.18 14.46 Favored 'General case' 0 C--N 1.4 2.775 0 N-CA-C 120.157 3.391 . . . . 0.0 120.157 171.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.6 -158.59 27.75 Favored Glycine 0 CA--C 1.469 -2.831 0 C-N-CA 128.585 2.993 . . . . 0.0 106.905 -177.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.416 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.331 1.2 m -105.8 129.39 54.0 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 114.677 -2.809 . . . . 0.0 107.559 168.278 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.507 ' CZ ' ' HD2' ' A' ' 110' ' ' LYS . 12.7 m-85 -96.59 134.92 39.21 Favored 'General case' 0 C--N 1.367 1.328 0 CA-C-N 123.404 2.82 . . . . 0.0 113.159 -171.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.513 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -146.16 152.15 38.78 Favored 'General case' 0 C--N 1.378 1.807 0 C-N-CA 123.9 0.88 . . . . 0.0 110.385 -175.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' A' ' 149' ' ' ASP . 8.5 p -142.95 141.12 27.11 Favored 'Isoleucine or valine' 0 C--N 1.371 1.525 0 C-N-CA 117.474 -1.69 . . . . 0.0 114.928 177.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 61.5 m -103.64 110.98 23.26 Favored 'General case' 0 C--N 1.377 1.799 0 C-N-CA 129.96 3.304 . . . . 0.0 106.206 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -123.78 114.9 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 C-N-CA 127.334 2.254 . . . . 0.0 109.87 -172.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.433 HG23 ' C ' ' A' ' 146' ' ' VAL . 4.7 m -102.16 130.15 48.72 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 120.322 -1.486 . . . . 0.0 113.807 -178.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.401 ' CG ' ' CE2' ' A' ' 104' ' ' TYR 0.481 7.1 p30 -138.39 -165.38 1.8 Allowed 'General case' 0 C--N 1.371 1.531 0 N-CA-C 114.752 1.389 . . . . 0.0 114.752 174.131 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.611 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 91.3 p -48.91 3.69 0.01 OUTLIER 'General case' 0 C--N 1.369 1.45 2 C-N-CA 134.986 5.315 . . . . 0.0 123.135 -163.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -105.65 5.92 31.58 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 107.454 -1.314 . . . . 0.0 107.454 163.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.395 6.9 mm100 64.27 39.98 6.97 Favored 'General case' 0 C--N 1.374 1.655 1 C-N-CA 133.403 4.681 . . . . 0.0 111.261 -171.164 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.433 ' C ' HG23 ' A' ' 141' ' ' THR . 3.1 m -113.88 134.77 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.826 0 CA-C-N 111.774 -2.466 . . . . 0.0 112.318 -170.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.14 123.45 34.61 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 129.13 2.972 . . . . 0.0 106.287 177.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.82 157.84 24.93 Favored 'General case' 0 CA--C 1.492 -1.261 0 C-N-CA 128.781 2.833 . . . . 0.0 105.038 -175.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.458 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 30.3 t70 -125.82 134.23 51.74 Favored 'General case' 0 CA--C 1.495 -1.135 0 CA-C-O 122.284 1.04 . . . . 0.0 109.108 -175.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.508 54.2 p -111.79 146.8 36.99 Favored 'General case' 0 C--O 1.252 1.227 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 172.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.0 m -53.95 147.87 11.57 Favored 'General case' 0 C--N 1.375 1.702 1 C-N-CA 135.261 5.424 . . . . 0.0 120.004 -157.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 41.3 p -69.38 110.89 4.92 Favored 'General case' 0 C--N 1.37 1.468 0 C-N-CA 126.115 1.766 . . . . 0.0 110.192 176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -103.36 109.46 21.1 Favored 'General case' 0 C--N 1.358 0.957 0 N-CA-C 103.98 -2.6 . . . . 0.0 103.98 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -94.54 107.22 19.21 Favored 'General case' 0 C--N 1.346 0.451 0 CA-C-O 123.622 1.677 . . . . 0.0 110.99 -175.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.82 115.09 47.84 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.933 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -178.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.1 m -107.99 132.09 53.87 Favored 'General case' 0 C--N 1.369 1.415 0 CA-C-N 113.039 -1.891 . . . . 0.0 107.53 -174.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.463 HG22 ' CB ' ' A' ' 133' ' ' ALA . 34.8 m -128.8 105.46 13.0 Favored 'Isoleucine or valine' 0 C--N 1.365 1.274 0 CA-C-O 124.276 1.989 . . . . 0.0 113.73 -178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 48.8 m-20 -88.37 157.67 49.95 Favored Pre-proline 0 CA--C 1.556 1.211 0 C-N-CA 125.453 1.501 . . . . 0.0 109.663 175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.06 166.2 30.67 Favored 'Trans proline' 0 CA--C 1.548 1.196 1 C-N-CA 127.296 5.331 . . . . 0.0 107.596 153.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 13.0 p -66.97 125.65 26.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 118.361 -2.712 . . . . 0.0 110.233 -171.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.52 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 56.9 t -67.09 112.3 9.5 Favored Pre-proline 0 CA--C 1.561 1.393 0 N-CA-C 121.068 3.729 . . . . 0.0 121.068 -123.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.52 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 63.7 Cg_endo -62.69 148.3 93.58 Favored 'Trans proline' 0 C--N 1.381 2.275 1 C-N-CA 126.43 4.753 . . . . 0.0 114.942 173.181 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 90.82 -58.18 3.31 Favored Glycine 0 C--N 1.361 1.941 0 C-N-CA 125.497 1.522 . . . . 0.0 114.151 176.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.03 147.4 9.31 Favored Glycine 0 C--N 1.35 1.329 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 66.0 mt -96.76 59.09 1.71 Allowed 'General case' 0 C--N 1.363 1.169 0 O-C-N 120.714 -1.463 . . . . 0.0 111.763 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 42.9 mm-40 -76.88 64.49 2.41 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 126.85 2.06 . . . . 0.0 113.632 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 82.9 t60 . . . . . 0 C--N 1.353 0.721 0 C-N-CA 126.207 1.803 . . . . 0.0 108.742 -177.613 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.018 0 CA-C-O 121.863 0.84 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 17.0 tp -107.35 136.88 46.41 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 126.863 2.065 . . . . 0.0 108.665 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.4 t -94.39 172.61 8.09 Favored 'General case' 0 N--CA 1.433 -1.301 0 O-C-N 120.074 -1.641 . . . . 0.0 111.449 178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.449 HD22 ' HB3' ' A' ' 150' ' ' SER 0.42 0.5 OUTLIER -84.28 98.27 9.89 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-N 114.44 -1.255 . . . . 0.0 109.942 171.631 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 59.02 -72.51 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 117.912 -2.992 . . . . 0.0 115.418 -172.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -133.48 140.55 47.32 Favored 'General case' 0 C--N 1.363 1.157 0 C-N-CA 130.413 3.485 . . . . 0.0 107.07 167.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.284 0.0 OUTLIER -82.99 171.01 14.29 Favored 'General case' 0 CA--C 1.496 -1.119 0 C-N-CA 128.288 2.635 . . . . 0.0 111.201 177.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.49 ' HB3' ' H ' ' A' ' 94' ' ' SER . 0.3 OUTLIER -71.75 -31.81 67.05 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 113.379 -1.737 . . . . 0.0 113.716 172.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.9 m -171.97 172.63 4.67 Favored 'General case' 0 CA--C 1.504 -0.805 0 N-CA-C 100.483 -3.895 . . . . 0.0 100.483 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -122.47 -51.32 1.96 Allowed 'General case' 0 C--N 1.351 0.673 0 CA-C-N 120.561 1.528 . . . . 0.0 111.117 172.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 13.4 t -172.62 145.41 1.55 Allowed 'General case' 0 C--N 1.359 1.009 0 O-C-N 120.35 -1.469 . . . . 0.0 114.728 178.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 20.5 ttt -135.7 128.57 31.23 Favored 'General case' 0 C--N 1.371 1.517 0 O-C-N 121.36 -0.837 . . . . 0.0 109.608 160.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.4 p -104.9 114.49 28.72 Favored 'General case' 0 C--N 1.373 1.611 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 172.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.416 HG22 ' O ' ' A' ' 86' ' ' GLU 0.252 7.4 p -149.87 174.03 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.349 0.568 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.899 -167.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.416 ' O ' HG22 ' A' ' 85' ' ' VAL . 1.3 pp20? -89.31 144.23 26.24 Favored 'General case' 0 C--N 1.364 1.209 0 O-C-N 119.392 -2.067 . . . . 0.0 106.813 163.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.473 3.8 pt-20 -44.39 124.91 4.35 Favored 'General case' 0 N--CA 1.516 2.847 0 O-C-N 118.121 -2.862 . . . . 0.0 117.863 -172.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.542 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 122.05 50.4 0.24 Allowed Glycine 0 C--N 1.345 1.049 0 N-CA-C 105.75 -2.94 . . . . 0.0 105.75 -150.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 128' ' ' ALA . . . -97.04 152.28 18.9 Favored 'General case' 0 C--N 1.367 1.342 0 C-N-CA 127.023 2.129 . . . . 0.0 111.663 -176.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.05 113.79 26.79 Favored 'General case' 0 C--N 1.36 1.061 0 CA-C-O 122.466 1.127 . . . . 0.0 113.632 -169.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.578 HD12 ' SG ' ' A' ' 153' ' ' CYS . 0.3 OUTLIER -121.03 138.1 54.33 Favored 'General case' 0 CA--C 1.494 -1.173 0 C-N-CA 126.343 1.857 . . . . 0.0 115.9 174.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.8 OUTLIER -123.87 137.38 54.66 Favored 'General case' 0 CA--C 1.494 -1.173 1 N-CA-C 99.817 -4.142 . . . . 0.0 99.817 160.682 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 136' ' ' TYR . 4.0 mp -122.29 115.13 21.79 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 101.003 -3.702 . . . . 0.0 101.003 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.49 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 5.7 t -152.49 132.27 13.22 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 -174.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.6 m -149.84 174.43 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.052 1 C-N-CA 132.476 4.31 . . . . 0.0 105.629 176.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 15.3 t -104.15 141.24 36.59 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 119.773 -1.83 . . . . 0.0 107.72 176.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.76 146.01 35.47 Favored 'General case' 0 C--N 1.382 2.008 1 N-CA-C 124.947 5.166 . . . . 0.0 124.947 -173.422 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.9 p -156.95 175.33 14.24 Favored 'General case' 0 C--N 1.369 1.414 1 C-N-CA 133.786 4.834 . . . . 0.0 104.031 177.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.06 42.91 0.79 Allowed Glycine 0 C--N 1.367 2.273 0 O-C-N 119.597 -1.939 . . . . 0.0 117.779 171.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 81.85 25.69 52.05 Favored Glycine 0 C--N 1.361 1.961 0 C-N-CA 128.396 2.903 . . . . 0.0 114.851 178.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.4 p -116.91 110.01 17.78 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-O 116.519 -1.705 . . . . 0.0 108.368 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.66 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 71.8 -90.63 0.49 Allowed Glycine 0 C--N 1.371 2.516 0 C-N-CA 129.408 3.385 . . . . 0.0 110.731 -167.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.89 169.32 4.72 Favored 'Trans proline' 0 CA--C 1.564 1.975 1 C-N-CA 128.054 5.836 . . . . 0.0 117.326 160.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.528 ' HB3' HG12 ' A' ' 140' ' ' VAL . 64.7 m-85 -94.74 143.18 26.66 Favored 'General case' 0 CA--C 1.555 1.14 0 N-CA-C 120.373 3.472 . . . . 0.0 120.373 -167.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.8 t -103.24 142.34 34.35 Favored 'General case' 0 C--N 1.382 1.999 0 C-N-CA 128.772 2.829 . . . . 0.0 104.789 173.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.434 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -141.48 165.99 25.98 Favored 'General case' 0 C--N 1.351 0.654 1 N-CA-C 122.282 4.178 . . . . 0.0 122.282 -160.745 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.86 121.95 12.89 Favored 'General case' 0 C--N 1.359 1.018 0 C-N-CA 128.187 2.595 . . . . 0.0 106.642 176.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.409 ' CZ3' HG11 ' A' ' 138' ' ' VAL . 72.2 m95 -112.01 142.46 44.41 Favored 'General case' 0 C--N 1.357 0.914 0 C-N-CA 125.335 1.454 . . . . 0.0 111.878 -175.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.7 170.77 19.43 Favored 'General case' 0 CA--C 1.49 -1.358 0 CA-C-O 123.186 1.47 . . . . 0.0 107.187 174.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.568 ' HD3' ' CE2' ' A' ' 136' ' ' TYR . 0.1 OUTLIER -147.68 106.12 3.78 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 177.728 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.47 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.235 1.3 t70 34.5 53.07 0.58 Allowed 'General case' 0 C--N 1.377 1.794 2 N-CA-C 123.336 4.569 . . . . 0.0 123.336 140.062 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 81.69 -0.74 87.77 Favored Glycine 0 C--N 1.376 2.78 2 O-C-N 134.128 7.143 . . . . 0.0 119.292 -175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.469 ' HB2' ' HD2' ' A' ' 110' ' ' LYS . 3.6 m -124.8 147.18 55.46 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 129.3 3.04 . . . . 0.0 118.352 -172.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -66.33 138.07 49.61 Favored 'Trans proline' 0 N--CA 1.495 1.577 1 C-N-CA 125.984 4.456 . . . . 0.0 115.036 171.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.418 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -91.36 163.64 27.94 Favored Pre-proline 0 CA--C 1.548 0.894 0 O-C-N 117.816 -3.052 . . . . 0.0 115.57 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.418 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 9.5 Cg_endo -71.22 84.4 0.91 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 124.703 3.602 . . . . 0.0 115.841 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.3 t70 78.01 -62.5 0.36 Allowed 'General case' 0 C--N 1.362 1.137 0 C-N-CA 127.719 2.407 . . . . 0.0 114.762 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 79.64 171.63 0.16 Allowed 'General case' 0 CA--C 1.484 -1.558 0 C-N-CA 130.284 3.434 . . . . 0.0 114.791 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.424 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 75.64 72.38 0.09 Allowed 'General case' 0 C--N 1.358 0.972 0 CA-C-N 114.345 -1.298 . . . . 0.0 114.288 173.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -156.76 -51.93 0.01 OUTLIER Glycine 0 CA--C 1.483 -1.967 0 N-CA-C 118.976 2.35 . . . . 0.0 118.976 -173.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.263 . . 133.4 -73.11 0.0 OUTLIER 'General case' 0 C--N 1.352 0.707 0 C-N-CA 127.055 2.142 . . . . 0.0 107.356 -176.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.272 6.9 t -133.82 111.61 10.65 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-O 123.092 1.425 . . . . 0.0 113.459 -175.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.331 0.6 OUTLIER -127.07 141.65 51.72 Favored 'General case' 0 C--N 1.366 1.284 0 C-N-CA 129.042 2.937 . . . . 0.0 112.394 179.655 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 19.7 m -128.51 139.71 52.18 Favored 'General case' 0 C--N 1.366 1.318 0 O-C-N 120.702 -1.249 . . . . 0.0 109.302 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.7 100.08 51.16 Favored Pre-proline 0 C--N 1.355 0.81 0 C-N-CA 129.822 3.249 . . . . 0.0 105.145 176.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -77.49 -32.4 2.92 Favored 'Trans proline' 0 C--N 1.351 0.696 1 C-N-CA 125.93 4.42 . . . . 0.0 113.407 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.542 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.4 m -138.45 101.29 4.33 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 104.686 -2.338 . . . . 0.0 104.686 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.594 ' HB3' ' HB3' ' A' ' 89' ' ' ALA . . . -95.75 129.6 42.93 Favored 'General case' 0 N--CA 1.437 -1.087 0 C-N-CA 127.522 2.329 . . . . 0.0 109.615 176.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -87.59 175.58 7.85 Favored 'General case' 0 C--N 1.369 1.426 0 C-N-CA 128.169 2.588 . . . . 0.0 108.457 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.18 -51.35 18.63 Favored 'General case' 0 C--N 1.368 1.397 0 N-CA-C 118.5 2.778 . . . . 0.0 118.5 -171.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -63.92 -22.89 67.12 Favored 'General case' 0 C--N 1.363 1.172 0 C-N-CA 126.1 1.76 . . . . 0.0 114.748 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -82.87 -10.28 58.91 Favored 'General case' 0 C--N 1.359 0.998 0 C-N-CA 130.103 3.361 . . . . 0.0 111.909 174.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.583 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -94.35 166.37 12.11 Favored 'General case' 0 C--N 1.383 2.061 0 N-CA-C 116.59 2.071 . . . . 0.0 116.59 167.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 144.86 -156.34 26.86 Favored Glycine 0 CA--C 1.461 -3.289 0 C-N-CA 127.603 2.525 . . . . 0.0 108.867 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.325 1.4 m -113.54 130.45 56.35 Favored 'General case' 0 N--CA 1.495 1.812 0 C-N-CA 114.276 -2.969 . . . . 0.0 107.118 171.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.568 ' CE2' ' HD3' ' A' ' 110' ' ' LYS . 31.0 m-85 -97.16 135.02 39.72 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 126.882 2.073 . . . . 0.0 112.063 -168.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.47 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -148.83 148.79 30.32 Favored 'General case' 0 C--N 1.373 1.595 0 CA-C-O 123.449 1.595 . . . . 0.0 109.12 -174.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.409 HG11 ' CZ3' ' A' ' 108' ' ' TRP 0.291 0.8 OUTLIER -141.46 141.03 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -178.265 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 31.7 m -102.64 122.98 45.5 Favored 'General case' 0 C--N 1.377 1.8 0 C-N-CA 129.138 2.975 . . . . 0.0 107.201 176.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.528 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -134.54 126.72 48.83 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 C-N-CA 125.816 1.646 . . . . 0.0 113.391 -174.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 8.3 m -113.83 132.59 55.83 Favored 'General case' 0 N--CA 1.484 1.254 0 O-C-N 119.365 -2.084 . . . . 0.0 114.296 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.443 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.428 25.6 p30 -126.93 -174.36 3.12 Favored 'General case' 0 C--N 1.377 1.78 0 O-C-N 120.729 -1.232 . . . . 0.0 112.695 176.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.66 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 63.2 p -49.62 3.3 0.01 OUTLIER 'General case' 0 C--N 1.362 1.126 1 C-N-CA 136.302 5.841 . . . . 0.0 121.775 -164.551 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -104.21 4.47 33.95 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 118.215 -1.394 . . . . 0.0 107.798 163.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.405 91.8 mm-40 66.55 40.2 3.53 Favored 'General case' 0 C--N 1.375 1.683 1 C-N-CA 132.504 4.321 . . . . 0.0 110.156 -172.204 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.413 ' C ' HG23 ' A' ' 141' ' ' THR . 3.8 m -112.48 126.67 69.9 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.39 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.591 -170.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.461 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.3 OUTLIER -91.67 134.0 35.09 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 124.613 1.165 . . . . 0.0 109.724 -177.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 158.51 24.52 Favored 'General case' 0 N--CA 1.441 -0.916 0 C-N-CA 130.429 3.492 . . . . 0.0 105.686 177.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -127.21 136.51 52.13 Favored 'General case' 0 C--N 1.351 0.642 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.449 ' HB3' HD22 ' A' ' 75' ' ' LEU 0.252 0.1 OUTLIER -116.38 151.6 35.62 Favored 'General case' 0 CA--C 1.505 -0.778 0 C-N-CA 126.242 1.817 . . . . 0.0 110.772 -175.482 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 9.8 m -53.42 146.5 12.38 Favored 'General case' 0 CA--C 1.489 -1.399 1 C-N-CA 134.209 5.004 . . . . 0.0 119.441 -157.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 33.8 p -70.76 111.59 6.32 Favored 'General case' 0 C--N 1.37 1.467 0 C-N-CA 128.749 2.819 . . . . 0.0 108.867 174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.578 ' SG ' HD12 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -107.19 109.93 21.87 Favored 'General case' 0 C--N 1.351 0.644 0 N-CA-C 102.149 -3.278 . . . . 0.0 102.149 178.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -100.06 111.83 24.12 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-O 123.893 1.806 . . . . 0.0 111.556 -173.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.482 HG11 HD11 ' A' ' 91' ' ' LEU . 0.4 OUTLIER -122.03 123.94 70.15 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 O-C-N 119.375 -2.078 . . . . 0.0 108.882 -178.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.4 m -111.92 127.48 55.86 Favored 'General case' 0 C--N 1.369 1.44 0 CA-C-N 114.159 -1.382 . . . . 0.0 107.299 -175.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.583 HG22 ' CB ' ' A' ' 133' ' ' ALA . 26.9 m -123.93 105.81 16.06 Favored 'Isoleucine or valine' 0 C--N 1.367 1.362 0 CA-C-O 123.586 1.66 . . . . 0.0 113.093 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 24.4 m-20 -83.12 160.17 60.8 Favored Pre-proline 0 CA--C 1.556 1.208 0 O-C-N 120.545 -1.347 . . . . 0.0 109.964 174.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.5 166.07 30.89 Favored 'Trans proline' 0 CA--C 1.547 1.154 1 C-N-CA 126.284 4.656 . . . . 0.0 107.421 153.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 6.3 p -67.36 132.6 47.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 118.377 -2.702 . . . . 0.0 109.267 -174.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.09 115.41 20.9 Favored Pre-proline 0 C--N 1.365 1.253 0 N-CA-C 120.006 3.335 . . . . 0.0 120.006 -126.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -62.34 151.43 82.6 Favored 'Trans proline' 0 C--N 1.383 2.353 1 C-N-CA 126.478 4.786 . . . . 0.0 115.359 176.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.07 55.84 1.06 Allowed Glycine 0 C--N 1.366 2.209 0 C-N-CA 127.423 2.439 . . . . 0.0 118.104 -174.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -106.25 -36.3 2.72 Favored Glycine 0 C--N 1.356 1.676 0 C-N-CA 126.437 1.97 . . . . 0.0 113.115 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 3.3 pp -103.16 -5.39 23.26 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 125.402 1.481 . . . . 0.0 112.876 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 59.72 -60.62 0.06 Allowed 'General case' 0 C--N 1.364 1.235 0 C-N-CA 129.114 2.965 . . . . 0.0 118.758 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . 0.367 1.6 p-80 . . . . . 0 C--N 1.361 1.097 0 C-N-CA 131.69 3.996 . . . . 0.0 118.169 -178.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.124 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.7 tp -101.91 132.21 47.84 Favored 'General case' 0 C--N 1.352 0.7 0 C-N-CA 126.727 2.011 . . . . 0.0 111.114 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.3 t -98.91 172.79 7.2 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 127.875 2.47 . . . . 0.0 108.907 176.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.287 0.6 OUTLIER -77.67 98.89 5.61 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 120.79 -1.194 . . . . 0.0 109.298 176.745 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.9 m 59.81 -83.48 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 O-C-N 119.261 -2.149 . . . . 0.0 114.031 -166.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.8 tptp -133.33 141.1 47.78 Favored 'General case' 0 C--N 1.357 0.897 1 C-N-CA 132.251 4.22 . . . . 0.0 104.01 169.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.335 0.0 OUTLIER -82.68 173.35 11.99 Favored 'General case' 0 C--N 1.352 0.715 1 C-N-CA 132.581 4.353 . . . . 0.0 107.222 178.515 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.406 ' O ' HG22 ' A' ' 92' ' ' THR . 0.3 OUTLIER -69.99 -34.27 73.12 Favored 'General case' 0 CA--C 1.577 1.996 0 O-C-N 119.515 -1.991 . . . . 0.0 113.087 176.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -168.09 172.24 8.92 Favored 'General case' 0 CA--C 1.519 -0.248 1 O-C-N 115.33 -4.606 . . . . 0.0 101.173 171.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -128.61 -48.5 1.27 Allowed 'General case' 0 C--N 1.359 0.986 0 C-N-CA 125.842 1.657 . . . . 0.0 111.132 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 11.4 t -170.71 140.78 1.73 Allowed 'General case' 0 C--N 1.362 1.129 0 O-C-N 119.622 -1.924 . . . . 0.0 115.78 175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.17 117.07 13.2 Favored 'General case' 0 C--N 1.377 1.769 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 161.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.0 m -114.36 116.8 29.5 Favored 'General case' 0 C--N 1.363 1.186 0 O-C-N 118.209 -2.807 . . . . 0.0 108.334 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.0 p -149.46 172.09 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 125.828 1.651 . . . . 0.0 110.37 -170.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -82.45 129.7 34.96 Favored 'General case' 0 C--N 1.373 1.589 0 N-CA-C 105.29 -2.115 . . . . 0.0 105.29 163.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.258 9.1 pt-20 -41.53 123.01 2.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 120.397 3.48 . . . . 0.0 120.397 -152.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.597 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 142.08 52.97 0.04 OUTLIER Glycine 0 C--N 1.359 1.833 0 CA-C-N 109.73 -3.395 . . . . 0.0 110.654 -171.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -81.94 163.96 21.84 Favored 'General case' 0 C--N 1.374 1.631 0 C-N-CA 125.73 1.612 . . . . 0.0 112.928 175.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.67 108.83 18.43 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 124.272 1.029 . . . . 0.0 110.33 -177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 124' ' ' THR . 4.2 mp -119.46 123.09 43.2 Favored 'General case' 0 C--N 1.359 0.98 0 C-N-CA 125.797 1.639 . . . . 0.0 115.247 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -110.57 127.21 55.11 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 102.364 -3.198 . . . . 0.0 102.364 170.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.44 115.65 21.94 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 102.33 -3.211 . . . . 0.0 102.33 172.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.6 t -154.56 134.11 12.73 Favored 'General case' 0 C--N 1.362 1.139 0 O-C-N 119.947 -1.72 . . . . 0.0 112.461 -169.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.5 m -148.89 175.0 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.645 0 C-N-CA 131.637 3.975 . . . . 0.0 105.886 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.2 t -104.01 138.88 39.91 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 128.185 2.594 . . . . 0.0 104.625 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.631 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.35 142.19 33.8 Favored 'General case' 0 C--N 1.373 1.597 0 N-CA-C 121.642 3.942 . . . . 0.0 121.642 -174.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.3 m -158.52 174.19 15.46 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 131.092 3.757 . . . . 0.0 102.05 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -74.27 44.54 1.38 Allowed Glycine 0 C--N 1.367 2.292 0 CA-C-N 121.879 2.127 . . . . 0.0 117.232 174.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.77 28.06 52.07 Favored Glycine 0 C--N 1.358 1.754 0 C-N-CA 128.544 2.973 . . . . 0.0 115.289 176.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.7 m -117.93 110.96 18.36 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 114.372 -2.728 . . . . 0.0 107.114 173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.531 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.85 -87.4 0.86 Allowed Glycine 0 C--N 1.379 2.944 0 C-N-CA 129.729 3.538 . . . . 0.0 110.144 -176.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -60.18 168.12 6.62 Favored 'Trans proline' 0 CA--C 1.568 2.196 1 C-N-CA 126.51 4.806 . . . . 0.0 116.167 159.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 71.5 m-85 -103.2 143.59 32.43 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 119.593 3.182 . . . . 0.0 119.593 -165.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -103.52 146.49 28.46 Favored 'General case' 0 C--N 1.376 1.721 0 C-N-CA 127.255 2.222 . . . . 0.0 105.526 173.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.46 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -144.22 166.46 24.97 Favored 'General case' 0 C--N 1.354 0.778 1 N-CA-C 123.25 4.537 . . . . 0.0 123.25 -160.857 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.07 120.52 15.0 Favored 'General case' 0 C--N 1.361 1.074 0 C-N-CA 128.283 2.633 . . . . 0.0 106.25 172.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 33.5 m95 -112.54 146.65 38.14 Favored 'General case' 0 C--N 1.367 1.355 0 O-C-N 120.853 -1.155 . . . . 0.0 112.145 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.2 169.72 23.87 Favored 'General case' 0 CA--C 1.492 -1.273 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 171.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.472 ' NZ ' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -143.56 105.56 4.37 Favored 'General case' 0 N--CA 1.427 -1.604 0 N-CA-C 106.058 -1.83 . . . . 0.0 106.058 174.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.453 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.17 1.5 t70 34.79 52.79 0.6 Allowed 'General case' 0 C--N 1.376 1.744 1 N-CA-C 122.48 4.252 . . . . 0.0 122.48 140.265 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 89.07 -6.21 83.81 Favored Glycine 0 C--N 1.364 2.116 2 O-C-N 133.085 6.49 . . . . 0.0 119.003 -176.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.269 3.0 m -124.28 147.13 53.95 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 129.268 3.027 . . . . 0.0 117.671 -171.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.78 142.46 76.39 Favored 'Trans proline' 0 N--CA 1.495 1.604 1 C-N-CA 126.245 4.63 . . . . 0.0 114.973 172.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.406 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -99.26 158.9 31.42 Favored Pre-proline 0 CA--C 1.543 0.686 0 O-C-N 118.462 -2.649 . . . . 0.0 112.636 178.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 2.7 Cg_endo -65.04 86.9 0.18 Allowed 'Trans proline' 0 C--N 1.363 1.291 1 C-N-CA 126.336 4.691 . . . . 0.0 115.355 -177.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 73.21 -58.8 0.59 Allowed 'General case' 0 C--N 1.362 1.145 0 C-N-CA 128.268 2.627 . . . . 0.0 115.185 177.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 73.25 176.24 0.26 Allowed 'General case' 0 CA--C 1.483 -1.614 0 C-N-CA 130.824 3.65 . . . . 0.0 115.048 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.429 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.3 OUTLIER 72.15 60.98 0.13 Allowed 'General case' 0 C--N 1.355 0.809 0 CA-C-N 114.308 -1.314 . . . . 0.0 114.324 174.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.98 -82.98 0.07 OUTLIER Glycine 0 C--N 1.355 1.59 0 N-CA-C 116.316 1.287 . . . . 0.0 116.316 -170.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.631 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 165.8 -62.61 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.57 0 C-N-CA 126.509 1.924 . . . . 0.0 106.539 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.4 t -137.79 111.31 8.07 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 120.451 -1.406 . . . . 0.0 112.316 -177.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.314 31.8 p90 -127.33 140.75 51.98 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 126.111 1.764 . . . . 0.0 111.925 175.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 91' ' ' LEU . 25.6 m -128.65 139.91 52.02 Favored 'General case' 0 C--N 1.361 1.076 0 O-C-N 120.014 -1.679 . . . . 0.0 109.017 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.29 98.43 48.6 Favored Pre-proline 0 C--N 1.363 1.181 0 C-N-CA 129.075 2.95 . . . . 0.0 105.289 178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -77.39 -15.32 15.87 Favored 'Trans proline' 0 C--N 1.353 0.765 1 C-N-CA 126.413 4.742 . . . . 0.0 113.736 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.597 HG23 ' HA2' ' A' ' 88' ' ' GLY . 53.6 m -159.01 104.9 1.73 Allowed 'General case' 0 N--CA 1.433 -1.307 0 N-CA-C 101.813 -3.403 . . . . 0.0 101.813 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.527 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.86 134.45 33.94 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 127.326 2.25 . . . . 0.0 111.287 177.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -91.72 175.61 6.83 Favored 'General case' 0 C--N 1.365 1.276 0 C-N-CA 127.997 2.519 . . . . 0.0 110.789 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.1 -48.05 33.91 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 119.611 3.189 . . . . 0.0 119.611 -173.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.16 -9.15 51.5 Favored 'General case' 0 C--N 1.367 1.358 0 C-N-CA 126.722 2.009 . . . . 0.0 114.603 173.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.527 ' CB ' ' HB1' ' A' ' 128' ' ' ALA 0.333 2.9 m-20 -78.32 -19.86 52.65 Favored 'General case' 0 CA--C 1.572 1.816 0 C-N-CA 129.344 3.058 . . . . 0.0 111.532 168.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -67.88 122.71 18.74 Favored 'General case' 0 C--N 1.384 2.084 0 N-CA-C 120.546 3.536 . . . . 0.0 120.546 171.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 164.98 -155.96 27.67 Favored Glycine 0 CA--C 1.472 -2.65 0 C-N-CA 127.044 2.259 . . . . 0.0 109.254 173.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.409 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 19.4 m -119.33 131.82 55.78 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 115.64 -2.424 . . . . 0.0 108.441 171.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.472 ' HA ' ' HA ' ' A' ' 110' ' ' LYS 0.296 26.5 m-85 -95.39 134.23 38.44 Favored 'General case' 0 C--N 1.369 1.44 0 C-N-CA 129.799 3.239 . . . . 0.0 111.467 -172.209 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -143.3 145.09 32.42 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 124.67 1.188 . . . . 0.0 107.924 -173.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 11.3 p -135.75 143.6 35.98 Favored 'Isoleucine or valine' 0 C--N 1.359 1.02 0 C-N-CA 118.817 -1.153 . . . . 0.0 113.006 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.8 m -109.71 124.1 50.64 Favored 'General case' 0 C--N 1.371 1.506 0 C-N-CA 128.914 2.885 . . . . 0.0 105.392 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.46 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.0 OUTLIER -134.69 131.74 53.92 Favored 'Isoleucine or valine' 0 C--N 1.355 0.841 0 C-N-CA 127.701 2.4 . . . . 0.0 111.632 -176.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 7.5 m -119.63 134.17 55.34 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 126.479 1.912 . . . . 0.0 113.813 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.492 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.389 9.1 p-10 -125.51 -174.17 3.0 Favored 'General case' 0 C--N 1.383 2.044 0 CA-C-N 120.831 1.65 . . . . 0.0 113.176 175.722 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.531 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 3.6 p -49.24 -2.09 0.01 OUTLIER 'General case' 0 C--N 1.376 1.758 1 C-N-CA 136.801 6.04 . . . . 0.0 120.015 -165.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -101.44 4.82 41.68 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 117.755 -1.578 . . . . 0.0 108.751 165.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.409 72.5 mm-40 66.42 40.05 3.72 Favored 'General case' 0 C--N 1.376 1.744 1 C-N-CA 133.346 4.658 . . . . 0.0 110.146 -172.911 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.411 ' C ' HG23 ' A' ' 141' ' ' THR . 2.8 m -112.87 129.01 69.27 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.528 0 CA-C-N 111.365 -2.652 . . . . 0.0 111.362 -170.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.463 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.5 OUTLIER -92.04 140.38 29.71 Favored 'General case' 0 C--N 1.355 0.839 0 C-N-CA 124.48 1.112 . . . . 0.0 111.113 -179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? -117.78 156.56 28.11 Favored 'General case' 0 C--N 1.346 0.452 1 C-N-CA 132.193 4.197 . . . . 0.0 104.063 174.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -129.54 141.33 51.0 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 173.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.425 50.4 p -120.03 146.91 45.44 Favored 'General case' 0 C--O 1.251 1.17 0 CA-C-N 120.081 1.31 . . . . 0.0 109.05 178.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.9 m -54.07 148.43 10.94 Favored 'General case' 0 CA--C 1.484 -1.574 1 C-N-CA 137.304 6.242 . . . . 0.0 118.442 -160.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.4 p -68.45 109.85 3.88 Favored 'General case' 0 C--N 1.365 1.263 0 C-N-CA 125.553 1.541 . . . . 0.0 111.106 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.16 109.93 21.96 Favored 'General case' 0 C--N 1.366 1.298 0 N-CA-C 102.267 -3.234 . . . . 0.0 102.267 179.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.68 112.92 25.1 Favored 'General case' 0 C--N 1.352 0.68 0 CA-C-O 123.679 1.704 . . . . 0.0 111.82 -172.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.3 m -119.92 128.65 75.94 Favored 'Isoleucine or valine' 0 CA--C 1.485 -1.546 0 O-C-N 120.279 -1.513 . . . . 0.0 109.798 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 87.9 m -111.25 121.45 45.3 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 101.847 -3.39 . . . . 0.0 101.847 174.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.43 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 4.9 m -135.39 103.18 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 104.913 -2.255 . . . . 0.0 104.913 172.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -107.21 152.69 41.24 Favored Pre-proline 0 C--N 1.351 0.657 0 C-N-CA 125.547 1.539 . . . . 0.0 109.033 177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -66.09 166.09 22.05 Favored 'Trans proline' 0 C--N 1.366 1.477 1 C-N-CA 127.045 5.163 . . . . 0.0 110.176 160.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 7.2 p -67.56 132.82 48.31 Favored 'General case' 0 C--N 1.372 1.568 0 O-C-N 119.264 -2.148 . . . . 0.0 108.898 -176.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.11 114.71 19.67 Favored Pre-proline 0 CA--C 1.556 1.211 1 N-CA-C 121.99 4.07 . . . . 0.0 121.99 -123.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -62.69 154.87 62.58 Favored 'Trans proline' 0 C--N 1.388 2.614 1 C-N-CA 126.47 4.78 . . . . 0.0 114.248 171.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -60.51 45.94 0.04 OUTLIER Glycine 0 C--N 1.367 2.289 0 C-N-CA 128.688 3.042 . . . . 0.0 120.484 -174.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -95.72 -13.96 48.52 Favored Glycine 0 C--N 1.358 1.799 0 C-N-CA 127.481 2.467 . . . . 0.0 111.701 177.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 45.4 mt -89.56 -27.23 20.39 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.963 1.705 . . . . 0.0 111.717 178.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 68.56 -50.63 0.57 Allowed 'General case' 0 C--N 1.365 1.25 0 C-N-CA 128.543 2.737 . . . . 0.0 116.801 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 . . . . . 0 C--N 1.357 0.908 0 C-N-CA 128.433 2.693 . . . . 0.0 111.519 179.54 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.97 0 CA-C-O 121.862 0.839 . . . . 0.0 109.192 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.8 tt -107.24 120.92 43.45 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 126.553 1.941 . . . . 0.0 108.326 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 13.1 t -94.76 172.39 8.19 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 127.278 2.231 . . . . 0.0 110.397 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.262 1.3 pp -80.68 98.93 7.93 Favored 'General case' 0 C--N 1.366 1.296 0 O-C-N 119.75 -1.844 . . . . 0.0 109.058 174.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.7 m 59.09 -79.28 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 118.119 -2.863 . . . . 0.0 114.784 -167.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 7.0 tptm -133.82 140.48 46.92 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 131.078 3.751 . . . . 0.0 106.848 167.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.304 0.0 OUTLIER -83.67 172.2 12.51 Favored 'General case' 0 C--N 1.344 0.333 1 C-N-CA 132.121 4.168 . . . . 0.0 110.53 175.178 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.413 ' O ' HG22 ' A' ' 92' ' ' THR . 0.2 OUTLIER -69.77 -34.56 73.95 Favored 'General case' 0 CA--C 1.583 2.243 0 O-C-N 120.558 -1.339 . . . . 0.0 112.043 168.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 81' ' ' ALA . 21.7 m -169.54 171.63 7.49 Favored 'General case' 0 N--CA 1.464 0.264 1 O-C-N 115.876 -4.265 . . . . 0.0 102.062 172.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.407 ' N ' HG22 ' A' ' 80' ' ' THR . . . -125.8 -45.79 1.74 Allowed 'General case' 0 C--N 1.365 1.255 0 C-N-CA 126.51 1.924 . . . . 0.0 114.157 176.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 18.0 t -174.27 141.19 0.71 Allowed 'General case' 0 C--N 1.364 1.223 0 O-C-N 119.885 -1.759 . . . . 0.0 115.068 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 16.3 ttt -126.38 136.89 53.26 Favored 'General case' 0 C--N 1.38 1.9 0 CA-C-N 118.352 0.524 . . . . 0.0 109.927 157.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.4 m -114.59 113.37 24.29 Favored 'General case' 0 C--N 1.377 1.764 0 O-C-N 119.84 -1.788 . . . . 0.0 108.015 170.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.295 11.5 p -151.56 174.04 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.753 0 CA-C-O 123.569 1.652 . . . . 0.0 114.076 -170.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -83.19 144.5 29.76 Favored 'General case' 0 CA--C 1.562 1.441 0 C-N-CA 127.202 2.201 . . . . 0.0 105.573 158.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.421 4.5 pt-20 -44.01 124.37 3.8 Favored 'General case' 0 N--CA 1.501 2.125 0 O-C-N 117.202 -3.436 . . . . 0.0 118.071 -171.678 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.456 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 122.62 52.63 0.21 Allowed Glycine 0 C--N 1.358 1.787 0 C-N-CA 127.662 2.554 . . . . 0.0 109.887 -154.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.91 161.68 15.1 Favored 'General case' 0 C--N 1.376 1.731 0 C-N-CA 124.95 1.3 . . . . 0.0 110.908 175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.74 97.43 6.7 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 -175.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.787 HD21 ' CZ ' ' A' ' 136' ' ' TYR 0.298 53.7 tp -120.8 114.93 22.34 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 117.214 2.302 . . . . 0.0 117.214 -169.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -112.01 131.77 55.21 Favored 'General case' 0 C--N 1.373 1.591 0 N-CA-C 106.603 -1.629 . . . . 0.0 106.603 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.412 HD21 ' HG ' ' A' ' 91' ' ' LEU . 1.1 mm? -129.37 115.86 18.18 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 175.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.4 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 6.9 t -151.11 134.04 15.84 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 119.419 -2.051 . . . . 0.0 112.273 -173.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.75 173.79 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.851 0 C-N-CA 129.594 3.158 . . . . 0.0 104.786 177.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 10.1 t -104.01 141.06 36.85 Favored 'General case' 0 C--N 1.369 1.445 0 O-C-N 119.293 -2.129 . . . . 0.0 105.349 175.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -139.24 145.25 38.99 Favored 'General case' 0 C--N 1.365 1.262 0 N-CA-C 119.55 3.167 . . . . 0.0 119.55 -173.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 36.3 m -158.41 174.26 15.39 Favored 'General case' 0 C--N 1.351 0.674 0 C-N-CA 130.741 3.616 . . . . 0.0 101.561 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.15 43.2 1.46 Allowed Glycine 0 C--N 1.364 2.128 0 CA-C-N 121.879 2.127 . . . . 0.0 117.696 176.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.44 22.13 52.04 Favored Glycine 0 C--N 1.359 1.82 0 C-N-CA 127.785 2.612 . . . . 0.0 116.342 175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 76.1 m -116.95 111.44 19.61 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 114.018 -2.896 . . . . 0.0 107.944 176.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.507 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.93 -92.5 0.93 Allowed Glycine 0 C--N 1.38 3.004 0 CA-C-N 124.628 3.376 . . . . 0.0 110.118 -175.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -60.5 167.54 7.95 Favored 'Trans proline' 0 CA--C 1.564 1.998 1 C-N-CA 126.82 5.013 . . . . 0.0 116.19 159.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.572 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.1 m-85 -98.47 143.28 29.08 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 120.613 3.56 . . . . 0.0 120.613 -165.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.4 t -102.96 141.12 36.31 Favored 'General case' 0 C--N 1.381 1.945 0 N-CA-C 105.156 -2.164 . . . . 0.0 105.156 174.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.528 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -134.72 156.03 49.51 Favored 'General case' 0 C--N 1.347 0.494 1 N-CA-C 122.517 4.265 . . . . 0.0 122.517 -162.107 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -135.06 112.79 10.84 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 111.124 -2.762 . . . . 0.0 104.768 171.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.48 ' CE3' ' HB ' ' A' ' 138' ' ' VAL . 35.2 m95 -111.96 148.0 34.69 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.327 0.2 OUTLIER -159.36 169.93 22.92 Favored 'General case' 0 CA--C 1.485 -1.54 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 166.019 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.454 ' HE3' ' CE2' ' A' ' 136' ' ' TYR 0.337 33.6 mtpt -123.19 127.31 48.46 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 115.431 -2.223 . . . . 0.0 107.089 173.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.437 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.308 0.7 OUTLIER 32.35 51.04 0.21 Allowed 'General case' 0 C--N 1.373 1.61 2 N-CA-C 123.763 4.727 . . . . 0.0 123.763 123.185 . . . . . . . . 5 4 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 71.88 1.92 49.47 Favored Glycine 0 C--N 1.377 2.821 2 O-C-N 133.907 7.004 . . . . 0.0 120.592 -169.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.574 0.6 OUTLIER -125.73 147.83 59.94 Favored Pre-proline 0 CA--C 1.563 1.466 1 N-CA-C 123.023 4.453 . . . . 0.0 123.023 -168.346 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.26 149.32 88.68 Favored 'Trans proline' 0 N--CA 1.499 1.842 1 C-N-CA 126.088 4.526 . . . . 0.0 116.245 173.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.436 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -110.28 153.69 43.24 Favored Pre-proline 0 CA--C 1.549 0.911 0 O-C-N 119.567 -1.958 . . . . 0.0 111.545 178.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.413 ' HG2' ' CD2' ' A' ' 123' ' ' TYR . 13.3 Cg_endo -68.09 90.13 0.38 Allowed 'Trans proline' 0 CA--C 1.546 1.098 1 C-N-CA 125.969 4.446 . . . . 0.0 114.992 -179.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.5 t70 76.41 -52.63 0.6 Allowed 'General case' 0 C--N 1.364 1.221 0 C-N-CA 127.883 2.473 . . . . 0.0 114.474 176.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.424 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . 85.19 -62.89 0.06 Allowed 'General case' 0 CA--C 1.495 -1.16 0 C-N-CA 130.139 3.376 . . . . 0.0 116.282 173.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.6 t -58.04 55.81 0.0 OUTLIER 'General case' 0 N--CA 1.437 -1.078 1 C-N-CA 134.045 4.938 . . . . 0.0 118.13 -173.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -144.52 -78.1 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.89 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 -173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 160.93 -58.93 0.0 OUTLIER 'General case' 0 C--N 1.352 0.713 0 C-N-CA 125.172 1.389 . . . . 0.0 109.329 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.9 t -135.55 112.36 10.17 Favored 'General case' 0 C--N 1.355 0.834 0 CA-C-O 122.537 1.161 . . . . 0.0 111.169 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . 0.413 ' CD2' ' HG2' ' A' ' 116' ' ' PRO . 35.0 p90 -127.04 139.76 52.78 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 124.627 1.171 . . . . 0.0 110.338 175.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 32.6 m -129.99 140.39 50.9 Favored 'General case' 0 C--N 1.357 0.907 0 O-C-N 120.647 -1.283 . . . . 0.0 110.57 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.425 ' CB ' HD23 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -112.27 99.6 47.03 Favored Pre-proline 0 C--N 1.356 0.878 0 C-N-CA 130.213 3.405 . . . . 0.0 105.684 177.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -77.43 -13.28 16.75 Favored 'Trans proline' 0 CA--C 1.536 0.606 1 C-N-CA 126.04 4.493 . . . . 0.0 112.891 174.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.456 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -162.1 100.94 1.11 Allowed 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.21 133.5 35.33 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 127.826 2.451 . . . . 0.0 111.772 176.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.47 173.29 8.42 Favored 'General case' 0 C--N 1.369 1.437 0 C-N-CA 130.141 3.376 . . . . 0.0 111.265 177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.42 -45.6 25.65 Favored 'General case' 0 C--N 1.367 1.349 0 N-CA-C 118.543 2.794 . . . . 0.0 118.543 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.85 -17.86 65.1 Favored 'General case' 0 C--N 1.367 1.326 0 C-N-CA 126.229 1.812 . . . . 0.0 115.316 174.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.271 37.8 m-20 -84.09 -16.41 43.82 Favored 'General case' 0 C--N 1.362 1.144 1 C-N-CA 132.209 4.204 . . . . 0.0 110.72 171.996 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.28 156.05 35.43 Favored 'General case' 0 C--N 1.392 2.44 0 N-CA-C 115.613 1.709 . . . . 0.0 115.613 163.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 138.64 -157.36 24.61 Favored Glycine 0 CA--C 1.452 -3.865 0 C-N-CA 127.735 2.588 . . . . 0.0 106.862 175.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.434 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.251 3.3 m -119.73 135.73 54.72 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 114.657 -2.817 . . . . 0.0 107.27 167.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.787 ' CZ ' HD21 ' A' ' 91' ' ' LEU . 28.8 m-85 -96.99 134.74 39.96 Favored 'General case' 0 C--N 1.373 1.589 0 C-N-CA 128.434 2.694 . . . . 0.0 111.689 -172.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -146.39 154.57 41.78 Favored 'General case' 0 C--N 1.371 1.541 0 C-N-CA 124.729 1.211 . . . . 0.0 110.419 -176.611 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.48 ' HB ' ' CE3' ' A' ' 108' ' ' TRP . 14.8 p -142.91 139.95 27.54 Favored 'Isoleucine or valine' 0 C--N 1.368 1.38 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 55.3 m -107.67 110.81 22.77 Favored 'General case' 0 C--N 1.375 1.71 0 C-N-CA 131.334 3.854 . . . . 0.0 106.388 174.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.572 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -127.38 116.8 45.11 Favored 'Isoleucine or valine' 0 C--N 1.354 0.763 0 C-N-CA 125.892 1.677 . . . . 0.0 111.918 -172.519 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.5 m -102.34 131.12 49.15 Favored 'General case' 0 C--N 1.358 0.959 0 N-CA-C 114.978 1.473 . . . . 0.0 114.978 -178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.437 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.35 36.4 p-10 -125.65 179.31 5.22 Favored 'General case' 0 C--N 1.376 1.718 0 CA-C-N 120.408 1.458 . . . . 0.0 111.519 174.137 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.507 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 22.0 p -49.34 3.49 0.01 OUTLIER 'General case' 0 C--N 1.371 1.503 1 C-N-CA 136.57 5.948 . . . . 0.0 120.413 -169.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 62.7 mttm -103.51 4.83 36.33 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 166.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.524 2.0 mp0 64.51 40.03 6.43 Favored 'General case' 0 C--N 1.376 1.726 1 C-N-CA 133.518 4.727 . . . . 0.0 112.528 -173.842 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 4.0 m -112.68 123.48 68.41 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.651 0 CA-C-N 111.127 -2.761 . . . . 0.0 111.951 -171.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.04 123.28 34.39 Favored 'General case' 0 N--CA 1.437 -1.107 0 C-N-CA 128.555 2.742 . . . . 0.0 105.303 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.55 158.36 23.79 Favored 'General case' 0 N--CA 1.436 -1.172 0 C-N-CA 129.14 2.976 . . . . 0.0 103.218 -174.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.474 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 9.0 t70 -129.56 141.27 51.01 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-O 122.214 1.007 . . . . 0.0 109.872 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.548 22.4 p -114.79 139.66 49.54 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 170.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.0 m -55.0 147.84 14.81 Favored 'General case' 0 C--N 1.366 1.321 1 C-N-CA 138.044 6.538 . . . . 0.0 117.898 -163.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 42.8 p -68.67 110.53 4.32 Favored 'General case' 0 C--N 1.375 1.701 0 C-N-CA 125.732 1.613 . . . . 0.0 110.33 -175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.414 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 0.5 OUTLIER -101.2 110.35 22.36 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 103.985 -2.598 . . . . 0.0 103.985 -178.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.55 115.22 27.12 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-O 123.954 1.835 . . . . 0.0 113.171 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -116.85 128.25 74.28 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.197 0 O-C-N 119.65 -1.906 . . . . 0.0 107.602 177.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.9 m -114.36 122.74 47.59 Favored 'General case' 0 CA--C 1.493 -1.24 0 N-CA-C 101.226 -3.62 . . . . 0.0 101.226 178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 3.0 m -133.29 104.69 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 106.205 -1.776 . . . . 0.0 106.205 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 -90.29 158.79 43.13 Favored Pre-proline 0 C--N 1.356 0.89 0 C-N-CA 126.522 1.929 . . . . 0.0 109.651 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -68.86 165.19 30.69 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 124.862 3.708 . . . . 0.0 108.043 154.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -67.91 134.69 51.26 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 118.61 -2.556 . . . . 0.0 109.272 -172.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.423 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 95.6 t -65.36 107.96 1.79 Allowed Pre-proline 0 C--N 1.361 1.068 0 N-CA-C 120.698 3.592 . . . . 0.0 120.698 -125.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 48.5 Cg_endo -63.48 122.78 11.04 Favored 'Trans proline' 0 C--N 1.382 2.3 1 C-N-CA 125.371 4.047 . . . . 0.0 112.778 166.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 71.79 -72.11 0.87 Allowed Glycine 0 C--N 1.365 2.153 0 C-N-CA 127.407 2.432 . . . . 0.0 116.214 176.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -174.78 158.39 26.34 Favored Glycine 0 CA--C 1.49 -1.479 1 N-CA-C 102.277 -4.329 . . . . 0.0 102.277 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.561 ' H ' HD23 ' A' ' 165' ' ' LEU . 0.9 OUTLIER -96.15 -5.66 40.12 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 125.737 1.615 . . . . 0.0 114.099 -175.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 50.5 mm-40 71.55 -50.01 0.69 Allowed 'General case' 0 C--N 1.364 1.214 0 C-N-CA 129.634 3.174 . . . . 0.0 114.252 -178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 . . . . . 0 C--N 1.351 0.645 0 C-N-CA 131.56 3.944 . . . . 0.0 113.131 179.731 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.182 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 54.1 tp -102.6 119.71 39.29 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 125.318 1.447 . . . . 0.0 108.406 177.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.5 t -95.58 172.76 7.86 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 129.105 2.962 . . . . 0.0 109.927 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.9 98.63 5.7 Favored 'General case' 0 C--N 1.367 1.36 0 O-C-N 119.364 -2.085 . . . . 0.0 110.986 173.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.18 -79.11 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 118.842 -2.411 . . . . 0.0 113.823 -168.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 18.7 tptp -133.6 140.45 47.14 Favored 'General case' 0 C--N 1.361 1.102 0 C-N-CA 129.838 3.255 . . . . 0.0 105.077 164.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.354 3.2 t0 -83.5 174.14 10.86 Favored 'General case' 0 C--N 1.341 0.236 1 C-N-CA 133.396 4.678 . . . . 0.0 109.998 177.479 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.431 ' O ' HG22 ' A' ' 92' ' ' THR . 0.5 OUTLIER -70.22 -34.66 73.16 Favored 'General case' 0 CA--C 1.586 2.329 0 O-C-N 120.854 -1.154 . . . . 0.0 112.558 170.102 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 m -169.79 171.97 7.0 Favored 'General case' 0 N--CA 1.467 0.412 1 O-C-N 114.69 -5.006 . . . . 0.0 101.598 173.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.13 -45.9 1.24 Allowed 'General case' 0 C--N 1.354 0.802 0 C-N-CA 125.092 1.357 . . . . 0.0 111.159 176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 73.9 p -171.03 125.2 0.65 Allowed 'General case' 0 C--N 1.361 1.103 0 N-CA-C 118.094 2.627 . . . . 0.0 118.094 -177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.0 ttt -130.6 118.0 20.37 Favored 'General case' 0 C--N 1.376 1.726 0 CA-C-N 120.605 1.548 . . . . 0.0 109.346 160.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -110.61 115.14 29.08 Favored 'General case' 0 C--N 1.368 1.407 0 O-C-N 119.823 -1.798 . . . . 0.0 108.181 176.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.8 p -150.03 173.71 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.359 0.998 0 C-N-CA 126.848 2.059 . . . . 0.0 112.977 -169.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -73.46 144.59 46.21 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 128.042 2.537 . . . . 0.0 107.1 159.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.434 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.536 0.7 OUTLIER -44.13 123.28 3.3 Favored 'General case' 0 N--CA 1.518 2.965 0 CA-C-N 124.628 3.376 . . . . 0.0 118.248 -171.282 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.431 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 126.96 43.17 0.26 Allowed Glycine 0 C--N 1.358 1.755 0 CA-C-N 111.45 -2.614 . . . . 0.0 112.09 -157.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.44 164.93 20.64 Favored 'General case' 0 C--N 1.378 1.834 0 CA-C-N 119.707 1.753 . . . . 0.0 112.156 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.07 114.93 28.85 Favored 'General case' 0 C--N 1.352 0.685 0 C-N-CA 125.994 1.718 . . . . 0.0 108.556 -178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.453 ' O ' HG23 ' A' ' 124' ' ' THR . 7.0 mp -120.5 114.49 21.85 Favored 'General case' 0 C--N 1.356 0.848 0 C-N-CA 127.668 2.387 . . . . 0.0 114.693 -176.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -109.61 124.49 51.24 Favored 'General case' 0 C--N 1.364 1.235 0 N-CA-C 102.467 -3.16 . . . . 0.0 102.467 170.503 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -124.69 114.77 19.76 Favored 'General case' 0 C--N 1.36 1.04 0 N-CA-C 103.869 -2.641 . . . . 0.0 103.869 172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.4 t -153.62 134.09 13.56 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 120.021 -1.675 . . . . 0.0 112.182 -172.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 1.9 m -149.12 174.4 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.736 0 C-N-CA 130.513 3.525 . . . . 0.0 104.591 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -103.67 140.74 37.17 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 104.883 -2.265 . . . . 0.0 104.883 178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.599 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.16 142.39 34.04 Favored 'General case' 0 C--N 1.369 1.427 0 N-CA-C 120.588 3.551 . . . . 0.0 120.588 -173.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 87.3 m -158.47 174.54 14.94 Favored 'General case' 0 C--N 1.353 0.759 0 C-N-CA 130.337 3.455 . . . . 0.0 102.023 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -76.26 44.35 1.89 Allowed Glycine 0 C--N 1.366 2.2 0 CA-C-N 122.122 2.237 . . . . 0.0 117.639 175.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.67 20.16 62.27 Favored Glycine 0 C--N 1.358 1.806 0 C-N-CA 127.78 2.609 . . . . 0.0 114.776 178.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.409 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 45.2 p -116.75 110.81 18.91 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 113.948 -2.929 . . . . 0.0 108.285 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.595 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 73.03 -92.47 0.64 Allowed Glycine 0 C--N 1.376 2.762 0 C-N-CA 129.876 3.607 . . . . 0.0 111.065 -170.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -61.86 168.75 8.26 Favored 'Trans proline' 0 CA--C 1.566 2.113 1 C-N-CA 127.128 5.219 . . . . 0.0 117.207 160.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.592 ' HB3' HG12 ' A' ' 140' ' ' VAL . 75.8 m-85 -93.72 141.36 28.58 Favored 'General case' 0 CA--C 1.558 1.259 0 N-CA-C 121.186 3.772 . . . . 0.0 121.186 -167.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.0 t -103.24 147.0 27.58 Favored 'General case' 0 C--N 1.379 1.868 0 C-N-CA 128.19 2.596 . . . . 0.0 105.093 173.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.519 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -144.05 166.21 25.63 Favored 'General case' 0 C--N 1.346 0.413 0 N-CA-C 121.579 3.918 . . . . 0.0 121.579 -160.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -142.07 113.7 7.86 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 111.715 -2.493 . . . . 0.0 106.263 172.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -112.07 153.84 26.29 Favored 'General case' 0 C--N 1.376 1.722 0 O-C-N 120.149 -1.594 . . . . 0.0 107.87 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.345 0.0 OUTLIER -156.04 152.97 28.73 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 163.236 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.859 ' HZ1' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -128.27 103.86 7.41 Favored 'General case' 0 C--N 1.369 1.451 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 177.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.456 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.186 4.0 t70 37.54 54.98 1.46 Allowed 'General case' 0 CA--C 1.453 -2.76 1 CA-C-O 110.881 -4.39 . . . . 0.0 119.601 153.505 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 103.51 -17.0 51.62 Favored Glycine 0 C--N 1.372 2.559 2 O-C-N 134.729 7.518 . . . . 0.0 116.408 -175.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.421 ' HB3' ' HE2' ' A' ' 110' ' ' LYS 0.282 48.5 m -124.12 149.48 60.56 Favored Pre-proline 0 CA--C 1.56 1.358 0 C-N-CA 130.754 3.622 . . . . 0.0 119.304 -165.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -60.12 154.46 51.44 Favored 'Trans proline' 0 N--CA 1.507 2.315 1 C-N-CA 126.937 5.091 . . . . 0.0 116.378 171.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.576 ' HB ' ' HD2' ' A' ' 116' ' ' PRO 0.274 0.8 OUTLIER -95.12 164.59 18.9 Favored Pre-proline 0 N--CA 1.484 1.23 0 O-C-N 117.967 -2.958 . . . . 0.0 111.917 174.309 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.576 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 1.9 Cg_endo -67.98 92.24 0.38 Allowed 'Trans proline' 0 C--N 1.368 1.584 1 C-N-CA 126.491 4.794 . . . . 0.0 112.585 177.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 78.7 -65.89 0.21 Allowed 'General case' 0 C--N 1.351 0.671 0 C-N-CA 128.448 2.699 . . . . 0.0 111.721 -178.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 88.21 148.72 0.05 OUTLIER 'General case' 0 CA--C 1.466 -2.276 0 C-N-CA 128.029 2.532 . . . . 0.0 112.196 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.458 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 18.5 m 74.13 62.62 0.08 Allowed 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 113.177 -1.828 . . . . 0.0 115.17 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -137.01 -77.96 0.08 OUTLIER Glycine 0 CA--C 1.477 -2.322 0 N-CA-C 115.214 0.846 . . . . 0.0 115.214 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.599 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 160.53 -58.27 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.641 0 C-N-CA 124.639 1.176 . . . . 0.0 109.187 -177.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.4 t -141.68 112.85 7.46 Favored 'General case' 0 C--N 1.356 0.862 0 CA-C-O 123.367 1.556 . . . . 0.0 113.311 -174.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.257 0.0 OUTLIER -127.47 139.72 52.62 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 124.856 1.262 . . . . 0.0 108.931 172.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 91' ' ' LEU . 65.4 m -129.73 138.62 51.22 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 173.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.35 114.11 48.17 Favored Pre-proline 0 C--N 1.363 1.182 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 173.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.32 -14.07 16.57 Favored 'Trans proline' 0 C--N 1.354 0.852 1 C-N-CA 126.273 4.649 . . . . 0.0 112.83 174.739 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.431 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -161.83 106.41 1.25 Allowed 'General case' 0 N--CA 1.43 -1.475 0 N-CA-C 104.482 -2.414 . . . . 0.0 104.482 -179.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.536 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.47 134.97 33.7 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.074 2.55 . . . . 0.0 113.823 177.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -89.16 176.64 6.89 Favored 'General case' 0 C--N 1.371 1.536 0 C-N-CA 127.878 2.471 . . . . 0.0 110.568 174.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.04 -48.97 32.8 Favored 'General case' 0 C--N 1.368 1.413 0 N-CA-C 118.432 2.753 . . . . 0.0 118.432 -173.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -64.31 -17.35 63.57 Favored 'General case' 0 C--N 1.366 1.283 0 C-N-CA 127.104 2.162 . . . . 0.0 114.685 173.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.859 ' HA ' ' HZ1' ' A' ' 110' ' ' LYS 0.35 32.7 m-20 -83.67 -19.13 35.9 Favored 'General case' 0 CA--C 1.559 1.312 0 C-N-CA 130.894 3.678 . . . . 0.0 112.287 172.241 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -64.61 131.98 48.5 Favored 'General case' 0 CA--C 1.576 1.951 0 N-CA-C 118.723 2.86 . . . . 0.0 118.723 163.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 159.3 -158.82 29.89 Favored Glycine 0 CA--C 1.456 -3.616 0 C-N-CA 126.914 2.197 . . . . 0.0 107.737 167.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.333 22.8 m -116.88 136.02 53.27 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 114.964 -2.694 . . . . 0.0 108.316 170.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.529 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 22.9 m-85 -96.77 133.67 41.05 Favored 'General case' 0 CA--C 1.491 -1.292 0 O-C-N 119.24 -2.163 . . . . 0.0 114.143 -171.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.456 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -139.4 141.94 37.52 Favored 'General case' 0 C--N 1.37 1.487 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 -173.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 8.3 p -141.3 141.7 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.196 0 C-N-CA 117.614 -1.635 . . . . 0.0 114.704 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 18.1 m -107.64 118.9 37.93 Favored 'General case' 0 C--N 1.378 1.844 0 C-N-CA 128.488 2.715 . . . . 0.0 107.187 175.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.592 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -131.33 118.98 42.25 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 126.058 1.743 . . . . 0.0 111.697 -172.67 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.448 HG23 ' C ' ' A' ' 146' ' ' VAL . 6.6 m -108.24 129.36 55.21 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 -178.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.418 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.402 28.9 p-10 -124.02 -177.15 3.67 Favored 'General case' 0 C--N 1.372 1.559 0 O-C-N 120.944 -1.098 . . . . 0.0 112.885 174.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.595 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 86.2 p -50.15 3.93 0.01 OUTLIER 'General case' 0 C--N 1.36 1.026 2 C-N-CA 135.742 5.617 . . . . 0.0 121.954 -168.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -101.8 4.65 40.61 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 164.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.348 3.1 mp0 66.78 39.69 3.41 Favored 'General case' 0 C--N 1.379 1.887 1 C-N-CA 133.678 4.791 . . . . 0.0 109.974 -174.367 . . . . . . . . 3 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.448 ' C ' HG23 ' A' ' 141' ' ' THR . 4.3 m -113.13 123.97 69.3 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.62 0 CA-C-N 112.418 -2.174 . . . . 0.0 113.021 -170.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -91.31 123.67 34.92 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.251 2.221 . . . . 0.0 107.034 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.13 156.54 26.26 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 103.488 -2.782 . . . . 0.0 103.488 -177.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -130.35 147.07 52.02 Favored 'General case' 0 CA--C 1.5 -0.964 0 O-C-N 121.382 -0.824 . . . . 0.0 110.104 -176.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.294 58.7 p -123.64 143.7 50.08 Favored 'General case' 0 C--O 1.255 1.393 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 173.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.6 m -54.93 148.24 13.78 Favored 'General case' 0 C--N 1.377 1.791 2 C-N-CA 138.807 6.843 . . . . 0.0 114.699 -168.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 70.8 p -67.61 109.81 3.43 Favored 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.223 1.809 . . . . 0.0 111.238 -173.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -93.72 108.78 20.48 Favored 'General case' 0 C--N 1.37 1.488 0 N-CA-C 103.154 -2.906 . . . . 0.0 103.154 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -94.63 109.22 21.17 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 120.519 1.509 . . . . 0.0 111.465 -172.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -121.87 113.93 40.87 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.45 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 59.3 m -120.41 122.57 41.03 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 103.754 -2.684 . . . . 0.0 103.754 -175.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 4.5 m -120.32 104.89 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.034 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -178.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 64.1 m-20 -83.35 155.62 66.32 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.19 1.796 . . . . 0.0 110.931 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -69.65 165.83 29.53 Favored 'Trans proline' 0 C--N 1.36 1.172 1 C-N-CA 126.119 4.546 . . . . 0.0 107.6 154.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.2 p -67.31 133.35 49.48 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 118.166 -2.834 . . . . 0.0 110.3 -171.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.3 t -66.14 113.91 14.43 Favored Pre-proline 0 CA--C 1.554 1.126 0 N-CA-C 121.484 3.883 . . . . 0.0 121.484 -127.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -62.45 152.1 79.09 Favored 'Trans proline' 0 C--N 1.379 2.153 1 C-N-CA 126.145 4.563 . . . . 0.0 115.472 172.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.5 80.9 0.4 Allowed Glycine 0 C--N 1.368 2.321 0 C-N-CA 127.961 2.696 . . . . 0.0 115.078 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -152.99 -123.48 0.97 Allowed Glycine 0 C--N 1.348 1.198 0 N-CA-C 107.884 -2.087 . . . . 0.0 107.884 -177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 34.9 mt 65.65 -69.1 0.11 Allowed 'General case' 0 C--N 1.363 1.184 0 C-N-CA 128.692 2.797 . . . . 0.0 116.218 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -108.43 -15.26 14.49 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 129.042 2.937 . . . . 0.0 110.385 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 79.5 t60 . . . . . 0 C--N 1.353 0.761 0 C-N-CA 127.304 2.241 . . . . 0.0 109.175 -178.922 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.977 0 CA-C-O 121.872 0.844 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.0 tt -106.1 117.89 35.21 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 125.859 1.664 . . . . 0.0 106.841 178.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.7 t -94.77 173.08 7.78 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 128.097 2.559 . . . . 0.0 110.924 -178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.539 ' O ' ' HG ' ' A' ' 75' ' ' LEU 0.256 2.4 pt? -73.84 98.52 2.99 Favored 'General case' 0 C--N 1.365 1.25 0 O-C-N 120.702 -1.249 . . . . 0.0 110.496 171.029 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.4 t 58.08 -75.4 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.764 0 O-C-N 117.033 -3.542 . . . . 0.0 116.158 -170.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.1 tptp -133.38 142.1 48.22 Favored 'General case' 0 C--N 1.36 1.056 1 C-N-CA 132.99 4.516 . . . . 0.0 106.693 168.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.441 0.4 OUTLIER -81.63 170.57 15.67 Favored 'General case' 0 CA--C 1.51 -0.586 0 C-N-CA 131.656 3.983 . . . . 0.0 110.595 -178.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.554 ' O ' HG22 ' A' ' 92' ' ' THR . 1.2 mp -72.37 -35.31 68.46 Favored 'General case' 0 CA--C 1.578 2.046 0 O-C-N 119.942 -1.724 . . . . 0.0 111.38 167.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.519 ' HB ' ' SG ' ' A' ' 153' ' ' CYS . 19.1 m -172.25 179.75 2.5 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 100.399 -3.926 . . . . 0.0 100.399 174.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.12 -42.66 0.46 Allowed 'General case' 0 C--N 1.367 1.353 0 N-CA-C 118.598 2.814 . . . . 0.0 118.598 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.0 m -164.63 99.63 0.79 Allowed 'General case' 0 N--CA 1.477 0.9 0 O-C-N 118.449 -2.657 . . . . 0.0 115.601 -169.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 19.9 mmm -120.27 117.55 28.13 Favored 'General case' 0 C--N 1.369 1.449 0 CA-C-O 122.591 1.186 . . . . 0.0 109.664 168.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.5 p -115.15 114.86 25.85 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -150.94 174.63 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 112.973 -1.921 . . . . 0.0 111.17 -171.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -70.02 144.68 52.17 Favored 'General case' 0 CA--C 1.564 1.501 0 O-C-N 118.968 -2.332 . . . . 0.0 107.724 158.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.437 0.7 OUTLIER -44.14 123.17 3.26 Favored 'General case' 0 N--CA 1.523 3.176 0 O-C-N 117.675 -3.141 . . . . 0.0 117.733 -170.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.511 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 123.52 50.17 0.22 Allowed Glycine 0 C--N 1.347 1.152 0 CA-C-N 111.347 -2.661 . . . . 0.0 108.884 -154.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.478 ' HB1' HG12 ' A' ' 155' ' ' VAL . . . -95.9 139.43 32.12 Favored 'General case' 0 C--N 1.368 1.383 0 C-N-CA 125.298 1.439 . . . . 0.0 108.32 173.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.94 119.33 32.71 Favored 'General case' 0 C--N 1.348 0.521 0 N-CA-C 116.394 1.998 . . . . 0.0 116.394 -167.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.551 ' HG ' HG11 ' A' ' 155' ' ' VAL . 6.2 mt -121.46 129.14 52.79 Favored 'General case' 0 C--N 1.364 1.229 0 C-N-CA 128.194 2.598 . . . . 0.0 117.584 178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.554 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -115.95 118.48 33.05 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 100.352 -3.944 . . . . 0.0 100.352 167.792 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 5.0 mt -121.49 115.09 22.2 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 -179.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.496 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 8.8 t -155.03 131.58 10.54 Favored 'General case' 0 C--N 1.346 0.449 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -169.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.4 m -150.17 173.71 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.649 1 C-N-CA 131.748 4.019 . . . . 0.0 103.465 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.2 t -104.29 141.44 36.3 Favored 'General case' 0 C--N 1.37 1.483 0 CA-C-N 122.857 2.571 . . . . 0.0 106.67 174.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.668 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -134.75 145.53 48.53 Favored 'General case' 0 C--N 1.37 1.495 0 N-CA-C 119.618 3.192 . . . . 0.0 119.618 -174.38 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 54.6 m -158.29 174.29 15.38 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 131.644 3.978 . . . . 0.0 101.41 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -77.39 44.49 2.21 Favored Glycine 0 C--N 1.364 2.089 0 CA-C-N 122.111 2.232 . . . . 0.0 116.508 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.86 21.42 57.62 Favored Glycine 0 C--N 1.356 1.676 0 C-N-CA 127.297 2.379 . . . . 0.0 115.578 178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 90.7 m -117.6 111.25 18.94 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 114.799 -2.524 . . . . 0.0 107.728 174.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.621 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 78.57 -91.22 1.16 Allowed Glycine 0 C--N 1.375 2.721 0 C-N-CA 129.546 3.451 . . . . 0.0 109.679 -176.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -60.61 167.22 8.61 Favored 'Trans proline' 0 CA--C 1.57 2.312 1 C-N-CA 126.566 4.844 . . . . 0.0 116.288 160.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 142' ' ' ASP . 69.0 m-85 -98.94 145.33 27.14 Favored 'General case' 0 CA--C 1.554 1.107 0 N-CA-C 120.473 3.508 . . . . 0.0 120.473 -166.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.7 t -102.7 140.06 37.47 Favored 'General case' 0 C--N 1.378 1.826 0 N-CA-C 104.778 -2.304 . . . . 0.0 104.778 174.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.478 ' CE1' ' HA ' ' A' ' 119' ' ' SER . 0.0 OUTLIER -114.32 148.98 36.69 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 121.314 3.82 . . . . 0.0 121.314 -164.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -133.65 111.25 10.46 Favored 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 102.358 -3.201 . . . . 0.0 102.358 162.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.503 ' HB2' HG13 ' A' ' 115' ' ' ILE . 40.7 m95 -112.93 150.28 32.04 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 125.301 1.44 . . . . 0.0 108.661 179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -148.65 169.64 19.92 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 104.111 -2.551 . . . . 0.0 104.111 165.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -139.84 104.15 4.82 Favored 'General case' 0 N--CA 1.426 -1.647 0 N-CA-C 105.65 -1.982 . . . . 0.0 105.65 175.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.434 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.235 1.5 t70 34.77 52.85 0.6 Allowed 'General case' 0 CA--C 1.473 -1.994 2 N-CA-C 122.336 4.199 . . . . 0.0 122.336 142.339 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 93.77 -11.25 71.41 Favored Glycine 0 C--N 1.366 2.195 2 O-C-N 133.346 6.654 . . . . 0.0 118.629 -175.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 30.1 m -124.14 148.17 56.74 Favored Pre-proline 0 CA--C 1.564 1.497 0 C-N-CA 131.287 3.835 . . . . 0.0 121.034 -168.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -63.62 148.52 92.26 Favored 'Trans proline' 0 C--N 1.378 2.122 1 C-N-CA 126.834 5.023 . . . . 0.0 115.247 170.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.712 HD11 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -107.12 162.11 20.76 Favored Pre-proline 0 C--N 1.354 0.788 0 O-C-N 119.741 -1.85 . . . . 0.0 115.482 -177.545 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 9.0 Cg_endo -73.82 88.96 1.02 Allowed 'Trans proline' 0 C--N 1.363 1.335 1 C-N-CA 125.923 4.415 . . . . 0.0 114.699 -177.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.1 t70 82.19 -53.71 0.23 Allowed 'General case' 0 C--N 1.361 1.098 0 C-N-CA 128.528 2.731 . . . . 0.0 113.48 176.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.712 ' HB2' HD11 ' A' ' 115' ' ' ILE . . . 91.55 -48.34 0.02 OUTLIER 'General case' 0 CA--C 1.49 -1.348 0 C-N-CA 129.789 3.236 . . . . 0.0 113.639 177.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.478 ' HA ' ' CE1' ' A' ' 106' ' ' TYR 0.252 33.1 t -77.61 49.33 0.73 Allowed 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 129.479 3.112 . . . . 0.0 114.017 -174.718 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -131.0 -46.16 0.15 Allowed Glycine 0 C--N 1.367 2.267 1 N-CA-C 124.665 4.626 . . . . 0.0 124.665 -162.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.668 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.291 . . 99.72 -75.99 0.0 OUTLIER 'General case' 0 C--N 1.356 0.857 0 CA-C-N 120.734 2.267 . . . . 0.0 111.564 -177.578 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.298 6.5 t -130.95 102.32 6.0 Favored 'General case' 0 C--N 1.359 1.011 0 CA-C-O 123.528 1.633 . . . . 0.0 110.805 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.262 19.2 p90 -126.97 141.74 51.72 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 128.324 2.65 . . . . 0.0 111.485 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.483 HG23 ' O ' ' A' ' 91' ' ' LEU . 38.0 m -128.42 139.29 52.44 Favored 'General case' 0 C--N 1.355 0.838 0 O-C-N 119.645 -1.909 . . . . 0.0 107.861 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -116.16 92.39 35.51 Favored Pre-proline 0 C--N 1.358 0.96 0 C-N-CA 129.494 3.118 . . . . 0.0 104.362 175.072 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -68.47 -33.16 23.56 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.47 3.447 . . . . 0.0 112.719 176.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.511 HG23 ' HA2' ' A' ' 88' ' ' GLY . 97.5 m -127.4 104.12 7.74 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 126.008 1.723 . . . . 0.0 106.442 176.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -91.09 124.06 35.02 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 125.305 1.442 . . . . 0.0 110.51 173.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.38 170.86 13.16 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 126.91 2.084 . . . . 0.0 108.002 176.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.12 -47.51 23.37 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 118.705 2.854 . . . . 0.0 118.705 -170.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.65 -23.38 67.06 Favored 'General case' 0 C--N 1.366 1.306 0 C-N-CA 126.753 2.021 . . . . 0.0 115.061 173.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -83.43 -12.85 55.92 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.846 2.858 . . . . 0.0 112.574 172.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.634 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -88.51 155.83 19.43 Favored 'General case' 0 C--N 1.381 1.951 0 N-CA-C 118.242 2.682 . . . . 0.0 118.242 170.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 141.54 -149.39 21.07 Favored Glycine 0 CA--C 1.457 -3.554 0 N-CA-C 104.713 -3.355 . . . . 0.0 104.713 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.264 66.8 m -125.97 138.26 53.74 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 114.543 -2.863 . . . . 0.0 107.606 174.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 110' ' ' LYS . 8.7 m-85 -96.96 134.64 40.06 Favored 'General case' 0 CA--C 1.506 -0.738 0 C-N-CA 126.445 1.898 . . . . 0.0 112.054 -168.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.434 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -144.58 143.43 30.8 Favored 'General case' 0 C--N 1.365 1.26 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -175.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.409 HG21 ' CE2' ' A' ' 108' ' ' TRP . 14.9 p -143.25 143.51 24.68 Favored 'Isoleucine or valine' 0 C--N 1.364 1.236 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -176.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.4 m -111.56 122.63 48.33 Favored 'General case' 0 C--N 1.375 1.705 0 C-N-CA 130.921 3.688 . . . . 0.0 105.994 174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.421 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -134.55 120.37 32.35 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 124.518 1.127 . . . . 0.0 109.844 -172.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.412 HG23 ' C ' ' A' ' 146' ' ' VAL . 7.9 m -105.22 132.87 50.89 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 114.913 1.449 . . . . 0.0 114.913 -176.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.47 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.384 23.9 p-10 -126.12 -174.45 3.11 Favored 'General case' 0 C--N 1.38 1.904 0 C-N-CA 124.589 1.155 . . . . 0.0 112.691 176.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.621 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 6.5 p -49.24 0.31 0.01 OUTLIER 'General case' 0 C--N 1.372 1.551 1 C-N-CA 136.577 5.951 . . . . 0.0 120.821 -166.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -104.04 4.54 34.52 Favored 'General case' 0 C--N 1.358 0.938 0 C-N-CA 118.474 -1.29 . . . . 0.0 107.836 165.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.464 94.7 mm-40 67.24 40.3 2.82 Favored 'General case' 0 C--N 1.374 1.631 1 C-N-CA 132.707 4.403 . . . . 0.0 110.56 -172.692 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.412 ' C ' HG23 ' A' ' 141' ' ' THR . 3.5 m -112.78 126.07 70.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.346 0 CA-C-N 111.605 -2.543 . . . . 0.0 112.845 -171.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.7 OUTLIER -90.83 125.9 35.87 Favored 'General case' 0 C--N 1.358 0.941 0 C-N-CA 127.777 2.431 . . . . 0.0 108.109 -176.503 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -116.24 156.74 26.05 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 -176.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -130.65 146.88 52.24 Favored 'General case' 0 CA--C 1.5 -0.966 0 O-C-N 120.543 -1.348 . . . . 0.0 111.492 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.433 91.8 p -127.19 146.29 50.46 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 123.557 0.743 . . . . 0.0 111.807 176.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 22.0 m -54.61 148.59 12.19 Favored 'General case' 0 CA--C 1.488 -1.407 1 C-N-CA 138.496 6.718 . . . . 0.0 117.42 -164.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 81.8 p -68.56 110.2 4.1 Favored 'General case' 0 C--N 1.377 1.768 0 C-N-CA 127.764 2.426 . . . . 0.0 110.046 -178.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 80' ' ' THR . 1.0 OUTLIER -106.35 109.35 21.25 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 102.88 -3.007 . . . . 0.0 102.88 -172.308 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.54 122.46 42.64 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -168.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.551 HG11 ' HG ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -123.17 115.03 44.43 Favored 'Isoleucine or valine' 0 C--N 1.351 0.641 0 C-N-CA 125.045 1.338 . . . . 0.0 108.128 176.7 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 62.7 m -114.24 122.82 47.92 Favored 'General case' 0 C--N 1.372 1.561 0 N-CA-C 105.588 -2.004 . . . . 0.0 105.588 177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.634 HG22 ' CB ' ' A' ' 133' ' ' ALA . 33.4 m -120.36 108.07 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 C-N-CA 126.358 1.863 . . . . 0.0 111.485 -175.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 27.5 m-20 -87.21 157.15 53.99 Favored Pre-proline 0 CA--C 1.556 1.179 0 O-C-N 121.222 -0.924 . . . . 0.0 110.065 176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.55 165.89 31.23 Favored 'Trans proline' 0 CA--C 1.548 1.194 1 C-N-CA 126.182 4.588 . . . . 0.0 106.978 152.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 3.5 m -67.43 137.47 55.92 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 117.932 -2.98 . . . . 0.0 109.781 -172.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.47 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 42.3 t -65.49 107.52 1.54 Allowed Pre-proline 0 CA--C 1.556 1.19 0 N-CA-C 119.433 3.123 . . . . 0.0 119.433 -124.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.47 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 92.8 Cg_endo -63.28 154.71 66.26 Favored 'Trans proline' 0 C--N 1.381 2.268 1 C-N-CA 126.56 4.84 . . . . 0.0 114.601 172.063 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . 92.34 -57.04 2.77 Favored Glycine 0 C--N 1.358 1.77 0 C-N-CA 125.479 1.514 . . . . 0.0 112.768 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -177.12 151.3 10.94 Favored Glycine 0 C--N 1.35 1.332 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 82.7 mt -103.34 60.08 0.76 Allowed 'General case' 0 C--N 1.36 1.056 0 O-C-N 121.236 -1.155 . . . . 0.0 109.592 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -72.62 72.48 1.03 Allowed 'General case' 0 C--N 1.362 1.141 0 C-N-CA 127.181 2.192 . . . . 0.0 114.775 -178.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 . . . . . 0 C--N 1.357 0.927 0 C-N-CA 127.74 2.416 . . . . 0.0 113.158 -177.105 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.984 0 CA-C-O 121.853 0.835 . . . . 0.0 109.156 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 48.0 tp -86.79 129.15 34.99 Favored 'General case' 0 C--N 1.355 0.819 0 C-N-CA 126.384 1.874 . . . . 0.0 112.307 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.7 t -95.46 172.24 8.2 Favored 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 126.162 1.785 . . . . 0.0 110.621 175.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.567 ' H ' HD23 ' A' ' 75' ' ' LEU 0.374 0.4 OUTLIER -81.59 97.73 8.0 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 174.631 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 58.84 -76.33 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 118.662 -2.524 . . . . 0.0 115.082 -168.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 tptm -133.36 141.7 48.04 Favored 'General case' 0 C--N 1.36 1.06 1 C-N-CA 132.467 4.307 . . . . 0.0 106.327 169.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.287 0.0 OUTLIER -82.39 171.79 13.79 Favored 'General case' 0 C--N 1.348 0.53 0 C-N-CA 128.647 2.779 . . . . 0.0 110.507 177.895 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.422 HD23 ' H ' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -71.33 -30.63 66.43 Favored 'General case' 0 N--CA 1.425 -1.68 0 CA-C-N 113.608 -1.633 . . . . 0.0 112.405 176.653 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 m -171.48 172.94 4.92 Favored 'General case' 0 N--CA 1.469 0.504 0 O-C-N 116.726 -3.734 . . . . 0.0 101.032 174.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.48 -42.71 0.55 Allowed 'General case' 0 C--N 1.354 0.794 0 CA-C-N 120.467 1.485 . . . . 0.0 111.479 174.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 154' ' ' ALA . 58.1 m -162.86 113.39 1.45 Allowed 'General case' 0 C--N 1.356 0.875 0 N-CA-C 116.764 2.135 . . . . 0.0 116.764 -174.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.77 117.26 19.97 Favored 'General case' 0 C--N 1.371 1.532 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 162.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 25.6 m -116.41 116.81 28.38 Favored 'General case' 0 C--N 1.364 1.198 0 O-C-N 117.946 -2.971 . . . . 0.0 110.066 179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 11.5 p -149.57 172.29 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.361 1.086 0 C-N-CA 124.533 1.133 . . . . 0.0 113.059 -173.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -83.72 130.67 34.96 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 104.833 -2.284 . . . . 0.0 104.833 162.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.509 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.326 0.3 OUTLIER -41.53 123.09 2.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 120.076 3.361 . . . . 0.0 120.076 -150.492 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.62 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 141.64 48.84 0.05 OUTLIER Glycine 0 C--N 1.357 1.701 0 CA-C-N 109.941 -3.299 . . . . 0.0 111.896 -170.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.98 171.67 11.94 Favored 'General case' 0 C--N 1.37 1.471 0 C-N-CA 124.731 1.213 . . . . 0.0 112.95 175.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.54 115.77 30.2 Favored 'General case' 0 C--N 1.35 0.618 0 C-N-CA 125.251 1.42 . . . . 0.0 108.508 178.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.497 HD13 ' HB2' ' A' ' 128' ' ' ALA . 6.7 mp -120.47 113.06 19.76 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 127.467 2.307 . . . . 0.0 113.346 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -109.97 126.92 54.44 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 103.123 -2.917 . . . . 0.0 103.123 170.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.465 HD11 ' CD2' ' A' ' 136' ' ' TYR . 1.9 mm? -112.57 114.43 27.08 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 102.625 -3.102 . . . . 0.0 102.625 174.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 61.1 m -150.24 134.58 17.22 Favored 'General case' 0 C--N 1.368 1.389 0 CA-C-O 121.729 0.776 . . . . 0.0 112.043 -174.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -147.17 173.03 2.52 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 C-N-CA 131.521 3.928 . . . . 0.0 103.766 174.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 63.9 p -103.59 137.43 41.67 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.48 2.712 . . . . 0.0 108.121 -173.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.404 ' HB2' ' HE2' ' A' ' 106' ' ' TYR . . . -141.6 145.82 35.5 Favored 'General case' 0 C--N 1.384 2.098 1 N-CA-C 127.602 6.149 . . . . 0.0 127.602 -170.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.431 HG23 ' HG2' ' A' ' 103' ' ' PRO . 23.7 p -156.67 175.07 14.54 Favored 'General case' 0 C--N 1.37 1.491 1 C-N-CA 134.241 5.016 . . . . 0.0 103.985 173.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.64 40.19 0.78 Allowed Glycine 0 C--N 1.367 2.27 0 O-C-N 119.279 -2.138 . . . . 0.0 117.798 170.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.5 30.73 15.06 Favored Glycine 0 C--N 1.359 1.812 0 C-N-CA 128.54 2.972 . . . . 0.0 114.648 176.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.4 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 33.5 p -117.35 109.67 17.1 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-O 114.39 -2.719 . . . . 0.0 108.79 175.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.68 -90.64 0.86 Allowed Glycine 0 C--N 1.378 2.886 0 CA-C-N 124.147 3.158 . . . . 0.0 111.591 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.431 ' HG2' HG23 ' A' ' 98' ' ' THR . 62.8 Cg_endo -62.29 169.17 8.31 Favored 'Trans proline' 0 CA--C 1.569 2.256 1 C-N-CA 126.528 4.819 . . . . 0.0 113.62 158.119 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.45 ' HB3' HG12 ' A' ' 140' ' ' VAL . 61.0 m-85 -100.68 159.79 14.88 Favored 'General case' 0 C--N 1.349 0.587 0 N-CA-C 119.655 3.206 . . . . 0.0 119.655 -165.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.7 t -110.14 141.49 42.95 Favored 'General case' 0 C--N 1.368 1.392 0 N-CA-C 102.393 -3.188 . . . . 0.0 102.393 171.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.563 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.4 OUTLIER -138.39 151.03 47.12 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 120.501 3.519 . . . . 0.0 120.501 -165.203 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -129.11 124.51 34.93 Favored 'General case' 0 C--N 1.368 1.391 0 C-N-CA 128.776 2.83 . . . . 0.0 106.908 172.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.494 ' HB2' HG13 ' A' ' 115' ' ' ILE . 8.8 m95 -113.2 147.62 37.09 Favored 'General case' 0 C--N 1.363 1.161 0 C-N-CA 125.344 1.457 . . . . 0.0 113.76 -177.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.14 169.63 17.5 Favored 'General case' 0 CA--C 1.484 -1.586 0 N-CA-C 105.01 -2.218 . . . . 0.0 105.01 166.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.581 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.8 ptmm? -140.74 107.43 5.35 Favored 'General case' 0 N--CA 1.42 -1.97 0 O-C-N 119.92 -1.738 . . . . 0.0 108.087 173.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.446 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.205 1.7 t70 34.23 52.25 0.49 Allowed 'General case' 0 C--N 1.373 1.605 1 N-CA-C 123.649 4.685 . . . . 0.0 123.649 141.859 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 88.14 -5.98 84.11 Favored Glycine 0 C--N 1.367 2.271 2 O-C-N 132.724 6.265 . . . . 0.0 119.712 -175.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.405 ' HB2' ' NZ ' ' A' ' 110' ' ' LYS 0.359 2.2 m -124.05 149.37 60.03 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 130.468 3.507 . . . . 0.0 118.115 -171.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_endo -62.09 158.6 38.39 Favored 'Trans proline' 0 N--CA 1.498 1.753 0 C-N-CA 124.221 3.281 . . . . 0.0 115.161 164.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.1 OUTLIER -108.94 155.95 39.92 Favored Pre-proline 0 CA--C 1.544 0.716 0 O-C-N 120.04 -1.662 . . . . 0.0 110.255 177.345 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -69.06 84.37 0.54 Allowed 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 125.216 3.944 . . . . 0.0 115.837 -175.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 4.6 t70 80.13 -54.18 0.37 Allowed 'General case' 0 C--N 1.366 1.312 0 C-N-CA 129.302 3.041 . . . . 0.0 113.131 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 88.51 -163.52 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 130.405 3.482 . . . . 0.0 110.878 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 70.06 4.91 5.04 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 117.939 2.57 . . . . 0.0 117.939 171.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -98.95 -31.95 6.07 Favored Glycine 0 C--N 1.355 1.623 0 N-CA-C 120.651 3.02 . . . . 0.0 120.651 -163.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.279 . . 91.52 -52.91 0.02 OUTLIER 'General case' 0 CA--C 1.506 -0.746 0 C-N-CA 127.684 2.393 . . . . 0.0 111.317 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.319 12.1 t -140.33 97.44 3.22 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 123.022 1.392 . . . . 0.0 109.561 177.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.27 2.5 p90 -126.69 140.25 52.54 Favored 'General case' 0 C--N 1.365 1.257 0 C-N-CA 128.03 2.532 . . . . 0.0 111.374 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 12.8 m -129.58 140.26 51.26 Favored 'General case' 0 C--N 1.363 1.17 0 O-C-N 119.804 -1.81 . . . . 0.0 112.802 -175.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.45 ' HA ' ' HE2' ' A' ' 125' ' ' LYS 0.313 0.7 OUTLIER -108.73 111.99 60.69 Favored Pre-proline 0 C--N 1.373 1.609 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 168.183 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -77.65 -17.3 14.32 Favored 'Trans proline' 0 CA--C 1.538 0.681 1 C-N-CA 126.373 4.715 . . . . 0.0 113.503 171.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.62 HG23 ' HA2' ' A' ' 88' ' ' GLY . 61.5 m -157.79 107.05 2.1 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 103.277 -2.861 . . . . 0.0 103.277 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.555 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -94.33 134.79 36.44 Favored 'General case' 0 N--CA 1.443 -0.816 0 C-N-CA 127.234 2.213 . . . . 0.0 113.822 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.07 172.2 11.45 Favored 'General case' 0 C--N 1.371 1.505 0 C-N-CA 128.444 2.697 . . . . 0.0 110.47 174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.62 -45.81 28.0 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 119.817 3.265 . . . . 0.0 119.817 -171.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 81.9 mt-10 -62.75 -17.66 61.31 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 127.833 2.453 . . . . 0.0 114.977 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.555 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 44.0 m-20 -79.55 -14.89 58.54 Favored 'General case' 0 CA--C 1.563 1.456 0 C-N-CA 128.146 2.578 . . . . 0.0 112.713 170.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.4 ' HB2' ' H ' ' A' ' 157' ' ' VAL . . . -71.24 129.48 38.99 Favored 'General case' 0 C--N 1.389 2.325 1 N-CA-C 122.339 4.2 . . . . 0.0 122.339 172.379 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.73 -135.91 5.37 Favored Glycine 0 C--N 1.374 2.652 0 C-N-CA 130.314 3.816 . . . . 0.0 109.253 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.45 ' HB2' ' HE3' ' A' ' 137' ' ' LYS . 19.7 m -129.78 140.25 51.09 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 115.853 -2.339 . . . . 0.0 110.679 173.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.581 ' CZ ' ' HD2' ' A' ' 110' ' ' LYS . 43.2 m-85 -97.03 134.75 39.98 Favored 'General case' 0 C--N 1.366 1.323 0 C-N-CA 127.09 2.156 . . . . 0.0 113.016 -173.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -142.45 141.54 32.21 Favored 'General case' 0 C--N 1.368 1.398 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 -174.234 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.644 HG13 ' OG ' ' A' ' 150' ' ' SER 0.36 2.2 p -133.75 134.63 56.14 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 -175.439 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -106.94 107.81 19.01 Favored 'General case' 0 C--N 1.377 1.773 0 C-N-CA 130.345 3.458 . . . . 0.0 106.541 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.563 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -121.62 118.67 56.58 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 C-N-CA 128.243 2.617 . . . . 0.0 112.49 -168.106 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.418 HG23 ' C ' ' A' ' 146' ' ' VAL . 4.2 m -103.57 132.81 49.51 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 119.318 -2.114 . . . . 0.0 114.391 -177.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.449 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.327 24.4 p-10 -128.39 -178.96 4.77 Favored 'General case' 0 C--N 1.378 1.816 0 CA-C-N 120.321 1.419 . . . . 0.0 111.52 175.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.475 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 13.3 p -49.23 3.22 0.01 OUTLIER 'General case' 0 C--N 1.372 1.562 1 C-N-CA 136.515 5.926 . . . . 0.0 120.332 -169.26 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -101.01 4.78 42.7 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 118.004 -1.478 . . . . 0.0 107.618 162.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.439 0.7 OUTLIER 64.96 39.63 5.68 Favored 'General case' 0 C--N 1.372 1.569 1 C-N-CA 134.024 4.93 . . . . 0.0 111.635 -174.625 . . . . . . . . 4 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.418 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.19 133.7 58.21 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.49 0 CA-C-N 111.213 -2.721 . . . . 0.0 111.885 -170.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.84 125.78 35.83 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 127.65 2.38 . . . . 0.0 106.87 179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.8 158.78 22.37 Favored 'General case' 0 CA--C 1.486 -1.481 0 C-N-CA 129.267 3.027 . . . . 0.0 103.123 -176.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -126.47 135.33 51.22 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 123.836 1.779 . . . . 0.0 109.605 -174.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.644 ' OG ' HG13 ' A' ' 138' ' ' VAL 0.283 2.8 p -121.96 146.51 47.07 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 113.001 -1.908 . . . . 0.0 109.952 -176.19 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.3 m -54.14 147.1 13.53 Favored 'General case' 0 CA--C 1.481 -1.682 1 C-N-CA 136.91 6.084 . . . . 0.0 118.273 -158.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 68.7 p -69.47 110.67 4.86 Favored 'General case' 0 C--N 1.368 1.388 0 C-N-CA 127.677 2.391 . . . . 0.0 110.549 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 109.77 21.94 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 101.575 -3.491 . . . . 0.0 101.575 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 82' ' ' SER . . . -98.22 113.44 25.37 Favored 'General case' 0 C--N 1.358 0.946 0 CA-C-O 123.844 1.783 . . . . 0.0 112.837 -173.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.2 m -123.18 128.35 74.92 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.808 0 O-C-N 119.187 -2.196 . . . . 0.0 109.511 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 28.2 m -110.81 121.62 45.8 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 103.795 -2.669 . . . . 0.0 103.795 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 5.4 m -134.3 102.99 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 N-CA-C 104.179 -2.526 . . . . 0.0 104.179 173.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -106.92 150.25 39.53 Favored Pre-proline 0 C--N 1.348 0.531 0 O-C-N 120.168 -1.582 . . . . 0.0 108.681 176.436 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -69.23 166.4 27.07 Favored 'Trans proline' 0 C--N 1.357 0.978 1 C-N-CA 126.61 4.874 . . . . 0.0 109.393 161.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.47 134.14 50.81 Favored 'General case' 0 C--N 1.367 1.333 0 O-C-N 119.264 -2.148 . . . . 0.0 108.31 -176.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.451 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 58.5 t -66.47 109.36 3.26 Favored Pre-proline 0 C--N 1.362 1.143 0 N-CA-C 121.546 3.906 . . . . 0.0 121.546 -123.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.451 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 56.6 Cg_endo -63.11 148.76 92.97 Favored 'Trans proline' 0 C--N 1.385 2.49 1 C-N-CA 125.951 4.434 . . . . 0.0 114.194 169.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.39 50.93 1.73 Allowed Glycine 0 C--N 1.365 2.157 0 C-N-CA 126.545 2.021 . . . . 0.0 117.11 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -86.67 -19.89 55.35 Favored Glycine 0 C--N 1.359 1.836 0 C-N-CA 128.567 2.984 . . . . 0.0 113.184 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -101.84 -6.45 23.56 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 128.093 2.557 . . . . 0.0 109.336 175.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . 0.307 24.2 mt-10 64.87 -51.53 0.33 Allowed 'General case' 0 C--N 1.361 1.102 0 C-N-CA 131.26 3.824 . . . . 0.0 117.01 179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 74.5 t60 . . . . . 0 C--N 1.352 0.716 0 C-N-CA 127.123 2.169 . . . . 0.0 109.168 178.1 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.994 0 CA-C-O 121.393 0.616 . . . . 0.0 109.628 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.9 tp -107.25 145.92 32.1 Favored 'General case' 0 C--N 1.355 0.829 0 C-N-CA 126.727 2.011 . . . . 0.0 107.479 177.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.516 ' HA ' ' HB2' ' A' ' 78' ' ' ASP . 0.5 OUTLIER -94.4 138.42 32.37 Favored 'General case' 0 C--N 1.362 1.129 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 173.04 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -97.96 99.13 10.4 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 104.241 -2.503 . . . . 0.0 104.241 173.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 15.1 t 64.41 -76.03 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 O-C-N 119.563 -1.96 . . . . 0.0 111.824 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -133.75 115.06 14.1 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 128.261 2.624 . . . . 0.0 105.0 159.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.516 ' HB2' ' HA ' ' A' ' 74' ' ' THR 0.359 56.9 t0 -86.64 137.9 32.11 Favored 'General case' 0 C--N 1.371 1.527 0 N-CA-C 103.023 -2.955 . . . . 0.0 103.023 165.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.621 ' O ' HG22 ' A' ' 92' ' ' THR . 0.1 OUTLIER -72.71 -36.29 67.78 Favored 'General case' 0 C--O 1.211 -0.946 0 CA-C-N 122.503 2.41 . . . . 0.0 116.939 -171.643 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 8.3 m -172.61 172.41 4.26 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 117.279 -3.388 . . . . 0.0 104.499 178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -125.46 -48.33 1.69 Allowed 'General case' 0 C--N 1.355 0.844 0 C-N-CA 126.844 2.057 . . . . 0.0 112.061 175.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 16.2 t -173.68 138.07 0.64 Allowed 'General case' 0 C--N 1.362 1.117 0 O-C-N 119.36 -2.087 . . . . 0.0 115.088 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.3 ttt -141.03 116.56 10.18 Favored 'General case' 0 C--N 1.377 1.78 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 158.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.5 p -109.45 116.18 31.32 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 119.409 -2.057 . . . . 0.0 109.432 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -149.52 172.3 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.794 0 C-N-CA 126.327 1.851 . . . . 0.0 110.174 -171.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -80.86 133.8 35.65 Favored 'General case' 0 C--N 1.371 1.505 0 O-C-N 119.424 -2.048 . . . . 0.0 106.561 163.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.288 9.5 pt-20 -42.55 122.41 2.27 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 120.232 3.419 . . . . 0.0 120.232 -156.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.455 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 140.37 46.09 0.06 OUTLIER Glycine 0 C--N 1.361 1.954 0 CA-C-N 110.312 -3.131 . . . . 0.0 110.979 -164.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.38 167.12 16.79 Favored 'General case' 0 C--N 1.375 1.69 0 C-N-CA 125.222 1.409 . . . . 0.0 112.984 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -112.31 105.8 14.19 Favored 'General case' 0 C--N 1.352 0.692 0 C-N-CA 124.419 1.087 . . . . 0.0 110.578 -177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.9 mp -116.31 121.51 42.21 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 125.464 1.506 . . . . 0.0 113.418 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.621 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -105.08 131.04 53.09 Favored 'General case' 0 C--N 1.365 1.259 0 N-CA-C 102.221 -3.251 . . . . 0.0 102.221 172.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.65 HD11 ' CD2' ' A' ' 136' ' ' TYR . 4.2 mm? -120.2 113.57 20.63 Favored 'General case' 0 C--N 1.352 0.682 1 N-CA-C 98.967 -4.457 . . . . 0.0 98.967 170.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.6 m -153.67 132.79 12.59 Favored 'General case' 0 C--N 1.365 1.269 0 CA-C-N 121.093 1.769 . . . . 0.0 109.8 -174.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.7 m -149.22 174.64 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.532 0 C-N-CA 130.893 3.677 . . . . 0.0 104.104 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 3.4 t -103.89 139.65 38.78 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 128.25 2.62 . . . . 0.0 105.254 175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.497 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.58 144.26 34.14 Favored 'General case' 0 C--N 1.381 1.964 1 N-CA-C 123.91 4.781 . . . . 0.0 123.91 -174.83 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 61.7 p -156.71 175.62 13.82 Favored 'General case' 0 C--N 1.364 1.212 1 C-N-CA 133.812 4.845 . . . . 0.0 104.288 177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.54 40.0 0.76 Allowed Glycine 0 C--N 1.366 2.233 0 O-C-N 119.992 -1.693 . . . . 0.0 117.243 168.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.28 29.46 27.72 Favored Glycine 0 C--N 1.362 2.0 0 C-N-CA 128.199 2.809 . . . . 0.0 115.419 175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 66.7 m -117.94 110.6 17.92 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 115.178 -2.344 . . . . 0.0 109.008 173.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.517 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 77.59 -87.08 1.03 Allowed Glycine 0 C--N 1.377 2.822 0 C-N-CA 129.402 3.382 . . . . 0.0 109.655 -177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -59.93 168.65 5.53 Favored 'Trans proline' 0 CA--C 1.566 2.09 1 C-N-CA 126.628 4.885 . . . . 0.0 115.143 157.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.491 ' HB3' HG12 ' A' ' 140' ' ' VAL . 67.8 m-85 -103.98 146.59 28.47 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 119.621 3.193 . . . . 0.0 119.621 -166.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.9 t -102.64 140.01 37.48 Favored 'General case' 0 C--N 1.373 1.619 0 N-CA-C 105.165 -2.161 . . . . 0.0 105.165 171.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.421 ' CD2' ' N ' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -122.37 157.51 31.67 Favored 'General case' 0 C--N 1.347 0.457 0 N-CA-C 119.862 3.282 . . . . 0.0 119.862 -164.118 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -131.02 119.59 22.24 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-N 110.391 -3.095 . . . . 0.0 104.273 163.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.435 ' CE3' HG21 ' A' ' 138' ' ' VAL . 38.1 m95 -111.01 128.54 55.88 Favored 'General case' 0 C--N 1.379 1.87 0 CA-C-N 119.606 1.094 . . . . 0.0 111.235 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.328 0.2 OUTLIER -143.58 170.83 15.08 Favored 'General case' 0 C--N 1.377 1.779 0 CA-C-N 121.462 1.937 . . . . 0.0 108.145 170.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 31.4 tttt -151.0 107.3 3.47 Favored 'General case' 0 N--CA 1.415 -2.22 0 O-C-N 120.138 -1.601 . . . . 0.0 108.843 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.477 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.268 1.3 t70 34.25 52.42 0.5 Allowed 'General case' 0 CA--C 1.467 -2.249 2 N-CA-C 122.477 4.251 . . . . 0.0 122.477 142.186 . . . . . . . . 4 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 78.44 2.2 83.81 Favored Glycine 0 C--N 1.373 2.637 2 O-C-N 133.935 7.022 . . . . 0.0 118.266 -177.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.265 3.2 m -125.06 147.1 55.85 Favored Pre-proline 0 C--N 1.349 0.553 0 C-N-CA 127.672 2.389 . . . . 0.0 116.853 -172.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -62.63 152.37 78.3 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 124.697 3.598 . . . . 0.0 113.842 170.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.418 HG12 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -103.76 148.83 36.42 Favored Pre-proline 0 N--CA 1.451 -0.416 0 O-C-N 120.06 -1.65 . . . . 0.0 108.296 175.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -62.61 -78.53 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 124.996 3.797 . . . . 0.0 119.384 -166.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -125.42 63.65 1.18 Allowed 'General case' 0 C--N 1.349 0.548 0 C-N-CA 124.673 1.189 . . . . 0.0 108.387 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.418 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -63.66 150.5 44.13 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 119.386 3.106 . . . . 0.0 119.386 -175.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 81.16 75.94 0.03 OUTLIER 'General case' 0 C--N 1.363 1.193 0 C-N-CA 125.266 1.426 . . . . 0.0 111.987 175.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -165.24 -46.85 0.02 OUTLIER Glycine 0 CA--C 1.487 -1.686 0 N-CA-C 117.908 1.923 . . . . 0.0 117.908 -172.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.497 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.334 . . 135.65 -68.96 0.0 OUTLIER 'General case' 0 C--N 1.351 0.67 0 C-N-CA 128.174 2.59 . . . . 0.0 108.01 -178.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.256 9.0 t -138.33 115.93 11.34 Favored 'General case' 0 C--N 1.359 0.978 0 CA-C-N 120.61 1.55 . . . . 0.0 114.467 -174.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.302 4.3 p90 -127.77 140.69 51.89 Favored 'General case' 0 C--N 1.368 1.402 0 C-N-CA 129.458 3.103 . . . . 0.0 110.957 175.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 25.4 m -129.81 140.22 51.07 Favored 'General case' 0 C--N 1.358 0.951 0 O-C-N 118.344 -2.722 . . . . 0.0 110.368 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.37 96.42 35.61 Favored Pre-proline 0 C--N 1.367 1.355 0 C-N-CA 128.399 2.68 . . . . 0.0 106.982 177.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_endo -77.38 -14.64 16.22 Favored 'Trans proline' 0 C--N 1.359 1.127 1 C-N-CA 126.946 5.097 . . . . 0.0 114.502 -177.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.455 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -161.97 105.79 1.2 Allowed 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 102.195 -3.261 . . . . 0.0 102.195 176.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.479 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -94.28 133.95 37.27 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 127.173 2.189 . . . . 0.0 112.772 -178.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -86.5 177.97 7.24 Favored 'General case' 0 C--N 1.371 1.518 0 C-N-CA 128.191 2.596 . . . . 0.0 111.066 174.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.05 -48.6 33.11 Favored 'General case' 0 C--N 1.364 1.22 0 N-CA-C 118.955 2.946 . . . . 0.0 118.955 -173.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -67.44 -14.18 62.7 Favored 'General case' 0 C--N 1.366 1.296 0 C-N-CA 126.696 1.999 . . . . 0.0 114.573 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.479 ' CB ' ' HB1' ' A' ' 128' ' ' ALA 0.332 31.5 m-20 -82.58 -14.28 55.11 Favored 'General case' 0 CA--C 1.565 1.534 0 C-N-CA 130.354 3.462 . . . . 0.0 111.48 170.854 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.52 ' HB2' ' H ' ' A' ' 157' ' ' VAL . . . -74.79 133.86 41.88 Favored 'General case' 0 C--N 1.383 2.059 0 N-CA-C 118.09 2.626 . . . . 0.0 118.09 165.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.9 -158.92 31.6 Favored Glycine 0 C--N 1.37 2.421 0 C-N-CA 126.793 2.139 . . . . 0.0 109.492 172.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.268 11.0 t -117.74 135.94 53.7 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 114.612 -2.835 . . . . 0.0 106.879 169.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.65 ' CD2' HD11 ' A' ' 93' ' ' LEU 0.26 13.7 m-85 -97.4 134.49 40.59 Favored 'General case' 0 CA--C 1.506 -0.733 0 C-N-CA 127.072 2.149 . . . . 0.0 112.342 -173.305 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.587 ' HE2' HG22 ' A' ' 152' ' ' THR . 0.0 OUTLIER -143.63 153.96 43.05 Favored 'General case' 0 C--N 1.365 1.282 0 CA-C-O 123.231 1.491 . . . . 0.0 108.851 -174.399 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.638 HG13 HG22 ' A' ' 140' ' ' VAL . 1.1 t -143.62 148.15 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 117.388 -1.725 . . . . 0.0 114.672 -175.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -120.29 120.8 37.12 Favored 'General case' 0 C--N 1.381 1.96 0 C-N-CA 126.127 1.771 . . . . 0.0 106.308 171.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.638 HG22 HG13 ' A' ' 138' ' ' VAL . 0.1 OUTLIER -131.91 123.56 51.61 Favored 'Isoleucine or valine' 0 C--N 1.367 1.341 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -176.27 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.408 HG23 ' C ' ' A' ' 146' ' ' VAL . 3.6 m -106.63 133.62 51.03 Favored 'General case' 0 N--CA 1.483 1.211 0 O-C-N 119.366 -2.084 . . . . 0.0 114.625 -176.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.476 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.37 18.9 p-10 -127.85 -179.05 4.75 Favored 'General case' 0 C--N 1.38 1.929 0 CA-C-N 119.962 1.256 . . . . 0.0 112.064 175.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.517 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 8.0 p -49.17 1.33 0.01 OUTLIER 'General case' 0 C--N 1.375 1.713 1 C-N-CA 136.593 5.957 . . . . 0.0 119.964 -167.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -101.29 4.81 42.03 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 118.502 -1.279 . . . . 0.0 108.271 164.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.462 1.3 tp60 64.83 39.69 5.94 Favored 'General case' 0 C--N 1.371 1.502 1 C-N-CA 134.582 5.153 . . . . 0.0 111.569 -173.6 . . . . . . . . 3 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.408 ' C ' HG23 ' A' ' 141' ' ' THR . 3.4 m -112.88 131.45 64.44 Favored 'Isoleucine or valine' 0 CA--C 1.478 -1.795 0 CA-C-N 111.54 -2.573 . . . . 0.0 111.632 -169.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -92.64 128.72 38.59 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 126.249 1.82 . . . . 0.0 108.425 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.15 147.13 41.68 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 101.246 -3.613 . . . . 0.0 101.246 -178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -130.36 147.09 52.03 Favored 'General case' 0 CA--C 1.501 -0.925 0 O-C-N 119.43 -2.043 . . . . 0.0 107.051 -174.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 54.2 p -116.94 151.96 35.56 Favored 'General case' 0 C--O 1.249 1.075 0 O-C-N 120.822 -1.174 . . . . 0.0 113.273 -179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.3 148.04 15.61 Favored 'General case' 0 C--N 1.375 1.677 1 C-N-CA 136.782 6.033 . . . . 0.0 116.153 -172.019 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.587 HG22 ' HE2' ' A' ' 137' ' ' LYS . 6.1 p -68.1 111.63 4.59 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 127.034 2.134 . . . . 0.0 111.417 -178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 136' ' ' TYR . 1.8 m -97.06 108.45 21.19 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 102.461 -3.163 . . . . 0.0 102.461 177.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -99.73 106.81 18.75 Favored 'General case' 0 C--N 1.351 0.645 0 CA-C-O 124.704 2.192 . . . . 0.0 109.195 -172.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 29.7 m -118.46 127.79 75.47 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 O-C-N 120.309 -1.494 . . . . 0.0 107.421 -175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 92.6 m -115.8 122.16 44.59 Favored 'General case' 0 CA--C 1.484 -1.564 0 N-CA-C 103.279 -2.86 . . . . 0.0 103.279 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.52 ' H ' ' HB2' ' A' ' 133' ' ' ALA . 4.2 m -134.99 103.89 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 104.306 -2.479 . . . . 0.0 104.306 173.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -106.55 152.93 40.84 Favored Pre-proline 0 C--N 1.352 0.692 0 C-N-CA 125.469 1.507 . . . . 0.0 108.366 177.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -66.79 165.64 25.08 Favored 'Trans proline' 0 C--N 1.368 1.587 1 C-N-CA 127.102 5.201 . . . . 0.0 110.094 162.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 4.7 p -67.62 130.87 44.37 Favored 'General case' 0 C--N 1.369 1.446 0 O-C-N 119.559 -1.963 . . . . 0.0 109.264 -174.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.4 111.77 8.28 Favored Pre-proline 0 CA--C 1.552 1.051 1 N-CA-C 122.976 4.435 . . . . 0.0 122.976 -121.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -62.69 153.72 70.22 Favored 'Trans proline' 0 C--N 1.385 2.465 1 C-N-CA 126.007 4.471 . . . . 0.0 114.934 170.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -73.13 59.68 1.84 Allowed Glycine 0 C--N 1.366 2.213 0 C-N-CA 126.491 1.996 . . . . 0.0 116.615 -177.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -129.32 19.27 5.41 Favored Glycine 0 C--N 1.356 1.649 0 C-N-CA 126.483 1.992 . . . . 0.0 111.659 -176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.8 mt -92.07 -24.44 19.16 Favored 'General case' 0 C--N 1.36 1.051 0 C-N-CA 125.065 1.346 . . . . 0.0 109.973 175.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . 0.27 45.9 mm-40 64.89 -50.32 0.33 Allowed 'General case' 0 C--N 1.362 1.127 0 C-N-CA 130.756 3.622 . . . . 0.0 116.473 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 78.4 t60 . . . . . 0 C--N 1.357 0.935 0 C-N-CA 128.68 2.792 . . . . 0.0 114.844 175.729 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.146 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 45.8 tp -86.99 133.7 33.56 Favored 'General case' 0 C--N 1.36 1.035 0 CA-C-O 123.548 1.642 . . . . 0.0 111.041 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . 0.251 1.2 t -94.55 170.41 9.49 Favored 'General case' 0 N--CA 1.418 -2.074 0 C-N-CA 127.038 2.135 . . . . 0.0 110.524 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -93.3 98.67 11.4 Favored 'General case' 0 C--N 1.358 0.939 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 175.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 3.0 t 61.78 -80.17 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 119.724 -1.86 . . . . 0.0 112.111 -168.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -134.02 140.38 46.65 Favored 'General case' 0 C--N 1.36 1.03 0 C-N-CA 129.435 3.094 . . . . 0.0 107.029 162.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.362 0.3 OUTLIER -82.76 174.47 10.94 Favored 'General case' 0 C--N 1.351 0.65 1 C-N-CA 132.917 4.487 . . . . 0.0 108.834 175.419 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.403 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -70.03 -34.55 73.41 Favored 'General case' 0 CA--C 1.575 1.906 0 O-C-N 120.517 -1.364 . . . . 0.0 112.027 176.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 34.5 m -161.88 173.0 15.14 Favored 'General case' 0 C--N 1.348 0.511 0 O-C-N 117.221 -3.424 . . . . 0.0 103.652 172.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.98 -47.15 0.59 Allowed 'General case' 0 C--N 1.365 1.275 0 C-N-CA 127.834 2.454 . . . . 0.0 115.468 177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 35.7 p -172.36 116.25 0.34 Allowed 'General case' 0 C--N 1.368 1.385 0 N-CA-C 120.479 3.511 . . . . 0.0 120.479 -172.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 22.1 ttt -127.06 126.44 43.06 Favored 'General case' 0 C--N 1.38 1.905 0 CA-C-N 121.843 2.11 . . . . 0.0 114.267 165.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.9 m -105.5 116.44 31.94 Favored 'General case' 0 C--N 1.373 1.601 0 O-C-N 119.568 -1.957 . . . . 0.0 108.506 174.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.1 p -149.01 172.94 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.639 0 CA-C-O 122.714 1.245 . . . . 0.0 114.251 -169.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -86.1 123.99 32.02 Favored 'General case' 0 C--N 1.368 1.404 0 N-CA-C 102.708 -3.071 . . . . 0.0 102.708 161.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -42.07 122.31 2.08 Favored 'General case' 0 N--CA 1.521 3.097 0 CA-C-N 124.239 3.199 . . . . 0.0 118.234 -155.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.45 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 143.53 54.23 0.03 OUTLIER Glycine 0 C--N 1.356 1.672 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.636 -162.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.38 166.34 14.33 Favored 'General case' 0 C--N 1.363 1.152 0 C-N-CA 125.099 1.36 . . . . 0.0 112.143 175.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.9 111.16 22.1 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 124.166 0.986 . . . . 0.0 108.744 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.459 ' O ' HG23 ' A' ' 124' ' ' THR . 6.0 mp -119.75 116.01 25.06 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 125.854 1.662 . . . . 0.0 113.774 -173.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.93 125.09 52.47 Favored 'General case' 0 C--N 1.364 1.219 0 N-CA-C 103.223 -2.88 . . . . 0.0 103.223 173.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -121.24 113.61 20.2 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 101.412 -3.551 . . . . 0.0 101.412 171.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 58.8 m -147.92 133.38 18.66 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 119.753 -1.842 . . . . 0.0 111.387 -175.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.13 175.48 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.608 0 C-N-CA 130.258 3.423 . . . . 0.0 104.364 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.6 t -104.13 139.26 39.44 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 128.066 2.547 . . . . 0.0 105.69 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.76 147.48 37.41 Favored 'General case' 0 C--N 1.381 1.943 1 N-CA-C 123.885 4.772 . . . . 0.0 123.885 -175.053 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.4 p -157.04 176.06 13.26 Favored 'General case' 0 C--N 1.361 1.096 1 C-N-CA 133.999 4.92 . . . . 0.0 103.701 178.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -71.72 41.63 0.69 Allowed Glycine 0 C--N 1.367 2.288 0 N-CA-C 117.2 1.64 . . . . 0.0 117.2 167.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 83.1 29.0 35.25 Favored Glycine 0 C--N 1.361 1.936 0 C-N-CA 128.526 2.965 . . . . 0.0 115.476 176.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 26.5 p -117.02 110.15 17.88 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-O 114.334 -2.746 . . . . 0.0 108.598 176.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.603 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 75.09 -88.66 0.78 Allowed Glycine 0 C--N 1.38 3.003 0 C-N-CA 129.677 3.513 . . . . 0.0 110.022 -174.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -59.97 169.1 5.03 Favored 'Trans proline' 0 CA--C 1.571 2.335 1 C-N-CA 127.223 5.282 . . . . 0.0 116.139 158.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.578 ' HB3' HG12 ' A' ' 140' ' ' VAL . 57.3 m-85 -101.09 143.18 31.52 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 120.616 3.561 . . . . 0.0 120.616 -166.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 8.8 t -102.86 141.21 36.06 Favored 'General case' 0 C--N 1.379 1.876 0 N-CA-C 104.249 -2.5 . . . . 0.0 104.249 173.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.53 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -134.95 156.32 49.21 Favored 'General case' 0 C--N 1.347 0.49 0 N-CA-C 121.015 3.709 . . . . 0.0 121.015 -163.414 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -136.33 111.85 9.28 Favored 'General case' 0 N--CA 1.44 -0.954 0 CA-C-N 112.295 -2.23 . . . . 0.0 105.121 172.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.516 ' HB2' HG13 ' A' ' 115' ' ' ILE . 24.7 m95 -112.8 150.0 32.27 Favored 'General case' 0 C--N 1.353 0.748 0 C-N-CA 125.473 1.509 . . . . 0.0 108.68 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.295 0.1 OUTLIER -156.28 160.5 39.81 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 164.174 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.512 ' CB ' ' HA ' ' A' ' 136' ' ' TYR . 1.8 pptp? -133.93 104.98 6.51 Favored 'General case' 0 C--N 1.368 1.39 0 N-CA-C 116.469 2.025 . . . . 0.0 116.469 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.51 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.243 2.7 t70 37.45 55.17 1.42 Allowed 'General case' 0 CA--C 1.458 -2.585 1 CA-C-O 110.337 -4.649 . . . . 0.0 120.289 155.349 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 96.97 -10.15 65.89 Favored Glycine 0 C--N 1.376 2.786 2 O-C-N 134.632 7.457 . . . . 0.0 115.716 -176.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 73.9 m -124.68 148.86 60.45 Favored Pre-proline 0 CA--C 1.554 1.111 0 C-N-CA 129.995 3.318 . . . . 0.0 119.495 -165.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.25 43.8 Cg_endo -60.04 156.98 36.29 Favored 'Trans proline' 0 N--CA 1.5 1.909 1 C-N-CA 125.777 4.318 . . . . 0.0 116.865 167.782 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 108' ' ' TRP . 0.0 OUTLIER -112.13 150.02 41.81 Favored Pre-proline 0 CA--C 1.548 0.89 0 O-C-N 119.408 -2.057 . . . . 0.0 111.301 175.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -54.77 -81.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.09 1 C-N-CA 127.966 5.777 . . . . 0.0 119.516 -172.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -100.58 -42.1 6.68 Favored 'General case' 0 C--N 1.359 1.02 0 C-N-CA 125.461 1.504 . . . . 0.0 111.369 -176.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.447 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . 71.51 -68.93 0.2 Allowed 'General case' 0 C--N 1.356 0.889 0 C-N-CA 129.045 2.938 . . . . 0.0 118.155 172.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.302 8.3 t -75.8 52.77 0.7 Allowed 'General case' 0 N--CA 1.418 -2.051 1 C-N-CA 134.517 5.127 . . . . 0.0 115.544 -169.81 . . . . . . . . 3 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -150.07 -60.81 0.01 OUTLIER Glycine 0 CA--C 1.476 -2.359 0 N-CA-C 119.152 2.421 . . . . 0.0 119.152 -173.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 150.49 -62.68 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 -174.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.6 t -136.68 117.24 13.84 Favored 'General case' 0 C--N 1.359 0.991 0 O-C-N 120.39 -1.444 . . . . 0.0 113.003 -176.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -127.48 138.12 52.86 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 126.786 2.034 . . . . 0.0 110.751 172.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 91' ' ' LEU . 27.1 m -129.98 139.46 51.06 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 119.851 -1.781 . . . . 0.0 109.583 177.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.25 106.8 54.38 Favored Pre-proline 0 C--N 1.361 1.096 0 C-N-CA 127.799 2.439 . . . . 0.0 106.095 176.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -76.95 -11.9 17.92 Favored 'Trans proline' 0 C--N 1.357 0.999 1 C-N-CA 125.459 4.106 . . . . 0.0 112.738 177.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.45 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -161.24 111.88 1.72 Allowed 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 105.361 -2.089 . . . . 0.0 105.361 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -99.25 126.91 45.17 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.98 176.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.06 -179.31 5.65 Favored 'General case' 0 C--N 1.365 1.281 0 C-N-CA 128.746 2.818 . . . . 0.0 108.584 171.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.6 -53.77 13.72 Favored 'General case' 0 C--N 1.367 1.332 0 N-CA-C 117.309 2.337 . . . . 0.0 117.309 -174.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -69.2 0.14 5.23 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 127.913 2.485 . . . . 0.0 115.304 173.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -116.23 -7.46 11.8 Favored 'General case' 0 C--N 1.351 0.66 0 C-N-CA 131.423 3.889 . . . . 0.0 110.344 176.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -98.54 160.18 14.45 Favored 'General case' 0 C--N 1.397 2.643 0 N-CA-C 120.575 3.546 . . . . 0.0 120.575 168.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.64 -152.72 24.07 Favored Glycine 0 CA--C 1.465 -3.033 0 C-N-CA 127.643 2.544 . . . . 0.0 107.11 -177.126 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.315 19.4 m -118.12 136.52 53.54 Favored 'General case' 0 N--CA 1.507 2.384 0 C-N-CA 114.001 -3.08 . . . . 0.0 109.881 171.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.512 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 14.9 m-85 -96.73 133.65 41.02 Favored 'General case' 0 C--N 1.368 1.391 0 CA-C-N 123.136 2.698 . . . . 0.0 115.283 -171.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.51 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -141.16 146.38 36.93 Favored 'General case' 0 C--N 1.373 1.596 0 CA-C-O 121.132 0.492 . . . . 0.0 110.393 -175.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.402 HG21 ' CE2' ' A' ' 108' ' ' TRP . 15.0 p -141.53 143.49 27.39 Favored 'Isoleucine or valine' 0 C--N 1.372 1.564 0 N-CA-C 116.262 1.949 . . . . 0.0 116.262 178.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.8 m -107.67 120.39 42.11 Favored 'General case' 0 C--N 1.374 1.669 0 C-N-CA 130.341 3.457 . . . . 0.0 107.14 172.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.578 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -131.54 120.23 44.96 Favored 'Isoleucine or valine' 0 C--N 1.354 0.781 0 C-N-CA 125.975 1.71 . . . . 0.0 110.752 -173.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 4.4 m -106.88 132.02 53.3 Favored 'General case' 0 N--CA 1.482 1.139 0 O-C-N 120.475 -1.391 . . . . 0.0 114.522 -177.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.451 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.36 37.3 p-10 -125.93 179.35 5.25 Favored 'General case' 0 C--N 1.377 1.799 0 CA-C-N 119.578 1.081 . . . . 0.0 112.28 175.211 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.603 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 25.4 p -49.62 3.22 0.01 OUTLIER 'General case' 0 C--N 1.372 1.569 1 C-N-CA 135.384 5.474 . . . . 0.0 120.775 -168.906 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -101.96 4.75 40.32 Favored 'General case' 0 C--N 1.358 0.95 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 165.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.494 0.7 OUTLIER 65.72 40.04 4.54 Favored 'General case' 0 C--N 1.37 1.482 1 C-N-CA 133.653 4.781 . . . . 0.0 111.899 -174.342 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.68 124.49 69.4 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.649 0 CA-C-N 111.36 -2.655 . . . . 0.0 112.185 -170.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -91.63 123.72 35.25 Favored 'General case' 0 N--CA 1.436 -1.163 0 C-N-CA 127.623 2.369 . . . . 0.0 106.404 -178.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.71 153.38 31.47 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 101.809 -3.404 . . . . 0.0 101.809 -175.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -130.4 146.54 51.98 Favored 'General case' 0 CA--C 1.494 -1.204 0 O-C-N 120.958 -1.089 . . . . 0.0 109.688 -175.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.323 84.2 p -130.6 145.29 51.86 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 177.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 2.0 m -55.0 147.91 14.66 Favored 'General case' 0 C--N 1.376 1.734 1 C-N-CA 137.06 6.144 . . . . 0.0 117.725 -165.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 136' ' ' TYR . 70.5 p -67.34 110.22 3.46 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 128.528 2.731 . . . . 0.0 111.075 -173.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -94.74 108.19 20.2 Favored 'General case' 0 C--N 1.372 1.557 0 N-CA-C 103.026 -2.953 . . . . 0.0 103.026 -178.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.85 110.33 22.53 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 123.242 1.496 . . . . 0.0 112.654 -170.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.61 114.88 46.34 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.251 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -177.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . 0.294 0.6 OUTLIER -119.21 131.79 55.87 Favored 'General case' 0 C--N 1.368 1.371 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 25.5 m -123.04 115.29 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.313 0 CA-C-O 123.482 1.611 . . . . 0.0 112.366 -170.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -87.6 154.27 53.39 Favored Pre-proline 0 CA--C 1.557 1.212 0 C-N-CA 124.818 1.247 . . . . 0.0 108.719 174.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -72.36 166.64 29.17 Favored 'Trans proline' 0 C--N 1.361 1.19 1 C-N-CA 127.531 5.487 . . . . 0.0 107.15 153.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 18.7 p -66.7 131.2 45.45 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 118.025 -2.922 . . . . 0.0 110.293 -171.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 6.7 t -65.67 111.68 6.86 Favored Pre-proline 0 C--N 1.361 1.095 0 N-CA-C 120.814 3.635 . . . . 0.0 120.814 -128.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -62.35 154.48 63.42 Favored 'Trans proline' 0 C--N 1.381 2.289 1 C-N-CA 126.437 4.758 . . . . 0.0 114.658 172.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -67.81 48.99 0.34 Allowed Glycine 0 C--N 1.368 2.353 0 C-N-CA 128.16 2.79 . . . . 0.0 118.548 -175.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -112.28 35.1 4.83 Favored Glycine 0 C--N 1.353 1.487 0 C-N-CA 128.147 2.784 . . . . 0.0 110.726 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 71.0 mt -121.23 45.0 2.38 Favored 'General case' 0 C--N 1.354 0.784 0 C-N-CA 127.396 2.278 . . . . 0.0 105.814 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -66.97 64.74 0.06 Allowed 'General case' 0 C--N 1.361 1.074 0 N-CA-C 117.672 2.471 . . . . 0.0 117.672 -173.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 14.6 p80 . . . . . 0 C--N 1.366 1.287 0 C-N-CA 127.562 2.345 . . . . 0.0 115.157 -177.606 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.077 0 CA-C-O 121.499 0.666 . . . . 0.0 109.327 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.4 tp -107.51 129.26 54.98 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 126.874 2.07 . . . . 0.0 110.279 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -94.75 173.22 7.71 Favored 'General case' 0 C--N 1.355 0.836 0 C-N-CA 127.454 2.301 . . . . 0.0 109.965 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.412 ' O ' ' HG ' ' A' ' 75' ' ' LEU 0.352 1.0 OUTLIER -82.3 97.6 8.38 Favored 'General case' 0 CA--C 1.55 0.959 0 CA-C-O 123.231 1.491 . . . . 0.0 108.442 175.467 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 1.9 t 57.84 -72.05 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.803 0 O-C-N 116.315 -3.991 . . . . 0.0 116.135 -167.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.9 tmtm? -133.27 137.68 46.14 Favored 'General case' 0 C--N 1.363 1.169 0 C-N-CA 130.535 3.534 . . . . 0.0 109.025 173.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.48 1.4 m-20 -84.8 134.13 34.32 Favored 'General case' 0 C--N 1.378 1.848 0 N-CA-C 103.517 -2.771 . . . . 0.0 103.517 168.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.6 ' O ' HG22 ' A' ' 92' ' ' THR . 0.2 OUTLIER -72.76 -35.68 67.51 Favored 'General case' 0 C--N 1.359 1.02 0 CA-C-N 125.056 3.571 . . . . 0.0 112.67 -178.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.418 HG22 ' N ' ' A' ' 81' ' ' ALA . 36.6 m -171.92 171.84 4.96 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 103.333 -2.84 . . . . 0.0 103.333 169.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.418 ' N ' HG22 ' A' ' 80' ' ' THR . . . -123.24 -48.08 1.99 Allowed 'General case' 0 C--N 1.368 1.372 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 175.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 14.5 t -171.68 148.55 2.44 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 119.299 -2.125 . . . . 0.0 113.535 179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.49 117.35 6.27 Favored 'General case' 0 C--N 1.367 1.363 0 C-N-CA 124.21 1.004 . . . . 0.0 108.48 166.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 7.8 t -110.57 115.63 29.95 Favored 'General case' 0 C--N 1.366 1.321 0 O-C-N 118.792 -2.442 . . . . 0.0 107.348 177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . 0.25 9.5 p -150.97 174.16 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 125.411 1.484 . . . . 0.0 113.757 -169.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -77.68 132.89 38.4 Favored 'General case' 0 C--N 1.374 1.667 0 N-CA-C 105.226 -2.138 . . . . 0.0 105.226 159.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.359 0.0 OUTLIER -42.97 122.61 2.48 Favored 'General case' 0 N--CA 1.514 2.763 0 N-CA-C 119.606 3.187 . . . . 0.0 119.606 -161.426 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.479 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 139.84 50.76 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.223 0 CA-C-N 110.225 -3.171 . . . . 0.0 106.226 -163.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -94.47 145.91 24.45 Favored 'General case' 0 C--N 1.364 1.205 0 C-N-CA 126.72 2.008 . . . . 0.0 107.469 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -94.62 121.57 36.32 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 117.195 2.294 . . . . 0.0 117.195 -170.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 124' ' ' THR . 1.1 mm? -120.84 133.82 55.3 Favored 'General case' 0 C--N 1.372 1.583 0 C-N-CA 127.172 2.189 . . . . 0.0 115.956 172.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -123.81 120.36 32.4 Favored 'General case' 0 C--N 1.359 0.986 1 N-CA-C 98.155 -4.757 . . . . 0.0 98.155 165.302 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.4 HD11 ' CD1' ' A' ' 136' ' ' TYR . 1.2 mm? -115.19 115.49 26.8 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 102.018 -3.327 . . . . 0.0 102.018 176.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.45 ' H ' ' HB3' ' A' ' 79' ' ' LEU . 4.9 t -154.62 133.29 12.11 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 117.801 -1.559 . . . . 0.0 111.789 -174.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.87 174.35 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.743 0 C-N-CA 130.405 3.482 . . . . 0.0 105.573 176.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.8 t -104.03 141.53 36.04 Favored 'General case' 0 C--N 1.361 1.077 0 O-C-N 119.487 -2.008 . . . . 0.0 106.578 177.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.19 145.21 35.36 Favored 'General case' 0 C--N 1.376 1.759 1 N-CA-C 122.989 4.44 . . . . 0.0 122.989 -173.598 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.9 p -156.48 175.28 14.23 Favored 'General case' 0 C--N 1.364 1.223 1 C-N-CA 133.234 4.614 . . . . 0.0 103.36 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.61 41.49 1.0 Allowed Glycine 0 C--N 1.362 2.019 0 N-CA-C 118.156 2.022 . . . . 0.0 118.156 172.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 88.36 18.92 54.38 Favored Glycine 0 C--N 1.362 1.982 0 C-N-CA 127.14 2.305 . . . . 0.0 116.121 175.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 16.6 m -118.19 111.02 18.28 Favored 'General case' 0 N--CA 1.479 0.975 0 CA-C-O 115.039 -2.41 . . . . 0.0 110.185 175.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.592 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 79.35 -93.05 1.31 Allowed Glycine 0 C--N 1.379 2.961 0 C-N-CA 129.665 3.507 . . . . 0.0 109.221 -173.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -60.36 168.54 6.29 Favored 'Trans proline' 0 CA--C 1.564 1.998 1 C-N-CA 127.485 5.457 . . . . 0.0 116.316 159.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.585 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.0 m-85 -99.12 148.14 24.36 Favored 'General case' 0 CA--C 1.548 0.899 0 N-CA-C 119.804 3.261 . . . . 0.0 119.804 -165.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.9 t -110.7 144.69 39.25 Favored 'General case' 0 C--N 1.381 1.938 0 N-CA-C 103.666 -2.716 . . . . 0.0 103.666 175.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.484 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -141.09 165.95 26.14 Favored 'General case' 0 C--N 1.346 0.444 1 N-CA-C 122.345 4.202 . . . . 0.0 122.345 -159.75 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -139.15 118.49 12.81 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 110.723 -2.944 . . . . 0.0 105.044 172.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 85.7 m95 -111.79 134.48 53.32 Favored 'General case' 0 C--N 1.366 1.288 0 C-N-CA 125.797 1.639 . . . . 0.0 109.321 -179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.367 0.2 OUTLIER -155.79 170.01 23.06 Favored 'General case' 0 CA--C 1.488 -1.422 0 O-C-N 120.468 -1.395 . . . . 0.0 107.458 170.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.494 ' HD2' ' CZ ' ' A' ' 136' ' ' TYR . 1.6 ptmm? -143.01 106.49 4.6 Favored 'General case' 0 N--CA 1.429 -1.5 0 O-C-N 119.52 -1.988 . . . . 0.0 111.555 -177.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.508 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.141 2.0 t70 36.41 54.8 1.07 Allowed 'General case' 0 C--N 1.384 2.084 1 CA-C-O 109.687 -4.959 . . . . 0.0 121.53 149.042 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 77.33 2.83 80.81 Favored Glycine 0 C--N 1.386 3.319 2 O-C-N 135.353 7.908 . . . . 0.0 119.561 -172.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.274 1.0 OUTLIER -125.23 147.48 57.53 Favored Pre-proline 0 CA--C 1.566 1.592 0 C-N-CA 129.39 3.076 . . . . 0.0 117.936 -167.227 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -64.85 139.39 62.15 Favored 'Trans proline' 0 N--CA 1.504 2.103 1 C-N-CA 126.037 4.492 . . . . 0.0 117.501 169.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.494 HG12 ' HB2' ' A' ' 118' ' ' ALA . 0.0 OUTLIER -91.63 160.02 37.36 Favored Pre-proline 0 CA--C 1.553 1.059 0 O-C-N 118.441 -2.662 . . . . 0.0 112.773 175.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 12.3 Cg_endo -72.42 -82.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 124.959 3.773 . . . . 0.0 118.284 -172.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -117.29 60.85 0.75 Allowed 'General case' 0 C--N 1.357 0.923 0 C-N-CA 125.277 1.431 . . . . 0.0 109.643 -171.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.494 ' HB2' HG12 ' A' ' 115' ' ' ILE . . . -67.65 151.79 46.69 Favored 'General case' 0 CA--C 1.501 -0.917 0 C-N-CA 129.085 2.954 . . . . 0.0 117.565 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.464 ' HA ' ' CD2' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 80.54 63.71 0.02 OUTLIER 'General case' 0 C--N 1.358 0.952 0 C-N-CA 125.73 1.612 . . . . 0.0 111.015 178.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -148.36 -85.56 0.06 OUTLIER Glycine 0 C--N 1.355 1.598 0 N-CA-C 115.474 0.949 . . . . 0.0 115.474 -170.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.559 ' HB2' ' HB3' ' A' ' 97' ' ' ALA . . . 165.74 -65.75 0.0 OUTLIER 'General case' 0 C--N 1.351 0.671 0 C-N-CA 126.068 1.747 . . . . 0.0 106.712 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.263 14.8 t -133.03 110.11 10.0 Favored 'General case' 0 C--N 1.36 1.056 0 CA-C-O 122.994 1.378 . . . . 0.0 113.308 -177.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.293 9.4 p90 -127.09 141.12 51.85 Favored 'General case' 0 C--N 1.369 1.448 0 C-N-CA 128.339 2.656 . . . . 0.0 112.474 177.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 91' ' ' LEU . 25.5 m -128.82 139.7 52.05 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 119.924 -1.735 . . . . 0.0 108.854 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.71 92.19 45.45 Favored Pre-proline 0 C--N 1.354 0.801 0 C-N-CA 128.748 2.819 . . . . 0.0 104.903 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -74.43 -32.89 5.92 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 124.879 3.719 . . . . 0.0 112.854 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.479 HG23 ' HA2' ' A' ' 88' ' ' GLY . 69.0 m -128.38 100.6 5.86 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 105.97 -1.863 . . . . 0.0 105.97 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -93.67 118.5 31.47 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 125.877 1.671 . . . . 0.0 113.111 -179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.43 -179.06 6.86 Favored 'General case' 0 C--N 1.364 1.231 0 C-N-CA 127.451 2.301 . . . . 0.0 109.438 174.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -51.32 23.62 Favored 'General case' 0 C--N 1.366 1.316 0 O-C-N 117.803 -3.06 . . . . 0.0 118.088 -174.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -67.31 0.86 2.53 Favored 'General case' 0 C--N 1.366 1.32 0 C-N-CA 128.851 2.86 . . . . 0.0 115.111 171.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -116.36 -13.91 11.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 129.544 3.138 . . . . 0.0 111.102 175.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.458 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -97.75 154.64 17.46 Favored 'General case' 0 C--N 1.399 2.739 0 N-CA-C 117.915 2.561 . . . . 0.0 117.915 174.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 150.46 -157.78 27.36 Favored Glycine 0 C--N 1.382 3.095 0 C-N-CA 128.923 3.154 . . . . 0.0 109.81 -173.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.393 5.7 m -110.66 130.83 55.47 Favored 'General case' 0 N--CA 1.502 2.171 0 C-N-CA 112.343 -3.743 . . . . 0.0 107.545 167.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.502 ' HB2' ' HB3' ' A' ' 153' ' ' CYS . 24.5 m-85 -96.81 134.77 39.68 Favored 'General case' 0 C--N 1.364 1.238 0 CA-C-N 122.605 2.457 . . . . 0.0 113.011 -172.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.508 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -148.5 150.64 33.77 Favored 'General case' 0 C--N 1.376 1.743 0 C-N-CA 124.878 1.271 . . . . 0.0 110.456 -175.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 149' ' ' ASP . 8.9 p -143.67 137.49 24.95 Favored 'Isoleucine or valine' 0 C--N 1.371 1.501 0 C-N-CA 117.956 -1.497 . . . . 0.0 114.314 -179.151 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -105.23 111.77 24.65 Favored 'General case' 0 C--N 1.378 1.811 0 C-N-CA 130.34 3.456 . . . . 0.0 105.341 177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.585 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -127.21 112.21 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 128.124 2.569 . . . . 0.0 110.73 -169.59 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 8.0 m -99.3 130.93 45.62 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -177.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.458 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.364 25.3 p-10 -127.7 -177.03 3.94 Favored 'General case' 0 C--N 1.372 1.584 0 CA-C-N 119.234 0.925 . . . . 0.0 112.213 174.763 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.592 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 20.4 p -49.83 3.36 0.01 OUTLIER 'General case' 0 C--N 1.369 1.414 1 C-N-CA 136.749 6.02 . . . . 0.0 120.501 -169.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -101.27 4.89 42.18 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 163.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.358 2.1 mp0 65.44 39.53 5.12 Favored 'General case' 0 C--N 1.378 1.825 1 C-N-CA 134.249 5.02 . . . . 0.0 110.678 -175.149 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.452 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.58 133.4 59.64 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 CA-C-N 112.137 -2.302 . . . . 0.0 111.99 -170.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.51 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 1.8 t -91.69 132.16 36.57 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 120.744 1.611 . . . . 0.0 106.883 174.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.13 157.99 23.92 Favored 'General case' 0 CA--C 1.494 -1.18 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 -176.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 22.6 t70 -126.11 134.18 51.42 Favored 'General case' 0 CA--C 1.496 -1.102 0 CA-C-O 121.814 0.816 . . . . 0.0 109.294 -175.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.528 59.8 p -111.13 143.9 41.12 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 173.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 3.8 m -54.05 146.74 13.97 Favored 'General case' 0 C--N 1.368 1.404 1 C-N-CA 136.709 6.004 . . . . 0.0 119.405 -155.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 77.0 p -69.06 110.1 4.33 Favored 'General case' 0 C--N 1.376 1.719 0 C-N-CA 124.264 1.026 . . . . 0.0 110.711 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.502 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 4.7 t -100.02 110.12 22.43 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.14 103.89 15.86 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 122.758 1.266 . . . . 0.0 112.267 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 1.2 m -112.43 115.18 49.11 Favored 'Isoleucine or valine' 0 C--N 1.362 1.122 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 1.3 m -113.41 131.58 55.95 Favored 'General case' 0 CA--C 1.489 -1.381 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 -174.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.458 HG22 ' CB ' ' A' ' 133' ' ' ALA . 13.3 m -132.98 124.31 49.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 124.53 1.132 . . . . 0.0 111.574 -178.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -106.88 159.51 29.67 Favored Pre-proline 0 CA--C 1.553 1.075 0 C-N-CA 125.23 1.412 . . . . 0.0 107.343 166.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.38 167.24 27.48 Favored 'Trans proline' 0 C--N 1.359 1.111 1 C-N-CA 128.656 6.237 . . . . 0.0 110.022 162.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 11.9 p -67.55 127.61 33.35 Favored 'General case' 0 C--N 1.373 1.629 0 O-C-N 119.551 -1.968 . . . . 0.0 108.789 -178.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.4 t -65.75 122.05 78.69 Favored Pre-proline 0 C--N 1.364 1.223 0 N-CA-C 120.856 3.65 . . . . 0.0 120.856 -122.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.18 145.7 96.21 Favored 'Trans proline' 0 C--N 1.388 2.609 1 C-N-CA 126.107 4.538 . . . . 0.0 114.516 176.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.79 51.3 0.89 Allowed Glycine 0 C--N 1.366 2.206 0 C-N-CA 127.98 2.705 . . . . 0.0 117.921 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -106.67 34.69 5.54 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 127.34 2.4 . . . . 0.0 110.129 177.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -133.77 38.57 3.21 Favored 'General case' 0 C--N 1.35 0.596 0 C-N-CA 126.89 2.076 . . . . 0.0 109.836 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.0 mm-40 -75.46 58.38 1.01 Allowed 'General case' 0 C--N 1.36 1.029 0 C-N-CA 127.135 2.174 . . . . 0.0 115.67 -176.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 61.1 t-80 . . . . . 0 C--N 1.353 0.72 0 C-N-CA 125.48 1.512 . . . . 0.0 108.012 179.951 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.033 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.7 tp -102.71 127.84 49.68 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 126.639 1.976 . . . . 0.0 110.676 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 7.0 t -103.3 173.73 6.18 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 127.829 2.451 . . . . 0.0 108.522 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.289 0.9 OUTLIER -72.61 99.31 2.52 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 124.318 1.047 . . . . 0.0 110.185 174.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 57.89 -82.24 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 117.869 -3.02 . . . . 0.0 114.666 -170.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 1.2 tppm? -133.01 140.11 47.58 Favored 'General case' 0 C--N 1.361 1.101 0 C-N-CA 130.713 3.605 . . . . 0.0 105.122 167.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -84.54 172.02 12.0 Favored 'General case' 0 N--CA 1.443 -0.779 1 C-N-CA 135.039 5.336 . . . . 0.0 108.303 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 79' ' ' LEU . 0.5 OUTLIER -71.22 -36.81 71.99 Favored 'General case' 0 CA--C 1.575 1.907 0 O-C-N 118.956 -2.34 . . . . 0.0 115.943 -177.096 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -175.93 176.21 1.84 Allowed 'General case' 0 CA--C 1.5 -0.96 1 N-CA-C 97.987 -4.82 . . . . 0.0 97.987 167.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.25 -51.24 2.92 Favored 'General case' 0 C--N 1.349 0.551 0 CA-C-N 121.713 2.052 . . . . 0.0 107.862 162.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 30.0 t -166.67 135.61 2.9 Favored 'General case' 0 C--N 1.358 0.95 0 O-C-N 119.562 -1.961 . . . . 0.0 114.396 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 26.5 ttt -137.79 116.73 12.4 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-O 122.592 1.187 . . . . 0.0 109.388 161.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.8 p -108.57 115.22 29.68 Favored 'General case' 0 C--N 1.362 1.133 0 O-C-N 119.023 -2.298 . . . . 0.0 107.972 175.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.4 p -149.55 173.17 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.69 0 C-N-CA 127.535 2.334 . . . . 0.0 112.077 -169.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -74.59 136.27 42.05 Favored 'General case' 0 C--N 1.37 1.484 0 O-C-N 118.739 -2.476 . . . . 0.0 107.175 158.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.506 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.28 5.8 pt-20 -43.34 122.08 2.45 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 117.587 2.44 . . . . 0.0 117.587 -162.616 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.56 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 136.19 45.0 0.09 OUTLIER Glycine 0 C--N 1.352 1.43 0 CA-C-N 110.094 -3.23 . . . . 0.0 111.526 -162.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.23 164.57 21.11 Favored 'General case' 0 C--N 1.373 1.604 0 C-N-CA 125.07 1.348 . . . . 0.0 111.383 173.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -110.37 101.98 10.65 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 123.072 1.415 . . . . 0.0 113.897 -173.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 125' ' ' LYS . 1.2 mp -119.71 128.82 54.15 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -175.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.6 t -114.53 135.69 53.85 Favored 'General case' 0 C--N 1.358 0.953 1 N-CA-C 99.422 -4.288 . . . . 0.0 99.422 165.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -118.01 114.79 23.68 Favored 'General case' 0 CA--C 1.509 -0.618 0 N-CA-C 100.867 -3.753 . . . . 0.0 100.867 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 3.1 t -150.3 132.65 15.55 Favored 'General case' 0 C--N 1.366 1.321 0 C-N-CA 118.2 -1.4 . . . . 0.0 114.147 -168.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.5 m -149.59 174.76 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.943 1 C-N-CA 132.971 4.508 . . . . 0.0 106.198 177.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 7.0 t -104.37 141.52 36.18 Favored 'General case' 0 C--N 1.367 1.368 0 O-C-N 118.948 -2.345 . . . . 0.0 106.669 175.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.98 135.9 38.04 Favored 'General case' 0 C--N 1.374 1.654 0 N-CA-C 120.986 3.699 . . . . 0.0 120.986 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 73.0 m -157.69 172.11 19.11 Favored 'General case' 0 C--N 1.359 1.012 1 C-N-CA 131.789 4.035 . . . . 0.0 101.518 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -73.98 44.12 1.27 Allowed Glycine 0 C--N 1.367 2.301 0 CA-C-N 122.535 2.425 . . . . 0.0 117.381 177.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.29 25.49 57.1 Favored Glycine 0 C--N 1.355 1.596 0 C-N-CA 128.552 2.977 . . . . 0.0 115.422 177.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 88.2 m -117.9 110.96 18.38 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-O 114.444 -2.693 . . . . 0.0 107.587 173.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.544 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 78.03 -89.27 1.08 Allowed Glycine 0 C--N 1.376 2.783 0 C-N-CA 130.148 3.737 . . . . 0.0 109.953 -174.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -60.68 167.99 7.55 Favored 'Trans proline' 0 CA--C 1.564 2.01 1 C-N-CA 127.009 5.14 . . . . 0.0 116.258 159.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.588 ' HB3' HG12 ' A' ' 140' ' ' VAL . 82.1 m-85 -102.57 146.58 27.94 Favored 'General case' 0 CA--C 1.557 1.239 0 N-CA-C 120.036 3.347 . . . . 0.0 120.036 -166.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.8 t -105.63 153.83 21.26 Favored 'General case' 0 N--CA 1.496 1.871 0 C-N-CA 129.354 3.062 . . . . 0.0 104.083 173.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -155.02 164.9 38.25 Favored 'General case' 0 C--N 1.366 1.295 1 N-CA-C 122.231 4.16 . . . . 0.0 122.231 -161.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -132.29 114.63 14.64 Favored 'General case' 0 C--N 1.362 1.138 0 C-N-CA 128.614 2.766 . . . . 0.0 106.258 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -111.02 131.27 55.2 Favored 'General case' 0 C--N 1.368 1.404 0 C-N-CA 127.145 2.178 . . . . 0.0 109.807 -178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.313 0.0 OUTLIER -151.03 169.54 21.57 Favored 'General case' 0 CA--C 1.49 -1.365 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 168.602 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HD3' ' CD1' ' A' ' 136' ' ' TYR . 4.0 ttpt -135.61 107.68 7.17 Favored 'General case' 0 N--CA 1.422 -1.865 0 N-CA-C 104.101 -2.555 . . . . 0.0 104.101 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.426 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.24 0.8 OUTLIER 33.25 50.83 0.27 Allowed 'General case' 0 C--N 1.374 1.658 1 N-CA-C 123.546 4.647 . . . . 0.0 123.546 135.421 . . . . . . . . 5 4 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 82.96 -3.54 83.66 Favored Glycine 0 C--N 1.363 2.063 2 O-C-N 132.412 6.07 . . . . 0.0 120.199 -172.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.293 3.4 m -124.02 147.38 53.99 Favored Pre-proline 0 CA--C 1.553 1.083 0 C-N-CA 129.963 3.305 . . . . 0.0 118.598 -172.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -62.07 140.49 84.47 Favored 'Trans proline' 0 C--N 1.37 1.665 1 C-N-CA 126.215 4.61 . . . . 0.0 115.645 172.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.522 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -88.63 164.87 30.42 Favored Pre-proline 0 CA--C 1.547 0.845 0 O-C-N 119.694 -1.879 . . . . 0.0 111.23 175.24 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 90.6 Cg_exo -52.21 -44.62 44.86 Favored 'Trans proline' 0 C--N 1.353 0.793 1 C-N-CA 127.785 5.657 . . . . 0.0 118.72 -171.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -169.15 -50.43 0.02 OUTLIER 'General case' 0 C--N 1.348 0.507 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -179.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 81.03 -164.17 0.02 OUTLIER 'General case' 0 C--N 1.364 1.204 0 C-N-CA 129.328 3.051 . . . . 0.0 111.401 -178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t 82.6 3.17 1.14 Allowed 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 119.609 3.189 . . . . 0.0 119.609 170.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 169.97 85.11 0.06 OUTLIER Glycine 0 CA--C 1.475 -2.467 0 C-N-CA 115.597 -3.192 . . . . 0.0 119.125 170.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . 0.335 . . 87.47 -78.63 0.01 OUTLIER 'General case' 0 CA--C 1.499 -0.992 0 N-CA-C 116.936 2.199 . . . . 0.0 116.936 163.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.306 6.0 t -141.37 119.95 12.45 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-O 123.833 1.778 . . . . 0.0 115.153 -170.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -127.3 142.67 51.4 Favored 'General case' 0 C--N 1.368 1.372 0 C-N-CA 129.514 3.126 . . . . 0.0 109.883 178.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 21.7 m -126.38 139.0 53.62 Favored 'General case' 0 C--N 1.361 1.09 0 CA-C-N 122.345 2.339 . . . . 0.0 109.678 176.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.432 ' HB2' ' HB2' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -119.15 89.31 39.19 Favored Pre-proline 0 C--N 1.37 1.493 0 C-N-CA 129.056 2.942 . . . . 0.0 103.847 176.625 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -73.28 -31.39 9.36 Favored 'Trans proline' 0 N--CA 1.471 0.204 1 C-N-CA 125.512 4.142 . . . . 0.0 112.668 -172.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.56 HG23 ' HA2' ' A' ' 88' ' ' GLY . 55.2 m -143.98 100.53 3.58 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 100.772 -3.788 . . . . 0.0 100.772 177.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.693 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -86.93 134.58 33.5 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.312 1.845 . . . . 0.0 114.443 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -81.15 171.69 14.59 Favored 'General case' 0 C--N 1.366 1.302 0 C-N-CA 127.436 2.294 . . . . 0.0 112.343 178.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.1 -43.72 20.65 Favored 'General case' 0 C--N 1.37 1.477 0 N-CA-C 119.003 2.964 . . . . 0.0 119.003 -172.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -67.2 -13.32 61.85 Favored 'General case' 0 C--N 1.366 1.304 0 C-N-CA 128.545 2.738 . . . . 0.0 115.07 174.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.693 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 4.9 m-20 -74.31 -21.08 59.88 Favored 'General case' 0 CA--C 1.561 1.379 0 C-N-CA 128.113 2.565 . . . . 0.0 112.239 167.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -61.17 119.75 9.0 Favored 'General case' 0 C--N 1.386 2.183 0 N-CA-C 120.449 3.5 . . . . 0.0 120.449 172.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.97 -155.13 26.35 Favored Glycine 0 CA--C 1.468 -2.879 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.491 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.316 6.9 m -118.3 132.01 56.31 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 115.397 -2.521 . . . . 0.0 107.214 171.473 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.464 ' CD1' ' HD3' ' A' ' 110' ' ' LYS . 2.5 m-85 -97.06 133.81 41.24 Favored 'General case' 0 C--N 1.36 1.045 0 C-N-CA 125.85 1.66 . . . . 0.0 110.487 -170.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.491 ' HE3' ' HB2' ' A' ' 135' ' ' SER . 0.0 OUTLIER -145.62 144.5 30.49 Favored 'General case' 0 C--N 1.369 1.421 0 CA-C-O 122.091 0.948 . . . . 0.0 109.647 -174.394 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.291 7.5 p -141.8 135.94 30.23 Favored 'Isoleucine or valine' 0 C--N 1.364 1.218 0 C-N-CA 117.685 -1.606 . . . . 0.0 114.166 177.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 37.8 m -103.08 121.26 42.22 Favored 'General case' 0 C--N 1.38 1.915 0 C-N-CA 129.455 3.102 . . . . 0.0 106.238 176.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -132.22 120.44 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 C-N-CA 127.127 2.171 . . . . 0.0 110.497 -169.501 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.467 HG23 ' C ' ' A' ' 146' ' ' VAL . 14.1 m -107.78 133.35 52.3 Favored 'General case' 0 N--CA 1.479 1.008 0 O-C-N 119.877 -1.764 . . . . 0.0 112.816 -177.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.466 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.373 18.3 p-10 -129.76 -176.55 3.95 Favored 'General case' 0 C--N 1.377 1.77 0 C-N-CA 124.804 1.242 . . . . 0.0 111.929 176.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.544 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 8.1 p -49.37 1.5 0.01 OUTLIER 'General case' 0 C--N 1.369 1.437 1 C-N-CA 136.332 5.853 . . . . 0.0 120.519 -167.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -99.75 4.63 45.5 Favored 'General case' 0 C--N 1.363 1.167 0 C-N-CA 118.262 -1.375 . . . . 0.0 107.784 163.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.437 0.8 OUTLIER 65.67 39.77 4.72 Favored 'General case' 0 C--N 1.371 1.508 1 C-N-CA 133.961 4.904 . . . . 0.0 111.623 -174.524 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.467 ' C ' HG23 ' A' ' 141' ' ' THR . 3.0 m -113.43 131.94 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.675 0 CA-C-N 111.023 -2.808 . . . . 0.0 112.394 -169.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.2 124.0 35.07 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 127.856 2.462 . . . . 0.0 107.477 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.36 157.69 24.65 Favored 'General case' 0 CA--C 1.508 -0.648 0 C-N-CA 128.798 2.839 . . . . 0.0 103.835 -178.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -128.5 137.34 51.74 Favored 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.861 1.21 . . . . 0.0 109.672 -177.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.385 75.1 p -113.55 143.21 44.93 Favored 'General case' 0 C--O 1.25 1.127 0 C-N-CA 125.405 1.482 . . . . 0.0 109.245 176.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.2 m -54.11 148.47 10.99 Favored 'General case' 0 C--N 1.37 1.492 1 C-N-CA 135.839 5.656 . . . . 0.0 118.887 -159.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 66.6 p -69.09 111.31 4.99 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 127.718 2.407 . . . . 0.0 110.1 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.28 109.85 22.07 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 102.668 -3.086 . . . . 0.0 102.668 -178.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.05 105.99 18.1 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-O 124.433 2.063 . . . . 0.0 110.372 -174.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.1 m -118.46 128.21 75.44 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 -176.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 14.9 m -119.9 124.07 45.12 Favored 'General case' 0 CA--C 1.484 -1.565 0 N-CA-C 101.333 -3.58 . . . . 0.0 101.333 177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.506 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 2.5 m -126.63 103.91 11.97 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.268 0 N-CA-C 103.897 -2.631 . . . . 0.0 103.897 178.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 24.6 m-20 -82.79 155.71 67.97 Favored Pre-proline 0 C--N 1.358 0.97 0 C-N-CA 126.147 1.779 . . . . 0.0 111.41 -175.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -67.52 165.41 27.34 Favored 'Trans proline' 0 CA--C 1.544 1.023 1 C-N-CA 125.629 4.219 . . . . 0.0 108.678 155.546 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -67.53 134.75 51.85 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 118.796 -2.44 . . . . 0.0 110.599 -173.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.452 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 3.8 t -66.64 109.08 2.9 Favored Pre-proline 0 C--N 1.359 0.999 1 N-CA-C 122.001 4.074 . . . . 0.0 122.001 -124.244 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 32.2 Cg_endo -62.5 154.49 64.17 Favored 'Trans proline' 0 C--N 1.386 2.542 1 C-N-CA 126.228 4.619 . . . . 0.0 114.619 171.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.61 49.11 0.45 Allowed Glycine 0 C--N 1.368 2.329 0 C-N-CA 128.259 2.837 . . . . 0.0 118.033 -176.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -107.38 29.25 10.79 Favored Glycine 0 C--N 1.354 1.574 0 C-N-CA 127.675 2.56 . . . . 0.0 110.602 178.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 61.9 mt -115.78 46.59 1.49 Allowed 'General case' 0 C--N 1.355 0.837 0 C-N-CA 126.982 2.113 . . . . 0.0 107.431 176.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 47.2 mm-40 -71.51 62.56 0.38 Allowed 'General case' 0 C--N 1.359 1.021 0 C-N-CA 127.596 2.358 . . . . 0.0 115.75 -176.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 86.3 t60 . . . . . 0 C--N 1.353 0.727 0 C-N-CA 127.922 2.489 . . . . 0.0 109.693 179.051 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.172 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 16.6 tp -107.51 141.0 39.62 Favored 'General case' 0 C--N 1.357 0.909 0 C-N-CA 125.734 1.614 . . . . 0.0 110.544 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.9 t -94.54 173.06 7.81 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 126.187 1.795 . . . . 0.0 110.613 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.363 0.6 OUTLIER -86.99 98.96 11.55 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 127.274 2.23 . . . . 0.0 107.493 171.517 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 60.49 -76.73 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 118.553 -2.592 . . . . 0.0 115.575 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 24.7 tptt -133.33 140.39 47.38 Favored 'General case' 0 C--N 1.36 1.038 0 C-N-CA 129.238 3.015 . . . . 0.0 104.896 166.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.291 5.4 t0 -83.79 174.34 10.52 Favored 'General case' 0 CA--C 1.503 -0.858 1 C-N-CA 133.926 4.89 . . . . 0.0 110.23 178.765 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.521 ' HG ' ' H ' ' A' ' 79' ' ' LEU . 0.5 OUTLIER -70.16 -34.67 73.3 Favored 'General case' 0 CA--C 1.584 2.254 0 O-C-N 121.352 -0.842 . . . . 0.0 113.061 174.262 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 m -170.8 172.33 5.72 Favored 'General case' 0 N--CA 1.471 0.588 1 O-C-N 114.385 -5.197 . . . . 0.0 101.903 173.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -137.18 -41.94 0.57 Allowed 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.588 1.555 . . . . 0.0 111.349 177.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 58.1 m -163.73 117.49 1.52 Allowed 'General case' 0 C--N 1.363 1.191 0 N-CA-C 117.754 2.501 . . . . 0.0 117.754 -178.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 24.4 ttt -137.18 116.57 12.74 Favored 'General case' 0 C--N 1.377 1.791 0 CA-C-N 120.378 1.445 . . . . 0.0 109.079 155.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 17.1 m -113.25 117.02 30.7 Favored 'General case' 0 C--N 1.365 1.261 0 O-C-N 118.607 -2.558 . . . . 0.0 109.063 176.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.4 p -149.4 172.58 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.937 0 C-N-CA 126.058 1.743 . . . . 0.0 110.156 -170.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -82.99 130.9 35.19 Favored 'General case' 0 C--N 1.373 1.625 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 163.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -41.85 122.34 2.02 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 119.542 3.164 . . . . 0.0 119.542 -153.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.484 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 143.61 43.36 0.05 OUTLIER Glycine 0 C--N 1.356 1.662 0 CA-C-N 109.721 -3.399 . . . . 0.0 110.7 -163.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.53 168.02 14.89 Favored 'General case' 0 C--N 1.374 1.67 0 C-N-CA 124.802 1.241 . . . . 0.0 112.543 175.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.48 99.37 8.15 Favored 'General case' 0 C--N 1.353 0.753 0 C-N-CA 124.188 0.995 . . . . 0.0 109.595 -177.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.1 mp -110.03 111.78 23.38 Favored 'General case' 0 C--N 1.35 0.599 0 C-N-CA 125.494 1.518 . . . . 0.0 113.94 -173.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.44 HG22 ' O ' ' A' ' 79' ' ' LEU . 0.9 OUTLIER -105.19 125.5 51.05 Favored 'General case' 0 C--N 1.371 1.534 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 174.025 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -122.67 114.87 21.17 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 103.539 -2.763 . . . . 0.0 103.539 174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 4.3 t -151.14 134.3 16.01 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 120.938 -1.101 . . . . 0.0 112.197 -173.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.1 m -149.03 173.85 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.727 0 C-N-CA 130.769 3.627 . . . . 0.0 103.703 176.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 9.2 t -104.16 138.47 40.6 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.591 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.3 142.15 33.88 Favored 'General case' 0 C--N 1.366 1.301 0 N-CA-C 120.012 3.338 . . . . 0.0 120.012 -174.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 95.5 m -158.26 174.33 15.33 Favored 'General case' 0 C--N 1.353 0.734 0 C-N-CA 130.826 3.65 . . . . 0.0 102.178 -179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.36 44.29 1.64 Allowed Glycine 0 C--N 1.366 2.244 0 O-C-N 118.681 -2.512 . . . . 0.0 117.452 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.24 21.36 65.14 Favored Glycine 0 C--N 1.359 1.838 0 C-N-CA 128.823 3.106 . . . . 0.0 114.749 179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 10.1 p -116.55 111.34 19.78 Favored 'General case' 0 CA--C 1.509 -0.625 0 C-N-CA 126.165 1.786 . . . . 0.0 106.823 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.753 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 70.51 -90.72 0.38 Allowed Glycine 0 C--N 1.364 2.115 0 C-N-CA 130.649 3.976 . . . . 0.0 111.586 -169.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -60.74 168.39 7.05 Favored 'Trans proline' 0 CA--C 1.568 2.184 1 C-N-CA 127.457 5.438 . . . . 0.0 117.289 160.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.619 ' HB3' HG12 ' A' ' 140' ' ' VAL . 74.6 m-85 -93.64 142.32 27.49 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 121.317 3.821 . . . . 0.0 121.317 -167.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 10.1 t -102.96 155.13 18.57 Favored 'General case' 0 C--N 1.383 2.025 0 C-N-CA 128.23 2.612 . . . . 0.0 104.905 172.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.47 ' CD1' ' HA ' ' A' ' 119' ' ' SER . 0.0 OUTLIER -155.59 166.94 32.0 Favored 'General case' 0 C--N 1.362 1.133 1 N-CA-C 122.402 4.223 . . . . 0.0 122.402 -159.375 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.36 114.18 7.65 Favored 'General case' 0 C--N 1.362 1.14 0 CA-C-N 112.166 -2.288 . . . . 0.0 107.596 173.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -113.29 155.07 25.78 Favored 'General case' 0 C--N 1.373 1.606 0 O-C-N 119.622 -1.924 . . . . 0.0 110.965 178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 8.0 p -149.06 159.13 44.51 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 106.036 -1.839 . . . . 0.0 106.036 167.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' CE ' ' HA ' ' A' ' 132' ' ' ASP . 0.0 OUTLIER -123.5 102.23 7.76 Favored 'General case' 0 C--N 1.377 1.797 0 C-N-CA 114.411 -2.916 . . . . 0.0 112.673 161.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.45 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.173 1.6 t70 36.47 54.17 1.06 Allowed 'General case' 0 CA--C 1.458 -2.58 0 CA-C-O 111.972 -3.87 . . . . 0.0 120.526 149.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 105.93 -17.17 42.14 Favored Glycine 0 C--N 1.363 2.055 1 O-C-N 133.193 6.558 . . . . 0.0 116.573 -172.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.7 m -122.73 146.41 47.95 Favored Pre-proline 0 CA--C 1.573 1.854 0 C-N-CA 131.344 3.858 . . . . 0.0 119.876 -170.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . 0.266 65.1 Cg_endo -65.08 136.12 46.73 Favored 'Trans proline' 0 N--CA 1.509 2.43 1 C-N-CA 128.684 6.256 . . . . 0.0 116.334 176.739 . . . . . . . . 3 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.516 ' HB ' ' CD ' ' A' ' 116' ' ' PRO 0.421 0.6 OUTLIER -84.64 164.95 40.32 Favored Pre-proline 0 N--CA 1.485 1.316 2 O-C-N 116.123 -4.111 . . . . 0.0 116.846 179.889 . . . . . . . . 5 4 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.516 ' CD ' ' HB ' ' A' ' 115' ' ' ILE . 2.8 Cg_exo -67.1 80.88 0.37 Allowed 'Trans proline' 0 C--N 1.384 2.446 1 C-N-CA 127.3 5.333 . . . . 0.0 112.571 179.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 80.29 -62.21 0.25 Allowed 'General case' 0 C--N 1.353 0.737 0 C-N-CA 127.874 2.47 . . . . 0.0 110.815 -176.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.469 ' HB2' ' CG1' ' A' ' 115' ' ' ILE . . . 84.94 162.28 0.1 Allowed 'General case' 0 C--N 1.372 1.554 0 C-N-CA 129.207 3.003 . . . . 0.0 111.448 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.47 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.2 OUTLIER 74.03 59.54 0.08 Allowed 'General case' 0 C--N 1.355 0.825 0 CA-C-O 122.767 1.27 . . . . 0.0 114.127 174.95 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -141.44 -85.51 0.09 OUTLIER Glycine 0 C--N 1.356 1.648 0 N-CA-C 117.487 1.755 . . . . 0.0 117.487 -170.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.591 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.26 . . 160.01 -71.13 0.0 OUTLIER 'General case' 0 C--N 1.353 0.755 0 C-N-CA 124.98 1.312 . . . . 0.0 110.437 -177.589 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 15.1 t -136.09 104.96 5.86 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 122.859 1.314 . . . . 0.0 113.838 -175.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.299 7.8 p90 -128.05 140.97 51.65 Favored 'General case' 0 C--N 1.363 1.174 0 C-N-CA 127.713 2.405 . . . . 0.0 110.563 174.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 70.9 m -129.07 139.27 52.09 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 119.931 -1.73 . . . . 0.0 109.094 177.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.259 1.3 mmmm -105.76 111.67 64.6 Favored Pre-proline 0 C--N 1.372 1.548 0 N-CA-C 105.885 -1.895 . . . . 0.0 105.885 171.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -77.21 -16.89 15.33 Favored 'Trans proline' 0 C--N 1.354 0.823 1 C-N-CA 126.37 4.713 . . . . 0.0 113.339 178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.484 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.0 OUTLIER -162.18 101.27 1.1 Allowed 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 102.735 -3.061 . . . . 0.0 102.735 177.769 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.549 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -88.53 134.59 33.82 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 127.395 2.278 . . . . 0.0 113.167 -178.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -84.17 176.83 8.51 Favored 'General case' 0 C--N 1.372 1.579 0 C-N-CA 128.351 2.66 . . . . 0.0 112.718 177.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.73 -46.63 29.97 Favored 'General case' 0 C--N 1.37 1.467 0 N-CA-C 119.414 3.116 . . . . 0.0 119.414 -172.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -60.98 -16.88 48.01 Favored 'General case' 0 C--N 1.365 1.247 0 C-N-CA 129.142 2.977 . . . . 0.0 115.0 174.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.549 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 7.4 m-20 -80.43 -22.04 41.58 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 128.79 2.836 . . . . 0.0 113.855 170.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.518 ' HB2' ' H ' ' A' ' 157' ' ' VAL . . . -65.27 124.63 22.71 Favored 'General case' 0 C--N 1.382 2.014 0 N-CA-C 120.234 3.42 . . . . 0.0 120.234 173.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 163.14 -159.27 31.76 Favored Glycine 0 CA--C 1.463 -3.217 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 173.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.4 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.311 50.5 m -112.6 133.78 54.47 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 115.002 -2.679 . . . . 0.0 107.775 171.482 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.427 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 5.9 m-85 -96.2 133.43 40.53 Favored 'General case' 0 CA--C 1.489 -1.38 0 O-C-N 118.988 -2.32 . . . . 0.0 110.311 -171.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -142.61 142.98 32.22 Favored 'General case' 0 CA--C 1.492 -1.285 0 O-C-N 125.111 1.507 . . . . 0.0 107.329 -173.44 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 13.1 p -133.45 143.4 39.1 Favored 'Isoleucine or valine' 0 C--N 1.36 1.031 0 CA-C-N 113.44 -1.709 . . . . 0.0 113.781 179.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 21.7 m -110.86 120.75 43.42 Favored 'General case' 0 C--N 1.38 1.898 0 C-N-CA 127.71 2.404 . . . . 0.0 106.135 171.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.619 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -132.58 120.49 42.37 Favored 'Isoleucine or valine' 0 C--N 1.361 1.101 0 C-N-CA 126.439 1.896 . . . . 0.0 112.143 -172.154 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 11.9 m -108.75 129.63 55.37 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 119.652 -1.905 . . . . 0.0 114.338 -178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.442 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.468 17.5 p30 -126.67 -167.84 1.78 Allowed 'General case' 0 C--N 1.376 1.735 0 CA-C-N 119.972 1.26 . . . . 0.0 113.057 175.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.753 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 20.2 p -49.77 -0.52 0.01 OUTLIER 'General case' 0 C--N 1.365 1.259 2 C-N-CA 135.08 5.352 . . . . 0.0 122.04 -162.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -105.91 4.68 29.84 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 118.637 -1.225 . . . . 0.0 108.119 167.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.41 87.3 mm-40 68.29 40.32 2.11 Favored 'General case' 0 C--N 1.375 1.717 0 C-N-CA 131.635 3.974 . . . . 0.0 109.819 -170.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 2.9 m -112.52 122.9 67.61 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.135 0 CA-C-N 111.991 -2.368 . . . . 0.0 112.528 -170.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -90.49 124.11 34.73 Favored 'General case' 0 C--N 1.362 1.115 0 C-N-CA 128.646 2.778 . . . . 0.0 107.254 -177.739 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.17 157.33 24.98 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 129.303 3.041 . . . . 0.0 103.066 -179.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -130.2 143.36 50.74 Favored 'General case' 0 CA--C 1.5 -0.955 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 -177.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.39 5.0 p -124.62 148.18 48.05 Favored 'General case' 0 C--O 1.26 1.626 0 CA-C-N 119.378 0.99 . . . . 0.0 109.509 176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 1.2 m -54.4 147.01 14.53 Favored 'General case' 0 C--N 1.385 2.127 2 C-N-CA 137.817 6.447 . . . . 0.0 115.776 -162.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 73.5 p -68.82 109.8 4.04 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 113.159 -1.837 . . . . 0.0 111.721 -172.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -91.92 108.95 20.29 Favored 'General case' 0 C--N 1.368 1.412 0 N-CA-C 102.711 -3.07 . . . . 0.0 102.711 178.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.31 109.02 21.6 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 123.889 1.804 . . . . 0.0 110.029 -173.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -121.83 128.24 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 O-C-N 120.367 -1.458 . . . . 0.0 108.676 -176.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 98.3 m -112.79 121.54 45.01 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 102.281 -3.229 . . . . 0.0 102.281 175.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.518 ' H ' ' HB2' ' A' ' 133' ' ' ALA . 4.2 m -135.03 102.28 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 N-CA-C 104.951 -2.24 . . . . 0.0 104.951 171.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -107.37 153.07 41.43 Favored Pre-proline 0 C--N 1.349 0.545 0 O-C-N 119.983 -1.698 . . . . 0.0 108.762 176.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -69.2 166.36 27.16 Favored 'Trans proline' 0 C--N 1.361 1.204 1 C-N-CA 126.873 5.049 . . . . 0.0 109.734 161.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 8.2 p -67.42 133.19 49.11 Favored 'General case' 0 C--N 1.371 1.54 0 O-C-N 119.161 -2.212 . . . . 0.0 108.643 -176.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.403 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 32.3 t -66.56 113.15 11.55 Favored Pre-proline 0 CA--C 1.554 1.11 0 N-CA-C 121.349 3.833 . . . . 0.0 121.349 -122.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 19.8 Cg_endo -62.51 148.46 93.29 Favored 'Trans proline' 0 C--N 1.388 2.625 1 C-N-CA 126.211 4.607 . . . . 0.0 114.32 175.086 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.19 48.92 0.71 Allowed Glycine 0 C--N 1.365 2.151 0 C-N-CA 128.168 2.794 . . . . 0.0 117.625 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -104.41 37.48 3.76 Favored Glycine 0 C--N 1.354 1.543 0 C-N-CA 127.55 2.5 . . . . 0.0 110.061 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.02 39.49 2.33 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 126.525 1.93 . . . . 0.0 109.652 -177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.3 mm-40 -76.53 62.63 1.93 Allowed 'General case' 0 C--N 1.359 0.98 0 C-N-CA 126.688 1.995 . . . . 0.0 115.611 -177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 2.3 p80 . . . . . 0 C--N 1.358 0.943 0 C-N-CA 126.977 2.111 . . . . 0.0 111.734 179.33 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.183 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 51.0 tp -67.15 135.72 53.98 Favored 'General case' 0 C--N 1.366 1.315 0 C-N-CA 127.697 2.399 . . . . 0.0 112.727 177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.7 t -94.28 172.5 8.17 Favored 'General case' 0 N--CA 1.422 -1.873 0 C-N-CA 127.29 2.236 . . . . 0.0 111.192 -175.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.444 0.8 OUTLIER -82.17 97.8 8.4 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.529 -2.123 . . . . 0.0 107.558 174.025 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 58.54 -74.55 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 118.56 -2.588 . . . . 0.0 116.196 -170.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 25.5 tptt -132.85 141.15 48.28 Favored 'General case' 0 C--N 1.36 1.064 0 C-N-CA 131.382 3.873 . . . . 0.0 106.433 171.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.313 1.5 t70 -82.93 173.41 11.83 Favored 'General case' 0 CA--C 1.503 -0.86 1 C-N-CA 133.447 4.699 . . . . 0.0 109.232 179.871 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.633 ' HG ' ' H ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -72.05 -34.26 68.63 Favored 'General case' 0 CA--C 1.576 1.965 0 CA-C-N 113.989 -1.46 . . . . 0.0 111.588 179.284 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 39.6 m -163.94 172.57 13.77 Favored 'General case' 0 C--N 1.351 0.647 0 O-C-N 116.556 -3.84 . . . . 0.0 104.049 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -134.68 -40.83 0.78 Allowed 'General case' 0 C--N 1.359 0.989 0 C-N-CA 128.111 2.564 . . . . 0.0 112.944 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 66.6 p -176.0 136.13 0.29 Allowed 'General case' 0 C--N 1.369 1.423 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 34.8 tpp -134.22 118.27 17.42 Favored 'General case' 0 C--N 1.375 1.684 0 CA-C-N 119.69 1.132 . . . . 0.0 109.855 163.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.7 t -111.18 115.65 29.74 Favored 'General case' 0 C--N 1.377 1.788 0 CA-C-O 123.553 1.644 . . . . 0.0 107.796 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 9.3 p -150.75 174.4 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 C-N-CA 127.495 2.318 . . . . 0.0 110.938 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -73.57 143.83 46.28 Favored 'General case' 0 CA--C 1.566 1.592 0 C-N-CA 126.556 1.943 . . . . 0.0 106.643 156.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.433 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.381 0.0 OUTLIER -44.14 123.38 3.36 Favored 'General case' 0 N--CA 1.514 2.773 0 O-C-N 116.947 -3.596 . . . . 0.0 116.626 -172.668 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.417 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 124.73 48.72 0.21 Allowed Glycine 0 C--N 1.353 1.516 0 CA-C-N 111.705 -2.498 . . . . 0.0 109.338 -151.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.19 156.75 18.11 Favored 'General case' 0 C--N 1.372 1.557 0 C-N-CA 125.487 1.515 . . . . 0.0 111.515 171.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.76 105.25 13.68 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 124.609 1.164 . . . . 0.0 111.282 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.548 HD23 ' CE1' ' A' ' 136' ' ' TYR . 3.4 mp -120.31 125.52 48.27 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 127.002 2.121 . . . . 0.0 115.361 -174.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -108.62 122.27 46.74 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 103.741 -2.688 . . . . 0.0 103.741 170.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -123.46 115.48 21.65 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 175.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.633 ' H ' ' HG ' ' A' ' 79' ' ' LEU . 86.2 p -157.29 131.57 8.41 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 120.775 -1.203 . . . . 0.0 113.967 -172.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.465 HG11 HG21 ' A' ' 140' ' ' VAL . 10.1 m -148.97 173.12 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 C-N-CA 129.955 3.302 . . . . 0.0 105.974 178.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 70.2 p -103.77 124.71 49.4 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 115.082 -2.389 . . . . 0.0 109.808 -172.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.556 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -136.72 138.18 40.72 Favored 'General case' 0 C--N 1.386 2.154 1 N-CA-C 125.318 5.303 . . . . 0.0 125.318 -170.875 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 99' ' ' GLY . 61.5 m -157.49 174.57 15.19 Favored 'General case' 0 C--N 1.367 1.354 1 C-N-CA 132.023 4.129 . . . . 0.0 101.678 169.307 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.438 ' H ' HG22 ' A' ' 98' ' ' THR . . . -69.27 46.99 0.5 Allowed Glycine 0 C--N 1.366 2.228 0 N-CA-C 120.03 2.772 . . . . 0.0 120.03 -177.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.58 21.0 60.76 Favored Glycine 0 C--N 1.356 1.657 0 C-N-CA 127.146 2.308 . . . . 0.0 116.156 175.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.412 ' O ' ' HD2' ' A' ' 103' ' ' PRO . 7.9 p -116.45 111.11 19.53 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 115.686 -2.102 . . . . 0.0 107.234 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.678 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 70.98 -90.43 0.41 Allowed Glycine 0 C--N 1.377 2.844 0 C-N-CA 128.105 2.764 . . . . 0.0 111.814 -170.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.412 ' HD2' ' O ' ' A' ' 101' ' ' THR . 62.4 Cg_endo -66.57 167.52 18.82 Favored 'Trans proline' 0 CA--C 1.571 2.343 1 C-N-CA 126.35 4.7 . . . . 0.0 115.211 162.454 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.417 ' HB3' HG12 ' A' ' 140' ' ' VAL . 67.4 m-85 -90.82 145.54 24.68 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 121.009 3.707 . . . . 0.0 121.009 -166.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.7 t -102.16 140.4 36.49 Favored 'General case' 0 C--N 1.38 1.895 0 N-CA-C 103.481 -2.785 . . . . 0.0 103.481 175.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.569 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -132.14 158.26 42.12 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 121.589 3.922 . . . . 0.0 121.589 -160.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.27 119.66 10.94 Favored 'General case' 0 C--N 1.36 1.029 0 CA-C-N 112.423 -2.171 . . . . 0.0 106.977 174.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -112.38 151.59 29.61 Favored 'General case' 0 C--N 1.367 1.335 0 O-C-N 119.943 -1.723 . . . . 0.0 107.848 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.4 0.0 OUTLIER -157.78 146.08 19.04 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 119.559 -1.963 . . . . 0.0 105.771 164.939 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.849 ' HG2' HG22 ' A' ' 115' ' ' ILE 0.307 65.8 mmtt -126.43 99.67 5.93 Favored 'General case' 0 C--N 1.365 1.27 0 C-N-CA 115.987 -2.285 . . . . 0.0 111.613 -178.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.458 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.356 0.8 OUTLIER 36.65 53.22 1.05 Allowed 'General case' 0 CA--C 1.46 -2.489 1 CA-C-O 111.615 -4.04 . . . . 0.0 121.267 157.612 . . . . . . . . 5 4 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 94.45 -5.26 70.52 Favored Glycine 0 C--N 1.372 2.547 2 O-C-N 133.509 6.756 . . . . 0.0 114.965 -176.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.4 m -124.09 148.56 57.78 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 131.179 3.792 . . . . 0.0 115.956 -168.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -60.36 161.69 19.5 Favored 'Trans proline' 0 CA--C 1.55 1.288 0 C-N-CA 124.244 3.296 . . . . 0.0 116.187 168.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.849 HG22 ' HG2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -93.27 165.57 18.07 Favored Pre-proline 0 N--CA 1.443 -0.791 0 C-N-CA 131.373 3.869 . . . . 0.0 109.305 179.079 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.45 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 44.6 Cg_exo -51.24 -44.29 43.82 Favored 'Trans proline' 0 CA--C 1.538 0.675 1 C-N-CA 127.433 5.422 . . . . 0.0 118.757 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -158.62 -50.82 0.06 Allowed 'General case' 0 C--N 1.348 0.504 0 C-N-CA 126.245 1.818 . . . . 0.0 106.972 -178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . 0.256 . . 97.49 140.52 0.02 OUTLIER 'General case' 0 CA--C 1.464 -2.352 0 C-N-CA 128.819 2.847 . . . . 0.0 110.472 -177.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 73.9 m 69.75 34.71 2.57 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.163 -1.835 . . . . 0.0 114.243 172.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -108.2 -18.46 9.78 Favored Glycine 0 CA--C 1.47 -2.762 0 N-CA-C 117.877 1.911 . . . . 0.0 117.877 -164.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.556 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.313 . . 81.99 -73.03 0.04 OUTLIER 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 126.309 1.844 . . . . 0.0 111.786 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.28 13.4 t -128.62 104.22 7.54 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 123.199 1.476 . . . . 0.0 112.459 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.346 0.0 OUTLIER -127.49 140.99 51.78 Favored 'General case' 0 C--N 1.362 1.128 0 C-N-CA 128.192 2.597 . . . . 0.0 112.16 174.194 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 22.8 m -123.48 138.59 54.55 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 120.334 -1.479 . . . . 0.0 107.869 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.67 106.75 57.52 Favored Pre-proline 0 C--N 1.369 1.415 0 N-CA-C 103.449 -2.796 . . . . 0.0 103.449 170.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -76.72 -32.46 3.53 Favored 'Trans proline' 0 C--N 1.356 0.958 1 C-N-CA 126.925 5.083 . . . . 0.0 111.733 -179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.417 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -144.47 103.98 4.01 Favored 'General case' 0 N--CA 1.42 -1.928 1 N-CA-C 99.855 -4.128 . . . . 0.0 99.855 176.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.586 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -95.37 133.38 39.38 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 128.335 2.654 . . . . 0.0 107.611 176.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -90.42 -176.1 4.68 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 127.956 2.502 . . . . 0.0 113.084 -176.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.29 -45.12 34.44 Favored 'General case' 0 C--N 1.369 1.419 0 N-CA-C 119.024 2.972 . . . . 0.0 119.024 -173.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -69.04 -7.58 37.03 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 126.753 2.021 . . . . 0.0 114.974 174.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.586 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 4.9 m-20 -81.54 -17.9 46.85 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 127.293 2.237 . . . . 0.0 110.236 168.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -63.92 114.02 3.82 Favored 'General case' 0 C--N 1.386 2.158 0 N-CA-C 119.081 2.993 . . . . 0.0 119.081 171.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 165.63 -156.87 29.08 Favored Glycine 0 CA--C 1.454 -3.75 0 N-CA-C 108.314 -1.914 . . . . 0.0 108.314 175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.404 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.334 23.7 m -112.85 133.08 55.01 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 114.667 -2.813 . . . . 0.0 107.257 174.423 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.548 ' CE1' HD23 ' A' ' 91' ' ' LEU . 4.2 m-85 -96.99 132.39 42.85 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 118.506 -2.621 . . . . 0.0 113.547 -168.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.458 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -144.05 151.35 39.54 Favored 'General case' 0 C--N 1.394 2.543 0 CA-C-N 120.066 1.303 . . . . 0.0 112.138 -173.531 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 14.3 p -141.59 143.07 27.91 Favored 'Isoleucine or valine' 0 C--N 1.378 1.82 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 174.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 72.1 m -113.15 121.04 43.33 Favored 'General case' 0 C--N 1.373 1.623 0 C-N-CA 129.684 3.194 . . . . 0.0 107.366 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.569 HG13 ' HB3' ' A' ' 106' ' ' TYR . 0.1 OUTLIER -132.8 125.37 52.38 Favored 'Isoleucine or valine' 0 C--N 1.359 1.005 0 C-N-CA 126.311 1.844 . . . . 0.0 113.112 -177.212 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 4.0 m -112.0 133.85 53.92 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 119.156 -2.215 . . . . 0.0 116.027 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.403 ' HB3' ' CD1' ' A' ' 104' ' ' TYR 0.39 23.2 p30 -127.98 -173.91 3.06 Favored 'General case' 0 C--N 1.379 1.868 0 CA-C-N 120.226 1.375 . . . . 0.0 113.46 178.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.678 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 19.8 p -49.25 2.76 0.01 OUTLIER 'General case' 0 C--N 1.363 1.191 2 C-N-CA 136.349 5.86 . . . . 0.0 122.097 -165.466 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.89 4.62 25.57 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 164.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.447 98.3 mm-40 67.53 40.1 2.68 Favored 'General case' 0 C--N 1.371 1.526 1 C-N-CA 132.22 4.208 . . . . 0.0 110.576 -172.6 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . . . . . . . . . 3.8 m -112.76 127.18 70.13 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.293 0 CA-C-N 111.462 -2.608 . . . . 0.0 112.447 -171.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.9 OUTLIER -91.64 134.45 34.68 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 125.754 1.622 . . . . 0.0 110.318 -176.693 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 5.7 tmmm? -116.78 141.05 48.72 Favored 'General case' 0 CA--C 1.504 -0.797 0 N-CA-C 102.38 -3.193 . . . . 0.0 102.38 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -128.87 146.95 50.8 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.304 1.7 p -119.41 141.7 48.87 Favored 'General case' 0 C--O 1.249 1.07 0 CA-C-O 121.521 0.677 . . . . 0.0 110.738 175.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 4.4 m -54.23 148.22 11.78 Favored 'General case' 0 CA--C 1.479 -1.768 2 C-N-CA 138.253 6.621 . . . . 0.0 115.672 -168.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 78.3 p -68.19 110.17 3.89 Favored 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 128.594 2.758 . . . . 0.0 110.881 -173.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.54 109.46 22.05 Favored 'General case' 0 C--N 1.363 1.193 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 -176.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -88.98 113.17 24.21 Favored 'General case' 0 C--N 1.347 0.494 0 CA-C-O 124.566 2.126 . . . . 0.0 111.086 -173.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 96.3 t -112.58 114.99 48.57 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 -172.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 62.2 m -120.76 123.05 41.71 Favored 'General case' 0 CA--C 1.489 -1.37 0 N-CA-C 103.022 -2.955 . . . . 0.0 103.022 175.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.433 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 3.3 m -123.42 105.29 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 178.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -82.63 156.86 67.9 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.709 1.204 . . . . 0.0 110.477 177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -70.0 165.75 30.21 Favored 'Trans proline' 0 CA--C 1.544 0.986 1 C-N-CA 125.665 4.244 . . . . 0.0 107.835 154.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 12.2 p -67.27 132.46 47.78 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 118.543 -2.598 . . . . 0.0 109.175 -173.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 65.2 t -65.13 115.52 21.98 Favored Pre-proline 0 C--N 1.366 1.285 0 N-CA-C 120.073 3.36 . . . . 0.0 120.073 -126.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.16 145.73 96.23 Favored 'Trans proline' 0 C--N 1.383 2.376 1 C-N-CA 126.519 4.813 . . . . 0.0 115.238 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -71.22 61.48 1.06 Allowed Glycine 0 C--N 1.365 2.158 0 C-N-CA 128.615 3.007 . . . . 0.0 117.564 -174.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -103.99 -48.84 1.12 Allowed Glycine 0 C--N 1.355 1.6 0 C-N-CA 127.364 2.411 . . . . 0.0 110.99 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -87.87 -12.28 45.31 Favored 'General case' 0 C--N 1.357 0.907 0 C-N-CA 127.388 2.275 . . . . 0.0 113.766 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 65.94 -42.05 0.36 Allowed 'General case' 0 C--N 1.367 1.359 0 C-N-CA 129.57 3.148 . . . . 0.0 116.841 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 . . . . . 0 C--N 1.351 0.653 0 C-N-CA 130.073 3.349 . . . . 0.0 113.18 -177.826 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.057 0 CA-C-O 122.303 1.049 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 21.1 tp -106.94 117.51 34.26 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 176.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.3 t -104.08 172.78 6.61 Favored 'General case' 0 N--CA 1.429 -1.504 0 C-N-CA 126.399 1.879 . . . . 0.0 110.02 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.453 ' H ' HD23 ' A' ' 75' ' ' LEU 0.355 0.5 OUTLIER -76.14 97.48 4.12 Favored 'General case' 0 C--N 1.358 0.955 0 CA-C-O 122.473 1.13 . . . . 0.0 110.603 173.886 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 59.68 -77.5 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.334 0 O-C-N 119.128 -2.232 . . . . 0.0 114.466 -170.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 12.3 tptt -132.97 140.98 48.06 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 130.146 3.378 . . . . 0.0 103.376 167.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.428 45.1 t0 -83.02 171.82 13.4 Favored 'General case' 0 CA--C 1.511 -0.542 1 C-N-CA 134.279 5.032 . . . . 0.0 107.321 179.52 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.697 HD22 ' H ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -72.38 -37.61 68.7 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 118.21 2.67 . . . . 0.0 118.21 178.572 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.9 m -173.86 172.5 3.46 Favored 'General case' 0 CA--C 1.504 -0.814 1 N-CA-C 99.221 -4.363 . . . . 0.0 99.221 177.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.43 -47.55 2.54 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 121.051 1.75 . . . . 0.0 109.599 168.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 78.7 p -170.42 132.57 1.0 Allowed 'General case' 0 C--N 1.36 1.055 0 O-C-N 119.765 -1.835 . . . . 0.0 115.878 176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 12.7 tpt -130.75 116.26 17.76 Favored 'General case' 0 C--N 1.373 1.612 0 CA-C-N 120.603 1.547 . . . . 0.0 107.793 164.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.0 p -109.86 115.52 29.97 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 119.397 -2.065 . . . . 0.0 107.813 177.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -149.55 174.27 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 126.157 1.783 . . . . 0.0 111.499 -168.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -74.08 135.74 43.0 Favored 'General case' 0 C--N 1.368 1.405 0 O-C-N 118.87 -2.394 . . . . 0.0 107.087 158.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.336 0.4 OUTLIER -44.04 122.62 2.96 Favored 'General case' 0 N--CA 1.515 2.813 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -165.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.587 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 131.74 50.81 0.1 OUTLIER Glycine 0 N--CA 1.438 -1.22 0 CA-C-N 111.337 -2.665 . . . . 0.0 108.722 -162.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.61 160.67 19.55 Favored 'General case' 0 C--N 1.369 1.415 0 C-N-CA 126.382 1.873 . . . . 0.0 109.443 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.02 99.95 8.73 Favored 'General case' 0 C--N 1.352 0.707 0 CA-C-O 122.494 1.14 . . . . 0.0 110.723 -173.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.479 HD22 ' HB2' ' A' ' 128' ' ' ALA 0.276 9.0 mp -113.27 114.24 26.41 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 126.679 1.992 . . . . 0.0 115.74 -169.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -106.92 137.17 45.48 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 103.97 -2.604 . . . . 0.0 103.97 170.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.579 ' HA ' ' HB3' ' A' ' 79' ' ' LEU . 1.7 mm? -124.84 116.09 21.7 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 103.841 -2.651 . . . . 0.0 103.841 179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.697 ' H ' HD22 ' A' ' 79' ' ' LEU . 3.6 t -150.37 131.94 14.84 Favored 'General case' 0 C--N 1.38 1.908 0 N-CA-C 118.783 2.883 . . . . 0.0 118.783 -171.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.5 m -149.57 172.81 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.36 1.039 0 C-N-CA 129.926 3.29 . . . . 0.0 106.849 175.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 2.6 t -105.45 138.12 42.16 Favored 'General case' 0 C--N 1.371 1.515 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 175.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -139.42 143.91 37.85 Favored 'General case' 0 C--N 1.371 1.535 0 N-CA-C 119.914 3.302 . . . . 0.0 119.914 -172.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -156.96 174.69 15.13 Favored 'General case' 0 C--N 1.361 1.091 1 C-N-CA 134.169 4.988 . . . . 0.0 102.881 177.521 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.19 45.57 1.75 Allowed Glycine 0 C--N 1.37 2.422 0 O-C-N 118.706 -2.496 . . . . 0.0 117.73 178.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 79.83 23.41 62.01 Favored Glycine 0 C--N 1.363 2.073 0 C-N-CA 128.073 2.749 . . . . 0.0 112.787 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 52.5 m -115.96 110.93 19.64 Favored 'General case' 0 CA--C 1.502 -0.889 0 C-N-CA 126.442 1.897 . . . . 0.0 107.565 -174.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.466 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 66.95 -102.6 0.79 Allowed Glycine 0 CA--C 1.548 2.106 0 CA-C-O 116.667 -2.185 . . . . 0.0 109.783 -160.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.58 169.51 5.38 Favored 'Trans proline' 0 C--N 1.377 2.041 1 C-N-CA 129.128 6.552 . . . . 0.0 118.168 160.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.617 ' HB3' HG12 ' A' ' 140' ' ' VAL . 76.9 m-85 -81.74 142.3 32.77 Favored 'General case' 0 C--N 1.358 0.965 1 N-CA-C 124.301 4.926 . . . . 0.0 124.301 -164.407 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.4 t -102.32 141.06 35.76 Favored 'General case' 0 C--N 1.379 1.887 0 N-CA-C 104.234 -2.506 . . . . 0.0 104.234 174.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.555 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -134.51 162.91 30.94 Favored 'General case' 0 C--N 1.351 0.662 1 N-CA-C 122.85 4.389 . . . . 0.0 122.85 -161.947 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -143.49 121.18 11.86 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 127.992 2.517 . . . . 0.0 106.951 176.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -112.16 138.2 49.16 Favored 'General case' 0 C--N 1.362 1.146 0 C-N-CA 126.577 1.951 . . . . 0.0 111.422 -175.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -149.1 169.97 19.46 Favored 'General case' 0 CA--C 1.49 -1.346 0 CA-C-O 123.119 1.438 . . . . 0.0 107.335 172.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.464 ' HD3' ' CE1' ' A' ' 136' ' ' TYR . 13.8 ttpt -145.64 104.99 3.94 Favored 'General case' 0 N--CA 1.422 -1.851 0 O-C-N 119.37 -2.081 . . . . 0.0 105.875 177.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.472 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.239 1.2 t70 34.76 53.47 0.63 Allowed 'General case' 0 CA--C 1.472 -2.024 2 CA-C-O 110.414 -4.613 . . . . 0.0 123.073 141.976 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 80.74 -1.11 84.67 Favored Glycine 0 C--N 1.377 2.859 2 O-C-N 134.349 7.28 . . . . 0.0 118.964 -173.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 4.5 t -124.96 145.43 50.14 Favored Pre-proline 0 CA--C 1.555 1.172 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 -171.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -64.79 136.24 48.36 Favored 'Trans proline' 0 N--CA 1.495 1.588 1 C-N-CA 126.158 4.572 . . . . 0.0 115.315 173.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.447 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -85.23 165.6 35.54 Favored Pre-proline 0 CA--C 1.552 1.039 0 O-C-N 119.337 -2.102 . . . . 0.0 116.319 178.364 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 1.8 Cg_endo -68.1 81.45 0.5 Allowed 'Trans proline' 0 C--N 1.363 1.319 1 C-N-CA 125.406 4.071 . . . . 0.0 114.647 174.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 74.82 -62.15 0.46 Allowed 'General case' 0 C--N 1.36 1.037 0 C-N-CA 127.43 2.292 . . . . 0.0 115.033 177.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 85.3 162.68 0.1 Allowed 'General case' 0 CA--C 1.481 -1.703 0 C-N-CA 129.431 3.092 . . . . 0.0 112.584 178.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 79.16 52.98 0.02 OUTLIER 'General case' 0 C--N 1.357 0.907 0 CA-C-N 113.531 -1.668 . . . . 0.0 111.049 178.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -121.99 -86.44 0.84 Allowed Glycine 0 C--N 1.362 2.018 0 CA-C-N 114.172 -1.376 . . . . 0.0 116.494 -170.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 94' ' ' SER 0.339 . . 144.45 -74.97 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 127.406 2.282 . . . . 0.0 111.079 177.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.3 9.0 t -126.0 93.47 3.83 Favored 'General case' 0 C--N 1.362 1.119 0 CA-C-O 123.909 1.814 . . . . 0.0 110.301 178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.277 3.3 p90 -125.98 141.05 52.13 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 126.228 1.811 . . . . 0.0 110.319 -177.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 88.8 m -129.71 139.8 51.26 Favored 'General case' 0 CA--C 1.493 -1.238 0 O-C-N 120.389 -1.444 . . . . 0.0 110.041 -178.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.408 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -111.09 103.93 55.51 Favored Pre-proline 0 C--N 1.358 0.953 0 C-N-CA 129.485 3.114 . . . . 0.0 105.293 176.484 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -72.65 -32.76 9.14 Favored 'Trans proline' 0 CA--C 1.533 0.448 0 C-N-CA 124.718 3.612 . . . . 0.0 113.772 -175.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.587 HG23 ' HA2' ' A' ' 88' ' ' GLY . 99.4 m -136.54 100.99 4.51 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 178.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.479 ' HB2' HD22 ' A' ' 91' ' ' LEU . . . -93.07 124.04 36.76 Favored 'General case' 0 C--N 1.349 0.586 0 C-N-CA 124.212 1.005 . . . . 0.0 113.196 177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -93.93 -178.49 4.67 Favored 'General case' 0 C--N 1.364 1.234 0 C-N-CA 129.2 3.0 . . . . 0.0 109.719 175.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -47.89 -54.19 13.39 Favored 'General case' 0 C--N 1.368 1.4 0 N-CA-C 118.189 2.663 . . . . 0.0 118.189 -173.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -66.13 1.03 1.65 Allowed 'General case' 0 C--N 1.365 1.241 0 C-N-CA 128.6 2.76 . . . . 0.0 115.357 172.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -116.06 -18.56 10.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 129.409 3.084 . . . . 0.0 111.266 175.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.407 ' CB ' HG22 ' A' ' 157' ' ' VAL . . . -95.18 164.55 12.81 Favored 'General case' 0 C--N 1.391 2.412 0 N-CA-C 117.751 2.501 . . . . 0.0 117.751 175.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 146.87 -155.86 26.74 Favored Glycine 0 C--N 1.383 3.149 0 C-N-CA 128.318 2.866 . . . . 0.0 109.734 -177.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.356 6.9 m -109.41 130.73 55.49 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 112.974 -3.491 . . . . 0.0 107.135 164.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.464 ' CE1' ' HD3' ' A' ' 110' ' ' LYS 0.255 3.5 m-85 -97.01 134.49 40.31 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 125.704 1.602 . . . . 0.0 111.492 -169.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -145.49 152.61 40.05 Favored 'General case' 0 C--N 1.365 1.281 0 CA-C-N 119.459 1.027 . . . . 0.0 109.021 -175.746 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.39 142.69 28.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 C-N-CA 116.568 -2.053 . . . . 0.0 111.592 178.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.5 m -105.99 119.37 39.03 Favored 'General case' 0 C--N 1.368 1.401 0 C-N-CA 129.778 3.231 . . . . 0.0 106.286 177.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.617 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -134.16 124.27 45.66 Favored 'Isoleucine or valine' 0 C--N 1.35 0.591 0 C-N-CA 124.268 1.027 . . . . 0.0 113.613 -173.36 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 147' ' ' SER . 6.0 m -109.23 131.71 54.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 119.412 -2.055 . . . . 0.0 114.599 179.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.453 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.444 10.2 p-10 -128.45 -170.48 2.26 Favored 'General case' 0 C--N 1.367 1.366 0 O-C-N 120.682 -1.261 . . . . 0.0 113.894 175.21 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.466 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 22.1 p -48.71 3.84 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.317 1 C-N-CA 136.218 5.807 . . . . 0.0 121.634 -164.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -106.74 4.57 27.82 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 118.286 -1.366 . . . . 0.0 107.898 163.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.433 89.9 mm-40 66.45 40.09 3.67 Favored 'General case' 0 C--N 1.373 1.62 1 C-N-CA 132.924 4.49 . . . . 0.0 110.273 -171.992 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.418 ' C ' HG23 ' A' ' 141' ' ' THR . 4.2 m -112.54 126.32 69.92 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.233 0 C-N-CA 128.08 2.552 . . . . 0.0 112.061 -171.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.3 OUTLIER -91.83 130.24 37.64 Favored 'General case' 0 C--N 1.361 1.081 0 C-N-CA 124.61 1.164 . . . . 0.0 109.849 -178.203 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.62 158.89 23.84 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 129.755 3.222 . . . . 0.0 104.455 177.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -129.77 146.51 51.52 Favored 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 105.512 -2.033 . . . . 0.0 105.512 175.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.404 87.8 p -116.4 150.19 38.18 Favored 'General case' 0 C--O 1.254 1.303 0 C-N-CA 124.469 1.108 . . . . 0.0 110.004 177.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -54.92 148.83 12.59 Favored 'General case' 0 C--N 1.382 2.012 1 C-N-CA 134.245 5.018 . . . . 0.0 118.719 -158.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 136' ' ' TYR . 76.0 p -68.74 111.13 4.66 Favored 'General case' 0 C--N 1.367 1.34 0 C-N-CA 127.866 2.466 . . . . 0.0 110.434 -177.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -98.16 109.25 22.04 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 103.113 -2.921 . . . . 0.0 103.113 -179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -95.52 107.43 19.59 Favored 'General case' 0 C--N 1.352 0.7 0 CA-C-O 124.84 2.257 . . . . 0.0 110.882 -174.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.0 m -119.75 120.25 62.77 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.049 0 O-C-N 119.821 -1.799 . . . . 0.0 106.386 -175.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 2.6 m -112.07 135.76 52.3 Favored 'General case' 0 C--N 1.364 1.235 0 N-CA-C 107.073 -1.455 . . . . 0.0 107.073 -174.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.407 HG22 ' CB ' ' A' ' 133' ' ' ALA . 29.7 m -128.17 104.96 12.69 Favored 'Isoleucine or valine' 0 C--N 1.361 1.079 0 CA-C-O 124.136 1.922 . . . . 0.0 112.672 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -85.97 161.36 50.13 Favored Pre-proline 0 CA--C 1.557 1.243 0 C-N-CA 125.457 1.503 . . . . 0.0 109.814 176.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -67.99 165.96 26.37 Favored 'Trans proline' 0 C--N 1.364 1.381 1 C-N-CA 127.788 5.659 . . . . 0.0 108.613 153.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 17.7 p -67.28 131.53 45.93 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 118.53 -2.606 . . . . 0.0 109.815 -175.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 3.4 t -66.14 111.6 6.97 Favored Pre-proline 0 CA--C 1.552 1.041 0 N-CA-C 121.434 3.864 . . . . 0.0 121.434 -125.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -62.51 147.44 94.84 Favored 'Trans proline' 0 C--N 1.382 2.317 1 C-N-CA 126.091 4.528 . . . . 0.0 114.107 171.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.06 48.4 0.67 Allowed Glycine 0 C--N 1.365 2.161 0 C-N-CA 128.044 2.735 . . . . 0.0 117.933 -176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -104.25 33.68 6.38 Favored Glycine 0 C--N 1.354 1.566 0 C-N-CA 127.512 2.482 . . . . 0.0 110.437 177.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -128.49 36.29 4.28 Favored 'General case' 0 C--N 1.349 0.577 0 C-N-CA 127.789 2.436 . . . . 0.0 110.119 -176.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -75.01 65.54 1.46 Allowed 'General case' 0 C--N 1.358 0.972 0 C-N-CA 127.238 2.215 . . . . 0.0 116.553 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 84.9 t60 . . . . . 0 C--N 1.354 0.799 0 C-N-CA 126.296 1.838 . . . . 0.0 109.777 178.162 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.034 0 CA-C-O 121.614 0.721 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 57.4 tp -107.28 122.29 46.27 Favored 'General case' 0 C--N 1.354 0.764 0 C-N-CA 126.644 1.978 . . . . 0.0 109.048 178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 5.5 t -94.96 173.36 7.62 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 127.593 2.357 . . . . 0.0 110.11 176.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 75' ' ' LEU 0.28 0.6 OUTLIER -78.95 97.91 6.22 Favored 'General case' 0 C--N 1.363 1.193 0 O-C-N 120.303 -1.498 . . . . 0.0 109.547 175.971 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 57.97 -73.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 117.44 -3.287 . . . . 0.0 115.93 -167.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.98 140.37 47.75 Favored 'General case' 0 C--N 1.362 1.147 0 C-N-CA 130.015 3.326 . . . . 0.0 107.119 172.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.47 0.6 OUTLIER -83.9 142.35 30.62 Favored 'General case' 0 C--N 1.375 1.675 0 N-CA-C 104.783 -2.303 . . . . 0.0 104.783 172.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 92' ' ' THR . 0.3 OUTLIER -72.14 -26.95 62.3 Favored 'General case' 0 C--N 1.371 1.522 0 CA-C-N 124.773 3.442 . . . . 0.0 112.354 -177.569 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 22.9 m -172.13 175.46 3.74 Favored 'General case' 0 C--N 1.317 -0.822 1 C-N-CA 132.142 4.177 . . . . 0.0 101.478 168.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -119.75 -62.86 1.44 Allowed 'General case' 0 C--N 1.361 1.097 0 C-N-CA 126.827 2.051 . . . . 0.0 113.065 169.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 19.7 p -179.99 125.14 0.07 Allowed 'General case' 0 C--N 1.36 1.048 0 O-C-N 118.434 -2.666 . . . . 0.0 117.636 -175.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 86.1 mmm -120.29 134.63 55.22 Favored 'General case' 0 C--N 1.379 1.888 0 CA-C-N 120.464 1.483 . . . . 0.0 113.198 168.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.2 p -114.54 115.66 27.56 Favored 'General case' 0 C--N 1.365 1.241 0 O-C-N 119.127 -2.233 . . . . 0.0 108.629 173.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 p -150.1 173.74 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-N 114.011 -1.449 . . . . 0.0 113.134 -167.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -81.11 131.48 35.3 Favored 'General case' 0 CA--C 1.556 1.211 0 C-N-CA 128.01 2.524 . . . . 0.0 104.931 161.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . 0.317 0.2 OUTLIER -43.23 122.38 2.51 Favored 'General case' 0 N--CA 1.518 2.968 0 CA-C-N 123.418 2.827 . . . . 0.0 118.55 -161.727 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.54 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 134.57 54.24 0.07 OUTLIER Glycine 0 C--N 1.35 1.354 0 CA-C-N 111.854 -2.43 . . . . 0.0 111.503 -164.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.69 172.27 10.99 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 124.775 1.23 . . . . 0.0 112.095 173.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -111.55 100.95 9.41 Favored 'General case' 0 C--N 1.356 0.881 0 O-C-N 120.9 -1.125 . . . . 0.0 109.298 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 128' ' ' ALA . 0.2 OUTLIER -121.47 114.31 21.08 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 125.531 1.532 . . . . 0.0 111.218 -172.511 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 79' ' ' LEU 0.29 2.4 t -113.84 137.54 51.52 Favored 'General case' 0 CA--C 1.49 -1.359 0 N-CA-C 104.899 -2.26 . . . . 0.0 104.899 179.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 7.1 mt -126.68 115.74 19.91 Favored 'General case' 0 CA--C 1.499 -0.99 0 N-CA-C 103.593 -2.743 . . . . 0.0 103.593 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 6.1 t -152.86 132.41 13.01 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.808 1.289 . . . . 0.0 112.185 -169.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 m -149.9 175.55 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.665 1 C-N-CA 132.171 4.188 . . . . 0.0 106.583 -178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 5.1 t -103.98 140.97 36.98 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 127.853 2.461 . . . . 0.0 106.375 177.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.516 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -141.33 144.38 34.54 Favored 'General case' 0 C--N 1.381 1.978 1 N-CA-C 122.934 4.42 . . . . 0.0 122.934 -174.871 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 60.5 p -156.41 175.84 13.49 Favored 'General case' 0 C--N 1.364 1.199 1 C-N-CA 133.883 4.873 . . . . 0.0 104.094 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.38 40.33 0.75 Allowed Glycine 0 C--N 1.365 2.183 0 C-N-CA 125.858 1.694 . . . . 0.0 117.232 167.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 85.06 30.67 25.12 Favored Glycine 0 C--N 1.361 1.944 0 C-N-CA 127.616 2.531 . . . . 0.0 116.164 175.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.41 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 63.5 m -117.44 110.9 18.58 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 113.653 -3.07 . . . . 0.0 108.351 175.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.479 ' H ' ' CB ' ' A' ' 143' ' ' SER . . . 72.79 -86.73 0.54 Allowed Glycine 0 C--N 1.383 3.15 0 CA-C-N 124.837 3.471 . . . . 0.0 110.172 -177.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -59.86 168.13 6.12 Favored 'Trans proline' 0 CA--C 1.57 2.291 1 C-N-CA 126.102 4.535 . . . . 0.0 115.364 157.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.568 ' HB3' HG12 ' A' ' 140' ' ' VAL . 78.4 m-85 -105.97 145.13 31.72 Favored 'General case' 0 CA--C 1.547 0.854 0 N-CA-C 119.798 3.259 . . . . 0.0 119.798 -164.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 9.6 t -103.02 141.51 35.68 Favored 'General case' 0 C--N 1.378 1.837 0 N-CA-C 104.105 -2.554 . . . . 0.0 104.105 173.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.48 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -140.13 160.98 38.74 Favored 'General case' 0 C--N 1.347 0.466 1 N-CA-C 121.923 4.045 . . . . 0.0 121.923 -160.133 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -136.2 120.89 18.41 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 128.674 2.79 . . . . 0.0 105.796 175.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -112.05 132.8 54.6 Favored 'General case' 0 C--N 1.366 1.29 0 C-N-CA 125.178 1.391 . . . . 0.0 111.574 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.89 169.69 17.58 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 123.252 1.501 . . . . 0.0 107.334 172.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.49 ' HD3' ' CE1' ' A' ' 136' ' ' TYR . 13.0 ttpp -142.79 105.7 4.53 Favored 'General case' 0 N--CA 1.413 -2.285 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 177.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.459 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.22 1.7 t70 34.91 53.63 0.66 Allowed 'General case' 0 CA--C 1.472 -2.035 2 CA-C-O 109.685 -4.96 . . . . 0.0 123.473 140.739 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 84.09 -10.43 60.74 Favored Glycine 0 C--N 1.383 3.179 2 O-C-N 135.222 7.826 . . . . 0.0 119.365 -172.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.407 9.8 p -124.89 147.15 55.6 Favored Pre-proline 0 CA--C 1.563 1.471 0 C-N-CA 130.607 3.563 . . . . 0.0 120.586 -167.724 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -63.8 139.72 70.17 Favored 'Trans proline' 0 N--CA 1.499 1.817 1 C-N-CA 126.484 4.789 . . . . 0.0 116.933 177.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.41 ' HB ' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -89.51 164.27 30.23 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 119.237 -2.164 . . . . 0.0 115.568 178.628 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 8.8 Cg_endo -72.05 82.9 1.23 Allowed 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 125.119 3.879 . . . . 0.0 115.009 177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 74.52 -61.06 0.5 Allowed 'General case' 0 C--N 1.36 1.05 0 C-N-CA 126.626 1.97 . . . . 0.0 115.846 176.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 79.16 176.21 0.14 Allowed 'General case' 0 CA--C 1.488 -1.416 0 C-N-CA 130.3 3.44 . . . . 0.0 114.805 176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.418 ' HA ' ' CD1' ' A' ' 106' ' ' TYR . 0.1 OUTLIER 74.55 70.08 0.1 Allowed 'General case' 0 C--N 1.356 0.864 0 CA-C-N 113.784 -1.553 . . . . 0.0 114.752 173.355 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -154.77 -53.11 0.01 OUTLIER Glycine 0 CA--C 1.488 -1.62 0 N-CA-C 120.078 2.791 . . . . 0.0 120.078 -172.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.516 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.292 . . 131.94 -65.87 0.0 OUTLIER 'General case' 0 C--N 1.351 0.634 0 C-N-CA 127.129 2.172 . . . . 0.0 107.777 -176.017 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.27 14.7 t -137.53 108.84 6.86 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-N 120.475 1.489 . . . . 0.0 113.688 -175.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . 0.289 0.2 OUTLIER -128.02 140.25 52.08 Favored 'General case' 0 C--N 1.372 1.567 0 C-N-CA 127.881 2.472 . . . . 0.0 111.846 177.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 5.8 m -129.39 139.75 51.57 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 119.909 -1.745 . . . . 0.0 111.596 179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.62 105.27 56.68 Favored Pre-proline 0 C--N 1.358 0.949 0 C-N-CA 129.377 3.071 . . . . 0.0 105.966 173.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -75.56 -11.51 20.47 Favored 'Trans proline' 0 C--N 1.353 0.782 1 C-N-CA 125.745 4.297 . . . . 0.0 112.819 175.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.54 HG23 ' HA2' ' A' ' 88' ' ' GLY . 62.1 m -157.93 105.65 1.99 Allowed 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.791 ' HB2' HD21 ' A' ' 91' ' ' LEU . . . -94.17 118.9 32.22 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.313 1.045 . . . . 0.0 112.825 177.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -85.97 -176.98 6.2 Favored 'General case' 0 C--N 1.367 1.351 0 C-N-CA 127.131 2.173 . . . . 0.0 109.236 172.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.12 -54.19 14.08 Favored 'General case' 0 C--N 1.368 1.384 0 O-C-N 118.273 -2.767 . . . . 0.0 117.209 -175.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -65.8 0.79 1.58 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 128.692 2.797 . . . . 0.0 115.58 172.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -116.43 -18.33 10.46 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 129.299 3.04 . . . . 0.0 111.347 176.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -92.65 164.74 13.29 Favored 'General case' 0 C--N 1.397 2.655 0 CA-C-N 122.534 2.424 . . . . 0.0 116.673 176.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 142.24 -155.08 25.42 Favored Glycine 0 CA--C 1.459 -3.446 0 C-N-CA 127.107 2.289 . . . . 0.0 109.012 -176.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . 0.351 9.3 m -113.49 133.41 55.23 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 111.912 -3.915 . . . . 0.0 108.595 166.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.49 ' CE1' ' HD3' ' A' ' 110' ' ' LYS 0.252 21.1 m-85 -96.26 135.2 38.41 Favored 'General case' 0 C--N 1.366 1.303 0 CA-C-N 122.228 2.285 . . . . 0.0 110.984 -170.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.459 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -145.77 147.52 31.97 Favored 'General case' 0 C--N 1.366 1.303 0 C-N-CA 123.982 0.913 . . . . 0.0 108.908 -176.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 149' ' ' ASP . 10.4 p -138.76 137.38 42.95 Favored 'Isoleucine or valine' 0 C--N 1.365 1.267 0 C-N-CA 118.189 -1.404 . . . . 0.0 113.402 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 113.89 27.74 Favored 'General case' 0 C--N 1.38 1.905 0 C-N-CA 129.29 3.036 . . . . 0.0 105.848 176.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.568 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.1 OUTLIER -128.98 119.68 49.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 125.936 1.694 . . . . 0.0 110.513 -171.41 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.403 HG23 ' C ' ' A' ' 146' ' ' VAL . 5.2 m -106.24 133.1 51.47 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.228 -1.545 . . . . 0.0 113.719 -176.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.484 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.328 15.6 p-10 -126.21 179.43 5.26 Favored 'General case' 0 C--N 1.376 1.757 0 C-N-CA 124.164 0.986 . . . . 0.0 111.971 174.923 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.479 ' CB ' ' H ' ' A' ' 102' ' ' GLY . 13.1 p -49.18 2.29 0.01 OUTLIER 'General case' 0 C--N 1.375 1.677 1 C-N-CA 136.971 6.108 . . . . 0.0 119.306 -170.768 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 45.4 mttp -101.28 4.24 41.53 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 165.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.523 0.9 OUTLIER 62.89 39.87 10.12 Favored 'General case' 0 C--N 1.372 1.554 1 C-N-CA 134.266 5.026 . . . . 0.0 112.715 -172.692 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.403 ' C ' HG23 ' A' ' 141' ' ' THR . 4.6 m -112.85 128.37 69.61 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.858 0 CA-C-N 111.596 -2.547 . . . . 0.0 111.882 -170.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.02 123.0 35.06 Favored 'General case' 0 N--CA 1.442 -0.865 0 C-N-CA 126.456 1.902 . . . . 0.0 106.777 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.35 157.74 24.56 Favored 'General case' 0 CA--C 1.494 -1.181 0 C-N-CA 128.031 2.532 . . . . 0.0 104.804 -174.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 138' ' ' VAL . 27.3 t70 -125.06 140.32 53.0 Favored 'General case' 0 CA--C 1.493 -1.23 0 CA-C-O 122.708 1.242 . . . . 0.0 108.205 -176.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.486 44.6 p -116.98 144.05 45.01 Favored 'General case' 0 C--O 1.254 1.334 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 173.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 6.8 m -54.11 147.98 11.84 Favored 'General case' 0 CA--C 1.478 -1.789 2 C-N-CA 138.798 6.839 . . . . 0.0 118.049 -159.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 73.6 p -68.29 109.77 3.76 Favored 'General case' 0 C--N 1.367 1.348 0 C-N-CA 124.486 1.114 . . . . 0.0 111.907 -176.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -95.22 108.49 20.63 Favored 'General case' 0 C--N 1.373 1.608 0 N-CA-C 102.653 -3.092 . . . . 0.0 102.653 -178.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -97.53 113.72 25.48 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 123.732 1.729 . . . . 0.0 111.152 -172.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -122.33 116.21 48.41 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 97.7 m -111.24 128.26 55.87 Favored 'General case' 0 C--N 1.372 1.549 0 N-CA-C 105.081 -2.192 . . . . 0.0 105.081 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 33.1 m -123.17 108.37 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.253 0 CA-C-O 123.78 1.752 . . . . 0.0 111.669 -176.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 19.4 m-20 -85.25 155.99 60.04 Favored Pre-proline 0 CA--C 1.552 1.044 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.243 175.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -71.3 166.3 29.72 Favored 'Trans proline' 0 C--N 1.359 1.124 1 C-N-CA 126.931 5.087 . . . . 0.0 107.418 154.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 23.3 p -66.86 132.46 48.05 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 118.515 -2.616 . . . . 0.0 109.169 -172.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.81 124.8 87.47 Favored Pre-proline 0 C--N 1.366 1.283 0 N-CA-C 118.536 2.791 . . . . 0.0 118.536 -127.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -62.16 154.82 60.2 Favored 'Trans proline' 0 C--N 1.386 2.518 1 C-N-CA 126.641 4.894 . . . . 0.0 114.994 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -70.12 50.89 0.75 Allowed Glycine 0 C--N 1.367 2.279 0 C-N-CA 127.426 2.441 . . . . 0.0 118.019 -177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -110.6 32.39 6.63 Favored Glycine 0 C--N 1.355 1.632 0 C-N-CA 127.776 2.608 . . . . 0.0 110.872 179.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 67.6 mt -119.21 43.52 2.57 Favored 'General case' 0 C--N 1.356 0.853 0 C-N-CA 127.249 2.219 . . . . 0.0 106.422 176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -68.42 52.67 0.08 Allowed 'General case' 0 C--N 1.36 1.04 0 C-N-CA 129.504 3.122 . . . . 0.0 117.011 -173.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 . . . . . 0 C--N 1.352 0.709 0 C-N-CA 128.854 2.861 . . . . 0.0 109.46 -179.569 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.262 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 40.9 tp -108.45 121.36 44.79 Favored 'General case' 0 C--N 1.358 0.951 0 C-N-CA 125.364 1.466 . . . . 0.0 108.849 174.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 8.0 t -106.2 173.64 6.23 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 126.444 1.898 . . . . 0.0 108.844 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . 0.315 0.9 OUTLIER -72.05 98.14 2.03 Favored 'General case' 0 C--N 1.361 1.068 0 CA-C-O 122.332 1.063 . . . . 0.0 110.536 173.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 58.26 -77.26 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.584 0 O-C-N 117.87 -3.019 . . . . 0.0 115.487 -168.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -132.97 141.11 48.14 Favored 'General case' 0 C--N 1.362 1.137 1 C-N-CA 133.178 4.591 . . . . 0.0 105.139 172.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . 0.293 12.1 t70 -82.85 171.56 13.78 Favored 'General case' 0 C--N 1.344 0.362 1 C-N-CA 131.88 4.072 . . . . 0.0 109.854 -179.671 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.43 -27.74 63.5 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 114.911 1.448 . . . . 0.0 114.911 -171.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . 0.288 0.6 OUTLIER -175.09 -177.02 1.01 Allowed 'General case' 0 N--CA 1.476 0.83 1 N-CA-C 98.716 -4.549 . . . . 0.0 98.716 162.75 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -114.86 -53.09 2.67 Favored 'General case' 0 C--N 1.348 0.53 0 O-C-N 119.567 -1.958 . . . . 0.0 106.767 162.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . . . . . . . . . 79.0 p -168.91 128.92 1.12 Allowed 'General case' 0 C--N 1.357 0.911 0 O-C-N 120.037 -1.664 . . . . 0.0 115.079 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' MET . . . . . . . . . . . . . 15.0 tpt -124.95 123.45 39.92 Favored 'General case' 0 C--N 1.374 1.654 0 CA-C-N 120.81 1.641 . . . . 0.0 111.247 167.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.2 t -112.05 116.73 31.01 Favored 'General case' 0 C--N 1.374 1.652 0 O-C-N 119.724 -1.86 . . . . 0.0 107.273 171.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -149.67 173.7 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 112.065 -2.334 . . . . 0.0 109.981 -173.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -76.55 144.7 39.51 Favored 'General case' 0 CA--C 1.558 1.259 0 C-N-CA 126.302 1.841 . . . . 0.0 106.609 158.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.449 ' HB3' ' HB ' ' A' ' 157' ' ' VAL 0.436 0.0 OUTLIER -44.42 121.97 2.84 Favored 'General case' 0 N--CA 1.515 2.807 0 O-C-N 117.376 -3.327 . . . . 0.0 118.339 -168.027 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.422 ' HA2' HG23 ' A' ' 127' ' ' THR . . . 129.74 55.49 0.1 OUTLIER Glycine 0 C--N 1.36 1.866 0 CA-C-N 112.05 -2.341 . . . . 0.0 110.651 -155.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -93.5 165.23 12.85 Favored 'General case' 0 C--N 1.369 1.413 0 O-C-N 120.643 -1.504 . . . . 0.0 110.487 173.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -109.93 100.96 9.84 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-O 123.17 1.462 . . . . 0.0 113.393 -173.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.4 mp -119.36 127.23 52.96 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 125.113 1.365 . . . . 0.0 111.835 -175.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.452 ' HA ' HG23 ' A' ' 124' ' ' THR . 4.8 t -116.04 115.3 25.88 Favored 'General case' 0 CA--C 1.49 -1.363 0 N-CA-C 103.741 -2.689 . . . . 0.0 103.741 168.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -107.12 112.0 24.71 Favored 'General case' 0 C--N 1.357 0.927 0 N-CA-C 103.04 -2.948 . . . . 0.0 103.04 173.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.9 t -146.35 131.2 18.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 CA-C-N 114.726 -1.125 . . . . 0.0 110.621 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 26.1 m -150.54 174.23 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.351 0.649 1 C-N-CA 131.789 4.035 . . . . 0.0 103.565 178.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 13.3 t -106.38 140.39 39.37 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 122.096 2.225 . . . . 0.0 106.976 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 121' ' ' ALA . . . -139.71 142.61 36.85 Favored 'General case' 0 C--N 1.379 1.863 0 N-CA-C 121.021 3.712 . . . . 0.0 121.021 -174.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 29.2 p -156.29 175.54 13.86 Favored 'General case' 0 C--N 1.367 1.346 1 C-N-CA 134.365 5.066 . . . . 0.0 103.352 178.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -72.73 39.77 0.78 Allowed Glycine 0 C--N 1.368 2.31 0 O-C-N 119.514 -1.991 . . . . 0.0 117.649 174.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 82.19 26.08 49.49 Favored Glycine 0 C--N 1.362 1.983 0 C-N-CA 128.459 2.933 . . . . 0.0 114.427 178.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.2 p -116.88 109.84 17.58 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 116.249 -1.834 . . . . 0.0 107.856 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.652 ' H ' ' HB3' ' A' ' 143' ' ' SER . . . 72.01 -91.07 0.51 Allowed Glycine 0 C--N 1.374 2.643 0 C-N-CA 129.073 3.225 . . . . 0.0 111.053 -167.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -60.22 169.16 5.29 Favored 'Trans proline' 0 CA--C 1.566 2.111 1 C-N-CA 127.993 5.795 . . . . 0.0 116.968 160.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.49 ' HB3' HG12 ' A' ' 140' ' ' VAL . 75.1 m-85 -94.58 146.27 24.24 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -168.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 3.8 t -102.69 140.78 36.53 Favored 'General case' 0 C--N 1.382 2.013 0 N-CA-C 103.591 -2.744 . . . . 0.0 103.591 174.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.429 ' HB3' HG13 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -135.46 139.84 44.38 Favored 'General case' 0 C--N 1.352 0.691 1 N-CA-C 123.668 4.692 . . . . 0.0 123.668 -158.356 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -126.07 111.56 14.83 Favored 'General case' 0 C--N 1.371 1.533 0 C-N-CA 126.403 1.881 . . . . 0.0 107.238 175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TRP . . . . . 0.462 ' CE2' HG21 ' A' ' 138' ' ' VAL . 76.4 m95 -113.06 145.14 41.42 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 126.053 1.741 . . . . 0.0 111.405 -177.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . 0.32 0.0 OUTLIER -157.95 156.38 31.16 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 164.211 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.498 ' HG2' HG22 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -128.05 102.84 6.91 Favored 'General case' 0 C--N 1.37 1.493 0 C-N-CA 117.271 -1.771 . . . . 0.0 113.517 175.962 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.453 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 1.231 2.5 t70 36.94 54.53 1.19 Allowed 'General case' 0 CA--C 1.456 -2.656 1 CA-C-O 110.772 -4.442 . . . . 0.0 120.837 152.829 . . . . . . . . 4 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 98.19 -11.49 63.74 Favored Glycine 0 C--N 1.37 2.462 2 O-C-N 133.928 7.018 . . . . 0.0 116.041 -175.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.262 3.6 m -123.96 149.16 59.14 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 131.216 3.806 . . . . 0.0 117.161 -168.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -63.15 152.32 80.27 Favored 'Trans proline' 0 N--CA 1.494 1.544 1 C-N-CA 125.473 4.115 . . . . 0.0 116.211 169.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.498 HG22 ' HG2' ' A' ' 110' ' ' LYS . 0.0 OUTLIER -99.04 157.76 33.51 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.469 1.508 . . . . 0.0 109.243 174.522 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 115' ' ' ILE . 5.3 Cg_exo -62.64 -75.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.839 1 C-N-CA 126.039 4.493 . . . . 0.0 116.773 -170.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -102.86 -34.46 8.97 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 125.267 1.427 . . . . 0.0 111.281 -177.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . 75.93 -72.36 0.11 Allowed 'General case' 0 CA--C 1.486 -1.512 0 C-N-CA 130.075 3.35 . . . . 0.0 114.393 176.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . 0.348 5.2 t -81.82 72.64 8.87 Favored 'General case' 0 N--CA 1.416 -2.155 1 C-N-CA 133.627 4.771 . . . . 0.0 111.348 -175.108 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -159.23 -41.5 0.02 OUTLIER Glycine 0 CA--C 1.469 -2.794 0 N-CA-C 122.072 3.589 . . . . 0.0 122.072 -168.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.535 ' HB2' ' HB3' ' A' ' 97' ' ' ALA 0.301 . . 105.16 -62.57 0.0 OUTLIER 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 125.505 1.522 . . . . 0.0 110.151 179.051 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . 0.296 15.3 t -136.49 96.33 3.33 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-O 122.622 1.201 . . . . 0.0 113.841 -176.229 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -126.5 138.0 53.44 Favored 'General case' 0 C--N 1.368 1.379 0 C-N-CA 127.121 2.169 . . . . 0.0 107.823 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.452 HG23 ' HA ' ' A' ' 92' ' ' THR . 91.5 m -128.92 133.2 47.78 Favored 'General case' 0 CA--C 1.478 -1.789 0 O-C-N 119.536 -1.977 . . . . 0.0 106.256 -176.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.83 93.22 8.49 Favored Pre-proline 0 C--N 1.359 1.018 0 N-CA-C 102.53 -3.137 . . . . 0.0 102.53 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.69 -11.83 26.27 Favored 'Trans proline' 0 C--N 1.348 0.544 1 C-N-CA 125.525 4.15 . . . . 0.0 111.048 177.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' THR . . . . . 0.422 HG23 ' HA2' ' A' ' 88' ' ' GLY . 1.2 m -161.62 104.29 1.22 Allowed 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 104.759 -2.312 . . . . 0.0 104.759 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 132' ' ' ASP . . . -87.16 133.48 33.63 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 128.253 2.621 . . . . 0.0 113.119 176.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.11 178.92 5.72 Favored 'General case' 0 C--N 1.368 1.374 0 C-N-CA 128.995 2.918 . . . . 0.0 110.683 177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -48.13 -45.3 32.99 Favored 'General case' 0 C--N 1.367 1.354 0 N-CA-C 118.937 2.94 . . . . 0.0 118.937 -174.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -66.88 -17.59 64.97 Favored 'General case' 0 C--N 1.364 1.238 0 C-N-CA 126.855 2.062 . . . . 0.0 114.205 174.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.566 ' CB ' ' HB1' ' A' ' 128' ' ' ALA . 36.5 m-20 -82.05 -14.26 56.13 Favored 'General case' 0 CA--C 1.573 1.854 0 C-N-CA 128.52 2.728 . . . . 0.0 111.361 170.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.28 127.15 32.03 Favored 'General case' 0 C--N 1.393 2.48 0 N-CA-C 119.474 3.139 . . . . 0.0 119.474 167.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 153.18 -147.9 18.01 Favored Glycine 0 CA--C 1.473 -2.542 0 C-N-CA 128.404 2.907 . . . . 0.0 108.651 176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.451 ' HB2' ' HE3' ' A' ' 137' ' ' LYS 0.265 21.1 m -125.46 140.08 53.09 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 114.47 -2.892 . . . . 0.0 109.533 173.317 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.473 ' HA ' ' CB ' ' A' ' 110' ' ' LYS . 16.9 m-85 -95.91 134.52 38.8 Favored 'General case' 0 C--N 1.367 1.361 0 O-C-N 118.722 -2.486 . . . . 0.0 112.456 -172.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . 0.453 ' HE3' ' HB2' ' A' ' 111' ' ' ASP . 0.0 OUTLIER -142.45 146.68 35.07 Favored 'General case' 0 C--N 1.368 1.393 0 C-N-CA 123.993 0.917 . . . . 0.0 108.602 -174.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . 0.462 HG21 ' CE2' ' A' ' 108' ' ' TRP 0.251 13.4 p -146.99 139.95 19.47 Favored 'Isoleucine or valine' 0 C--N 1.363 1.185 0 C-N-CA 118.64 -1.224 . . . . 0.0 114.144 176.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -114.48 115.67 27.63 Favored 'General case' 0 C--N 1.375 1.702 0 C-N-CA 127.22 2.208 . . . . 0.0 106.321 174.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.49 HG12 ' HB3' ' A' ' 104' ' ' TYR . 0.0 OUTLIER -127.09 116.46 44.51 Favored 'Isoleucine or valine' 0 C--N 1.369 1.444 0 C-N-CA 127.996 2.518 . . . . 0.0 112.155 -171.345 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.415 HG23 ' C ' ' A' ' 146' ' ' VAL . 4.0 m -99.12 132.89 44.11 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 116.129 1.9 . . . . 0.0 116.129 -176.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.448 ' HB3' ' CD2' ' A' ' 104' ' ' TYR 0.424 16.2 p-10 -126.58 -176.93 3.82 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-N 120.769 1.622 . . . . 0.0 112.171 173.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.652 ' HB3' ' H ' ' A' ' 102' ' ' GLY . 77.5 p -49.58 3.3 0.01 OUTLIER 'General case' 0 C--N 1.36 1.025 1 C-N-CA 136.634 5.973 . . . . 0.0 121.279 -165.15 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.29 4.47 36.57 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 164.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.422 81.0 mm-40 65.52 40.01 4.79 Favored 'General case' 0 C--N 1.374 1.659 1 C-N-CA 132.874 4.47 . . . . 0.0 111.183 -172.55 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' VAL . . . . . 0.415 ' C ' HG23 ' A' ' 141' ' ' THR . 3.4 m -112.64 130.09 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.177 0 CA-C-N 112.121 -2.309 . . . . 0.0 111.754 -172.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 141' ' ' THR . 0.0 OUTLIER -90.59 124.57 35.14 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 128.742 2.817 . . . . 0.0 107.733 -177.501 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.69 152.89 32.34 Favored 'General case' 0 CA--C 1.491 -1.316 0 N-CA-C 103.426 -2.805 . . . . 0.0 103.426 -175.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 45.8 p30 -130.56 147.14 52.21 Favored 'General case' 0 CA--C 1.494 -1.19 0 CA-C-O 123.061 1.41 . . . . 0.0 112.455 -175.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . 0.283 9.9 p -119.15 144.75 46.49 Favored 'General case' 0 C--O 1.259 1.58 0 CA-C-N 113.82 -1.536 . . . . 0.0 108.277 168.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 8.8 m -55.12 148.83 13.29 Favored 'General case' 0 CA--C 1.478 -1.804 3 C-N-CA 140.098 7.359 . . . . 0.0 115.101 -172.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 72.5 p -68.58 109.86 3.95 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 127.835 2.454 . . . . 0.0 109.49 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.34 108.92 21.07 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 102.274 -3.232 . . . . 0.0 102.274 -176.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -92.88 112.74 24.81 Favored 'General case' 0 C--N 1.346 0.423 0 CA-C-O 122.426 1.108 . . . . 0.0 111.502 -172.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.0 m -121.61 118.37 55.6 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.052 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' THR . . . . . . . . . . . . . 58.5 m -119.36 122.79 42.61 Favored 'General case' 0 CA--C 1.489 -1.38 0 N-CA-C 101.893 -3.373 . . . . 0.0 101.893 178.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.449 ' HB ' ' HB3' ' A' ' 87' ' ' GLU . 3.8 m -123.55 105.02 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.299 0 N-CA-C 104.226 -2.509 . . . . 0.0 104.226 -178.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 -82.72 155.94 68.06 Favored Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 125.756 1.622 . . . . 0.0 110.951 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -70.98 165.81 31.14 Favored 'Trans proline' 0 CA--C 1.547 1.126 1 C-N-CA 126.179 4.586 . . . . 0.0 107.891 154.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 10.7 p -67.2 125.12 25.04 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 118.598 -2.564 . . . . 0.0 109.063 -172.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.419 ' HA ' ' HD2' ' A' ' 162' ' ' PRO . 9.1 p -66.53 117.95 49.23 Favored Pre-proline 0 C--N 1.366 1.285 1 N-CA-C 122.696 4.332 . . . . 0.0 122.696 -125.018 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 161' ' ' VAL . 31.0 Cg_endo -62.73 143.56 92.36 Favored 'Trans proline' 0 C--N 1.382 2.31 1 C-N-CA 125.988 4.459 . . . . 0.0 114.604 171.284 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -68.28 56.28 0.44 Allowed Glycine 0 C--N 1.367 2.302 0 C-N-CA 128.107 2.765 . . . . 0.0 117.48 -178.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -120.92 -120.48 2.75 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 128.201 2.81 . . . . 0.0 106.922 178.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 28.8 mt 68.78 42.08 1.46 Allowed 'General case' 0 C--N 1.366 1.297 0 C-N-CA 128.342 2.657 . . . . 0.0 111.009 -177.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -69.82 65.24 0.22 Allowed 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.998 2.519 . . . . 0.0 116.5 -171.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 . . . . . 0 C--N 1.357 0.916 0 C-N-CA 129.045 2.938 . . . . 0.0 114.152 -176.473 . . . . . . . . 0 0 . 1 stop_ save_